0000742112-21-000076.txt : 20211027 0000742112-21-000076.hdr.sgml : 20211027 20211027162929 ACCESSION NUMBER: 0000742112-21-000076 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 131 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211027 DATE AS OF CHANGE: 20211027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 211353357 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 MAIL ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 10-Q 1 ivc-20210930.htm 10-Q ivc-20210930
000074211212/312021Q3FALSEP5YP5YP5YP5DP3Y00007421122021-01-012021-09-30xbrli:shares0000742112us-gaap:CommonStockMember2021-10-250000742112us-gaap:CommonClassBMember2021-10-25iso4217:USD00007421122021-07-012021-09-3000007421122020-07-012020-09-3000007421122020-01-012020-09-30iso4217:USDxbrli:sharesxbrli:pure00007421122021-09-3000007421122020-12-310000742112us-gaap:CommonStockMember2020-12-310000742112us-gaap:CommonStockMember2021-09-300000742112us-gaap:CommonClassBMember2021-09-300000742112us-gaap:CommonClassBMember2020-12-3100007421122019-12-310000742112us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-09-3000007421122020-09-300000742112us-gaap:CommonStockMember2021-06-300000742112us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-06-300000742112us-gaap:AdditionalPaidInCapitalMember2021-06-300000742112us-gaap:RetainedEarningsMember2021-06-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300000742112us-gaap:TreasuryStockMember2021-06-3000007421122021-06-300000742112us-gaap:CommonStockMember2021-07-012021-09-300000742112us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300000742112us-gaap:TreasuryStockMember2021-07-012021-09-300000742112us-gaap:RetainedEarningsMember2021-07-012021-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000742112us-gaap:CommonStockMember2021-09-300000742112us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-09-300000742112us-gaap:AdditionalPaidInCapitalMember2021-09-300000742112us-gaap:RetainedEarningsMember2021-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300000742112us-gaap:TreasuryStockMember2021-09-300000742112us-gaap:CommonStockMember2020-06-300000742112us-gaap:CommonStockMemberus-gaap:CommonClassBMember2020-06-300000742112us-gaap:AdditionalPaidInCapitalMember2020-06-300000742112us-gaap:RetainedEarningsMember2020-06-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300000742112us-gaap:TreasuryStockMember2020-06-3000007421122020-06-300000742112us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300000742112us-gaap:TreasuryStockMember2020-07-012020-09-300000742112us-gaap:RetainedEarningsMember2020-07-012020-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300000742112us-gaap:CommonStockMember2020-09-300000742112us-gaap:CommonStockMemberus-gaap:CommonClassBMember2020-09-300000742112us-gaap:AdditionalPaidInCapitalMember2020-09-300000742112us-gaap:RetainedEarningsMember2020-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-300000742112us-gaap:TreasuryStockMember2020-09-300000742112us-gaap:CommonStockMember2020-12-310000742112us-gaap:CommonStockMemberus-gaap:CommonClassBMember2020-12-310000742112us-gaap:AdditionalPaidInCapitalMember2020-12-310000742112us-gaap:RetainedEarningsMember2020-12-310000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000742112us-gaap:TreasuryStockMember2020-12-310000742112us-gaap:CommonStockMember2021-01-012021-09-300000742112us-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-300000742112us-gaap:TreasuryStockMember2021-01-012021-09-300000742112us-gaap:RetainedEarningsMember2021-01-012021-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300000742112us-gaap:CommonStockMember2019-12-310000742112us-gaap:CommonStockMemberus-gaap:CommonClassBMember2019-12-310000742112us-gaap:AdditionalPaidInCapitalMember2019-12-310000742112us-gaap:RetainedEarningsMember2019-12-310000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000742112us-gaap:TreasuryStockMember2019-12-310000742112us-gaap:CommonStockMember2020-01-012020-09-300000742112us-gaap:AdditionalPaidInCapitalMember2020-01-012020-09-300000742112us-gaap:TreasuryStockMember2020-01-012020-09-300000742112us-gaap:RetainedEarningsMember2020-01-012020-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-09-3000007421122020-01-012020-03-0700007421122020-01-012020-03-3100007421122021-01-012021-03-3100007421122020-03-070000742112us-gaap:RiskLevelLowMember2021-01-012021-09-300000742112us-gaap:RiskLevelMediumMember2021-01-012021-09-300000742112us-gaap:RiskLevelHighMember2021-01-012021-09-30ivc:payment00007421122020-01-012020-12-310000742112ivc:NorthAmericaNAMember2021-09-300000742112ivc:NorthAmericaNAMember2021-01-012021-09-300000742112ivc:AllOtherMember2021-09-300000742112ivc:AllOtherMember2021-01-012021-09-300000742112ivc:NorthAmericaNAMember2020-12-310000742112ivc:NorthAmericaNAMember2020-01-012020-12-310000742112ivc:AllOtherMember2020-12-310000742112ivc:AllOtherMember2020-01-012020-12-310000742112ivc:IVCCanadaMember2020-12-310000742112ivc:IVCCanadaMember2020-01-012020-12-310000742112us-gaap:MachineryAndEquipmentMember2021-09-300000742112us-gaap:MachineryAndEquipmentMember2020-12-310000742112us-gaap:LandBuildingsAndImprovementsMember2021-09-300000742112us-gaap:LandBuildingsAndImprovementsMember2020-12-310000742112ivc:CapitalizedSoftwareMember2021-09-300000742112ivc:CapitalizedSoftwareMember2020-12-310000742112us-gaap:FurnitureAndFixturesMember2021-09-300000742112us-gaap:FurnitureAndFixturesMember2020-12-310000742112us-gaap:LeaseholdImprovementsMember2021-09-300000742112us-gaap:LeaseholdImprovementsMember2020-12-310000742112us-gaap:CustomerListsMember2021-09-300000742112us-gaap:CustomerListsMember2020-12-310000742112us-gaap:TrademarksMember2021-09-300000742112us-gaap:TrademarksMember2020-12-310000742112us-gaap:DevelopedTechnologyRightsMember2021-09-300000742112us-gaap:DevelopedTechnologyRightsMember2020-12-310000742112us-gaap:PatentsMember2021-09-300000742112us-gaap:PatentsMember2020-12-310000742112us-gaap:LicensingAgreementsMember2021-09-300000742112us-gaap:LicensingAgreementsMember2020-12-310000742112us-gaap:OtherIntangibleAssetsMember2021-09-300000742112us-gaap:OtherIntangibleAssetsMember2020-12-310000742112srt:MinimumMember2021-01-012021-09-300000742112srt:MaximumMember2021-01-012021-09-300000742112srt:WeightedAverageMember2021-01-012021-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2021-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2020-12-310000742112ivc:ConvertibleSeniorNotesat4.50February2022Domainus-gaap:ConvertibleSubordinatedDebtMember2021-09-300000742112ivc:ConvertibleSeniorNotesat4.50February2022Domainus-gaap:ConvertibleSubordinatedDebtMember2020-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Domain2021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Domain2020-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Domain2021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Domain2020-12-310000742112ivc:ConvertibleSeniorNotesAt425March2026Domainus-gaap:ConvertibleSubordinatedDebtMember2021-09-300000742112ivc:ConvertibleSeniorNotesAt425March2026Domainus-gaap:ConvertibleSubordinatedDebtMember2020-12-310000742112ivc:OtherNotesandCapitalLeaseObligationsMember2021-09-300000742112ivc:OtherNotesandCapitalLeaseObligationsMember2020-12-310000742112ivc:ConvertibleSeniorSubordinatedDebenturesat5.00February2021Domainus-gaap:ConvertibleSubordinatedDebtMember2021-01-012021-09-300000742112us-gaap:LetterOfCreditMember2021-09-300000742112us-gaap:LetterOfCreditMember2020-12-310000742112us-gaap:RevolvingCreditFacilityMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMember2021-09-300000742112us-gaap:RevolvingCreditFacilityMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMembercurrency:EUR2021-09-300000742112us-gaap:RevolvingCreditFacilityMembercurrency:GBPivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMember2021-09-300000742112us-gaap:RevolvingCreditFacilityMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMember2020-12-310000742112us-gaap:RevolvingCreditFacilityMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMembercurrency:EUR2020-12-310000742112us-gaap:RevolvingCreditFacilityMembercurrency:GBPivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMember2020-12-310000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2020-12-310000742112us-gaap:LetterOfCreditMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMember2021-09-300000742112us-gaap:RevolvingCreditFacilityMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMember2021-01-012021-09-300000742112srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember2021-01-012021-09-300000742112us-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember2021-01-012021-09-300000742112srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember2021-01-012021-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMembersrt:MaximumMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember2021-01-012021-09-300000742112srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMember2021-01-012021-09-300000742112us-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMember2021-01-012021-09-300000742112us-gaap:RevolvingCreditFacilityMemberivc:RevolvingCreditAndSecurityAgreementNorthAmericaCreditAgreementMemberus-gaap:LineOfCreditMember2021-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:LetterOfCreditMemberus-gaap:LineOfCreditMember2021-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:LineOfCreditMemberivc:SwingLineLoansDomain2021-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainivc:AmountAvailabletoInvacareLimitedandInvacarePoirierSASDomainus-gaap:LineOfCreditMember2021-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-01-012021-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainsrt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:LineOfCreditMember2021-01-012021-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:LineOfCreditMember2021-01-012021-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainsrt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMemberus-gaap:LineOfCreditMember2021-01-012021-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMembersrt:MaximumMemberus-gaap:LineOfCreditMember2021-01-012021-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainsrt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-01-012021-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberus-gaap:LineOfCreditMember2021-01-012021-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2016-03-3100007421122016-01-012016-03-310000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2016-12-310000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2019-09-3000007421122019-01-012019-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2019-10-012019-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2019-12-310000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2019-12-310000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2020-04-012020-06-300000742112ivc:ConvertibleSeniorNotesat4.50February2022Domainus-gaap:ConvertibleSubordinatedDebtMember2020-04-012020-06-300000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:ConvertibleSubordinatedDebtMember2020-04-012020-06-300000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:ConvertibleSubordinatedDebtMember2021-09-300000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:ConvertibleSubordinatedDebtMember2020-12-310000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2020-09-3000007421122020-06-012020-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2020-07-012020-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2020-01-012020-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2021-07-012021-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2021-01-012021-09-300000742112ivc:ConvertibleSeniorNotesat4.50February2022Domainus-gaap:ConvertibleSubordinatedDebtMember2017-06-300000742112ivc:ConvertibleSeniorNotesat4.50February2022Domainus-gaap:ConvertibleSubordinatedDebtMember2021-01-012021-09-300000742112ivc:ConvertibleSeniorNotesat4.50February2022Domainus-gaap:ConvertibleSubordinatedDebtMember2019-01-012019-12-310000742112ivc:ConvertibleSeniorNotesat4.50February2022Domainus-gaap:ConvertibleSubordinatedDebtMember2017-04-012017-06-300000742112ivc:ConvertibleSeniorNotesat4.50February2022Domainus-gaap:ConvertibleSubordinatedDebtMember2017-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt450February2022Member2021-03-310000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:ConvertibleSubordinatedDebtMember2021-01-012021-03-310000742112ivc:ConvertibleSeniorNotesat4.50February2022Domainus-gaap:ConvertibleSubordinatedDebtMember2020-07-012020-09-300000742112ivc:ConvertibleSeniorNotesat4.50February2022Domainus-gaap:ConvertibleSubordinatedDebtMember2020-01-012020-09-300000742112ivc:ConvertibleSeniorNotesat4.50February2022Domainus-gaap:ConvertibleSubordinatedDebtMember2021-07-012021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2021-01-012021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Domain2021-01-012021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2019-10-012019-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2020-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2020-07-012020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2020-01-012020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2021-07-012021-09-300000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:ConvertibleSubordinatedDebtMember2021-01-012021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Domain2021-01-012021-09-300000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:ConvertibleSubordinatedDebtMember2021-07-012021-09-300000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:ConvertibleSubordinatedDebtMember2020-07-012020-09-300000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:ConvertibleSubordinatedDebtMember2020-01-012020-09-300000742112ivc:ConvertibleSeniorNotesAt425March2026Domainus-gaap:ConvertibleSubordinatedDebtMember2021-03-110000742112ivc:ConvertibleSeniorNotesAt425March2026Memberus-gaap:ConvertibleSubordinatedDebtMember2021-09-300000742112ivc:ConvertibleSeniorNotesAt425March2026Memberus-gaap:ConvertibleSubordinatedDebtMember2021-01-012021-09-300000742112ivc:ConvertibleSeniorNotesAt425March2026Memberus-gaap:ConvertibleSubordinatedDebtMember2021-03-110000742112ivc:ConvertibleSeniorNotesAt425March2026Memberus-gaap:ConvertibleSubordinatedDebtMember2021-07-012021-09-300000742112ivc:CARESActLoanMember2020-05-150000742112ivc:CARESActLoanMember2021-09-3000007421122015-04-2300007421122015-07-012015-09-3000007421122015-04-222015-04-230000742112ivc:A20YearsMember2021-09-3000007421122020-07-010000742112ivc:A126YearsMember2021-09-3000007421122020-12-010000742112ivc:EuropeEMEAMemberus-gaap:ProductMember2021-07-012021-09-300000742112ivc:EuropeEMEAMemberivc:ServicesMember2021-07-012021-09-300000742112ivc:EuropeEMEAMember2021-07-012021-09-300000742112ivc:NorthAmericaNAMemberus-gaap:ProductMember2021-07-012021-09-300000742112ivc:ServicesMemberivc:NorthAmericaNAMember2021-07-012021-09-300000742112ivc:NorthAmericaNAMember2021-07-012021-09-300000742112ivc:AllOtherMemberus-gaap:ProductMember2021-07-012021-09-300000742112ivc:AllOtherMemberivc:ServicesMember2021-07-012021-09-300000742112ivc:AllOtherMember2021-07-012021-09-300000742112us-gaap:ProductMember2021-07-012021-09-300000742112ivc:ServicesMember2021-07-012021-09-300000742112ivc:EuropeEMEAMemberus-gaap:ProductMember2021-01-012021-09-300000742112ivc:EuropeEMEAMemberivc:ServicesMember2021-01-012021-09-300000742112ivc:EuropeEMEAMember2021-01-012021-09-300000742112ivc:NorthAmericaNAMemberus-gaap:ProductMember2021-01-012021-09-300000742112ivc:ServicesMemberivc:NorthAmericaNAMember2021-01-012021-09-300000742112ivc:AllOtherMemberus-gaap:ProductMember2021-01-012021-09-300000742112ivc:AllOtherMemberivc:ServicesMember2021-01-012021-09-300000742112us-gaap:ProductMember2021-01-012021-09-300000742112ivc:ServicesMember2021-01-012021-09-300000742112ivc:EuropeEMEAMemberus-gaap:ProductMember2020-07-012020-09-300000742112ivc:EuropeEMEAMemberivc:ServicesMember2020-07-012020-09-300000742112ivc:EuropeEMEAMember2020-07-012020-09-300000742112ivc:NorthAmericaNAMemberus-gaap:ProductMember2020-07-012020-09-300000742112ivc:ServicesMemberivc:NorthAmericaNAMember2020-07-012020-09-300000742112ivc:NorthAmericaNAMember2020-07-012020-09-300000742112ivc:AllOtherMemberus-gaap:ProductMember2020-07-012020-09-300000742112ivc:AllOtherMemberivc:ServicesMember2020-07-012020-09-300000742112ivc:AllOtherMember2020-07-012020-09-300000742112us-gaap:ProductMember2020-07-012020-09-300000742112ivc:ServicesMember2020-07-012020-09-300000742112ivc:EuropeEMEAMemberus-gaap:ProductMember2020-01-012020-09-300000742112ivc:EuropeEMEAMemberivc:ServicesMember2020-01-012020-09-300000742112ivc:EuropeEMEAMember2020-01-012020-09-300000742112ivc:NorthAmericaNAMemberus-gaap:ProductMember2020-01-012020-09-300000742112ivc:ServicesMemberivc:NorthAmericaNAMember2020-01-012020-09-300000742112ivc:NorthAmericaNAMember2020-01-012020-09-300000742112ivc:AllOtherMemberus-gaap:ProductMember2020-01-012020-09-300000742112ivc:AllOtherMemberivc:ServicesMember2020-01-012020-09-300000742112ivc:AllOtherMember2020-01-012020-09-300000742112us-gaap:ProductMember2020-01-012020-09-300000742112ivc:ServicesMember2020-01-012020-09-300000742112ivc:GeneralTermsandConditionsMember2021-01-012021-09-300000742112ivc:LargeNationalCustomersMember2021-01-012021-09-300000742112ivc:GovernmentTendersMember2021-01-012021-09-300000742112ivc:OtherCustomersMember2021-01-012021-09-30ivc:votes0000742112us-gaap:CommonClassBMember2021-01-012021-09-300000742112us-gaap:CommonStockMember2021-01-012021-09-300000742112us-gaap:EmployeeStockOptionMember2021-09-300000742112ivc:A2018PlanMember2021-01-012021-09-300000742112ivc:A2013PlanMember2021-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberivc:RestrictedStockandRestrictedStockUnitsRSUsMember2021-01-012021-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberivc:RestrictedStockandRestrictedStockUnitsRSUsMember2020-01-012020-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PerformanceSharesMember2021-01-012021-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PerformanceSharesMember2020-01-012020-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-09-300000742112ivc:RestrictedStockandRestrictedStockUnitsRSUsMember2021-09-300000742112us-gaap:PerformanceSharesMember2021-09-300000742112us-gaap:EmployeeStockOptionMember2021-01-012021-09-300000742112ivc:RangeOfExercisePriceRangeMinMember2021-01-012021-09-300000742112ivc:RangeOfExercisePriceMaxMember2021-01-012021-09-300000742112us-gaap:PerformanceSharesMember2021-01-012021-09-300000742112srt:MinimumMemberivc:RangeOfExercisePriceRangeMinMember2021-01-012021-09-300000742112srt:MaximumMemberivc:RangeOfExercisePriceRangeMinMember2021-01-012021-09-300000742112us-gaap:EmployeeStockOptionMemberivc:RangeOfExercisePriceRangeMinMember2021-09-300000742112us-gaap:EmployeeStockOptionMemberivc:RangeOfExercisePriceRangeMinMember2021-01-012021-09-300000742112ivc:RestrictedStockandRestrictedStockUnitsRSUsMember2020-12-310000742112ivc:RestrictedStockandRestrictedStockUnitsRSUsMember2021-01-012021-09-300000742112us-gaap:PerformanceSharesMember2020-12-310000742112us-gaap:PerformanceSharesMembersrt:WeightedAverageMember2021-01-012021-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2021-06-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2021-06-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-06-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-06-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2021-07-012021-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2021-07-012021-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-07-012021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-07-012021-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2021-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2021-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310000742112ivc:AccumulatedLongTermNotesAdjustmentMember2020-12-310000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-12-310000742112us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2021-01-012021-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-012021-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2020-06-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2020-06-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-06-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-06-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2020-07-012020-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2020-07-012020-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-07-012020-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-07-012020-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2020-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2020-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310000742112ivc:AccumulatedLongTermNotesAdjustmentMember2019-12-310000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-12-310000742112us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2020-01-012020-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-01-012020-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-09-300000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2021-01-012021-09-300000742112ivc:EuropeEMEAMemberus-gaap:ContractTerminationMember2021-01-012021-09-300000742112us-gaap:EmployeeSeveranceMemberivc:NorthAmericaNAMember2020-01-012020-09-300000742112ivc:AllOtherMemberus-gaap:EmployeeSeveranceMember2020-01-012020-09-300000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2020-01-012020-09-300000742112ivc:EuropeEMEAMemberus-gaap:ContractTerminationMember2020-01-012020-09-300000742112us-gaap:EmployeeSeveranceMemberivc:NorthAmericaNAMember2020-12-310000742112ivc:NorthAmericaNAMemberus-gaap:ContractTerminationMember2020-12-310000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2020-12-310000742112ivc:EuropeEMEAMemberus-gaap:ContractTerminationMember2020-12-310000742112ivc:EuropeEMEAMember2020-12-310000742112ivc:AllOtherMemberus-gaap:EmployeeSeveranceMember2020-12-310000742112ivc:AllOtherMemberus-gaap:ContractTerminationMember2020-12-310000742112us-gaap:EmployeeSeveranceMember2020-12-310000742112us-gaap:ContractTerminationMember2020-12-310000742112us-gaap:EmployeeSeveranceMemberivc:NorthAmericaNAMember2021-01-012021-03-310000742112ivc:NorthAmericaNAMemberus-gaap:ContractTerminationMember2021-01-012021-03-310000742112ivc:NorthAmericaNAMember2021-01-012021-03-310000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2021-01-012021-03-310000742112ivc:EuropeEMEAMemberus-gaap:ContractTerminationMember2021-01-012021-03-310000742112ivc:EuropeEMEAMember2021-01-012021-03-310000742112ivc:AllOtherMemberus-gaap:EmployeeSeveranceMember2021-01-012021-03-310000742112ivc:AllOtherMemberus-gaap:ContractTerminationMember2021-01-012021-03-310000742112ivc:AllOtherMember2021-01-012021-03-310000742112us-gaap:EmployeeSeveranceMember2021-01-012021-03-310000742112us-gaap:ContractTerminationMember2021-01-012021-03-310000742112us-gaap:EmployeeSeveranceMemberivc:NorthAmericaNAMember2021-03-310000742112ivc:NorthAmericaNAMemberus-gaap:ContractTerminationMember2021-03-310000742112ivc:NorthAmericaNAMember2021-03-310000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2021-03-310000742112ivc:EuropeEMEAMemberus-gaap:ContractTerminationMember2021-03-310000742112ivc:EuropeEMEAMember2021-03-310000742112ivc:AllOtherMemberus-gaap:EmployeeSeveranceMember2021-03-310000742112ivc:AllOtherMemberus-gaap:ContractTerminationMember2021-03-310000742112ivc:AllOtherMember2021-03-310000742112us-gaap:EmployeeSeveranceMember2021-03-310000742112us-gaap:ContractTerminationMember2021-03-3100007421122021-03-310000742112us-gaap:EmployeeSeveranceMemberivc:NorthAmericaNAMember2021-04-012021-06-300000742112ivc:NorthAmericaNAMemberus-gaap:ContractTerminationMember2021-04-012021-06-300000742112ivc:NorthAmericaNAMember2021-04-012021-06-300000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2021-04-012021-06-300000742112ivc:EuropeEMEAMemberus-gaap:ContractTerminationMember2021-04-012021-06-300000742112ivc:EuropeEMEAMember2021-04-012021-06-300000742112ivc:AllOtherMemberus-gaap:EmployeeSeveranceMember2021-04-012021-06-300000742112ivc:AllOtherMemberus-gaap:ContractTerminationMember2021-04-012021-06-300000742112ivc:AllOtherMember2021-04-012021-06-300000742112us-gaap:EmployeeSeveranceMember2021-04-012021-06-300000742112us-gaap:ContractTerminationMember2021-04-012021-06-3000007421122021-04-012021-06-300000742112us-gaap:EmployeeSeveranceMemberivc:NorthAmericaNAMember2021-06-300000742112ivc:NorthAmericaNAMemberus-gaap:ContractTerminationMember2021-06-300000742112ivc:NorthAmericaNAMember2021-06-300000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2021-06-300000742112ivc:EuropeEMEAMemberus-gaap:ContractTerminationMember2021-06-300000742112ivc:EuropeEMEAMember2021-06-300000742112ivc:AllOtherMemberus-gaap:EmployeeSeveranceMember2021-06-300000742112ivc:AllOtherMemberus-gaap:ContractTerminationMember2021-06-300000742112ivc:AllOtherMember2021-06-300000742112us-gaap:EmployeeSeveranceMember2021-06-300000742112us-gaap:ContractTerminationMember2021-06-300000742112us-gaap:EmployeeSeveranceMemberivc:NorthAmericaNAMember2021-07-012021-09-300000742112ivc:NorthAmericaNAMemberus-gaap:ContractTerminationMember2021-07-012021-09-300000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2021-07-012021-09-300000742112ivc:EuropeEMEAMemberus-gaap:ContractTerminationMember2021-07-012021-09-300000742112ivc:AllOtherMemberus-gaap:EmployeeSeveranceMember2021-07-012021-09-300000742112ivc:AllOtherMemberus-gaap:ContractTerminationMember2021-07-012021-09-300000742112us-gaap:EmployeeSeveranceMember2021-07-012021-09-300000742112us-gaap:ContractTerminationMember2021-07-012021-09-300000742112us-gaap:EmployeeSeveranceMemberivc:NorthAmericaNAMember2021-09-300000742112ivc:NorthAmericaNAMemberus-gaap:ContractTerminationMember2021-09-300000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2021-09-300000742112ivc:EuropeEMEAMemberus-gaap:ContractTerminationMember2021-09-300000742112ivc:EuropeEMEAMember2021-09-300000742112ivc:AllOtherMemberus-gaap:EmployeeSeveranceMember2021-09-300000742112ivc:AllOtherMemberus-gaap:ContractTerminationMember2021-09-300000742112us-gaap:EmployeeSeveranceMember2021-09-300000742112us-gaap:ContractTerminationMember2021-09-300000742112us-gaap:EmployeeStockOptionMember2021-07-012021-09-300000742112us-gaap:EmployeeStockOptionMember2021-01-012021-09-300000742112us-gaap:EmployeeStockOptionMember2020-07-012020-09-300000742112us-gaap:EmployeeStockOptionMember2020-01-012020-09-300000742112us-gaap:EmployeeStockOptionMember2021-09-300000742112us-gaap:EmployeeStockOptionMember2020-09-300000742112us-gaap:ForeignExchangeForwardMember2021-01-012021-09-300000742112us-gaap:ForeignExchangeForwardMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardUSDCHFMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardUSDCHFMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardUSDCHFMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardUSDCHFMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardUSDEURMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardUSDEURMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardUSDEURMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardUSDEURMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardUSDGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardUSDGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardUSDGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardUSDGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardUSDSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardUSDSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardUSDSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardUSDSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardUSDMXPMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardUSDMXPMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardUSDMXPMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardUSDMXPMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardEURCHFMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardEURCHFMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardEURCHFMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardEURCHFMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardEURGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardEURGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardEURGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardEURGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardEURSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardEURSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardEURSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardEURSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardEURNOKMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardEURNOKMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardEURNOKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardEURNOKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardAUDNZDMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardAUDNZDMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardAUDNZDMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardAUDNZDMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardDKKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardDKKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardDKKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardDKKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardNOKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardNOKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardNOKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardNOKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardAUDTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardAUDTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardAUDTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardAUDTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardNZDTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardNZDTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardNZDTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardNZDTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardUSDTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardUSDTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardUSDTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardUSDTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardEURTHBMember2021-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardEURTHBMember2021-01-012021-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardEURTHBMember2020-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardEURTHBMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardGBPTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112ivc:ForeignExchangeForwardGBPTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardGBPTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112ivc:ForeignExchangeForwardGBPTHBMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardAUDUSDMemberus-gaap:NondesignatedMember2021-09-300000742112ivc:ForeignExchangeForwardAUDUSDMemberus-gaap:NondesignatedMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardAUDUSDMemberus-gaap:NondesignatedMember2020-12-310000742112ivc:ForeignExchangeForwardAUDUSDMemberus-gaap:NondesignatedMember2020-01-012020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardCADUSDMember2021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardCADUSDMember2021-01-012021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardCADUSDMember2020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardCADUSDMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardEURUSDMemberus-gaap:NondesignatedMember2021-09-300000742112ivc:ForeignExchangeForwardEURUSDMemberus-gaap:NondesignatedMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardEURUSDMemberus-gaap:NondesignatedMember2020-12-310000742112ivc:ForeignExchangeForwardEURUSDMemberus-gaap:NondesignatedMember2020-01-012020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardDKKUSDMember2021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardDKKUSDMember2021-01-012021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardDKKUSDMember2020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardDKKUSDMember2020-01-012020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPUSDMember2021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPUSDMember2021-01-012021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPUSDMember2020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPUSDMember2020-01-012020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardNOKUSDMember2021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardNOKUSDMember2021-01-012021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardNOKUSDMember2020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardNOKUSDMember2020-01-012020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardSEKUSDMember2021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardSEKUSDMember2021-01-012021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardSEKUSDMember2020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardSEKUSDMember2020-01-012020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURGBPMember2021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURGBPMember2021-01-012021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURGBPMember2020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURGBPMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardAUDNZDMemberus-gaap:NondesignatedMember2021-09-300000742112ivc:ForeignExchangeForwardAUDNZDMemberus-gaap:NondesignatedMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardAUDNZDMemberus-gaap:NondesignatedMember2020-12-310000742112ivc:ForeignExchangeForwardAUDNZDMemberus-gaap:NondesignatedMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardEURNOKMemberus-gaap:NondesignatedMember2021-09-300000742112ivc:ForeignExchangeForwardEURNOKMemberus-gaap:NondesignatedMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardEURNOKMemberus-gaap:NondesignatedMember2020-12-310000742112ivc:ForeignExchangeForwardEURNOKMemberus-gaap:NondesignatedMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardAUDTHBMemberus-gaap:NondesignatedMember2021-09-300000742112ivc:ForeignExchangeForwardAUDTHBMemberus-gaap:NondesignatedMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardAUDTHBMemberus-gaap:NondesignatedMember2020-12-310000742112ivc:ForeignExchangeForwardAUDTHBMemberus-gaap:NondesignatedMember2020-01-012020-12-310000742112ivc:ForeignExchangeForwardUSDTHBMemberus-gaap:NondesignatedMember2021-09-300000742112ivc:ForeignExchangeForwardUSDTHBMemberus-gaap:NondesignatedMember2021-01-012021-09-300000742112ivc:ForeignExchangeForwardUSDTHBMemberus-gaap:NondesignatedMember2020-12-310000742112ivc:ForeignExchangeForwardUSDTHBMemberus-gaap:NondesignatedMember2020-01-012020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURTHBMember2021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURTHBMember2021-01-012021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURTHBMember2020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURTHBMember2020-01-012020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPTHBMember2021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPTHBMember2021-01-012021-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPTHBMember2020-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPTHBMember2020-01-012020-12-310000742112us-gaap:NondesignatedMember2021-09-300000742112us-gaap:NondesignatedMember2021-01-012021-09-300000742112us-gaap:NondesignatedMember2020-12-310000742112us-gaap:NondesignatedMember2020-01-012020-12-310000742112us-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112us-gaap:ForeignExchangeForwardMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-09-300000742112us-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112us-gaap:ForeignExchangeForwardMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000742112us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMember2021-09-300000742112us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:AccruedLiabilitiesMember2021-09-300000742112us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMember2020-12-310000742112us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:AccruedLiabilitiesMember2020-12-310000742112us-gaap:OtherCurrentAssetsMember2021-09-300000742112us-gaap:AccruedLiabilitiesMember2021-09-300000742112us-gaap:OtherCurrentAssetsMember2020-12-310000742112us-gaap:AccruedLiabilitiesMember2020-12-310000742112us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2021-07-012021-09-300000742112us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2021-01-012021-09-300000742112us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2020-07-012020-09-300000742112us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2020-01-012020-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeForwardMember2021-07-012021-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeForwardMember2021-01-012021-09-300000742112us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2020-07-012020-09-300000742112us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2020-01-012020-09-300000742112us-gaap:SalesMemberus-gaap:CashFlowHedgingMember2021-07-012021-09-300000742112us-gaap:SalesMemberus-gaap:CashFlowHedgingMember2021-01-012021-09-300000742112us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2021-07-012021-09-300000742112us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2021-01-012021-09-300000742112us-gaap:CashFlowHedgingMember2021-07-012021-09-300000742112us-gaap:CashFlowHedgingMember2021-01-012021-09-300000742112us-gaap:SalesMemberus-gaap:CashFlowHedgingMember2020-07-012020-09-300000742112us-gaap:SalesMemberus-gaap:CashFlowHedgingMember2020-01-012020-09-300000742112us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2020-07-012020-09-300000742112us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2020-01-012020-09-300000742112us-gaap:CashFlowHedgingMember2020-07-012020-09-300000742112us-gaap:CashFlowHedgingMember2020-01-012020-09-300000742112us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel1Member2021-09-300000742112us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel2Member2021-09-300000742112us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel3Member2021-09-300000742112us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel1Member2020-12-310000742112us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel2Member2020-12-310000742112us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel3Member2020-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-09-300000742112us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310000742112us-gaap:OtherCurrentAssetsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2021-09-300000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMember2021-09-300000742112us-gaap:OtherCurrentAssetsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2020-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMember2020-12-310000742112us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2021-09-300000742112us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2021-09-300000742112us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2020-12-310000742112us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2020-12-310000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-09-300000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorNotesat5.00February2021Member2021-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorNotesat5.00February2021Member2020-12-310000742112us-gaap:CarryingReportedAmountFairValueDisclosureMemberivc:ConvertibleSeniorNotesAt450February2022Member2021-09-300000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorNotesAt450February2022Member2021-09-300000742112us-gaap:CarryingReportedAmountFairValueDisclosureMemberivc:ConvertibleSeniorNotesAt450February2022Member2020-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorNotesAt450February2022Member2020-12-310000742112us-gaap:CarryingReportedAmountFairValueDisclosureMemberivc:ConvertibleSeniorNotesat5.00November2024Member2021-09-300000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorNotesat5.00November2024Member2021-09-300000742112us-gaap:CarryingReportedAmountFairValueDisclosureMemberivc:ConvertibleSeniorNotesat5.00November2024Member2020-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorNotesat5.00November2024Member2020-12-310000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-09-300000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-09-300000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310000742112ivc:ConvertibleSeniorNotesAt425March2026Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-09-300000742112ivc:ConvertibleSeniorNotesAt425March2026Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-09-300000742112ivc:ConvertibleSeniorNotesAt425March2026Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310000742112ivc:ConvertibleSeniorNotesAt425March2026Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310000742112ivc:OtherNotesandCapitalLeaseObligationsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-09-300000742112ivc:OtherNotesandCapitalLeaseObligationsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-09-300000742112ivc:OtherNotesandCapitalLeaseObligationsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310000742112ivc:OtherNotesandCapitalLeaseObligationsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310000742112us-gaap:IntersegmentEliminationMemberivc:EuropeEMEAMember2021-07-012021-09-300000742112us-gaap:IntersegmentEliminationMemberivc:EuropeEMEAMember2020-07-012020-09-300000742112us-gaap:IntersegmentEliminationMemberivc:EuropeEMEAMember2021-01-012021-09-300000742112us-gaap:IntersegmentEliminationMemberivc:EuropeEMEAMember2020-01-012020-09-300000742112us-gaap:IntersegmentEliminationMemberivc:NorthAmericaNAMember2021-07-012021-09-300000742112us-gaap:IntersegmentEliminationMemberivc:NorthAmericaNAMember2020-07-012020-09-300000742112us-gaap:IntersegmentEliminationMemberivc:NorthAmericaNAMember2021-01-012021-09-300000742112us-gaap:IntersegmentEliminationMemberivc:NorthAmericaNAMember2020-01-012020-09-300000742112ivc:AllOtherMemberus-gaap:IntersegmentEliminationMember2021-07-012021-09-300000742112ivc:AllOtherMemberus-gaap:IntersegmentEliminationMember2020-07-012020-09-300000742112ivc:AllOtherMemberus-gaap:IntersegmentEliminationMember2021-01-012021-09-300000742112ivc:AllOtherMemberus-gaap:IntersegmentEliminationMember2020-01-012020-09-300000742112us-gaap:IntersegmentEliminationMember2021-07-012021-09-300000742112us-gaap:IntersegmentEliminationMember2020-07-012020-09-300000742112us-gaap:IntersegmentEliminationMember2021-01-012021-09-300000742112us-gaap:IntersegmentEliminationMember2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomainivc:EuropeEMEAMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomainivc:EuropeEMEAMember2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomainivc:EuropeEMEAMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomainivc:EuropeEMEAMember2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:MobilityandSeatingDomain2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:MobilityandSeatingDomain2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:MobilityandSeatingDomain2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:MobilityandSeatingDomain2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomainivc:EuropeEMEAMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomainivc:EuropeEMEAMember2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomainivc:EuropeEMEAMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomainivc:EuropeEMEAMember2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:OtherDomain2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:OtherDomain2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:OtherDomain2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:OtherDomain2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMember2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMember2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomainivc:NorthAmericaNAMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomainivc:NorthAmericaNAMember2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomainivc:NorthAmericaNAMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomainivc:NorthAmericaNAMember2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:MobilityandSeatingDomainivc:NorthAmericaNAMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:MobilityandSeatingDomainivc:NorthAmericaNAMember2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:MobilityandSeatingDomainivc:NorthAmericaNAMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:MobilityandSeatingDomainivc:NorthAmericaNAMember2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomainivc:NorthAmericaNAMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomainivc:NorthAmericaNAMember2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomainivc:NorthAmericaNAMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomainivc:NorthAmericaNAMember2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMemberivc:OtherDomain2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMemberivc:OtherDomain2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMemberivc:OtherDomain2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMemberivc:OtherDomain2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMember2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMember2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMemberivc:MobilityandSeatingDomain2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMemberivc:MobilityandSeatingDomain2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMemberivc:MobilityandSeatingDomain2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMemberivc:MobilityandSeatingDomain2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomainivc:AllOtherMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomainivc:AllOtherMember2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomainivc:AllOtherMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomainivc:AllOtherMember2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMemberivc:RespiratoryTherapyDomain2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMemberivc:RespiratoryTherapyDomain2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMemberivc:RespiratoryTherapyDomain2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMemberivc:RespiratoryTherapyDomain2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMemberivc:OtherDomain2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMemberivc:OtherDomain2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMemberivc:OtherDomain2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMemberivc:OtherDomain2020-01-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMember2020-07-012020-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:AllOtherMember2020-01-012020-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
[☒] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2021
OR
[☐] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from            to           
Commission File Number 001-15103
INVACARE CORPORATION
(Exact name of registrant as specified in its charter)
ivc-20210930_g1.jpg 
Ohio95-2680965
(State or other jurisdiction of
incorporation or organization)		(IRS Employer Identification No.)
One Invacare Way,Elyria,Ohio44035
(Address of principal executive offices)(Zip Code)
(440) 329-6000
(Registrant's telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each classTrading SymbolName of exchange on which registered
Common Shares, without par valueIVCNew York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 (the “Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “small reporting company” in Rule 12b-2 of the Exchange Act. (Check One):    Large accelerated filer ☐    Accelerated filer ☒  Non-accelerated filer  ☐ Smaller reporting company ☐ Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐  No  ☒
As of October 25, 2021, the registrant had 35,019,682 Common Shares and 3,667 Class B Common Shares outstanding.


ivc-20210930_g1.jpg

Table of Contents
 
 ItemPage
PART I: FINANCIAL INFORMATION
2
1
3
4
PART II: OTHER INFORMATION
1
2
6

About Invacare Corporation

Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), age related, bariatric) conditions. The company's products are important parts of care for people with a wide range of challenges, from those who are active and heading to work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, dealers and government health services in North America, Europe and Asia Pacific. For more information about the company and its products, visit the company's website at www.invacare.com. The contents of the company's website are not part of this Quarterly Report on Form 10-Q and are not incorporated by reference herein.



MD&AOverview

Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations.

The discussion and analysis presented below is concerned with material changes in financial condition and results of operations between the periods specified in the condensed consolidated balance sheets at September 30, 2021 and December 31, 2020, and in the condensed consolidated statement of comprehensive income (loss) for the three and nine months ended September 30, 2021 and September 30, 2020. All comparisons


presented are with respect to the same period last year, unless otherwise stated. This discussion and analysis should be read in conjunction with the condensed consolidated financial statements and accompanying notes that appear elsewhere in this Quarterly Report on Form 10-Q and the MD&A included in the company's Annual Report on Form 10-K for the year ended December 31, 2020. For some matters, SEC filings from prior periods may be useful sources of information.
OVERVIEW

OVERVIEW
Invacare is a multi-national company with integrated capabilities to design, manufacture and distribute durable medical devices. The company makes products that help people move, breathe, rest and perform essential hygiene, and with those products the company supports people with congenital, acquired and degenerative conditions. The company's products and solutions are important parts of care for people with a range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company operates in facilities in North America, Europe and Asia Pacific, which are the result of more than 50 acquisitions made over the company's 40+ year history.
COVID-19 Impact on Access to Healthcare and Global Supply Chain
The company continues to actively monitor the coronavirus (COVID-19) pandemic, which has negatively impacted the business primarily by limiting access to healthcare and disrupting the global supply chain. These factors resulted in operational inefficiencies which in turn burdened profitability.
Demand for the company's products remains high as evidenced by a strong order book and elevated backlog. However, efficiently fulfilling orders during the third quarter continued to be challenging due to global supply chain and logistics disruptions. These disruptions delayed the delivery of components required for final assembly and order fulfillment and impacted the efficiency of the manufacturing operations. In addition, a short-term disruption in access to freight forwarders in Europe and a tight global labor market impacted the company's ability to fulfill confirmed orders during the third quarter. As a result, backlog has increased in all product categories from December 31, 2020 and June 30, 2021.
Sales grew in the third quarter of 2021 as compared to last year with benefit of improved access to customers, despite continuing supply chain challenges which increased the company's cost structure and burdened its profitability. In all regions, the company has adjusted pricing and/or implemented surcharges, where applicable, to offset the substantially higher supply chain costs. However, the company has opted not to impose more robust cost containment measures to partially offset the impact of reduced profitability. The company believes its human capital resources will be essential to facilitate anticipated sales and profitability recovery for the remainder of 2021 and to address current backlog and anticipated demand.
The extent to which the company’s operations will be further impacted by the pandemic will depend largely on future developments, which remain highly uncertain and difficult to accurately predict, including, among other things, new information which may emerge concerning the severity of the pandemic; new and growing outbreaks of COVID-19 or new strains of COVID-19; actions by government authorities to contain COVID-19 or treat its impact, such as reimposed public health restrictions or restrictions on access to healthcare facilities; efforts to combat COVID-19, such as vaccine development and distribution; and global supply chain disruption which may impact access to components and products.
The company continues to experience high demand globally for its products. The company continues to work to optimize its capacity to produce these critical products and resolve global supply chain challenges that are compounded by the effects of the pandemic. As a result, there are practical limits to the extent the company can increase output. In addition, the company continues to take steps to offset cost increases from pandemic-related supply chain disruptions. While the company believes the decline in net sales is temporary in nature, the rebound of the business will depend
1
MD&AOverview
on the continued restoration of access to healthcare and loosening of public health measures, and will be impacted by several items including government actions and policies related to the pandemic, and the magnitude of the pandemic.
Strategy
The company has committed to providing medical products that deliver the best clinical value; promote recovery, independence and active lifestyles; and support long-term conditions and palliative care. The company's strategy aligns its resources to produce products and solutions that assist customers and end-users with the most clinically complex needs. By focusing the company's efforts to provide the best possible assistance and outcomes to the people and caregivers who use its products, the company aims to improve its financial condition for sustainable profit and growth. To execute this strategy, the company is undertaking a substantial multi-year business optimization plan.
Business Optimization Efforts
The company is executing a multi-year strategy to return the company to profitability by focusing its resources on products and solutions that provide greater healthcare value in clinically complex rehabilitation and post-acute care. The company's business optimization actions and growth plan balances innovative organic growth, product portfolio changes across all regions, and cost improvements in supply chain and administrative functions. Key elements of the enhanced transformation and growth plan are:
•Globally, continue to drive all business segments and product lines based on their potential to achieve a leading market position and to support profitability goals;
•In Europe, leverage centralized innovation and supply chain capabilities while reducing the cost and complexity of a legacy infrastructure;
•In North America, adjust the portfolio to consistently grow profitability amid cost increases by adding new products, reducing costs and continuing to improve customers' experience;
•In Asia Pacific, remain focused on sustainable growth and expansion in the southeast Asia region; and
•Take actions globally to reduce working capital and improve free cash flow.
As it navigates the uncertain business environment resulting from COVID-19, the company continues to allocate more resources to the business units experiencing increased demand and expects to continue taking actions to mitigate the potential negative financial and operational impacts on other parts of the company's business that have declined. In the
medium-term, the company still expects to execute on its business optimization strategy, such as global IT modernization initiative which is expected to ultimately result in optimization of the operating structure. IT modernization activities continued in 3Q21.
Outlook
The company participates in growing durable healthcare markets and serves a persistent need for its products. The company anticipates improvements in operating efficiency, together with the moderation of supply chain challenges will yield improved financial performance. As a result, the company continues to expect improvement in profitability and cash flow performance for the year.
The company's earnings performance is expected to benefit from: (1) new product introductions with improved commercialization plans and additional investments in the sales force and demonstration equipment, which are expected to result in profitable incremental sales, as well as higher sales and margins on existing products; and (2) margin expansion expected as a result of efficiencies related to the plant consolidations in Germany; supply chain actions to expand gross profits and pricing actions, offset by higher material and freight costs, and the impact of U.S. tariff exclusions which expired on January 1, 2021. The company expects SG&A expense to be higher than 2020 levels but lower than 2019 levels as it adds back sales and marketing related spending to support sales growth and activity-based spending. Stock compensation expense is expected to be lower than 2020 levels. In addition, while the new IT system implementation is a key project for the company in North America during 2021, benefits related to improved customer experience and efficiencies have not been considered in the guidance as a result of the anticipated timing to roll out the new system in North America.

Cash flow for 2021 has funded payments for severance costs related to the German plant consolidation and value added taxes and other taxes deferred from 2020 as a result of programs implemented by many jurisdictions as result of the pandemic. In addition, with the return to growth in 2Q21 and 3Q21, the company has a significant investment in working capital including an increase of $10,117,000 in inventory levels during the quarter to mitigate supply chain disruptions and in preparation for expected sequential sales growth. The company anticipates this investment in working capital will convert to cash over the next few quarters.

The company has historically generated negative cash flow performance during the first half of the year. This pattern has continued in 2021 in part due to the timing of annual one-time payments such as customer rebates and employee bonuses earned during the prior year, and higher working capital usage from revenue growth and seasonal inventory
2
MD&AOverview
increases. Quarterly cash flow was impacted by timing of sales growth which impacted accounts receivable collections. The company anticipates spending no more than $20,000,000 on capital expenditures in 2021.
The actions taken by the company earlier this year to optimize the balance sheet for the current environment, as well as the continued borrowing availability under the ABL revolving credit facilities, and the anticipated generation of earnings and free cash flow, should provide the company sufficient liquidity to manage the business and meet its obligations.
Favorable Long-Term Demand
Ultimately, demand for the company's products and services is based on the need to provide care for people with certain conditions. The company's medical devices provide solutions for end-users and caregivers. Therefore, the demand for the company's medical equipment is largely driven by population growth and the incidence of certain conditions where treatment may be supplemented by the company's devices. The company also provides solutions to help equipment providers and residential care operators deliver cost-effective and high-quality care. The company believes that its commercial team, customer relationships, products and solutions, supply chain infrastructure, and strong research and development pipeline will create sustainable and favorable business potential.
3
MD&ANet Sales
RESULTS OF OPERATIONS - NET SALES

The company operates in two primary business segments: North America and Europe with each selling the company's primary product categories, which include: lifestyle, mobility and seating and respiratory therapy products. Sales in Asia Pacific are reported in All Other and include products similar to those sold in North America and Europe.
($ in thousands USD)3Q21*3Q20% Change
Fav/(Unfav)		Foreign Exchange % ImpactConstant Currency % Change
Fav/(Unfav)
Europe127,026 116,285 9.2 4.7 4.5 
North America88,054 88,055 — 0.4 (0.4)
All Other (Asia Pacific)9,120 7,566 20.6 3.6 17.0 
Consolidated224,200 211,906 5.8 2.9 2.9 
($ in thousands USD)YTD 3Q21**YTD 3Q20% Change
Fav/(Unfav)		Foreign Exchange % ImpactDivestiture % ImpactConstant Currency % Change
Fav/(Unfav)
Europe361,097 339,147 6.5 8.1 — (1.6)
North America260,275 261,595 (0.5)0.6 — (1.1)
All Other (Asia Pacific)24,894 25,904 (3.9)9.4 (10.8)(2.5)
Consolidated646,266 626,646 3.1 5.0 (0.4)(1.5)
* Date format is quarter and year in each instance.
** YTD means the first nine months of the year in each instance.
The table above provides net sales change as reported and as adjusted to exclude the impact of foreign exchange translation and divestitures (constant currency net sales). “Constant currency net sales" is a non-Generally Accepted Accounting Principles ("GAAP") financial measure, which is defined as net sales excluding the impact of foreign currency translation and divestitures. The current year's functional currency net sales are translated using the prior year's foreign exchange rates. These amounts are then compared to the prior year's sales to calculate the constant currency net sales change. For the divestiture impact, the company adjusted a portion of net sales as the Dynamic Controls business was divested as of March 7, 2020. Management believes this financial measure provides meaningful information for evaluating the core operating performance of the company.
The global pandemic continued to impact sales across all segments in different ways. Public health restrictions started to ease and increase access to healthcare professionals and institutions needed for certain product selections. Global supply chain challenges continued to delay receipt of components and limit conversion of orders to sales. These factors continued to impact each of the regions in 3Q21.
Across all regions, 1Q20 sales were not impacted by the pandemic.
Europe - Constant currency net sales increased $5,234,000, or 4.5% in 3Q21 compared to 3Q20 as sales
started to recover from pandemic-related challenges led by increased sales in lifestyle products reflecting the improving restoration of access to healthcare and the easing of public health restrictions. While respiratory demand continues to be strong, fulfilling that demand has been hindered by the availability of components to fill orders. Constant currency net sales decreased YTD 3Q21 compared to YTD 3Q20 primarily due to the impacts of the pandemic.
North America - Constant currency net sales for 3Q21 decreased $375,000 or 0.4% compared to 3Q20. Growth in mobility & seating and respiratory products net sales was more than offset by decreased net sales of lifestyle products. Improved access to healthcare professionals and institutions benefits were outpaced by supply chain disruptions. Constant currency net sales decreased YTD 3Q21 compared to YTD 3Q20 primarily due to the impacts of the pandemic.
All Other - Constant currency net sales, which relate entirely to the Asia Pacific region, increased $1,283,000 or 17.0% for 3Q21 compared to 3Q20 driven by growth in respiratory products. Constant currency net sales decreased 2.5% YTD 3Q21 compared to YTD 3Q20 primarily driven by lower lifestyle products sales. Growth in the region was negatively impacted by delayed receipt of product to fulfill existing orders.


4
MD&ANet Sales





ivc-20210930_g2.jpg
Constant currency net sales of mobility and seating products, which comprise most of the company's clinically complex product portfolio, decreased to 39.3% of constant currency net sales in 3Q21 from 39.7% in 3Q20 and decreased to 37.6% YTD 3Q21 from 38.1% YTD 3Q20 where 1Q20 was not materially affected by the pandemic.

The decreased mix percentage of mobility and seating products over the prior year quarter reflects supply chain challenges within the mobility and seating portfolio.

5
MD&AGross Profit

GROSS PROFIT
ivc-20210930_g3.jpg
Gross profit increased $270,000 and gross profit as a percentage of net sales for 3Q21 decreased 140 basis points to 26.9%, primarily attributable to increased material and freight costs as well as unfavorable operating variances. These were partially offset by favorable product mix. Higher costs continue to be impacted by supply chain challenges including availability of freight and component shortages, which impacted several of our manufacturing and assembly locations in Europe and North America. To mitigate these cost increases, the company adjusted pricing and surcharges, where applicable, but benefit of those actions are not anticipated to be realized until 4Q21.

ivc-20210930_g4.jpg
Gross profit decreased $3,912,000 and gross profit as a percentage of net sales for YTD 3Q21 decreased 150 basis points to 27.2%, primarily attributable to unfavorable operational variances and freight increases, partially offset by favorable product mix. Unfavorable operating variances for
YTD 3Q21 were the result of increased costs due to component shortages and transportation delays which impacted labor costs and efficiencies in several manufacturing and assembly locations in Europe and North America as well as increased freight costs.

Gross profit drivers by segment:
Europe - Gross profit dollars for 3Q21 increased $3,173,000 from higher net sales compared to 3Q20. Gross profit as a percentage of net sales increased 0.2% compared to 3Q20. Gross profit was positively impacted by favorable product mix and favorable foreign currency offset by higher freight costs and unfavorable operations variances influenced by continued supply chain disruptions.
Gross profit dollars increased $4,854,000 and gross profit as a percentage of net sales decreased 0.5% for YTD 3Q21 compared to YTD 3Q20. The increase in gross profit dollars was driven by favorable product mix and foreign currency offset by unfavorable operating variances and higher freight costs, including expediting costs.
North America - Gross profit dollars decreased $2,799,000 and gross profit as a percentage of net sales decreased 0.8% for 3Q21 compared to 3Q20 driven by unfavorable operating variances and higher material and freight costs, including expediting costs, which more than offset favorable product mix.
Gross profit dollars decreased $7,582,000 and gross profit as a percentage of net sales decreased 0.9% for YTD 3Q21 compared to YTD 3Q20. The decrease in gross profit dollars was driven by operating variances and increased material and freight costs on lower net sales.
All Other - Asia Pacific gross profit dollars increased $15,000 and gross profit as a percentage of net sales decreased 1.4% for 3Q21 compared to 3Q20 primarily driven by higher material and freight costs.
Asia Pacific gross profit dollars decreased $1,319,000 and gross profit as a percentage of net sales increased 0.7% for YTD 3Q21 compared to YTD 3Q20. The decrease in gross profit dollars was driven by the divestiture of the Dynamic Controls business as of March 7, 2020 which benefited gross profit dollars in YTD 3Q20.
All Other also includes the impact of intercompany profit eliminations for the consolidated company.
6
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
($ in thousands USD)3Q213Q20Reported ChangeForeign Exchange ImpactConstant Currency Change
SG&A expenses - $56,135 55,530 605 1,261 (656)
SG&A expenses - % change1.1 2.3 (1.2)
% to net sales25.0 26.2 

($ in thousands USD)YTD 3Q21YTD 3Q20Reported ChangeForeign Exchange ImpactDivestiture ImpactConstant Currency Change
SG&A expenses - $178,721 174,672 4,049 7,636 (826)(2,761)
SG&A expenses - % change2.3 4.4 (0.5)(1.6)
% to net sales27.7 27.9 
The table above provides selling, general and administrative (SG&A) expenses change as reported and as adjusted to exclude the impact of foreign exchange translation and divestitures (constant currency SG&A). “Constant currency SG&A" is a non-GAAP financial measure, which is defined as SG&A expenses excluding the impact of foreign currency translation and divestitures. The current year's functional currency SG&A expenses are translated using the prior year's foreign exchange rates. These amounts are then compared to the prior year's SG&A expenses to calculate the constant currency SG&A expenses change. Management believes this financial measure provides meaningful information for evaluating the core operating performance of the company.

The divestiture impact is related to a portion of the SG&A expenses related to the Dynamic Controls business divested on March 7, 2020.

Constant currency SG&A decreased $656,000 or 1.2% for 3Q21 compared to the same period last year primarily due reduced people costs partially offset by foreign currency transactions. 3Q21 expense benefited from reduced stock compensation expense of $2,080,000 attributable to lowering of performance awards projected payout achievement, in line with full year external guidance profitability expectations, and lower share price on awards where variable accounting applies.

Constant currency SG&A decreased $2,761,000 or 1.6% for YTD 3Q21 compared to the same period last year primarily due to reduced employment costs partially offset by unfavorable foreign currency transactions. Stock compensation expense was $1,596,000 lower in YTD 3Q21 compared to YTD 3Q20. 2Q20 had also benefited from a gain on the sale of a building of $971,000.

SG&A expense drivers by segment:

Europe - SG&A expenses for 3Q21 increased $1,220,000 or 4.9% compared to 3Q20 with foreign currency translation increasing SG&A expenses by $1,037,000, or 4.2%. Constant currency SG&A expenses increased $183,000, or 0.7%. Savings from people costs reductions were more than offset by foreign currency transactions losses and increased sales and marketing costs.
SG&A expenses for YTD 3Q21 increased $3,100,000 or 3.9% compared to YTD 3Q20 with foreign currency translation increasing SG&A expenses by $6,224,000, or 7.8%. Constant currency SG&A expenses decreased $3,124,000, or 3.9%. The decreased expense was primarily attributable to lower employment costs and sales and marketing expenses. 2Q20 also benefited from a gain on the sale of a building of $971,000.
North America - SG&A expenses for 3Q21 increased $1,716,000, or 7.8%, compared to 3Q20 with foreign currency translation increasing SG&A expenses by $120,000, or 0.6%. Constant currency SG&A expenses increased $1,596,000, or 7.2% primarily attributable to sales and marketing and commissions expenses.
SG&A expenses for YTD 3Q21 increased $484,000 or 0.7% compared to YTD 3Q20 with foreign currency translation increasing SG&A expenses by $618,000, or 0.9%. Constant currency SG&A expenses decreased $134,000, or 0.2%. The decreased expense was primarily attributable to lower employment costs.

All Other - SG&A expenses for 3Q21 decreased $2,331,000 compared to 3Q20 with foreign currency translation increasing SG&A expenses by $104,000. Constant currency SG&A expenses decreased by $2,435,000. All Other includes SG&A related to the Asia Pacific businesses and non-allocated corporate costs. Constant currency SG&A expenses
7
related to Asia Pacific businesses for 3Q21 increased 40.6% or $960,000, compared to 3Q20 driven primarily by increased foreign currency transactions as well as sales and marketing and facility costs attributable to expanding the market in the region. Corporate costs decreased $3,395,000 due to lower employment costs, including stock compensation benefit. Stock compensation expense was reduced (benefit) in 3Q21 by $2,080,000 from reducing projected payout achievement of performance awards, in line with full year external guidance on profitability, and lower share price on awards where variable accounting applies.
SG&A expenses for YTD 3Q21 increased $465,000 compared to YTD 3Q20 with foreign currency translation increasing SG&A expenses by $794,000 and divestitures decreasing SG&A expenses by $826,000. Constant currency SG&A expenses increased $497,000. Constant currency SG&A expenses related to Asia Pacific businesses for YTD 3Q21 increased $3,293,000 or 66.8% compared to YTD 3Q20 driven primarily by costs to expand the market in the region and unfavorable foreign currency transactions. Corporate costs decreased $2,798,000 due to lower employment costs, including stock compensation benefit of $1,596,000.
8
MD&AOperating Income (Loss)
OPERATING INCOME (LOSS)
($ in thousands USD)3Q213Q20$ Change% ChangeYTD 3Q21YTD 3Q20$
Change		% Change
Europe9,554 7,600 1,954 25.7 18,378 16,624 1,754 10.6 
North America(1,523)2,992 (4,515)--(2,308)5,759 (8,067)--
All Other(3,856)(6,082)2,226 36.6 (19,025)(17,377)(1,648)(9.5)
Gain on sale of business— — — — — 9,790 (9,790)(100.0)
Charges related to restructuring(377)(1,580)1,203 76.1 (2,476)(4,657)2,181 46.8 
Impairment of goodwill(28,564)— (28,564)100.0 (28,564)— (28,564)100.0 
Consolidated Operating Income (Loss)(24,766)2,930 (27,696)--(33,995)10,139 (44,134)--
For 3Q21, consolidated operating loss increased compared to 3Q20 operating income as higher gross profit was more than offset by higher SG&A expenses and $28,564,000 impairment of goodwill in the North America segment (refer to "Notes to Condensed Consolidated Financial Statements - Long-Term Assets - Goodwill" for further discussion of the goodwill impairment). Gross profit benefited from revenue growth partially offset by the negative impacts of higher costs influenced by supply chain challenges.
For YTD 3Q21 consolidated operating income (loss) declined compared to YTD 3Q20 due to impairment of goodwill of $28,564,000 in YTD 3Q21 as well as a $9,790,000 gain from the divestiture of Dynamic Controls in YTD 3Q20 as well as lower gross profit and higher SG&A expenses.

Operating income (loss) by segment:
Europe - Operating income for 3Q21 increased by $1,954,000, or 25.7%, primarily due to higher gross profit impacted by revenue growth partially offset by higher SG&A expenses.
Operating income for YTD 3Q21 increased $1,754,000 compared to YTD 3Q20. The increase from last year is the result of higher gross profit, with benefit of foreign currency, partially offset by higher SG&A expense. In addition, YTD 3Q20 benefited from the sale of a building for a gain of $971,000.
North America - Operating loss for 3Q21 increased by $4,515,000, or 150.9%, primarily due to higher SG&A expenses and lower gross profit. Gross profit was negatively impacted by higher costs associated with supply chain challenges.
Operating loss for YTD 3Q21 was $2,308,000 compared to YTD 3Q20 operating income of $5,759,000 due to lower gross profit impacted by reduced sales and unfavorable costs associated with supply chain challenges.
All Other - Operating loss for All Other includes the operating results of the Asia Pacific businesses, as well as unallocated SG&A expenses and intercompany eliminations. Operating loss improved $2,226,000, or 36.6%, primarily driven by lower SG&A expenses, including reduction in stock compensation expense.
Operating loss for YTD 3Q21 increased $1,648,000 or 9.5% compared to YTD 3Q20 due to lower gross profit and higher net SG&A expenses including foreign currency transactions. Lower net sales and gross profit in the Asia Pacific region is primarily attributable to the divestiture of Dynamic Controls which benefited YTD 3Q20.

Charges Related to Restructuring Activities
Restructuring charges were $377,000 for 3Q21 compared to $1,580,000 for 3Q20 and were principally related to severance costs. Restructuring charges were incurred in the Europe segment of $255,000 and North America segment of $122,000.
Restructuring charges were $2,476,000 for YTD 3Q21 compared to $4,657,000 for YTD 3Q20 and were principally related to severance costs. Restructuring charges were incurred in the Europe segment of $1,501,000 and North America segment were $975,000.

9
MD&AOther Items
OTHER ITEMS
Impairment of goodwill
($ in thousands USD)3Q213Q20$ Change
Impairment of goodwill 28,564 — 28,564 
($ in thousands USD)YTD 3Q21YTD 3Q20$ Change
Impairment of goodwill 28,564 — 28,564 
During the third quarter of 2021, the company's reporting units of North America / HME and Institutional Products Group were merged into one reporting unit of North America, consistent with the operating segment. Developments in the third quarter of 2021 and the completion of the reporting units merger were tied most closely to the actions of the company to implement components of a new ERP system which both changes the level of discrete financial information readily available and the go-forward manner in which the company assesses performance and allocates resources to the North America operating segment.

The reporting unit change within the North America operating segment in the third quarter of 2021 was a triggering event and required the company to perform an interim goodwill impairment test. Based on the interim goodwill impairment test, the company concluded the carrying value of the North America reporting unit was above its fair value. That conclusion resulted in the recording of impairment of goodwill in the third quarter of 2021 of $28,564,000.
As a result of the goodwill impairment, the company recorded a reversal of deferred taxes related to the tax deductible goodwill previously deducted by the company, resulting in the company recognizing a tax benefit of $661,000 for the three months ended September 30, 2021.

Loss (gain) on debt extinguishment including debt finance changes and fees
($ in thousands USD)3Q213Q20$ Change
Loss (gain) on debt extinguishment including debt finance fees(10,131)761 (10,892)
During the third quarter of 2021, the company applied for forgiveness of its CARES Act loan along with its accrued interest. The company received notification of approval of its debt forgiveness including accrued interest, in full, and the company recorded a gain on extinguishment of debt of $10,131,000.
During the third quarter of 2020, the company repurchased and retired $24,466,000 of its 2021 Notes. The
result of the transaction was a loss on debt extinguishment including debt and finance fees of $761,000.
($ in thousands USD)YTD 3Q21YTD 3Q20$ Change
Loss (gain) on debt extinguishment including debt finance fees(9,422)7,360 (16,782)

During the first quarter of 2021, the company repurchased and retired, at par plus accrued interest, $78,850,000 of its 2022 Notes. The result of the transaction was a loss on debt extinguishment including debt and finance fees of $709,000. The YTD 3Q21 gain also includes the gain on the extinguishment of debt for the forgiveness of the CARES Act loan and accrued interest.

During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 Notes, for $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Exchange Notes due 2024 (the "Series II Notes") of the company and $5,593,000 in cash. The result of the second and third quarter 2020 transactions was a YTD 3Q20 loss on debt extinguishment including debt and finance fees of $7,360,000.

Interest
($ in thousands USD)3Q213Q20$ Change% Change
Interest expense6,284 7,402 (1,118)(15.1)
Interest income— (7)7 (100.0)
($ in thousands USD)YTD 3Q21YTD 3Q20$ Change% Change
Interest expense18,099 21,132 (3,033)(14.4)
Interest income(1)(90)89 (98.9)

The decrease in interest expense for 3Q21 and YTD 3Q21 compared to the same period of prior year was primarily related to the adoption of ASU 2020-06 which eliminated interest expense from convertible debt discount amortization upon adoption on January 1, 2021 offset by accretion from the Series II 2024 Notes which commenced in the second quarter of 2020. Refer to "Accounting Policies" in the Notes to the Condensed Consolidated Financial Statements for discussion of adoption.
10
MD&AOther Items
Income Taxes
The company had an effective tax rate of 8.8% and 11.3% on losses before tax for the three and nine months ended September 30, 2021, respectively, compared to an expected benefit of 21% on the pre-tax loss for each period. The company had an effective tax rate of 39.2% and 26.8% on losses before tax for the three and nine months ended September 30, 2020, respectively, compared to an expected benefit of 21.0% on the pre-tax loss for each period. The company's effective tax rate for the three and nine months ended September 30, 2021 and September 30, 2020 were unfavorable as compared to the U.S. federal statutory rate, principally due to the negative impact of the company not being able to record tax benefits related to the significant losses in countries which had tax valuation allowances. The effective tax rate was increased for the three and nine months ended September 30, 2021 and September 30, 2020 by certain taxes outside the United States, excluding countries with tax valuation allowances, that were at an effective rate higher than the U.S. statutory rate, except for the gain on the disposition of Dynamic Controls which was not taxable locally for the three months ended March 31, 2020. In addition, the company had accrued withholding taxes on earnings of its Chinese subsidiary based on the expectation of not permanently reinvesting those earnings. The sale of this entity, without such distribution resulted in the reversal of this accrual in the amount of $988,000 for the three months ended March 31, 2020. As a result of the impairment of goodwill in North America for the three and nine months ended September 30, 2021, the company recorded a reversal of deferred taxes related to the tax deductible goodwill previously deducted by the company, resulting in the company recognizing a tax benefit of $661,000 for the three months ended September 30, 2021.

As a result of the COVID-19 pandemic and the global impact on business activity, various governments have provided programs to help offset the liquidity pressures and impact on society. The company has taken advantage of some of these programs and will continue to consider other programs as they are announced. To date, the company has determined it has benefited or will benefit from: 1) deferral of U.S. payroll tax related to employer portion of social security from 2020, to be paid over 2 years; 2) a U.S. business interest limitation increase from 30% to 50% of US Federal adjusted taxable income for the 2019 and 2020 tax years; 3) the treatment of qualified improvement property as 15-year property in the U.S.; 4) and the deferral of income and indirect tax payments over various periods in other countries around the world where the company operates. Such programs had resulted in tax deferrals totaling approximately $11,000,000 for the twelve months ended December 31, 2020 as a benefit to operating cash flows. For 3Q21 and YTD 3Q21 approximately $1,086,000 and $4,619,000, respectively, was paid related to the tax deferrals from 2020.
11
MD&ALiquidity and Capital Resources
LIQUIDITY AND CAPITAL RESOURCES

The company continues to maintain an adequate liquidity position through its cash balances and bank lines of credit (refer to Long-Term Debt in the Notes to Condensed Consolidated Financial Statements included in this report) as described below.

Key balances on the company's balance sheet and related metrics:
($ in thousands USD)September 30, 2021December 31, 2020$ Change% Change
Cash and cash equivalents73,656 105,298 (31,642)(30.0)
Working capital (1)
146,918 144,080 2,838 2.0 
Total debt (2)
386,865 339,928 46,937 13.8 
Long-term debt (2)
380,613 330,903 49,710 15.0 
Total shareholders' equity (3)
239,714 333,846 (94,132)(28.2)
Credit agreement borrowing availability (4)
39,486 36,509 2,977 8.2 
(1)    Current assets less current liabilities.
(2)    Total debt and Long-term debt include finance leases but exclude debt issuance costs recognized as a deduction from the carrying amount of debt liability and debt discounts in 2020 classified as debt or equity and operating leases.
(3)    2021 reflects the adoption of ASU 2020-06 "Debt with Conversion and Other Options" on January 1, 2021 which reduced total shareholders' equity by $25,128,000 and purchase of capped calls, related to the 2026 notes issued in 1Q21, also reduced total shareholders' equity by $18,787,000.
(4)    Reflects the combined availability of the company's North American and European asset-based revolving credit facilities before borrowings. At September 30, 2021, the company had $16,046,000 of borrowings outstanding on the European credit facility and $22,150,000 of borrowings outstanding on its North America credit facility. Outstanding borrowings are based on credit availability calculated on a month lag related to the European credit facility.
The company's cash and cash equivalents balances were $73,656,000 and $105,298,000 at September 30, 2021 and December 31, 2020, respectively. The decrease in cash in the first nine months of 2021 is primarily attributable to use from operating activities and cash used for continued investment in business improvement initiatives. In the first quarter of 2021, the company issued $125,000,000 principal amount of 2026 Notes, paid $5,369,000 in financing costs through September 30, 2021, purchased capped calls related to the 2026 Notes for $18,787,000, repurchased $78,850,000 principal amount of 2022 Notes and repaid $1,250,000 principal amount of 2021 Notes. Cash used by operating activities was partially offset by credit facilities borrowings. The North America and Europe credit facilities under the company's Credit Agreement provides for asset-based-lending senior secured revolving credit facilities.

Refer to "Long-Term Debt" in the Notes to the Condensed Consolidated Financial statements included in this report for a summary of the material terms of the Company's long-term indebtedness.

Debt repayments, acquisitions, divestitures, the timing of vendor payments, the timing of customer rebate payments, the granting of extended payment terms to significant national accounts and other activity can have a significant impact on the company's cash flow and borrowings outstanding such that the cash reported at the end of a given period may be materially different than cash levels during a given period.
While the company has cash balances in various jurisdictions around the world, there are no material restrictions regarding the use of such cash for dividends within the company, loans or other purposes.

The company's total debt outstanding, inclusive of the company's convertible senior notes due 2022, 2024 and 2026 and finance lease obligations, increased by $46,937,000 to $386,865,000 at September 30, 2021 from $339,928,000 as of December 31, 2020. The increase is primarily driven by the adoption of ASU 2020-06, issuance of $125,000,000 principal amount of 2026 Notes and additional credit facilities borrowings, offset by repayment of $1,250,000 principal amount of 2021 Notes, repurchase of $78,850,000 principal amount of 2022 Notes and forgiveness of $10,000,000 for the company's previously outstanding CARES Act loan.

The company may from time to time seek to retire or purchase its convertible senior notes, in open market purchases, privately negotiated transactions or otherwise. Such purchases, if any, will depend on prevailing market conditions, the company’s liquidity requirements, contractual restrictions and other factors. The amounts involved in any such transactions, individually or in the aggregate, may be material.

The company is actively managing its business to maintain cash flow and liquidity. As discussed elsewhere in this report, the company has taken several defensive measures
12
MD&ALiquidity and Capital Resources
to enhance liquidity in response to the COVID-19 pandemic, including reducing expenses, managing capital expenditures, suspending its cash dividend, leveraging borrowings available under its credit facilities, raising capital and refinancing its near-term convertible debt, and accessing other government programs in the US and Europe. The company has started making payments on payroll and value added tax deferrals from 2020 in 2021 and in the third quarter of 2021, the company applied for, and received full forgiveness of its CARES Act loan along with its accrued interest.

Based on the company's current expectations, the company believes that its cash and cash equivalent balances and available borrowing capacity under its Credit Agreement should be sufficient to meet working capital needs, capital requirements and commitments for at least the next twelve months. Notwithstanding the company's expectations, if the company's operating results fail to improve or continue to deteriorate as the result of pressures on the business due to, for example, prolonged, or worsening of, negative impacts of the COVID-19 pandemic, supply chain, labor, freight and logistics costs and disruptions, currency fluctuations or regulatory issues or the company's failure to execute its business plans or if the company's business improvement actions take longer than expected to materialize, the company may require additional financing, or may be unable to comply with its obligations under the credit facilities, and its lenders could demand repayment of any amounts outstanding under the company's credit facilities. If additional financing is required, there can be no assurance that financing will be available on terms satisfactory to the company, if at all. As the company cannot predict the duration or scope of the COVID-19 pandemic and its impact on the company’s customers and suppliers, the negative financial impact to the company’s results cannot be reasonably estimated, but could be material.

The company also has an agreement with De Lage Landen, Inc. (“DLL”), a third-party financing company, to provide lease financing to the company's U.S. customers. Either party could terminate this agreement with 180 days' notice or 90 days' notice by DLL upon the occurrence of certain events. Should this agreement be terminated, the company's borrowing needs under its credit facilities could increase.

While most of the company's debt has fixed interest, should interest rates increase, the company expects that it would be able to absorb modest rate increases without any material impact on its liquidity or capital resources. The weighted average interest rate on revolving credit borrowings, excluding finance leases, was 4.4% for the three and nine months ended September 30, 2021 and 4.6% for the year ended December 31, 2020. Refer to "Long-Term Debt" and "Leases and Commitments" in the Notes to the Condensed Consolidated Financial Statements for more details regarding the company's credit facilities and lease liabilities, respectively.


CAPITAL EXPENDITURES

The company estimates that capital investments for 2021 could be approximately $20,000,000 compared to actual capital expenditures of $22,304,000 in 2020. The continued investment at this level relates primarily to the new ERP system. The company believes that its balances of cash and cash equivalents and existing borrowing facilities will be sufficient to meet its operating cash requirements and fund capital expenditures (refer to "Liquidity and Capital Resources"). The Credit Agreement limits the company's annual capital expenditures to $35,000,000.


DIVIDEND POLICY

On May 21, 2020, the Board of Directors suspended the quarterly dividend on the company's Common Shares in light of the impacts of the COVID-19 pandemic on the business. The Board of Directors suspended the company's regular dividend on the Class B Common Shares starting in the third quarter of 2018. Less than 4,000 Class B Common Shares remain outstanding and suspending the regular Class B dividend allows the company to save on the administrative costs and compliance expenses associated with that dividend. Holders of Class B Common Shares are entitled to convert their shares into Common Shares at any time on a share-for-share basis and would be eligible for any Common Share dividends declared following any such conversion.
13
MD&ACash Flows
CASH FLOWS
ivc-20210930_g5.jpg
The increase in cash used by operating activities for the nine months ended September 30, 2021 was driven primarily by increased working capital to support net sales growth including $37,199,000 of inventory. Inventories increased to mitigate supply chain disruptions and in preparation for the expected sequential sales growth in the fourth quarter. This inventory should largely convert to net sales within the next two quarters.
ivc-20210930_g6.jpg
The year over year change in cash flows related to investing activities was driven primarily by gross proceeds of $14,563,000 from the sale of Dynamic Controls in the first quarter of 2020. ERP-related implementation costs continued to be capitalized for the nine months ended September 30, 2021. The company used $2,113,000 to purchase new ERP licenses in the first nine months of 2020.
ivc-20210930_g7.jpg
Cash flows provided by financing activities in the first nine months of 2021 included credit facility borrowings, the issuance of $125,000,000 principal amount of 2026 Notes, payment of $5,369,000 in financing costs, purchase of capped calls related to the 2026 Notes for $18,787,000, repurchase of $78,850,000 principal amount of 2022 Notes and repayment of $1,250,000 principal amount of 2021 Notes. Borrowings on credit facilities are under the company's Credit Agreement which provides an asset-based-lending senior secured revolving credit facilities.
14
MD&ACash Flows
Free cash flow is a non-GAAP financial measure and is reconciled to the corresponding GAAP measure as follows:
 ($ in thousands USD)3Q213Q20YTD 3Q21YTD 3Q20
Net cash provided (used) by operating activities(775)4,147 (36,825)822 
Plus: Sales of property and equipment— 3 23 396 
Less: Purchases of property and equipment(5,350)(5,945)(14,397)(16,824)
Free Cash Flow (usage)(6,125)(1,795)(51,199)(15,606)
 
Free cash flow for the first nine months 2021 and 2020 was primarily impacted by the same items that affected cash flows used by operating activities. Free cash flow is a non-GAAP financial measure that is comprised of net cash provided (used) by operating activities plus purchases of property and equipment less proceeds from sales of property and equipment. Management believes that this financial measure provides meaningful information for evaluating the overall financial performance of the company and its ability to repay debt or make future investments (including acquisitions, etc.).

In the third quarter of 2021, the company initiated accounts receivable factoring programs within the Nordic countries of Norway, Sweden and Denmark which benefited free cash flow by $2,500,000.

Generally, the first half of the year is cash consumptive and impacted by significant disbursements related to annual customer rebate payments which normally occur in the first quarter of the year and earned employee bonuses historically paid in the second quarter of the year. In addition, investment in inventory is typically heavy in the first half of the year with planning around the company's supply chain to fulfill shipments in the second half of the year and can be impacted by footprint rationalization projects. The growth in inventory in the first three quarters of 2021 was also impacted by supply chain challenges which prevented the completion and sale of products. As well, inventories increased to mitigate the impact from supply chain challenges. Historically, the company realizes stronger cash flow in the second half of the year versus the first half of the year. Given the company's anticipation of net sales growth for 2021, seasonality of cash flow has been and will also be impacted by working capital needed to support sales growth. However, because the company cannot predict the duration or scope of the COVID-19 pandemic and its negative impact on the company’s cash flows, these historic trends may not apply in 2021 or beyond.
15
MD&ACash Flows


The company's approximate cash conversion days at September 30, 2021, December 31, 2020 and September 30, 2020 were as follows:
ivc-20210930_g8.jpg
For the quarter ended September 30, 2021, days in inventory and days in accounts payable were both impacted by the business disruption due to the COVID-19 pandemic, including supply chain disruptions. Days in receivables were impacted by timing of revenue recognized during the quarter.

Days in receivables are equal to current quarter net current receivables divided by trailing four quarters of net sales multiplied by 365 days. Days in inventory and accounts payable are equal to current quarter net inventory and accounts payable, respectively, divided by trailing four quarters of cost of sales multiplied by 365 days. Total cash conversion days are equal to days in receivables plus days in inventory less days in accounts payable.

The company provides a summary of days of cash conversion for the components of working capital so investors may see the rate at which cash is disbursed, collected and how quickly inventory is converted and sold.
16
MD&AAccounting Estimates and Pronouncements
ACCOUNTING ESTIMATES AND PRONOUNCEMENTS

CRITICAL ACCOUNTING ESTIMATES

The Condensed Consolidated Financial Statements included in the report include accounts of the company and all majority-owned subsidiaries. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions in certain circumstances that affect amounts reported in the accompanying Condensed Consolidated Financial Statements and related footnotes. In preparing the financial statements, management has made its best estimates and judgments of certain amounts included in the financial statements, giving due consideration to materiality. However, application of these accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties and, thus, actual results could differ from these estimates. Refer to the Critical Accounting Estimates section within MD&A of company's Annual Report on Form 10-K for the period ending December 31, 2020.

































RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

For the company’s disclosure regarding recently issued accounting pronouncements, see Accounting Policies - Recent Accounting Pronouncements in the Notes to the Condensed Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q.

17
MD&AForward-Looking Statements
FORWARD-LOOKING STATEMENTS

This Form 10-Q contains forward-looking statements within the meaning of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. Terms such as “will,” “should,” “could,” “plan,” “intend,” “expect,” “continue,” “believe” and “anticipate,” as well as similar comments, denote forward-looking statements that are subject to inherent uncertainties that are difficult to predict. Actual results and events may differ significantly from those expressed or anticipated as a result of various risks and uncertainties, which include, but are not limited to, the following: the duration and scope of the COVID-19 pandemic, the pace of resumption of access to healthcare, including clinics and elective care, and loosening of public health restrictions, or any reimposed restrictions on access to healthcare or tightening of public health restrictions which could impact the demand for the company’s products; global shortages in, or increasing costs for, transportation and logistics services and capacity; the availability and cost to the company of needed products, components or raw materials from its suppliers; actions that governments, businesses and individuals take in response to the pandemic, including mandatory business closures and restrictions on onsite commercial interactions; the impact of the pandemic and actions taken in response to the pandemic on global and regional economies and economic activity; the pace of recovery when the COVID-19 pandemic subsides; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; the effects of steps the company takes to reduce operating costs; the inability of the company to sustain profitable sales growth, achieve anticipated improvements in segment operating performance, convert high inventory levels to cash or reduce its costs; lack of market acceptance of the company's new product innovations; revised product pricing and/or product surcharges; circumstances or developments that may make the company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current and planned business initiatives, in particular the key elements of its growth plan such as its new product introductions, commercialization plans; additional investments in sales force and demonstration equipment, product distribution strategy in Europe, supply chain actions and global information technology outsourcing and ERP implementation activities; possible adverse effects on the company's liquidity, including the company's ability to address future debt maturities; adverse changes in government and third-party payor reimbursement levels and practices; consolidation of health care providers; increasing pricing pressures in the markets for the company's products; risks of failures in, or disruptions to, legacy IT systems; risks of cybersecurity attack, data breach or data loss and/or delays in or inability to recover or restore data and IT systems; adverse effects of the company's consent decree of injunction with the U.S. Food and Drug Administration (FDA), including but not limited to, compliance costs, inability to rebuild negatively impacted customer relationships, unabsorbed capacity
utilization, including fixed costs and overhead; any circumstances or developments that might adversely impact the third-party expert auditor's required audits of the company's quality systems at the facilities impacted by the consent decree, including any possible failure to comply with the consent decree or FDA regulations; regulatory proceedings or the company's failure to comply with regulatory requirements or receive regulatory clearance or approval for the company's products or operations in the United States or abroad; adverse effects of regulatory or governmental inspections of the company's facilities at any time and governmental investigations or enforcement actions; product liability or warranty claims; product recalls, including more extensive warranty or recall experience than expected; possible adverse effects of being leveraged, including interest rate or event of default risks; exchange rate fluctuations, particularly in light of the relative importance of the company's foreign operations to its overall financial performance; legal actions, including adverse judgments or settlements of litigation or claims in excess of available insurance limits; tax rate fluctuations; additional tax expense or additional tax exposures, which could affect the company's future profitability and cash flow; uncollectible accounts receivable; risks inherent in managing and operating businesses in many different foreign jurisdictions; decreased availability or increased costs of materials which could increase the company's costs of producing or acquiring the company's products, including the adverse impacts of tariffs and increases in commodity costs or freight costs; heightened vulnerability to a hostile takeover attempt or other shareholder activism; provisions of Ohio law or in the company's debt agreements, charter documents or other agreements that may prevent or delay a change in control, as well as the risks describe in the Annual Report on Form 10-K and from time to time in the company's reports as filed with the Securities and Exchange Commission. Except to the extent required by law, the company does not undertake and specifically declines any obligation to review or update any forward-looking statements or to publicly announce the results of any revisions to any of such statements to reflect future events or developments or otherwise.
18
Financial Statements
Part I.    FINANCIAL INFORMATION
Item 1.    Financial Statements.

INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statement of Comprehensive Income (Loss) (unaudited)
 (In thousands, except per share data)Three Months Ended September 30,Nine Months Ended September 30,
2021202020212020
Net sales$224,200 $211,906 $646,266 $626,646 
Cost of products sold163,890 151,866 470,500 446,968 
Gross Profit60,310 60,040 175,766 179,678 
Selling, general and administrative expenses56,135 55,530 178,721 174,672 
Gain on sale of business— — — (9,790)
Charges related to restructuring activities377 1,580 2,476 4,657 
Impairment of goodwill28,564 — 28,564 — 
Operating Income (Loss)(24,766)2,930 (33,995)10,139 
Loss (gain) on debt extinguishment including debt finance charges and fees(10,131)761 (9,422)7,360 
Interest expense6,284 7,402 18,099 21,132 
Interest income— (7)(1)(90)
Loss Before Income Taxes(20,919)(5,226)(42,671)(18,263)
Income tax provision1,840 2,050 4,830 4,900 
Net Loss$(22,759)$(7,276)$(47,501)$(23,163)
Dividends Declared per Common Share$— $— $— $0.0125 
Net Loss per Share—Basic$(0.65)$(0.21)$(1.36)$(0.68)
Weighted Average Shares Outstanding—Basic35,013 34,419 34,826 34,213 
Loss per Share—Assuming Dilution$(0.65)$(0.21)$(1.36)$(0.68)
Weighted Average Shares Outstanding—Assuming Dilution35,488 34,530 35,371 34,313 
Net Loss$(22,759)$(7,276)$(47,501)$(23,163)
Other comprehensive income (loss):
Foreign currency translation adjustments(19,202)35,944 (6,487)36,859 
Defined Benefit Plans:
Amortization of prior service costs and unrecognized losses(27)(193)(422)(362)
Deferred tax adjustment resulting from defined benefit plan activity20 9 (43)25 
Valuation reserve associated with defined benefit plan activity(20)(9)43 (25)
Current period gain (loss) on cash flow hedges1,423 (2,047)649 (1,159)
Deferred tax benefit (provision) related to gain on cash flow hedges(170)285 (73)171 
Other Comprehensive Income (Loss)(17,976)33,989 (6,333)35,509 
Comprehensive Income (Loss)$(40,735)$26,713 $(53,834)$12,346 
(Elements as a % of Net Sales)
Net sales100.0 %100.0 %100.0 %100.0 %
Cost of products sold73.1 71.7 72.8 71.3 
Gross Profit26.9 28.3 27.2 28.7 
Selling, general and administrative expenses25.0 26.2 27.7 27.9 
Gain on sale of business— — — (1.6)
Charges related to restructuring activities0.2 0.7 0.4 0.7 
Impairment of goodwill12.7 — 4.4 — 
Operating Income (Loss)(11.0)1.4 (5.3)1.6 
Loss (gain) on debt extinguishment including debt finance charges and fees(4.5)0.4 (1.5)1.2 
Interest expense2.8 3.5 2.8 3.4 
Interest income— — — — 
Loss Before Income Taxes(9.3)(2.5)(6.6)(2.9)
Income tax provision0.8 1.0 0.7 0.8 
Net Loss(10.2)%(3.4)%(7.4)%(3.7)%
See notes to condensed consolidated financial statements.
19
Financial Statements
INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(unaudited)
September 30,
2021		December 31,
2020
Assets(In thousands)
Current Assets
Cash and cash equivalents$73,656 $105,298 
Trade receivables, net115,923 108,588 
Installment receivables, net292 379 
Inventories, net151,335 115,484 
Other current assets36,151 44,717 
Total Current Assets377,357 374,466 
Other Assets6,177 5,925 
Intangibles, net27,357 27,763 
Property and Equipment, net62,212 56,243 
Finance Lease Assets, net65,758 64,031 
Operating Lease Assets, net12,480 15,092 
Goodwill370,739 402,461 
Total Assets$922,080 $945,981 
Liabilities and Shareholders’ Equity
Current Liabilities
Accounts payable$110,234 $85,424 
Accrued expenses104,210 126,273 
Current taxes payable5,203 3,359 
Current portion of long-term debt3,121 5,612 
Current portion of finance lease obligations3,118 3,405 
Current portion of operating lease obligations4,553 6,313 
Total Current Liabilities230,439 230,386 
Long-Term Debt306,334 239,441 
Finance Lease Long-Term Obligations66,070 63,137 
Operating Leases Long-Term Obligations 7,742 8,697 
Other Long-Term Obligations71,781 70,474 
Shareholders’ Equity
Preferred Shares (Authorized 300 shares; none outstanding)
— — 
Common Shares (Authorized 150,000 shares; 39,417 and 38,613 issued and outstanding at September 30, 2021 and December 31, 2020, respectively)—no par
9,977 9,816 
Class B Common Shares (Authorized 12,000 shares; 4 and 4 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively)—no par
2 2 
Additional paid-in-capital277,711 326,088 
Retained earnings20,707 58,538 
Accumulated other comprehensive income 39,103 45,436 
Treasury Shares (4,397 and 4,184 shares at September 30, 2021 and December 31, 2020, respectively)
(107,786)(106,034)
Total Shareholders’ Equity239,714 333,846 
Total Liabilities and Shareholders’ Equity$922,080 $945,981 
See notes to condensed consolidated financial statements.
20
Financial Statements
INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statement of Cash Flows (unaudited)
 
For the Nine Months Ended September 30,
20212020
Operating Activities(In thousands)
Net loss$(47,501)$(23,163)
Adjustments to reconcile net loss to net cash used by operating activities:
Gain on sale of business— (9,790)
Depreciation and amortization12,511 10,360 
Amortization of operating lease right of use assets4,757 5,284 
Provision for losses on trade and installment receivables327 554 
Provision (benefit) for deferred income taxes(148)111 
Provision for other deferred liabilities165 594 
Provision for equity compensation5,369 6,965 
Gain on disposals of property and equipment(232)(1,066)
Loss (gain) on debt extinguishment including debt finance charges and fees(9,422)7,360 
Impairment of goodwill28,564 — 
Convertible debt discount amortization and accretion2,637 8,629 
Amortization of debt fees1,622 1,329 
Changes in operating assets and liabilities:
Trade receivables(8,030)6,160 
Installment sales contracts, net222 532 
Inventories, net(37,199)(22,021)
Other current assets8,215 1,691 
Accounts payable24,769 5,903 
Accrued expenses(24,182)1,616 
Other long-term liabilities731 (226)
Net Cash Provided (Used) by Operating Activities(36,825)822 
Investing Activities
Purchases of property and equipment(14,397)(16,824)
Proceeds from sale of property and equipment23 396 
Proceeds from sale of business— 14,563 
Change in other long-term assets(93)67 
Other— (2,176)
Net Cash Used by Investing Activities(14,467)(3,974)
Financing Activities
Proceeds from revolving lines of credit and long-term borrowings154,830 72,551 
Repurchases of convertible debt, payments on revolving lines of credit and finance leases(109,139)(59,483)
Payment of financing costs(5,369)(1,307)
Payment of dividends— (414)
Purchases of capped calls(18,787)— 
Payments to debt holders— (5,593)
Purchases of treasury shares(1,752)(1,702)
Net Cash Provided by Financing Activities19,783 4,052 
Effect of exchange rate changes on cash(133)5,862 
Increase (decrease) in cash and cash equivalents(31,642)6,762 
Cash and cash equivalents at beginning of year105,298 80,063 
Cash and cash equivalents at end of period$73,656 $86,825 
See notes to condensed consolidated financial statements.
21
Financial Statements
INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statement of Shareholders' Equity (unaudited)
(In thousands)Common
Shares		Class B
Shares		Additional
Paid-in-
Capital		Retained
Earnings		Accumulated Other
Comprehensive
Income (Loss)		Treasury
Shares		Total
June 30, 2021 Balance$9,977 $2 $278,152 $43,466 $57,079 $(107,786)$280,890 
Performance awards— — (1,250)— — — (1,250)
Restricted share awards— — 809 — — — 809 
Net loss— — — (22,759)— — (22,759)
Foreign currency translation adjustments— — — — (19,202)— (19,202)
Unrealized gain on cash flow hedges— — — — 1,253 — 1,253 
Defined benefit plans: Amortization of prior service costs and unrecognized losses and credits— — — — (27)— (27)
Total comprehensive loss— — — — — — (40,735)
September 30, 2021 Balance$9,977 $2 $277,711 $20,707 $39,103 $(107,786)$239,714 
June 30, 2020 Balance$9,815 $2 $322,770 $70,931 $4,648 $(106,020)$302,146 
Performance awards— — 818 — — — 818 
Restricted share awards— — 821 — — (9)812 
Net loss— — — (7,276)— — (7,276)
Foreign currency translation adjustments— — — — 35,944 — 35,944 
Unrealized loss on cash flow hedges— — — — (1,762)— (1,762)
Defined benefit plans: Amortization of prior service costs and unrecognized losses and credits— — — — (193)— (193)
Total comprehensive income— — — — — — 26,713 
September 30, 2020 Balance$9,815 $2 $324,409 $63,655 $38,637 $(106,029)$330,489 
See notes to condensed consolidated financial statements.
22
Financial Statements
INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statement of Shareholders' Equity (unaudited)
(In thousands)Common
Shares		Class B
Shares		Additional
Paid-in-
Capital		Retained
Earnings		Accumulated Other
Comprehensive
Income (Loss)		Treasury SharesTotal
January 1, 2021 Balance$9,816 $2 $326,088 $58,538 $45,436 $(106,034)$333,846 
Performance awards52 — 747 — — (668)131 
Restricted share awards109 — 4,461 — — (1,084)3,486 
Net loss— — — (47,501)— — (47,501)
Foreign currency translation adjustments— — — — (6,487)— (6,487)
Unrealized gain on cash flow hedges— — — — 576 — 576 
Defined benefit plans: Amortization of prior service costs and unrecognized losses and credits— — — — (422)— (422)
Total comprehensive loss(53,834)
Adoption of ASU 2020-06— — (34,798)9,670 — — (25,128)
Purchase of capped calls$— $— (18,787)$— $— $— (18,787)
September 30, 2021 Balance$9,977 $2 $277,711 $20,707 $39,103 $(107,786)$239,714 
January 1, 2020 Balance$9,588 $2 $312,650 $87,475 $3,128 $(104,327)$308,516 
Exercise of share options90 — (90)— — (1,121)(1,121)
Performance awards— — 2,494 — — — 2,494 
Restricted share awards137 — 4,334 — — (581)3,890 
Net loss— — — (23,163)— — (23,163)
Foreign currency translation adjustments— — — — 36,859 — 36,859 
Unrealized loss on cash flow hedges— — — — (988)— (988)
Defined benefit plans: Amortization of prior service costs and unrecognized losses and credits— — — — (362)— (362)
Total comprehensive income12,346 
Dividends— — — (414)— — (414)
Exchange of convertible notes— — 5,021 — — — 5,021 
Adoption of credit loss standard— — — (243)— — (243)
September 30, 2020 Balance$9,815 $2 $324,409 $63,655 $38,637 $(106,029)$330,489 
See notes to condensed consolidated financial statements.
23
Notes to Financial StatementsAccounting Policies

Accounting Policies
Principles of Consolidation:  The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2021 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2021 and 2020, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year.

Use of Estimates:  The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.

Recent Accounting Pronouncements (Already Adopted): 
In August 2020, the FASB issued ASU 2020-06 "Debt with Conversion and Other Options" (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity's Own Equity (Subtopic 815-40)", which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. ASU 2020-06 removes from U.S. GAAP the separation models for (1) convertible debt with a cash conversion feature (CCF) and (2) convertible instrument with a beneficial conversion feature (BCF). As a result, after adopting the ASU’s guidance, entities will not separately present in equity an embedded conversion feature in such debt. Instead, they will account for a convertible debt instrument wholly as debt, and for convertible preferred stock wholly as preferred stock (i.e., as a single unit of account), unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC 815 or (2) a convertible debt instrument was issued at a substantial premium. The guidance may be early adopted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years.

The company adopted ASU 2020-06 effective January 1, 2021, using the modified retrospective method, which resulted
in the removal of convertible debt discounts of $25,218,000, adjustment of $34,798,000 to additional paid-in-capital and $9,670,000 adjustment to retained earnings. Convertible debt discounts prior to adoption of ASU 2020-06 were amortized over the convertible debt term through interest expense. Subsequent to adoption, convertible debt discounts are not applicable when accounting for debt as a single unit of account. Interest expense for the three and nine months ended September 30, 2020 related to debt discount amortization (which was not recognized in 2021 due to adoption) were $2,273,000 or $0.07 per basic and diluted share and $7,613,000 or $0.22 per basic and diluted share, respectively. There was no impact of adoption on performance metrics used for short-term or long-term incentive compensation. Accretion specific to the Series II 2024 Notes was unaffected by adoption. Due to the valuation allowance, there was no net impact to income taxes for the adoption. Subsequent to adoption weighted average shares when calculating diluted earnings per share requires the application of the if-converted method for all convertible instruments.

Recent Accounting Pronouncements (Not Yet Adopted): 

In March 2020, the FASB issued ASU 2020-04 "Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting," which is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates if certain criteria are met. The guidance may be adopted in any period prior to the guidance expiration on December 31, 2022. The company is currently reviewing the impact of the adoption of ASU 2020-04 but does not expect the adoption to have a material impact on the company's financial statements.

24
Notes to Financial StatementsDivested Businesses
Divested Businesses
On March 7, 2020, the company, completed the sale (the “Transaction”) of its subsidiary, Dynamic Controls, a New Zealand incorporated unlimited company (“Dynamic Controls”), to Allied Motion Christchurch Limited, a New Zealand limited company (the “Purchaser”), pursuant to a Securities Purchase Agreement among the company, Invacare Holdings New Zealand, a New Zealand incorporated unlimited company, and the Purchaser, dated March 6, 2020 (the “Purchase Agreement”). Dynamic Controls was a producer of electronic control systems for powered medical mobility devices, including systems incorporating the LiNX™ technology platform. Dynamic Controls was a component of the All Other Segment.
Dynamic Controls was a supplier of power mobility products and respiratory components to the company as well as supplying power mobility products to external customers. Sales in 2020 through the date of disposition were $5,331,000, including intercompany sales of $2,532,000, compared to sales for the full year of 2019 of $30,261,000, including intercompany sales of $13,087,000. Income before income taxes was approximately $445,000 in 2020, through the date of disposition, compared to $853,000 in 2019, inclusive of intercompany profits on sales to the company.
The transaction was the result of considering options for the products sold by Dynamic Controls which resulted in selling the business to a third-party which can provide access to further technological innovations to further differentiate the company’s power mobility products.
The gross proceeds from the Transaction were $14,563,000, net of taxes and expenses. The company realized a pre-tax gain of $9,790,000 with a remaining accrued expenses balance of $172,000 as of September 30, 2021.
The Purchase Agreement contains customary indemnification obligations of each party with respect to breaches of their respective representations, warranties and covenants, and certain other specified matters, which are subject to certain exceptions, terms and limitations described further in the Purchase Agreement.

At the closing of the Transaction, the parties entered into a supply agreement pursuant to which Dynamic Controls will supply certain electronic components as required by the company for the five-year period following the Transaction, including ongoing supply and support of the LiNX™ electronic control system with informatics technology, continued contract manufacturing of certain electronic components for the company’s respiratory products and continued infrastructure and applications support for the
informatics solution for the company’s respiratory products. The estimated continued inflows and outflows following the disposal with the Purchaser are not expected to be material to the company.
The assets and liabilities of Dynamic Controls as of March 7, 2020 consisted of the following (in thousands):
March 7, 2020
Trade receivables, net$4,129 
Inventories, net3,082 
Other assets855 
Property and equipment, net600 
Operating lease assets, net2,127 
Total assets$10,793 
Accounts payable$4,692 
Accrued expenses2,473 
Current taxes payable41 
Current portion of operating lease obligations366 
Long-term obligations1,019 
Total liabilities$8,591 

Trade receivables as of March 7, 2020 includes receivables previously classified as intercompany related to product sold by Dynamic Controls to other Invacare entities.
25
Notes to Financial StatementsCurrent Assets
Current Assets

Receivables

Receivables consist of the following (in thousands):
September 30, 2021December 31, 2020
Accounts receivable, gross$141,003 $131,055 
Customer rebate reserve(12,689)(10,730)
Cash discount reserves(7,285)(7,320)
Allowance for doubtful accounts(4,227)(4,031)
Other, principally returns and allowances reserves(879)(386)
Accounts receivable, net$115,923 $108,588 

Reserves for customer rebates and cash discounts are recorded as a reduction in revenue and netted against gross accounts receivable. Customer rebates in excess of a given customer's accounts receivable balance are classified in Accrued Expenses. Customer rebates and cash discounts are estimated based on the most likely amount principle as well as historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such, the company estimates the expected returns based on an analysis of historical experience and adjusts revenue accordingly.

During the third quarter of 2021, the company entered into an agreement with a bank to sell certain trade receivables with governmental entity customers in the Nordic Region without recourse. Under ASC 860, the sale of the receivables qualify as a true sale and not a secured borrowing. No gain or loss was recorded on the sale of the receivables. Bank charges are recorded as interest expense. Interest expense attributable to the program for these bank charges was $11,000 for the three months ended September 30, 2021.

Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities predominantly located throughout the United States, Australia, Canada, New Zealand and Europe. A significant portion of products sold to providers, both foreign and domestic, are ultimately funded through government reimbursement programs such as Medicare and Medicaid in the U.S. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability.

The company's approach is to separate its receivables into good-standing and collection receivables. Good-standing
receivables are assigned to risk pools of high, medium and low. The risk pools are driven by the specifics associated with the geography of origination. Expected loss percentages are calculated and assigned to each risk pool, driven primarily by historical experience. The historical loss percentages are calculated for each risk pool and then judgmentally revised to consider current risk factors as well as consideration of the impact of forecasted events, as applicable. The expected loss percentages are then applied to receivables balances each period to determine the allowance for doubtful accounts.

In North America, excluding Canada, good-standing receivables are assigned to the low risk pool and assigned an expected loss percentage of 1.0% as these receivables are deemed to share the same risk profile and collections efforts are the same. Installment receivables in North America are characterized as collection receivables and thus reserves based on specific analysis of each customer. In Canada, good-standing receivables are deemed low risk and assigned a loss percentage of 0.2%.

In Europe, expected losses are determined by each location in each region. Most locations have a majority of their receivables assigned to the low risk pool, which has an average expected loss percentage of 0.5%. About half of the locations have a portion of their receivables assigned as medium risk with an average expected loss percentage of 1.1%. Only a few locations have any receivables characterized as high risk and the average credit loss percentage for those locations is 2.8%. Collection risk is generally low as payment terms in certain key markets, such as Germany, are immediate and in many locations the ultimate customer is the government.

In the Asia Pacific region, receivables are characterized as low risk, which have an average expected loss percentage of 0.3%. Historical losses are low in this region where the use of credit insurance is often customary.


26
Notes to Financial StatementsCurrent Assets
The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2021
Balance as of beginning of period$4,031 
Current period provision432 
Recoveries (direct write-offs), net(236)
Balance as of end of period$4,227 

The company did not make any material changes to the assignment of receivables to the different risk pools or to the expected loss reserves in the quarter. The company is monitoring the impacts of the COVID-19 pandemic and the possibility for an impact on collections, but to date this has not materially impacted 2021.

For collections receivables, the estimated allowance for uncollectible amounts is based primarily on management’s evaluation of the financial condition of each customer. In addition, as a result of the company's financing arrangement with DLL, a third-party financing company which the company has worked with since 2000, management monitors the collection status of these contracts in accordance with the company’s limited recourse obligations and provides amounts necessary for estimated losses in the allowance for doubtful accounts and establishes reserves for specific customers as needed.

The company writes off uncollectible trade accounts receivable after such receivables are moved to collection status and legal remedies are exhausted. See Concentration of Credit Risk in the Notes to the Condensed Consolidated Financial Statements for a description of the financing arrangement. Long-term installment receivables are included in “Other Assets” on the condensed consolidated balance sheet.

The company has recorded a contingent liability in the amount of $314,000 related to the contingent aspect of the company's guarantee associated with its arrangement with DLL. The contingent liability is recorded applying the same expected loss model used for the trade and installment receivables recorded on the company's books. Specifically, historical loss history is used to determine the expected loss percentage, which is then adjusted judgmentally to consider other factors, as needed.

The company’s U.S. customers electing to finance their purchases can do so using DLL. The installment receivables recorded on the books of the company represent a single portfolio segment of finance receivables to the independent provider channel and long-term care customers. The portfolio segment is comprised of two classes of receivables
distinguished by geography and credit quality. The U.S. installment receivables are the first class and represent installment receivables repurchased from DLL because the customers were in default. Default with DLL is defined as a customer being delinquent by three payments.

The estimated allowance for uncollectible amounts and evaluation for both classes of installment receivables is based on the company’s quarterly review of the financial condition of each individual customer with the allowance for doubtful accounts adjusted accordingly. Installments are individually and not collectively reviewed. The company assesses the bad debt reserve levels based upon the status of the customer’s adherence to a legally negotiated payment schedule and the company’s ability to enforce judgments, liens, etc.

For purposes of granting or extending credit, the company utilizes a scoring model to generate a composite score that considers each customer’s consumer credit score and/or D&B credit rating, payment history, security collateral and time in business. Additional analysis is performed for most customers desiring credit greater than $250,000, which generally includes a detailed review of the customer’s financial statements as well as consideration of other factors such as exposure to changing reimbursement laws.

Interest income is recognized on installment receivables based on the terms of the installment agreements. Installment accounts are monitored and if a customer defaults on payments and is moved to collection, interest income is no longer recognized. Subsequent payments received once an account is put on non-accrual status are generally first applied to the principal balance and then to the interest. Accruing of interest on collection accounts would only be restarted if the account became current again.

All installment accounts are accounted for using the same methodology regardless of the duration of the installment agreements. When an account is placed in collection status, the company goes through a legal process for pursuing collection of outstanding amounts, the length of which typically approximates eighteen months. Any write-offs are made after the legal process has been completed.
27
Notes to Financial StatementsCurrent Assets
Installment receivables consist of the following (in thousands):
 September 30, 2021December 31, 2020
 CurrentLong-TermTotalCurrentLong-TermTotal
Installment receivables$345 $909 $1,254 $704 $1,105 $1,809 
Allowance for doubtful accounts(53)(41)(94)(325)(162)(487)
Installment receivables, net$292 $868 $1,160 $379 $943 $1,322 
Installment receivables purchased from DLL during the nine months ended September 30, 2021 which increased the gross installments receivables by $93,000. No sales of
installment receivables were made by the company during the quarter.

The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2021		Year Ended December 31, 2020
Balance as of beginning of period$487 $1,514 
Current period provision (benefit)(105)66 
Direct write-offs charged against the allowance(288)(1,093)
Balance as of end of period$94 $487 
 
Installment receivables by class as of September 30, 2021 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$239 $239 $94 $— 
Asia Pacific
Non-Impaired installment receivables with no related allowance recorded1,015 1,015 — — 
Total
Non-Impaired installment receivables with no related allowance recorded1,015 1,015 — — 
Impaired installment receivables with a related allowance recorded239 239 94 — 
Total installment receivables$1,254 $1,254 $94 $— 
28
Notes to Financial StatementsCurrent Assets
Installment receivables by class as of December 31, 2020 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$615 $615 $487 $— 
Asia Pacific
Non-impaired installment receivables with no related allowance recorded1,194 1,194 — — 
Canada
Non-impaired installment receivables with no related allowance recorded— — — 29 
Total
Non-impaired installment receivables with no related allowance recorded1,194 1,194 — 29 
Impaired installment receivables with a related allowance recorded615 615 487 — 
Total installment receivables$1,809 $1,809 $487 $29 

Installment receivables with a related allowance recorded as noted in the table above represent those installment receivables on a non-accrual basis. As of September 30, 2021, the company had no U.S. installment receivables past due of 90 days or more for which the company is still accruing interest. Individually, all U.S. installment receivables are
assigned a specific allowance for doubtful accounts based on management’s review when the company does not expect to receive both the contractual principal and interest payments as specified in the loan agreement.


The aging of the company’s installment receivables was as follows (in thousands):
September 30, 2021December 31, 2020
TotalU.S.Asia PacificTotalU.S.Asia Pacific
Current$1,015 $— $1,015 $1,194 $— $1,194 
0-30 days past due— — — — — — 
31-60 days past due— — — — — — 
61-90 days past due— — — — — — 
90+ days past due239 239 — 615 615 — 
$1,254 $239 $1,015 $1,809 $615 $1,194 

29
Notes to Financial StatementsCurrent Assets
Inventories, Net

Inventories consist of the following (in thousands):
September 30, 2021December 31, 2020
Finished goods$70,545 $55,264 
Raw materials69,842 51,174 
Work in process10,948 9,046 
Inventories, net$151,335 $115,484 

Other Current Assets


Other current assets consist of the following (in thousands):
September 30, 2021December 31, 2020
Tax receivables principally value added taxes$23,006 $22,500 
Prepaid inventory and freight1,864 2,700 
Receivable due from information technology provider1,488 2,995 
Recoverable income taxes685 2,182 
Derivatives (foreign currency forward exchange contracts)606 1,321 
Service contracts393 633 
Deferred financing fees354 208 
Prepaid insurance276 3,963 
Prepaid and other current assets7,479 8,215 
Other Current Assets$36,151 $44,717 

In the fourth quarter of 2019, the company entered into an agreement to outsource substantially all of the company’s information technology ("IT") business service activities, including, among other things, support, rationalization and upgrading of the company’s legacy information technology systems and implementation of a global enterprise resource planning system. The agreement provides for reimbursement by the IT provider of IT expenses incurred by the company
which are shown as Receivable due from information technology provider above. The amount of pass through charges will diminish as IT expenses are recorded directly by the IT provider. In addition, a corresponding current payable is due to the information technology provider. Refer to "Accrued Expenses" in the notes to the Condensed Consolidated Financial Statements included elsewhere in this report.

30
Notes to Financial StatementsLong-Term Assets
Long-Term Assets

Other Long-Term Assets


Other long-term assets consist of the following (in thousands):
September 30, 2021December 31, 2020
Cash surrender value of life insurance policies$2,372 $2,327 
Deferred income taxes2,278 2,048 
Installment receivables868 943 
Deferred financing fees463 411 
Investments84 85 
Other112 111 
Other Long-Term Assets$6,177 $5,925 

Property and Equipment
Property and equipment consist of the following (in thousands):
September 30, 2021December 31, 2020
Machinery and equipment$292,897 $294,045 
Land, buildings and improvements28,230 28,509 
Capitalized software28,149 17,527 
Furniture and fixtures10,288 10,001 
Leasehold improvements6,965 8,194 
Property and Equipment, gross366,529 358,276 
Accumulated depreciation(304,317)(302,033)
Property and Equipment, net$62,212 $56,243 

Machinery and equipment includes demonstration units placed in provider locations which are depreciated to their estimated recoverable values over their estimated useful lives.

In the fourth quarter of 2019, the company initiated the first stage of an Enterprise Resource Planning ("ERP") software implementation. As a result of the initiation of the ERP project, the company capitalized certain costs in accordance with ASC 350 as shown in capitalized software above.













31
Notes to Financial StatementsLong-Term Assets
Goodwill
The change in goodwill from December 31, 2020 to September 30, 2021 was due to foreign currency translation and goodwill impairment charge in the North America segment.

In accordance with Intangibles—Goodwill and Other, ASC 350, goodwill is tested annually for impairment or whenever events or changes in circumstances indicate the carrying value of a reporting unit could be above its fair value. A reporting unit is defined as an operating segment or one level below. The company has historically determined that its reporting units were North America / HME, Europe, Institutional Products Group and Asia Pacific.

During the third quarter of 2021, the company's reporting units of North America / HME and Institutional Products Group merged into one reporting unit of North America, consistent with the operating segment. Developments in the third quarter of 2021 and the conclusion of the reporting units merger were tied most closely to the actions of the company to implement components of a new ERP system which changes both the level of discrete financial information readily available and the go-forward manner in which the company assesses performance and allocates resources to the North America operating segment.

The reporting unit change within the North America operating segment in the third quarter of 2021 was a triggering event and required the company to perform an interim goodwill impairment test. Based on the interim goodwill test, the company concluded that the carrying value of the North America reporting unit was above its fair value. That conclusion resulted in the recording of impairment of goodwill in the third quarter of 2021 of $28,564,000.

The company completed its interim test in the third quarter of 2021 consistent with the process of its annual impairment assessment in the fourth quarter of each year or whenever events or changes in circumstances indicate the carrying value of a reporting unit could be below a reporting unit's fair value. The fair values of the company's reporting units were calculated using inputs that are not observable in the market and included management's own estimates regarding the assumptions that market participants would use and thus these inputs are deemed Level III inputs in regard to the fair value hierarchy. To calculate the fair values of the reporting units, the company utilizes a discounted cash flow method in which the company forecasts income statement and balance sheet amounts based on assumptions regarding projected sales growth, operating income, inventory turns, days' sales outstanding, etc. to forecast future cash flows. The projected operating income used has a significant impact upon the discounted cash flow methodology utilized in the
company's interim or annual impairment assessment as lower projected operating income would result in lower fair value estimates. The cash flows are discounted using a weighted average cost of capital (WACC) discount rate where the cost of debt is based on quoted rates for 20-year debt of potential acquirer companies of similar credit risk and the cost of equity is based upon the 20-year treasury rate for the risk-free rate, a market risk premium, the industry average beta and a small cap stock adjustment. The assumptions used are based on a market participant's point of view and yielded a discount rate of 11.19% in the third quarter of 2021's valuation for the company's impairment analysis for the reporting units with goodwill compared to 11.27% used in the annual impairment test in 2020. The WACC used has a significant impact upon the discounted cash flow methodology utilized in the company's impairment assessment as a higher WACC would decrease the fair value estimates.

The company also utilizes an Enterprise Value (EV) to Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) Method to compute the fair value of its reporting units which considers potential acquirers and their EV to EBITDA multiples adjusted by an estimated premium. While more weight is given to the discounted cash flow method, the EV to EBITDA Method does provide corroborative evidence of the reasonableness of the discounted cash flow method results.

While there was no impairment in the third quarter of 2021 related to goodwill for the Europe reporting unit, a future potential impairment could be possible if actual results differ materially from forecasted results used in the valuation analysis. Furthermore, the company's valuation can differ materially if financial projections or the market inputs used to determine the WACC change significantly. For instance, higher interest rates or greater stock price volatility would increase the WACC and thus increase the chance of impairment. In consideration of this potential, the company assessed the results if the discount rate used were 100 basis points higher for the third quarter of 2021 impairment analysis and determined that there still would not be an indicator of potential impairment for the Europe reporting unit. In addition, business changes impacting the company's assessment of reporting units could possibly also have a material impact on impairment assessment results.

There is no goodwill in the Asia Pacific reporting unit and the results of the Europe reporting unit assessment quantified its fair value to be substantially in excess of carrying value in the interim goodwill assessment completed in the third quarter of 2021.
As part of the company's interim assessment of goodwill for impairment, the company also considers the potential for impairment of any intangible assets or other long-lived assets.
32
Notes to Financial StatementsLong-Term Assets
The company concluded there was no impairment of intangible or long-lived assets as of September 30, 2021. Refer to Other Long-Term Assets, Property and Equipment and Intangibles in the Notes to the Condensed Consolidated Financial Statements for a description of any other asset
impairments and refer to Goodwill in the company's Annual Report on Form 10-K for the period ending December 31, 2020 for further disclosure regarding the company's impairment analysis review methodology.
Intangibles

The company's intangibles consist of the following (in thousands):
 
 September 30, 2021December 31, 2020
 Historical
Cost		Accumulated
Amortization		Historical
Cost		Accumulated
Amortization
Customer lists$54,222 $54,222 $54,502 $54,502 
Trademarks25,016 — 25,112 — 
Developed technology7,889 7,318 7,924 7,204 
Patents5,542 5,542 5,556 5,556 
License agreements2,904 1,143 2,899 979 
Other1,149 1,140 1,162 1,151 
Intangibles$96,722 $69,365 $97,155 $69,392 

All the company’s intangible assets have been assigned definite lives and continue to be amortized over their useful lives, except for trademarks shown above, which have indefinite lives.

The changes in intangible balances reflected on the balance sheet from December 31, 2020 to September 30, 2021 were the result of foreign currency translation on historical cost and accumulated amortization.

The company evaluates the carrying value of definite-lived assets annually in the fourth quarter and whenever events or circumstances indicate possible impairment. In the third quarter of 2021, the company assessed its intangible assets for impairment based on the goodwill impairment conclusion of North America. Based on the assessment, the company concluded there was no intangible asset impairment.

Definite-lived assets are determined to be impaired if the future undiscounted cash flows expected to be generated by the asset are less than the carrying value. Actual impairment amounts for definite-lived assets are then calculated using a discounted cash flow calculation.

Any impairment for indefinite-lived intangible assets is calculated as the difference between the future discounted cash flows expected to be generated by the asset less than the carrying value for the asset.

Amortization expense related to intangible assets was $304,000 in the first nine months of 2021 and is expected to be $405,000 in 2021, $402,000 in 2022, $402,000 in 2023,
$361,000 in 2024, $212,000 in 2025 and $211,000 in 2026. Amortized intangible assets are being amortized on a straight-line basis over remaining lives of 3 to 8 years with a weighted average remaining life of approximately 7 years.

33
Notes to Financial StatementsCurrent Liabilities
Current Liabilities

Accrued Expenses

Accrued expenses consist of accruals for the following (in thousands):
September 30, 2021December 31, 2020
Taxes other than income taxes, primarily value added taxes$27,103 $32,710 
Salaries and wages24,869 34,029 
Warranty11,363 10,991 
Professional8,917 7,375 
Freight4,463 3,190 
IT service contracts4,038 3,799 
Interest3,823 2,076 
Deferred revenue3,413 3,516 
Product liability, current portion2,901 2,453 
Rebates2,242 8,644 
Derivative liabilities (foreign currency forward exchange contracts)2,086 1,432 
Severance804 6,249 
Insurance652 878 
Rent511 585 
Supplemental executive retirement program liability391 391 
Other items, principally trade accruals6,634 7,955 
Accrued Expenses$104,210 $126,273 

Generally, the company's products are covered by warranties against defects in material and workmanship for various periods depending on the product from the date of sales to the customer. Certain components carry a lifetime warranty. A provision for estimated warranty cost is recorded at the time of sale based upon actual experience. In addition, the company has sold extended warranties that, while immaterial, require the company to defer the revenue associated with those warranties until earned. The company has established procedures to appropriately defer such revenue. The company continuously assesses the adequacy of its product warranty accrual and makes adjustments as needed. Historical analysis is primarily used to determine the company's warranty reserves. Claims history is reviewed and provisions are adjusted as needed. However, the company does consider other events, such as a product field action and recalls, which could require additional warranty reserve provision.







Accrued rebates relate to several volume incentive programs the company offers its customers. The company accounts for these rebates as a reduction of revenue when the products are sold. Rebates are netted against gross accounts receivables. If rebates are in excess of such receivables, they are then classified as accrued expenses. The reduction in accrued rebates from December 31, 2020 to September 30, 2021 primarily relates to payments principally made in the first quarter each year, earned from the previous year.

The reduction in accrued severance from December 31, 2020 to September 30, 2021 primarily relates to payments of restructuring costs with respect to the German manufacturing facility consolidation.

In the fourth quarter of 2019, the company entered into an agreement with an IT provider to outsource substantially all of the company’s information technology business service activities, including, among other things, support, rationalization and upgrading of the company’s legacy information technology systems and implementation of a global ERP. Accrued expenses related to IT outsourcing are reflected in IT service contracts.

34
Notes to Financial StatementsCurrent Liabilities




The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):
Balance as of January 1, 2021$10,991 
Warranties provided during the period5,087 
Settlements made during the period(5,187)
Changes in liability for pre-existing warranties during the period, including expirations472 
Balance as of September 30, 2021$11,363 

Warranty reserves are subject to adjustment in future periods as new developments change the company's estimate of the total cost.










































35
Notes to Financial StatementsLong-Term Liabilities
Long-Term Liabilities

Long-Term Debt

Debt consists of the following (in thousands):
September 30, 2021December 31, 2020
Convertible senior notes at 5.00%, due in February 2021$— $1,242 
Convertible senior notes at 4.50%, due in June 20222,637 73,869 
Convertible senior notes Series I at 5.00%, due in November 202472,073 62,984 
Convertible senior notes Series II at 5.00%, due November 202477,270 64,919 
Convertible senior notes at 4.25%, due in March 2026118,682 — 
Other obligations38,793 42,039 
309,455 245,053 
Less current maturities of long-term debt(3,121)(5,612)
Long-Term Debt$306,334 $239,441 
On September 30, 2015, the company entered into an Amended and Restated Revolving Credit and Security Agreement, which was subsequently amended (the “Credit Agreement”) and which matures on January 16, 2024. The Credit Agreement was entered into by and among the company, certain of the company’s direct and indirect U.S. and Canadian subsidiaries and certain of the company’s European subsidiaries (together with the company, the “Borrowers”), certain other of the company’s direct and indirect U.S., Canadian and European subsidiaries (the “Guarantors”), and PNC Bank, National Association (“PNC”), JPMorgan Chase Bank, N.A., J.P. Morgan Europe Limited, KeyBank National Association, and Citizens Bank, National Association (the “Lenders”). PNC is the administrative agent (the “Administrative Agent”) and J.P. Morgan Europe Limited is the European agent (the “European Agent”) under the Credit Agreement. In connection with entering into the company's Credit Agreement, the company incurred fees which were capitalized and are being amortized as interest expense. As of September 30, 2021, debt fees yet to be amortized through January 2024 totaled $817,000.

The company had outstanding letters of credit of $8,350,000 and $7,752,000 as of September 30, 2021 and December 31, 2020, respectively. Outstanding letters of credit and other reserves impacting borrowing capacity were $7,641,000 and $7,616,000 as of September 30, 2021 and December 31, 2020, respectively. The company had $22,150,000 outstanding borrowings under its North America Credit Facility as of September 30, 2021. The company had outstanding borrowings of $9,446,000 (€8,000,000) under its French Credit Facility and $6,600,000 (£4,800,000) under its UK Credit Facility as of September 30, 2021, together referred
to as the European Credit Facility. The company had outstanding borrowings of $20,000,000 under its North America Credit Facility as of December 31, 2020. The company had outstanding borrowings of $7,636,000 (€6,400,000) under its French Credit Facility and $3,866,000 (£2,900,000) under its UK Credit Facility as of December 31, 2020, together referred to as the European Credit Facility. The weighted average interest rate on all borrowings, excluding finance leases, was 4.4% for the nine months ended September 30, 2021 and 4.6% for the year ended December 31, 2020.

North America Borrowers Credit Facility

For the company's North America Borrowers, the Credit Agreement provides for an asset-based-lending senior secured revolving credit facility which is secured by substantially all the company’s U.S. and Canadian assets, other than real estate. The Credit Agreement provides the company and the other Borrowers with a credit facility in an aggregate principal amount of $60,000,000, subject to availability based on a borrowing base formula, under a senior secured revolving credit, letter of credit and swing line loan facility (the “North America Credit Facility”). Up to $20,000,000 of the North America Credit Facility will be available for issuance of letters of credit. The aggregate principal amount of the North America Credit Facility may be increased by up to $25,000,000 to the extent requested by the company and agreed to by any Lender or new financial institution approved by the Administrative Agent.

The aggregate borrowing availability under the North America Credit Facility is determined based on a borrowing
36
Notes to Financial StatementsLong-Term Liabilities
base formula. The aggregate usage under the North America Credit Facility may not exceed an amount equal to the sum of (a) 85% of eligible U.S. accounts receivable plus (b) the lesser of (i) 70% of eligible U.S. inventory and eligible foreign in-transit inventory and (ii) 85% of the net orderly liquidation value of eligible U.S. inventory and eligible foreign in-transit inventory (not to exceed $4,000,000), plus (c) the lesser of (i) 80% of the net orderly liquidation value of U.S. eligible machinery and equipment and (ii) $0 as of September 30, 2021 (subject to reduction as provided in the Credit Agreement), plus (d) 85% of eligible Canadian accounts receivable, plus (e) the lesser of (i) 70% of eligible Canadian inventory and (ii) 85% of the net orderly liquidation value of eligible Canadian inventory, less (f) swing loans outstanding under the North America Credit Facility, less (g) letters of credit issued and undrawn under the North America Credit Facility, less (h) a $3,000,000 minimum availability reserve, less (i) other reserves required by the Administrative Agent, and in each case subject to the definitions and limitations in the Credit Agreement. As of September 30, 2021, the company was in compliance with all covenant requirements. As of September 30, 2021, the company had gross borrowing base of $40,566,000 and net borrowing availability of $23,176,000 under the North America Credit Facility under the Credit Agreement, considering the minimum availability reserve, then-outstanding letters of credit, other reserves and the $6,750,000 dominion trigger amount described below. Borrowings under the North America Credit Facility are secured by substantially all of the company’s U.S. and Canadian assets, other than real estate.

Interest will accrue on outstanding indebtedness under the Credit Agreement at the LIBOR rate, plus a margin ranging from 2.25% to 2.75%, or at the alternate base rate, plus a margin ranging from 1.25% to 1.75%, as selected by the company. Borrowings under the North America Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization.

The Credit Agreement contains customary representations, warranties and covenants. Exceptions to the operating covenants in the Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale and leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Credit Agreement, as amended. The Credit Agreement also contains a covenant requiring the company to maintain minimum availability under the North America Credit Facility of not less than (i) 12.5% of the maximum amount that may be drawn under the North America Credit Facility for five (5) consecutive business days, or (ii) 11.25% of the maximum amount that may be drawn under the North American facility on any business day. The company also is subject to dominion
triggers under the North America Credit Facility requiring the company to maintain borrowing capacity of not less than $6,750,000 on any business day or any five consecutive days in order to avoid triggering full control by an agent for the Lenders of the company's cash receipts for application to the company’s obligations under the agreement.

The Credit Agreement contains customary default provisions, with certain grace periods and exceptions, which provide for events of default that include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption of any material manufacturing facilities for more than 10 consecutive days. The proceeds of the North America Credit Facility will be used to finance the working capital and other business needs of the company. There was $22,150,000 of outstanding borrowings under the North America Credit Facility on September 30, 2021.

European Credit Facility

The Credit Agreement also provides for a revolving credit, letter of credit and swing line loan facility which gives the company and the European Borrowers the ability to borrow up to an aggregate principal amount of $30,000,000, with a $5,000,000 sublimit for letters of credit and a $2,000,000 sublimit for swing line loans (the “European Credit Facility”). Up to $15,000,000 of the European Credit Facility will be available to each of Invacare Limited (the “UK Borrower”) and Invacare Poirier SAS (the “French Borrower” and, together with the UK Borrower, the “European Borrowers”). The European Credit Facility matures in January 2024, together with the U.S. and Canadian Credit Facility.

The aggregate borrowing availability for each European Borrower under the European Credit Facility is determined based on a borrowing base formula. The aggregate borrowings of each of the European Borrowers under the European Credit Facility may not exceed an amount equal to (a) 85% of the European Borrower’s eligible accounts receivable, less (b) the European Borrower’s borrowings and swing line loans outstanding under the European Credit Facility, less (c) the European Borrower’s letters of credit issued and undrawn under the European Credit Facility, less (d) a $3,000,000 minimum availability reserve, less (e) other reserves required by the European Agent, and in each case subject to the definitions and limitations in the Credit Agreement. As of September 30, 2021, the gross borrowing base to the European Borrowers under the European Credit Facility was $22,684,000 and the net borrowing availability was $16,310,000, considering the $3,000,000 minimum availability reserve and a $3,375,000 dominion trigger amount described below. Borrowing availability is based on a prior
37
Notes to Financial StatementsLong-Term Liabilities
month base in USD. Actual borrowings in GBP and EUR fluctuate in USD between date of borrowing and when translated for consolidated reporting.

The aggregate principal amount of the European Credit Facility may be increased by up to $10,000,000 to the extent requested by the company and agreed to by any Lender or Lenders that wish to increase their lending participation or, if not agreed to by any Lender, a new financial institution that agrees to join the European Credit Facility and that is approved by the Administrative Agent and the European Agent.

Interest will accrue on outstanding indebtedness under the European Credit Facility at the LIBOR rate, plus a margin ranging from 2.50% to 3.00%, or for swing line loans, at the overnight LIBOR rate, plus a margin ranging from 2.50% to 3.00%, as selected by the company. The margin that will be adjusted quarterly based on utilization. Borrowings under the European Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization.

The European Credit Facility is secured by substantially all the personal property assets of the UK Borrower and its in-country subsidiaries, and all the receivables of the French Borrower and its in-country subsidiaries. The UK and French facilities (which comprise the European Credit Facility) are cross collateralized, and the US personal property assets previously pledged under the U.S. and Canadian Credit Facility also serve as collateral for the European Credit Facility.

The European Credit Facility is subject to customary representations, warranties and covenants generally consistent with those applicable to the U.S. and Canadian Credit Facility. Exceptions to the operating covenants in the Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale/leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Credit Agreement. The Credit Agreement also contains a covenant requiring the European Borrowers to maintain undrawn availability under the European Credit Facility of not less than (i) 12.5% of the maximum amount that may be drawn under the European Credit Facility for five (5) consecutive business days, or (ii) 11.25% of the maximum amount that may be drawn under the European credit facility on any business day. The European Borrowers also are subject to cash dominion triggers under the European Credit Facility requiring the European Borrower to maintain borrowing capacity of not less than $3,750,000 on any business day or $3,375,000 for five consecutive business days in order to avoid triggering full control by an agent for the Lenders of the European
Borrower’s cash receipts for application to its obligations under the European Credit Facility.

The European Credit Facility is subject to customary default provisions, with certain grace periods and exceptions, consistent with those applicable to the U.S. and Canadian Credit Facility, which provide that events of default include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, cross-default, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption in the operations of any material manufacturing facility for more than 10 consecutive days. The proceeds of the European Credit Facility will be used to finance the working capital and other business needs of the company. As of September 30, 2021, the company had borrowings of $9,446,000 (€8,000,000) under its French Credit Facility and $6,600,000 (£4,800,000) under its UK Credit Facility as of September 30, 2021, together referred to as the European Credit Facility.

In January 2021, the Credit Agreement was amended to provide for, among other things, the addition of the company's Netherlands subsidiary as a guarantor under the European revolving credit facility, amendments to the restrictive covenants in the Credit Agreement to (1) increase the maximum amount of permitted miscellaneous indebtedness to $30,000,000 from $10,000,000 and (2) permit up to $9,000,000 of financing based on certain European public and government receivables, and terms that, upon the occurrence of certain events related to a transition from the use of LIBOR, permit the agent for the lenders to amend the Credit Agreement to replace the LIBOR rate and/or the Euro rate with a benchmark replacement rate.

In March 2021, the Credit Agreement was further amended to permit the issuance of the 2026 Notes and the capped call transactions entered into by the company in connection with the issuance of the 2026 Notes, as further discussed in the sections below.

Convertible senior notes due 2021

In the first quarter of 2016, the company issued $150,000,000 aggregate principal amount of 5.00% Convertible Senior Notes due 2021 (the “2021 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2021 Notes bore interest at a rate of 5.00% per year payable semi-annually in arrears on February 15 and August 15 of each year, beginning August 15, 2016. The 2021 Notes matured on February 15, 2021. At maturity, $1,250,000 principal amount of 2021 Notes were outstanding, which the company repaid in cash.

38
Notes to Financial StatementsLong-Term Liabilities
In connection with the offering of the 2021 Notes, the company entered into privately negotiated convertible note hedge transactions with two financial institutions (the “option counterparties”). The company evaluated the note hedges under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the note hedges should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $27,975,000.

The company entered into separate, privately negotiated warrant transactions with the option counterparties at a higher strike price relating to the same number of the company’s common shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding common shares and the company’s earnings per share to the extent that the price of the company’s common shares exceeds the strike price of those warrants. The initial strike price of the warrants is $22.4175 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the warrants met the definition of a derivative, are indexed to the company's own stock and should be classified in shareholder's equity. The amount paid for the warrants and capitalized in shareholder's equity was $12,376,000.

The net proceeds from the offering of the 2021 Notes were approximately $144,034,000, after deducting fees and offering expenses of $5,966,000, which were paid in 2016. These debt issuance costs were capitalized and were amortized as interest expense through February 2021. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

During the third quarter of 2019, the company used an aggregate of $14,708,000 in cash to repurchase a total amount of $16,000,000 in principal amount of 2021 Notes. After recognizing expenses on unamortized fees and discounts associated with the repurchased 2021 Notes, the repurchases resulted in a net reduction of debt of $14,367,000 and a net loss on the repurchases of $280,000.

During the fourth quarter of 2019, the company entered into separate privately negotiated agreements with certain holders of its 2021 Notes to exchange $72,909,000 in aggregate principal amount of 2021 Notes for aggregate consideration of $72,909,000 in aggregate principal amount of new 5.00% Convertible Senior Exchange Notes due 2024 (the “Series I 2024 Notes”) of the company and $6,928,000 in cash. Refer to "Convertible senior notes Series I due 2024"
below for more information. As a result of the exchange transaction in the fourth quarter of 2019 and the repurchase of $16,000,000 in principal amount of 2021 Notes in the third quarter of 2019, a partial unwind of the note hedge options and warrants entered into with the issuance of the 2021 Notes also occurred during the fourth quarter of 2019. Note hedge options outstanding related to the 2021 Notes were reduced from the original number of 300,000 to 138,182 and warrants relating to the 2021 Notes were reduced from the initial number of 9,007,380 to 3,860,624. The partial unwind of the note hedge options and warrants resulted in no net impact to cash or paid in capital.

During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Exchange Notes due 2024 (the “Series II 2024 Notes”) of the company and $5,593,000 in cash.

During the third quarter of 2020, the company repurchased $24,466,000 aggregate principal amount of 2021 Notes, resulting in a $761,000 loss on debt extinguishment. As a result of the repurchase of 2021 Notes in the third quarter of 2020 and the exchange of 2021 Notes for new notes in the second quarter of 2020, a partial unwind of the note hedge options and warrants entered into with the issuance of the 2021 Notes also occurred. The partial unwind of the note hedge options and warrants resulted in no net impact to cash or paid-in-capital. Note hedge options outstanding relating to the 2021 Notes were reduced 62,341 and subsequently expired on February 15, 2021. The warrants began to expire on May 15, 2021 and then partially expire on each trading day over the 220 trading day period following May 15, 2021. Warrants outstanding on September 30, 2021 were 1,770,968. If exercised, one Common Share is issuable upon exercise of each warrant, but may be adjusted to include additional Common Shares for each warrant under certain circumstances if the relevant share price exceeds the warrant strike price for the relevant measurement period at the time of exercise. Common Shares are reserved for issuance upon exercise of the remaining warrants relating to the 2021 Notes at two Common Shares per warrant.
The liability components of the 2021 Notes consist of the following (in thousands):
39
Notes to Financial StatementsLong-Term Liabilities
September 30, 2021December 31, 2020
Principal amount of liability component$— $1,250 
Unamortized discount— (7)
Debt fees— (1)
Net carrying amount of liability component$— $1,242 

The unamortized discount was reduced to $0 upon adoption of ASU 2020-06, effective January 1, 2021. The effective interest rate on the liability component was 11.1% upon original issuance including consideration of the discount. Non-cash discount interest expense of $261,000 and $1,767,000 was recognized for the three and nine months ended September 30, 2020. Interest expense of $0 and $8,000 was accrued for the three and nine months ended September 30, 2021, compared to $241,000 and $1,617,000 for the three and nine months ended September 30, 2020 based on the stated coupon rate of 5.0%.

Convertible senior notes due 2022

In the second quarter of 2017, the company issued $120,000,000 aggregate principal amount of 4.50% Convertible Senior Notes due 2022 (the “2022 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2022 Notes bear interest at a rate of 4.50% per year payable semi-annually in arrears on June 1 and December 1 of each year, beginning December 1, 2017. The 2022 Notes will mature on June 1, 2022, unless repurchased or converted in accordance with their terms prior to such date. Prior to December 1, 2021, the 2022 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Prior to May 16, 2019, the 2022 Notes were convertible, subject to certain conditions, into cash only. On May 16, 2019, the company obtained shareholder approval under applicable New York Stock Exchange rules such that conversion of the 2022 Notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. At September 30, 2021, $2,650,000 aggregate principal amount of the 2022 Notes remained outstanding, following the exchange transactions completed in the second quarter of 2020 and the repurchase of debt completed in the first quarter of 2021, as further discussed below.

Holders of the 2022 Notes may convert their 2022 Notes at their option at any time prior to the close of business on the business day immediately preceding December 1, 2021 only under the following circumstances: (1) during any fiscal
quarter commencing after September 30, 2017 (and only during such fiscal quarter), if the last reported sale price of the company’s common shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2022 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2022 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2022 Notes on each such trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after December 1, 2021 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2022 Notes, holders may convert their 2022 Notes, at the option of the holder, regardless of the foregoing circumstances.

Holders of the 2022 Notes will have the right to require the company to repurchase all or some of their 2022 Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 61.6095 common shares per $1,000 principal amount of 2022 Notes (equivalent to an initial conversion price of approximately $16.23 per common share). Until the company received shareholder approval on May 16, 2019 authorizing it to elect to settle future conversions of the 2022 Notes in common shares, the company separately accounted for the conversion features as a derivative. The derivative was capitalized on the balance sheet as a long-term liability with adjustment to reflect fair value each quarter until the change to the conversion features as a result of the shareholder approval received on May 16, 2019 resulted in the termination of the derivative. The fair value of the convertible debt conversion liability at issuance was $28,859,000. The company recognized a loss of $6,193,000 in 2019 related to the convertible debt conversion liability.

In connection with the offering of the 2022 Notes, the company entered into privately negotiated convertible note hedge transactions with one financial institution (the “option counterparty”). These transactions cover, subject to customary anti-dilution adjustments, the number of the company’s common shares that will initially underlie the 2022 Notes, and are expected generally to reduce the potential equity dilution, and/or offset any cash payments in excess of the principal amount due, as the case may be, upon conversion of the 2022 Notes. The company evaluated the note hedges under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the note hedges
40
Notes to Financial StatementsLong-Term Liabilities
should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and were adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $24,780,000.

The company entered into separate, privately negotiated warrant transactions with the option counterparty at a higher strike price relating to the same number of the company’s common shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding common shares and the company’s earnings per share to the extent that the price of the company’s common shares exceeds the strike price of those warrants. The initial strike price of the warrants is $21.4375 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the warrants meet the definition of a derivative, are indexed to the company's own shares and should be classified in shareholder's equity. The amount paid for the warrants and capitalized in shareholder's equity was $14,100,000.

There were 120,000 note hedge options relating to the 2022 Notes outstanding at September 30, 2021, but only 2,650 remained available for exercise. Note hedge options related to the 2022 Notes will expire on June 1, 2022.

Warrants relating to the 2022 Notes outstanding on September 30, 2021 were 7,393,141. If exercised, one common share is issuance upon exercise of each warrant, but may be adjusted under certain circumstances if the relevant share price exceeds the warrant strike price for the relevant share price exceeds the warrant strike price for the relevant measurement period at the time of exercise. Common shares are reserved for issuance upon exercise of the remaining warrants relating to the 2022 Notes at two common shares per warrant. The warrants will begin to expire on September 1, 2022 and then partially expire on each trading day over the 220 trading day period following September 1, 2022.

The net proceeds from the offering of the 2022 Notes were approximately $115,289,000, after deducting fees and offering expenses of $4,711,000, which were paid in 2017. These debt issuance costs were capitalized and are being amortized as interest expense through June 2022. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. A portion of the net proceeds from the offering were used to pay the cost of the convertible note hedge transactions (after such cost is partially offset by the proceeds to the company from the warrant transactions), which net cost was $10,680,000.

During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new Series II 2024 Notes and $5,593,000 in cash.

During the first quarter of 2021, the company repurchased $78,850,000 in principal amount of 2022 Notes, resulting in a loss on debt extinguishment of $709,000.

The liability components of the 2022 notes consist of the following (in thousands):
September 30, 2021December 31, 2020
Principal amount of liability component$2,650 $81,500 
Unamortized discount— (6,772)
Debt fees(13)(859)
Net carrying amount of liability component$2,637 $73,869 

The unamortized discount was reduced to $0 upon adoption of ASU 2020-06, effective January 1, 2021. The effective interest rate on the liability component was 10.9% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption of ASU 2020-06 includes coupon interest and amortization of debt fees. Non-cash discount interest expense of $1,046,000 and $3,829,000 was recognized for the three and nine months ended September 30, 2020. Interest expense of $30,000 and $829,000 was accrued for the three and nine months ended September 30, 2021 compared to $917,000 and $3,487,000 for the three and nine months ended September 30, 2020 based on the stated coupon rate of 4.5%. The effective interest rate of the 2022 Notes as of September 30, 2021 was 5.3%. The 2022 Notes were not convertible as of September 30, 2021 nor was the applicable conversion threshold met.

Convertible senior notes Series I due 2024

During the fourth quarter of 2019, the company entered into separate privately negotiated agreements with certain holders of its 2021 Notes to exchange $72,909,000 in aggregate principal amount of 2021 Notes for aggregate consideration of $72,909,000 in aggregate principal amount of new 5.00% Convertible Senior Exchange Notes due 2024 (the “Series I 2024 Notes”) of the company and $6,928,000 in cash.

The notes bear interest at a rate of 5.00% per year payable semi-annually in arrears on May 15 and November 15 of each
41
Notes to Financial StatementsLong-Term Liabilities
year, beginning May 15, 2020. The notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series I 2024 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series 2024 Notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election.

Prior to the maturity of the Series I 2024 Notes, the company may, at its election, redeem for cash all or part of the Series I 2024 Notes if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the Series I 2024 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series I 2024 Notes, which means the company is not required to redeem or retire the Series I 2024 Notes periodically.

Holders of the Series I 2024 Notes may convert their Series I 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending December 31, 2019 (and only during such calendar quarter), if the last reported sale price of the company’s common shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the Series I 2024 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series I 2024 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s common shares and the applicable conversion rate for the Series I 2024 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series I 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the Series I 2024 Notes will have the right to require the company to repurchase all or some of their Series I 2024
Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 common shares per $1,000 principal amount of Series I 2024 Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series I 2024 Notes, holders may convert their Series I 2024 Notes, at the option of the holder, regardless of the foregoing circumstances.

A loss of $5,885,000 was recorded a part of the exchange transaction, which included the write-off of fees related to the portion of the 2021 Notes exchanged. Debt issuance costs of $1,394,000 were capitalized and are being amortized as interest expense through November 15, 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

The liability components of the Series I 2024 Notes consist of the following (in thousands):
September 30, 2021December 31, 2020
Principal amount of liability component$72,909 $72,909 
Unamortized discount— (8,888)
Debt fees(836)(1,037)
Net carrying amount of liability component$72,073 $62,984 

The unamortized discount was reduced to $0 upon adoption of ASU 2020-06, effective January 1, 2021. The effective interest rate on the liability component was 8.77% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption includes coupon interest and amortization of debt fees. Non-cash discount interest expense of $468,000 and $1,370,000 was recognized for the three and nine months ended September 30, 2020. Interest expense of $911,000 and $2,733,000 was accrued for the three and nine months ended September 30, 2021 compared to $912,000 and $2,735,000 for the three and nine months ended September 30, 2020 based on the stated coupon rate of 5.0%. The effective interest rate of the Series I 2024 notes as of September 30, 2021 was 5.4%. The Series I 2024 Notes were not convertible as of September 30, 2021 nor was the applicable conversion threshold met.

Convertible senior notes Series II due 2024

During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of
42
Notes to Financial StatementsLong-Term Liabilities
2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Exchange Notes due 2024 (the “Series II 2024 Notes”) of the company and $5,593,000 in cash.

The Series II 2024 Notes bear interest at a rate of 5.00% per year, payable semi-annually in arrears on May 15 and November 15 of each year, beginning November 15, 2020. The Series II 2024 Notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series II 2024 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series II 2024 Notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election.

Prior to the maturity of the Series II 2024 Notes, the company may, at its election, redeem for cash all or part of the Series II 2024 Notes, if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the accreted principal amount of the Series II 2024 Notes to be redeemed, plus any accrued and unpaid interest, if any, on the original principal amount of the New Notes redeemed to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series II 2024 Notes, which means the company is not required to redeem or retire the Series II 2024 Notes periodically.

Holders of the Series II 2024 Notes may convert their Series II 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the company’s common shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the Series II 2024 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series II 2024 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the
company’s common shares and the applicable conversion rate for the Series II 2024 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series II 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the Series II 2024 Notes will have the right to require the company to repurchase all or some of their Series II 2024 Notes at 100% of the accreted principal amount, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 common shares per $1,000 principal amount of Series II 2024 Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series II 2024 Notes, holders may convert their Series II 2024 Notes, at the option of the holder, regardless of the foregoing circumstances.

The principal amount of the Series II 2024 Notes also will accrete at a rate of approximately 4.7% per year commencing June 4, 2020, compounding on a semi-annual basis. The accreted portion of the principal is payable in cash upon maturity but does not bear interest and is not convertible into the company’s common shares. The total amount accreted as of September 30, 2021 was $4,450,000, of which $890,000 and $2,637,000 was for the three and nine months ended September 30, 2021, respectively and $762,000 and $1,016,000 for the three and nine months ended September 30, 2020, respectively. Remaining accretion until maturity (at current principal) was $12,172,000 at September 30, 2021.

A loss of $6,599,000 was recorded a part of the exchange transaction, which included the write-off of fees related to portions of the 2021 Notes and 2022 Notes exchanged. Debt issuance costs of $1,505,000 were capitalized and are being amortized as interest expense through November 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

The liability components of the Series II 2024 Notes consist of the following (in thousands):
September 30, 2021December 31, 2020
Principal amount of liability component - including accretion$78,325 $75,688 
Unamortized discount— (9,461)
Debt fees(1,055)(1,308)
Net carrying amount of liability component$77,270 $64,919 

The unamortized discount was reduced to $0 upon adoption of ASU 2020-06, effective January 1, 2021. The
43
Notes to Financial StatementsLong-Term Liabilities
effective interest rate on the liability component was 8.99% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption includes coupon interest, accretion and amortization of debt fees. Interest expense for accretion of $890,000 and $2,637,000 was accrued for the three and nine months ended September 30, 2021. Non-cash interest, including accretion, of $1,260,000 and $1,663,000 was recognized for the three and nine months ended September 30, 2020. Interest expense of $923,000 and $1,200,000 was recognized for the three and nine months ended September 30, 2020 compared to $923,000 and $2,770,000 for the three and nine months ended September 30, 2021 based on the stated coupon rate of 5.0%. The effective interest rate of the Series II 2024 Notes as of September 30, 2021 including coupon interest, amortization of debt fees and accretion to maturity was 10.3%. The Series II 2024 Notes were not convertible as of September 30, 2021 nor was the applicable conversion threshold met.

Convertible senior notes due 2026

In the first quarter of 2021, the company issued $125,000,000 aggregate principal amount of 4.25% Convertible Senior Notes due 2026 (the “2026 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act.

The notes bear interest at a rate of 4.25% per year payable semi-annually in arrears on March 15 and September 15 of each year, beginning September 15, 2021. The notes will mature on March 15, 2026, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to September 15, 2025, the 2026 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The 2026 Notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election.

The company may not redeem the 2026 Notes prior to March 20, 2024. The company may, at its election, redeem for cash all or part of the 2026 Notes, on or after March 20, 2024, if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the 2026 Notes,
which means the company is not required to redeem or retire the 2026 Notes periodically.

Holders of the 2026 Notes may convert their 2026 Notes at their option at any time prior to the close of business on the business day immediately preceding September 15, 2025 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2021 (and only during such calendar quarter), if the last reported sale price of the company’s common shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the 2026 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2026 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s common shares and the applicable conversion rate for the 2026 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls any or all of the 2026 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date. Holders of the 2026 Notes will have the right to require the company to repurchase all or some of their 2026 Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 94.6096 common shares per $1,000 principal amount of 2026 notes (equivalent to an initial conversion price of approximately $10.57 per common share). On or after September 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2026 Notes, holders may convert their 2026 Notes, at the option of the holder, regardless of the foregoing circumstances.

Debt issuance costs of $7,305,000 were capitalized and are being amortized as interest expense through March 2026. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

The liability components of the 2026 Notes consist of the following (in thousands):
September 30, 2021
Principal amount of liability component$125,000 
Debt fees(6,318)
Net carrying amount of liability component$118,682 

44
Notes to Financial StatementsLong-Term Liabilities
Interest expense of $1,328,000 and $2,892,000 was accrued for the three and nine months ended September 30, 2021 based on the stated coupon rate of 4.25%. The effective interest rate of the 2026 Notes as of September 30, 2021 was 5.3%. The 2026 Notes were not convertible as of September 30, 2021 nor was the applicable conversion threshold met.

In March 2021, in connection with the pricing of the 2026 Notes, the company entered into capped call transactions (the “Capped Call Transactions”) with certain option counterparties. The company used $18,787,000 of the net proceeds of the private offering of the 2026 Notes to pay the cost of the Capped Call Transactions with the offset recorded to additional paid-in-capital.

The Capped Call Transactions are expected generally to reduce the potential dilution upon conversion of the 2026 Notes and/or offset any cash payments the company is required to make in excess of the principal amount of converted notes, as the case may be, in the event that the market price per share of the company’s common shares, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which is initially $10.57, corresponding to the initial conversion price of the 2026 Notes, subject to anti-dilution adjustments. If, however, the market price per company common share, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions, which is initially $16.58 (subject to adjustments), there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the Capped Call Transactions. The Capped Call Transactions expire March 15, 2026, subject to earlier exercise. There were 125,000 capped call options related to the 2026 Notes outstanding on September 30, 2021.

The company will not be required to make any cash payments to the option counterparties upon the exercise of the options that are a part of the Capped Call Transactions, but the company will be entitled to receive from the option counterparties a number of company common shares, an amount of cash or a combination thereof generally based on the amount by which the market price per company common share, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions during the relevant valuation period under the Capped Call Transactions. However, if the market price per Company common share, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions during such valuation period, the number of company common shares and/or the amount of cash the company expects to receive upon exercise of the Capped Call Transactions will be capped based on the amount by
which the cap price exceeds the strike price of the Capped Call Transactions.

For any conversions of the 2026 Notes prior to September 15, 2025, a corresponding portion of the relevant Capped Call Transactions may be terminated at the company’s option. Upon any such termination, the company expects to receive from the option counterparties a number of company common shares, or, if the company so elects, subject to certain conditions, an amount of cash, in each case, with a value equal to the fair value of such portion of the relevant Capped Call Transactions being terminated, as calculated in accordance with the terms of the relevant Capped Call Transaction.

The Capped Call Transactions are separate transactions, in each case, entered into by the company with the option counterparties, and are not part of the terms of the 2026 Notes and will not affect any holder’s rights under the 2026 Notes. Holders of the 2026 Notes will not have any rights with respect to the Capped Call Transactions.

CARES Act Loan

On May 15, 2020 the company entered into an unsecured loan agreement in the aggregate amount of $10,000,000 pursuant to sections 1102 and 1106 of the Coronavirus Aid, Relief and Economic Security, "CARES," Act which was evidenced by a promissory note, dated May 13, 2020, and bears interest at a fixed rate of 1.00%. Payments which were to commence in May 2021 under the program, had been deferred until the third quarter of 2021. This loan may be forgivable, partially or in full, if certain conditions are met, principally based on having been disbursed for permissible purposes and based on average levels of employment over a designated period of time. At the time of the loan, no assurance could be given that the company would be granted forgiveness of the loan upon application in whole or in part. As of June 30, 2021, the company had recorded $10,000,000 of the amount borrowed in current maturities of long term debt.

In the third quarter of 2021, the company applied for forgiveness of the CARES Act debt along with its accrued interest. The company received notification of approval of its debt forgiveness inclusive of accrued interest, in full, and as a result, the company recorded a gain on extinguishment of debt of $10,131,000.
45
Notes to Financial StatementsLong-Term Liabilities
Other Long-Term Obligations

Other long-term obligations consist of the following (in thousands):
September 30, 2021December 31, 2020
Deferred income taxes$22,909 $23,234 
Product liability13,374 12,304 
Pension 9,063 9,088 
Deferred compensation6,380 5,318 
Deferred gain on sale leaseback5,257 5,502 
Supplemental executive retirement plan liability5,222 5,368 
Death benefit obligation plan4,537 4,723 
Uncertain tax obligation including interest3,124 3,114 
Other1,915 1,823 
Other Long-Term Obligations$71,781 $70,474 

On April 23, 2015, the company entered into a real estate sale leaseback transaction which resulted in the company recording an initial deferred gain of $7,414,000, the majority of which is included in Other Long-Term Obligations and will be recognized over the 20-year life of the leases. The gains realized were $80,000 and $237,000 for the three and nine months ended September 30, 2021 respectively, compared to $77,000 and $228,000 for the three and nine months ended September 30, 2020, respectively.














46
Notes to Financial StatementsLong-Term Liabilities
Leases and Commitments

The company reviews new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and certain non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.

The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2021, the company is committed under non-cancelable leases, which have initial or remaining terms in excess of one year and expire on various dates through 2040.

On April 23, 2015, the company sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the U.S. and Canadian Credit Facility. The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases.

In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company
recorded four finance leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the consolidated balance sheet. The gains realized were $80,000 and $237,000 for the three and nine months ended September 30, 2021 compared to $77,000 and $228,000 for the three and nine months ended September 30, 2020.

In December 2018, the company entered into a 20-year lease agreement in Germany. The lease commenced in July 2020. The lease increased the company's finance lease obligation by $36,916,000 and increased the finance lease expense compared to previous periods.

In December of 2020, the company entered into a 12.6-year lease agreement in Germany. The lease increased the company's finance lease obligation by $5,561,000 and increased the finance lease expense compared to previous periods.
Lease expenses for the three and nine months ended September 30, 2021 and September 30, 2020, respectively, were as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Operating leases$1,811 $1,926 $5,592 $6,210 
Variable and short-term leases764 1,077 2,825 2,936 
Total operating leases$2,575 $3,003 $8,417 $9,146 
Finance lease interest cost$1,146 $829 $3,487 $1,483 
Finance lease depreciation1,265 980 3,807 2,346 
Total finance leases$2,411 $1,809 $7,294 $3,829 










47
Notes to Financial StatementsLong-Term Liabilities


Future minimum operating and finance lease commitments, as of September 30, 2021, are as follows (in thousands):
Finance 
Leases		Operating Leases
2021$2,578 $2,022 
20227,068 4,424 
20236,964 2,466 
20246,892 1,808 
20256,797 1,442 
Thereafter80,350 2,565 
Total future minimum lease payments110,649 14,727 
Amounts representing interest(41,461)(2,432)
Present value of minimum lease payments69,188 12,295 
Less: current maturities of lease obligations(3,118)(4,553)
Long-term lease obligations$66,070 $7,742 
Supplemental cash flow amounts for the nine months ended September 30, 2021 were as follows (in thousands):
Cash Activity: Cash paid in measurement of amounts for lease liabilitiesSeptember 30, 2021
Operating leases$8,501 
Finance leases6,311 
Total$14,812 
Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligationsSeptember 30, 2021
Operating leases$5,418 
Finance leases6,345 
Total$11,763 




















Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2021:
September 30, 2021
Weighted-average remaining lease term - finance leases16.1 years
Weighted-average remaining lease term - operating leases4.9 years
Weighted-average discount rate - finance leases6.47%
Weighted-average discount rate - operating leases7.12%


48
Notes to Financial StatementsRevenue
Revenue

The company has two revenue streams: products and services. Services include repair, refurbishment, preventive maintenance and rental of product. Services for the North America segment include maintenance and repair of products. Services for the Europe segment include repair, refurbishment and preventive maintenance services. Services in All Other, are in the Asia Pacific region, and include rental and repair of products.

The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2021 and September 30, 2020 (in thousands):
Three Months Ended September 30, 2021
ProductServiceTotal
Europe$123,671 $3,355 $127,026 
North America87,936 118 88,054 
All Other7,788 1,332 9,120 
Total$219,395 $4,805 $224,200 
% Split98%2%100%
Nine Months Ended September 30, 2021
ProductServiceTotal
Europe$351,680 $9,417 $361,097 
North America259,623 652 260,275 
All Other21,010 3,884 24,894 
Total$632,313 $13,953 $646,266 
% Split98%2%100%
Three Months Ended September 30, 2020
ProductServiceTotal
Europe$113,043 $3,242 $116,285 
North America87,821 234 88,055 
All Other6,428 1,138 7,566 
Total$207,292 $4,614 $211,906 
% Split98%2%100%
Nine Months Ended September 30, 2020
ProductServiceTotal
Europe$329,943 $9,204 $339,147 
North America260,999 596 261,595 
All Other22,565 3,339 25,904 
Total$613,507 $13,139 $626,646 
% Split98%2%100%
The company's revenues are principally related to the sale of products, approximately 98%, with the remaining 2% related to services including repair, refurbishment, preventive maintenance and rental of products. While the company has a significant amount of contract types, the sales split by contract type is as follows: general terms and conditions (30%), large national customers (30%), governments, principally pursuant to tender contracts (21%) and other customers including buying groups and independent customers (19%).

All product and substantially all service revenues are recognized at a point in time. The remaining service revenue, recognized over time, are reflected in the Europe segment and include multiple performance obligations. For such contracts, the company allocates revenue to each performance obligation based on its relative standalone selling price. The company generally determines the standalone selling price based on the expected cost-plus margin methodology.    

Revenue is recognized when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the company’s products and services. Revenue is measured as the amount of consideration expected to be received in exchange for transferring product or providing services. The amount of consideration received and revenue recognized by the company can vary as a result of variable consideration terms included in the contracts related to customer rebates, cash discounts and return policies. Customer rebates and cash discounts are estimated based on the most likely amount principle and these estimates are based on historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such the company estimates the expected returns based on an analysis of historical experience. The company adjusts its estimate of revenue at the earlier of when the most likely amount of consideration it expects to receive changes or when the consideration becomes fixed. The company generally does not expect that there will be significant changes to its estimates of variable consideration (refer to “Receivables” and "Accrued Expenses" in the Notes to the Condensed Consolidated
49
Notes to Financial StatementsRevenue
Financial Statements include elsewhere in this report for more detail).

Depending on the terms of the contract, the company may defer the recognition of a portion of the revenue at the end of a reporting period to align with transfer of control of the company’s products to the customer. In addition, to the extent performance obligations are satisfied over time, the company defers revenue recognition until the performance obligations are satisfied. As of September 30, 2021 and December 31, 2020, the company had deferred revenue of $3,413,000 and $3,516,000, respectively, related to outstanding performance obligations.
50
Notes to Financial StatementsEquity Compensation
Equity Compensation

The company’s Common Shares have a $0.25 stated value. The Common Shares and the Class B Common Shares generally have identical rights, terms and conditions and vote together as a single class on most issues, except that the Class B Common Shares have ten votes per share and, in general, can only be transferred to family members or for estate planning purposes. Holders of Class B Common Shares are entitled to convert their shares into Common Shares at any time on a share-for-share basis. When Class B Common Shares are transferred out of a familial relationship, they automatically convert to Common Shares.

As of September 30, 2021, 3,667 Class B Common Shares remained outstanding. Prior conversions of Class B Common Shares have virtually eliminated the company’s dual class voting structure. As of September 30, 2021, the holders of the Common Shares represented approximately 99.9% of the company’s total outstanding voting power.

Equity Compensation Plan

On May 17, 2018, the shareholders of the company approved the Invacare Corporation 2018 Equity Compensation Plan (the “2018 Plan”), which was adopted on March 27, 2018 by the company's Board of Directors (the “Board”). The company’s Board adopted the 2018 Plan in order to authorize additional Common Shares for grant as equity compensation, and to reflect changes to Section 162(m) of the Internal Revenue Code (the “Code”) resulting from the U.S. Tax Cuts and Jobs Act of 2017.
Following shareholder approval of the 2018 Plan, all of the Common Shares then-remaining available for issuance under the Invacare Corporation 2013 Equity Compensation Plan (the “2013 Plan”) and all of the Common Shares that were forfeited or remained unpurchased or undistributed upon termination or expiration of awards under the 2013 Plan and under the Invacare Corporation 2003 Performance Plan (the “2003 Plan”), become available for issuance under the 2018 Plan. Awards granted previously under the 2013 Plan and 2003 Plan will remain in effect under their original terms.
The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of stock options or stock appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a stock option or a SAR will count against the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003
Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share.
The Compensation and Management Development Committee of the Board (the “Compensation Committee”), in its discretion, may grant an award under the 2018 Plan to any director or employee of the company or an affiliate. As of September 30, 2021, 3,439,806 Common Shares were available for future issuance under the 2018 Plan in connection with the following types of awards with respect to the company's Common Shares: incentive stock options, nonqualified stock options, SARs, restricted stock, restricted stock units, unrestricted stock and performance shares. The Compensation Committee also may grant performance units that are payable in cash. The Compensation Committee has the authority to determine which participants will receive awards, the amount of the awards and the other terms and conditions of the awards. The Common Shares available for future issuance under the 2018 Plan as of September 30, 2021 includes an additional 2,500,000 Common Shares that were added pursuant to an amendment approved by shareholders at the company’s 2021 annual shareholders meeting on May 20, 2021. 

At September 30, 2021, an aggregate of 802,637 Common Shares underlie awards which were forfeited or expired unexercised under the 2003 and 2013 Plans and thus are available to be transferred under the 2018 Plan.
The 2018 Plan provides that shares granted come from the company's authorized but unissued Common Shares or treasury shares. In addition, the company's stock-based compensation plans allow employee participants to exchange shares for minimum withholding taxes, which results in the company acquiring treasury shares.
51
Notes to Financial StatementsEquity Compensation
The amounts of equity-based compensation expense recognized as part of SG&A expenses in All Other in business segment reporting were as follows (in thousands):
For the Nine Months Ended September 30,
20212020
Restricted stock and restricted stock units$4,570 $4,471 
Performance shares and performance share units799 2,494 
Total stock-based compensation expense$5,369 $6,965 

As of September 30, 2021, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan and previous plans, which is related to non-vested options and shares, was as follows (in thousands):
September 30, 2021
Restricted stock and restricted stock units$7,924 
Performance shares and performance share units4,021 
Total unrecognized stock-based compensation expense$11,945 


Total unrecognized compensation cost will be adjusted for future changes in actual and estimated forfeitures and for updated vesting assumptions for the performance share awards (refer to "Stock Options" and "Performance Shares and Performance Share Units" below). No tax benefits for stock compensation were realized during the three and nine months ended September 30, 2021 and 2020, respectively, due to a valuation allowance against deferred tax assets. In accordance with ASC 718, any tax benefits resulting from tax deductions in excess of the compensation expense recognized is classified as a component of financing cash flows.

Stock Options

Generally, non-qualified stock option awards have a term of ten years and were granted with an exercise price per share equal to the fair market value of the company’s Common Shares on the date of grant.

The following table summarizes information about stock option activity for the nine months ended September 30, 2021:
Weighted Average
Exercise Price
Options outstanding at January 1, 20211,081,804 $16.07 
Forfeited(331,645)23.71
Options outstanding at September 30, 2021750,159 $12.69 
Options exercise price range at September 30, 2021$12.15 to$17.47 
Options exercisable at September 30, 2021750,159 
Shares available for grant at September 30, 2021*3,439,806 
________
 *    Shares available for grant under the 2018 Plan as of September 30, 2021 reduced by net restricted stock and restricted stock unit and performance share and performance share unit award activity of 2,671,108 shares.

The following table summarizes information about stock options outstanding at September 30, 2021:
 Options OutstandingOptions Exercisable
Exercise PricesNumber
Outstanding at
September 30, 2021		Weighted Average
Remaining
Contractual Life (Years)		Weighted Average
Exercise Price		Number
September 30, 2021		Weighted Average
Exercise Price
$12.15 – $20.00
750,159 4.2$12.69 750,159 $12.69 

52
Notes to Financial StatementsEquity Compensation

The 2018 Plan provides for a one-year minimum vesting period for stock options and, generally, options must be exercised within ten years from the date granted. No stock options were issued in 2021 or 2020.

Restricted Stock and Restricted Stock Units

The following table summarizes information about restricted stock and restricted stock units (primarily for non-U.S. recipients):
Weighted Average Fair Value
Restricted stock / units unvested at January 1, 20211,145,058 $8.62 
Granted647,743 8.46 
Vested(550,258)9.34 
Forfeited(55,685)8.47 
Restricted stock / units unvested at September 30, 20211,186,858 $8.20 

The restricted awards generally vest ratably over the three years after the award date. Unearned restricted stock compensation, determined as the market value of the shares at the date of grant, is being amortized on a straight-line basis over the vesting period.

Performance Shares and Performance Share Units

The following table summarizes information about performance shares and performance share units (primarily for non-U.S. recipients):
 Weighted Average Fair Value
Performance shares / units unvested at January 1, 20211,026,785 $8.55 
Granted471,819 8.49 
Performance shares / units unvested at September 30, 20211,498,604 $8.53 


During the nine months ended September 30, 2021, performance shares and performance share units (for non-U.S. recipients) were granted as performance awards with a three year performance period with payouts based on achievement of certain performance goals. The awards are classified as equity awards as they will be settled in common shares upon vesting. The number of shares earned will be determined at the end of the three-year performance period based on achievement of performance criteria for January 1, 2018 through December 31, 2020, January 1, 2019 through
December 31, 2021, January 1, 2020 through December 31, 2022 and January 1, 2021 through December 31, 2023, respectively established by the Compensation Committee at the time of grant. Recipients will be entitled to receive a number of Common Shares equal to the number of performance shares that vest based upon the levels of achievement which may range between 0% and 150% of the target number of shares with the target being 100% of the initial grant.

The fair value of the performance awards is based on the stock price on the date of grant discounted for the estimated value of dividends foregone as the awards are not eligible for dividends except to the extent vested. The grant fair value is further updated each reporting period while variable accounting applies. The company assesses the probability that the performance targets will be met with expense recognized whenever it is probable that at least the minimum performance criteria will be achieved. Depending upon the company's assessment of the probability of achievement of the goals, the company may not recognize any expense associated with performance awards in a given period, may reverse prior expense recorded or record additional expense to recognize the cumulative estimated achievement level of proportionate term of the award. Performance award compensation expense is generally expected to be recognized over three years. The company continues to recognize expense related to the awards granted in 2019, 2020 and 2021 as it is considered probable that the performance goals for those awards will be met.

In the third quarter of 2021, reduced stock compensation expense was a benefit and is attributable to updated payout projections and change in the share price.


53
Notes to Financial StatementsAccumulated Other Comprehensive Income
Accumulated Other Comprehensive Income by Component

Changes in accumulated other comprehensive income ("OCI") (in thousands):
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2021$60,381 $2,146 $(4,069)$(1,379)$57,079 
OCI before reclassifications(19,155)(47)(209)944 (18,467)
Amount reclassified from accumulated OCI— — 182 309 491 
Net current-period OCI(19,155)(47)(27)1,253 (17,976)
September 30, 2021$41,226 $2,099 $(4,096)$(126)$39,103 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2020$50,329 $(517)$(3,674)$(702)$45,436 
OCI before reclassifications(9,103)2,616 (440)(643)(7,570)
Amount reclassified from accumulated OCI— — 18 1,219 1,237 
Net current-period OCI(9,103)2,616 (422)576 (6,333)
September 30, 2021$41,226 $2,099 $(4,096)$(126)$39,103 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2020$16,455 $(9,133)$(3,468)$794 $4,648 
OCI before reclassifications35,231 713 281 (2,501)33,724 
Amount reclassified from accumulated OCI— — (474)739 265 
Net current-period OCI35,231 713 (193)(1,762)33,989 
September 30, 2020$51,686 $(8,420)$(3,661)$(968)$38,637 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2019$8,898 $(2,491)$(3,299)$20 $3,128 
OCI before reclassifications42,788 (5,929)122 (1,340)35,641 
Amount reclassified from accumulated OCI— — (484)352 (132)
Net current-period OCI42,788 (5,929)(362)(988)35,509 
September 30, 2020$51,686 $(8,420)$(3,661)$(968)$38,637 











54
Notes to Financial StatementsAccumulated Other Comprehensive Income
Reclassifications out of accumulated OCI were as follows (in thousands):
Amount reclassified from OCIAmount reclassified from OCIAffected line item in the Statement of Comprehensive (Income) Loss
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Defined Benefit Plans 
Service and interest costs$182 $(474)$18 $(484)Selling, general and administrative expenses
Tax— — — — Income tax provision
Total after tax$182 $(474)$18 $(484)
Derivatives
Foreign currency forward contracts hedging sales$476 $(481)$657 $(692)Net sales
Foreign currency forward contracts hedging purchases(92)1,259 746 1,029 Cost of products sold
Total loss before tax384 778 1,403 337 
Tax(75)(39)(184)15 Income tax provision
Total after tax$309 $739 $1,219 $352 
55
Notes to Financial StatementsCharges Related to Restructuring Activities
Charges Related to Restructuring Activities

The company's restructuring charges were originally necessitated primarily by continued declines in Medicare and Medicaid reimbursement by the U.S. government, as well as similar healthcare reimbursement pressures abroad, which negatively affect the company's customers (e.g. home health care providers) and continued pricing pressures faced by the company due to the outsourcing by competitors to lower cost locations. Restructuring decisions were also the result of reduced profitability in each of the segments. Restructuring actions have continued into 2021.

For the nine months ended September 30, 2021, charges totaled $2,476,000 which were related to North America of $975,000 and Europe of $1,501,000. In North America costs were incurred related to severance. The European charges were for severance costs of $895,000 and contract terminations of $606,000, primarily related to the closure of a German manufacturing facility. Payments for the nine months ended September 30, 2021 were $7,367,000 and the cash payments were funded with the company's cash on hand. The 2021 charges are expected to be paid out within 24 months.
For the nine months ended September 30, 2020, charges totaled $4,657,000 which were related to North America of $865,000, Europe of $3,674,000 and All Other of $118,000. In North America and All Other, costs were incurred related to severance. The European charges were for severance costs $3,328,000 and contract terminations $346,000 primarily related to the closure of a German manufacturing facility. Payments for the nine months ended September 30, 2020 were $5,692,000 and the cash payments were funded with company's cash on hand. Most of the 2020 charges have been paid out.
There have been no material changes in accrued balances related to the charges, either as a result of revisions to the plans or changes in estimates. In addition, the savings anticipated as a result of the company's restructuring plans have been or are expected to be achieved, primarily resulting in reduced salary and benefit costs principally impacting selling, general and administrative expenses, and to a lesser extent, costs of products sold. To date, the company's liquidity has been sufficient to absorb these charges and payments.

56
Notes to Financial StatementsCharges Related to Restructuring Activities
A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2021 is as follows (in thousands):
SeveranceContract TerminationsTotal
December 31, 2020 Balances
North America$179 $— $179 
Europe5,904 4 5,908 
All Other166 — 166 
Total6,249 4 6,253 
Charges
North America 822 — 822 
Europe454 276 730 
All Other— — — 
Total 1,276 276 1,552 
Payments
North America (236)— (236)
Europe (6,047)— (6,047)
All Other— — — 
Total (6,283)— (6,283)
March 31, 2021 Balances
North America765 — 765 
Europe311 280 591 
All Other166 — 166 
Total$1,242 $280 $1,522 
Charges
North America$31 $— $31 
Europe408 108 516 
All Other— — — 
Total439 108 547 
Payments
North America(91)— (91)
Europe(234)(198)(432)
All Other(18)— (18)
Total(343)(198)(541)
June 30, 2021 Balances
North America705 — 705 
Europe485 190 675 
All Other148 — 148 
Total$1,338 $190 $1,528 
Charges
North America122 — 122 
Europe33 222 255 
All Other— — — 
Total155 222 377 
Payments
North America(225)— (225)
Europe(308)(34)(342)
All Other24 — 24 
Total(509)(34)(543)
57
Notes to Financial StatementsCharges Related to Restructuring Activities
SeveranceContract TerminationsTotal
September 30, 2021 Balances
North America602 — 602 
Europe210 378 588 
All Other172 — 172 
Total$984 $378 $1,362 
58
Notes to Financial StatementsIncome Taxes
Income Taxes

The company had an effective tax rate of 8.8% and 11.3% on losses before tax for the three and nine months ended September 30, 2021, respectively, compared to an expected benefit of 21.0% on the pre-tax loss for each period. The company had an effective tax rate of 39.2% and 26.8% on losses before tax for the three and nine months ended September 30, 2020, respectively, compared to an expected benefit of 21.0% on the pre-tax loss for each period. The company's effective tax rate for the three and nine months ended September 30, 2021 and September 30, 2020 were unfavorable as compared to the U.S. federal statutory rate, principally due to the negative impact of the company not being able to record tax benefits related to the significant losses in countries which had tax valuation allowances. The effective tax rate was increased for the three and nine months ended September 30, 2021 and September 30, 2020 by certain taxes outside the United States, excluding countries with tax valuation allowances, that were at an effective rate higher than the U.S. statutory rate, except for the gain on the disposition of Dynamic Controls which was not taxable locally for the three months ended March 31, 2020. In addition, the company had accrued withholding taxes on earnings of its Chinese subsidiary based on the expectation of not permanently reinvesting those earnings. The sale of this entity, without such distribution resulted in the reversal of this accrual in the amount of $988,000 for the three months ended March 31, 2020. As a result of the impairment of goodwill in North America in the three and nine months ended September 30, 2021, the company recorded a reversal of deferred taxes related to the tax deductible goodwill previously deducted by the company, resulting in the company recognizing a tax benefit of $661,000 for the three and nine months ended September 30, 2021.

59
Notes to Financial StatementsNet Income (Loss) Per Common Share
Net Loss Per Common Share

The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.
(In thousands except per share data)For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Basic
Weighted average common shares outstanding35,013 34,419 34,826 34,213 
Net loss$(22,759)$(7,276)$(47,501)$(23,163)
Net loss per common share$(0.65)$(0.21)$(1.36)$(0.68)
Diluted
Weighted average common shares outstanding35,013 34,419 34,826 34,213 
Share options and awards475 111 545 100 
Weighted average common shares assuming dilution35,488 34,530 35,371 34,313 
Net loss$(22,759)$(7,276)$(47,501)$(23,163)
Net loss per common share *$(0.65)$(0.21)$(1.36)$(0.68)
________
* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
For the three and nine months ended September 30, 2021, shares associated with equity compensation awards of 682,668 and 1,163,526, respectively, and for the three and nine months September 30, 2020, shares associated with equity compensation awards of 1,703,694 and 1,703,694, respectively, were excluded from the weighted average common shares assuming dilution as incremental shares were anti-dilutive.

At September 30, 2021, the majority of the anti-dilutive incremental shares were awards granted at an exercise price above $14.49, which was higher than the average fair market value price of $7.30 and $8.30 for the three and nine months ended September 30, 2021. At September 30, 2020, the majority of the anti-dilutive incremental shares were awards granted at an exercise price above $24.45 or above, which was higher than the average fair market value price of $6.93 and $7.12 for the three and nine months ended September 30, 2020.

For the three and nine months ended September 30, 2021 and September 30, 2020, respectively, no shares were included in the common shares assuming dilution related to the company's issued warrants as the average market price of the company shares for these periods did not exceed the strike price of the warrants.

Further, upon adoption of ASU 2020-06, effective in 2021 for the company, use of the if-converted earnings per share method is required. However, no shares were included in the weighted average common shares assuming dilution for the three months and nine months ended September 30, 2021 related to the company's convertible senior notes as conversion prices were above the company's average stock price for the period and other requirements for the notes to be convertible to shares were not met.

60
Notes to Financial StatementsConcentration of Credit Risk
Concentration of Credit Risk

The company manufactures and distributes durable medical equipment to the home health care, retail and extended care markets. The company performs credit evaluations of its customers’ financial condition. The company utilizes De Lage Landen, Inc. (“DLL”), a third-party financing company, to provide lease financing to Invacare's U.S. customers. The DLL agreement provides for direct leasing between DLL and the Invacare customer. The company retains a recourse obligation of $858,000 at September 30, 2021 to DLL for events of default under the contracts, which total $6,919,000 at September 30, 2021. Guarantees, ASC 460, requires the company to record a guarantee liability as it relates to the limited recourse obligation. As such, the company has recorded a liability for this guarantee obligation within other long-term obligations. The company's recourse is reevaluated by DLL biannually, considers activity between the biannual dates and excludes any receivables purchased by the company from DLL. The company monitors the collections status of these contracts and has provided amounts for estimated losses in its allowances for doubtful accounts in accordance with Receivables, ASC 310-10-05-4. Credit losses are provided for in the financial statements.































Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities located throughout the United States, Australia, Canada, New Zealand and Europe or also direct from governmental entities in certain countries. A significant portion of products sold to dealers, both foreign and domestic, is ultimately funded through government reimbursement programs such as Medicare and Medicaid. Changes in these programs can have a significant shift in reimbursement to customers from managed care entities. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability. In addition, reimbursement guidelines in the home health care industry have a substantial impact on the nature and type of equipment an end user can obtain as well as the timing of reimbursement and, thus, affect the product mix, pricing and payment patterns of the company’s customers.

61
Notes to Financial StatementsDerivatives
Derivatives

ASC 815 requires companies to recognize all derivative instruments in the consolidated balance sheet as either assets or liabilities at fair value. The accounting for changes in fair value of a derivative is dependent upon whether or not the derivative has been designated and qualifies for hedge accounting treatment and the type of hedging relationship. For derivatives designated and qualifying as hedging instruments, the company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

Cash Flow Hedging Strategy

The company uses derivative instruments in an attempt to manage its exposure to transactional foreign currency exchange risk. Foreign forward exchange contracts are used to manage the price risk associated with forecasted sales denominated in foreign currencies and the price risk associated with forecasted purchases of inventory over the next twelve months.

The company recognizes its derivative instruments as assets or liabilities in the consolidated balance sheet measured at fair value. All the company’s derivative instruments are designated and qualify as cash flow hedges. Accordingly, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The remaining gain or loss on the derivative instrument in excess of the cumulative change in the fair value of the hedged item, if any, is recognized in current earnings during the period of change.



















To protect against increases/decreases in forecasted foreign currency cash flows resulting from inventory purchases/sales over the next year, the company utilizes foreign currency forward contracts to hedge portions of its forecasted purchases/sales denominated in foreign currencies. The gains and losses are included in cost of products sold and selling, general and administrative expenses on the condensed consolidated statement of comprehensive income (loss). If it is later determined that a hedged forecasted transaction is unlikely to occur, any prospective gains or losses on the forward contracts would be recognized in earnings. The company does not expect any material amount of hedge ineffectiveness related to forward contract cash flow hedges during the next twelve months.

The company has historically not recognized any material amount of ineffectiveness related to forward contract cash flow hedges because the company generally limits its hedges to between 50% and 90% of total forecasted transactions for a given entity’s exposure to currency rate changes and the transactions hedged are recurring in nature. Furthermore, most of the hedged transactions are related to intercompany sales and purchases for which settlement occurs on a specific day each month. Forward contracts with a total notional amount in USD of $90,800,000 and $155,783,000 matured for the nine months ended September 30, 2021 and September 30, 2020, respectively.






62
Notes to Financial StatementsDerivatives
Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):
 September 30, 2021December 31, 2020
 Notional
Amount		Unrealized
Net Gain
(Loss)		Notional
Amount		Unrealized
Net Gain
(Loss)
USD / CHF321 4 1,675 (11)
USD / EUR14,840 83 56,187 (636)
USD / GBP644 (23)2,467 (19)
USD / SEK727 (4)2,658 (41)
USD / MXN817 98 2,230 334 
EUR / CHF1,119 2 5,037 10 
EUR / GBP4,960 (218)19,060 44 
EUR / SEK2,882 (40)10,162 (73)
EUR / NOK1,215 (66)4,167 (64)
AUD / NZD190 1 781 (13)
DKK / SEK750 6 3,329 9 
NOK / SEK823 (39)3,431 (50)
AUD / THB— — 4,963 (221)
NZD / THB425 (42)1,755 (55)
USD / THB624 60 4,152 (56)
EUR / THB188 13 1,332 18 
GBP / THB— — 842 10 
$30,525 $(165)$124,228 $(814)

Derivatives Not Qualifying or Designated for Hedge Accounting Treatment

The company utilizes foreign currency forward contracts that are not designated as hedges in accordance with ASC 815. These contracts are entered into to eliminate the risk associated with the settlement of short-term intercompany trading receivables and payables between Invacare Corporation and its foreign subsidiaries. The currency forward contracts are entered into at the same time as the intercompany
receivables or payables are created so that upon settlement, the gain/loss on the settlement is offset by the gain/loss on the foreign currency forward contract. No material net gain or loss was realized by the company in 2021 or 2020 related to these contracts and the associated short-term intercompany trading receivables and payables.
















63
Notes to Financial StatementsDerivatives

Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2021 and 2020, respectively, and outstanding were as follows (in thousands USD):
 September 30, 2021December 31, 2020
 Notional
Amount		Gain
(Loss)		Notional
Amount		Gain
(Loss)
USD / AUD$6,153 $50 $6,046 $(159)
USD / CAD14,616 (74)8,320 88 
USD / EUR60,000 (494)— — 
USD / DKK21,732 (198)8,690 207 
USD / GBP38,144 (438)16,062 338 
USD / NOK22,798 11 9,053 264 
USD / SEK4,597 (37)— — 
EUR / GBP8,157 (22)— — 
AUD / NZD6,790 (77)6,579 (35)
EUR / CHF5 — — — 
AUD / THB1,206 (107)— — 
USD / THB414 40 — — 
EUR / THB126 9 — — 
GBP / THB198 22 — — 
$184,936 $(1,315)$54,750 $703 

The fair values of the company’s derivative instruments were as follows (in thousands):
 September 30, 2021December 31, 2020
 AssetsLiabilitiesAssetsLiabilities
Derivatives designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts$267 $432 $424 $1,238 
Derivatives not designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts339 1,654 897 194 
Total derivatives$606 $2,086 $1,321 $1,432 

The fair values of the company’s foreign currency forward exchange contract assets and liabilities are included in Other Current Assets and Accrued Expenses, respectively in the Condensed Consolidated Balance Sheets.

The effect of derivative instruments on Accumulated Other Comprehensive Income (OCI) and the Condensed Statement of Comprehensive Income (Loss) was as follows (in thousands):
64
Notes to Financial StatementsDerivatives
Derivatives (foreign currency forward exchange contracts) in ASC 815 cash flow hedge
relationships		Amount of Gain
(Loss) Recognized  in Accumulated OCI on Derivatives
(Effective Portion)		Amount of Gain (Loss)
Reclassified from
Accumulated OCI into
Income (Effective
Portion)		Amount of Gain (Loss)
Recognized in Income on
Derivatives (Ineffective  Portion and Amount Excluded from
Effectiveness Testing)
Three months ended September 30, 2021
Foreign currency forward exchange contracts$944 $(309)$51 
Nine months ended September 30, 2021
Foreign currency forward exchange contracts$(643)$(1,219)$(37)
Three months ended September 30, 2020
Foreign currency forward exchange contracts$(2,501)$(739)$(662)
Nine months ended September 30, 2020
Foreign currency forward exchange contracts$(1,340)$(352)$(718)
Derivatives (foreign currency forward exchange contracts) not designated as hedging
instruments under ASC 815		  Amount of Gain (Loss)
Recognized in Income on Derivatives
Three months ended September 30, 2021
Foreign currency forward exchange contracts$(592)
Nine months ended September 30, 2021
Foreign currency forward exchange contracts$(1,315)
Three months ended September 30, 2020
Foreign currency forward exchange contracts$(1,320)
Nine months ended September 30, 2020
Foreign currency forward exchange contracts$(1,077)
The gains or losses recognized as the result of the settlement of cash flow hedge foreign currency forward contracts are recognized in net sales for hedges of inventory sales and in cost of products sold for hedges of inventory purchases. For the three and nine months ended September 30, 2021, net sales were decreased by $476,000 and $657,000 while cost of products sold was decreased by $92,000 and increased by $746,000 for net pre-tax realized losses of $384,000 and $1,403,000, respectively. For the three and nine months ended September 30, 2020, net sales were increased by $481,000 and $692,000 while cost of products sold was increased by $1,259,000 and $1,029,000 for net realized pre-tax losses of $778,000 and $337,000, respectively.

Losses of $592,000 and $1,315,000 were recognized in selling, general and administrative (SG&A) expenses for the three and nine months ended September 30, 2021 compared to losses of $1,320,000 and $1,077,000 for the three and nine months ended September 30, 2020 related to forward contracts not designated as hedging instruments. The forward contracts were entered into to offset gains/losses that were also recorded in SG&A expenses on intercompany trade receivables or payables. The gains/losses on the non-designated hedging instruments were substantially offset by gains/losses on intercompany trade payables.

The company's derivative agreements provide the counterparties with a right of set off in the event of a default. The right of set off would enable the counterparty to offset any net payment due by the counterparty to the company under the applicable agreement by any amount due by the company to the counterparty under any other agreement. For example, the terms of the agreement would permit a counterparty to a derivative contract that is also a lender under the company's Credit Agreement to reduce any derivative settlement amounts owed to the company under the derivative contract by any amounts owed to the counterparty by the company under the Credit Agreement. In addition, the agreements contain cross-default provisions that could trigger a default by the company under the agreement in the event of a default by the company under another agreement with the same counterparty. The company presents derivatives on a net basis in its financial statements for those subject to provisions that are similar to master netting agreements.


65
Notes to Financial StatementsFair Values
Fair Values

Pursuant to ASC 820, the inputs used to derive the fair value of assets and liabilities are analyzed and assigned a level I, II or III priority, with level I being the highest and level III being the lowest in the hierarchy. Level I inputs are quoted prices in active markets for identical assets or liabilities.



Level II inputs are quoted prices for similar assets or liabilities in active markets: quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. Level III inputs are based on valuations derived from valuation techniques in which one or more significant inputs are unobservable.
The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):
 Basis for Fair Value Measurements at Reporting Date
Quoted Prices in Active
Markets for Identical
Assets / (Liabilities)		Significant Other
Observable
Inputs		Significant Other
Unobservable
Inputs
Level ILevel IILevel III
September 30, 2021
Forward exchange contracts—net—$(1,480)—
December 31, 2020
Forward exchange contracts—net—$(111)—

The carrying values and fair values of the company’s financial instruments are as follows (in thousands):
 September 30, 2021December 31, 2020
 Carrying ValueFair ValueCarrying ValueFair Value
Cash and cash equivalents$73,656 $73,656 $105,298 $105,298 
Other investments84 84 85 85 
Installment receivables, net of reserves1,160 1,160 1,322 1,322 
Forward contracts in Other current assets606 606 1,321 1,321 
Forward contracts in Accrued expenses(2,086)(2,086)(1,432)(1,432)
Total debt (including current maturities of long-term debt) *(309,455)(279,747)(245,053)(237,948)
2021 Notes — — (1,242)(1,264)
2022 Notes(2,637)(2,559)(73,869)(70,633)
Series I 2024 Notes(72,073)(64,643)(62,984)(60,035)
Series II 2024 Notes(77,270)(73,697)(64,919)(64,090)
2026 Notes(118,682)(100,055)— — 
Other(38,793)(38,793)(42,039)(41,926)
________
* The company's total debt is shown net of applicable discounts and fees associated with the convertible senior notes due in 2021, 2022, 2024 and 2026 on the company's condensed consolidated balance sheet. Accordingly, the fair values of the convertible senior notes due in 2021, 2022, 2024 and 2026 included in the long-term debt presented in this table are also shown net of the discounts and fees. Discount balances applicable to the company's convertible senior notes were eliminated upon adoption of ASU 2020-06 on January 1, 2021, but are included in the balances above for the period prior to adoption. Refer to Long-Term Debt footnote for discount balances by convertible senior notes series. Total debt excludes operating and finance leases obligations.
66
Notes to Financial StatementsFair Values
The company, in estimating its fair value disclosures for financial instruments, used the following methods and assumptions:

Cash, cash equivalents: The carrying value reported in the balance sheet for cash, cash equivalents equals its fair value.

Other investments: The company has an investment in a limited partnership, which is accounted for using the cost method, adjusted for any estimated declines in value. The investment was acquired in private placement and there is no quoted market price or stated rate of return. The company does not have the ability to easily sell the investment. The company completes an evaluation of the residual value related to such investments in the fourth quarter of each year.

Installment receivables: The carrying value reported in the balance sheet for installment receivables approximates its fair value. The interest rates associated with these receivables have not varied significantly since inception. Management believes that after consideration of the credit risk, the net book value of the installment receivables approximates market value.
































Forward contracts: The company operates internationally, and as a result, is exposed to foreign currency fluctuations. Specifically, the exposure includes intercompany loans and third-party sales or payments. In an attempt to reduce this exposure, foreign currency forward contracts are utilized and accounted for as hedging instruments. The forward contracts are used to hedge the following currencies: AUD, CAD, CHF, DKK, EUR, GBP, MXN, NOK, NZD, SEK, THB, and USD. The company does not use derivative financial instruments for speculative purposes. Fair values for the company’s foreign exchange forward contracts are based on quoted market prices for contracts with similar maturities. The company’s forward contracts are included in Other current assets or Accrued expenses in the condensed consolidated balance sheets.

Total debt: Fair value for the company’s convertible debt is based on quoted market-based estimates as of the end of the period, while the revolving credit facility fair value is based upon an estimate of the market for similar borrowing arrangements. The fair values are deemed to be categorized as Level 2 in the fair value hierarchy. Other total debt is primarily attributable to credit facilities borrowings where the carrying value reported in the balance approximates its fair value and the CARES Act Loan as of December 31, 2020 which utilized the fair value factor of the 2022 Notes to approximate fair value. At September 30, 2021 the CARES Act Loan balance was zero.
67
Notes to Financial StatementsBusiness Segments
Business Segments
The company operates in two primary business segments: North America and Europe with each selling the company's primary product categories, which include: lifestyle, mobility and seating and respiratory therapy products. Sales in Asia Pacific are reported in All Other and include products similar to those sold in North America and Europe. The accounting policies of each segment are the same as those described in the summary of significant accounting policies for the company's consolidated financial statements. Intersegment sales and transfers are based on the costs to manufacture plus a reasonable profit element.

Segment performance is measured and resources are allocated based on a number of factors, with the primary income or loss measure being segment operating income (loss). Segment operating income (loss) represents net sales less cost of products sold less selling general and administrative expenses. Segment operating income (loss)
excludes unallocated corporate general and administrative expenses not allocated to the segments and intersegment sales and profit eliminations, which are included in All Other. In addition, segment operating income (loss) further excludes charges related to restructuring activities, asset impairment and gain on sale of business (as applicable).

This performance measure, segment operating income (loss), is used by the Chief Operating Decision Maker (CODM) for purposes of making decisions about allocating resources to a segment and assessing its performance. In addition, this metric is reviewed by the company's Board of Directors regarding segment performance and is a key metric in the performance management assessment of the company's employees.




68
Notes to Financial StatementsBusiness Segments
The information by segment is as follows (in thousands):
 For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Revenues from external customers
Europe$127,026 $116,285 $361,097 $339,147 
North America88,054 88,055 260,275 261,595 
All Other (Asia Pacific)9,120 7,566 24,894 25,904 
Consolidated$224,200 $211,906 $646,266 $626,646 
Intersegment revenues
Europe$6,221 $6,027 $17,758 $14,438 
North America15,044 23,625 45,903 66,356 
All Other (Asia Pacific)— 1,116 — 3,645 
Consolidated$21,265 $30,768 $63,661 $84,439 
Restructuring charges before income taxes
Europe$255 $1,434 $1,501 $3,674 
North America122 146 975 865 
All Other— — — 118 
Consolidated$377 $1,580 $2,476 $4,657 
Operating income (loss)
Europe$9,554 $7,600 $18,378 $16,624 
North America(1,523)2,992 (2,308)5,759 
All Other(3,856)(6,082)(19,025)(17,377)
Charge expense related to restructuring activities(377)(1,580)(2,476)(4,657)
Gain on sale of business— — — 9,790 
Impairment of goodwill(28,564)— (28,564)— 
Consolidated operating income (loss)(24,766)2,930 (33,995)10,139 
Gain (loss) on debt extinguishment including debt finance charges and associated fees10,131 (761)9,422 (7,360)
Net interest expense(6,284)(7,395)(18,098)(21,042)
Loss before income taxes$(20,919)$(5,226)$(42,671)$(18,263)
69
Notes to Financial StatementsBusiness Segments
Net sales by product, are as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Europe
Lifestyle$61,683 $50,307 $181,628 $160,628 
Mobility and Seating56,535 54,851 152,660 147,275 
Respiratory Therapy4,225 6,070 13,613 16,680 
Other(1)4,583 5,057 13,196 14,564 
$127,026 $116,285 $361,097 $339,147 
North America
Lifestyle$38,666 $41,845 $114,951 $124,888 
Mobility and Seating28,414 26,572 82,243 82,485 
Respiratory Therapy20,856 19,405 62,429 53,626 
Other(1)118 233 652 596 
$88,054 $88,055 $260,275 $261,595 
All Other (Asia Pacific)
Mobility and Seating$3,171 $2,670 $9,239 $10,757 
Lifestyle3,230 3,375 8,736 10,176 
Respiratory Therapy1,215 195 2,547 1,043 
Other(1)1,504 1,326 4,372 3,928 
$9,120 $7,566 $24,894 $25,904 
Total Consolidated$224,200 $211,906 $646,266 $626,646 
   ________________________
(1)Includes various services, including repair services, equipment rentals and external contracting.

70
Notes to Financial StatementsContingencies
Contingencies
General

In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions in which various plaintiffs seek damages for injuries allegedly caused by defective products. All the product liability lawsuits that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended or prohibited diplomatic or trade relations. The amount recorded for identified contingent liabilities is based on estimates. Amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. Actual costs to be incurred in future periods may vary from the estimates, given the inherent uncertainties in evaluating certain exposures.

As a medical device manufacturer, the company is subject to extensive government regulation, including numerous laws directed at preventing fraud and abuse and laws regulating reimbursement under various government programs. The marketing, invoicing, documenting, developing, testing, manufacturing, labeling, promoting, distributing and other practices of health care suppliers and medical device manufacturers are all subject to government scrutiny. Most of the company's facilities are subject to inspection at any time by the FDA or similar medical device regulatory agencies in other jurisdictions. Violations of law or regulations can result in administrative, civil and criminal penalties and sanctions, which could have a material adverse effect on the company's business.

Medical Device Regulatory Matters
The FDA in the United States and comparable medical device regulatory authorities in other jurisdictions regulate virtually all aspects of the marketing, invoicing, documenting, development, testing, manufacturing, labeling, promotion, distribution and other practices regarding medical devices. The company and its products are subject to the laws and regulations of the FDA and other regulatory bodies in the various jurisdictions where the company's products are manufactured or sold. The company's failure to comply with the regulatory requirements of the FDA and other applicable medical device regulatory requirements can subject the company to administrative or judicially imposed sanctions or
enforcement actions. These sanctions include injunctions, consent decrees, warning letters, civil penalties, criminal penalties, product seizure or detention, product recalls and total or partial suspension of production.
In December 2012, the company became subject to a consent decree of injunction filed by the FDA with respect to the company's Corporate facility and its Taylor Street manufacturing facility in Elyria, Ohio. The consent decree initially limited the company's (i) manufacture and distribution of power and manual wheelchairs, wheelchair components and wheelchair sub-assemblies at or from its Taylor Street manufacturing facility, except in verified cases of medical necessity, (ii) design activities related to wheelchairs and power beds that take place at the impacted Elyria facilities and (iii) replacement, service and repair of products already in use from the Taylor Street manufacturing facility. Under the terms of the consent decree, in order to resume full operations, the company had to successfully complete independent, third-party expert certification audits at the impacted Elyria facilities, comprising three distinct certification reports separately submitted to, and subject to acceptance by, the FDA; submit its own report to the FDA; and successfully complete a reinspection by the FDA of the company's Corporate and Taylor Street facilities.
On July 24, 2017, following its June 2017 reinspection of the Corporate and Taylor Street facilities, the FDA notified the company that it is in substantial compliance with the FDA Act, FDA regulations and the terms of the consent decree and, that the company was permitted to resume full operations at those facilities including the resumption of unrestricted sales of products made in those facilities.
The consent decree will continue in effect for at least five years from July 24, 2017, during which time the company's Corporate and Taylor Street facilities must complete two semi-annual audits in the first year and then four annual audits in the next four years performed by a company-retained expert firm. The expert audit firm will determine whether the facilities remain in continuous compliance with the FDA Act, FDA regulations and the terms of the consent decree. The FDA has the authority to inspect these facilities and any other FDA registered facility, at any time.
The FDA has continued to actively inspect the company's facilities, other than through the processes established under the consent decree. The company expects that the FDA will, from time to time, inspect substantially all the company's domestic and foreign FDA-registered facilities.
In June 2021, the FDA inspected the company's Corporate and Taylor Street facilities in Elyria and North Ridgeville,
71
Notes to Financial StatementsContingencies
Ohio and issued its observations on Form 843. The company has submitted its response to FDA in a timely manner.
The results of regulatory claims, proceedings, investigations, or litigation are difficult to predict. An unfavorable resolution or outcome of any FDA warning letters or inspectional observations, or other FDA enforcement related to company facilities, could materially and adversely affect the company's business, financial condition, and results of operations.
The limitations previously imposed by the FDA consent decree negatively affected net sales in the North America segment and, to a certain extent, the Asia Pacific region beginning in 2012. The limitations led to delays in new product introductions. Further, uncertainty regarding how long the limitations would be in effect limited the company's ability to renegotiate and bid on certain customer contracts and otherwise led to a decline in customer orders.
Although the company has been permitted to resume full operations at the Corporate and Taylor Street facilities, the negative effect of the consent decree on customer orders and net sales in the North America segment and Asia Pacific region has been considerable, and it is uncertain as to whether, or how quickly, the company will be able to rebuild net sales to more typical historical levels, irrespective of market conditions. Accordingly, when compared to the company's 2010 results, the previous limitations in the consent decree had, and likely may continue to have, a material adverse effect on the company's business, financial condition and results of operations.
Warranty Matters
The company's warranty reserves are subject to adjustment in future periods based on historical analysis of warranty claims and as new developments occur that may change the company's estimates related to specific product recalls. Refer to Current Liabilities in the Notes to the Condensed Consolidated Financial Statements for the total provision amounts and a reconciliation of the changes in the warranty accrual.
Any of the above contingencies could have an adverse impact on the company's financial condition or results of operations.
For additional information regarding the consent decree, other regulatory matters, and risks and trends that may impact the company’s financial condition or results of operations, please see the following sections of the company's Annual Report on Form 10-K for the year ended December 31, 2020: Item 1. Business - Government Regulation and Item 1A. Risk Factors; Item 3. Legal Proceedings; and Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources.
72
Notes to Financial StatementsMarket Risk and Controls
Item 3. Quantitative and Qualitative Disclosures About Market Risk.

The company is at times exposed to market risk through various financial instruments, including fixed rate and floating rate debt instruments. Additionally, the company operates internationally and, as a result, is exposed to foreign currency fluctuations. Specifically, the exposure results from intercompany loans, intercompany sales or payments and third-party sales or payments. While the company is exposed to increases in interest rates, including on borrowings under its Credit Agreement, its exposure to the volatility of the current market environment is currently limited until the Credit Agreement expires in 2024. Should the company be required to seek and obtain additional or alternative financing, such financing, if available, may require the company to pay substantially higher interest rates. As discussed elsewhere in this report, the COVID-19 pandemic has negatively impacted, and will continue to negatively impact the company’s business and results of operations. As we cannot predict the duration or scope of the COVID-19 pandemic and its impacts on the supply chain, the negative financial impact to the company’s results cannot be reasonably estimated, but could be material.
































Item 4.    Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures
As of September 30, 2021, an evaluation was performed, under the supervision and with the participation of the company’s management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based on that evaluation, the company’s management, including the Chief Executive Officer and Chief Financial Officer, concluded that the company’s disclosure controls and procedures were effective as of September 30, 2021, in ensuring that information required to be disclosed by the company in the reports it files and submits under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms and (2) accumulated and communicated to the company’s management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate to allow for timely decisions regarding required disclosure.

(b) Changes in Internal Control Over Financial Reporting
The company is currently implementing a new enterprise resource planning (ERP) system. This project is a multi-year initiative and is intended to improve efficiency and effectiveness of certain financial and business transaction processes, as well as the underlying systems environment. These initiatives are not being implemented in response to any identified internal control deficiency or weakness. During the quarter ended September 30, 2021, the company continued its phased implementation of the new ERP.
Other than the ERP system implementation described above, no other changes in the company’s internal control over financial reporting have occurred during the company’s last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the company’s internal control over financial reporting.


73
Part IIOther Information
Part II. OTHER INFORMATION


Item 1.    Legal Proceedings.
In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions in which various plaintiffs seek damages for injuries allegedly caused by defective products. All the product liability lawsuits that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended or prohibited diplomatic or trade relations. Management does not believe that the outcome of any of these actions will have a material adverse effect upon the company's business or financial condition.
In December 2012, the company became subject to a consent decree of injunction filed by FDA in the U.S. District Court for the Northern District of Ohio with respect to the company's Corporate facility and its Taylor Street manufacturing facility in Elyria, Ohio. On July 24, 2017, following its reinspection of the Corporate and Taylor Street facilities, FDA notified the company that it was in substantial compliance with the FDA Act, FDA regulations and the terms of the consent decree and that the company was permitted to resume full operations at those facilities, including the resumption of unrestricted sales of products made in those facilities. The consent decree will continue in effect for at least five years from July 24, 2017, during which time the company's Corporate and Taylor Street facilities must complete to two semi-annual audits in the first year and then four annual audits in the next four years performed by a company-retained expert firm. The expert audit firm will determine whether the facilities remain in continuous compliance with the FDA Act, regulations and the terms of the consent decree.
FDA has the authority to inspect the Corporate and Taylor Street facilities, and any other FDA registered facility, at any time. FDA also has the authority to order the company to take a wide variety of actions if the FDA finds that the company is not in compliance with the consent decree, FDA Act or FDA regulations, including requiring the company to cease all operations relating to Taylor Street products. The FDA also can order the company to undertake a partial cessation of operations or a recall, issue a safety alert, public health advisory, or press release, or to take any other corrective action the FDA deems necessary with respect to Taylor Street products.


FDA also has authority under the consent decree to assess liquidated damages of $15,000 per violation per day for any violations of the consent decree, FDA Act or FDA regulations. FDA also may assess liquidated damages for shipments of adulterated or misbranded devices in the amount of twice the sale price of any such adulterated or misbranded device. The liquidated damages, if assessed, are limited to a total of $7,000,000 for each calendar year. The authority to assess liquidated damages is in addition to any other remedies otherwise available to FDA, including civil money penalties.

For additional information regarding the consent decree, please see the "Contingencies" note to the financial statements contained in Part I of this Quarterly Report on Form 10-Q, the risk factors referred to in Part I, Item 1A of this Quarterly Report on Form 10-Q, and the following sections of the company's Annual Report on Form 10-K for the period ending December 31, 2020: Item 1. Business - Government Regulation; Item 1A. Risk Factors; and Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Outlook and - Liquidity and Capital Resources.
74
Part IIOther Information
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

The following table presents information with respect to repurchases of common shares made by the company during the three months ended September 30, 2021.
PeriodTotal Number
of Shares
Purchased (1)		Avg. Price Paid
Per Share $		Total Number
of Shares Purchased 
as Part of Publicly
Announced Plans 
or Programs		Maximum Number
of Shares That May 
Yet Be Purchased Under the Plans or 
Programs (2)
7/1/2021-7/31/2021—$— —2,453,978
8/1/2021-8/31/2021—— —2,453,978
9/1/2021-9/30/2021—— —2,453,978
Total
—$— —2,453,978
________ 
(1)No shares were repurchased between July 1, 2021 and September 30, 2021 or were surrendered to the company by employees for minimum tax withholding purposes in conjunction with the vesting of restricted shares awarded to the employees or the exercise of non-qualified options by employees under the company's equity compensation plans.

(2)In 2001, the Board of Directors authorized the company to purchase up to 2,000,000 Common Shares, excluding any shares acquired from employees or directors as a result of the exercise of options or vesting of restricted shares pursuant to the company’s performance plans. The Board of Directors reaffirmed its authorization of this repurchase program on November 5, 2010, and on August 17, 2011 authorized an additional 2,046,500 shares for repurchase under the plan. To date, the company has purchased 1,592,522 shares under this program, with authorization remaining to purchase 2,453,978 shares. The company purchased no shares pursuant to this Board authorized program during the quarter ended September 30, 2021.

Under the terms of the company's Credit Agreement, repurchases of shares by the company generally are not permitted except in certain limited circumstances in connection with the vesting or exercise of employee equity compensation awards. Refer to Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources, regarding covenants of the company's senior credit facilities with respect to share purchases.
75
Part IIOther Information
Item 6.    Exhibits
Exhibit      
No. 		 
Employment Contract, dated as of October 4, 2021, by and between the company and Joost Beltman
Change of Control Agreement dated as of June 7, 2021, between the company and Rick A. Cassiday
Chief Executive Officer Rule 13a-14(a)/15d-14(a) Certification (filed herewith).
Chief Financial Officer Rule 13a-14(a)/15d-14(a) Certification (filed herewith).
Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
101.INS*XBRL instance document
101.SCH*XBRL taxonomy extension schema
101.CAL*XBRL taxonomy extension calculation linkbase
101.DEF*XBRL taxonomy extension definition linkbase
101.LAB*XBRL taxonomy extension label linkbase
101.PRE*XBRL taxonomy extension presentation linkbase
104Cover page of the Quarterly Report on Form 10-Q formatted in Inline XBRL.
 
* Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

76
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  INVACARE CORPORATION
Date:October 27, 2021By: /s/ Kathleen P. Leneghan
Name:  Kathleen P. Leneghan
   Title:  Senior Vice President and Chief Financial Officer
   (As Principal Financial and Accounting Officer and on behalf of the registrant)

77
 EX-101.SCH 2 ivc-20210930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000010001 - Document - DEI Document link:presentationLink link:calculationLink link:definitionLink 100010002 - Statement - Condensed Consolidated Statement of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 100020003 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100030004 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 100040005 - Statement - Condensed Consolidated Statement Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 100050006 - Statement - Condensed Consolidated Statement of Shareholders' Equity Statement link:presentationLink link:calculationLink link:definitionLink 210011001 - Disclosure - Accounting Policies link:presentationLink link:calculationLink link:definitionLink 220022001 - Disclosure - Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 240034001 - Disclosure - Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 210041002 - Disclosure - Divested Businesses (Notes) link:presentationLink link:calculationLink link:definitionLink 230053001 - Disclosure - Divested Businesses (Tables) link:presentationLink link:calculationLink link:definitionLink 240064002 - Disclosure - Divested Businesses (Details) link:presentationLink link:calculationLink link:definitionLink 210071003 - Disclosure - Receivables link:presentationLink link:calculationLink link:definitionLink 230083002 - Disclosure - Receivables (Tables) link:presentationLink link:calculationLink link:definitionLink 240094003 - Disclosure - Receivables (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240104004 - Disclosure - Receivables (Schedule of Accounts Receivable) (Details) link:presentationLink link:calculationLink link:definitionLink 240114005 - Disclosure - Receivables Schedule for Allowance for Credit Losses (Details) link:presentationLink link:calculationLink link:definitionLink 240124006 - Disclosure - Receivables (Installment Recevables) (Details) link:presentationLink link:calculationLink link:definitionLink 240134007 - Disclosure - Receivables (Rollforward of Allowance for Doubtful Accounts) (Details) link:presentationLink link:calculationLink link:definitionLink 240144008 - Disclosure - Receivables (Installment Receivables by Class) (Details) link:presentationLink link:calculationLink link:definitionLink 240154009 - Disclosure - Receivables (Aging of Installment Receivables) (Details) link:presentationLink link:calculationLink link:definitionLink 210161004 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 230173003 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 240184010 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 210191005 - Disclosure - Other Current Assets link:presentationLink link:calculationLink link:definitionLink 230203004 - Disclosure - Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 240214011 - Disclosure - Other Current Assets Components of Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 210221006 - Disclosure - Other Long-Term Assets link:presentationLink link:calculationLink link:definitionLink 230233005 - Disclosure - Other Long-Term Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 240244012 - Disclosure - Other Long-Term Assets Components of Other Long-Term Assets (Details) link:presentationLink link:calculationLink link:definitionLink 240254013 - Disclosure - Other Long-Term Assets Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210261007 - Disclosure - Property And Equipment link:presentationLink link:calculationLink link:definitionLink 230273006 - Disclosure - Property And Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 240284014 - Disclosure - Property And Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 210291008 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 240304015 - Disclosure - Goodwill Goodwill Details (Details) link:presentationLink link:calculationLink link:definitionLink 210311009 - Disclosure - Intangibles link:presentationLink link:calculationLink link:definitionLink 230323007 - Disclosure - Intangibles (Tables) link:presentationLink link:calculationLink link:definitionLink 240334016 - Disclosure - Intangibles (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240344017 - Disclosure - Intangibles (Intangible Table) (Details) link:presentationLink link:calculationLink link:definitionLink 240354018 - Disclosure - Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 210361010 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 230373008 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 240384019 - Disclosure - Accrued Expenses Components of Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 240394020 - Disclosure - Accrued Expenses Warranty Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 210401011 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 230413009 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 240424021 - Disclosure - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 240434022 - Disclosure - Long-Term Debt Leverage Ratios (Details) link:presentationLink link:calculationLink link:definitionLink 240444023 - Disclosure - Long-Term Debt Components of Convertible Debt (Details) link:presentationLink link:calculationLink link:definitionLink 240454024 - Disclosure - Long-Term Debt Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240464025 - Disclosure - Long-Term Debt Sale Leaseback Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 210471012 - Disclosure - Other Long-Term Obligations link:presentationLink link:calculationLink link:definitionLink 230483010 - Disclosure - Other Long-Term Obligations (Tables) link:presentationLink link:calculationLink link:definitionLink 240494026 - Disclosure - Other Long-Term Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 210501013 - Disclosure - Leases and Commitments (Notes) link:presentationLink link:calculationLink link:definitionLink 230513011 - Disclosure - Leases and Commitments (Tables) link:presentationLink link:calculationLink link:definitionLink 240524027 - Disclosure - Leases and Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 240534028 - Disclosure - Leases and Commitments Lease Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 240544029 - Disclosure - Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 240554030 - Disclosure - Leases and Commitments Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 240564031 - Disclosure - Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details) link:presentationLink link:calculationLink link:definitionLink 210571014 - Disclosure - Revenue Revenue link:presentationLink link:calculationLink link:definitionLink 230583012 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 240594032 - Disclosure - Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 210601015 - Disclosure - Equity Compensation link:presentationLink link:calculationLink link:definitionLink 230613013 - Disclosure - Equity Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 240624033 - Disclosure - Equity Compensation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240634034 - Disclosure - Equity Compensation Share-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 240644035 - Disclosure - Equity Compensation Unrecognized Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 240654036 - Disclosure - Equity Compensation (Options Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 240664037 - Disclosure - Equity Compensation (Stock Options Outstanding by Exercise Price) (Details) link:presentationLink link:calculationLink link:definitionLink 240674038 - Disclosure - Equity Compensation Restricted Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 240684039 - Disclosure - Equity Compensation Performance Share Activity (Details) link:presentationLink link:calculationLink link:definitionLink 240694040 - Disclosure - Equity Compensation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 210701016 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component link:presentationLink link:calculationLink link:definitionLink 230713014 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Tables) link:presentationLink link:calculationLink link:definitionLink 240724041 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 240734042 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 210741017 - Disclosure - Charges Related To Restructuring Activities link:presentationLink link:calculationLink link:definitionLink 230753015 - Disclosure - Charges Related To Restructuring Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 240764043 - Disclosure - Charges Related To Restructuring Activities (Details) link:presentationLink link:calculationLink link:definitionLink 240774044 - Disclosure - Charges Related To Restructuring Activities Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210781018 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 240794045 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 210801019 - Disclosure - Net Earnings (Loss) Per Common Share link:presentationLink link:calculationLink link:definitionLink 230813016 - Disclosure - Net Earnings (Loss) Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 240824046 - Disclosure - Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 240834047 - Disclosure - Net Earnings (Loss) Per Common Share Textuals (Details) link:presentationLink link:calculationLink link:definitionLink 210841020 - Disclosure - Concentration Of Credit Risk link:presentationLink link:calculationLink link:definitionLink 240854048 - Disclosure - Concentration Of Credit Risk (Details) link:presentationLink link:calculationLink link:definitionLink 210861021 - Disclosure - Derivatives link:presentationLink link:calculationLink link:definitionLink 230873017 - Disclosure - Derivatives (Tables) link:presentationLink link:calculationLink link:definitionLink 240884049 - Disclosure - Derivatives Notional Amounts - Designated as Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 240894050 - Disclosure - Derivatives Notional Amounts - Not Designated as Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 240904051 - Disclosure - Derivatives Balance Sheet Location (Details) link:presentationLink link:calculationLink link:definitionLink 240914052 - Disclosure - Derivatives Gain (Loss) in Statement of Finacial Position (Details) link:presentationLink link:calculationLink link:definitionLink 240924053 - Disclosure - Derivatives Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240934054 - Disclosure - Derivatives Fair Value of Convertible Debt Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 210941022 - Disclosure - Fair Values link:presentationLink link:calculationLink link:definitionLink 230953018 - Disclosure - Fair Values (Tables) link:presentationLink link:calculationLink link:definitionLink 240964055 - Disclosure - Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) link:presentationLink link:calculationLink link:definitionLink 240974056 - Disclosure - Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 210981023 - Disclosure - Business Segments link:presentationLink link:calculationLink link:definitionLink 230993019 - Disclosure - Business Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 241004057 - Disclosure - Business Segments (Information by Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 211011024 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 241024058 - Disclosure - Contingencies Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink EX-10.1 3 q32021ivc10-qexhibit101.htm EX-10.1 Document

Exhibit 10.1
image.jpg


EMPLOYMENT CONTRACT

Invacare B.V.
Chamber of Commerce No. 18041272
Galvanistraat 14-3
6716 AE EDE
(hereinafter referred to as ”the employer”)
And
J.W.A. Beltman
(hereinafter referred to as ”the employee”)
entered into this Employment Contract today.

1.COMMENCEMENT OF SERVICE AND SENIORITY

1.1    The Employee will commence the position with effect from 1st of June 2021. This contract will be concluded for unlimited time. Regarding anciennity the date of employment will be 1st of July 2008. This contract suspersedes and replaces the Employment Contract dated April 25, 2008, and the letter agreement dated May 20, 2019 as amended by letter dated August 1, 2020 (the "Previous Contract").

2.     JOB DESCRIPTION

2.1    The employee is appointed in the position of SVP & GM -North America and will perform all the usual work in the field of General Management, Sales, Marketing & Operations. The employee will primarily report to the Chairman, President and CEO Invacare Corporation.

2.2    A job description is attached to this Employment Contract as Appendix 1. The employer may amend that job description within reasonable limits at any time, without giving the employee prior notice. If the employer amends the job description, the employee will be provided with a copy of the amended job description and a copy will also be attached to this Employment Contract.

3. PLACE OF WORK

3.1    The employee's current place of work is the employee's residence, or other suitable remote work place in The Netherlands.



3.2    The employee must take into account business trips both within the Netherlands and abroad.

4. WORKING HOURS

4.1    The Employee’s normal working hours are 38 hours a week exclusive of ½ hour daily lunch break. The employee is working 5 days a week.

4.2    Regulation B, “Overtime not remunerated”, recorded in Chapter 6 of the Employee Handbook, applies. The employee is expected to work overtime when that is in the employer’s interest. Such overtime will not be separately remunerated or otherwise compensated, since the salary level of this position is deemed to include payment for overtime.

5. SALARY, PENSION, ETC.

5.1 The employee will receive a gross monthly salary of EUR 28,395. The gross monthly salary is the salary before the withholding of statutory payroll tax and social security contributions payable by the employee. The gross monthly salary is paid no later than on the last day of the month. The holiday allowance amounts to 8% of the gross monthly salary. The holiday allowance is paid on a monthly basis. The gross annual salary amounts to 12 times the gross monthly salary plus 8% holiday allowance.

5.2 The employee is entitled to participate in the Executive Incentive Bonus Plan (MBO), with a targeted bonus of 50% of the gross annual salary and is linked to specific targets as determined by the employer each year.

5.3    The employee will take part in the company pension scheme with Be Frank, provided that the pension insurer does not object, as recorded in more detail in the pension regulations in question. A gross pension scheme compensation will be done for the part of the salary over the legal cap (€122.189 in 2021). the compensation is calculated as the premium that the employer would have paid to the pension provider on the salary part above the legal cap ; this compensation is capped for the part of salary over €112,189 (legal cap in 2021) to a maximum annual gross salary €300,000. A maximum of 5% of the gross annual salary (maximum €300,000) after deduction of the single state pension can be withheld.

5.4    If the employee so wishes, the employee may take part in the collective medical expenses insurance taken out by the employer, provided that the insurer does not object, all of this as recorded in the Employee Handbook. The premium is to be paid by the employer as far as the premium is applicable to the employee and his partner.

5.5    The employee will be included in the collective WGA / WIA insurance and WGA / WIA top-up insurance, provided that the insurer does not object to your registration. The premium is the WGA / WIA and is payable by the employer. For the WGA / WIA top-up insurance, the employee pays a personal contribution of 1.25% of the part of the salary related to the top-up.



5.6    Subject to determination and approval by the Compensation and Management Development Committee of the Board of Directors of Invacare Corporation, employee will be eligible to receive grants of restricted stock units on an annual basis.

6. HOLIDAY

6.1    The employee is entitled to 200 hours of paid leave per year in the event of an employment contract for 38 hours a week.

6.2    On reaching a certain number of years of age the employee is entitled to additional annual days of paid leave, as recorded in more detail in the Employee Handbook.

6.3    Holidays and days’ off must be approved by the supervisor beforehand. The employer has the right to unilaterally schedule business closure days. Those days off must be taken as paid leave and will be deducted from the employee’s outstanding paid leave.

7. OTHER CONDITIONS

7.1    The employee will be provided with a mobile telephone. Normal use for limited, brief private calls is permitted.

7.2    The employer will provide the employee with a laptop computer, software and other appurtenances.

7.3 The parties particularly, but not exclusively, agree that if, contrary to the parties’ assumptions, expense allowances or other allowances must at any time be regarded as taxable wages within the meaning of the Wet op de loonbelasting (Wages and Salaries Tax Act) and/or the social security acts, the statutory payroll tax and social security contributions due will be payable by the employee, also if they have not yet been withheld by the employer.

8. TERMINATION

8.1    The employee can terminate the employment contract for an indefinite period with due observance of a notice period of 3 months.

8.2    The employer may terminate the employment contract upon six (6) months' prior written notice.

8.3    The employment will terminate automatically and without notice at the end of the calendar month in which the Employee reaches the age according to which the employment may lawfully end due to age pursuant to the Netherlands law, at present 68 years.

8.4    No later than on the date on which this Employment Contract ends the employee must return to the employer all the items made available by or on behalf of the employer, including keys, credit cards, laptop computer, car, mobile telephone, insurance cards,


etc. The employee in no event has the right to sell or encumber any items made available to him by or on behalf of the employer.

9. LOYALTY AND ANCILLARY ACTIVITIES

9.1    During the term of this Employment Contract the employee must be loyal towards the employer in every respect. If the employee fails to comply with this provision, the employer may claim compensation for any loss pursuant to the general rules of Dutch law.

9.2    The Employee is entitled (taken into account the content of this article) to undertake tasks etc. outside the scope of the Employee’s duties to the extent that it is without inconvenience to the Company, including without any negative effect on the Employee’s work for the Company. The position of the Company on such work or offices, etc. should be obtained in advance. The Company must give permittance of these tasks in writing.

10. CONFIDENTIALITY

10.1    During the term of this Employment Contract and after its termination the employee must keep all information that comes to his attention in respect of his employment regarding the employer and businesses affiliated with it strictly secret and must observe strict confidentiality in that regard. This in any event includes but is not limited to business data, financial data and personnel data. In light of the confidential nature of that information, it may not be disclosed to third parties in any manner whatsoever. This duty of confidentiality also applies to all matters and relationships regarding customers, suppliers or advisors of the employer and businesses affiliated with it.

10.2    Violation of this provision is deemed to be a material breach of the employment contract, and the employer is thus entitled to terminate the employment if the Employee violates the duty of confidentiality in full or in part. Further, the Company is entitled to claim compensation for any loss pursuant to the general rules of Dutch law.

11. KNOW-HOW AND INVENTIONS

11.1    All materials, documents, drafts, etc., that the employee receives from or for the benefit of the employer or a business affiliated with it, or contacts or suppliers, customers or principals of the employer and/or businesses affiliated with it, during the term of his employment at the employer are and will remain the employer’s property and must be returned to the employer by the employee by the last actual day of work at the latest. The employee may not sell and/or encumber any of the items referred to above.

11.2    The employer has the full ownership of any and all know-how etc. developed by the employee during the term of his employment, regardless of the media on which it is recorded.

11.3    If the employee makes an invention, only the employer has the right to patent or cause the patenting of that invention, regardless of whether making inventions directly


or indirectly forms part of the employee’s duties or the employee was appointed (or also appointed) for that purpose. Insofar as he is reasonably able to do so, the employee must make the invention available to the employer along with all the information, descriptions, details and related matters required for a proper understanding of the invention. If the employee makes the invention within 6 months after termination of the employment, the invention will be regarded as the result of the work that the employee was required to perform for the employer as part of the employment. However, all of this is without prejudice to the employer’s right to claim the rights regarding an invention also in other cases. The employee must immediately inform the employer of any possible invention made by the employee. The employee must in that regard provide the employer with all the information that it requires to assess the importance of the invention.

11.4    Other intellectual property rights, including but not limited to works, products or procedures, drawings or designs, trademarks, databases and trade names, that the employee has created or caused to be created, independently or otherwise, and the entitlement thereto are vested exclusively in the employer, regardless of whether those intellectual property rights arose during or outside working hours and regardless of whether the creation of intellectual property rights directly or indirectly forms part of the employee’s duties or the employee was appointed (or also appointed) for that purpose.

11.5    The salary stated in clause 5.1 is based on the tasks assigned to the employee. The employee acknowledges that his salary therefore includes all compensation for a possible performance as an inventor or for any other intellectual property right.

11.6    If and insofar as additional agreements must be made in any manner whatsoever or the employee’s further cooperation is otherwise required in order to create or cause the creation of any intellectual property rights in the employer’s name or to lawfully transfer such rights from the employee to the employer, the employee undertakes to do anything that is necessary to arrange for that creation or transfer. The employer is also entitled to assign any intellectual property rights belonging to the Company pursuant to Clause 11 of this Employment Contract.

12. NON-COMPETITION

12.1    During the employment and for 12 months thereafter, the employee shall not in any part of the world be engaged or financially interested, directly or in-directly, in any company or business that competes in full or in part with the business conducted by the Company at the time in North America or Europe or by affiliated companies. This limitation shall include any financial interest or occupation in or with the competing company in question, including financing, ownership in full or in part or co-ownership, any kind of employment and any kind of occupation as consultant, board member, etc.

12.2    For 12 months after the effective date of termination, the employee shall not, without the prior written consent of the Company, be in contact or have business relations, directly or indirectly, with customers, suppliers or collaborators who have or


have had business relations with the Company with the last 18 months before the effective date of termination.

12.3    “The effective date of termination” shall be construed as the date where the Employee may be ordered or be entitled to leave his/her position.

12.4    Violation of the non-competition clause implies that the employee shall pay a penalty to the Company. The penalty is paid each time such violation of the non-competition clause.

12.5    For a period of 12 months after contract of employment has ended, the Employee shall notify the Company in writing of the commencement of any other business activity

13.0 PENALTY CLAUSE

13.1    On breach of the provisions of clauses 9 to 12 above, the employee will forfeit to the employer, on the grounds of Section 7:650(6) of the Dutch Civil Code, if necessary expressly notwithstanding Section 7:650(3) and (5) of the Dutch Civil Code, an immediately payable penalty of EUR 25,000 for each breach and a penalty of EUR 2,500 for each day on which that breach continues, notwithstanding the employer’s right to additionally demand specific performance and, at its discretion, to recover the loss actually incurred from the employee instead of the penalty.

13.2    Breach by the employee of the provisions of clauses 9 to 12 above may furthermore be urgent cause for the employer to terminate the employment contract within the meaning of Section 7:677 in conjunction with Section 7:678 of the Dutch Civil Code.

14. UNILATERAL AMENDMENT CLAUSE

14.1    The employer reserves the right to unilaterally amend this Employment Contract. The employer may exercise that right if it has such a compelling interest in the amendment that the employee’s interest that would be harmed by the amendment must recently give way by standards of reasonableness and fairness. The amendments will not enter into effect until they have been notified to the employee in writing.

14. OTHER PROVISIONS

14.1    This Employment Contract is governed by Dutch law.

14.2    This employee's employment is not governed by any collective bargaining agreement.

14.3    The employee must immediately inform the Human Resources Department of any change in his private address.

14.4    If the employee is absent due to sickness or other circumstances, he must inform the Human Resources Department accordingly before 9 a.m. The employer may request


additional documentation in order to verify the reason and the duration of the absence, in accordance with the customary rules.

14.5    In addition to the employment conditions recorded in this Employment Contract, the employment conditions and guidelines recorded in the Employee Handbook furthermore apply. In the event of inconsistencies between this Employment Contract and the Employee Handbook, the provisions of this Employment Contract will prevail.

14.6    By signing this Employment Contract the employee gives the employer his consent to make sensitive personal data available to a prospective buyer of the company or the business conducted by the company. This also applies to the due diligence process in question preceding possible sale of the company.

15. SIGNATURE AND ENTIRE AGREEMENT

15.1    This Employment Contract will be signed in duplicate originals. The Employer will keep one copy and the Employee will keep the other. This Employment Contract will enter into force on the date of signature.

15.2    All earlier agreements concluded between the Employer and the Employee concerning the subject matter of this Employment Contract, both orally and in writing, will lapse on signature of this Employment Contract. Notwithstanding anything to the contrary in this Contract, nothing in this Contract shall alter, amend to terminate any of the provisions of the Indemnity Agreement and the Change of Control Agreement between Invacare Corporation and employee, both dated as of August 26, 2020.

16. PRECEDENCE

16.1    This Employment Contract has been drawn up in Dutch and translated into English. In the event of inconsistencies between the Dutch and the English version, the Dutch text will take precedence.




Place: Ede, the Netherlands

On behalf of the employer:

/s/ D. De La Feunte
/s/ Marco Koole

Date: October 4, 2021


Employee:

/s/ J.W.A. Beltman

Date: September 17, 2021










 EX-10.2 4 q32021ivc10-qexhibit102.htm EX-10.2 Document

Exhibit 10.2
INVACARE CORPORATION

AGREEMENT
    This AGREEMENT (“Agreement”), is made as of the [*] day of [month, 2021], between INVACARE CORPORATION, an Ohio corporation (“Invacare”), and ______________ (the Executive”).
    Invacare desires to enter into an agreement with Executive in recognition of the importance of the Executive’s services to the continuity of management of Invacare and based upon its determination that it will be in the best interests of Invacare to encourage the Executive’s continued attention and dedication to the Executive’s duties in the potentially disruptive circumstances of a possible Change of Control of Invacare. (As used in this Agreement, the term “Change of Control” and certain other capitalized terms have the meanings ascribed to them in Section 8 hereof.)
    Invacare and the Executive agree, effective as of the date first set forth above (the “Effective Date”), as follows:
1.    Severance Benefits if Employment is Terminated in Certain Circumstances Within Two Years of a Change of Control. If, within two years following the occurrence of a Change of Control, the Executive’s employment with Invacare is terminated by Invacare for any reason other than Cause, Disability, or death, or is terminated by the Executive for Good Reason, then the provisions of this Section 1 shall become applicable in all respects and Invacare shall pay to the Executive the amounts specified in Sections 1.1 and 1.2 on the dates indicated therein, and shall cause certain rights of the Executive to vest as provided in Section 1.3:
1.1    Lump Sum Severance Benefit. Subject to Section 1.6, Invacare shall pay to the Executive, on the sixtieth (60th) day after the Termination Date, a lump sum severance benefit in an amount equal to two times: (i) the Executive’s Annual Base Salary plus (ii) the Executive’s Prior Bonus Amount. In addition, Invacare shall pay to the Executive, on the sixtieth (60th) day after the Termination Date, an amount equal to the Executive’s Prorated Bonus Amount.
1.2    Insurance Benefits. Subject to Section 1.6, Invacare shall pay to the Executive, on the sixtieth (60th) day after the Termination Date, a lump sum amount equal to twenty-four (24) times the current monthly COBRA premium rate in effect as of the Termination Date for the level of coverage in which the Executive and his or her eligible dependents were enrolled under Invacare’s medical plan immediately prior to the Termination Date.
1.3    Vesting of Certain Rights. Subject to Section 1.6, Invacare shall cause the Executive’s rights under the Invacare Deferred Compensation Plus Plan to become, as of the Termination Date, immediately vested in full.    


1.4    Equity Awards.
(a)    Invacare Remains the Surviving Entity or the Post-CIC Entity Assumes Equity Awards. If, upon the occurrence of a Change of Control (i) Invacare is the surviving entity following such Change of Control or (ii) all outstanding equity awards held by the Executive are Assumed by the Post-CIC Entity, and if the Executive’s employment is terminated by Invacare or the Post-CIC Entity for any reason other than Cause, Disability, or death, or is terminated by the Executive for Good Reason within two years following the occurrence of the Change of Control, then in respect of all options to purchase Invacare stock, all shares of restricted stock, all restricted stock units and all performance shares that have been granted to the Executive pursuant to any award agreement, plan or arrangement sponsored by Invacare (or any corresponding replacement awards granted by a Post-CIC Entity) and which remain outstanding as of the Termination Date, and notwithstanding any other provision to the contrary contained in any award agreement, plan or arrangement, and subject to Section 1.6, Invacare shall:
(i)with respect to all options, cause such options:    
(A)to become exercisable in full as of the Termination Date;
(B)to continue to be exercisable until the earlier of (1) the expiration date of the option or (2) the second anniversary of the Termination Date; provided that, if the award agreement underlying such option provides for a longer period of exercisability following the Termination Date, then this clause (2) shall be the end of such longer period; and
(C)to be exercisable (and/or to be eligible to satisfy any tax withholding requirements in connection with the exercise of the options) using shares of Invacare common stock previously owned by the Executive and/or shares subject to the options being exercised as consideration in lieu of a cash payment or other arrangement, but only to the extent that any such exercise of the option (and/or withholding tax payments) would not result in Invacare being required to take an additional charge in respect of such exercise in determining and reporting its net income for financial accounting purposes; and

2

(ii)with respect to any awards of restricted stock or restricted stock units that are not subject to the attainment of performance goals, cause such awards:
(A)to become vested in full as of the Termination Date; and
(B)to be eligible to satisfy any tax withholding requirements in connection with such vesting of the restricted stock or restricted stock units by using shares of Invacare common stock previously owned by the Executive and/or shares of restricted stock or restricted stock units that become so vested as consideration (in lieu of a cash payment or other arrangement) for the payment of withholding tax, but only to the extent that any such withholding tax payments would not result in Invacare being required to take an additional charge in respect of such accelerated vesting or withholding tax payment in determining and reporting its net income for financial accounting purposes.
(iii)with respect to any awards of restricted stock, restricted stock units or performance shares that are subject to the attainment of performance goals, cause such awards:
(A)to be earned or vest in accordance with their terms as if all of the performance goals applicable to such awards had been achieved at their target levels as of the Termination Date; and
(B)to be eligible to satisfy any tax withholding requirements in connection with such vesting of the restricted stock, restricted stock units or performance shares by using shares of Invacare common stock previously owned by the Executive and/or shares of restricted stock, restricted stock units or performance shares that become so vested as consideration (in lieu of a cash payment or other arrangement) for the payment of withholding tax, but only to the extent that any such withholding tax payments would not result in Invacare being required to take

3

an additional charge in respect of such accelerated vesting or withholding tax payment in determining and reporting its net income for financial accounting purposes.
(b)Post-CIC Entity Does Not Assume Equity Awards. If, upon the occurrence of a Change of Control, the Post-CIC Entity does not Assume all options to purchase Invacare stock, all shares of restricted stock, all restricted stock units or all performance shares that have been granted to the Executive pursuant to any award agreement, plan or arrangement sponsored by Invacare and which remain outstanding as of the date of the Change of Control, and notwithstanding any other provision to the contrary contained in any award agreement, plan or arrangement, then:
(i)any such options, shares of restricted stock, restricted stock units or performance shares not Assumed by the Post-CIC Entity shall become fully vested and exercisable and any restrictions that apply to such awards shall lapse;
(ii)any awards of restricted stock, restricted stock units or performance shares that are subject to the attainment of performance goals and not Assumed by the Post-CIC Entity shall immediately vest and become immediately payable in accordance with their terms, subject to the last paragraph of this Section 1.4, as if all of the performance goals applicable to such awards had been achieved at their the target levels as of the date of the Change of Control;
(iii)for each stock option not Assumed by the Post-CIC Entity, the Executive shall receive a payment equal to the difference between the consideration (consisting of cash or other property (including securities of a successor or parent corporation)) received by holders of Invacare’s common stock in the Change of Control transaction and the exercise price of the applicable stock option, if such difference is positive. Such payment shall be made in the same form as the consideration received by holders of Invacare’s common stock. Any stock option with an exercise price that is higher than the per share consideration received by holders of Invacare’s common stock in connection with the Change of Control shall be cancelled for no additional consideration;
(iv)with respect to any awards of restricted stock or restricted stock units that are not Assumed by the Post-CIC Entity and are not subject to the attainment of performance goals, the Executive shall receive the consideration (consisting of cash or other property (including securities of a successor or parent corporation)) that the Executive would have

4

received in the Change of Control transaction had he or she been, immediately prior to such transaction, a holder of the number of shares of Invacare’s common stock equal to the number of shares of restricted stock or number of restricted stock units held by the Executive; and
(v)subject to the last paragraph of this Section 1.4, the payments contemplated by Sections 1.3(b) (iii) and (iv) shall be made at the same time as consideration is paid to the holders of Invacare’s common stock in connection with the Change of Control.
Notwithstanding anything to the contrary in this Agreement, if the payment or benefit of any award constitutes a deferral of compensation under Code Section 409A, then to the extent necessary to comply with Code Section 409A, payment or delivery with respect to such award shall be made on the date of payment or delivery originally provided for such payment or benefit.
1.5    Later Time for Payment on Account of Termination. Notwithstanding the preceding provisions of Section 1, solely to the extent required to comply with applicable provisions of Code Section 409A with respect to any amounts or benefits not exempt from Code Section 409A, payments made pursuant to Sections 1.1, 1.2, 1.3 or 1.4, on account of the Executive’s termination of employment shall: (a) not commence until the date that is six months and a day following the Termination Date; and (b) upon commencement, include along with the initial payment an amount sufficient to reimburse the Executive for reasonable lost interest at a rate of Prime Plus One per annum, compounded annually, incurred during the period commencing on the date which is sixty (60) days after the Termination Date through the date of payment by Invacare. In the event that Invacare, in the exercise of its reasonable discretion, determines that a delay in payments under this Section 1.5 is required in order to comply with Code Section 409A, Invacare shall, within two business days after the Termination Date, deposit the entire amount due and to become due under Section 1, in the trust established by Invacare with Wells Fargo Bank, National Association, successor in interest to Wachovia Bank of North Carolina, N.A., pursuant to a Benefit Security Trust Agreement dated August 21, 1996, as such agreement may be amended from time to time in accordance with its terms. Payments to the Executive from such trust shall thereafter be made in accordance with this Section 1.5; provided, however, that Invacare shall remain fully obligated to the Executive for the full and complete satisfaction of its liabilities and obligations under this Agreement.

1.6    Release Requirement. Notwithstanding any provision herein to the contrary, as a condition to the Executive’s receipt of any post-termination benefits pursuant to this Agreement, (i) the Executive shall execute a release of all claims in favor of Invacare in the form attached hereto as Exhibit B (the “Release”) within the sixty (60) day period following the Termination Date and (ii) any applicable revocation period has expired during such sixty (60) day period without the Executive’s revocation

5

of the Release. In the event the Executive does not sign, or signs and revokes the Release, within the sixty (60) day period following the Termination Date, the Executive shall not be entitled to the aforesaid payments and benefits.

1.7    Best Pay Provision. If any payment or benefit the Executive would receive under this Agreement, when combined with any other payment or benefit Executive receives in connection with the termination of Executive's employment with the Company (a "Payment"), would, after taking into account any shareholder approval satisfying Section 280G of the Internal Revenue Code of any such payment or benefit, or of any other payment or benefit with respect to the Executive (a) constitute a "parachute payment" within the meaning of Section 280G of the Internal Revenue Code, and (b) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code (the "Excise Tax"), then such Payment shall be either (i) the full amount of such Payment or (ii) such lesser amount (with cash payments being reduced before stock option compensation) as would result in no portion of the Payment being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local employment taxes, income taxes, and the Excise Tax, results in the Executive's receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.
All determinations required to be made under this Section 1.7, including whether and to what extent the Payments shall be reduced and the assumptions to be used in arriving at such determination, shall be made by the Accounting Firm in good faith. The Accounting Firm shall provide detailed supporting calculations both to the Executive and the Company at such time as is requested by the Company. All fees and expenses of the Accounting Firm shall be borne solely by the Company. Any determination by the Accounting Firm shall be binding upon the Executive and the Company. For purposes of making the calculations required by this Section 1.7, the Accounting Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good-faith interpretations concerning the application of Sections 280G and 4999 of the Internal Revenue Code.
2.    Other Benefits.
2.1    Reimbursement of Certain Expenses After a Change of Control. Invacare shall pay, as incurred (in no event later than the end of the Executive’s taxable year following the year in which such expenses were incurred), all expenses incurred by the Executive at any time during the longer of 20 years or the Executive’s lifetime, including the reasonable fees of counsel engaged by the Executive, in respect of enforcing the Executive’s rights hereunder and/or defending any action brought to have this Agreement, or any provision hereof, declared invalid or unenforceable.
2.2    Sick Leave Pay for Executive. If, after a Change of Control and prior to the Termination Date, (i) Invacare or the Post-CIC Entity does not maintain a disability plan covering the Executive that is no less favorable than the

6

disability plan sponsored by Invacare immediately prior to the Change of Control, and (ii) the Executive is unable to perform services for Invacare for any period by reason of accidental bodily injury or sickness, then Invacare will pay and provide to the Executive, as sick leave pay, all compensation and benefits to which the Executive would have been entitled had the Executive continued to be actively employed by Invacare through the earliest of the following dates (the “Sick Leave Period”): (a) the first date on which the Executive is again capable of performing ongoing services for Invacare consistent with past practice, or (b) the date on which the Executive’s employment is terminated by Invacare by reason of Disability or otherwise, or (c) the date on which Invacare has paid and provided 29 months of compensation and benefits to the Executive during the period of the Executive’s incapacity, or (d) the date of the Executive’s death. Notwithstanding the foregoing, the Sick Leave Period may not be greater than 6 months unless the Executive’s injury or sickness can be expected to result in death or can be expected to last for a continuous period of not less than 6 months, and such injury or sickness renders the Executive unable to perform the duties of his or her position of employment or any substantially similar position of employment. The foregoing sick leave pay is intended to compensate Executive for compensation and benefits that he otherwise would have earned during the Sick Leave Period, and shall not reduce or otherwise have any effect on Executive’s rights to receive any other compensation, benefits or other Payments hereunder for any other reason, including as may be owed arising out of cessation of Executive’s employment.
3.    No Set-Off; No Obligation to Seek Other Employment or to Otherwise Mitigate Damages; No Effect Upon Other Plans. Invacare’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense, or other claim whatsoever which Invacare may have against the Executive. The Executive shall not be required to mitigate damages, or the amount of any payment provided for under this Agreement by seeking other employment or otherwise. The amount of any payment provided for under this Agreement shall not be reduced by any compensation or benefits earned by the Executive as the result of employment by another employer or otherwise after the termination of the Executive’s employment.
4.    Taxes; Withholding of Taxes. Without limiting the right of Invacare to withhold taxes pursuant to this Section 4, the Executive shall be responsible (after taking into account all payments to be made by Invacare to or on behalf of the Executive under Section 1 hereof,) for all income, excise, and other taxes (federal, state, city, or other) imposed on or incurred by the Executive as a result of receiving the payments provided in this Agreement, including, without limitation, the payments provided under Section 1 of this Agreement. Invacare may withhold from any amounts payable under this Agreement all federal, state, city, or other taxes as Invacare shall determine to be required pursuant to any law or government regulation or ruling. Without limiting the generality of the foregoing, Invacare may withhold from any amount payable under this Agreement amounts sufficient to satisfy any withholding requirements that

7

may arise out of any benefit provided to or in respect of the Executive by Invacare under Section 1 of this Agreement.
5.    Term of this Agreement. This Agreement shall be effective as of the date first above written and shall thereafter apply to any Change of Control occurring on or before [month *, 2022] or during any succeeding applicable term, and on [month *, 2022] and on [month *] of each succeeding year thereafter (a “Renewal Date”), the term of this Agreement, if not previously terminated, shall be automatically extended for an additional year unless either party has given notice to the other, at least one year in advance of that Renewal Date, that the Agreement shall not apply to any Change of Control occurring after that Renewal Date.
5.1    Termination of Agreement Upon Termination of Employment Before a Change of Control. This Agreement shall automatically terminate on the first date occurring before a Change of Control on which the Executive is no longer employed by Invacare, except that, for purposes of this Agreement, any involuntary termination of employment of the Executive or any termination by the Executive for Good Reason that is effected within 6 months before a Change in Control and primarily in contemplation of a Change of Control that actually occurs after the date of the termination shall be deemed to be a termination of the Executive’s employment as of the date immediately after that Change of Control, and in such case, the Change in Control shall constitute the Termination Date and the date as of which the Executive’s right to payment hereunder shall become vested and this Agreement shall not be deemed to be terminated for such purpose.
5.2    No Termination of Agreement During Two-Year Period Beginning on Date of a Change of Control. After a Change of Control, this Agreement may not be terminated. However, if the Executive’s employment with Invacare continues for more than two years following the occurrence of a Change of Control, then, for all purposes of this Agreement, that particular Change of Control shall thereafter be treated for purposes of this Agreement as if it never occurred; provided, however, that the foregoing shall not deprive Executive of any rights, benefits or payments (or allow Invacare to avoid any obligations) that were or became vested under this or any other agreement, plan or arrangement.
6.    Code Section 409A.
6.1    Code Section 409A Compliance. This Agreement is intended to meet the requirements for exemption from (or to the extent not exempt, compliance with) Code Section 409A (including without limitation, the exemptions for short-term deferrals and separation pay arrangements), and this Agreement shall be so construed and administered. Notwithstanding anything in this Agreement to the contrary, at any time prior to a Change in Control, Invacare and the Executive may amend this Agreement, retroactively or prospectively, while maintaining the spirit of this Agreement and after consultation with Executive, to secure exemption from (or, to the extent not

8

exempt, to ensure compliance with), the requirements of 409A and to avoid adverse tax consequences to Executive thereunder. Furthermore, at any time prior to a Change in Control, the Executive agrees to execute such further instruments and take such further action as may be necessary to comply with 409A or to avoid adverse tax consequences to Executive thereunder.
6.2    Reimbursements. Any reimbursement paid to Executive by Invacare, either pursuant to this Agreement or under any reimbursement arrangement or policy of Invacare shall be made within ninety (90) days following Executive’s submitting evidence of the incurrence of expenses, and in all events prior to the last day of the calendar year following the calendar year in which Executive incurred the expense.  In no event will the amount of expenses so reimbursed by the Company in one year affect the amount of expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year.
7.    Miscellaneous.
        7.1    Successor to Invacare. In the event that
(a)Invacare transfers all or substantially all of its assets to another corporation or entity; or

(b)(i) Invacare consolidates with or merges with or into any other corporation or entity and

(ii) either (x) Invacare is not the surviving corporation or entity of such consolidation or merger or (y) Invacare is the surviving corporation or entity of such consolidation or merger but the shareholders of Invacare immediately prior to the consummation of such merger or consolidation do not own securities representing a majority of the outstanding voting power of such surviving corporation or entity or its parent after the consummation of the consolidation or merger, then, in any of such events, the entity surviving such consolidation or merger and each Affiliate thereof having an individual net worth of $5 million or more shall assume joint and several liability for this Agreement in a signed writing and deliver a copy thereof to the Executive. Upon such assumption, the successor corporation or entity and each Affiliate thereof having an individual net worth of $5 million or more shall become obligated to perform the obligations of Invacare under this Agreement and the term “Invacare” as used in this Agreement shall be deemed to refer to such successor entity and such Affiliates jointly and severally. Any failure

9

of Invacare to obtain the written agreement of such successor or surviving entity (including a parent successor entity) and the required Affiliates to assume this Agreement before the effectiveness of any such succession shall be deemed to be a material breach of this Agreement.

7.2    Notices. Notices and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given when delivered in person or by confirmed facsimile transmission (to the Senior Vice President and General Counsel of Invacare in the case of notices to Invacare and to the Executive in the case of notices to the Executive) or three business days after being mailed by United States registered mail, return receipt requested, postage prepaid, addressed as follows:
If to Invacare:
Invacare Corporation
One Invacare Way
Elyria, OH 44035
Attention: Senior Vice President & General Counsel
If to the Executive:
_______________
_______________
_______________

or such other address as either party may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.
    7.3    Employment Rights. Nothing expressed or implied in this Agreement shall create any right or duty on the part of Invacare or the Executive to have the Executive continue as an officer of Invacare or an Affiliate of Invacare or to remain in the employment of Invacare or an Affiliate of Invacare.
    7.4    Administration. Invacare shall be responsible for the general administration of this Agreement and for making payments under this Agreement. All fees and expenses billed by the Accounting Firm for services contemplated under this Agreement shall be the responsibility of Invacare.
    7.5    Source of Payments. Any payment specified in this Agreement to be made by Invacare may be made directly by Invacare solely from its general assets, and the Executive shall have the rights of an unsecured general creditor of Invacare with respect thereto. In the event that Invacare establishes a rabbi trust and/or purchases an insurance policy insuring the life of the Executive to recover the cost of providing

10

benefits hereunder, neither the Executive nor his or her Beneficiary shall have any rights whatsoever in the assets of such rabbi trust or such policy or the proceeds therefrom.
    7.6    Validity. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement which shall remain in full force and effect.
    7.7    Modification; Waiver. No provision of this Agreement may be modified, waived, or discharged unless such waiver, modification, or discharge is agreed to in a writing signed by the Executive and Invacare. No waiver by either party hereto at any time of any breach by the other party of, or compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same time or at any prior or subsequent time.
    7.8    Entire Agreement; Supercession. Except as otherwise specifically provided herein, this Agreement, including its attachments, contains the entire agreement between the parties concerning the subject matter hereof and incorporates and supersedes any and all prior discussions or agreements, written or oral, the parties may have had with respect to such subject matter; provided, however, that except as expressly provided otherwise herein, nothing in this Agreement shall affect any rights the Executive or anyone claiming through the Executive may have in respect of either (a) any Employee Benefit Plan which provides benefits to or in respect of the Executive or (b) any other agreements the Executive may have with Invacare or an Affiliate of Invacare, including without limitation any employment or severance protection agreements the Executive may have with Invacare or an Affiliate of Invacare.
    7.9    Post-Mortem Payments; Designation of Beneficiary. In the event that, following the termination of the Executive’s employment with Invacare, the Executive is entitled to receive any payments pursuant to this Agreement and the Executive dies, such payments shall be made to the Executive’s Beneficiary designated hereunder. At any time after the execution of this Agreement, the Executive may prepare, execute, and file with the Secretary or the Senior Vice President, Human Resources, of Invacare a copy of the Designation of Beneficiary form attached to this Agreement as Exhibit A; provided, that if the Executive has already filed a similar beneficiary form with Invacare, then such form shall remain in effect for purposes of this Agreement until the Executive files an amended form. The Executive shall thereafter be free to amend, alter or change such form; provided, however, that any such amendment, alteration or change shall be made by filing a new Designation of Beneficiary form with the Secretary or the head of Human Resources of Invacare. In the event the Executive fails to designate a beneficiary, following the death of the Executive, all payments of the amounts specified by this Agreement which would have been paid to the Executive’s designated beneficiary pursuant to this Agreement shall instead be paid to the Executive’s spouse, if any, if he or she survives the Executive or, if there is no spouse or he or she does not survive the Executive, to the Executive’s estate.

11

    7.10    Service with Affiliates. Any services the Executive performs for an Affiliate of Invacare shall be deemed performed for Invacare. Any transfer of the Executive’s employment from Invacare to an Affiliate of Invacare, or from an Affiliate of Invacare to Invacare, or from an Affiliate of Invacare to another Affiliate of Invacare shall be deemed not to constitute a termination of the Executive’s employment with Invacare.
    7.11    Time Periods. Any action required to be taken under this Agreement within a certain number of days shall be taken within that number of calendar days; provided, however, that if the last day for taking such action falls on a weekend or a holiday, the period during which such action may be taken shall be automatically extended to the next business day. If the day for taking any action under this Agreement falls on a weekend or a holiday, such action may be taken on the next business day. Notwithstanding the foregoing, no such extension shall permit an action to be taken at a time that would cause an exempt payment to become subject to Code Section 409A or to cause a payment that would otherwise be compliant with Code Section 409A to cease to be so compliant.
    7.12    Incorporation by Reference. The incorporation herein of any terms by reference to another document shall not be affected by the termination of any agreement set forth in such other document or the invalidity of any provisions thereof.
7.13    Binding Effect; Construction of Agreement. This Agreement shall inure to the benefit of and be enforceable by the Executive’s personal representatives, executors, administrators, successors, heirs, and designees (including, without limitation, the Beneficiary). Upon the Executive’s death, for purposes of this Agreement, the term “Executive” shall be deemed to include, as applicable, any person (including, without limitation, the Beneficiary) who is entitled to benefits under this Agreement following the Executive’s death.
    7.14    Governing Law. All questions concerning the construction, validity and interpretation of this Agreement and the exhibits hereto will be governed by and construed in accordance with the internal laws of the State of Ohio, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Ohio or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Ohio.
    7.15    Representations and Warranties of Invacare. Invacare represents and warrants to the Executive that (i) Invacare is a corporation duly organized, validly existing, and in good standing under the laws of the State of Ohio; (ii) Invacare has the power and authority to enter into and carry out this Agreement, and there exists no contractual or other restriction upon its so doing; (iii) Invacare has taken such corporate action as is necessary or appropriate to enable it to enter into and perform its obligations under this Agreement; and (iv) this Agreement constitutes the legal, valid and binding obligation of Invacare, enforceable against Invacare in accordance with its terms.

12

    7.16     Gender. The use of the feminine, masculine or neuter pronoun shall not be restrictive as to gender and shall be interpreted in all cases as the context may require.
8.    Definitions.
8.1    Accounting Firm. The term “Accounting Firm” means the independent auditors of Invacare for the fiscal year preceding the year in which the Change of Control occurred and such firm’s successor or successors; provided, however, if such firm is unable or unwilling to serve and perform in the capacity contemplated by this Agreement, Invacare shall select another national accounting firm of recognized standing to serve and perform in that capacity under this Agreement, except that such other accounting firm shall not be the then independent auditors for Invacare or any of its Affiliates.
8.2    Affiliate. The term “Affiliate” shall mean, with respect to any person or entity, any other person or entity which controls, is controlled by, or is under common control with such person or entity within the meaning of Section 414(b) or (c) of the Internal Revenue Code.
8.3    Annual Base Salary. “Annual Base Salary” means the highest annual rate of base salary payable by Invacare to the Executive at any time between the Effective Date and the Termination Date.
8.4    Assumed. For purposes of this Agreement, a stock option, share of restricted stock, restricted stock unit or performance share shall be considered “Assumed” if all of the following conditions are met:
(a) stock options are converted into replacement awards in a manner that complies with Code Section 409A;
(b) awards of restricted stock and restricted stock units that are not subject to performance goals are converted into replacement awards covering a number of shares of the Post-CIC Entity, as determined in a manner substantially similar to how the same number of common shares underlying the awards of restricted stock or restricted stock units would be treated in the Change of Control transaction; provided that, to the extent that any portion of the consideration received by holders of Invacare’s common stock in the Change of Control transaction is not in the form of the common stock of the Post-CIC Entity, the number of shares covered by the replacement awards shall be based on the average of the high and low selling prices of the common stock of such Post-CIC Entity on the established stock exchange on the trading day immediately preceding the date of the Change of Control;
(c) awards of restricted stock, restricted stock units and performance shares that are subject to performance goals are converted into replacement awards that preserve the value of such awards at the time of the Change of Control;

13

(d) the replacement awards contain provisions for scheduled vesting and treatment on termination of employment (including the definitions of Cause and Good Reason, if applicable) that are no less favorable to the Executive than the underlying awards being replaced, and all other terms of the replacement awards (other than the security and number of shares represented by the replacement awards) are substantially similar to, or more favorable to the Executive than, the terms of the underlying awards; and
(e) the security represented by the replacement awards, if any, is of a class that is publicly held and widely traded on an established stock exchange.
8.5    Beneficiary. “Beneficiary” means the person designated by the Executive as his or her beneficiary pursuant to Section 7.9 or such other person as determined pursuant to Section 7.9 hereof.
8.6    Cause. The employment of the Executive by Invacare shall have been terminated for “Cause” if, after a Change of Control and prior to the termination of employment, any of the following has occurred:
(a)    the Executive shall have been convicted of a felony,
(b)    the Executive commits an act or series of acts of dishonesty in the course of the Executive’s employment which are materially inimical to the best interests of Invacare and which constitutes the commission of a crime, all as determined by the vote of three-fourths of all of the members of the Board of Directors of Invacare (other than the Executive, if the Executive is a Director of Invacare), which determination is confirmed by a panel of three arbitrators appointed and acting in accordance with the rules of the American Arbitration Association for the purpose of reviewing that determination,
(c)    any federal or state regulatory agency with jurisdiction over Invacare has issued a final order, with no further right of appeal, that has the effect of suspending, removing, or barring the Executive from continuing his or her service as an officer or director of Invacare, or
(d)    the Executive’s breach of any Technical Information Agreement & Non-Competition Agreement entered into by the Executive.
8.7    Change of Control. A “Change of Control” shall be deemed to have occurred at the first time on which, after the Effective Date:
(a)    There is a report filed on Schedule 13D or Schedule 14D1 (or any successor schedule, form, or report), each as adopted under the Securities Exchange Act of 1934, as amended, disclosing the acquisition, in a transaction or series of transactions, by any person (as the term “person” is used in Section 13(d) and Section 14(d)(2) of the Securities Exchange Act of 1934, as amended), other than (1) Invacare or

14

any of its subsidiaries, (2) any employee benefit plan or employee stock ownership plan or related trust of Invacare or any of its subsidiaries, or (3) any person or entity organized, appointed or established by Invacare or any of its subsidiaries for or pursuant to the terms of any such plan or trust, of such number of shares of Invacare as entitles that person to exercise 30% or more of the voting power of Invacare in the election of Directors; or
(b)    During any period of twenty-four (24) consecutive calendar months, individuals who at the beginning of such period constitute the Directors of Invacare cease for any reason to constitute at least a majority of the Directors of Invacare unless the election of each new Director of Invacare (over such period) was approved or recommended by the vote of at least two-thirds of the Directors of Invacare then still in office who were Directors of Invacare at the beginning of the period; or
(c)    There is a merger, consolidation, combination (as defined in Section 1701.01(Q), Ohio Revised Code), majority share acquisition (as defined in Section 1701.01(R), Ohio Revised Code), or control share acquisition (as defined in Section 1701.01(Z)(1), Ohio Revised Code, or in Invacare’s Articles of Incorporation) involving Invacare and, as a result of which, the holders of shares of Invacare prior to the transaction become, by reason of the transaction, the holders of such number of shares of the surviving or acquiring corporation or other entity as entitles them to exercise in the aggregate less than fifty percent (50%) of the voting power of the surviving or acquiring corporation or other entity in the election of Directors; or
(d)    There is a sale, lease, exchange, or other transfer (in one transaction or a series of related transactions) of all or substantially all of the assets of Invacare, but only if the transferee of the assets in such transaction is not a subsidiary of Invacare; or
(e)    The shareholders of Invacare approve any plan or proposal for the liquidation or dissolution of Invacare, but only if the transferee of the assets of Invacare in such liquidation or dissolution is not a subsidiary of Invacare.
If an event described in any of Clauses (a), (b), (c), (d), and (e) occurs, a Change of Control shall be deemed to have occurred for all purposes of this Agreement and, except as provided in the last sentence of Section 5.2, that Change of Control shall be irrevocable.
8.8     Code. “Code” means the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.    
8.9    Demotion or Removal. The Executive shall be deemed to have been subjected to “Demotion or Removal” if, during the two-year period commencing on the date of a Change of Control, other than by Voluntary Resignation or with the Executive’s written consent, the Executive ceases to hold the highest position held by Executive at any time during the two-year period ending on the date of the

15

Change of Control with all of the duties, authority, and responsibilities of that office as in effect at any time during the two-year period ending on the date of the Change of Control.
8.10    Disability. For purposes of this Agreement, the Executive’s employment will have been terminated by Invacare by reason of “Disability” of the Executive only if (a) as a result of accidental bodily injury or sickness, the Executive has been unable to perform his or her normal duties for Invacare for a period of 180 consecutive days, and (b) the Executive begins to receive payments under the executive long term disability plan or its successor plan(s) sponsored by Invacare not later than 30 days after the Termination Date.
8.11 Employee Benefit Plan. “Employee Benefit Plan” means any plan or arrangement defined as such in 29 U.S.C. §1002 which provides benefits to the employees of Invacare or its Affiliates.
8.12 Good Reason. The Executive shall have “Good Reason” to terminate his or her employment under this Agreement if, at any time after a Change of Control has occurred and before the second anniversary of that Change of Control, one or more of the events listed in (a) through (f) of this Section 8.12 occurs and, based on that event, the Executive gives notice of such event (and of Executive’ intention to terminate his or her employment if Invacare does not cure such condition(s)) on a date that is both (i) within 90 days of the occurrence of that event and (ii) not later than the second anniversary of that Change of Control, and Invacare does not cure the condition(s) constituting the event within 30 days after such notice:
(a) The Executive is subjected to a Demotion or Removal involving a material diminution in the Executive’s authority, duties, or responsibilities or in those of the individual to whom the Executive is required to report; or
(b)    The Executive’s Annual Base Salary is materially reduced (which for this purpose shall be deemed to occur if the reduction is five percent (5%) or greater); or
(c)    The Executive’s opportunity for incentive compensation is materially reduced from the level of his or her opportunity for incentive compensation as in effect immediately before the date of the Change of Control or from time to time thereafter (which for this purpose shall be deemed to occur if the reduction is equivalent to a five percent (5%) or greater reduction in Executive’s Annual Base Salary); or
(d)    The Executive is excluded (other than by his or her volitional action(s)) from full participation in any benefit plan or arrangement maintained for senior executives of Invacare generally, and such exclusion materially reduces the benefits provided to the Executive; or

16

(e)    The Executive’s principal place of employment for Invacare is relocated a material distance (which for this purpose shall be deemed to be more than 35 miles) from Executive’s principal place of employment on the date of the Change of Control; or
(f)    Any other action or inaction that constitutes a material breach by Invacare of this Agreement or any other agreement under which the Executive provides his or her services to Invacare.
8.13    Post-CIC Entity. “Post-CIC Entity” means any entity (or any successor or parent thereof) that effects a Change of Control pursuant to Section 8.7.
8.14    Prime Plus One. “Prime Plus One” means the prime rate of interest, as reported by the Wall Street Journal or its successors, plus 1%.
8.15    Prior Bonus Amount. “Prior Bonus Amount” means an amount equal to the average of the bonuses earned by the Executive under Invacare’s annual bonus plan with respect to the three fiscal years immediately preceding the fiscal year in which a Change of Control occurs, provided however, if the Change of Control occurs prior to Executive completing three full years of employment with Invacare, then “Prior Bonus Amount” will mean the average of the bonuses earned for the actual number of fiscal years the Executive was employed.
8.16    Prorated Bonus Amount. “Prorated Bonus Amount” means an amount equal to (a) times (b), in which (a) equals the Executive’s Annual Base Salary multiplied by the higher of (i) the target bonus percentage in effect for the Executive under Invacare’s bonus plan during the fiscal year immediately preceding the fiscal year in which the Change of Control occurs, or (ii) the target bonus percentage in effect for the Executive under Invacare’s bonus plan during the fiscal year in which the Termination Date occurs; and (b) equals a quotient, in which the numerator is the number of days the Executive was employed by Invacare during the year in which the Termination Date occurs and the denominator is 365.
8.17    Termination Date. “Termination Date” means the date on which (and related terms, such as “termination of employment” and “terminate employment” mean a situation in which) the Executive incurs a separation from service with Invacare and all of its Affiliates within the meaning of Code Section 409A. A separation from service under Code Section 409A includes a quit, discharge, or retirement, or a leave of absence (including military leave, sick leave, or other bona fide leave of absence such as temporary employment by the government, at the point that such leave exceeds the greater of: (i) six months; (ii) the period for which the Participant’s right to reemployment is provided either by statute or by contract, or (iii) in the case of sick leave, twenty-nine (29) months, if the Executive’s injury or sickness can be expected to result in death or can be expected to last for a continuous period of not less than 6 months, and such injury or sickness renders the Executive unable to perform the duties of his or her position of employment or any substantially similar position of employment).

17

A separation from service under Code Section 409A also occurs upon a permanent decrease in service to a level that is no more than twenty percent (20%) of its prior level. For this purpose, whether a separation from service has occurred is determined based on whether it is reasonably anticipated that no further services will be performed by the Executive after a certain date or that the level of bona fide services the Executive will perform after such date (whether as an employee or as an independent contractor) would permanently decrease to no more than twenty percent (20%) of the average level of bona fide services performed (whether as an employee or an independent contractor) over the immediately preceding 36-month period (or the full period of services if the Executive has been providing services less than 36 months).
8.18    Voluntary Resignation. A “Voluntary Resignation” shall have occurred if the Executive terminates his or her employment with Invacare by voluntarily resigning at his or her own instance without having been requested to so resign by Invacare, except that any resignation by the Executive will not be deemed to be a Voluntary Resignation if, at the time of that resignation, the Executive had Good Reason to resign, which had not been waived in writing by the Executive.
IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.
INVACARE CORPORATION
(“Invacare”)


By:     
Name:
Title:


    
(the “Executive”)




18

Schedule of Change of Control Agreements


NamePositionDate of Agreement
Matthew E. MonaghanPresident and Chief Executive OfficerApril 1, 2015
Kathleen L. LeneghanSenior Vice President and Chief Financial OfficerFebruary 22, 2018
Ralf A. LeddaSenior Vice President and General Manager, Europe, Middle East & AfricaNovember 1, 2016
Joost BeltmanSenior Vice President and General Manager, North AmericaAugust 26, 2020
Angela GoodwinSenior Vice President and Chief Information Technology OfficerMay 21, 2020
Rick A. CassidaySenior Vice President and Chief Human Resources OfficerJune 7, 2021

19
 EX-31.1 5 q32021ivcex311.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATIONS
I, Matthew E. Monaghan, certify that:
1.    I have reviewed this quarterly report on Form 10-Q of Invacare Corporation;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 /s/ MATTHEW E. MONAGHAN
Date:October 27, 2021
Matthew E. Monaghan
President and Chief Executive Officer
(Principal Executive Officer)


 EX-31.2 6 q32021ivcex312.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATIONS
I, Kathleen P. Leneghan, certify that:
1.    I have reviewed this quarterly report on Form 10-Q of Invacare Corporation;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 /s/ KATHLEEN P. LENEGHAN
Date:October 27, 2021
Kathleen P. Leneghan
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)


 EX-32.1 7 q32021ivcex321.htm EX-32.1 Document

Exhibit 32.1
Certification
Pursuant to Section 18 U.S.C. Section 1350,
as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of Invacare Corporation (the “company”) on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Matthew E. Monaghan, President and Chief Executive Officer of the company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company.
 /s/ MATTHEW E. MONAGHAN
Date:October 27, 2021Matthew E. Monaghan
President and Chief Executive Officer
(Principal Executive Officer)
A signed original of this written statement required by Section 906 has been provided to Invacare Corporation and will be retained by Invacare Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

 EX-32.2 8 q32021ivcex322.htm EX-32.2 Document

Exhibit 32.2
Certification
Pursuant to Section 18 U.S.C. Section 1350,
as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of Invacare Corporation (the “company”) on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kathleen P. Leneghan, Senior Vice President and Chief Financial Officer of the company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company.
 /s/ KATHLEEN P. LENEGHAN
Date:October 27, 2021Kathleen P. Leneghan
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
A signed original of this written statement required by Section 906 has been provided to Invacare Corporation and will be retained by Invacare Corporation and furnished to the Securities and Exchange Commission or its staff upon request.


 EX-101.CAL 9 ivc-20210930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 ivc-20210930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT GRAPHIC 11 image.jpg begin 644 image.jpg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end EX-101.LAB 12 ivc-20210930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT EUR / SEK Foreign Exchange Forward EUR / SEK [Member] Foreign Exchange Forward EUR / SEK [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Restatement [Axis] Revision of Prior Period [Axis] Receivable Type [Axis] Receivable Type [Axis] Other, principally returns and allowances reserves Returns and Allowances Reserve Returns and Allowances Reserve Amortization of Debt Discount (Premium) Amortization of Debt Discount (Premium) Financing Receivables Not Past 90 Days Due Financing Receivables Not Accruing Interest Past 90 Days Due Financing Receivables Not Accruing Interest Past 90 Days Due Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Deferred financing fees Debt Issuance Costs, Noncurrent, Net Revolving Credit and Security Agreement (New Credit Agreement) Revolving Credit and Security Agreement (New Credit Agreement) [Member] Revolving Credit and Security Agreement (New Credit Agreement) [Member] License agreements Licensing Agreements [Member] Large National Customers Large National Customers [Member] Large National Customers [Member] Range [Domain] Statistical Measurement [Domain] Liabilities and Shareholders’ Equity Liabilities and Equity [Abstract] Risks and Uncertainties [Abstract] Risks and Uncertainties [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Finance Lease, Right-of-Use Asset, Amortization Finance Lease, Right-of-Use Asset, Amortization Security Exchange Name Security Exchange Name Debt Instrument, Fee Amount Debt fees Debt Instrument, Fee Amount, Net Balance Shown as a Liability Debt Instrument, Fee Amount, Net Balance Shown as a Liability Proceeds from revolving lines of credit and long-term borrowings Proceeds from Issuance of Long-term Debt Total Current Liabilities Liabilities, Current EUR / GBP Foreign Exchange Forward EUR / GBP [Member] Foreign Exchange Forward EUR / GBP [Member] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Performance Shares Performance Shares [Member] Other [Domain] Other [Domain] Other Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Net Gain (Loss), as a percent of Net Sales Net Gain (Loss), as a percent of Net Sales Net Gain (Loss), as a percent of Net Sales Deferred Tax Reversal, related to Goodwill Impairment Deferred Tax Reversal, related to Goodwill Impairment Deferred Tax Reversal, related to Goodwill Impairment Variable Rate [Domain] Variable Rate [Domain] Professional Accrued Professional Fees, Current Right-of-Use Asset Obtained in Exchange for Total Lease Liability Right-of-Use Asset Obtained in Exchange for Total Lease Liability Right-of-Use Asset Obtained in Exchange for Total Lease Liability Fair value stock price Average Fair Value Stock Price Average Fair Value Stock Price Finance Lease, Liability, Payments, Due Finance Lease, Liability, Payment, Due Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Assets Assets [Abstract] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Accumulated Other Comprehensive Income (Loss) by Component Comprehensive Income (Loss) Note [Text Block] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments 2021 Lessee, Operating Lease, Liability, to be Paid, Year One Class B Common Shares [Member] Class B Common Shares [Member] Common Class B [Member] Options outstanding at beginning of period (in shares) Options outstanding at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2024 Lessee, Operating Lease, Liability, to be Paid, Year Four Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Long-term debt net of current maturities Long-term Debt and Lease Obligation Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Total Unearned Interest Deferred Revenue Deferred Revenue Preferred Shares (Authorized 300 shares; none outstanding) Preferred Stock, Value, Issued Exercise price range, lower limit (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 90+ days past due Installment Receivable, Greater than 90 Days Past Due Installment Receivable, Greater than 90 Days Past Due Percentage of eligible domestic inventory and in-transit inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Domestic, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Domestic, Percent Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Common Stock, Par or Stated Value Per Share Common Stock, Par or Stated Value Per Share Allowance for doubtful accounts, long-term Financing Receivable, Allowance for Credit Loss, Noncurrent Other Long-Term Obligations Other Long-Term Obligations Other Liabilities, Noncurrent Amount of Gain (Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Work in process Inventory, Work in Process, Net of Reserves Impaired installment receivables with a related allowance recorded Impaired Financing Receivable, with Related Allowance, Recorded Investment Net loss (gain) on debt extinguishment, as a Percent of Net Sales [Line Items] Net loss (gain) on debt extinguishment, as a Percent of Net Sales Net loss (gain) on debt extinguishment, as a Percent of Net Sales Liability Components of Convertible 2024 Note Liability Components of Convertible 2024 Note [Table Text Block] Liability Components of Convertible 2024 Note Inventories, net Inventories, net Inventory, Net Fair Value, Measurement Frequency [Domain] Measurement Frequency [Domain] Percentage of eligible Canadian accounts receivable Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Foreign, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Foreign, Percent Expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Statement [Line Items] Statement [Line Items] Class of Stock [Domain] Class of Stock [Domain] Weighted average interest rate (as a percent) Long-term Debt, Weighted Average Interest Rate, at Point in Time Tax Period [Axis] Tax Period [Axis] Convertible Senior Notes at 4.50% February 2022 Convertible Senior Notes at 4.50% February 2022 [Member] Convertible Senior Notes at 4.50% February 2022 Receivables Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Consecutive business days for minimum undrawn balance Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn Balance Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn Balance Statement [Table] Statement [Table] Type of Restructuring [Domain] Type of Restructuring [Domain] Range [Axis] Statistical Measurement [Axis] Deferred income taxes Deferred Tax Assets, Tax Deferred Expense Interest Income, Other Interest Income, Other Derivative, Price Risk Option Strike Price Class of Warrant or Right, Exercise Price of Warrants or Rights Weighted Average Weighted Average [Member] Line of Credit Facility, Fair Value of Amount Outstanding Line of Credit Facility, Fair Value of Amount Outstanding Entity Small Business Entity Small Business Principles of Consolidation Consolidation, Policy [Policy Text Block] Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Debt Disclosure Debt Disclosure [Text Block] Total installment receivables Financing Receivable, Interest Income, Accrual Method Financing Receivable, Interest Income, Accrual Method Disposal Group, Including Discontinued Operation, Revenue Disposal Group, Including Discontinued Operation, Revenue Cost of products sold Cost of Products Sold Cost of Revenue Percentage of domestic accounts receivable Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Domestic, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Domestic, Percent Amendment Flag Amendment Flag Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Minimum required undrawn balance (as a percent) Line of Credit, Covenant Compliance, Required Undrawn Balance, Minimum, Percent Line of Credit, Covenant Compliance, Required Undrawn Balance, Minimum, Percent Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Options available for grant at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Other items, principally trade accruals Other Accrued Liabilities, Current Sale Leaseback Transaction, Net Proceeds, Investing Activities Sale Leaseback Transaction, Net Proceeds, Investing Activities Charges Related To Restructuring Activities Restructuring and Related Activities Disclosure [Text Block] Measurement Frequency [Axis] Measurement Frequency [Axis] Convertible Senior Notes at 5.00% November 2024 Convertible Senior Notes at 5.00% November 2024 [Member] Convertible Senior Subordinated Debentures at 4.125% February 2027 [Member] Financial Instruments [Domain] Financial Instruments [Domain] Fair Value, by Balance Sheet Grouping Fair Value, by Balance Sheet Grouping [Table Text Block] Gain (Loss) Gain (Loss) Gain (Loss) Derivative, Gain (Loss) on Derivative, Net Fair Value Measurement [Domain] Fair Value Measurement [Domain] Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) Impaired installment receivables with a related allowance recorded Impaired Financing Receivable, with Related Allowance, Unpaid Principal Balance Deferred financing fees Prepaid Debt Fees Prepaid Debt Fees Debt Instrument, Net Proceeds Debt Instrument, Net Proceeds Debt Instrument, Net Proceeds Average period of adjudication Notes, Loans, Financing Receivable, Average Period of Adjudication Notes, Loans, Financing Receivable, Average Period of Adjudication Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Product liability Product Liability, Noncurrent Product Liability, Noncurrent Total Cash Paid in Measurement of Amounts for Lease Liabilities Total Cash Paid in Measurement of Amounts for Lease Liabilities Total Cash Paid in Measurement of Amounts for Lease Liabilities Property, Plant and Equipment by Type [Axis] Long-Lived Tangible Asset [Axis] Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Adoption of Credit Loss Standard Adoption of Credit Loss Standard Adoption of Credit Loss Standard Revenue from External Customers by Products and Services [Table Text Block] Revenue from External Customers by Products and Services [Table Text Block] Income Statement Location [Domain] Income Statement Location [Domain] 2022 Lessee, Operating Lease, Liability, to be Paid, Year Two Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Selling, general and administrative expenses Amortization of prior service costs and unrecognized gains Selling, General and Administrative Expense Lease, Cost [Table] Lease, Cost [Table Text Block] Amortization of operating lease right of use assets Operating Lease, Right-of-Use, Amortization Operating Lease, Right-of-Use, Amortization Long-term debt Long-term debt Long-term Debt and Lease Obligation, Including Current Maturities 2023 Lessee, Operating Lease, Liability, to be Paid, Year Three Other Assets Other Long-Term Assets Other Assets, Noncurrent Lifestyle Products [Domain] Lifestyle Products [Domain] Lifestyle Products Plan Name [Axis] Plan Name [Axis] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Net loss from Continuing Operations Net loss from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Total Assets Assets Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Exercise Price Range [Domain] Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Antidilutive Securities [Axis] Antidilutive Securities [Axis] Cost of Sales [Member] Cost of Sales [Member] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Debt Instrument Exchange Amount Debt Instrument Exchange Amount Debt Instrument Exchange Amount IT service contracts IT Service Contract IT Service Contract Schedule of Other Assets, Noncurrent Schedule of Other Assets, Noncurrent [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Description Share-based Compensation Arrangement by Share-based Payment Award, Description Divested Businesses Mergers, Acquisitions and Dispositions Disclosures [Text Block] Options Exercisable - Weighted Average Exercise Price (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Financing Receivable Portfolio Segment Financing Receivable Portfolio Segment [Domain] Other Other Intangible Assets [Member] Share-based Compensation, Performance Shares Award Unvested Activity Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block] Uncertain tax obligation including interest Liability for Uncertainty in Income Taxes, Noncurrent Sales [Member] Sales [Member] USD / GBP Foreign Exchange Forward GBP / USD [Member] Foreign Exchange Forward GBP / USD [Member] Schedule of Amounts Recognized in Other Comprehensive Income (Loss) Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Total installment receivables Financing Receivable, Unpaid Principal Balance Financing Receivable, Unpaid Principal Balance Net orderly liquidation value of domestic eligible machinery and equipment Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Property, Plant and Equipment, Liquidation Value, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Property, Plant and Equipment, Liquidation Value, Percent Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] USD / CHF Foreign Exchange Forward USD / CHF [Member] Foreign Exchange Forward USD / CHF Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Inventories, net Increase (Decrease) in Inventories Revolving Credit and Security Agreement (North America Credit Agreement) Revolving Credit and Security Agreement (North America Credit Agreement) [Member] Revolving Credit and Security Agreement (North America Credit Agreement) Tax receivables principally value added taxes Value Added Tax Receivable, Current Legal Entity Type of Counterparty [Domain] Legal Entity Type of Counterparty [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Series II Convertible Senior Notes at 5.00% November 2024 [Domain] Series II Convertible Senior Notes at 5.00% November 2024 [Domain] Series II Convertible Senior Notes at 5.00% November 2024 Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance Finance Lease, Interest Expense Finance Lease, Interest Expense Accrued Expenses Accounts Payable and Accrued Liabilities [Member] Machinery and equipment Machinery and Equipment [Member] Common Stock, Shares, Issued Common Stock, Shares, Outstanding Schedule of Other Current Assets Schedule of Other Current Assets [Table Text Block] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Liability Components of Convertible 2022 Note Liability Components of Convertible 2022 Note [Table Text Block] Liability Components of Convertible 2022 Note [Table Text Block] [Table Text Block] Customer rebate reserve Customer Rebate Reserve Customer Rebate Reserve Performance achievement level, upper range Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Upper Range, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Upper Range, Percentage Senior secured revolving credit facility, due in October 2015 Revolving Credit Facility Revolving Credit Facility [Member] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Other Current Assets Other Current Assets [Text Block] Derivative Instruments and Hedging Activities [Abstract] Derivative Instruments and Hedging Activities [Abstract] Derivative Instruments and Hedging Activities [Abstract] Loss Before Income Taxes Earnings (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Options outstanding at beginning of period - Weighted Average Exercise Price (in dollars per share) Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share) Options Outstanding - Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Restricted Stock and Restricted Stock Units (RSUs) Restricted Stock and Restricted Stock Units (RSUs) [Member] Restricted Stock and Restricted Stock Units (RSUs) [Member] Common Stock, Shares Authorized Common Stock, Shares Authorized Stock options and awards Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Property and equipment, gross Property, Plant and Equipment, Gross Foreign Exchange Forward Contracts, by Exchange [Domain] Foreign Exchange Forward Contracts, by Exchange [Domain] Foreign Exchange Forward Contracts, by Exchange [Domain] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent Sale Leaseback Transaction, Description [Axis] Sale Leaseback Transaction, Description [Axis] Europe (EMEA) Europe (EMEA) [Member] Europe (EMEA) Impaired Financing Receivable, Related Allowance Impaired Financing Receivable, Related Allowance AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] Insurance Accrued Insurance, Current Sale Leaseback Transaction [Table] Sale Leaseback Transaction [Table] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Use of Estimates Use of Estimates, Policy [Policy Text Block] Performance achievement level, target range Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Percentage Level of Performance Award Achievement, Target Series II Convertible Senior Notes at 5.00% November 2024 Series II Convertible Senior Notes at 5.00% November 2024 [Member] Series II Convertible Senior Notes at 5.00% November 2024 USD / SEK Foreign Exchange Forward SEK/USD [Member] Foreign Exchange Forward SEK/USD Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Scenario, Unspecified [Domain] Scenario [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Consolidation Items [Domain] Consolidation Items [Domain] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Valuation Allowance [Table] Valuation Allowance [Table] Convertible Preferred Stock, Shares Issued upon Conversion Convertible Preferred Stock, Shares Issued upon Conversion Other Long-Term Obligations Other Liabilities Disclosure [Text Block] Income (Loss) from Continuing Operations before Income Taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Customer lists Customer Lists [Member] Hedging Designation [Axis] Hedging Designation [Axis] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Percent of the Applicable Conversion Price Percent of the Applicable Conversion Price Percent of the Applicable Conversion Price Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Risk Level, Medium Risk Level, Medium [Member] Designated as Hedging Instrument [Member] Designated as Hedging Instrument [Member] Non-Impaired installment receivables with no related allowance recorded Financing Receivable, with No Related Allowance, Interest Income, Accrual Method Financing Receivable, with No Related Allowance, Interest Income, Accrual Method $12.15 – $20.00 Range of Exercise Price Range Min [Member] Range of Exercise Price Range Min Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location Derivatives Not Designated as Hedging Instruments [Table Text Block] Gain on sale of business, as a Percent of Net Sales Gain on sale of business, as a Percent of Net Sales Gain on sale of business, as a Percent of Net Sales Other Intangibles Intangible Assets Disclosure [Text Block] Goodwill [Line Items] Goodwill [Line Items] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Sale and Leaseback Transaction, Gain (Loss), Net Sale and Leaseback Transaction, Gain (Loss), Net Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Share-based Payment Arrangement, Option, Exercise Price Range [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Settlements made during the period Standard and Extended Product Warranty Accrual, Decrease for Payments Finished goods Inventory, Finished Goods, Net of Reserves Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-based Payment Arrangement [Abstract] Legal Entity of Counterparty, Type [Axis] Legal Entity of Counterparty, Type [Axis] Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Current portion of operating lease obligations Operating Lease, Liability, Current Operating Lease, Liability, Current Notional amount of derivatives, matured during period Notional Amount of Derivatives, Matured During Period Notional Amount of Derivatives, Matured During Period Industry Sector [Domain] Industry Sector [Domain] Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability North America (NA) North America (NA) [Member] North America (NA) Convertible due 2021 - Bond Hedge, Fair Value at Issuance Convertible due 2021 - Bond Hedge, Fair Value at Issuance Convertible due 2021 - Bond Hedge, Fair Value at Issuance Class of Financing Receivable, Type Class of Financing Receivable [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Schedule of Derivatives Instruments Statements of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Schedule for Allowance for Credit Losses Allowance for Credit Losses [Table Text Block] Allowance for Credit Losses Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Interest Income Recognized Impaired Financing Receivable, Interest Income, Accrual Method [Abstract] United Kingdom, Pounds United Kingdom, Pounds Industry of Counterparty [Domain] Industry of Counterparty [Domain] Liability Components of Convertible Series II 2024 Note Liability Components of Convertible Series II 2024 Note [Table Text Block] Liability Components of Convertible Series II 2024 Note Entity Registrant Name Entity Registrant Name Operating Lease, Weighted Average Discount Rate, Percent Operating Lease, Weighted Average Discount Rate, Percent Debt Instrument, Fee Amount Debt Instrument, Fee Amount Intersegment revenues Intersegment Eliminations [Member] Issuance of warrants Proceeds from Issuance of Warrants Proceeds from Issuance of Warrants Sale Leaseback Transaction, Annual Payments Sale Leaseback Transaction, Annual Payments Sale Leaseback Transaction, Annual Payments Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) Contract Termination Contract Termination [Member] Warranties provided during the period Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Contract Type [Axis] Contract Type [Axis] Contract Type [Axis] Payment of dividends Payments of Ordinary Dividends, Common Stock Payments of Ordinary Dividends, Common Stock Deferred gain on sale leaseback, Net Deferred gain on sale leaseback, Net Deferred gain on sale leaseback, Net Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Service contracts Prepaid Service Contracts Prepaid Service Contracts Beginning Balance Ending Balance Restructuring Reserve Restructuring Reserve Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables Convertible Senior Notes at 5.00% November 2024 [Domain] Convertible Senior Notes at 5.00% November 2024 [Domain] Convertible Senior Notes at 5.00% November 2024 [Domain] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restructuring Cost and Reserve [Axis] Restructuring Type [Axis] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Accrued Expenses Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Goodwill Goodwill Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Class of Warrant or Right, Outstanding Class of Warrant or Right, Outstanding Dividends Declared per Common Share Common Stock, Dividends, Per Share, Declared Debt Instrument, Face Amount Debt Instrument, Face Amount Other long-term liabilities Increase (Decrease) in Other Deferred Liability Other current assets Other current assets Other Assets, Current Canceled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Financing Lease Liability, non-current Financing Lease Liability, non-current Financing Lease Liability, non-current Equity [Abstract] Equity [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Entities [Table] Entities [Table] Derivative Contract [Domain] Derivative Contract [Domain] Weighted Average Shares Outstanding—Assuming Dilution Average common shares assuming dilution Weighted Average Number of Shares Outstanding, Diluted Letter of Credit Letter of Credit [Member] Debt Discount Amortization, per Basic and Diluted Share Debt Discount Amortization, per Basic and Diluted Share Debt Discount Amortization, per Basic and Diluted Share Performance achievement level, lower range Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Lower Range, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Lower Range, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Debt Disclosure [Abstract] Debt Disclosure [Abstract] Assets and Liabilities of Divested Business [Table Text Block] Assets and Liabilities of Divested Business [Table Text Block] Assets and Liabilities of Divested Business Schedule of Accounts Receivable [Abstract] Schedule of Accounts Receivable [Abstract] Schedule of Accounts Receivable [Abstract] Net Cash Provided by Financing Activities Net Cash Provided by (Used in) Financing Activities Repurchases of convertible debt, payments on revolving lines of credit and finance leases Repayments of Long-term Debt Disposal Group, Including Discontinued Operation, Inventory Disposal Group, Including Discontinued Operation, Inventory Schedule of Share-based Compensation, Stock Options Outstanding Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Selling, general and administrative expenses, as a Percent of Net Sales Selling, general and administrative expenses, as a Percent of Net Sales Selling, general and administrative expenses, as a Percent of Net Sales Investments Long-term Investments Counterparty Name [Axis] Counterparty Name [Axis] Line of Credit Facility, Covenant Feature, Dominion Trigger Line of Credit Facility, Covenant Feature, Dominion Trigger Line of Credit Facility, Covenant Feature, Dominion Trigger Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Document Fiscal Year Focus Document Fiscal Year Focus Non-Impaired installment receivables with no related allowance recorded Financing Receivable, with No Related Allowance, Recorded Investment Financing Receivable, with No Related Allowance, Recorded Investment USD / EUR Foreign Exchange Forward USD / EUR [Member] Foreign Exchange Forward USD / EUR [Member] Future amortization expense, 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Two Installment Receivables, Current Financing Receivable, before Allowance for Credit Loss, Current Current portion of long-term debt Long-term Debt, Current Maturities Entity Current Reporting Status Entity Current Reporting Status Total installment receivables Financing Receivable, Recorded Investment Financing Receivable, Recorded Investment Other Liabilities Disclosure [Abstract] Other Liabilities Disclosure [Abstract] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Common Stock, Shares, Issued Common Stock, Shares, Issued Cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of period Cash and Cash Equivalents, at Carrying Value Schedule of Impaired Financing Receivable [Table] Schedule of Impaired Financing Receivable [Table] Options Outstanding - Number Outstanding at end of period (in shares) Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Long-Term Debt Long-term Debt, Excluding Current Maturities Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts Receivable, Net Accounts Receivable, after Allowance for Credit Loss USD / MXN Foreign Exchange Forward USD / MXP [Member] Foreign Exchange Forward USD / MXP [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Total Shareholders’ Equity Total Shareholders’ Equity Total Shareholders’ Equity Stockholders' Equity Attributable to Parent Revenue Recognition, Deferred Revenue [Policy Text Block] Revenue Recognition, Deferred Revenue [Policy Text Block] Severance Other Employee-related Liabilities, Current Derivative assets (liabilities), at fair value, net Derivative Assets (Liabilities), at Fair Value, Net Entity Address, City or Town Entity Address, City or Town Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] 2025 Lessee, Operating Lease, Liability, to be Paid, Year Five Financial Instrument [Axis] Financial Instrument [Axis] Disposal Group, Including Discontinued Operation, Other Assets Disposal Group, Including Discontinued Operation, Other Assets Gain (Loss) on Repurchase of Debt Instrument Gain (Loss) on Repurchase of Debt Instrument Type of Adoption [Domain] Accounting Standards Update [Domain] Debt Instrument Repurchase Amount, Cash Paid Debt Instrument Repurchase Amount, Cash Paid Debt Instrument Repurchase Amount, Cash Paid Product Product [Member] Short-term Lease, Cost Short-term Lease, Cost Deferred tax adjustment resulting from defined benefit plan activity Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax Gain on disposals of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Indefinite-lived Intangible Assets by Major Class [Axis] Indefinite-lived Intangible Assets [Axis] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Future amortization expense, 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Three Total Assets Disposal Group, Including Discontinued Operation, Assets Installment Receivable, Not Past Due Installment Receivable, Not Past Due Installment Receivable, Not Past Due Prepaid insurance Prepaid Insurance Schedule of Notional Amounts of Outstanding Derivative Positions Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Finance Lease Long-Term Obligations Finance Lease, Liability, Noncurrent Sale Leaseback Transaction, Immediate Loss Recognized Sale Leaseback Transaction, Immediate Loss Recognized Sale Leaseback Transaction, Immediate Loss Recognized Other Comprehensive Income (Loss) Other Comprehensive Income (Loss), Net of Tax Related Allowance for Doubtful Accounts Impaired Financing Receivable, Related Allowance [Abstract] Impaired Financing Receivable, Related Allowance [Abstract] Leases [Abstract] Leases [Abstract] Debt Instrument, Interest Rate on Liability Component, Effective Percentage Debt Instrument, Interest Rate on Liability Component, Effective Percentage Debt Instrument, Interest Rate on Liability Component, Effective Percentage Interest expense, as a Percent of Net Sales Interest expense, as a Percent of Net Sales Interest expense, as a Percent of Net Sales Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total Current Assets Assets, Current Goodwill Goodwill Disclosure [Text Block] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Charges related to restructuring activities Charges Charges Restructuring Charges Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Other Notes and Capital Lease Obligations Other Notes and Capital Lease Obligations [Member] Other Notes and Capital Lease Obligations [Member] Amortization of prior service costs and unrecognized losses Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Accumulated Defined Benefit Plans Adjustment [Member] Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Gain on sale of business Gain (Loss) on Disposition of Business Disposal Groups, Including Discontinued Operations, Name [Domain] Disposal Group Name [Domain] Shareholders’ Equity Stockholders' Equity Attributable to Parent [Abstract] Future amortization expense, 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Five Document Fiscal Period Focus Document Fiscal Period Focus Pension Liability, Defined Benefit Pension Plan, Noncurrent Class of Financing Receivable, Type of Borrower [Domain] Class of Financing Receivable, Type of Borrower [Domain] Capped Call Options, Outstanding Capped Call Options, Outstanding Capped Call Options, Outstanding Entity Filer Category Entity Filer Category Purchases of capped calls Purchases of capped calls Purchase of Capped Calls Purchase of Capped Calls Common Shares [Member] Common Stock [Member] Common Stock [Member] Accumulated Translation Adjustment [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Product and Service [Domain] Product and Service [Domain] Current period gain (loss) on cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Risk Level, High Risk Level, High [Member] Disposal Group, Including Discontinued Operation, Inter-Company Revenue Disposal Group, Including Discontinued Operation, Inter-Company Revenue Disposal Group, Including Discontinued Operation, Inter-Company Revenue Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Schedule of Financing Receivable, Allowance for Credit Losses [Table] Financing Receivable, Allowance for Credit Loss [Table] Finance Lease, Weighted Average Discount Rate, Percent Finance Lease, Weighted Average Discount Rate, Percent Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent Notional Amount Notional Amount, Derivative Notional Amount, Derivative Lease Contractual Term [Axis] Lease Contractual Term [Axis] Net Revenue Net Revenue Net Revenue Remaining Accretion Remaining Accretion Remaining Accretion Leasehold improvements Leasehold Improvements [Member] Restatement [Domain] Revision of Prior Period [Domain] Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Other Customers Other Customers [Member] Other Customers [Member] Total Installment Receivables Financing Receivable, before Allowance for Credit Loss Loss per Share—Assuming Dilution Earnings Per Share, Diluted [Abstract] Cash, Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Derivative, Amount of Hedged Item Derivative, Amount of Hedged Item Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Stock Options Share-based Payment Arrangement, Option [Member] Debt Instrurment Repurchase Amount, Net Reduction of debt Debt Instrurment Repurchase Amount, Net Reduction of debt Debt Instrurment Repurchase Amount, Net Reduction of debt Non-Impaired installment receivables with no related allowance recorded Financing Receivable, with No Related Allowance, Unpaid Principal Balance Financing Receivable, with No Related Allowance, Unpaid Principal Balance Capital Lease Obligations Capital Lease Obligations Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Treasury Stock, Shares Treasury Stock, Shares Severance Employee Severance [Member] Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable IVC Canada IVC Canada [Member] IVC Canada Debt Instrument, Net Carrying Amount Debt Instrument, Net Carrying Amount Debt Instrument, Net Carrying Amount Debt Instrument, Net Carrying Amount Tax Period [Domain] Tax Period [Domain] Supplemental executive retirement program liability Deferred Compensation Cash-based Arrangements, Liability, Current Financing Receivable, Recorded Investment, Past Due [Line Items] Financing Receivable, Past Due [Line Items] Additional paid-in-capital Additional Paid in Capital Future amortization expense, 2022 Finite-Lived Intangible Asset, Expected Amortization, Year One Net Sales Revenues Class of Stock [Axis] Class of Stock [Axis] Supplemental executive retirement plan liability Deferred Compensation Cash-based Arrangements, Liability, Classified, Noncurrent Product liability, current portion Product Liability, Current Product Liability, Current Convertible Senior Notes at 4.25% March 2026 [Domain] Convertible Senior Notes at 4.25% March 2026 [Domain] Convertible Senior Notes at 4.25% March 2026 Accrued expenses Accrued expenses Accrued Liabilities, Current Loss per Share—Assuming Dilution Net earnings (loss) per per common share—assuming dilution (in dollars per share) Earnings Per Share, Diluted Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Schedule of Long-term Debt Instruments Schedule of Long-term Debt Instruments [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Proceeds from sale of business Proceeds from Divestiture of Businesses, Net of Cash Divested Entity Emerging Growth Company Entity Emerging Growth Company Historical Cost Indefinite-lived Intangible Assets (Excluding Goodwill) Debt Instrument, Convertible, Threshold Consecutive Trading Days Debt Instrument, Convertible, Threshold Consecutive Trading Days Provision (benefit) for deferred income taxes Deferred Income Tax Expense (Benefit) Adoption of ASU 2020-06, Convertible Debt Discounts Removed Adoption of ASU 2020-06, Convertible Debt Discounts Removed Adoption of ASU 2020-06, Convertible Debt Discounts Removed Derivative liabilities Derivative Liability, Fair Value, Gross Liability Rent Accrued Rent, Current Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Maximum Maximum [Member] Preferred Stock, Shares Authorized Preferred Stock, Shares Authorized Dividends, Common Stock, Cash Dividends, Common Stock, Cash Convertible Debt, Conversion Rate of Commmon Shares, Principal Convertible Debt, Conversion Rate of Commmon Shares, Principal Convertible Debt, Conversion Rate of Commmon Shares, Principal Financing Leases, Future Minimum Payments, Interest Included in Payments Financing Leases, Future Minimum Payments, Interest Included in Payments Financing Leases, Future Minimum Payments, Interest Included in Payments Gross Profit, as a Percent of Net Sales Gross Profit, as a Percent of Net Sales Gross Profit, as a Percent of Net Sales Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Effective income tax rate, continuing operations Effective Income Tax Rate Reconciliation, Percent Concentration Of Credit Risk Concentration Risk Disclosure [Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss Number of missed payments before delinquent Notes, Loans, and Financing Receivables, Number of Missed Payments before Delinquent Notes, Loans, and Financing Receivables, Number of Missed Payments before Delinquent Interest Revenue (Expense), Net Interest Revenue (Expense), Net Other Prepaid Expense and Other Assets, Noncurrent Trading Symbol Trading Symbol Debt Instrument, Warrants Issued and Outstanding Debt Instrument, Warrants Issued and Outstanding Debt Instrument, Warrants Issued and Outstanding Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Debt Instrument, Repurchase Amount Debt Instrument, Repurchase Amount Valuation reserve associated with defined benefit plan activity Other Comprehensive Income (Loss), Deferred Tax Valuation Reserve Other Comprehensive Income (Loss), Deferred Tax Valuation Reserve Debt Instrument, Increase, Accrued Interest Debt Instrument, Increase, Accrued Interest Entity Shell Company Entity Shell Company Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Fair Value, Measurements, Recurring Fair Value, Recurring [Member] Finance Lease, Liability, Payments, Due Year Two Finance Lease, Liability, to be Paid, Year Two Document Type Document Type Convertible Senior Notes at 5.00% February 2021 Convertible Senior Notes at 5.00% February 2021 [Member] Convertible Senior Notes at 5.00% February 2021 [Member] Schedule of Product Warranty Liability Schedule of Product Warranty Liability [Table Text Block] Schedule for Allowance for Credit Losses [Abstract] Schedule for Allowance for Credit Losses [Abstract] Schedule for Allowance for Credit Losses [Abstract] Convertible Senior Notes, Percentage of Principal Required for Repurchase Convertible Senior Notes, Percentage of Principal Required for Repurchase Convertible Senior Notes, Percentage of Principal Required for Repurchase Treasury Stock [Member] Treasury Stock [Member] Payables and Accruals [Abstract] Payables and Accruals [Abstract] Convertible Debt Discount Amortization and Accretion Convertible Debt Discount Amortization and Accretion Convertible Debt Discount Amortization and Accretion Credit Loss Status [Domain] Credit Loss Status [Domain] Events of Default Under Contract by Third Party Concentration Risk, Recourse for Customer Lease Obligation Under Default Concentration Risk, Recourse for Customer Lease Obligation Under Default Segments [Axis] Segments [Axis] Respiratory Therapy [Domain] Respiratory Therapy [Domain] Respiratory Therapy Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 Plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 and 2013 Plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 and 2013 Plans Payments to debt holders Payments to Debt Holders Payments to Debt Holders Other Current Assets Other Current Assets [Member] USD / THB Foreign Exchange Forward USD / THB [Member] Foreign Exchange Forward USD / THB Derivative assets Derivative Asset Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain] Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain] Convertible Senior Subordinated Debentures at 5.00% February 2021 General Terms and Conditions General Terms and Conditions [Member] General Terms and Conditions [Member] Line of Credit Line of Credit [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Derivatives Derivative Instruments and Hedging Activities Disclosure [Text Block] Warranty Balance as of January 1, 2021 Balance as of September 30, 2021 Product Warranty Accrual, Current Intangibles, net Intangible Assets, Net (Excluding Goodwill) Line Of Credit Facility Gross Borrowing Base Line Of Credit Facility Gross Borrowing Base Line Of Credit Facility Gross Borrowing Base Deferred revenue Deferred Revenue, Current Operating Income (Loss) Operating Income (Loss) Operating Income (Loss) Swing Line Loans Swing Line Loans [Domain] Swing Line Loans [Domain] Line of Credit Facility, Covenant Feature, Prior Limit Line of Credit Facility, Covenant Feature, Prior Limit Line of Credit Facility, Covenant Feature, Prior Limit Variable Rate [Axis] Variable Rate [Axis] Other investments Other Investments Purchases of treasury shares Payments for Repurchase of Common Stock Payments for Repurchase of Common Stock EUR / NOK Foreign Exchange Forward EUR / NOK [Member] Foreign Exchange Forward EUR / NOK [Member] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Furniture and fixtures Furniture and Fixtures [Member] Current taxes payable Taxes Payable, Current Entity Address, State or Province Entity Address, State or Province Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Common Stock, Holders Percentage of Total Outstanding Common Stock, Holders Percentage of Total Outstanding Common Stock, Holders Percentage of Total Outstanding Accounts payable Accounts Payable, Current Product Liability Contingency Product Liability Contingency [Line Items] Derivatives (foreign currency forward exchange contracts) Derivative Asset, Current Retained earnings Retained Earnings (Accumulated Deficit) Operating Lease, Right-of-Use Asset Operating Lease, Right-of-Use Asset Other Long-Term Assets Other Assets Disclosure [Text Block] Adjustments for Error Correction [Domain] Error Correction, Type [Domain] Debt Instrument, Unamortized Discount Unamortized discount Debt Instrument, Unamortized Discount Loss (gain) on debt extinguishment including debt finance charges and fees Loss (gain) on debt extinguishment including debt finance charges and fees Gain (Loss) on Extinguishment of Debt Unamortized Financing Costs Unamortized Financing Costs Unamortized Financing Costs Operating Leases, Future Minimum Payments, Interest Included in Payments Operating Leases, Future Minimum Payments, Interest Included in Payments Operating Leases, Future Minimum Payments, Interest Included in Payments 2013 Plan [Member] 2013 Plan [Member] 2013 Plan [Member] Finance Lease, Liability, Payments, Due Next Twelve Months Finance Lease, Liability, to be Paid, Year One Net award activity (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease) Hedging Designation [Domain] Hedging Designation [Domain] Options exercisable at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number All Other All Other [Member] All Other Exchange of Convertible Notes Exchange of Convertible Notes Exchange of Convertible Notes Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] Payment of financing costs Payments of Financing Costs Other Payments for (Proceeds from) Other Investing Activities Accumulated Long-Term Notes Adjustment [Member] Accumulated Long-Term Notes Adjustment [Member] Accumulated Long-Term Notes Adjustment [Member] Receivable due from information technology provider Receivable Due From Information Technology Provider Receivable Due From Information Technology Provider USD / AUD Foreign Exchange Forward AUD / USD [Member] Foreign Exchange Forward AUD / USD [Member] Convertible Debt Conversion Feature Gain (Loss) Convertible Debt Conversion Feature Gain (Loss) Convertible Debt Conversion Feature Gain (Loss) Convertible Debt Conversion Feature Gain (Loss) Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Percentage of net orderly liquidation value of eligible Canadian inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Liquidation Value, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Liquidation Value, Percent Geographical [Domain] Geographical [Domain] Impairment of goodwill, as a Percent of net Sales Impairment of goodwill, as a Percent of net Sales Impairment of goodwill, as a Percent of net Sales Contract Type [Domain] Contract Type [Domain] [Domain] for Contract Type [Axis] Financing Receivable Portfolio Segment [Axis] Financing Receivable Portfolio Segment [Axis] Range of Exercise Price Max [Member] Range of Exercise Price Max [Member] Range of Exercise Price Max EUR / CHF Foreign Exchange Forward EUR / CHF [Member] Foreign Exchange Forward EUR / CHF [Member] Receivables, Expected Loss Percentage, North America excluding Canada Receivables, Expected Loss Percentage, North America excluding Canada Receivables, Expected Loss Percentage, North America excluding Canada Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Interest Interest Payable, Current Risk Factor [Domain] Risk Factor [Domain] [Domain] for Risk Factor Current period provision (benefit) Allowance for Loan and Lease Losses, Adjustments, Other Credit Facility [Axis] Credit Facility [Axis] Debt Instrument, Fair Value Disclosure Debt Instrument, Fair Value Disclosure Schedule of Aging of Installment Receivables Financing Receivable, Past Due [Table Text Block] Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance Revolving Credit and Security Agreement (Europe Credit Agreement) Revolving Credit and Security Agreement (Europe Credit Agreement) [Member] [Domain] Revolving Credit and Security Agreement (Europe Credit Agreement) [Member] [Domain] Industry Sector [Axis] Industry Sector [Axis] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] USD / GBP Foreign Exchange Forward USD / GBP [Member] Foreign Exchange Forward USD / GBP [Member] Accounts receivable, gross Accounts Receivable, before Allowance for Credit Loss Selling, General and Administrative Expenses Selling, General and Administrative Expenses [Member] Lifetime to date - Accretion Expense Lifetime to date - Accretion Expense Lifetime to date - Accretion Expense Accretion Rate Accretion Rate Accretion Rate Class of Financing Receivable, Type of Borrower [Axis] Type of Borrower [Axis] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method Revenue Recognition, Multiple-deliverable Arrangements [Line Items] Revenue Recognition, Multiple-deliverable Arrangements [Line Items] Change in other long-term assets Payments for (Proceeds from) Long-term Investments Liability Components of Convertible 2021 Note Liability Components of Convertible 2021 Note [Table Text Block] [Table Text Block] for Liability Components of Convertible 2021 Note Lessee, Finance Leases Lessee, Finance Leases [Text Block] Accretion Expense Accretion Expense Maximum value of net orderly liquidation value domestic inventory and in-transit inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Amount Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Amount Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Operating Activities Billing Status, Type [Axis] Billing Status, Type [Axis] Entity Central Index Key Entity Central Index Key Line of Credit Facility, Current Borrowing Capacity Line of Credit Facility, Current Borrowing Capacity Death benefit obligation plan Life Insurance Liability, Noncurrent Life Insurance Liability, Noncurrent Derivative Instrument [Axis] Derivative Instrument [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of Financing Receivables Past Due [Table] Financing Receivable, Past Due [Table] Disposal Group, Including Discontinued Operation, Liabilities Disposal Group, Including Discontinued Operation, Liabilities Lessee, Finance Lease, Term of Contract Lessee, Finance Lease, Term of Contract Recoverable income taxes Income Taxes Receivable, Current Geographical [Axis] Geographical [Axis] Percent of the Product of the Last Reported Sale Price, Common Shares Percent of the Product of the Last Reported Sale Price, Common Shares Percent of the Product of the Last Reported Sale Price, Common Shares Segments [Domain] Segments [Domain] Allowance for Loan and Lease Losses, Adjustments, Other Allowance for Losses, Adjustments, Other Allowance for Losses, Adjustments, Other Risk Level, Low Risk Level, Low [Member] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Revenue Recognition, Multiple-deliverable Arrangements Revenue Recognition, Multiple-deliverable Arrangements [Table Text Block] Interest Expense, Sale of Receivables Interest Expense, Sale of Receivables Interest Expense, Sale of Receivables Effect of exchange rate changes on cash Effect of Exchange Rate on Cash and Cash Equivalents Income Statement Location [Axis] Income Statement Location [Axis] Options Outstanding - Weighted Average Remaining Contractual Life Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Receivables, Expected Loss Percentage, Europe Receivables, Expected Loss Percentage, Europe Receivables, Expected Loss Percentage, Europe Foreign Exchange Forward Contracts, by Exchange [Axis] Foreign Exchange Forward Contracts, by Exchange [Axis] Foreign Exchange Forward Contracts, by Exchange [Axis] General Lease Term General Lease Term General Lease Term Rebates Accrued Marketing Costs, Current Adjustments for Change in Accounting Principle [Domain] Change in Accounting Principle, Type [Domain] Last Reported Sales Price Period, Common Stock Last Reported Sales Price Period, Common Stock Last Reported Sales Price Period, Common Stock Amortization expense Amortization of Intangible Assets Revenue [Abstract] Revenue [Abstract] Revenue [Abstract] Business Segments Segment Reporting Disclosure [Text Block] Operating Gain (Loss), as a Percent of Net Sales Operating Gain (Loss), as a Percent of Net Sales Operating Gain (Loss), as a Percent of Net Sales Sale Leaseback Transaction [Line Items] Sale Leaseback Transaction [Line Items] Scenario [Axis] Scenario [Axis] Derivative liabilities (foreign currency forward exchange contracts) Derivative Liability, Current Title of 12(b) Security Title of 12(b) Security Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Reversal of Accrued Withholding Taxes on Earnings Reversal of Accrued Withholding Taxes on Earnings Reversal of Accrued Withholding Taxes on Earnings Cap Price of Capped Call Transaction Cap Price of Capped Call Transaction Cap Price of Capped Call Transaction Industry of Counterparty, Type [Axis] Industry of Counterparty, Type [Axis] Geographic Distribution [Axis] Geographic Distribution [Axis] USD / NOK Foreign Exchange Forward NOK / USD [Member] Foreign Exchange Forward NOK / USD [Member] Vesting [Domain] Vesting [Domain] Finance Lease, Liability, Fiscal Year Maturity Finance Lease, Liability, Fiscal Year Maturity [Table Text Block] Interest expense Interest Expense Depreciation and amortization Depreciation, Depletion and Amortization Convertible Subordinated Debt Convertible Subordinated Debt [Member] Product and Service [Axis] Product and Service [Axis] Period for recognition of unrecognized compensation costs Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Finance Lease, Liability, Payments, Due Year Five Finance Lease, Liability, to be Paid, Year Five 61-90 days past due Installment Sales, 61 to 90 Days Past Due Installment Sales, 61 to 90 Days Past Due Unsecured Debt, Current Unsecured Debt, Current Convertible Debt Conversion Feature, Fair Value at Issuance Convertible Debt Conversion Feature, Fair Value at Issuance Convertible Debt Conversion Feature, Fair Value at Issuance Allowance for Doubtful Accounts [Roll Forward] Financing Receivable, Allowance for Credit Loss [Roll Forward] Operating Lease, Expense Operating Lease, Expense GBP / THB Foreign Exchange Forward GBP / THB [Member] Foreign Exchange Forward GBP / THB Sale Leaseback Transactions [Abstract] Sale Leaseback Transactions [Abstract] Sale Leaseback Transactions [Abstract] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Accounts payable Increase (Decrease) in Accounts Payable Raw materials Inventory, Raw Materials, Net of Reserves Allowance for doubtful accounts Balance as of beginning of period Balance as of end of period Financing Receivable, Allowance for Credit Loss Unrealized Gain (Loss) Unrealized Gain (Loss) on Derivatives New Accounting Pronouncements, Not yet Adopted New Accounting Pronouncements, Not yet Adopted [Policy Text Block] New Accounting Pronouncements, Not yet Adopted Debt Instrument [Axis] Debt Instrument [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Operating Segments [Member] Operating Segments [Member] Sale Leaseback Transaction, Deferred Gain, Gross Sale Leaseback Transaction, Deferred Gain, Gross USD / SEK Foreign Exchange Forward USD / SEK [Member] Foreign Exchange Forward USD / SEK [Member] Accrued expenses Increase (Decrease) in Accrued Liabilities Derivative liabilities Derivative Liability Adjustments to reconcile net loss to net cash used by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Entity Information [Line Items] Entity Information [Line Items] Financing Receivable, Allowance for Credit Losses, Write-downs Allowance for Credit Losses, Write-downs Allowance for Credit Losses, Write-downs Options Exercisable - Number Exercisable At end of period (in shares) Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Revenue Recognition, Multiple-deliverable Arrangements [Table] Revenue Recognition, Multiple-deliverable Arrangements [Table] Letters of Credit Outstanding, Amount Letters of Credit Outstanding, Amount Concentration Risk Type [Axis] Concentration Risk Type [Axis] Long-term Debt and Capital Lease Obligations, Current Long-term Debt and Lease Obligation, Current Schedule of Installment Receivables by Class Impaired Financing Receivables [Table Text Block] Contingent Liability, Guarantee Contingent Liability, Guarantee Contingent Liability, Guarantee Fair Value Estimate of Fair Value Measurement [Member] Award requisite service period Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Minimum availability reserve Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Availability Reserve, Minimum Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Availability Reserve, Minimum Operating Leases Long-Term Obligations Operating Lease, Liability, Noncurrent Future amortization expense, 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Four Adjustments for Change in Accounting Principle [Axis] Change in Accounting Principle, Type [Axis] Receivables, Expected Loss Percentage, Canada Receivables, Expected Loss Percentage, Canada Receivables, Expected Loss Percentage, Canada Non-Impaired Financing Receivable, Related Allowance Non-Impaired Financing Receivable, Related Allowance Non-Impaired Financing Receivable, Related Allowance Current Assets Assets, Current [Abstract] 12.6 Years 12.6 Years [Member] 12.6 Years Common Stock, Number of Votes Common Stock, Number of Votes Common Stock, Number of Votes Interest income, as a Percent of Net Sales Interest income, as a Percent of Net Sales Interest income, as a Percent of Net Sales Financing Receivable, Allowance for Credit Losses [Line Items] Financing Receivable, Allowance for Credit Loss [Line Items] Subsegments [Domain] Subsegments [Domain] Comprehensive Income (Loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive Income (Loss), Net of Tax, Attributable to Parent Finance Lease, Liability, Payments, Due Year Three Finance Lease, Liability, to be Paid, Year Three Patents Patents [Member] Interruption of material manufacturing facilities, period Line of Credit, Covenant Compliance, Interruption of Manufacturing Facilities Period Line of Credit, Covenant Compliance, Interruption of Manufacturing Facilities Period Collateral [Axis] Collateral Held [Axis] Debt Instrument, Non-Cash Interest Expense Recognized in the Period Debt Instrument, Non-Cash Interest Expense Recognized in the Period Debt Instrument, Non-Cash Interest Expense Recognized in the Period Allowance for Credit Losses Allowance for Credit Losses Allowance for Credit Losses City Area Code City Area Code Document Period End Date Document Period End Date AUD / NZD Foreign Exchange Forward AUD / NZD [Member] Foreign Exchange Forward AUD / NZD [Member] Percentage of net orderly liquidation value of domestic inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Percent Installment sales contracts, net Increase (Decrease) in Finance Receivables Amount reclassified from accumulated OCI Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Cash discount reserves Cash Discount Reserves Cash Discount Reserves Receivables, Expected Loss Percentage, AsiaPac Receivables, Expected Loss Percentage, AsiaPac Receivables, Expected Loss Percentage, AsiaPac Land, buildings and improvements Land, Buildings and Improvements [Member] Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan Share-based Payment Arrangement, Cost by Plan [Table Text Block] Sale Leaseback Transaction, Lease Term Sale Leaseback Transaction, Lease Term Sale Leaseback Transaction, Lease Term Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Provision for equity compensation Share-based Payment Arrangement, Noncash Expense Unsecured Debt Unsecured Debt Cover [Abstract] Cover [Abstract] Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] Amount of Gain (Loss) Recognized  in Accumulated OCI on Derivatives (Effective Portion) Amount of Gain (Loss) Recognized  in Accumulated OCI on Derivatives (Effective Portion) Base Rate Base Rate [Member] Restructuring Reserve, Accrual Adjustment Restructuring Reserve, Accrual Adjustment OCI before reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] 20 Years 20 Years [Member] 20 Years Mobility and Seating [Domain] Mobility and Seating [Domain] Mobility and Seating Lessee, Operating Leases Lessee, Operating Leases [Text Block] Weighted-Average Remaining Lease Terms and Discount Rates [Table] Weighted-Average Remaining Lease Terms and Discount Rates [Table Text Block] Weighted-Average Remaining Lease Terms and Discount Rates [Table Text Block] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Award Date [Domain] Award Date [Domain] Gain (loss) Before Income Taxes, as a Percent of Net Sales Gain (loss) Before Income Taxes, as a Percent of Net Sales Gain (loss) Before Income Taxes, as a Percent of Net Sales Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Equity Components [Axis] Equity Components [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Minimum Minimum [Member] Receivables [Abstract] Receivables [Abstract] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Additional amount of machinery and equipment Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Additional Long-Lived Asset Amount Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Additional Long-Lived Asset Amount Award Date [Axis] Award Date [Axis] Schedule of Cash Flow, Supplemental Disclosures [Table] Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] NOK / SEK Foreign Exchange Forward NOK / SEK [Member] Foreign Exchange Forward NOK / SEK [Member] Salaries and wages Accrued Salaries, Current Entity Interactive Data Current Entity Interactive Data Current Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Schedule of Share-based Compensation, Stock Options, Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] 0-30 days past due Installment Receivable, 0 to 30 Days Past Due Installment Receivable, 0 to 30 Days Past Due Future amortization expense, remainder of fiscal year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Business Day Period Business Day Period Business Day Period Derivative [Table] Derivative [Table] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Government Tenders Government Tenders [Member] Government Tenders [Member] Total Installment Receivables Impaired Financing Receivable, Recorded Investment [Abstract] Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Schedule of Unrecognized Compensation Cost, Nonvested Awards Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block] Exercise Price Range [Axis] Exercise Price Range [Axis] Debt Instrument, Interest Rate, Effective Percentage Debt Instrument, Interest Rate, Effective Percentage Consolidation Items [Axis] Consolidation Items [Axis] Not Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument [Member] Accrued Expenses Accrued Liabilities [Member] Trade receivables, net Accounts Receivable, after Allowance for Credit Loss, Current Goodwill, Impairment Loss Goodwill, Impairment Loss Goodwill, Impairment Loss Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Debt Instrument, Convertible, Threshold Trading Days Debt Instrument, Convertible, Threshold Trading Days AUD / THB Foreign Exchange Forward AUD / THB [Member] Foreign Exchange Forward AUD / THB Trademarks Trademarks [Member] Prepaid and other current assets Other Prepaid Expense, Current Payments Payments for Restructuring Financing Receivable, Impaired [Line Items] Financing Receivable, Impaired [Line Items] Income Tax Provision, as a Percent of Net Sales Income Tax Provision, as a Percent of Net Sales Income Tax Provision, as a Percent of Net Sales Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Document Transition Report Document Transition Report Derivative assets Derivative Asset, Fair Value, Gross Asset Sale Leaseback Transaction, Name [Domain] Sale Leaseback Transaction, Name [Domain] Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Convertible Senior Notes at 4.25% March 2026 Convertible Senior Notes at 4.25% March 2026 [Member] Convertible Senior Notes at 4.25% March 2026 Document Quarterly Report Document Quarterly Report Derivative, percentage of forcasted transactions with currency rate exposure Derivative, Percentage of Forcasted Transactions With Currency Rate Exposure Derivative, Percentage of Forcasted Transactions With Currency Rate Exposure 2018 Plan [Member] 2018 Plan [Member] 2018 Plan Vesting [Axis] Vesting [Axis] Installment receivables, net Installment receivables, net Financing Receivable, after Allowance for Credit Loss, Current Changes in liability for pre-existing warranties during the period, including expirations Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties Percentage of eligible Canadian inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Percent Credit Facility [Domain] Credit Facility [Domain] Debt Instrument, Convertible, Conversion Price Debt Instrument, Convertible, Conversion Price Net Loss per Share—Basic Net earnings (loss) per common share Earnings Per Share, Basic Contingencies Contingencies Disclosure [Text Block] Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Entity File Number Entity File Number Taxes other than income taxes, primarily value added taxes Accrual for Taxes Other than Income Taxes, Current Installment receivables, net, long-term Installment receivables Financing Receivable, after Allowance for Credit Loss, Noncurrent Operating Lease, Weighted Average Remaining Lease Term Operating Lease, Weighted Average Remaining Lease Term Collateral [Domain] Collateral Held [Domain] USD / CAD Foreign Exchange Forward CAD / USD [Member] Foreign Exchange Forward CAD / USD [Member] Geographic Distribution [Domain] Geographic Distribution [Domain] Adjustments to reconcile net loss to net cash used by operating activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] Common Shares Common Stock, Value, Outstanding Cost of Products Sold, as a Percent of Net Sales Cost of Products Sold, as a Percent of Net Sales Cost of Products Sold, as a Percent of Net Sales Allocated Share-based Compensation Expense Share-based Payment Arrangement, Expense Balance Sheet Location [Axis] Balance Sheet Location [Axis] Charges related to restructuring activities, as a Percent of Net Sales Charges related to restructuring activities, as a Percent of Net Sales Charges related to restructuring activities, as a Percent of Net Sales Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Disposal Group Name [Axis] Disposal Group Name [Axis] Schedule of Installment Receivables Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Finance Lease, Liability, Payments, Due Year Four Finance Lease, Liability, to be Paid, Year Four All Currencies [Domain] All Currencies [Domain] Receivable [Domain] Receivable [Domain] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Foreign currency forward contracts Forward exchange contracts—net Foreign Exchange Forward [Member] Debt Instrument, Hedge Options Debt Instrument, Hedge Options Debt Instrument, Hedge Options Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Defined Benefit Plans: Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent [Abstract] Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days Trade receivables Increase (Decrease) in Accounts Receivable Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Adoption of ASU 2020-06 Adoption of ASU 2020-06 Adoption of ASU 2020-06 Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] [Line Items] for Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] Liability Components of Convertible 2026 Note Liability Components of Convertible 2026 Note [Table Text Block] Liability Components of Convertible 2026 Note Installment receivables, net of reserves Receivables, Fair Value Disclosure Total Liabilities and Shareholders’ Equity Liabilities and Equity Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments Schedule of Financing Receivables Financing Receivables [Table Text Block] Financing Receivables [Table Text Block] Accumulated other comprehensive income Beginning Balance Ending Balance Accumulated Other Comprehensive Income (Loss), Net of Tax Income Taxes Income Tax Disclosure [Text Block] Schedule of Accounts Receivable Schedule of Accounts Receivable [Table Text Block] [Table Text Block] for Schedule of Accounts Receivable [Table] Deferred tax benefit (provision) related to gain on cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Service Services [Member] Services [Member] Disposal Group, Including Discontinued Operation, Accounts Payable Disposal Group, Including Discontinued Operation, Accounts Payable Retained Recourse Obligation For Events Of Default Under Contracts Concentration Risk, Retained Recourse Obligation For Default of Customer Lease Obligations Under Contract Concentration Risk, Retained Recourse Obligation For Default of Customer Lease Obligations Under Contract Operating Lease, Cost Operating Lease, Cost Hedging Relationship [Axis] Hedging Relationship [Axis] Installment receivables, net Financing Receivable, after Allowance for Credit Loss Disposal Group, Including Discontinued Operation, Earnings Before Taxes Disposal Group, Including Discontinued Operation, Earnings Before Taxes Disposal Group, Including Discontinued Operation, Earnings Before Taxes Antidilutive securities excluded from computation of earnings per share, amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Net Sales, as a Percent of Net Sales Net Sales, as a Percent of Net Sales Net Sales, as a Percent of Net Sales Finance Lease, Weighted Average Remaining Lease Term Finance Lease, Weighted Average Remaining Lease Term Provision for other deferred liabilities Other Noncash Income (Expense) Finite-Lived intangible assets, useful life Finite-Lived Intangible Asset, Useful Life Equity Component [Domain] Equity Component [Domain] Gross Profit Gross Profit Property and Equipment, net Property and equipment, net Property, Plant and Equipment, Net Debt Instrument, Hedge Options available for exercise Debt Instrument, Hedge Options available for exercise Debt Instrument, Hedge Options available for exercise Entity Tax Identification Number Entity Tax Identification Number Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Deferred compensation Deferred Compensation Liability, Classified, Noncurrent Shareholders' Equity Transactions Share-based Payment Arrangement [Text Block] Net Loss Net loss Net Loss Net Income (Loss) Attributable to Parent Receivables Billing Status [Domain] Receivables Billing Status [Domain] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] London Interbank Offered Rate (LIBOR) London Interbank Offered Rate (LIBOR) [Member] Inventories Inventory Disclosure [Text Block] Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] Restructuring and Related Activities, Expected Payout Period Restructuring and Related Activities, Expected Payout Period Restructuring and Related Activities, Expected Payout Period Current Fiscal Year End Date Current Fiscal Year End Date Contract Type Sales Split Contract Type Sales Split Contract Type Sales Split Adjustments for Error Corrections [Axis] Error Correction, Type [Axis] Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Finance Lease, Liability Finance Lease, Liability Convertible Senior Notes at 4.50% February 2022 [Domain] Convertible Senior Notes at 4.50% February 2022 [Domain] Convertible Senior Notes at 4.50% February 2022 Freight Accrued Freight Expense, Current Freight Accrual, Current [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Developed technology Developed Technology Rights [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Euro Member Countries, Euro Euro Member Countries, Euro Finance Lease, Liability, Payments, Due after Year Five Finance Lease, Liability, to be Paid, after Year Five NZD / THB Foreign Exchange Forward NZD / THB [Member] Foreign Exchange Forward NZD / THB Other Other Sundry Liabilities, Noncurrent 31-60 days past due Installment Receivable, 31 to 60 Days Past Due Installment Receivable, 31 to 60 Days Past Due Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Disposal Group, Including Discontinued Operation, Accrued Liabilities Disposal Group, Including Discontinued Operation, Accrued Liabilities Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] EUR / USD Foreign Exchange Forward EUR / USD [Member] Foreign Exchange Forward EUR / USD [Member] Financing Receivable, Gross Financing Receivable, Gross Financing Receivable, Gross Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Line of Credit Facility, Remaining Borrowing Capacity Line of Credit Facility, Remaining Borrowing Capacity Historical Cost Finite-Lived Intangible Assets, Gross Provision for losses on trade and installment receivables Accounts Receivable, Credit Loss Expense (Reversal) CARES Act Loan [Member] CARES Act Loan [Member] CARES Act Loan Less allowance for depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Allowance for doubtful accounts, current Financing Receivable, Allowance for Credit Loss, Current Currency [Axis] Currency [Axis] Convertible due 2022 - Bond Hedge, Fair Value at Issuance Convertible due 2022 - Bond Hedge, Fair Value at Issuance Convertible due 2022 - Bond Hedge, Fair Value at Issuance Capitalized Software [Member] Capitalized Software [Member] Capitalized Software [Member] Product Liability Contingency [Table] Product Liability Contingency [Table] Hedging Relationship [Domain] Hedging Relationship [Domain] Finance Lease, Right-of-Use Asset Finance Lease, Right-of-Use Asset, after Accumulated Amortization Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Risk Factor [Axis] Risk Factor [Axis] Risk Factor Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Weighted Average Shares Outstanding—Basic Average common shares outstanding Weighted Average Number of Shares Outstanding, Basic Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Canceled - Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price EUR / THB Foreign Exchange Forward EUR / THB [Member] Foreign Exchange Forward EUR / THB Financing Lease, Cost Financing Lease, Cost Financing Lease, Cost Cash Flow Hedging [Member] Cash Flow Hedging [Member] Carrying Value Reported Value Measurement [Member] Additional increase in borrowing capacity available Line of Credit Facility, Additional Borrowing Capacity Line of Credit Facility, Additional Borrowing Capacity Plan Name [Domain] Plan Name [Domain] Prepaid inventory and freight Prepaid Inventory Prepaid Inventory Installment Receivables, Long-Term Financing Receivable, before Allowance for Credit Loss, Noncurrent Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Income tax provision Income tax provision Income Tax Expense (Benefit) Credit amount requiring additional analysis Financing Receivable Credit Limit Financing Receivable Credit Limit Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Current portion of finance lease obligations Finance Lease, Liability, Current Finance Lease, Liability, Current Local Phone Number Local Phone Number Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative [Line Items] Derivative [Line Items] Exercise price range, upper limit (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Other current assets Increase (Decrease) in Other Operating Assets Stock Issued During Period, Value, Stock Options Exercised Stock Issued During Period, Value, Stock Options Exercised Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Finite-Lived Intangible Assets [Table] Remaining borrowing capacity Line of Credit Facility, Covenant Feature, Increase Limit Line of Credit Facility, Covenant Feature, Increase Limit USD / DKK Foreign Exchange Forward DKK / USD [Member] Foreign Exchange Forward DKK / USD [Member] Borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Award Type [Axis] Award Type [Axis] Deferred income taxes Deferred Income Taxes and Other Tax Liabilities, Noncurrent Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Valuation Allowance [Line Items] Valuation Allowance [Line Items] Class of Financing Receivable, Type [Axis] Class of Financing Receivable [Axis] Lease Contractual Term [Domain] Lease Contractual Term [Domain] Amortization of debt fees Amortization of Debt Issuance Costs Debt Instrument, Loss on Exchange Debt Instrument, Loss on Exchange Debt Instrument, Loss on Exchange Retained Earnings [Member] Retained Earnings [Member] Preferred Stock, Shares Outstanding Preferred Stock, Shares Outstanding Measurement Basis [Axis] Measurement Basis [Axis] Divested Businesses [Abstract] Divested Businesses [Abstract] Divested Businesses [Abstract] Direct write-offs charged against the allowance Financing Receivable, Allowance for Credit Loss, Writeoff Amount Available to Invacare Limited and Invacare Poirier SAS Amount Available to Invacare Limited and Invacare Poirier SAS [Domain] Invacare Limited and Invacare Poirier SAS Net Cash Used by Investing Activities Net Cash Provided by (Used in) Investing Activities Equity Award [Domain] Award Type [Domain] Schedule of Installment Receivables Allowance for Doubtful Accounts Financing Receivable, Allowance for Credit Loss [Table Text Block] Schedule of Restructuring and Related Costs Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Antidilutive share granted, average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Property And Equipment Property, Plant and Equipment Disclosure [Text Block] Commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Cash surrender value of life insurance policies Cash Surrender Value of Life Insurance Treasury Shares (4,397 and 4,184 shares at September 30, 2021 and December 31, 2020, respectively) Treasury Stock, Value Sale Leaseback Transaction, Lease Terms Sale Leaseback Transaction, Lease Terms Net Earnings (Loss) Per Common Share Earnings Per Share [Text Block] DKK / SEK Foreign Exchange Forward DKK / SEK [Member] Foreign Exchange Forward DKK / SEK [Member] Current Liabilities Liabilities, Current [Abstract] U.S. statutory income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Credit Loss Status [Axis] Credit Loss Status [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Unpaid Principal Balance Impaired Financing Receivable, Unpaid Principal Balance [Abstract] Net Loss per Share—Basic Earnings Per Share, Basic [Abstract] Subsegments [Axis] Subsegments [Axis] EX-101.PRE 13 ivc-20210930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 ivc-20210930_g1.jpg begin 644 ivc-20210930_g1.jpg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ivc-20210930_g2.jpg begin 644 ivc-20210930_g2.jpg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ivc-20210930_g3.jpg begin 644 ivc-20210930_g3.jpg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ivc-20210930_g4.jpg begin 644 ivc-20210930_g4.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" M% (4 P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH BO;VSTVSEU'4;N*"W@B:2>> M:0(D:*,LS,> 22>!BOFC4_^"S7_!+NP\47_@ZR_;/\(ZS?:6<:D/"[SZO# M:\D?O)K*.6),$$'+<8.>AK\&_P!FK]G_ ,'VFDZ'X?T^.&26&W5)M2N0@$MY<,!F6>5@79SGDX& - M^'7[T/0?$?PI_:<\$>);/Q-K":3H4N@^([>[-W?M')*+4+$S,LHCB ME8HP#*(V) P:]4KXD_:E_P""/_PE\=_\%&?@?_P4G^!O@?2M!\;^#/&DC_$6 M2PCCMDU_2YK&ZB^TRJ,"2[AF>(!_OO'(X8MY<87:_P""C7_!;;]D3_@ECXZT M/P1^UIX4\?V0\3VC1S:5I.I7 ' ME65U.9E<3;F2-A#'*L;L5D9"K[?1/VC?^"L?[./P#_:CT;]A_P +>$O&?Q2^ M,>LV+7H^'7PSTZTN;VPM1$9?.NYKVZM;6U4QC>!).K[2K;<.A8 ^GJ*^>?V( M/^"G?[+?[>^M>+O 'PGU+6=#\=_#_4I+'QU\-_&FFBPUS0YHY6B;S85=XY$$ MBE#)#)(@; + D \9K7_!9#X"77QY^(?P$^"7P)^+7Q7N?A%-'!\4?$'PT\,6 MM]I_ARX8R V[^;>0W%W,IAE#16<-PX,3KCD?"V\BF;39]0TPKJ%\ZWDMG'#%;*S,TLLL1*(2"%.Z3RPK[I @FDC\: M))*%^9E4Z$5!/< LQ'^\?6@#]A?AY_P55_X)G?%C7+;PO\.OV_O@]JNJ7L@C ML],MOB)IWVFX0QY*Y@1L94&O=/^"$G_!0/ MXC?LY_\ !O[I?[5G[:&A^-O$GA;P1X@U&PTO5M,LTO+V'PU"Z)%X&UPP4E%$;.7\ MM2] 'T[5/Q#XAT#PEH-[XI\5ZY9Z9IFG6LESJ&HZA%O^"UO[-4/QH\!_ C]HWX0?$_X':U\4[)+GX;3_%O0[&UM/$.Y MD588Y[&]NEMY\R1CR;GR9 9(U*AI$5OC[_@\2_:I\4> ?V![?]F7PMX2\=VB M^+O$^D3ZYXKM- E'A^XL0;Y_[,DOP=@NC-:0S?9CR8U#=#0!]Y^'?^"P'_!, MGQ3XOLO ^E_MI>"$O=3TZXO](EO]0:TM-2M8#()9[6ZG5(+F-3#,"\4C#,3@ M$[3CT7]EO]LC]EW]MCP+=_$K]E/XW:%XYT2PU)["_OM$N2WV:Y558Q2(P#H= MK*PW ;E8$9!S7X]?LF_LS?\ !-']K?\ X(Z?#/\ :K_;F_8?^+NO?\*"^#[Z M3J>N6]A=:?#,/\ @E7\ M /V)OB]\2?\ @FII/QO\::+H_B2.?Q>GB+PY_:/B+5+L6X^S6EG:6$:K* KX M&$7!D9I'"@LH!^J=%?A+_P $I?\ @OQ\2?VP_P#@I7\:OVB/B+^SG\5_$'AI M_!^FZ)X \$_"_P &SZ^_AO3TO97\R\$& DDS-ODF(PS (/DC0#]VJ "BOG_] MH#_@I'\ _@7\?=+_ &2-%T7Q+\0_BYJ^C2:O:?#3X?6-O<:E'8)G-S/)=3V] MK:IZ>=/&6R-H(.:XC]A#_@M'^R%^WS\^'?Q* MT6&PU-1;R^3.T?V>>>&3RY" RK)O 8-MV_-0!];T5\1_M8_\%^?V%/V'_P!J MVU_8]_:>L/''A;Q-?369L]1O-"MSI1_M"_M[_L6_LF:[:>&?VFOVG?!G@._O M[?S[*V\4ZW%9M<1Y(W)YA ;D'ITJE^WC_P % OV7O^";GP+F_:!_:K\>-H^C M?:UL]-L[.W-Q?:K=LK,MM;0@@R2%59B25154LS*H)K\5/^#HC_@HU\,_VV/^ M";OPMMM/^ /Q6^&^K:A\3+'Q!X=T[XJ^#%TV76=&;2=05KRTEAFGADC5IK8. MGF"5?.B+( ZD@'[]_#OXB^!/BYX%TGXG?##Q;8:]X=UVQCO=&UK2[E9K:]MY M!N26-UX=6!R".M;-?+G_ 1*_P"41?[.?_9(]%_])EIG_!9K_@H-)_P3+_X) M[^-OVH=$L;>\\2PI#I/@NRNUW12ZM=/Y<+..-R1+YD[+D;E@9006S0!Z7^TU M^WI^QE^QJEJ/VHOVF/!_@JYOTWZ?IFM:S&E[>+G&Z&U4F:5.02" =?\./B;\/_ (O>%4\<_##Q=8Z[ MHTE]>6<6IZ;.)())K6ZEM;A5<<-LGAEC)&02AP2,&MVOD/\ 8*^#NO\ _!(O M_@E)I7PI^*&A:MXJ7X1Q^(IKS_A%H8)[N^TH:U?W45Y'$\J*6-G)'.T0;>,L M@5G 4^5^$O\ @Z$_X)2^+OV=O&O[2\7C?Q98:+X)U*PTV;3-2\.+%J.KWMXE MP\%O8P"4^_X)YC_ (*=7_C? M4/!WPNC%RM]/XPL!!>VD\-PUN;H&3D#SRP_X+^?LC:1 MH7P\^)/QT^#?Q:^%7P[^*\XB^'WQ1^(7ANQ@T+52R[HF9[6^N+BS25")$>ZA MA5H\R9V*S ^Y:*\-_;H_P""AG[.'_!/;X2:7\6OCIJNIWB^(]:M]'\(>'?" M]B+W5/$.H3\QVUG#O578@9W,Z(. 6!90>?\ @Q_P4S^'7Q5_:=T[]CCQ?^SW M\5OAQ\1=3\,7OB"WT+X@>'+6&-M/MI((VF2[L[NXMI]S3@!899"IC<2",[0P M!])45\C:U_P60^ EU\>?B'\!/@E\"?BU\5[GX131P?%'Q!\-/#%K?:?X0_*@ &_:JM;:^_9?^)%C>P)+#-X"UA)8I%RKJ;*8$$'J M"*_GX_X,I_"_AGQI\=?V@/"_C'P[8ZMIE[X!TN*]T[4[1)X+B-KN4,CQN"KJ M02"""#F@#^ASX2?'#X*_'[PL/'/P)^+_ (7\:Z(TFQ=8\):_;:E:EL9V^;;N MZ9P1QFNHK^83_@C3KOBSX#?\'0'BWX%_L4WUPOPQO_B5XQTC6=%TN5GTY_#M MJU\T#/@E3'!)'!Y,AYSL4$^:0W[1>(_^"^7[#7@']N.3_@GK\5=-\<>$?B'; MZB+6]'B'1+>+3K5#:_:UN9+M+EXUMS;D2^9D@*><$$ ^V:*^-/V /\ @NU^ MPA_P4O\ VFO&'[+7[+5_XLOM7\(:)+K!UO5=!6VTW5[*.YAMI)K1S*92%DN( M>)HHB0^5! .*NL_\%U?V6M4\8_$KPW^SS\&_BM\9M,^#MNTWQ-\7?"_P_87. MDZ&$$A=?-O+ZV>\91#,2MHDY(B8KN H ^U:\:_:(_P""A?[%?[*/B%_!_P ? M?VB= T'6H=(DU:ZT3?)=7UKIZ??O9K>V226&W'>:15CZ_-Q5/X-_\%#?V;/V ME/V1;C]M/]F35]8^)'A2WM97;3?!FB2W>L-<1;?,LA8X6472[E/E$ D,K#*L MK'^??_@D=\:M _:=_P""Z7[3D7[3OP9^)GCS1_CAX8\5>$]>T+2O#EW-J&EV M%_X@TV%?MZ0NLNG6MM!&L$DFX?9]J+Q@4 ?OMX<_X*O?\$VO&'CGP-\-?"G[ M:OP^U+7/B5 LO@C3K'7XY7U0-*\**I7(1VECDB6.0J[2(R %@5KZ#K\%O$_[ M(?\ P;K_ +(O_!7+X-_LYWOP@^.G@7XJ>%_&>A6?A?PRD\5UH?B'4;C45;3= M3N[AY9YI(S-)&V8Y8P$C5'B&QHZ[[_@ZL_X+._$K]G'P+/\ \$[O@5\/_%.A MZCX]TUXO%?Q"U/1Y[.UFTM@HGLM+DD51=M(KB.:=,QQJ[1J6=V,0!^U=%>6_ MLL_M36'[5'AS5/$EA\!OBEX"72[Y;9K+XI^!I]"N;HL@;S((YB3+&,X+#@'B MO4J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _E/\ ^"XOP^U_ M]C'_ (.0T^.GQ0L)8O#.L?$3PMXZTG4IXSY=UIT&O:IX:N#X&UO3[74)[;.FZA?V+7ELC$95WBCFB:5?99$S_>%>"?\ M!2/_ ();?LD?\%3O@]%\)OVG_!\[SZ:\DWAGQ7HTRP:KH M*17C?:I*[D1E\J_9H_9#_P""OW[&_P ,--_9\\ ?MM?"/XG>$O#]HEEX8UCX MI?#G4XM:L+.,!8;:62QU$1W:QH H9PKD*,MC !\0_#W_@X7_P""GOCC_@L" M_P#P2>D\$? >WGA^)]_X4F\;+X1UIE,-HTQ>[%K_ &N#N:*$L(C)@,P4OCYJ M\O\ ^#X*+585_99AUV]M[F^33_%ZWEQ:6K012RC^P][I&SN8U+9(4NY (!9L M9/VI^R1_P;@:'\*/^"BUS_P5,_:4_:JO/%_Q+NO%M_XE31?!_A9-%T2WOKM9 M5D4I//=SRQ*)GVCS(VSMR3@@[_\ P6X_X(,^.?\ @LUX_P#!&NZS^V=IWP^T M'P!8WT.AZ/;_ O?4[F26\-N;B2:Y.JP*X/V6+8JQ+M .2V<@ ^GOV8_V'OV M4O!GP=^"VIK^S]X.O->^&O@FQM?"'B:]\.6TNHZ:6ME\Z6&Y9#(CRNTDCL&! M=Y'8Y9B:_%;_ (-[O$?C3XF?\'-?[2/C3XNRS2>(UTGQL]TMWG?;S)X@L;?R M0#]T1QYC5?X50 <"OWZ^!?@WX@?#OX1^'_ GQ/\ &^E>)-:T?3(K.[UO1?#\ MFEV]V(U"*XMI+JY:,E0,CS6!.2, X'QQ\3O^",NK^!?^"EK_ /!5?]@OXOZ' MX'\>Z[IUQ8^/_"/BWPU+J&A^(EG1%DN!]GN()K68F.*1BI=7EB5R 6D\P _, MK]FWQ5XQ\*?\'J/BS2OAW+*EGKOBK7K'Q';P$A)[/_A'I+B028["X@BEY_CC M3O7!?MY? [_@IS_P;_?M[>-O^"D'[%'C!_$GP>^(7C&]O[W6K+.HZ1*)[Z62 M32=;@1OD>*=Y84N,J23^[ECE9XU_8;_@G-_P1B\+?L>_M1?$C]O_ ..WQ3A^ M(_QP^*&HW<^IZ]::'_9VF:';W,PEEM-/MFEF=02J(99)&?&WQ-XMOI?#WC[X77%_+X.M=6+3I MH=1B68".Z8^7/&4\\&1=H9D(!\]?%7X6?"O_ (.&?^" OA_2?V2=-TGX6^); MOQ_>ZYH?@C4]4(LW\613:A=:AIJ2MRTA>.;#3_AKJ?BJ)TUOP7K,B/96!28'%[8 MR+$".OU,T?_ ((FZ;\&_P#@G?\ #+]A3]DS]I75_ 6J_#GQ M]9^+X?B=_8T=W?7.J1//)-.;8ND9$K3>7Y3,R" >6WF#.ZGKW_!(+XO?M0_M M\?"?]N7_ (* _''P+XDNO@A; ^"]#^'?@"XTA=3ODF\^&]OY;J^NGQ%,JRI; MQG8KC.[!<. ??%?@#_P?.?\ -KO_ '.W_N K]_J_-?\ X+-_\$%/C%_P63\< M^$-8^('[=&@>"M \ C5%\+:+I/P>FNIU6^D@,IN;F36E$SA+6W7*11+E6.T; ML ;^QO_ ,$1OV#/VJOV*_V=OBW^U=HOCOXG7%K\(/#-]I.A>-OB?K-WI&ER M2Z5:NZ6UB+E888NB^4%V;452"!BO9O\ @M5X.\)?#[_@BC\=_ O@/PQI^BZ) MI'PFN[32M(TJS2WMK.WC152**) %C15 50 .*]A_85_9Z^,7[*7[-GA']G M/XK?&K0?'4'@?POIN@:!K&C^")M$E>TLX!;QFY1]0NUED,:199/+&58[?F 6 MA_P4=_9+\<_MT_L=^,?V3/!'QBT[P(/'%C_9VL>(-0\)OK#1V+',J0PK>6H6 M5L*!(SLJC=\A)!4 _+/_ (,]/V3OV?OB_P#\$S?BYKWQC^$GA[Q8GB[XJ3:# MK5AXCTB&]M[C3[/3M.N(86CF5E*B:ZEDQC[P1NJ@CP;_ (/ [.X\-?M=_LS? MLW^'_#UKHOPRT/P2H\.Z#IEHMOI]K+)J(MIXHHD 1%2WM[10H&%4@# -?K#_ M ,$4_P#@DU\0/^"/WP5\1?L\S_M1Z5\1O"^M^)I_$%OCX=R:/?6E]+;VMNX, MW]I7*20^7:)A/*5@S$[R/EK>_P""OW_!(#X&_P#!7GX':7\._B+XGO/"GBKP MK>R7G@CQSIEHMQ-I4LJJLT;PLR>?!($C+QAT;=%&P=2O(!^:_P#P?#-!;?#S M]G"\A;R[N+7O$IMI4.'1?)TTMM(Y'(0_@*ZW_@YN\4>-_&__ ;O_ CQI\3' ME;Q)J_B/P7>^(&G!WF^E\/7TDY;/?S&?/O7TW\>?^")?QE_X*+_&[X2?$/\ MX*F?M(>$_&'A;X.VDO\ 9O@GP!X+N-,B\2WDS0-/") "H M8*Z;CGT3_@M#_P $G_B%_P %<_@;H7[-NG_M/Z-\-O"6D>(;;7+A1\.)-7OK MF\@ANH$59O[3MHXX/+N3^[\IFW(#YF#MH \>_97_ .53:X_[-&\4?^FK4*^? MO^#(K_DT/XU?]E(L_P#TWI7W-\,O^"8?[07PV_X).:A_P2XM_P!KWPK=17'@ M>]\'V'CI_A+<)+;Z3=Q7$,^^T_MDK)<".?"2B1$4IEHGS7-_\$1_^",/CS_@ MC=H'C/P!%^UMIGQ&\->,;^'49;-_AL^DW=I>1Q^4'6<:G<(T93@H8LY (<<@ M@'YC?\&2/'[3GQ_S_P!"AI?_ *6S5_1;7Y=?L6_\&X7B3]@7]L+QO\8_V:/V M_=?\.?#+Q[^YUSP%8^$81JCV/VCSUL8]6:.;3XI:SI%[XC;7 MO&(UZZ\/6$MK8RW'V"9G\B*6661(PWW0[LV "3FOOO\ :F_X-LM3^.'_ 56 MF_X*T!)=2MKA+-;.7['?/.%A26!2I62"4+O M<8=&"*GPK_X-K;GX#_\ !55/^"CGP:_;[\8:;9S7^#(RGAE()!!X(-3_P#!T^[6O_!=_P#9FOK<[)E\(^%R MLB\$%?%&H$<^Q-?=_P#P49_X-ZOBQ_P4"_X*'^'/^"@D_P"WGHOA+4/!7]DQ M^$/#D7P>DO8K>'3[R2\@6YF.LQFX/M&T$ MFW2::.-;N%K*2X9OLLS1QL(_/+QF.,B1\,)/F_\ :L_X-XOVW?V^OV4O '[/ M7[8/_!5$:Q>> =8M?[(NM.^'2QV,6GPVC?^DRU\Y?\'9_[/GCOX\?\$@-NGZ/K5]HL-A(EFB@10&.$L"$ (#,2Q&,DXS7L.IZ9INMZ M;<:-K.GP7=G=P/#=VEU$LD4T3J59'5@0RD$@@C!!Q0!^0G_!EM\2?#GB'_@F MEXX^&EK=1#5O#?Q>O)[ZU4C>+>ZT^Q,$I'HS0SH/^N)KV3_@X'_X*F?MJ?\ M!(OX8^%/C]\$-*^%_B;PYXH\5#06T'Q5X8U'[;93&SDN!-]IM]11)E8P2C;Y M*%7,^,1,<]W5@1AECP<@U^Q?PL_X)UZ?^S/_P $T5_X)Q?LN?%J M?2;6S\*ZCHFE>+_&FC#6)H1?33RW$\EO;RV:R/FYFV .BJ=F0X4AO!?^")'_ M 0S^('_ 1FUWQO#I'[8^E?$+P[X^%B^L:7<_"^33+N&:S6Y$+P7*ZK,JJ? MM+;U:%]VU=I3DD ^'_\ @\H\*:7^SO\ L@_LZ?LU_ #P!I?A#X8CQ7KMU/X< M\,Z;'9:?!>0PVYM@(855%)%Y?OTR69VY.372?\'(^F:/IG_!MS^S7IUO%&([ M35_ L5A@<*%\+WRC;_P#/X5^I/\ P4P_X)Q? C_@J1^RYJ/[,7QW^U6D#W<> MH^'O$&FA3=Z+J42NL=U$&!5OEDDC=#P\*4L[5K*S%W<3WLT5JR6KNA>*-R MQD8]2&4 ^5?CW_P3D_:4_P""M7_!OE^R7KWPT\90R_&/X;^#[G4O#7A?4]56 MVN/$>DQE+7$+NPQ.D,.G,DC$)\^UF4R*U/\ ^" ?_!93XY?&']M?PI_P3I_X M*B?#6^O_ (M>$;75]-^'/C_7[.6TUW3IEM/,O=+U-&V^:9+>U!$SC>SV\?F" M1V61?U _:L_X)]_$#XBO\$;O]C;]H"V^"US\#)KA?#26_A8:K93V#6"V::9- M:F>$/:F-%5EWAL(I0JX5U\\^"/\ P2.\8ZA_P4Z/_!6+]LOXI>$/$/Q#TKPL MN@^$-!^'WA"?2M+T]?(D@>^F:YNKB:ZN6AGFB&6541@/FVIL /Q__;R^!W_! M3G_@W^_;V\;?\%(/V*/&#^)/@]\0O&-[?WNM66=1TB43WTLDFDZW C?(\4[R MPI<94DG]W+'*SQK^W?\ P1>_:]^!_P"W!_P3_P##'Q\^ WPO7P18:CJVK'7O M!\5PTL>E:U)?37-^D;G[T4EQNA_";XV?LZ_ M#3]N#P+J'P\^-OB;Q;?2^'O'WPNN+^7P=:ZY?7<\L6G30ZC$LP$=TQ\N>,IY MX,B[0S(?HG_@G!^P3\*_^":7[(?AC]D?X2:G=ZE9:"LT^HZYJ$:I<:K?3R&6 M>Y=5X3(=(N]-N];UWP=-K0@AN('B+PPQWUH%E7 M>65G9UR!E"*^ /\ @C__ ,&\/QB_X(^_&G7_ (J?##]OK0/%UCXKTB'3?$.B M:Y\&)H3)#'.)5>":+6\Q2CYE#,LBXX;O+#",'D*#7X6_\%#?A5X2 M^-G_ >,:!\,O'FF17VBZEXS\&G5-/N$#17D$6AV4SP2*>'CD$>QU/#*S*># M7])]?EY\6?\ @WH^-WQ0_P""M%3\%)I=/ MC@L[2*SBMW?^W5D,_#_A^"VU:[,.GS,DDEQ$@DE:(*)%W$\QIUVBOSB_X, MX],T<_\ !-S]H;4+V&-OM'C2:&\W#[T*:/&0#[?O'_,U^WUYHUKKOA^7P]XK MM+34(+RS:WU*"2U_<7*.FV13&Q;Y&!(VDMP<$FOS@^!__!#3X_\ [!-E\:?A M7_P3E_:S\,^'/AO\:HG\S0?'W@FYU.^\'3/%+ TVGW,%["+C$4S!%N$./)AW M,Y5RX!\0?\&._B[Q[)X@_:&\!BXGD\+Q6?AZ_:)B3%;W[O?1AE'16DB0ANY$ M"?W16#_P;5?\K'O[47_8O>.?_4MTVOUZ_P""9'_!*'X5?\$G_P!E"^^ /[,_ MBB.[\4:S.;_Q#X\\4:.;AM4U'8$222VAGB*V\:C;';I,NT%B79W=V^;_ /@G M+_P;V_&7_@GG^W[XI_;XT;]OC0/%6J>.HM3M_%V@7GP9EM89H+^_AOK@6\BZ MVQ@<2P)L9EE"C(*M0!\'_P#!:+_E;2_9P_['#X9_^GQ:7_@]U_Y.1^ '_8H: MM_Z605]V?MH?\&\_QE_:_P#^"G?A[_@IQ+^WWH/AW7?!NO:)J'A/PS'\&);J MUMTTJZ6YM8KB0ZVC7!+K^\=1$&W':J< >@_\%L/^"$GAG_@L9X,\!ZAK'QW; MP/X^\!PSPVWB&T\.F[L+^&X$1GB>T:X5XQYD2O&PF8H&=6\S(*@'Z 45YG^R MK\&/B]\%_AM_9/Q]_:1U;XJ>,;Z9)M:\4W^E0Z;;LRQ)$L=K80$Q6D05-Q + ML\CR.SG< OIE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 445\K_MN?\%7/@_\ L?\ M[1OPQ_8OT3P=J'CCXP?%J_BA\,>#]-O([6*TM7E:/[=?7,@;[/;YCEP521V\ MF3"?+F@#ZHHKY;_X)T_\%7?@7_P4/\0_$/X3>'O#>J>#_B5\)O$4^C?$'P'K MLL4DUE-%<2V[3031$I++_P % MZCXQ\6>+_%%EX;^'OP^T*=$U#Q)JUS(%2WA+_*BHF^225OE1$.>2H(![E14& ME3:C<:9;7&L6,=M=O C75M#/YJ12%0617VKO .0&VC.,X'2IZ "BBB@ HKY= M_P""GG_!6G]F;_@E?X'\.ZS\:H=6UOQ)XTU%K'P5X*\.I$U]JLRE [EI72.& M!&EB#R.W!D4*K'BN0_8I_P""R?A']JW]O'XE?\$XO&G[/NO^"/B3\,[*6\U- MUU*/4]+N88I((Y-ERB1LC9N8BH:,*P+8;( (!]HT5\Y_\%(O^"@EW_P3@^"U MU^T5XF_9@\:^//!FD1H_B35?!=S8-)I"O((UDE@N)XY&CW,@+H&"[@6P 2/- MO^"3G_!=?]C_ /X*ZWOB;PI\%M,U[PMXJ\+HES<^%/%RVZ7=W8MA?MD'DRR+ M)&LA$;X.Y"R;@!(I(!]JT5\U?MM?\%!?&'[&'C?P3X6D_8R\>>/++XA>+[/P MOX9UGPCJFE")]6N4=XK>9+JZB>!2(Y3YK#R@(F+,N1GZ&\+:GK&L^'+'5O$' MAN71[ZYM4DN]*GN8YGM)",M$SQ$HY4\$J2#C@F@"_117.?%#XN?#;X+:!9^* M/BCXNM=&L=0U[3M%L9[K&M&V1A8(?.NK^YD)$5I;1 @RS2$'"Y M #,Q5%9@ >K45\C?\/'OVF_"WPVB^/WQ>_X)9_$_0_ #V/V^\N=*\0Z3JNO MZ78E0ZW%WH\,PF4!"&DBA>>:, YCRI ]B_8D_; ^%W[>O[-.A?M6?!1+S_A% M/$U]JD6ARW\!BEN(+/4KJP$Y1@&02&V,@5@&57 8 @T >KT45YK^U[^T1-^R M9^SCXM_:1?X7ZOXNL/!6B7.LZWI.A75M%="PMH7FN)H_M,D:.4CC9MF[V_BI; M823220^:&3R)9!M XY(.:^LZ "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "O!_P#@I5^WQ\.O^":'['7BK]KSXE>&[W6[7P^L$&GZ%IT@CEU*]N)5A@@\ MQ@1$I=@6D(.U%8A7("M[Q7R3_P %O/VRO@'^PY_P3O\ %WQ;_:)^!>E?$W1] M0N+;1M.\ :]9Q3V.M:A.Q:".X$J.BQ)Y33,VTD"'Y1NVT ?$O[5__!?+_@H) M^S'^PO\ !/\ X*CZ7X4^!/C/X5_%K6(;&]\%:9I&M6NL:/.\-S*UH-2EO##, M\9L[J%Y?L:*LD0VI(K;A]4_M]?\ !;/X??LD_P#!);PO_P %-O GP[GUQOB- MIVC_ /"!>&M5F\D?;=1MFN4CNWCSM6&**=G"??,.Q6&\./Q*_P""JOQ5TK]H M3_@A[\%/VA?&_P"TIX6N?%GBCXI*/#OP*^'=Y;:7X=^'^@V]IJL)M;;1K=LM M*L@@\R[N1)(AN%B1E1V,OZF> /@7^QY^UY_P;R_LS_LH_M?>))](TCXA>'/# M&@>&/$NGR1^9H?B-[*62PFW.<*6>-K<*0=YN1&=HD+J >L? ;]NS_@H1XBUG M]GCQSXH_X45\3/A-\;=76TU?X@_"BSU2T/AN5]*N[F.T:WN;RY$FZY@6'[27 M3:R/%);QNZ$??%?S3?L7?#+_ (*6_P#!NO\ \%D/A=^Q9K/C,^*/AG\;?&=C MIB6NFRN^E>(+"YNH[1]02W%=(\>7NE?:=8\=?$.PO+S3;.[>P^WPZ?!96DL#W,KVQ M60NUQ"@W; 6;BN _X)J_\%T/C]\;/^"H/Q"_X)-_MM?"WP5;>-O"U_JMOH'C M+X;17EOINHM8$L\33R1EX 95<2G!0H5Y#5Y#_P %"_\ @I-\+?&G_!=3 MPC^P'\"/#WPX^%/C:UDCT?X@_M4^(O#6G2:_I5N^G/>/INE75W&4MW>!A:K/ M+O\ WUUL1%"[I/D/_@E._P -])_X.T_$D?PY^)4GB?P[!K?C!-.\47_B=M6D MU*--*N=UQ)?2.YN68JS-(6(/., 8 !_2W7XO_P#!4[]ECXR?!+_@XL_9X_X* M::]X5U/4/@].^FZ3XB\4V=G)/;^%[J-;JV/VPQAOLUN1<12B9\)DR@D%.?V@ MHH _%S_@@U^R[\4_"_\ P4Z_;$_X*V_$_0[WP;\(?%>N>*D\(:MXHMWT]-8L M+G7CJ;ZHJS!2+:*"V0^E:C_ ,%"OVF]5_X+._'>RDT[ MP%H=E>Z!^R[H&MKY*Z=H.XI?>)YDDQY5Q?E"J,0I2V4 [E9&J?\ X*$>(M?_ M ."DG[5EA_P1[^$&M74'@C1[>S\1_M5>)],F9&M=&9A)9>&8Y5.4N=090\@! M#+;*2-P9TKXW_P"#K3XA>,_"GQ4_9)_87\-PMH?P=\2>(8_[&4E8ONCSE)&40@ _;7PMXO\)^.='3Q#X)\4:=K&GRL5COM* MO8[B%R.H#QDJ2/K6C7X>?L\_$/QM^S9_P>(?$7]ESX P_P!D_#CQ_H4$OC/P MEI,0BTV"2/PC;W\=YY" 1QR_:D0>8 #_ *7(N<.0?W#H _//]NG_ (+0>-/ M7_!23X?_ /!(O]A_P;X7UOXL^++B)_%'B;QJ+B;1_"MNUL]WM>VM9(IKN?[) M&UP4$L2A6B&YC(?+@^ W_!9WXD^ ?^"JVJ?\$@_^"@/A7PC:^,KN&"?X??$; MP#;W5GI.OB:U%U';RV5W/<2V6=YX3ODM3&Q^\JR9M^.CPLO\ #47_ 4P\!^, M_CE_P>"_"/P;\++>:YU'0/$'@?4M5-H"3:VECY>I74CXZ!;568YX(('>@#A/ M^#M&[_:;D_X*6_".#XKVO@B.RBL&/PW7P]>WKN]@=5/EMJ(FC41W!8 ,(-R; M1P2:_HH^ >D?%R'X?6/B#]HWPYX(LOB+>Q,OBB;P";B33Y=DL@@$4MU&D\@$ M/EY\P##EPO&"?P-_X/$V4?\ !2+]G')''A2,G_P<-7]%- 'S1_P6'TW3]9_X M)L_%+1]7L8KFTN],LX;JVGC#I+&VH6RLC*>&4@D$'J#7\_\ _P %=O\ @G7^ MT+_P;Q_M_P#AC]O#]AG4KZQ^'6H^(6O/!.HC?-'HMVP9I]!O>8J;SF M6 NI)>)WK^@+_@L#>V>G?\$XOB9>7]U'#$EEI^^65PJKG4K4#)/N:]4_:G_9 M?^"_[9OP"\3?LT_M ^$HM:\*>*M/:UU&U; DB.0T<\+X/ES1N%DC<U M'P]X*_X*4?!;_@J=^S3^R]^TC\*)8[/4!^TGX?LO&7A:2$_P#@EI\-/"EAH/@$>-OBC\3-:_LCX;^" MS>_9XKF<-&CW-S+@E((VFA4A1N=Y44;1OD3\/OV1_P!@?]I[_@D9_P '"?PG M_8W\<>)-1N/!7B?XAVFIZ#JT 9+#Q580)<_9+IDY47$)DDC=/O1.\@!*2!G] MQ_X/+=+\;_#K]M3]G#]HR]L-2D\+66B2P6TMA=R6[)?6>I)=3(DT9#02M%+ M5=2K?)E3E,@ _0SQ'_P5:_:3_8H_X*._"G]@W_@HAI_PYU;3/C=I$'_"&>/O MAKHU_I46EZT\YM_[-NK:]O+LSQM,8HTN4>+)FC+0J"VS\X_^"]'[5/\ P4)\ M2?\ !=GX"?LFZ]KG@NTT3P[\2O"FO_"KPG8ZE>/I<]W/JZPVEYK$OD)*\Y:+ M#B)&6"*1EB+LSO)^CFK_ +#7_!%_]I?PS\(_VZ_&_CCQA\18IM8TMOA+X@\0 M_&SQ-K=R-0N+F%[>UMH9;^5_.$ZH98 N8_)D,H58W*_F_P#\%Y ;'_@Z<_9I MO+W]U$VJ_#F022<+L'B.4%LGL"IY]C0!^^'[.$W[3\_PU1_VN]/\!6WC#[;+ MYD7PWO+V?3?LW'E$->QQR^9][<-N.F":_.O_ (.X?V/?C[^U-_P3ET7Q9\!] M!U#7'^&?C9/$/B+0-,C:2:73_LEQ!)=1QKEI&@,BL0 2(WE?HAS^HNC^(O#_ M (A^U?V!KEG??8;Q[2]^QW*R?9[A,;X7VD[77(RIY&>17SM^W+_P4"\&_L.? M'CX#>&OBQK]AI'@[XK>+=0\-:KK.H$)'87?V/S;*5Y"0(XVG40LQ^4>>&8@* M2 #\L/\ @E9_P>(>!]2T70_@A_P4^\)W.E:E!#%9CXM^';9I[6[( 43:A9H/ M,A<@9>6#S%9FSY48K]3/#/Q(_9&_X)S?\$X_$7[0_P ,O$<6M_"/P[;>(/'. MES>%Y(;F*XM]2U*[U3[-9&,B,QF:\,,7(55V!B "1\Q_\%D/^#3]I.7]D/_ (-W_C9^T3^V#X&NO%'PG\.^+-3_ .$:\,:I:I-%K-K/ M#9VTUE&DRM&;6:_F,1RK1B1[@D'#"@#TWXA_\%\OV^]:_P""6S?\%A/@'X3^ M!C>!;#QD-&\0_"W6])UFZUK2T-\MJH;4X[RW@DF/FV\A46@0)."&8J5KZEUG M]N+PK_P4?_X-]_B=^V1X0\*7&@P>+_V?O&OVO0[JX$KV%W;:?J%K8@ MF@DV/M4LA5BJDE1^-W[1?[1GA']L#_@@;\2_C[XB^+/@3X;6B?$6RTCX5_LM M_"NYM=$TG18TU.TEN+JZLH2DVJ7DL;2R[I@T2*AF2-7.8_NW_@DA=VLG_!HM MXVM4N8VEB^#WQ0,L8<%D!?6<$CMG!Q]#0!PG_!E;XCT'P=^Q5\?/%WBG5H+# M3-*\;VUYJ-]=2!(K:"+3=\DCL> JJI)/8"O>?AQ_P6M_;1_;9_9K^/\ ^WQ^ MPM\,OASIGPB^!LUZFDZ=\1-(U&[UCQPNGVBWU\R2VUY;QZ41:/&T:M#=EGD5 M6VX)'Q'_ ,&WG@+QS\5/^"&O[(M>T35;'1K2U!,MS<2^'ID2% M .=TA.P>[5'_ ,&G?AG]D7]J[]G[XK?L-_'GXG>.;'Q%<:Y-J<7@[1?B]KFA M66OZ+>6,-K=)]AL;R&&Z9# 5F+(SF.>-6)50% /T$^-__!QM\(?!W_!O^ M"JGPP^%\FH:MXGUJ/PQI?@;4K["6'B,^<9K>YF106ABCMYIPRJK2Q^4,1F3* M=K\!OVZ?^"@_B'Q%^SQXQ\5'X%?$SX2_&[5C:ZM\1/A/::I:'P[,VDWEU':- M;W-YGP^:]\, M?#/Q[\[OI9!(N^T%BRQLT9G>6W.QS*R?FU M^Q)\-O\ @I=_P;N?\%DOA?\ L1Z]XR/B?X9_&SQC9::MKILSR:5K]A2)@Q /Z5Z*** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K MSG]JS]DO]GK]MSX)ZI^SO^U!\-;7Q5X1U=XY+K3+F>6%EEC8-'+%-"Z2PR*1 MPZ,IP2,X)!]&HH ^/+/_ ((%_P#!)#3OV9=1_9(L/V-="A\'ZMJ=OJ6HLFH7 MG]ISWD <0SMJ)F^U[D$LH5?-V!99%"[78'K%_P""/O\ P3HB_9-TW]ART_9M ML(/A?IFO1ZT/#4&J7B&ZOXPP6XN+D3?:)Y.1\SR$X1%SM0*/I>B@#YQ^$7_! M*O\ 9#^$?QWTC]I@Z7XO\7^-O#.EOIO@[7?B1\0=5\12>'+-PP>&Q^WW$H@R MK%3)@R8)&_#-GZ.HHH ^5OVB?^")?_!+[]K#]I9/VN/V@_V3M'\2^.2L O;^ MZU&\2VU$P(L<375I',MO=%454S+&VY556W!5 -7_ .")?_!+O6_VL;/]M?4/ MV2-"/C^PEMIK6[BN[J.P2>WC2*";^STE%IO1$0 ^5C*AL;@&KZIHH *1U+H5 M5RI(P&7&1[\TM% 'D'['/[%'PB_8F\'^(?#OPVU+7-:U3QCXMO?$OC/Q?XLO M([G5M>U.Z?<\]S+%%$AVKMC1$1$1$ R6)H_MV?\$]?V7O\ @HS\*[3X4?M- M^"Y[Z'2=274O#NMZ5?-::EHEZO N+6X3F-L<%2&1L#[RH]VX(FWZ%HHH \2_:W_X)W_LG?MM:MX9\7_';X=SR>*?!-Z+SP7X MV\/:S=:3K>ASA@X:VO;22.51N ;82R;@&VY -5_V7_\ @F_^R9^R/\2O$_QR M^%_@6^OOB%XT/_%5_$3Q=K]WK.N:D@VXB:[NY'>.(!(QY4>Q"(H\J=BX]UHH M ^4OVKO^")'_ 32_;C^*B_&K]J[X#ZSXS\2Q0>1:7^H_$_Q)&EG#YC2"*WA MAU!(K:,.[,$B15!8D"OI?P/X,T?X>^%++P9H%YJMQ9V$92";7->N]3NV!8M^ M\NKR66>8Y)YD=B!@ X UJ* /'?VO_V"_P!F+]O/P7_PK?\ :G\*^(/$7AQ_ M+^T^'K+X@:WI5A=F.3S$,]OI]Y!'<%7"L#(K$%5(^Z,=U\'O@]X-^!?@>W^' M?@*[\02Z9:$?9_\ A)?%^I:WHHH X+XQ_ MLS?!7X]^*O WCKXG>"H+_6OAOXG77_!>K E+C3;P1M&Q1QR8W1BKQG*MA21N M1"N=^UQ^QK^S/^W9\';KX"_M6_";3_%_ABYG2X6RO&DBDM;A P2>">)EEMY0 M&8!XV5MK,I)5F!].HH ^1?V%O^"&/_!-#_@G5\1I?C%^S3\ ?L_BY[=[>V\2 M:_K-SJ5U91.NUUMS.[+ 64E6=%#LK,I8J2*[#]N3_@E!^P-_P4=U/0/$'[7O MP#M_$NJ^&%*:+K5IK%YIM[!"7WF SVQ\)W5U=:-I&MJ9+-9YX?)>5XL[9&"9V[ MLA2=P&X CURB@#Y5U+_@CQ^RCK'@U_@_JGC?XP7'PXDB$$GPOF^-.O/H3VX_ MY=3$UT93;8P/LWF^3@;=FWBO:?%'[*/[-_C']G"Z_9!U[X,:"_PRN]!_L67P M5;60M[%+$ !88TBV^5MP&5D*LK ,I# &O0:* /CWX6_\$#?^"1_P>^#/B_X$ M>#/V,M!_L+QW8K9^*9=2U&]O+^[@65)DC6]GF:XMU66**11#(@#Q(_WE!KH_ MA3_P1M_X)U?!']E[Q)^QS\+/@-O'?[+)M]8U;4#>ZU9:#XFO\ 3[#4+AFW/(]O;S*D95Y>XDD\DD_= MM% 'B_QH_P"">7[''Q^_9UT#]DGXE? _39OAKX9NK2?1?!^F2RV%I;&V1T@5 M?LKQLJIO) ##+8)S7-?"'_@E;^R)\(?CQI/[3/\ 9?B_Q?XX\-Z4^F>$-?\ MB1\0-5\12^';-PP>&Q^WW$H@RK,IDP9""PWX9L_1M% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%4?$_BCPUX)\.WWC#QGXBL=(TG3+5[K4M4U.[2WMK2!%+ M/+++(0L:*H)+,0 !DFO%?@__ ,%,_P!AGXY?$&X^%O@']HOPZVN#6/[-TFQU M"_2U.NR_9X+@-IQE*B]4I<1X,6XGDXVX8@'O%%'?'GA32_'/A#5 M8[_2=:TZ"_TN^ASLN+::-9(Y%R <,C*1D=Z -&BOF?5?^"S/_!)_0]4N=%U; M_@H?\(K>[L[AX+F"3QO:!HY$8JRGY^H((_"O6]'_ &IOV;M?^ R?M2:1\<_" MTWPXDM'ND\<#6H5TMH5E,)<7!8)CS5*=>6^4<\4 =[17GGP8_:P_9U_:%US5 M_"GP?^+&F:OK.@)%)K>A9>WU"QCE&8I9;6=4F2-QG9(4V-@[2<&O0Z "BN9^ M*_QH^$?P)\+CQK\9_B7H?A;2GNH[6*_U[4X[6.:XD.(X(S(1YDKGA8UR['A0 M36+XS_:F_9_^&?P3E_:-^*WQ,LO!_@FW9!<>(/&<,NCQ0[YA!'O6\2)U#R,J MH2H#[E*Y# D ] HKYN\+_P#!8;_@ECXV\3:=X,\(?\% /A3J6K:O?0V6EZ=9 M>,K62:ZN)7$<<4:A\L[.RJ .22!7J_Q9_:7^!?P/UK3/"_Q,^(MG8:SK44LV MD:!!%+=ZC>Q18\V6*TMU>>2-"RAY%0JA90Q&1D [JBN<^%7Q>^%_QQ\&P_$+ MX/\ C[2O$FBW$TL*:CI%XLT:S1N4EA8J?DE1PR/&V&1E*L 0171T %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 ?'W_!=+]G#]I#]I_P#X)XZ_X)_96TN#6?%FC>(M'\1Q M^$;N0+#XFM]/O8[J337!(5P_EAA&Q =HE3(W9'B__!,G]K3]E#_@K1;_ !&\ M->,]'D\'?$K1/CQHOCVY^%OBB-8M?\.7FE6VB+YBI(JLT?VFPN+=I4 813%9 M%B,NROL_]L#]KOX?_L7>#_#/Q0^+C"T\):GXTM-#\1^()=PAT&"YAG\N^G(4 MA(%G2!))'*I&DK.S +@_E5^W1\.?@%^T-^U/!\>?V%/&FCZG^U(G[5NBGP%K MWP]U>.YN;OPR-$T;^T)M0-LS*VDQ1^<6FE^0$M$&(F=& /M__@X-^'?@+QK_ M ,$AOCGK/B_P7I6IWFB> KJYT:\O]/CFEL)A)"WF0NREHFS&A)4@G:/2O:OV M1_#F^,?&FE:5YFU_5)H]-TT^;+ TLTBW-S'*S,S.PC=B2<5[/^V#X"_9"^)WP*U;P7^W#I7@J]^'UPHEU2+Q[<00V,9C^99? M,F91$Z=5D5E9>H(H ^*/^"OOBV3X#_\ !5[]@_XU_#6Z%IXM\4?$/4? GB". MU8!]6\.WWV198IP.98H))#,@.0DC;QAL&OTCO+RUT^TEU"^N$A@@C:2:61L* MB*,EB3T S7Y<_L9?\$_/A;^T-_P4ST']M_P'\ W\#?!/X(^'I]/^"L&LV=P MNJ^--4N5,<^O3F\+77V&./\ =VBSG+;$G0(IPWU_X*_X*$?L;?M5?M._%/\ MX)M>"_B1=R?$7P7H*]'ETJ> "WD6.*9[>9U"2^4US"K8/60$;AD@ _//] MB3_@HEHOQ_\ &GQ/_P""VG[3G[.?Q<\>>&/#FOZAHGP;M?"O@K[;IOP]\)6H M"W&JH+B6%9;NY.\W4]L)Y8DMV0F.,[!^DC>%_P!B_P#X*H? CP#\7[R#2/B? M\,;RX3Q%X=T[4+59]*U*X5)8$>[M9D_>M 7F7R)AMCE!+Q^9$A3X[_X(E?%+ MX2_\$_O^"??B'_@GU^VWXOT'P=XQ^!/B+7[+Q+HWB"X2)]=TJ\OKB]M-2LX7 M^:]MKI+DQQ^6'+O&8\;\*?8/^#>_]E#XH_L<_P#!+7P-\+?C#H-[HNM:C?ZG MKQ\-ZB")]%MKV\DGM[253RDHA:-I$."DDCJ>5- ''?'#]BG]CC6?^"HO[//P M ^!G[)GPS\*2^ X]0^+?CC5/"O@/3].NDALA_9^BVYF@A5]LFH74EQLSAO[, MSCYH_MZ?M)^#-0\0?L_\ QN\%:+X.N?&&D0_: M;SP+JFGFYEC@, ^=K28233L(^68LP#-$$D^C?^";:?\ "]/C9^T!^WS>#S;7 MQS\03X.\!W'WD/AOPT9=/22)CSLGU-M6GXX(=#V&/-M7U#P?=_\ !9SXL>$/ M^"@JZ*O@K6O@[I&E_L^VWC7RAHFHV$RR_P#"36\7VC]P]Z\XMA+'S,ULD>08 MQ0!Z+_P2:^&GB&YT[XL_MM:EJNFP:7^T;X_3QIX7\+Z+J\%[;:5I@L8+2WDD MFMV>![VX2 37'DNZ*Y5 [E"Q^NZ_/?\ X(HZE:I<74OF3+'!8+O>%(A&S7'ERD MRHIV5]+/VGM;TGQKX/_ &KK+PY)K_A#QS+I&E>(?"FEW%C9>(=,-A97 M=O?BWGFF:&0_:WAD19'19;>0*Q H ];HKXM_9T_;=_:T\>_\%B/BE^PK\:O# MO@K2_"7@WX3Z?XE\/1>%Y+BYN)Y+JZB3=<7,ZQ[BH,BA4BC7N=QQCL_V\M<_ MX*HZYXZ\-_#;_@FCI?PPTE(-,GU'QMXP^,%O?/I^'<1VEE9K9AGDG)CN))6\9!&\UP)G4!®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ivc-20210930_g5.jpg begin 644 ivc-20210930_g5.jpg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end GRAPHIC 19 ivc-20210930_g6.jpg begin 644 ivc-20210930_g6.jpg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�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ivc-20210930_g7.jpg begin 644 ivc-20210930_g7.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" M2@*T P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *H^)O$NA^#O#]YXJ\3: MBEII]A T]Y=2 E8HU&2QP"< 5>HH \:^ 7_!1']A/]J?QQ-\,_V'/$UO=72VZ,JO+Y2,6VJSJ"<<;AGK6Q\:/VR_V5_V=/%>D^!OC MI\=O#OA35]>D6/0M.UN^$$NHR$X$< ;_ %SYQ\J9/(XYK^?7_@IM_P $[_VD M/V-_&-]_P7E_8%UZ_M-1T'X_>/3X]L;&+=_8SVWC'5[*"\6-0 ]C+;QQVUQ" M1@9R=R2OY?Z;_LR_\%,/@=_P5M^&7[*'[0'@VRL[3Q'I?Q]-KXW\)2.))M U M9?!OB5B%SR87QYD,O\2<'#HZJ ?H[;W$-W;I=6[[HY$#HV,9!&0>:?7RE^T1 M_P %,XO!O[=?A3_@FC^S;\-]/\:_%KQ#X=N/$&MG6_$#Z;I'AC2HXW99KN>* MWN)7FE90J01Q9_>(SNBLI;PGQC_P74\9_$'_ ();_&W]K7]G3X"V%E\5/@CK M%_X>^(7@?Q)XA$MKXZ'K5]XHUC_A: M-QXV%QJ.N:K/XCO))TFTX6J_9UWR7&)!.XQ"N$4. FO_ ,'-O_!0OXF?\$^/ M^":UWK'P.UV?2?&GQ$\1P>%-&URTPOC?W]ICKY\%JLCV^." M?,"\$'H:[+X3_M=?LM_'C5K+0?@G^T)X/\6WM_IUW?6UIX<\007LA@M98(KE MV6)F,?E27,".K896E (SG'Q__P &T?['GPP_9M_X)9?#WXIZ+X>M9/&GQ7TK M_A*/&GBB2,/>:B]S*\EO$\IRYCB@,:A,[=_F/C=(Q/TFG["GP;\/_P#!0&'_ M (*(>$M%L-&\4W/PRU/PCXO>SM!&=;CFO=-NK:YF9%QJL7QZU/2K+P/8>)]6&D6FG"\C$DMUJETL<_V:"U4GS6C24DC"@KEU /M M#QOXW\)?#;PAJ/C[QYK]OI6BZ1:/=:GJ5V^V*UA09:1S_"H')/0#FN2_9V_: MQ_9G_:X\-7WC']F'XZ>&/'NE:9??8M1U#PMJ\=Y#;W&Q7\IVC)"ML96P>S"O M*OAA^TQ\=/C(?B]\(/CI\ -&\+-X6^'NF:MHWB7POXQ;6]'\4VFIQ:H!/:3- M:V[!$^P@,CIN#2=T\N23\0O^#?'_ (*&?'7_ ()X_P#!)[XZ_'3X2_L;77Q+ MTGPI\1H-5\7ZI>>+H-&LM/M)+2S@"Q,T^!?VP_AQH=YI>E>-M*>X72[]U>6RN(9Y;:X@9EP'V M3PRH' &X*&P,X'Q3_P '!L!S@ M^AKW>OYF_P!NCXK?LT_&S_@W _9/_9-^&^K:-XZ^/ U6R.@>#?"934M>TV$? M;A<^9!;[YH$??"GEL 9',9"MY9*_H?\ &G_@J7^TO_P0G_X)5_LUZS^US^SK M)\2/$VJ^';30/%!N/'QL=1T[4$M6FCAFS9W"SLD"".23S,^9&>&SNH _56BO MB+]GS_@KC\5_CC^US<_#+6OV O'/@WX)_P#"MIO%^E?'WQ-*\.F7UK&B.)MA M@$<4,BEVCWS"*O'/[)?Q"_X*3_ @_8VBUG]GOX;^. M4\.ZCJM]XY:T\3:K!YMI%)J=KIQLF@$2->0XBENE=QO),90@@'Z;45^?'_!1 MO_@O%9_L3_L@_#']OKX,_LP'XN?"3XF10+;>(;3QH=*N=,N)XGFABGMVL9\! MECD0MO!26-HV4':6]QUC]NCXHZCX#_9Y\7_!_P"!/AGQ;/\ 'FYM<6T'Q%E@ MBT:SETN74WOUE_LU_M5O%!"RLQ6%C)+ @4F48 /3=(_;$_9!XM14W]O;,J.':/UV21N5!W!)%8@*P)[7QMXV\*?#CP MI?>.?'.N0:9I&F0&;4-0N21'!&" 78CH!GK7Y:?LW_'[]DG7_P#@YB^)'P'/CK8^%IEU?XN:?\ $NZU"UO+5=.LI8W33Y+6&.&:6TDMXW:WBE-N_[R-2CL ?6W[.?[8'[+7[7FDZGKO[ M+WQ_\*>/K+1KB.#5KKPKK,5XEI*ZED20QD[20"0#U KT>OPD_P"#,/QSX1^& M7[(G[2OQ*\>ZW!I.@^'O$=CJ>M:E=G;%9VD%A<2S2OCHJ(C,?8&OK.7_ (.% M8=,_9E\,?\%&?$G[+#V'[-GBOXGOX0L/%1_#_]O;]B_P"*GQJG_9O^'?[3?@W5_']J)C=>#+/6 MHVU*$1+ODW6^=Z[5PQR.AS7@/[;W_!8:W^ O[9GPP_X)S?LL_!>T^*7QD^*- MJ-0L[*^\4_V5H^BZ:4FE%W=74=O.-]T:@'[P>)O$NA>#?#U[XK\3ZE'9Z=IUL]Q>WBW$<&K7/A768KQ+25U+(DAC)VE@I(! MZ@&O2*_G#_X-D/VD/VI_V:_V1?VF_'_[,7[(EK\3Y/#^O6NLZXFI^-XM%ABM MK>TN7:"WQ!/+;2OV@O\ @E!X@_X* M?_LN?LO77BZ3P'_9E_X++:_P#M5_\ !*K4_P#@I;\,?V:M(FOK'5+FQ@^&?_"Q7:ZFGBNE MMH[1KH:=M2\G>2(Q0^6RL+B',JER% /NFO!OB;_P5$_X)W_!;QY+\+?B_P#M MD> /"_B2!U670=?\016EV"Q*K^ZE(8AB#@@8/;->S^#[SQ7J/A73K_QUH%EI M6LS6<;ZIINFZFU[!:SE07CCG:*$S*IR YC3.,[1TK^?;_@YNUG0_"W_!P;^R MEXI\1:E;6%A8:%X0N=0O[J01QP01^*[]WD=CPJJH8DG@ $T ?LOIG_!6'_@F MGK/C/2_AUIO[<7PUEU[6[Z&RTC1_^$I@%Q>7$SK'%%'&6RS.[*H ')(%=WI7 M[8?[+FN?M*ZE^QSI'QW\-W'Q1TC2EU+4O \6HJ=0M[9E1P[1^NR2-RN=P1U8 M@*P)^LZ#XST3X&ZMX)\0Z;X[L++S_LGB$Z MC>WC):3-@%4CTVWC:2(@,+F:,E@"*^>/V>/C_P#LDZ[_ ,',_P 1/@WJ?_!/ MFR\._'6R\+2KJOQ=T_XEW5_:WEJ-,LYHG33Y+6&.*>2TDMXGI21/IGQ6@&FW M[VEU! 7FN+FQ@-I XF!#[9'\QHX_+P[.GHO_ 2=_P""Y/PK_P""D?[&'Q!_ M:P\;_#2X^'Z3_:!U&*WM8+0W?VN&18HVD5HDE^0H&5HF'S#:Q / MNNBORF^)_P#PXLWO+=_*:RG#QM#&^265E;:-IR2 #[HHK\ MU-;_ .#@+Q[\,?V[/@=^R[^T-^P5JO@?PE^T#:Z>? GBR\\;V]UJ*R7LRV]L MUS810E8%,[Q*R--YB)*KL P>%?H#]J'_ (*9VWPQ_;8\"_\ !-W]GCX<6'C? MXQ>-M%N=;N+76?$#Z9I'AS2H8I7^U7MS%;W$I>0PNL<$<3,QP6:-60L ?2'Q M(^)'@+X/^ =8^*?Q2\7Z?H'ASP_I\M]K6M:I^%>E?&_P#9^^)&E>+?">MH[:7KNC7'FP3[)&C< ]5971D92 RLI! ( MK\X6_P""RWP^_;^_X),_M'_$;XP_L(27,GPG>Z\/_&7X3:UXVEM8+JV 83-9 MZE%9ES*-C$(8HGC>/[X^1VK_ +)G_!2WX*?L6?\ !N]H7_!0']DG]A&'1/AY MX8U.YAN?AE<_$N9[N!)=>?3GN5OY;*5KJ5[F5)6614"H[!6_=JC 'ZJT5^2' MQ<_X.>_B+\'?V:_@O^V[XQ_X)J:QI_PA^*>J-I]WK]U\1;9KVWF1I/-^R6BV M^ZXC"12LDDWV?S6B=0JH8YG^H_\ @I%_P6*\ _L,?$'X/?L\_#KX9/\ $3XH M_'77+/3_ 'X=.L_V98Q17-S#;1WEY=F&9H8C+.H4+$[,$D^Z%R0#[,HKX!\ M!?\ !93XWZI_P5(N/^"3WCG]C'1(/&NEVUKJ.J>)=(^*H?3YM*EB@GDO+6*Y MT^&6=XH9]S6W#DQ2!68+NK[^H R/'_C_ ,$_"OP3JOQ(^)'BFQT/0-#L9+W5 M]7U.X6*"TMXU+/([MPJ@"M<$$9!K\OO^#H77/CY\7?V&/&?[)_[,4'VBZTSP M=_PL#XKF)FWP^&+*]B5+8;1D27$RSW"]FBT:[4]0#ZA_P;C_ /!0#_AOW_@F M%X.UKQ1K?VOQI\/5'A#QGYLF999K2-!;739Y8S6K0.SG@R^'M L)[[6]:U&Z6*VLK>%6:661V.%5 K$D],&L7X _M M#?!']J?X5Z;\;OV=_B;I/B_PIJ_F#3]'O$>H0^(?A]_P +3FEO].B.H-;R:D;N:QE:\W3LID#!#$C#&40A0#];Z\V\ M=_MB?LN?#'X_>&/V6/B#\=_#>C_$3QI:M<^%_"%]J*I>ZC$"ZAD0_P!YHY%3 M."[1N%W%2!\[_"O_ (*P>-_CI_P3)\$?\%"O@]^S9H>M:IX\\1V&CZ1\.E^) M#I(9[O5UTI8OMG]FD&>.=M\D9B")&DK^80G/S3^VO^T'^R[X?_X.$_V=?A'^ MTQ_P3MTK6?B[J.@Z7-X'^*FD?%6\>WTNVGN+](_.L#90QW$EO=0WAC+DG#H^ M5.$0 _65Y8HV1))%4R-M0,V"QP3@>IP"?P-><>,OVQ/V7/A[^T+X<_9.\;_' M?PWI?Q(\76+7GAOP;>:BJ7U_ N\;T0^IBE"@D%S&X4-M./RA_:4_X*/_ /!0 M7QE_P+7T?3+!R(C;Z5#)%:73SWD MOFIG*I%$"=SLR-&/*?&__!R-^S!I?_!,GP/_ ,%#O!/@6>[N?'GC>'P99^#M M*K6^EO$,EI,UI;LOE"WB+ M*RD_OU(+(4D?WV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH *I>(?$?A[PCH=UXF\6:]9:7IMC"9;W4-1ND M@@MXQU=Y'(5%'J2!5VB@#Y#_ ."6?QX_9;_:M_9S^('@#P)\2O"'CBTD^,/Q M)37M$MM0M[Q9M/O?%NKSQ-+#D[[>>UNH75B"DB3#!(-?FO\ "+_@C?\ $'_@ ME#_P<6?!7Q!\%9=6F_9_^)GB36KG0E2XD>'2M0B\/ZNZZ7=\X9XEDF:WD?+- M"T@RS)*3^\E1S6MM[^32OB!X(FN9O% M&FVFH,?'%] LT\LELEZQGN_+$D@,ZKMEEDD12[1MC]/]=\/:!XHTYM'\3:'9 MZC:.07M;ZV2:-B.A*N"#5J&&&WA2WMXECC10J(BX"@< #H* /S$_P"#3KX] M?#+Q?_P2:\!_ 3PQK4U[XE\&W.OGQ7:PV,OE:4\VMW4\$,TI4(LLL4ZR(@)8 MJKG VUZC_P '$/\ P32\%OBK?1^'YKBS2 M>1[6>'[:8PX$++$R EU:%F*A61C]Z?"7]MOX;?M#ZSKEU^SKH6J^-_"&@:)- M=2_$+0X@VC:G?*PV:=IL[$#4I"HD9YK??!&0B&0NY5/3_$WP_P# ?C66";QE MX)TC5GMCFV?4]-BN#%_NEU.W\*U8HHH(E@@C5$10J(@P% Z #L* /Y;?C9^V M]\)V'_!.C]K;_@@'^RA^SA^VUKUW MH'AGQ&%\/:-\4%#V2^#?$MK8W,L<[23Q".2V<+-;R2$F#.)"D<;0J512NT@#' *DC'H<4 ? MB5_P;_W/[1'[(MM^UQ^R7\4OVE=(\??L]_![2"GA;XE1:H'T.WO98))9(;*Y M=RD:F%U:>W61T@F4 ',A:3XT_P""6WQ1^&WAO_@V?_;7\&^(/'VCV.KW7B*V M%MI=WJ44=Q-]H@L8X=D;,&;>\4JK@/_!JYXJ\,Z]_P0\^$&B:)X@LKR]T2[\1V MNL6EM=*\EC._B'4ITCE4',;&&:*0*V"4D5NA!KSS_@[V^)?P[T7_ (),ZM\- M-6\(]9\8Z)+I6@S:C&MY=QI<,[R1PEM[HHC:_5&B@#X5_P"# M<3QG\)/%G_!(7X,V/P^\2^'[_5M'\*?9O$MOI5U#):_BTDW*_:&M4L)XVG$>=WEA MW1=V,98#.:_;>B@#Y^^*_P .M._:Z_X)=^*?@W\!O%^E7$7Q!^!^H:!X6U?3 M+Y)+/?=:3):PLLD9*F,.P!(/ !':OPX^ /Q"\._!'_@U\_:$_83^*%RFA?&J MU^*[>'C\*]181Z_*]6^']],8[]:Y\.OA?IE_$PN;*T74O.U=Y"20^;R&"S7_GFNF,@ MX-?J_4=K9VEC$8+*UCA1I'D9(D"@N[%W; [LS,Q/: /YQO^#;WX:^(?VD/^"3W[;_ .RA\.;HIXV\;^&I5\,: M=-F+[\%^+K^TTSX4:@NOSR^(I9+F6XABMM/BE%O#=)-+-"ZR+%LV^:[!3(Z M_P!$MC8V6F6<6GZ;9Q6]O"@2&"",(D:CH%4< >PJM'X8\-0Z_)XJA\/6*:I+ M"(9=26T07#QC&$,F-Q7@<9QQ0!^$_P"V?I%I_P $UO\ @Z%^"/[;G[06EGPI M\&O%'A*WT?3?$=P[2:=HDJ^';C1C9R7!X7R93#([,>(IO,/&XC*_9O\ VA?A M9\4/^#R#Q5\:/">MSOX7\1>&;>QT/6+K3YH8KUG\+6$$$B%U'[FX:/,$IPDR M21LA82(3^^&M:!H7B2Q.F>(M%M+^V+JYM[VV65"P.0=K C(/(/:IK>PL;2:: MYM;***2Y,K'P9)JFE+XB\-6GBB86,GB&P6TOX/-L%FVF^!G3R?W._P#>,J=6 /\ M1!6;>^#/!^I1V$.H^%--N$TIE;2UGL(W%F5 "F($?NR !MQC H _++_ (-. M_P!@SXF?L]?\$S_%&K?M)^ [C3E^,7B:74;3POK=H4=]%^QQVT;S0N 5\_\ M?L%8?-$8VZ.*\*_X(G?L3?M'_LH?\%7OCM_P3$U))YO@9\/?&NF?$J.6]#LM MVR"4Z#&K="\ADM;F1N?WV@*H/# _JA_P4]\,_P#!07Q7^R/J^G?\$R/'^A^' M/BO'J5G-IUYKUO;R1SVB2@W$"&YBEA21UP TB$8##*DAEZ3]DOX9?%G1K77_ M (X?M'Z)HVG_ !&\>RV;ZYI>A7[7EKH]G:6XAM-.CN&CC,RHS7-RS; !-?3J MI9 K$ ]@K^#K#PDGBN_M=7ADA MT=X?%%Y-*ERZL5A9(BLC*Y!56!( (K^CBB@#S'X0_!7X):=\:/&/[6WPAN=' MN)OBAH&B6>M7^@^4]OJ3:9)J/E7AEB)6:1EOC$7Y.VVC&3@ ?C/^SU\7/A9= M_P#!Z-\3_$-K\1]#DL-5T#^R-,ODU6(PW>H)X>TR%K2-]VUYA+#+'Y8);?&R MXR"*_>:B@#\#_P#@D-\=?@II'_!T1^V%X_U;XN>&K70=1\+>*'T_6[G6X$M+ ME8-7TR>8QS,X1PD,$\K$$X2&1ONHQ'-_\&G/[06B?!+]A?\ ;%\;Z3X=B\7Z M_P"%[ >)[/P#;3*UYK4%MIUXPC2'#.R22*L18(V#(!@DA3_0I10!_)S^V/\ MM/I^W7_P19?XQ:OI7B-?%^A_'F$W_@_P;X'NM'\ ^ -">VOEA@M([>-;!I[B M>>-FED>6\)RK,J8,GUY_P"PLSK-C()YG#;8H]D4C;F(&$8]!7:_P#!3KXE>+_^"4O_ !O^"HOQA\/ZI>_!7X@^'[73+GQ)IEH]Q!:PMI7]G7$2E ;:WMNLL;X.1E6!!YH _.G_@IS^W5^ MR;^TU_P13_:0^)OP#\1E_!^I^"IK/3/&=_HLFDV'B/5;E2/L]F;M8I;R9=D8 M=UC*%G"*[O'*L?YY^#_BQ\+T_P"#)GQ%X&?XB:(-;7Q"-.;1SJD7VK[6_C6& M\6#RMV_S#;!IPN,^4K/C:":_HIM[>WM+=+6U@2**) D<<:A510, #@ #M3Z M /Y=O^"G'Q0^&_B'_@V,_8M\%:%X\T>\UBW\6W?VC2K748WN8OL\>HQS;HU8 MLNQIH0V1P94S]X9^Z?\ @M-K'["^H^,?V%/VCKW]HS3/!GQ/M=0L-4^'?Q!O M@+SPJ-+T[[)?3'53$V]HO/$447DL"7N9 Y5,NG[05\(?\%;/^";_ ,0_VZ?C MQ\(/&?BGX/\ @_XM_"+P*FIOXH^$^L:RVB:G*_^"C5]_P %&OA7\3_C7XAT$:5X M1\ > M22VM=#T^*SCMY9(8IYWN;^8PQ,6D 5$$TOR?=*_I1\3?B?\.?@OX!U M7XI_%SQSI7AKPWH=J;G5](-:N8_B-<:MJGB-H5)M]/6TCEGM8(# M+AY)S-YA13&(R)"R?JG0!^>'["_AV/\ X*5^#_'?[%]2BTS1+1[BPTRQNDU+3+N>&1[2-KB6!G5!->7&U?F+-^6O_!&[ M]H[X8?\ !$O_ (+J_$W]A3Q#\?=(U7X.>-]0&AVWC)M;MY+&.8*+O1[RXN(B M(5D$=P]I,1M5);A]VT1G']+-% 'X#?M ?&_5/^",_P#P=">(?VUOVGM-U.+X M-?'/PX+&W\=6MC+=01V4UG8AB/+#;VM[RQB#Q)F00%9%5MR*WVU_P5J^*W@? M]OK_ ((3?'_Q!^QAX(U[7]!NM)M;O1M5M?"T]G%X@6'4;.\O+JSBE1)KB-$C ME+3^6$=D?8TFUB/T3USP[X?\3V/]F>)=#L]1MO,5_L]]:I,FX=&VN",CL:MJ MJHH1% 4# ' % 'XA?LG_M5_ 76_^#1[Q?\ #2Q^(%LNI^&?@IXCT?73)M$\::%%=(\L-M>W$X,UB$-M MD: DA(U &2I)/XT^@#\5/^#;/]C?]JWX"?M"_&7]D'X^7#S_ U_9N^+ M%W>>$?M,#*=0\17U@;:*[B)./(&ER?:1$1P^IQ2?>%<)_P %>?BY\+-+_P"# ML7]EC7=2^(^AP6/AGPMX?L?$=Y-JL2Q:7XD$EPZ( 97"J@9B/O':JKD]E Z 5)0!^%'[4?BW1/V4O M^#P_P=\?_P!H!KOPYX.\0>""FB:]61)I8$9XB3&S*"4)&"0>W!(I] '\[5WK?P;_X M)E_\'&_QTE_X*=6/B30_AC\;)+_5/"7CFQU35;*U4W-S'=V\C2:=(DDT*9GM M'&&\N0*6"J"U?8O[4G[/?_!%+4_^";GAOX$ZG\#KKX7? 'XN?&OR?"7C^ W& MGC2]9;0[F6W\3HEZ&DAM9!8/9[YU2-XF$Q'DNLI_5+7?#'AKQ1#%;^)?#UCJ M,<$RS0)?6B3".0='4.#AAV(YJU;/M=K'+Y;%D\R,-M)4J2,],JS#Z,1 MWH _&?\ X-E?!7[4O[+G[7G[07[!,?[0EG\6_@%\.;2SE\+>.-$N_M.DQZK< MF&=+>RD#ND3O;S2FYMHW=8IH>N6+R?LY531-!T/PUIR:1XGDM80$G),*Y)^@JGXQ_Y%B]_ZX&KFG?\@^#_ M *XK_(4 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !61XCDD35 M=)5)& :\(8 ]1M/6M>L?Q+_R%]'_ .OT_P#H)H V**** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH R+.20^,[V(R,5%G&0N> L>R_Y'>] M_P"O*+^9K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH Q_ __((E_P"OV;_T*MBL?P/_ ,@B M7_K]F_\ 0JV* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S?&/ M_(L7O_7 U_]>47\S6Q6/9?\CO>_]>47\S6Q0 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110!C^!_\ D$2_]?LW_H5;%8_@?_D$2_\ 7[-_Z%6Q0 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% &;XQ_P"18O?^N!JYIW_(/@_ZXK_(53\8 M_P#(L7O_ %P-7-._Y!\'_7%?Y"@":BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH *Q_$O_(7T?_K]/_H)K8K'\2_\A?1_^OT_^@F@#8HHHH **** M"BBB@ HHHH **** "BBB@ KYH_:R_:U\;>%?VI?A_P#L2?"?6M)\/Z[XZ\-Z MOKMYXJUJR-U]EM+*,D6]G )(UENI6#G<[%8DB9BDA( ^EZ^2_P#!)_\ ;3_:.\,^(/!7_!/O]MSP18PZ M[?\ PRL]?^%/CG0B#9^(M$2WC(@F0 >7=0Q\-@*&$;94'8\W5_\ !5[_ ).= M_8X_[+_#_P"DS5])_9WLN)_88FE!Q<*C7+;DDN2;C)6LNEME9IW5[GE?6>?* M/:4IR33BG?=.\4T[Z]?N>CL>Y?MX_M:P_L<_ I/B#I^A0:MXBU[Q%I_AKP7I M%W.8H;S5[Z7RH%E=>5B0;Y7QR4B8#DBO,OVA_P!I;]H?]@7Q;\-_''Q]^(FC M>-OAUXX\66OA7Q;=VOAD:;<>&M1NE";_4-WV8:G9^8$24J&*JR2R+ MN .UBI((!!^2/^"KOC?]K;]J/X8_!']B/XG_ +.^C>#?&7Q-^*&G">TT[QHF MIS>18JTE[?0QPPX2TC#K(7DD$BKQL."PGA[ 9=CH8>F^5\TJBK562OHH\EKV)/V?+WX%>$? IU:6#PII?Q"L=4DUB6TBQ&+FX% MNI2/SF5I4C.'1)%5U5@17U=9?\CO>_\ 7E%_,UYU^WC\;M:_9Z_9)\:_$GPA M&9?$8TL:;X0MD/S3ZU>R)9V$:COFZGAR!V!]*^=RBM4ABU3ITH3E-J*YUS)7 M?9Z=M>B]3T\;3C*BY2G**C=OE=GHOZT/GCX)_M__ +3W@#_@G#\6OVUOVK]/ M\)^)[[P3XAUJS\+Q>!+&XM;#6+>QN!8+.KS,SF*2]6<>9M!$2!MI/%=;\8?V MC_VA_P!F3X(> /VH?$'Q=\/_ !"TSQ/XCT"PUWPYI'AQ+:"Z@U:>*%)-'E21 MI2\;3)(JSM-YL:,,H2&7K_&?AG]G/]@O_@F9=>!?CKID6J_#SP'\-ETSQ/:- M;^8=90PK!*FUB-TES-(1R5R\V25ZCX&\,_"WX[?\$B_%7PM^,O[1_AN?QQ^S MBVL+/IGAW4-7GOI_@OJ6H28A<;\1W:PI((A<%!M9IO*$+R_Z1]=@,+EN:U*M M6E3BKU9UVOTA_:4L/VT?&6H0^"?V5/%/A+P7!%8BYU+QKXLT=]5,LS,P2SM;2.6 M, @)NEFE;"B2-420ES'P7_!,/]JC]H?]HKP?\0_ G[4_A71[7QO\*OB)>>$M M9UGPS'(NFZPT*1N+B$.25;:XW+Z,C83=L7WWXI:#\0O$_@:_T'X6_$&W\*ZW M1%=@<$;B5XY!KXZ_X)(>,/VCOA9\7/C-_P $^?VG M;O2?$&M_#?5+37]/\?:1IJVK>([?6&GN6N+I5 !N"X)9SEBS.I9O+#MX.$A2 MQ7#^)7+3V.KQ)-+-!*LL5S#);3QM-*JO^\3;(P*'.1[ M3171AL35PM3GA;56=TFFGY-/_-;K4SJTH5HVE^#:_(^7_P!D/]A_QMX2\4> M_P!HC]IKQ7::EXT\'?"RR\)^%_#FDZ<+>R\-0&&+[7E_.F-W=R-&J/.&2/8N MU(P"6.E^V;^Q)\4_VJ?C!\*?B;X;^/NA^%K7X4>,H_$FF:7=^ YM1>^N555, M1'YG0X+\9/G'P:_9#TGP3\8]4_:>^+?B]_&_P 3M7T\:;_PD<]@ M+6UT;3@VX:?IEIOD^R0%LNQ:2261B2\C< >Q45Q4\77HTI4Z;LI:.R5VNU][ M>2T?4WE1ISFI25[;?YV[^9\H^-K#]J&P_P""I_A;6/ '[1RZAX#OM$-MXP^% M::%&R:99+97;C4Y;H-NC=KQ;..-2 TGFR 92*3'KO[0G[/FI?'KQY\+]0U#Q M)!;^&_ GC<>*-7TAK,=1V^GQ1Q^.=0=( MU4O:1%R!@L>F3Z\ #\*VJZ)YE55G;F=Y:)WNC*.%@ MHSC)MJ4N;5ORTU>VFVV^AP?[3_[.GP\_:V^ /BG]G+XJPW#:#XKTPVEZ]G($ MF@8,LD4T9((#QRHDBY!&Y!D$9%>9>.?V0?C/\?O@OI_[-?[3WQG\/>(O!\=Q M8'Q/<:3X3EM-0\2P6<\4\44S/=21VWF201F9HU8N-X3R=P*_1-%1A\RQF%IQ MA3E91ES1T3Y9:+FBVKIZ+;LGNE:JN%H5I.4UNK/?5=GW6K^]]V>,?%OX;?MQ M7_QQM?'GP'_:A\(Z3X.;2$M;_P "^+_AT=1C6Y#L6O([JVN[:?+O$KV:VRW MXO)MK:W@5F M%O:P1[A'&7=LO(SR2.[,?1Z*F>/Q$Z'L=$K).T8Q;2=US-).6J3U;NTF]4AQ MPU)5.?5N]]6W9[:)NR^04445QFX4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110!C^!_^01+_ -?LW_H5;%8_@?\ Y!$O M_7[-_P"A5L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F^,?^ M18O?^N!JYIW_ "#X/^N*_P A5/QC_P BQ>_]<#5S3O\ D'P?]<5_D* )J*** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'\2_\A?1_P#K]/\ Z":V M*Q_$O_(7T?\ Z_3_ .@F@#8HHHH **** "BBB@ HHHH **** /,OVU?B%XO^ M$G[&WQ:^*WP]U?\ L_7_ Q\,M>U;0[_ .SQR_9KRVTZ>:&79*K(^V1%;:ZL MIQ@@C(K^G5:G%)SA&5M.G,G8^4XBQ.(H5J:IS<;I[-K\C[7 M_P"(B?\ X+&_]'A?^8^\/?\ ROH_XB)_^"QO_1X7_F/O#W_ROKXHHK]C_P!4 M^%?^@"C_ ."H?_(GSOU_'?\ /V7_ ($_\S[7_P"(B?\ X+&_]'A?^8^\/?\ MROH_XB)_^"QO_1X7_F/O#W_ROKXHHH_U3X5_Z */_@J'_P B'U_'?\_9?^!/ M_,^U_P#B(G_X+&_]'A?^8^\/?_*^C_B(G_X+&_\ 1X7_ )C[P]_\KZ^***/] M4^%?^@"C_P""H?\ R(?7\=_S]E_X$_\ ,^T4_P"#A?\ X+!1WSZDG[7F)I$" M._\ P@'A_D#H,?8,5-_Q$3_\%C?^CPO_ #'WA[_Y7U\444?ZI\*_] %'_P % M0_\ D0^OX[_G[+_P)_YGVO\ \1$__!8W_H\+_P Q]X>_^5]'_$1/_P %C?\ MH\+_ ,Q]X>_^5]?%%%'^J?"O_0!1_P#!4/\ Y$/K^._Y^R_\"?\ F?:__$1/ M_P %C?\ H\+_ ,Q]X>_^5]'_ !$3_P#!8W_H\+_S'WA[_P"5]?%%%'^J?"O_ M $ 4?_!4/_D0^OX[_G[+_P "?^9]K_\ $1/_ ,%C?^CPO_,?>'O_ )7T?\1$ M_P#P6-_Z/"_\Q]X>_P#E?7Q111_JGPK_ - %'_P5#_Y$/K^._P"?LO\ P)_Y MG]2W_!"C]JGX]?MD_P#!/W2?C=^TCX[_ .$C\47/B74[6?4_[+M;/=#%*%C7 MR[6*.,8'&0N3W)K[&K\]_P#@V+_Y13Z%_P!CCK7_ */%?H17\A<7T*.&XHQE M*C%1A&I-)))))-Z)+1(_0L!*4\#3E)W;BOR"BBBOG#K"BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#'\#_P#((E_Z_9O_ $*MBL?P M/_R")?\ K]F_]"K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M#-\8_P#(L7O_ %P-7-._Y!\'_7%?Y"J?C'_D6+W_ *X&KFG?\@^#_KBO\A0! M-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_B7_D+Z/_U^G_T$ MUL5C^)?^0OH__7Z?_030!L4444 %%%% !1110 4444 %%%% 'C/_ 4<_P"4 M>?QY_P"R,>*/_33W_!1S_E'G\>?^R,>*/_33_\ P;%_\HI]"_[''6O_ $>*_0BO MXGXU_P"2NQW_ %]G_P"E,_2\M_Y%]+_"OR"BBBOESM"BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@#'\#_ /((E_Z_9O\ T*MBL?P/ M_P @B7_K]F_]"K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@# M-\8_\BQ>_P#7 U?QY_[(QXH_\ 33*_0BOXGXU_Y*['?]?9_^E,_2\M_Y%]+_"OR"BBBOESM"BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'\#_\ ((E_Z_9O_0JV*Q_ M_P#R")?^OV;_ -"K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@#-\8_\ (L7O_7 U,_\%'/^ M4>?QY_[(QXH_]--S7\A-?U[?\%'/^4>?QY_[(QXH_P#33/IHD?_1-,M[*;?!%,^Z,F,DN4E0[\13!\WXM?\'#?P;\2_![ MQ6_Q@_X(X?M::O\ #N.*_P!,\7ZCJ?P?M;K0FBAE>UNXI[@W;6[1K(DD;Y;: M&4@\BO/_ -GW]O3]D;]GCX4^(O '[,7_ ;K?MM^%- \=NMYX@N_"GPY MU;JR,U_%??:&3#-M"R[0LC@##L" ?I)^P]\2?B/\1_@:\7Q<\::9XH\1^%_% M6L^&-5\6Z+IZVEKKLNFW\UF;Q8%9E@D?RL2Q*Q1)UF5?E45Z_7S!_P $:_&_ MP]^(G_!.3X=^+?A;^S=JGPDT2\BOY+3P'JMG=PM8E[^X=I8Q=,SM%.S&Y5@S MJ1/PQP:^GZ "BBB@ HHHH **** "BBB@ HHHH Q_ _\ R")?^OV;_P!"K8K' M\#_\@B7_ *_9O_0JV* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH S?&/\ R+%[_P!<#5S3O^0?!_UQ7^0JGXQ_Y%B]_P"N!JYIW_(/@_ZXK_(4 M 34444 %%%% !1110 4444 %%%% !1110 445S'Q7^,_PK^!OAI?%OQ:\=Z; MH-C+.+>U?4+I8VNIR"5@A0G=-*0I(C0%C@\<&KITZE6:A!-M[):LF4HPCS2= MD=/17G/P _:S_9Y_:=TJ._\ @S\4=*U6[.FP7UYH8NT34;&&9%=&N+4GS(@0 MZC)&TGH377?$'X@>"OA3X'U;XE?$?Q-::-H.AV$E[JVJW\NR&U@C4L[L?0 = M.IZ#)-:5,-B:5?V,X-3VLT[W]-R8U:4Z?M(R3CWOH;%8_B7_ )"^C_\ 7Z?_ M $$U/X1\6>'?'OA/2_'/A#58[[2=:TZ"_P!+OH@0EQ;S1K)'(N0#AD92,@'F ML+XN^.O!?PSTFV\>_$3Q7IVAZ)I1R%49(')Y) ZFL MU3J.IR6?->UNM^UNY7-'EYKZ'745R7PJ^._PA^-L>H-\+?'EEJTNDRI'JMG$ M6CN;)G7='YT$@62(.OS(64!UY7(YJA\<_P!J']G3]F2QT[4OVA?C9X:\&0:M M+)%I\C=M#+G'3<,]16JPF*E7]@J^GWG>45Q_P ,OV@O@?\ &;X\*P&83^(M-U*.2RC M\D9E+3 [ $'WCG P<]*Y#X)_M_\ [%/[1WCJ?X8_ S]I[P;XG\06Z.YTG2M9 MC>:5$SO>)VU6 MOIW^1Z_1117*;!1110 4444 >,_\%'/^4>?QY_[(QXH_]--S7\A-?U[?\%'/ M^4>?QY_[(QXH_P#33OV^M:=XD\/ M6VKVQ73;K5M/U>WUB**[$0W"&XNK8+,Z@OB:1P&;K\:?%7_@N)^VI\/)Y_A7 M:?\ !!W]HN]^).PP6UI9V$=[X:>YZ!EUFU62.2 '!,@1?EZ[.WU3_P %.?C7 M\?OV=/V#?B3\:OV7] L-0\<:!HD72VMWFN2.01 M<@C(/S'8?\$WO^"Z6M6,.KZA_P '%;PS742RRQ:;^S%H$ENI89Q&_P!I3TTF[U; M5;K4GL8"I9=D1N2IVED#;@K,N&/T?7AG_!.'X6?&;X*_LEZ5\,_VA/C?'\2/ M&6F^*_%/]N>.8X(H?[7>3Q%J,J3-#$[I;MYAW?B?Q5KEGIFFZ?;O M<7^HZA3#-FR\PC[6NV=,>7N)Y.,8)X+_ (*^? OXZ_M _L1ZSX3_ M &==.AU3Q)I>N:7KB>&KEP(M?ALKI+A[!@2 P?8&"$X=HU7C=FO*_P!@/]I3 M]G#_ (*30^.=!\4Z9)X7\>:3\8M*\93_ \\0QK'K.A76G6^DCS%210S)]HL MYH&D0!A'*5<1F3;7TN!R?#5\FGCIN4E%M2Y6OW?P\LI*S;4KRUT7NVO=Z>5B M,=5IXZ.'C975U>_O;W2>R:LN[UVL?5O[0O[6_P"S/^R?I%CK?[1_QN\/>#H- M3E:/31K5^L5&,O(%W+N*@A=PR1D5U/PV^)OP\^,?@C3_B5\*/&VE^ M(O#^JP^;IVL:->I<6]PH)4E70D$A@5(Z@@@X((K@OVA+O]DWX#:'XC_:7_:+ ML-%@MY-)6RU;5]:L#?2/9QH["SAB*NQ0YE%4N9$\G1F1P&CDA@2$NN "\C,A= M&5VYO[.PL\CEC(J:E&48W:]R3DFVE9:.-NK=^RT1K]9JQS!4&XV:;M?WE:UF M^Z=^RMYGUYXQ_P"18O?^N!K!\ _'#X/>/?%^L?"SP/\ $S1=8\1>%K6V?Q)I M&F:@D\VE^=O$2SA"?*=C%)\C8;"YQ@C.WXWABN/"5_;W$2O&]LRNCKD,#P00 M>HKXC_X)]>#_ IX%_X*^?MA>'/!7ANQTC3H]'^'\D5AIMHD$,;/H[NY5$ 5 M=SLS' Y+$]37/@,#1Q>$Q524FI4H*:ML_P!Y"#3_ / [_(TQ.(G1K48I*TY. M+\O=E+3_ ,!/J[XZ?M:?LQ_LQ2Z9!^T-\>?"O@R365E;2H_$>LQ6K78BV"0Q MAR"P7S$R1TW#UK,^#/[<_P"QS^T3XO;X?_ G]I?P9XMUM;-[MM*T#7H;F<0( M5#R%$).T%U!/^T/6K7Q"_8Y_9G^,7Q)D^*_QJ^#'AWQKJ_\ 9<6FV#>+]&M] M1ATZU1WD\NWBG1DB+O(S.X&]_E!8JB*OA?[#/P0^#+_MO_'+]H#X/?"/PQX6 MT'PR]G\-?#D7AC0+;3XIY;-1>:O,R0(H=C=W$-OO//\ H&.V!U4,+DU;+:M2 M]3VD(W;]U023MUO9)MOMT_%'T]\6OBW\-?@3 M\.M5^+7Q@\9V/A[PWHEN)M4U?49=D5NA8*,]22695"@$LS $D"MS3M0L]6T M^#5=.N!+;W,*RP2KT=& *L,^H(-?FO\ \%KKV^_:E_8(^,'Q:@O9D^'7P[CM M[3POT0^%G_),/#G_ & ; M/_T0E1C,JA@\II8ER?M)3G&4>D>6,))>OOZ]MMTRJ&,E6QDZ27NJ,6GWNY+[ MM-.^^UC>HHHKQ#O"BBB@ HHHH **** "O@O_ (*O:A\=?V;?VE/A9_P4)\-? M"O4O'_P\\!^'-;T7QOH&C+YE[HD=^BJVK01G@X50KMP D>UF57+K]Z5XQ\9_ MVQ/A#\(OC0?V??B]XGT[PRVO^"VU/PSK.MWJVUKJ-P)9HI[)99-L8F51#(L> M[>ZR.0OR<^SD->MA\P]I3I>U7+)2CKK"2<96:U3LV[K;?57.',:=.KAN64^3 M56?9IW6^FZV>YQ7_ 3LO_VS)\-_A=X2U3 MSY8)"J>)/$\$;?N\C[]KI[%.OB:V4 MR7LKJTE)Q:L[15GJT[=[7U36O7[N_8:_Y,G^#W_9+/#_ /Z;;>OF+_@HMXSO M_B-_P5%_9&_8_O#N\.W6O:KXSUZS?F.[GTZUDFL0X_B6.2&5MIR"S(>JBMG] MF#XR^#_^":O_ 2Z\'?'7]KC]HSQ+XIT"_T+0;K3[B\T1))M)BN["T2#3($M MD!>*,JQ#O\V"V3T%8'[=C6FGZ/\.:3^W-_P5:^"'BGX5ZU9Z]X(^ &BZSKGBGQ+I-RM MQ8_VKJ"0Q6>G)/&2C7"^0EPR DI'@MM\Q<^Q:3_P5'_8.UWQ=XI^&:?'[3H? M%'A+6[G1]5\(7UE<0ZM<7<+E'BM+)XQ/?DD$+]G23=VSFNBE7Q&#AA)4\,ZT MXT;54N=.*E5FX^]!IQER&?#^D0Z?8W$,=T9Y;&:VB M4(B&Y1EN(0,.1*C[E=L_/_\ P5!_9,^&.H_&S]E^Y_9U^'>D>'/BA#\;-.;3 M-1\-:;%:31^';2*6YU-I?*50]O$B0\-D RA!_K6#=C^SQKWPG_X))?\ !/"^ M^(W[2ER/!VD3^*=9UZU\+Y1[BQ_M&^GN;+1H(U;;)<+ 8T9%.U764E@B%QY? M\(O^"R?_ 3-B\6W?QY\>_M&1^*?BIXEM$TO1O#'AOPGJUP=+M6D#0:)8-+: M1HSR2[#+<.8Q/-M+%(XX8XYP&%S>CF%;$Y="K5HPE446E*2DY)KWFE9JUG-O M1I6ZJSQ%;!3PU.EBG"%22BW=I62=]+Z[WY5T?H?HO13+62>6VCEN;?RI&C!D MBWAMC8Y7(ZX/&:?7P1]&%%%% !1110!XS_P4<_Y1Y_'G_LC'BC_TTW-?R$U_ M7M_P4<_Y1Y_'G_LC'BC_ ---S7\A-?T?X'_\BO&?XX_^DGQW$_\ 'I^C_,** M**_<3Y@**** "BBB@ HHHH **** "BBB@ HHHH _I4_X-B_^44^A?]CCK7_H M\5^A%?GO_P &Q?\ RBGT+_L<=:_]'BOT(K^)^-?^2NQW_7V?_I3/TO+?^1?2 M_P *_(****^7.T**** "BBB@ HHHH \B_;X^!TG[2/[&WQ%^"]O\8+_X?SZS MX:F^R>-=.UJ33GT6>$B>*Y:XC96CB62)3)R 8]ZG@FOS$TS]@S_@B)X+T6W\ M+:;_ ,'(GQ-M8=+M4MK>PM_VT]"@6)(U"K&L:JJQ@ !0 HX' K]'?\ @IU\ M*=2^-7[$?C'P!9?#/4O&UM)90NY=V1^??BWX8_P#!+/X&_#_3?VX/B#_P0VU6'X._$703:7GA;4OV M?K+_ (2?P+K5C//;A[O3_FDM[:_A";)4D*)+;(['-YN !]N?\$8],^"^C_\ M!.CP38?L^_''6OB-X3.K^([G3?%OB74$N]3NC<:_J%Q)'>SQ_)/G^%T<4>I1Z%X/N-%CTZY@ MTD:E-55+F:U\F:9L RRR/*?\ 65]5T %%%% !1110 4444 %%%% ! M1110!C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\ U^S?^A5L4 %%%% !1110 444 M4 %%%% !1110 4444 >;?M.?M,>"_P!E7PQH'Q!^);"V\-:AXJMM)US6I-PB MT>*>*;9=S$ A8A,D*.[%519"Y/RX/YT_M?>!O@S\;?VB(?C'^Q_XJTS4/VA5 M_:-TH^#M9\$ZFEQ<7.@#2=*^VRWI@9@VFQQ^:6ED^0$M&#^]=&_5YE5E*LH( M(P01UK \#_"KX=_#6^UO4O GA*TTN;Q'JG]HZT]JI'VFY\F*'>1G"_NX8QM7 M"Y!.,LQ/T.39S1R>]6$'[2S7Q>[)-K22MMNI*_O+33<\S'8&>.M"4ERWOMJO M-.^_;L]==CSWQE_P4!_8J^'?QJU3]G/XG?M(^%O#'B_2+&&[O])\4WW]FIY, MR!XS'/>,H= M8\(Z>VGO AL[.Q_TW4HK<*&2">Y>X:(!07BB1E!1D)^O+S0-!U"_AU6_T2TG MNK?'V>YFME:2+!R-K$97GGBIKT7;6'H1DE545.\DT^62E>*45;5:7YK*ZUO'[Q]*KH7\-[K/BK5FU?Q%?VU M@MK#+<"W@M8TA@5F$,,5M;6\*)N8XBW,SNS.WHNG?\@^#_KBO\A6RQ^ P<\7 M3P\).%:"A&\M8^_"=W[OO:PLM(W3OH]"'AL175&5624H/F=EO[LH]]-)7ZZG M'?M*?&S0_P!F_P#9^\9_'GQ$@DM?"7AN[U,VY.##[Y_%7BC3,"\M-=U42W%]=QL>L MB75S*R$GC8O3%>]ZEIFFZS9/IVKZ?!=6\F/,@N8E=&P01E6!!P0#]0*GK@IX MV5'">RIJSYU)O?X5:*MY7DWWNNQT2H*I6YY/3E:MZ[_?9>EO,_)W_@J5_P $ M^_C[^SI_P3"\=W5Y_P %%/'OB?PEX8T+3;6#P)?>'M,MK":V2^M(8H28(E9$ MCRC*%(YC Z5^AG[%?PM\>?"+]GG0O"WQ$^..M?$"_EMH[I-K45Z6/XBQF8Y9'"5E&ZG*;DHPC?F45:T8JUN5MN_O7L_ MA1RX;+*&%Q;K4V]8J-FY.UFWU;[[=+:;L****^?/2"BBB@ HHHH **^,_%/_ M <%_P#!(;P5XGU+P;XF_:X^S:EI-_-9:A;?\(%K[^5/$Y21-R6!5L,I&02# MC@D50_XB,?\ @C5_T>+_ .8]\1?_ "OH ^VZJZWH>C>)=*GT/Q!I<%[9W,92 M>VN8PZ.IZ@@U\7?\1&/_ 1J_P"CQ?\ S'OB+_Y7T?\ $1C_ ,$:O^CQ?_,> M^(O_ )7TTVG= TFK,^Q? ?@7PE\,?!6E?#OP'HD6FZ+HFGPV.EV,+,5@@B0( MBY8EFPH'S,2Q/))))K6KXD_XB,?^"-7_ $>+_P"8]\1?_*^C_B(Q_P""-7_1 MXO\ YCWQ%_\ *^G*4IR$+CPUX7U^STJYNV53J M5WI:WAM5!SYD43,$,RD HS[D5@&9' V')\+?#;PC\(/!?@GX2>!=.-MH?AJR MM]*TJV=RY2V@@$4:LQY8[5&6/).2>M?+7_$1C_P1J_Z/%_\ ,>^(O_E?6;KG M_!Q%_P $=KS4=-GMOVP-R6]R7F/_ K_ ,0C:-N,\Z?S^%5[:I[+V5_=O>WG MW_R[:VW8N2//S]=C[GL-.T_2K5;#2[&&V@3.R&WB"(N3DX X')S3$T;1X]3? M6X])MEO9$"27:P*)67C@OC)' XSVKXM_XB,?^"-7_1XO_F/?$7_ROH_XB,?^ M"-7_ $>+_P"8]\1?_*^HYI7W'9'VW17Q)_Q$8_\ !&K_ */%_P#,>^(O_E?1 M_P 1&/\ P1J_Z/%_\Q[XB_\ E?2&?;=%?$G_ !$8_P#!&K_H\7_S'OB+_P"5 M]'_$1C_P1J_Z/%_\Q[XB_P#E?0!]MT5\2?\ $1C_ ,$:O^CQ?_,>^(O_ )7U M[?\ L<_\%%OV-_V_D\12?LD?&+_A+1X3-H-?/_"/:C8?93<^=Y'_ !^V\._= M]GF^YNQLYQD9 /;**** /&?^"CG_ "CS^//_ &1CQ1_Z:;FOY":_KV_X*.?\ MH\_CS_V1CQ1_Z:;FOY":_H_P/_Y%>,_QQ_\ 23X[B?\ CT_1_F%%%%?N)\P% M%%% !1110 4444 %%%% !1110 4444 ?TJ?\&Q?_ "BGT+_L<=:_]'BOT(K\ M]_\ @V+_ .44^A?]CCK7_H\5^A%?Q/QK_P E=CO^OL__ $IGZ7EO_(OI?X5^ M04445\N=H4444 %%%% !1110!X[^WIX_^(WPU_9AU;Q%\)OB':>$?$%SKV@: M58^*]0L(;JWT87^M6-C)>313?(\44=P\CABHVHWSI]]?B#]H#X__ +9'[:__ M 4$T#_@E/\ L-_MK:MX?T3X7^&/^$@_:,^.6B:3ITVH&ZE 1PK;0S' M*DJB@A2VXN;>59/NS]MWXO\ AKX$_LK>,OB7XP^">H_$G3K;3X[2Y\ :3IL= MY<^(?M<\=HMC';R K.TK3A/+(._=MP*=,\,^ ;>P34 @W%IVMV5Y %&,$GY.XB_>VUG)$ MVZ*6-OE#2=U*"ZQDK6D^G;4\O-\=5P&&52FDVW;7T?9KL?M3_Q$3_\ M!'+_ */"_P#,?>(?_E?1_P 1$_\ P1R_Z/"_\Q]XA_\ E?7\O5%?LO\ Q!3A M7_G]6_\ H?_ "L^<_UEQW\L?N?^9_4+_P 1$_\ P1R_Z/"_\Q]XA_\ E?1_ MQ$3_ /!'+_H\+_S'WB'_ .5]?R]44?\ $%.%?^?U;_P*'_RL/]9<=_+'[G_F M?U"_\1$__!'+_H\+_P Q]XA_^5]'_$1/_P $(?_ )7U_+U11_Q!3A7_ )_5O_ H?_*P_P!9<=_+ M'[G_ )G]0O\ Q$3_ /!'+_H\+_S'WB'_ .5]'_$1/_P1R_Z/"_\ ,?>(?_E? M7\O5%'_$%.%?^?U;_P "A_\ *P_UEQW\L?N?^9_4+_Q$3_\ !'+_ */"_P#, M?>(?_E?1_P 1$_\ P1R_Z/"_\Q]XA_\ E?7\O5%'_$%.%?\ G]6_\"A_\K#_ M %EQW\L?N?\ F?UD_LO?\%>/^">'[9WQ4C^"G[-7[0G_ DGB>6PFO8],_X1 M/5K/,$0!D?S+JTBCXW#C=DYX!KZ3K^;3_@U\_P"4IVG_ /8B:Q_Z#%7])=?B MO'_#>!X5SU8+"2E*')&5YM-W;?915M.Q])E.-JX["^TJ))W:T_X=A1117Q)Z M9_&=^U+_ ,G.?$;_ +'S5_\ TMEKA*[O]J7_ ).<^(W_ &/FK_\ I;+7"4 % M%%% !1110 4444 %%%% !1110 4444 %?MW_ ,&='_'G^T1_UU\)_P M8K\1 M*_;O_@SH_P"//]HC_KKX3_EK% '[8T444 >,_P#!1S_E'G\>?^R,>*/_ $TW M-?R$U_7M_P %'/\ E'G\>?\ LC'BC_TTW-?R$U_1_@?_ ,BO&?XX_P#I)\=Q M/_'I^C_,****_<3Y@**** "BBB@ HHHH **** "BBB@ HHHH _I4_P"#8O\ MY13Z%_V..M?^CQ7Z$5^>_P#P;%_\HI]"_P"QQUK_ -'BOT(K^)^-?^2NQW_7 MV?\ Z4S]+RW_ )%]+_"OR"BBBOESM"BBB@ HHHH **** /+?VTOB)\7/A3^S M7XA\=? /X1V'CSQM:2V$?A3PEJ=P(8-0OYK^WA@5Y20(@KR*_F$@)LW$@ D? M(/\ PT__ ,')LJ;8_P#@F%\#8G885I?B_N"'U(#<@>@-?6/[>'Q1^+GPB_9; M\0>)?@%_9:>.-2O])\/>$;O6UW65CJ.K:I::7;WDZ@'=%!)>+.ZX.Y8B,'-? M(/@G_@WV\;6>NI\8?B1_P6:_:TU+XFNWGW?B;0?'UOI^G&<\E4TZ2WG5;?/' MV_P!1N+T6%H9 &\B 3^6H( 7:ORA:^A*\7_8)^,GC#XS_L_F\^(7C;3O M%&O>%O%FN>%-7\6:1:+;VVNS:7J,]C]N2)"4B:585>2-"424RHA*J#7M% !1 M6!\4O%^N^ ?A[JWC+PSX#U#Q/?Z?:F6UT#2G5;B^;('EQE_E!YSSZ5\\?\-] M_M,_](P?BG_X'67_ ,50!]345^>W[3?_ 7]\(?L::WI?AS]IW]COQYX/O=; MM9+G2K?4KJ%FN(D8*SKY:L,!B!SBO,?^(LO]C'_HCOBK_O\ #_XU0!^J]%?E M1_Q%E_L8_P#1'?%7_?X?_&J/^(LO]C'_ *([XJ_[_#_XU0!^J]%?E1_Q%E_L M8_\ 1'?%7_?X?_&J/^(LO]C'_HCOBK_O\/\ XU0!^J]%?E1_Q%E_L8_]$=\5 M?]_A_P#&J/\ B++_ &,?^B.^*O\ O\/_ (U0!^G_ ('_ .01+_U^S?\ H5;% M?DUH'_!UK^QKH]D]K+\(O%#EIWDRLHZ,M 'Z@45\L_\ #??[3/\ TC!^*?\ X'67_P 5 M1_PWW^TS_P!(P?BG_P"!UE_\50!]35_+_P#\'%__ "F(^+7_ %R\/_\ IAT^ MOW:_X;[_ &F?^D8/Q3_\#K+_ .*K\?/^"J?_ 3N_P""EO[TP!_W^IR M?\$//^"KTB"1/V*/%)5AD$3VG(_[_4?ZV<*_]!]'_P &P_\ D@^H8[_GU+_P M%_Y'RG17U;_PXY_X*P?]&3^*O^_]I_\ 'J/^''/_ 5@_P"C)_%7_?\ M/\ MX]1_K9PK_P!!]'_P;#_Y(/J&._Y]2_\ 7_D?*5%?5O_ XY_P""L'_1D_BK M_O\ VG_QZC_AQS_P5@_Z,G\5?]_[3_X]1_K9PK_T'T?_ ;#_P"2#ZACO^?4 MO_ 7_D?*5%?5O_#CG_@K!_T9/XJ_[_VG_P >H_X<<_\ !6#_ *,G\5?]_P"T M_P#CU'^MG"O_ $'T?_!L/_D@^H8[_GU+_P !?^1[)_P:^?\ *4[3_P#L1-8_ M]!BK^DNOY]O^"/7[#/\ P4A_X)\?ME6W[1/Q*_8&\;ZGID/AR_T]K73[FS$A M><(%/^M/ VGM7ZQ_\-]_M,_](P?BG_X'67_Q5?S7XL8_ YCQ2JN$JQJ0]G%7 MA)25[RTNFU<^SR&E5HX'EJ1:=WNK=CZFHKY9_P"&^_VF?^D8/Q3_ / ZR_\ MBJ/^&^_VF?\ I&#\4_\ P.LO_BJ_,SVC^73]J7_DYSXC?]CYJ_\ Z6RUPE?: MWQD_X(P?\%6OB'\7_%?C_2_V'/%D5MKOB2^U"WCDN;//VK/VI_VL?CK^R[\2?@CX>_X)F_$ZVO_ !CX!UC0[&XGO;(I M%-=V4UNC-\XX#2 GV%?AI_PXY_X*P?\ 1D_BK_O_ &G_ ,>K]]\'H_ULX5_P"@ M^C_X-A_\D'U#'?\ /J7_ ("_\CY2HKZI3_@B-_P57>Z>Q3]BWQ0944,\?GVF M0#T/^NJ3_AQS_P %8/\ HR?Q5_W_ +3_ ./4?ZV<*_\ 0?1_\&P_^2#ZACO^ M?4O_ %_Y'RE17U;_P ..?\ @K!_T9/XJ_[_ -I_\>H_X<<_\%8/^C)_%7_? M^T_^/4?ZV<*_]!]'_P &P_\ D@^H8[_GU+_P%_Y'RE17U;_PXY_X*P?]&3^* MO^_]I_\ 'J/^''/_ 5@_P"C)_%7_?\ M/\ X]1_K9PK_P!!]'_P;#_Y(/J& M._Y]2_\ 7_D?*5%?5O_ XY_P""L'_1D_BK_O\ VG_QZC_AQS_P5@_Z,G\5 M?]_[3_X]1_K9PK_T'T?_ ;#_P"2#ZACO^?4O_ 7_D?M/_P;%_\ **?0O^QQ MUK_T>*_0BORY_P""0?B/]M;_ ()_?L7Z=^SE\2?^"<'Q&U/5+/7K^]>ZL+RS M$92>0,H^^>0/>OJ#_AOO]IG_ *1@_%/_ ,#K+_XJOY"XOKT<3Q1C*M&2E"52 M;33333;U36C1^A8",H8&G&2LU%?D?4U%5="U"ZU;1+/5;W2Y;&:YM8Y9K*<@ MO;LR@F-L<94G!QW%6J^<.L**** "BBB@ HHI&)"D@$X'0=Z .1^/_AKX,^,/ M@CXK\,?M$/I2>!;[0;F+Q7+K=^+2TBL3&?-DDG+)Y 5U$,RJ=VPR ;<03R^:WS2>9O;EC7NU?.W_!*GXK_ MGXX_L0^'_BM^S/\ "F7P1X'UGQ3XKET'PS-I:6+VBKXDU-)"ULGRVYDE624Q M#[GF;>U?1- !1110!^"__!W]_P G!_!O_L3=1_\ 2M*_'NOV$_X._O\ DX/X M-_\ 8FZC_P"E:5^/= !1110 4444 %%%% !1110 4444 %%%% !7N7_!,7_E M)'^S_P#]EI\+_P#IUMJ\-KW+_@F+_P I(_V?_P#LM/A?_P!.MM0!_7U1110 M4444 %%%% !1110 4444 9OC'_D6+W_K@:N:=_R#X/\ KBO\A5/QC_R+%[_U MP-7-._Y!\'_7%?Y"@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M *Q_$O\ R%]'_P"OT_\ H)K8K'\2_P#(7T?_ *_3_P"@F@#8HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@#'LO^1WO?^O*+^9K8K'LO^1WO M?^O*+^9K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#XO_P"" MI?[:WQ8_X)T?!FTO/@1^QYXYU[3=7\6:>B^)? %GIUY#97=]K$JCMKJUO(S-9W,&U[ ME_P3%_Y21_L__P#9:?"__IUMJ /Z^J*** "BBB@ HHHH **** "BBB@#-\8_ M\BQ>_P#7 U!_V"OB5XL_ M8TG\CXCV.AI)H-XFF"]DLX_M$0N[F*W*MY\T5H;B6.+:V^2-%"L3M/R[X<_X M(N?M.^+/#]CXIC_X+_\ [3FJ)J5G%=1ZGHOB*VBL[M)%#++ J;U6-@0R@,PP M1@GK7N?[9_C;]@K]O3_@F1\1Y_%G[4_A.'X0^(M,ETR_^)=AKT+6&DWL=W'' M!.9PX7=%?+;D*6&XA1G# U^>EG^PA_P:"6=I':#]KCPB_EH%WM^T->@M@=2% MNP!^ ]J /T\_P"";'P3U?\ 9T_9'TOX+Z_\=]2^)M]H7B_Q7'>>.-:N7FO= M3E?Q)J4K&Y=R2UPAD,4AZ;XFQQBO=Z^:O^"1'@S]EGX>_L"^%/!G[%'CJY\2 M_"[3_$7BF/PCK5U/YQN(?^$CU,R!9=S>=&LQE1)B& MU[E_P3%_Y21_L_\ _9:?"_\ Z=;:@#^OJBBB@ HHHH **** "BBB@ HHHH S M?&/_ "+%[_UP-7-._P"0?!_UQ7^0JGXQ_P"18O?^N!JYIW_(/@_ZXK_(4 34 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/XE_Y"^C_ /7Z?_03 M6Q6/XE_Y"^C_ /7Z?_030!L4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110!CV7_([WO_ %Y1?S-;%8]E_P CO>_]>47\S6Q0 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% 'E_BC]C']F#Q)^S/XC_9 M/@KX=T/ MX=^*--O;/4_#'AO1X+"U NBS32QQ1($24R,9-X7._#G M>)=4TCPSXJOO%QEO_$(LKN2T:]BL$M-L-K)+#+L:2X#LJJX0JZFOE3Q%_P % M@_VO_P!I7]J?QG\#O^"2W[%.@_%[PG\*;X:?\0/B/XH\;KH^F7>J#/F:;ITN MQA+(F"#-\ZYY*A#')* ?PU#4+S3M#TJ MU2"ULVO+V>]FCABC"I%'YUQ*510%52% P*["O/OV6_V@+#]ISX):5\7(/!FI M^&;VXFNK'7_"VM[/MFB:I:7,EI>V,Q0E6:*XAE0.IVR*JNN5=37H- !1110! M^"__ =_?\G!_!O_ +$W4?\ TK2OQ[K]A/\ @[^_Y.#^#?\ V)NH_P#I6E?C MW0 4444 %%%% !1110 4444 %%%% !1110 5[E_P3%_Y21_L_P#_ &6GPO\ M^G6VKPVOR_P"1WO?^O*+^9K8K'LO^1WO?^O*+^9K8 MH **** "BBB@ HHHH **** "BBB@ HHHH **** "JVM:-I?B+1[OP_KEC'=6 M5];26]Y;3+E)HG4JZ,.X*D@_6K-% 'X\_M4?\$C_ -OR'1=8_8T_8]_96^ U MIX.\0:Q=KH_[06HZI+#K?AS1KJY>8VTEC@DWD"2- ES#O#QQH^V*4ED^M?@Y M_P $>?V'/V(?V2]'^%_PX_8SM?BCK'AS2XX[B3R[*'5/$=\V/-NYI;RXAA0L MY+',GR1@(@8(JU]HT4 ?-/\ P2Y_9.N_V8_@'?:QXZ^"7A_P'XZ\<^)=4UOQ M7X?\.W27,&G1RZC=RV%@)X_EG%M:S1Q%UX9_,8 ;L5]+444 %%%% 'X+_P#! MW]_R<'\&_P#L3=1_]*TK\>Z_83_@[^_Y.#^#?_8FZC_Z5I7X]T %%%% !111 M0 4444 %%%% !1110 4444 %>Y?\$Q?^4D?[/_\ V6GPO_Z=;:O#:]R_X)B_ M\I(_V?\ _LM/A?\ ].MM0!_7U1110 4444 %%%% !1110 4444 9OC'_ )%B M]_ZX&KFG?\@^#_KBO\A5/QC_ ,BQ>_\ 7 UR_Y'>]_P"O*+^9K8K'LO\ D=[W_KRB_F:V* "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH _!?_@[^_P"3@_@W_P!B;J/_ M *5I7X]U^PG_ =_?\G!_!O_ +$W4?\ TK2OQ[H **** "BBB@ HHHH **** M "BBB@ HHHH *]R_X)B_\I(_V?\ _LM/A?\ ].MM7AM>Y?\ !,7_ )21_L__ M /9:?"__ *=;:@#^OJBBB@ HHHH **** "BBB@ HHHH S?&/_(L7O_7 U_]>47\S6Q6/9?\CO>_]>47\S6Q0 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% 'X+_ /!W]_R<'\&_^Q-U'_TK2OQ[ MK]A/^#O[_DX/X-_]B;J/_I6E?CW0 4444 %%%% !1110 4444 %%%% !1110 M 5[E_P $Q?\ E)'^S_\ ]EI\+_\ IUMJ\-KW+_@F+_RDC_9__P"RT^%__3K; M4 ?U]4444 %%%% !1110 4444 %%%% &;XQ_Y%B]_P"N!JYIW_(/@_ZXK_(5 M3\8_\BQ>_P#7 UR_Y'>]_Z\HOYFMB ML>R_Y'>]_P"O*+^9K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@#\%_\ @[^_Y.#^#?\ V)NH_P#I6E?CW7["?\'?W_)P M?P;_ .Q-U'_TK2OQ[H **** "BBB@ HHHH **** "BBB@ HHHH *]R_X)B_\ MI(_V?_\ LM/A?_TZVU>&U[E_P3%_Y21_L_\ _9:?"_\ Z=;:@#^OJBBB@ HH MHH **** "BBB@ HHHH S?&/_ "+%[_UP-7-._P"0?!_UQ7^0JGXQ_P"18O?^ MN!JYIW_(/@_ZXK_(4 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !6/XE_Y"^C_ /7Z?_036Q6/XE_Y"^C_ /7Z?_030!L4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110!CV7_([WO_ %Y1?S-;%8]E_P CO>_] M>47\S6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% 'X+_\'?W_ "<'\&_^Q-U'_P!*TK\>Z_83_@[^_P"3@_@W_P!B;J/_ M *5I7X]T %%%% !1110 4444 %%%% !1110 4444 %>Y?\$Q?^4D?[/_ /V6 MGPO_ .G6VKPVOR_Y'>]_Z\HOYFMBL>R_Y'>]_Z\HOYFMB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M/P7_ .#O[_DX/X-_]B;J/_I6E?CW7[_?\''_ /P3&_;A_;V^,7PT\5?LG?!' M_A*[#P_X9O;35Y_^$ETRQ^SS27"NB[;RYB9\J"'?\ Y84 ?$E%?;?_ !#G?\%E?^C.O_,A>'?_ )84?\0YW_!97_HSK_S( M7AW_ .6% 'Q)17VW_P 0YW_!97_HSK_S(7AW_P"6%'_$.=_P65_Z,Z_\R%X= M_P#EA0!\245]M_\ $.=_P65_Z,Z_\R%X=_\ EA1_Q#G?\%E?^C.O_,A>'?\ MY84 ?$E%?:MC_P &[O\ P6)U*$SV7['^]%'?_EA1_Q#G?\ !97_ M *,Z_P#,A>'?_EA0!\25[E_P3%_Y21_L_P#_ &6GPO\ ^G6VKVG_ (ASO^"R MO_1G7_F0O#O_ ,L*]5_83_X(+_\ !6#X-?MM?!_XN_$G]E/^S?#OA;XGZ#JV MNZA_PG.A3?9;.VU""::7RXKYG?;&C-M168XP 3@4 ?T>4444 %%%% !1110 M4444 %%%% &;XQ_Y%B]_ZX&KFG?\@^#_ *XK_(53\8_\BQ>_]<#5S3O^0?!_ MUQ7^0H FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q+_ ,A? M1_\ K]/_ *":V*Q_$O\ R%]'_P"OT_\ H)H V**** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH Q[+_D=[W_KRB_F:V*Q[+_D=[W_KRB_F:V* M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BH&U+3DU%-'>_@%W+ \T=J91YCQJ55G"YR5!= 3T!91W%3T6: **** M"BBB@#'\#_\ ((E_Z_9O_0JV*Q_ _P#R")?^OV;_ -"K8H **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@#-\8_\ (L7O_7 U_\ 7E%_,UL5 MCV7_ ".][_UY1?S-;% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %9'Q U'Q/H_@/6]7\$Z2E_K-KI%S-I%A(?EN;I8F:* M,\CAG"KU[UKUF^,O%FA^ ?"&J^.O$]TT&FZ+IL]_J$RQLYC@AC:21@J@EB%4 MG &35T[NHK*^NW?R)E;E>MC\PO\ @G#?_!K_ (*&3^&+_P =_%?QE<_%R'X< M^)E^)VI1^+]0T_7?#VN#5M-6)H5CE06<**S>3%&JP;4*LC,LBU]9?M,?M%_% M/]C?]COX<^#[[6K77?C)XSN?#_@+P[>7V98;OQ)=QQP2WTP&"\496:X;H&VJ MA*[\CP?_ (*,_L,>'_'?[2=A^U?^R#\15^%OQ2TSX6:[XNM_&OATI';:_+93 MZ=Y<=^OW)HI(9Y5:0@[@R^8)44)7G_QL^/WC_P#:B\0_\$VOVD_B7X<32CXH M\;S7&NVL*,EO_:4B6J6TB*V=JR%)9(P22%<#)ZG]-J8;#9UB:&*@[T'SR=.6 M\)1C4J*"Z.G+E<5:VB2:3M?Y2%6K@*52C)?O%RI36TDW"/-Y25[N_5W39]V? M$3]EOQ1K/P;T[X$?#GXP^(?#EOJVJ++\0O'.GZCL\0ZG (6\YXKHJ?*N9Y5@ M0R@ 10!TB$>V()\EW/[/WC[_ ()L?\%*?@3X5_9G^-WCK7O GQGNM7TOQEX M\8^)9]5B@-G:"X.H0-,2R%0P=FZCR]NXK)M7]!O'GCSPA\,/"%_X]\>Z]!IF MD:9!YMY>3YPHR % +.[,5544%G9E506(!\=^'_@R*^^)US^W/\ M*1Q>'[X M:1_8O@/0=8E1#X8TJ>9"WF\X_M&]E$)E"YV!(+=-Q5WE^6RO-<71HU55]ZE* M,XN-E[\Y1:CTNW%M2O\ 92LK-I/U\9@Z,ZD.32:<7>_PQ3N_DU=6ZMZZ+3R: MW^(MS^VQ_P %3?B!^S!XEU*^;X:? WP=I[ZGX?L[^6W@UOQ!J(69);HQ,IGA M@MPR) V4$NYR"57;K?L'?&_Q5X5_;(^/'_!._P 9>([_ %>R^&UYIVN?#W4= M5O7N;I-$U&V2%;_X.?\%JOVJ_!WB6 M%HW^(7AKPSXM\,R2#'VNQA22VN'3/4)'O"*Z@3B*:^%C:SW,8;H6A,.''\/F+ZU[&*H8;V&(H+^%#"T M9P_Z^2=&\E_>R]$HQ:_P""?3GQ0\ ? M$CXJ_".?X;_#;XD7G@]]9UDV^M>)](D"ZCI^G;F:,?%EQJ]O M?V\Z-))J*B8EDDAC2:1GYP0F"JEU;[X\-?$3P%HWPPO?B9J?C/2X?#MH+F\N M=<:^3[)';H26E,H.W: #SGM7F'AOP]8?$+XFQ_MW_M!H/#NA>$-&NX?AKH^O MC[,VCV4Z@7>L7BR8,-W$M/U)=9^ EI??#E]:L$GC0 MP75O#<_9_,!"S*PF8[?F"2,>C'.C^SG\*#\"O^"[7Q6\)_ _2TTSP#XH^">G M^)/&6C:9$(K"UU][\6]NXC3"QS20Q7,F,#=YDK5ZN(P&#CEL:%&3C*-"-:3M MI4;:O%N]_=348K:\6K7DVHZ>D))+?=IN\EYJZ7-NWZ)G _L:_M/>#_VS/V8?!O[3 M'@>W-O9>*](6XELFDWM97*,T5Q;%N-QCF22/=@9V9QS7IM?!7_!N/!?Q?\$\ M+B9MW]ES?$W7W\/?W?L?G(HV=MOFK-T[YK[UKS<_P5'+<[Q&%I?#"_]>47\S6Q0 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !5/Q#H&C>+- OO"WB/3H[ MS3M2LY;6_M)AE)X9$*.C#T*D@_6KE%--Q=UN)I-69\S_ /#JO]G%->TO3HM7 M\8-X$TWPO>:)_P *ZNO'.K3Z?)!//:RB'<]V7%H!;;6L^8'#*"H5-K=1^VM^ MQ_8?M(? +2_ ?PZ;3O#WB7P%KVF>)/A?>_9MEKI6K::X>T4I&/D@90T#!1\L MH%?5%%.GG6:X>BZ&'KU*=)W]R,Y*. MNZM>VOGOUN*6 P=6:J5:<93T]YQ5]-M;'"?%O]F_X5?&C7]&\9>+-.O[3Q#X M=6=-#\2Z!K%QIVHV<)9YGV;@B. M=;PG_P $,O\ @EKX*\8Z/X]T#]F%QJF@:K!J.E2WGCK7;J.*YAD62-S%/?/' M( R@E75E8<$$$BOISP/_ ,@B7_K]F_\ 0JV*]&7$>?.KW0-<\?Z%%?"?B? MPGI.CZDI\:[SXLUIO$-[_:NJ,T7D[Y+\3"Y5EC 2/9(OE* L>P =_17G+&8 MN-)4U4ERK97=EK?\]?77A\^"!8ZH_AP^'_ EHGFO9Z%% MY?DB^NIW+,(H%;S278RSLFQ=\CU[117;5SS-<7.#QE:=91=U&$?V65I)6QQND..*[^BBO.K5JN(K2JU7>4FVV^K>K?S9TTX0I0 M4(*R2LEY(****R+"BBB@ HHHH **** "BBB@#-\8_P#(L7O_ %P-7-._Y!\' M_7%?Y"J?C'_D6+W_ *X&KFG?\@^#_KBO\A0!-1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %8_B7_D+Z/_U^G_T$UL5C^)?^0OH__7Z?_030!L44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!CV7_([WO\ UY1? MS-;%8]E_R.][_P!>47\S6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%9/CKP=I?Q!\(W_@O6[B[AM-1@,,\EC_P $_P#H;?'?_A97 M/^-'_#O?X)_]#;X[_P#"RN?\: /=**\+_P"'>_P3_P"AM\=_^%E<_P"-'_#O M?X)_]#;X[_\ "RN?\: /=**\+_X=[_!/_H;?'?\ X65S_C1_P[W^"?\ T-OC MO_PLKG_&@#W2BO"_^'>_P3_Z&WQW_P"%E<_XT?\ #O?X)_\ 0V^._P#PLKG_ M !H ]<\#_P#((E_Z_9O_ $*MBOC;]D#]D+X;?%3X8ZAXC\4>*?%ZW$'BK4K) M!9>*+B%/+BG*)E0>6QU/>O5?^'>_P3_Z&WQW_P"%E<_XT >Z45X7_P .]_@G M_P!#;X[_ /"RN?\ &C_AWO\ !/\ Z&WQW_X65S_C0![I17A?_#O?X)_]#;X[ M_P#"RN?\:/\ AWO\$_\ H;?'?_A97/\ C0![I17A?_#O?X)_]#;X[_\ "RN? M\:/^'>_P3_Z&WQW_ .%E<_XT >Z45X7_ ,.]_@G_ -#;X[_\+*Y_QH_X=[_! M/_H;?'?_ (65S_C0![I17A?_ [W^"?_ $-OCO\ \+*Y_P :/^'>_P $_P#H M;?'?_A97/^- 'NE%>%_\.]_@G_T-OCO_ ,+*Y_QH_P"'>_P3_P"AM\=_^%E< M_P"- 'NE%>%_\.]_@G_T-OCO_P +*Y_QH_X=[_!/_H;?'?\ X65S_C0![I17 MA?\ P[W^"?\ T-OCO_PLKG_&C_AWO\$_^AM\=_\ A97/^- 'L7C'_D6+W_K@ M:N:=_P @^#_KBO\ (5\H_M3_ +%_PN^&O[/7BSQWX<\5>,FOM+TIIK87?BNX MEC+!E'S(3AASTKJ_ O[!7P:41^,+E5W-$K' SP,G MI0!]$T5X7_P[W^"?_0V^._\ PLKG_&C_ (=[_!/_ *&WQW_X65S_ (T >Z45 MX7_P[W^"?_0V^.__ LKG_&C_AWO\$_^AM\=_P#A97/^- 'NE%>%_P##O?X) M_P#0V^.__"RN?\:/^'>_P3_Z&WQW_P"%E<_XT >Z45X7_P .]_@G_P!#;X[_ M /"RN?\ &C_AWO\ !/\ Z&WQW_X65S_C0![I17A?_#O?X)_]#;X[_P#"RN?\ M:/\ AWO\$_\ H;?'?_A97/\ C0![I17A?_#O?X)_]#;X[_\ "RN?\:/^'>_P M3_Z&WQW_ .%E<_XT >Z45X7_ ,.]_@G_ -#;X[_\+*Y_QH_X=[_!/_H;?'?_ M (65S_C0![I17A?_ [W^"?_ $-OCO\ \+*Y_P :/^'>_P $_P#H;?'?_A97 M/^- 'NE8_B7_ )"^C_\ 7Z?_ $$UY'_P[W^"?_0V^.__ LKG_&O*OV@/V0O MAMX&^)WPN\.:)XI\7FW\2>*I++43<^*+B1Q&("X\MB?D;(ZB@#[)HKPO_AWO M\$_^AM\=_P#A97/^-'_#O?X)_P#0V^.__"RN?\: /=**\+_X=[_!/_H;?'?_ M (65S_C1_P .]_@G_P!#;X[_ /"RN?\ &@#W2BO"_P#AWO\ !/\ Z&WQW_X6 M5S_C1_P[W^"?_0V^._\ PLKG_&@#W2BO"_\ AWO\$_\ H;?'?_A97/\ C1_P M[W^"?_0V^.__ LKG_&@#W2BO"_^'>_P3_Z&WQW_ .%E<_XT?\.]_@G_ -#; MX[_\+*Y_QH ]THKPO_AWO\$_^AM\=_\ A97/^-'_ [W^"?_ $-OCO\ \+*Y M_P : /=**\+_ .'>_P $_P#H;?'?_A97/^-'_#O?X)_]#;X[_P#"RN?\: /= M**\+_P"'>_P3_P"AM\=_^%E<_P"-'_#O?X)_]#;X[_\ "RN?\: /=**\+_X= M[_!/_H;?'?\ X65S_C1_P[W^"?\ T-OCO_PLKG_&@#URR_Y'>]_Z\HOYFMBO MC;PE^R%\-M4_:\\7?"RY\4^+QI>E^%;"]M63Q1<"8R2NP;=)G++QP.U>J_\ M#O?X)_\ 0V^._P#PLKG_ !H ]THKPO\ X=[_ 3_ .AM\=_^%E<_XT?\.]_@ MG_T-OCO_ ,+*Y_QH ]THKPO_ (=[_!/_ *&WQW_X65S_ (T?\.]_@G_T-OCO M_P +*Y_QH ]THKPO_AWO\$_^AM\=_P#A97/^-'_#O?X)_P#0V^.__"RN?\: M/=**\+_X=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\ &@#W2BH- M+T^#2-,MM)MGD:.U@2*-I7+,550 23U.!R:GH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** //OV:_@SJ?P,\!7OA#5=:@OY+KQ#? M:BLUO&RJJSREPF#W .#7H-%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 <=^T%\,[[XR_!?Q%\+],U.*RN-;TYK:*ZG0LD9)!R0.2.*Z'PEHT MOASPIIGAZ>99'L-/AMWD08#E(U4D>QQ6A10 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !7GWQC^#.I_$WQ[X \7V.M06L?@[Q"^HW,,T;%KA3$ M4V*1T.3GFO0:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* //O#GP9U/1/VDO$GQQEUJ![37/#UGIT5BL;"2)H6)+D]"#FO0:** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@#E?C3X&\7_$OX;:CX"\$_$N_\'W>JB.WF\1Z3"C7MG;&1?M!MB^5BN&A M\Q(YB&\IW63:Q0*?SWTG]AKQQ^Q-_P %AO@C9_L,_&SXE:CX3\7>&_$-Y^T# MX/\ &7CZ_P!>L(-.@@1;'4Y6O99'BN9[V4QQDMEV@DV (EP*_3*ORV_X*6_L M">'/V8OV]?V:8?$][>Q>+-!NUFDOO/CN9 M9#B&VMI';;A%C#2$;XT8 'H/[=O[7WQ>^/?_ 5#^''_ 1I_9R^(^J>"K34 M_#,WC'XW>._#=QY.K6FBQA_*TRQF S:33ND8>X3$D:7$1C8$,#Z=^T3_ ,$M M? MA\&-8UW]A_P 5>+?AC\6]&TR:[\%>,='\:ZE/)=:C&A>*'4X[J>6/4[>9 MU5)5NEERK%@0P!'RS\6?#&I?LB?\'57@C]HGXD1M;>#/VA?A++X1\.^(;CY; M6'7;>.+&GLYX65Q9V^Q?XVNU"Y.['Z=_&3XM>!?@+\)O$OQL^)VN0Z;X=\)Z M'=:MK5].X58;:")I'//?"D =R0!R: /BO_@GY^VG\6O^"V7_ 2VT#QSX$\> MS_"_Q=J6OMX6^+FN^%9!'?:*]JHDO'THR*XAGN8GMO+9P3;+>LX+O N_PWX[ M_LB?$3_@D5^WQ^S%\1_V)_VE/BEK?ASXQ_%JU\"_$[X:^/?&UUKMMJ5K<1M+ M+JJ"X)9)8(HYY6?D@JF"J&17ZK_@V#^#VO?L=_\ !)36/CY^TI-#X0L?B)XV MU7XA/_;2VM8(9I2^ BNEH9U8]8Y8SWKZD\)>%=-^)WQ?B_X*2_M1 MQCPIX>\#Z!>VWPDT+Q,/LK:!I]RJB]UV^63!@O;N-$C2%L/;6HV,%FN)XT / M(?BO\9M8_;2_X+6#_@F]?Z[J5M\+OA%\)/\ A-/B%H^F:C-:CQ-K=W/;Q6-C M=O"RN]I#;SBY\G<$ED($BNJ**N_L3?'?Q-\"_P#@J_\ &C_@E/K/B/4=4\(6 M7@G3OB-\(QK&HRW=SHVG3M%:ZAI8GF9I)+=+N0/;HQ)BC9XP=BH%XGX)>#-1 M^"W_ =!?&;4O%L#06WQG_9XTK6O"-W*,1W3:;+8V%S;(QX,J^3YK(.0A#$8 M(-'P3\&:O\5O^#H+XS?&C187DT+X6?LYZ-X2UB\C'R)JNHW,&H0P$]"WV=97 M(ZCY<]10!^DE%%% !1110 4444 %%%% !1110 5YA^U!^SE=_M1>%[+X7ZU\ M6_$WACPE-.\GBJT\&:K+IFHZS&% CM/M\++-;6Y)9I1"4DDVQIYBH9$D]/JI MKVBV/B31;OP_J;7 MKVW>"A>%OV*=:UNQ^&_QC^$^O>(_BSX"NM%]2_8W_ ."PO[;W[&WQ77AWQCHAGCBNX+FRGE>*&=$D,RW<( M28!'!9MPV^Q^)O"P_P""OO[-_P *?B#X-^-_B[P/\'?&_A)/$?B6R\$:\VFZ MWJTT\4!MM+DO(EWP6T6ZZ^T+$5>62.) P02!\+_@X+^*^@?"_P#X)&_&'3-1 MW7&J^-M!7PCX5T>W0R7.JZIJ4JVT-O;Q*"TLN'>38H)VQ,>U;?["'AF/_@F+ M_P $I_@[\)_CP+J3Q'X?\(6&FR>'=+07-_J.NW(:;^RK.,$>?/YTCQK@A0L; M2,R1H[J ?.7[%GPF^-'_ 3C_P""V=U^P!\+?CYXW\>?!#QW\$9_'47AWQYK M\NJW/@^\AU 6@,-Q+EEAD<%0.-_G?-N:$.W6?\'"%U\5/ W@WX ?$/X??'[Q MKH%M??M-^#=!UGPQHNKK:Z=J=E<7$TDJW"Q(LL^6AA^221HP$X3))KZ2_9T^ M#MI\'?'FN_M/_M-Z_H\'Q;^,-_9:=- M\KQ:390+(;#PYI[, TR0*T\TLBJ# M//)<3E4C")%\[?\ !QJ0/@#^SV2?^;P/ ?\ Z-NJ /T+HHHH **** "BBB@ MHHHH ^ ?AK\7O%'@#XA6FG2S>!/%WACQ5?:8;6_4 M;DCN!:RJ)K>0J(W#J^U7+H ZJ:^=/^"'7[?/PRG_ ."$]( MU[Q[JES'\-++4;::+3K*"%YW2"Y@CDCEF=%+).SQQG9&E?,/_!<7]DCP%^Q- M\'_V=)/V>OBE\7]*OO%/[2/ACPEXIU2Z^.?BBZGU;2[B"\-Q%)YNH,B&1HD8 MM$J$$87:.*_8BOS(_P"#GAE'PE_98R0/^,Q_"!Y_ZX:A0!].>$?^"8OPI^%/ MQ]T?XL_"GQSX_AT1_#VHZ-XN\'>(_BKKVL6&I13^4\-RD>H7<_E7$4D(4,C) ME)7SD@5\0_\ !%?]FCP7^TM\;OVP=*^.7Q'^*^O0_#C]I37O"G@I#\;O%%J- M*TF"XF6*"/[-J,>2H4#S&R^!]ZOUYK\R/^#>,@_'[]O@@Y!_;'\3X/\ V]3T M 87[3_QT_:5_X(9_MN_"34==_:+\8_$S]E[XU>*%\,:QI'Q*UN36-5\"ZJY7 MRKBWU.X+7,UN58R>7,\IV6\X)+&-Z_52OR1_X..1;?MW?M!_LU?\$D?@C*NL M^.M3^*5MXS\9Q:>?,/A?0K:"6!KN[(_U*M'=3R*#RWD 9DC#?K=0!^=W_!6 M3_@G%I'C+]FWXJ_M=>,_VMOBYI_Q5\/Z-?ZK\.-4\)>.;_3;/2+N+<=+TFQT MRVD$4C32?9[=FVOM:=XCN[7^Q;M58I>I"DHMY'0DD^:C @8/ &/R MZ_::^!O[8O[I&;6 M]:*:5FF"6V':3>-GV-^Q'\>_!'[47[(/PU_:!^'6JP7FD^*O!FGWT+V\@812 M&!1- V/NO%*)(G7JKQLIY%?G_P"-_ >I?M=_\'6'@WXE?#)&NO#G[,7P6:V\ M?ZS!S#!J^HQ:JEOIQ<<>:8M2CEV9SMAE!QC% '?_ +7'_!&[Q9^T!\+_ !A^ MTE\5/V[?C!H'QM&G7FM>'=;\*_$*YL-!\'S1H\UOI]G91;$^QQ!4C>5L3S%7 ME+HSX7S3Q-_P5N_:O^&'_!ME\//VU/%+1_\ "\OB-I]IX6\,:E=6: 3:G=7U MQ:V^IM'MV%VLH&O -I1I"OR[#BOM']J"YU3]LF]US]ACX4:Y<6FA3QBR^-GC M33I2ITG39D#2:):RCC^TKN%PC8YM+:8S-MDDM5D^3/\ @XY^'?@[4_\ @EQH MNH_ 33["X\/_ +-WQD\+:KKV@^'0KII%A81&V:U\N/.SR8+^WZ-HWQMGU_P 2WE^?'.B7VZ"] MN;U+B5U>^68+V>>X-RCIM^\GEP,Y;H%&2<5^ MCNE:?%I.F6VE0.S);0)$C.:)\3?AYLU74?#/ACQMJEE:^+])@ -Q9/;6UPBF=8UWQO&!(^U MHLDNA3]%J* /BOP-_P %$OV;?VC?^"4/AS]HCX&>%9]*2YSL7=4OPZ_X)%P^#_V./!O[*^O_M+_ M !)U;4CK>EZC\5_'S_$C6$U?Q +97FFM[:X\\R6<$L_EQ>7$T96W+_,9?G;Y M>_X)>?L[?"CX4?\ !P]^U_\ "OP-HDEIX7\!1:3XE\%^&1=N=/T;5M>TRSEU M*\M[?/EQ2N':%7504A=HE(0D']<* /R"_:9_9;^'O@'_ (+V_LU_L=^$O'?Q M5L_AOXZ^''B34O%?AD?''Q4ZW]U;6M\\$AF?4C,FUH8SA'4';R#DY^K_ (@? M\$\/!G[/WP6_:%OO"GQ,\?W7A/Q'\/5U+P[I.M?$W6M0N_#>LV5EJ@FN+*[N M;E[B!'6:T8*)6Q)$YX78H\6_;)9?^(H;]CY2< ?#S6LG_MPFH _/?\ X(0_L=_#S]K/_@D=\,/C_P#&GXK?&6[\>>+K M75WU?Q=I_P ?/%=G>>9!K%];0O&(=16*/9%#$-H38Q3+*Q))UOV2OVM_VJ/V M%O\ @KFW_!'G]L/XUZG\4?"'Q \+2>)/@+\1_$R1G6HXHUG>73-0FC55N646 MMV!*P\PM%&?NSJD7H7_!L9_R@T^!/_7GKW_J0ZG7@GQ %M_P4/\ ^#H3X=^( MO@1*NK^#?V4O 5TGQ)\56)WVL.M7*WRQZ:LRY5Y0]Q!N0'(,-TI ,34 ?K'X M@AURXT&^M_#%_;6NI/9RKIUU>VS30PSE2(WDC5D+H&P2H920" PSFORY_P"" MC_\ P3G^)?[.VJ_"W]I/]B?]JGXQ:E^T9J_Q;T?3]WB#XA7=Y:>,8)I"]^EU MIY86L%I#;1RSND$4<$4$+KLQM*_JC7YM_P#!PU_P3U^#WQ$_94\5_P#!0+PI MXH\2^$_C9\(-,77/A]XTTGQ7?*\-Q%+%ML8K/X/"/@O7=0M5N(?#UNTT$5W MJAB;*RO#]J@"(PV9D+MN$91O1XO^"3'[+\_@!=!USQ+\2;_Q?]EQ)\6)OBAJ MZ^*#>;>;U+U;@&)]_P XA11;C 01>6-E?#7_ 7(\,_%SXZ0MPN]H4R"PS^OEG>V6H6 M46HV%W%/;SQ+)#/#(&21&&0RL."""""."* /SQ_X):_MX?M8?'73/VB_^"=W MQ:\8Z3J/[0'[/6L7.A:)X[U.R$=OXBLYO/CTW5[FWC !=3&KS(@4.KQ=&=C7 MB?\ P5F_X)T>.?\ @G3^R=K7_!3C]EC]OCXY/\8_AQJ.G:GK&J>,O'TVHV/B M]9[ZWM9;6YL<+ J,9P4AC0187RMA!5DZW_@B/X"U/XX?\%4?VT_^"EGAM&;X M=^*_&,?@_P "ZPG_ ![Z\=/?R[N[@;I)"&MX LHRK&5P#E&%?67BCPYH_P#P M4:^(NA:G?%)_@1\._$L6LPSO_J/'^OVVTO6/$>N>!]7UO18&U*Y\.30I>Z;+)&IEBB>>*549263?M MW#&5*G!'QM_P;2^//B+\2_\ @D_X8\9?%GXA:UXJ\077C/Q.-2U_Q#J4MW>7 MCKK%RN^265F9C@#J>.E?='A+Q=X7\>>'+3Q?X*U^TU72K^/S+'4K"<2P7,>2 M \;KD.AQPP)!&""00:^!/^#78@_\$@_">#_S._BK_P!/5U0!^AE%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'FW[6/[)/P+_;;^"] M[\ ?VBO"]UJWAJ^N[>[>"QUBYL)XKBWD$L,T<]M)'(C(ZAAAL'&"".*RO@5^ MP]\!/@!K5CXM\.Q>*O$6O:7I\ECI7B+XA>.]5\27VGVTFWS(;674[BO44 <7\??V=O@A^U)\.+GX1_M!?#/2_%7AZZE29M/U2$GR9 MT.8YX9%(>"9"58&OSD^.'_!,S]MSX/?M<>'OB)XH\;>,OVMOV7H+ MK?J7P.\<>,9)]5\.2!U>"]2*YFCM_$*VS("D=XSRE6("22JLU?J?10!X?\?/ MV9?V4/\ @IG\!XOA;^T#\./%&J^"UU.*YD\.W]QK_A5Y)XE#1^=#&]G-+&A8 M,JN&C#JK ;D!7Q+P1_P;E?\ !&KX=^/=!^)GA?\ 8]==9\,ZS;:KHL]_\1O$ M=Y%!=V\JRQ2-#<:B\4H#HI*2(R,!AE()%?;M% 'GOQW_ &7?@W^T9<^'M9^( M^A7B:WX0OY+WPEXGT+5[G3=5T::2,Q3&WN[5TE1)8SLDBW&.5K:M-JNNZA>7\][?ZOJ$N/-O+R[N7>>ZG8*H,DKL M0J*HPJJH[BB@ HHHH **** "BBB@ HHHH **** "O%OVN/V ?V) M_C9IOB2+6_A_?7%WX.\0^$O&FI:'?Z7+.L:S&.>QGB;YA%'USC9QC)S[310! MP7P1_9G^#_[/O]HWGP\T34)=5UE81KGB;Q'K][K&KZF(0PB6XO[^6:XE2,,^ MR-I-D>]MBJ&-8_[3G[&/P$_:SM-+NOBCX67P?XZ\-:E+INO^&YY M$*M-8W\!66$D8W1Y,4F )$D7Y:]5HH _,#]FC]C']M7]C;]N6Z^)/_!0)?$/ M[57@:'#_ F^,&^?4]7^'DWS*Z3:"'(1YD(5KVPAFF!C&XJDA6+ZS_:W_P"" M:?["?_!3$>&O&G[6'PCUWQ4F@VT@\/6MSXN\0:(ED)#^\2/ MS-JA2=H 'T910!\G_LM_\$//^"77[%_QPT[]I']G#]F$Z%XVTBTN+;3-=N_& MNMZF]K'/$T4H2.^O9HU+1NZ[MNX!V (R:]*_:U_8 _99_;EAT*U_:=\':[K] MOX:U:WU70[.Q\?ZUI5O:7\!D,-VL6GWD"&=/-DVRD%P&P#@#'LU% %/P]H5C MX8T2V\/Z;/>2P6D0CBDU'49[N=@.[S3N\DA_VG8GWJY110 4444 %%%% !11 M10 5\^?$K_@ES^Q=\7OVFM%_;(\?^"/%=Y\2_#:2Q^'?%,'Q6\26TNE12>;Y MD5M'!J"101,)YE,:($*R,I7;Q7T'10 RW@2V@2VC9RL:!5,DA=B ,Z)>_M4^ =>\2CPWJ2:CH-K!\1-=TVVL;U!M2ZC@L; MV&)9E&0)=N\9.#R<^[44 8<'P^T&V\#?\*\CO]<-AY!A^T2>)KY[[:6SG[:T MQN=V3]_S-P' ..*^=/AG_P $8_V!?@OJOB'7/@]X9^)WA2[\6ZG+J7BB?PW^ MT-XVL6U:\D8L]S<^3K"^=*Q9B9'RW)YYKZGHH \M_9P_8I_96_9(;5KO]GKX M)Z/X=U#7YO-\0:ZHDN=4U9\Y#7=]<-)M_\ !(G]J;7?V=?%^I7<]]JWA7P_K-S:>%_$ M-Q+_ *QVMHMPTRY8C/VFT12QSYB,2)$]6_X)HVFC?#+X$Z?\ _%G[&.N?!;Q MM(9IO&FDVME=:A8:IJ;H3<:FFOQ-.EX9RI<2W-S]K'RK(-P4GZFHH ^%]:_X M-LO^",GB/6+[Q#XA_9/U:^O]3NY;K4KV\^+WBR26[GE8O)+([:H2[NQ+,S$D MDDDU]*_L\?L3?LL?LJ?LWQ_LA_ OX-Z;I/PW2"]AD\*W M/+)<+(97#"5F^4A/N@*/4Z* /$_A'_P3U_9=^"WB[PYXT\*^%M:O[KP382V/ M@*#Q/XOU+5[;PK;2)Y;QZ;#>SRQV>8P(MZ .(@(@PC 2O;*** "BBB@ J.ZM MH[RUDLYFD"2QE&,4K1L 1@X92&4^A!!'4&I** /GWX4_\$N_V+_@E^TCKW[7 M?PU\#^*K'XC>*?+'B;Q+/\5?$=T^K*AC*)T?]LSQUX(\5W?Q-\.Q2Q>'_ !7!\5O$EM+I<,GG M>9#;QPZ@D4$3">93$B!"LC+MP<5ZG\:O@5\.OV@_AA?_ <^*,.LW'A[5;22 MUU*UTGQ5J.ERW4$D3Q2127%C/#,R,CL&4OALY() (["B@#Y<^''_ 1M_8+^ M$'PVB^#'PO\ #/Q+T+P;")!'X/TW]H/QK%I(61G>1/L8U?R"CL[LZ[-KEB6! M->W? /\ 9Q^ O[+/P\@^$_[.7PA\/^"O#EM(TJ:3X=TR.VB>5@ TK[ #)(V! MND9Y(OM-G<1 M-#-%OC973'? +_ ()6_LA?LZ6&B:'X1TOQIK6D^%[R*[\+ M>'O&_P 3-:UW2M&GB.Z*6VL+ZZDM8I(V^:.01[XVY1E.37T910!F^,O!GA#X MB>%-1\">/_"VG:YHFKV7_! M(7]L3P8F@7__ 3=^/'BC5OA+I5U /%_[)WB+XD:A8:5K>F*P$UAINHB82V4 M,D>4^R22K;+DX(C'D-^GU% 'A7PZ\%?L]?M$_LL2_LMR_L\^+OAWX0G\-KI. MJ?#R31]0\+MIMH0 ]C#=6#11LG5&:SN'C=68;F5SGP"7_@V/_P""(<]G_9\W M[&5V]OM"^0WQ5\4E,#H-O]IXP,#\J^]** .5MO@O\/=,^$%A\!_#NG7VB^%] M*T:VTG2[+P[KEYILUE9VZ)'#%#+_8]_82_9A_8) M\!2_"W]E/P5JWAOPY) GRAPHIC 21 ivc-20210930_g8.jpg begin 644 ivc-20210930_g8.jpg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end XML 22 ivc-20210930_htm.xml IDEA: XBRL DOCUMENT 0000742112 2021-01-01 2021-09-30 0000742112 us-gaap:CommonStockMember 2021-10-25 0000742112 us-gaap:CommonClassBMember 2021-10-25 0000742112 2021-07-01 2021-09-30 0000742112 2020-07-01 2020-09-30 0000742112 2020-01-01 2020-09-30 0000742112 2021-09-30 0000742112 2020-12-31 0000742112 us-gaap:CommonStockMember 2020-12-31 0000742112 us-gaap:CommonStockMember 2021-09-30 0000742112 us-gaap:CommonClassBMember 2021-09-30 0000742112 us-gaap:CommonClassBMember 2020-12-31 0000742112 2019-12-31 0000742112 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-09-30 0000742112 2020-09-30 0000742112 us-gaap:CommonStockMember 2021-06-30 0000742112 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000742112 us-gaap:RetainedEarningsMember 2021-06-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000742112 us-gaap:TreasuryStockMember 2021-06-30 0000742112 2021-06-30 0000742112 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000742112 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0000742112 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0000742112 us-gaap:CommonStockMember 2021-09-30 0000742112 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000742112 us-gaap:RetainedEarningsMember 2021-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0000742112 us-gaap:TreasuryStockMember 2021-09-30 0000742112 us-gaap:CommonStockMember 2020-06-30 0000742112 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-06-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000742112 us-gaap:RetainedEarningsMember 2020-06-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000742112 us-gaap:TreasuryStockMember 2020-06-30 0000742112 2020-06-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0000742112 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0000742112 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000742112 us-gaap:CommonStockMember 2020-09-30 0000742112 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000742112 us-gaap:RetainedEarningsMember 2020-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0000742112 us-gaap:TreasuryStockMember 2020-09-30 0000742112 us-gaap:CommonStockMember 2020-12-31 0000742112 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0000742112 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000742112 us-gaap:RetainedEarningsMember 2020-12-31 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000742112 us-gaap:TreasuryStockMember 2020-12-31 0000742112 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0000742112 us-gaap:TreasuryStockMember 2021-01-01 2021-09-30 0000742112 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0000742112 us-gaap:CommonStockMember 2019-12-31 0000742112 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2019-12-31 0000742112 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000742112 us-gaap:RetainedEarningsMember 2019-12-31 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000742112 us-gaap:TreasuryStockMember 2019-12-31 0000742112 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0000742112 us-gaap:TreasuryStockMember 2020-01-01 2020-09-30 0000742112 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000742112 2020-01-01 2020-03-07 0000742112 2020-01-01 2020-03-31 0000742112 2021-01-01 2021-03-31 0000742112 2020-03-07 0000742112 us-gaap:RiskLevelLowMember 2021-01-01 2021-09-30 0000742112 us-gaap:RiskLevelMediumMember 2021-01-01 2021-09-30 0000742112 us-gaap:RiskLevelHighMember 2021-01-01 2021-09-30 0000742112 2020-01-01 2020-12-31 0000742112 ivc:NorthAmericaNAMember 2021-09-30 0000742112 ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 ivc:AllOtherMember 2021-09-30 0000742112 ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 ivc:NorthAmericaNAMember 2020-12-31 0000742112 ivc:NorthAmericaNAMember 2020-01-01 2020-12-31 0000742112 ivc:AllOtherMember 2020-12-31 0000742112 ivc:AllOtherMember 2020-01-01 2020-12-31 0000742112 ivc:IVCCanadaMember 2020-12-31 0000742112 ivc:IVCCanadaMember 2020-01-01 2020-12-31 0000742112 us-gaap:MachineryAndEquipmentMember 2021-09-30 0000742112 us-gaap:MachineryAndEquipmentMember 2020-12-31 0000742112 us-gaap:LandBuildingsAndImprovementsMember 2021-09-30 0000742112 us-gaap:LandBuildingsAndImprovementsMember 2020-12-31 0000742112 ivc:CapitalizedSoftwareMember 2021-09-30 0000742112 ivc:CapitalizedSoftwareMember 2020-12-31 0000742112 us-gaap:FurnitureAndFixturesMember 2021-09-30 0000742112 us-gaap:FurnitureAndFixturesMember 2020-12-31 0000742112 us-gaap:LeaseholdImprovementsMember 2021-09-30 0000742112 us-gaap:LeaseholdImprovementsMember 2020-12-31 0000742112 us-gaap:CustomerListsMember 2021-09-30 0000742112 us-gaap:CustomerListsMember 2020-12-31 0000742112 us-gaap:TrademarksMember 2021-09-30 0000742112 us-gaap:TrademarksMember 2020-12-31 0000742112 us-gaap:DevelopedTechnologyRightsMember 2021-09-30 0000742112 us-gaap:DevelopedTechnologyRightsMember 2020-12-31 0000742112 us-gaap:PatentsMember 2021-09-30 0000742112 us-gaap:PatentsMember 2020-12-31 0000742112 us-gaap:LicensingAgreementsMember 2021-09-30 0000742112 us-gaap:LicensingAgreementsMember 2020-12-31 0000742112 us-gaap:OtherIntangibleAssetsMember 2021-09-30 0000742112 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0000742112 srt:MinimumMember 2021-01-01 2021-09-30 0000742112 srt:MaximumMember 2021-01-01 2021-09-30 0000742112 srt:WeightedAverageMember 2021-01-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Domain us-gaap:ConvertibleSubordinatedDebtMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-12-31 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Domain us-gaap:ConvertibleSubordinatedDebtMember 2021-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Domain us-gaap:ConvertibleSubordinatedDebtMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-12-31 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember 2021-09-30 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember 2020-12-31 0000742112 ivc:ConvertibleSeniorSubordinatedDebenturesat5.00February2021Domain us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-09-30 0000742112 us-gaap:LetterOfCreditMember 2021-09-30 0000742112 us-gaap:LetterOfCreditMember 2020-12-31 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2021-09-30 0000742112 currency:EUR us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2021-09-30 0000742112 currency:GBP us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2021-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2020-12-31 0000742112 currency:EUR us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2020-12-31 0000742112 currency:GBP us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2020-12-31 0000742112 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2021-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-12-31 0000742112 us-gaap:LetterOfCreditMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2021-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2021-01-01 2021-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2021-01-01 2021-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2021-01-01 2021-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2021-01-01 2021-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2021-01-01 2021-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementNorthAmericaCreditAgreementMember us-gaap:LineOfCreditMember 2021-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2021-09-30 0000742112 us-gaap:LetterOfCreditMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2021-09-30 0000742112 ivc:SwingLineLoansDomain ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2021-09-30 0000742112 ivc:AmountAvailabletoInvacareLimitedandInvacarePoirierSASDomain ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2021-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2021-01-01 2021-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2021-01-01 2021-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2021-01-01 2021-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2021-01-01 2021-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2021-01-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2016-03-31 0000742112 2016-01-01 2016-03-31 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2016-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2019-09-30 0000742112 2019-01-01 2019-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2019-10-01 2019-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2019-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2019-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2020-04-01 2020-06-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-04-01 2020-06-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-04-01 2020-06-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2021-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2020-09-30 0000742112 2020-06-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2020-07-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2020-01-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2021-07-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2017-06-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2019-01-01 2019-12-31 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2017-04-01 2017-06-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2017-12-31 0000742112 ivc:ConvertibleSeniorNotesAt450February2022Member us-gaap:ConvertibleSubordinatedDebtMember 2021-03-31 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-03-31 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-07-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-01-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2021-07-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Domain us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2019-10-01 2019-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-07-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-01-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2021-07-01 2021-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Domain us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2021-07-01 2021-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-07-01 2020-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-01-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Domain us-gaap:ConvertibleSubordinatedDebtMember 2021-03-11 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:ConvertibleSubordinatedDebtMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:ConvertibleSubordinatedDebtMember 2021-03-11 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:ConvertibleSubordinatedDebtMember 2021-07-01 2021-09-30 0000742112 ivc:CARESActLoanMember 2020-05-15 0000742112 ivc:CARESActLoanMember 2021-09-30 0000742112 2015-04-23 0000742112 2015-07-01 2015-09-30 0000742112 2015-04-22 2015-04-23 0000742112 ivc:A20YearsMember 2021-09-30 0000742112 2020-07-01 0000742112 ivc:A126YearsMember 2021-09-30 0000742112 2020-12-01 0000742112 us-gaap:ProductMember ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 ivc:ServicesMember ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:ProductMember ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 ivc:ServicesMember ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:ProductMember ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 ivc:ServicesMember ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:ProductMember 2021-07-01 2021-09-30 0000742112 ivc:ServicesMember 2021-07-01 2021-09-30 0000742112 us-gaap:ProductMember ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 ivc:ServicesMember ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:ProductMember ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 ivc:ServicesMember ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:ProductMember ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 ivc:ServicesMember ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 us-gaap:ProductMember 2021-01-01 2021-09-30 0000742112 ivc:ServicesMember 2021-01-01 2021-09-30 0000742112 us-gaap:ProductMember ivc:EuropeEMEAMember 2020-07-01 2020-09-30 0000742112 ivc:ServicesMember ivc:EuropeEMEAMember 2020-07-01 2020-09-30 0000742112 ivc:EuropeEMEAMember 2020-07-01 2020-09-30 0000742112 us-gaap:ProductMember ivc:NorthAmericaNAMember 2020-07-01 2020-09-30 0000742112 ivc:ServicesMember ivc:NorthAmericaNAMember 2020-07-01 2020-09-30 0000742112 ivc:NorthAmericaNAMember 2020-07-01 2020-09-30 0000742112 us-gaap:ProductMember ivc:AllOtherMember 2020-07-01 2020-09-30 0000742112 ivc:ServicesMember ivc:AllOtherMember 2020-07-01 2020-09-30 0000742112 ivc:AllOtherMember 2020-07-01 2020-09-30 0000742112 us-gaap:ProductMember 2020-07-01 2020-09-30 0000742112 ivc:ServicesMember 2020-07-01 2020-09-30 0000742112 us-gaap:ProductMember ivc:EuropeEMEAMember 2020-01-01 2020-09-30 0000742112 ivc:ServicesMember ivc:EuropeEMEAMember 2020-01-01 2020-09-30 0000742112 ivc:EuropeEMEAMember 2020-01-01 2020-09-30 0000742112 us-gaap:ProductMember ivc:NorthAmericaNAMember 2020-01-01 2020-09-30 0000742112 ivc:ServicesMember ivc:NorthAmericaNAMember 2020-01-01 2020-09-30 0000742112 ivc:NorthAmericaNAMember 2020-01-01 2020-09-30 0000742112 us-gaap:ProductMember ivc:AllOtherMember 2020-01-01 2020-09-30 0000742112 ivc:ServicesMember ivc:AllOtherMember 2020-01-01 2020-09-30 0000742112 ivc:AllOtherMember 2020-01-01 2020-09-30 0000742112 us-gaap:ProductMember 2020-01-01 2020-09-30 0000742112 ivc:ServicesMember 2020-01-01 2020-09-30 0000742112 ivc:GeneralTermsandConditionsMember 2021-01-01 2021-09-30 0000742112 ivc:LargeNationalCustomersMember 2021-01-01 2021-09-30 0000742112 ivc:GovernmentTendersMember 2021-01-01 2021-09-30 0000742112 ivc:OtherCustomersMember 2021-01-01 2021-09-30 0000742112 us-gaap:CommonClassBMember 2021-01-01 2021-09-30 0000742112 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2021-09-30 0000742112 ivc:A2018PlanMember 2021-01-01 2021-09-30 0000742112 ivc:A2013PlanMember 2021-09-30 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-09-30 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-09-30 0000742112 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-09-30 0000742112 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-09-30 0000742112 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-09-30 0000742112 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-09-30 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember 2021-09-30 0000742112 us-gaap:PerformanceSharesMember 2021-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0000742112 ivc:RangeOfExercisePriceRangeMinMember 2021-01-01 2021-09-30 0000742112 ivc:RangeOfExercisePriceMaxMember 2021-01-01 2021-09-30 0000742112 us-gaap:PerformanceSharesMember 2021-01-01 2021-09-30 0000742112 srt:MinimumMember ivc:RangeOfExercisePriceRangeMinMember 2021-01-01 2021-09-30 0000742112 srt:MaximumMember ivc:RangeOfExercisePriceRangeMinMember 2021-01-01 2021-09-30 0000742112 us-gaap:EmployeeStockOptionMember ivc:RangeOfExercisePriceRangeMinMember 2021-09-30 0000742112 us-gaap:EmployeeStockOptionMember ivc:RangeOfExercisePriceRangeMinMember 2021-01-01 2021-09-30 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember 2020-12-31 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember 2021-01-01 2021-09-30 0000742112 us-gaap:PerformanceSharesMember 2020-12-31 0000742112 srt:WeightedAverageMember us-gaap:PerformanceSharesMember 2021-01-01 2021-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2021-06-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2021-06-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-06-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-06-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-01 2021-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2021-07-01 2021-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-07-01 2021-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-07-01 2021-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2021-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2021-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2020-12-31 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2021-01-01 2021-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2020-06-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-06-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-06-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2020-07-01 2020-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2020-07-01 2020-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-07-01 2020-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-07-01 2020-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2020-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2020-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2019-12-31 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2020-01-01 2020-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-07-01 2021-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-07-01 2020-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-07-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-07-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-07-01 2021-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-07-01 2020-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:ContractTerminationMember ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:AllOtherMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2020-01-01 2020-09-30 0000742112 us-gaap:ContractTerminationMember ivc:EuropeEMEAMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2020-12-31 0000742112 us-gaap:ContractTerminationMember ivc:NorthAmericaNAMember 2020-12-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2020-12-31 0000742112 us-gaap:ContractTerminationMember ivc:EuropeEMEAMember 2020-12-31 0000742112 ivc:EuropeEMEAMember 2020-12-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:AllOtherMember 2020-12-31 0000742112 us-gaap:ContractTerminationMember ivc:AllOtherMember 2020-12-31 0000742112 us-gaap:EmployeeSeveranceMember 2020-12-31 0000742112 us-gaap:ContractTerminationMember 2020-12-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2021-01-01 2021-03-31 0000742112 us-gaap:ContractTerminationMember ivc:NorthAmericaNAMember 2021-01-01 2021-03-31 0000742112 ivc:NorthAmericaNAMember 2021-01-01 2021-03-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2021-01-01 2021-03-31 0000742112 us-gaap:ContractTerminationMember ivc:EuropeEMEAMember 2021-01-01 2021-03-31 0000742112 ivc:EuropeEMEAMember 2021-01-01 2021-03-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:AllOtherMember 2021-01-01 2021-03-31 0000742112 us-gaap:ContractTerminationMember ivc:AllOtherMember 2021-01-01 2021-03-31 0000742112 ivc:AllOtherMember 2021-01-01 2021-03-31 0000742112 us-gaap:EmployeeSeveranceMember 2021-01-01 2021-03-31 0000742112 us-gaap:ContractTerminationMember 2021-01-01 2021-03-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2021-03-31 0000742112 us-gaap:ContractTerminationMember ivc:NorthAmericaNAMember 2021-03-31 0000742112 ivc:NorthAmericaNAMember 2021-03-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2021-03-31 0000742112 us-gaap:ContractTerminationMember ivc:EuropeEMEAMember 2021-03-31 0000742112 ivc:EuropeEMEAMember 2021-03-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:AllOtherMember 2021-03-31 0000742112 us-gaap:ContractTerminationMember ivc:AllOtherMember 2021-03-31 0000742112 ivc:AllOtherMember 2021-03-31 0000742112 us-gaap:EmployeeSeveranceMember 2021-03-31 0000742112 us-gaap:ContractTerminationMember 2021-03-31 0000742112 2021-03-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2021-04-01 2021-06-30 0000742112 us-gaap:ContractTerminationMember ivc:NorthAmericaNAMember 2021-04-01 2021-06-30 0000742112 ivc:NorthAmericaNAMember 2021-04-01 2021-06-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2021-04-01 2021-06-30 0000742112 us-gaap:ContractTerminationMember ivc:EuropeEMEAMember 2021-04-01 2021-06-30 0000742112 ivc:EuropeEMEAMember 2021-04-01 2021-06-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:AllOtherMember 2021-04-01 2021-06-30 0000742112 us-gaap:ContractTerminationMember ivc:AllOtherMember 2021-04-01 2021-06-30 0000742112 ivc:AllOtherMember 2021-04-01 2021-06-30 0000742112 us-gaap:EmployeeSeveranceMember 2021-04-01 2021-06-30 0000742112 us-gaap:ContractTerminationMember 2021-04-01 2021-06-30 0000742112 2021-04-01 2021-06-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2021-06-30 0000742112 us-gaap:ContractTerminationMember ivc:NorthAmericaNAMember 2021-06-30 0000742112 ivc:NorthAmericaNAMember 2021-06-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2021-06-30 0000742112 us-gaap:ContractTerminationMember ivc:EuropeEMEAMember 2021-06-30 0000742112 ivc:EuropeEMEAMember 2021-06-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:AllOtherMember 2021-06-30 0000742112 us-gaap:ContractTerminationMember ivc:AllOtherMember 2021-06-30 0000742112 ivc:AllOtherMember 2021-06-30 0000742112 us-gaap:EmployeeSeveranceMember 2021-06-30 0000742112 us-gaap:ContractTerminationMember 2021-06-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:ContractTerminationMember ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:ContractTerminationMember ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:ContractTerminationMember ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:EmployeeSeveranceMember 2021-07-01 2021-09-30 0000742112 us-gaap:ContractTerminationMember 2021-07-01 2021-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2021-09-30 0000742112 us-gaap:ContractTerminationMember ivc:NorthAmericaNAMember 2021-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2021-09-30 0000742112 us-gaap:ContractTerminationMember ivc:EuropeEMEAMember 2021-09-30 0000742112 ivc:EuropeEMEAMember 2021-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:AllOtherMember 2021-09-30 0000742112 us-gaap:ContractTerminationMember ivc:AllOtherMember 2021-09-30 0000742112 us-gaap:EmployeeSeveranceMember 2021-09-30 0000742112 us-gaap:ContractTerminationMember 2021-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2021-07-01 2021-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2020-07-01 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2021-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember 2021-01-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDCHFMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDCHFMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDCHFMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDCHFMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDEURMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDEURMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDEURMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDEURMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDMXPMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDMXPMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDMXPMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDMXPMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURCHFMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURCHFMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURCHFMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURCHFMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardDKKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardDKKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardDKKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardDKKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardNOKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardNOKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardNOKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardNOKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardAUDTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardAUDTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardAUDTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardAUDTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardNZDTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardNZDTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardNZDTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardNZDTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardGBPTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardGBPTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardGBPTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardGBPTHBMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0000742112 us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardAUDUSDMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardAUDUSDMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardAUDUSDMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardAUDUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardCADUSDMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardCADUSDMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardCADUSDMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardCADUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURUSDMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURUSDMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURUSDMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardDKKUSDMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardDKKUSDMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardDKKUSDMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardDKKUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardGBPUSDMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardGBPUSDMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardGBPUSDMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardGBPUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardNOKUSDMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardNOKUSDMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardNOKUSDMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardNOKUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardSEKUSDMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardSEKUSDMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardSEKUSDMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardSEKUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardAUDTHBMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardAUDTHBMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardAUDTHBMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardAUDTHBMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDTHBMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDTHBMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDTHBMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardUSDTHBMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURTHBMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURTHBMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardEURTHBMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardEURTHBMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 ivc:ForeignExchangeForwardGBPTHBMember us-gaap:NondesignatedMember 2021-09-30 0000742112 ivc:ForeignExchangeForwardGBPTHBMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardGBPTHBMember us-gaap:NondesignatedMember 2020-12-31 0000742112 ivc:ForeignExchangeForwardGBPTHBMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 us-gaap:NondesignatedMember 2021-09-30 0000742112 us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 us-gaap:NondesignatedMember 2020-12-31 0000742112 us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-09-30 0000742112 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-09-30 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-12-31 0000742112 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-12-31 0000742112 us-gaap:OtherCurrentAssetsMember 2021-09-30 0000742112 us-gaap:AccruedLiabilitiesMember 2021-09-30 0000742112 us-gaap:OtherCurrentAssetsMember 2020-12-31 0000742112 us-gaap:AccruedLiabilitiesMember 2020-12-31 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2021-07-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2021-01-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2020-07-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2020-01-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-07-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-07-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2021-07-01 2021-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2021-01-01 2021-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0000742112 us-gaap:CashFlowHedgingMember 2021-07-01 2021-09-30 0000742112 us-gaap:CashFlowHedgingMember 2021-01-01 2021-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2020-07-01 2020-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2020-01-01 2020-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0000742112 us-gaap:CashFlowHedgingMember 2020-07-01 2020-09-30 0000742112 us-gaap:CashFlowHedgingMember 2020-01-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000742112 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-09-30 0000742112 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000742112 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-09-30 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-09-30 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0000742112 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-09-30 0000742112 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-09-30 0000742112 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000742112 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesAt450February2022Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesAt450February2022Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesAt450February2022Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesAt450February2022Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-09-30 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-09-30 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0000742112 us-gaap:IntersegmentEliminationMember ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:EuropeEMEAMember 2020-07-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:EuropeEMEAMember 2020-01-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:NorthAmericaNAMember 2020-07-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:NorthAmericaNAMember 2020-01-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:AllOtherMember 2020-07-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:AllOtherMember 2020-01-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember 2021-07-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember 2020-07-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember 2021-01-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:EuropeEMEAMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:EuropeEMEAMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:EuropeEMEAMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:EuropeEMEAMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:EuropeEMEAMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:EuropeEMEAMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:EuropeEMEAMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:EuropeEMEAMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:EuropeEMEAMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:EuropeEMEAMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:NorthAmericaNAMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:NorthAmericaNAMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:NorthAmericaNAMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:NorthAmericaNAMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:NorthAmericaNAMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:NorthAmericaNAMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:NorthAmericaNAMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:NorthAmericaNAMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:NorthAmericaNAMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:NorthAmericaNAMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:AllOtherMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:AllOtherMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:AllOtherMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:AllOtherMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:AllOtherMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:AllOtherMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:AllOtherMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:AllOtherMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:AllOtherMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:AllOtherMember 2020-01-01 2020-09-30 shares iso4217:USD iso4217:USD shares pure ivc:payment ivc:votes 0000742112 --12-31 2021 Q3 false P5Y P5Y P5Y P5D P3Y 10-Q true 2021-09-30 false 001-15103 INVACARE CORPORATION OH 95-2680965 One Invacare Way, Elyria, OH 44035 440 329-6000 Common Shares, without par value IVC NYSE Yes Yes Accelerated Filer false false false 35019682 3667 224200000 211906000 646266000 626646000 163890000 151866000 470500000 446968000 60310000 60040000 175766000 179678000 56135000 55530000 178721000 174672000 0 0 0 9790000 377000 1580000 2476000 4657000 28564000 0 28564000 0 -24766000 2930000 -33995000 10139000 10131000 -761000 9422000 -7360000 6284000 7402000 18099000 21132000 0 7000 1000 90000 -20919000 -5226000 -42671000 -18263000 1840000 2050000 4830000 4900000 -22759000 -7276000 -47501000 -23163000 0 0 0 0.0125 -0.65 -0.21 -1.36 -0.68 35013000 34419000 34826000 34213000 -0.65 -0.21 -1.36 -0.68 35488000 34530000 35371000 34313000 -22759000 -7276000 -47501000 -23163000 -19202000 35944000 -6487000 36859000 -27000 -193000 -422000 -362000 -20000 -9000 43000 -25000 -20000 -9000 43000 -25000 1423000 -2047000 649000 -1159000 170000 -285000 73000 -171000 -17976000 33989000 -6333000 35509000 -40735000 26713000 -53834000 12346000 1.000 1.000 1.000 1.000 0.731 0.717 0.728 0.713 0.269 0.283 0.272 0.287 0.250 0.262 0.277 0.279 0 0 0 -0.016 0.002 0.007 0.004 0.007 0.127 0 0.044 0 -0.110 0.014 -0.053 0.016 -0.045 0.004 -0.015 0.012 0.028 0.035 0.028 0.034 0 0 0 0 -0.093 -0.025 -0.066 -0.029 0.008 0.010 0.007 0.008 -0.102 -0.034 -0.074 -0.037 73656000 105298000 115923000 108588000 292000 379000 151335000 115484000 36151000 44717000 377357000 374466000 6177000 5925000 27357000 27763000 62212000 56243000 65758000 64031000 12480000 15092000 370739000 402461000 922080000 945981000 110234000 85424000 104210000 126273000 5203000 3359000 3121000 5612000 3118000 3405000 4553000 6313000 230439000 230386000 306334000 239441000 66070000 63137000 7742000 8697000 71781000 70474000 300000 300000 0 0 0 0 150000000 150000000 39417000 38613000 9977000 9816000 12000000 12000000 4000 4000 2000 2000 277711000 326088000 20707000 58538000 39103000 45436000 4397000 4184000 107786000 106034000 239714000 333846000 922080000 945981000 -47501000 -23163000 0 9790000 12511000 10360000 4757000 5284000 327000 554000 -148000 111000 -165000 -594000 5369000 6965000 232000 1066000 9422000 -7360000 28564000 0 2637000 8629000 1622000 1329000 8030000 -6160000 -222000 -532000 37199000 22021000 -8215000 -1691000 24769000 5903000 -24182000 1616000 731000 -226000 -36825000 822000 14397000 16824000 23000 396000 0 14563000 93000 -67000 0 2176000 -14467000 -3974000 154830000 72551000 109139000 59483000 5369000 1307000 0 414000 -18787000 0 0 5593000 1752000 1702000 19783000 4052000 -133000 5862000 -31642000 6762000 105298000 80063000 73656000 86825000 9977000 2000 278152000 43466000 57079000 -107786000 280890000 0 -1250000 0 -1250000 0 809000 0 809000 -22759000 -22759000 -19202000 -19202000 1253000 1253000 -27000 -27000 -40735000 9977000 2000 277711000 20707000 39103000 -107786000 239714000 9815000 2000 322770000 70931000 4648000 -106020000 302146000 818000 818000 821000 -9000 812000 -7276000 -7276000 35944000 35944000 -1762000 -1762000 -193000 -193000 26713000 9815000 2000 324409000 63655000 38637000 -106029000 330489000 9816000 2000 326088000 58538000 45436000 -106034000 333846000 52000 747000 -668000 131000 109000 4461000 -1084000 3486000 -47501000 -47501000 -6487000 -6487000 576000 576000 -422000 -422000 -53834000 -34798000 9670000 -25128000 -18787000 -18787000 9977000 2000 277711000 20707000 39103000 -107786000 239714000 9588000 2000 312650000 87475000 3128000 -104327000 308516000 90000 90000 1121000 1121000 2494000 2494000 137000 4334000 -581000 3890000 -23163000 -23163000 36859000 36859000 -988000 -988000 -362000 -362000 12346000 414000 414000 5021000 5021000 -243000 -243000 9815000 2000 324409000 63655000 38637000 -106029000 330489000 Accounting Policies<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2021 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2021 and 2020, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements (Already Adopted):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06 "Debt with Conversion and Other Options" (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity's Own Equity (Subtopic 815-40)", which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. ASU 2020-06 removes from U.S. GAAP the separation models for (1) convertible debt with a cash conversion feature (CCF) and (2) convertible instrument with a beneficial conversion feature (BCF). As a result, after adopting the ASU’s guidance, entities will not separately present in equity an embedded conversion feature in such debt. Instead, they will account for a convertible debt instrument wholly as debt, and for convertible preferred stock wholly as preferred stock (i.e., as a single unit of account), unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC 815 or (2) a convertible debt instrument was issued at a substantial premium. The guidance may be early adopted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company adopted ASU 2020-06 effective January 1, 2021, using the modified retrospective method, which resulted </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the removal of convertible debt discounts of $25,218,000, adjustment of $34,798,000 to additional paid-in-capital and $9,670,000 adjustment to retained earnings. Convertible debt discounts prior to adoption of ASU 2020-06 were amortized over the convertible debt term through interest expense. Subsequent to adoption, convertible debt discounts are not applicable when accounting for debt as a single unit of account. Interest expense for the three and nine months ended September 30, 2020 related to debt discount amortization (which was not recognized in 2021 due to adoption) were $2,273,000 or $0.07 per basic and diluted share and $7,613,000 or $0.22 per basic and diluted share, respectively. There was no impact of adoption on performance metrics used for short-term or long-term incentive compensation. Accretion specific to the Series II 2024 Notes was unaffected by adoption. Due to the valuation allowance, there was no net impact to income taxes for the adoption. Subsequent to adoption weighted average shares when calculating diluted earnings per share requires the application of the if-converted method for all convertible instruments. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements (Not Yet Adopted):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>In March 2020, the FASB issued ASU 2020-04 "Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting," which is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates if certain criteria are met. The guidance may be adopted in any period prior to the guidance expiration on December 31, 2022. The company is currently reviewing the impact of the adoption of ASU 2020-04 but does not expect the adoption to have a material impact on the company's financial statements. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2021 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2021 and 2020, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year.</span> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.</span> <div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements (Already Adopted):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06 "Debt with Conversion and Other Options" (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity's Own Equity (Subtopic 815-40)", which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. ASU 2020-06 removes from U.S. GAAP the separation models for (1) convertible debt with a cash conversion feature (CCF) and (2) convertible instrument with a beneficial conversion feature (BCF). As a result, after adopting the ASU’s guidance, entities will not separately present in equity an embedded conversion feature in such debt. Instead, they will account for a convertible debt instrument wholly as debt, and for convertible preferred stock wholly as preferred stock (i.e., as a single unit of account), unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC 815 or (2) a convertible debt instrument was issued at a substantial premium. The guidance may be early adopted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company adopted ASU 2020-06 effective January 1, 2021, using the modified retrospective method, which resulted </span></div>in the removal of convertible debt discounts of $25,218,000, adjustment of $34,798,000 to additional paid-in-capital and $9,670,000 adjustment to retained earnings. Convertible debt discounts prior to adoption of ASU 2020-06 were amortized over the convertible debt term through interest expense. Subsequent to adoption, convertible debt discounts are not applicable when accounting for debt as a single unit of account. Interest expense for the three and nine months ended September 30, 2020 related to debt discount amortization (which was not recognized in 2021 due to adoption) were $2,273,000 or $0.07 per basic and diluted share and $7,613,000 or $0.22 per basic and diluted share, respectively. There was no impact of adoption on performance metrics used for short-term or long-term incentive compensation. Accretion specific to the Series II 2024 Notes was unaffected by adoption. Due to the valuation allowance, there was no net impact to income taxes for the adoption. Subsequent to adoption weighted average shares when calculating diluted earnings per share requires the application of the if-converted method for all convertible instruments. 25218000 -34798000 9670000 2273000 0.07 7613000 0.22 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements (Not Yet Adopted):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span>In March 2020, the FASB issued ASU 2020-04 "Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting," which is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates if certain criteria are met. The guidance may be adopted in any period prior to the guidance expiration on December 31, 2022. The company is currently reviewing the impact of the adoption of ASU 2020-04 but does not expect the adoption to have a material impact on the company's financial statements. <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Divested Businesses</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 7, 2020, the company, completed the sale (the “Transaction”) of its subsidiary, Dynamic Controls, a New Zealand incorporated unlimited company (“Dynamic Controls”), to Allied Motion Christchurch Limited, a New Zealand limited company (the “Purchaser”), pursuant to a Securities Purchase Agreement among the company, Invacare Holdings New Zealand, a New Zealand incorporated unlimited company, and the Purchaser, dated March 6, 2020 (the “Purchase Agreement”). Dynamic Controls was a producer of electronic control systems for powered medical mobility devices, including systems incorporating the LiNX™ technology platform. Dynamic Controls was a component of the All Other Segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dynamic Controls was a supplier of power mobility products and respiratory components to the company as well as supplying power mobility products to external customers. Sales in 2020 through the date of disposition were $5,331,000, including intercompany sales of $2,532,000, compared to sales for the full year of 2019 of $30,261,000, including intercompany sales of $13,087,000. Income before income taxes was approximately $445,000 in 2020, through the date of disposition, compared to $853,000 in 2019, inclusive of intercompany profits on sales to the company. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction was the result of considering options for the products sold by Dynamic Controls which resulted in selling the business to a third-party which can provide access to further technological innovations to further differentiate the company’s power mobility products. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross proceeds from the Transaction were $14,563,000, net of taxes and expenses. The company realized a pre-tax gain of $9,790,000 with a remaining accrued expenses balance of $172,000 as of September 30, 2021.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Purchase Agreement contains customary indemnification obligations of each party with respect to breaches of their respective representations, warranties and covenants, and certain other specified matters, which are subject to certain exceptions, terms and limitations described further in the Purchase Agreement.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the closing of the Transaction, the parties entered into a supply agreement pursuant to which Dynamic Controls will supply certain electronic components as required by the company for the five-year period following the Transaction, including ongoing supply and support of the LiNX™ electronic control system with informatics technology, continued contract manufacturing of certain electronic components for the company’s respiratory products and continued infrastructure and applications support for the </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">informatics solution for the company’s respiratory products. The estimated continued inflows and outflows following the disposal with the Purchaser are not expected to be material to the company.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of Dynamic Controls as of March 7, 2020 consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">March 7, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,129 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,082 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">855 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">600 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,793 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,692 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current portion of operating lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">366 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,019 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,591 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables as of March 7, 2020 includes receivables previously classified as intercompany related to product sold by Dynamic Controls to other Invacare entities.</span></div></div></div> 5331000 2532000 30261000 13087000 445000 853000 14563000 -9790000 172000 <div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of Dynamic Controls as of March 7, 2020 consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">March 7, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,129 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,082 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">855 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">600 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,793 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,692 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current portion of operating lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">366 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,019 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,591 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 4129000 3082000 855000 600000 2127000 10793000 4692000 2473000 41000 366000 1019000 8591000 <div style="display:inline-block;vertical-align:top;width:46.666%"><div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Receivables</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.007%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,003 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">131,055 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer rebate reserve</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12,689)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10,730)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash discount reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,227)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,031)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other, principally returns and allowances reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(879)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">115,923 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">108,588 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for customer rebates and cash discounts are recorded as a reduction in revenue and netted against gross accounts receivable. Customer rebates in excess of a given customer's accounts receivable balance are classified in Accrued Expenses. Customer rebates and cash discounts are estimated based on the most likely amount principle as well as historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such, the company estimates the expected returns based on an analysis of historical experience and adjusts revenue accordingly. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the company entered into an agreement with a bank to sell certain trade receivables with governmental entity customers in the Nordic Region without recourse. Under ASC 860, the sale of the receivables qualify as a true sale and not a secured borrowing. No gain or loss was recorded on the sale of the receivables. Bank charges are recorded as interest expense. Interest expense attributable to the program for these bank charges was $11,000 for the three months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities predominantly located throughout the United States, Australia, Canada, New Zealand and Europe. A significant portion of products sold to providers, both foreign and domestic, are ultimately funded through government reimbursement programs such as Medicare and Medicaid in the U.S. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's approach is to separate its receivables into good-standing and collection receivables. Good-standing </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivables are assigned to risk pools of high, medium and low. The risk pools are driven by the specifics associated with the geography of origination. Expected loss percentages are calculated and assigned to each risk pool, driven primarily by historical experience. The historical loss percentages are calculated for each risk pool and then judgmentally revised to consider current risk factors as well as consideration of the impact of forecasted events, as applicable. The expected loss percentages are then applied to receivables balances each period to determine the allowance for doubtful accounts.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In North America, excluding Canada, good-standing receivables are assigned to the low risk pool and assigned an expected loss percentage of 1.0% as these receivables are deemed to share the same risk profile and collections efforts are the same. Installment receivables in North America are characterized as collection receivables and thus reserves based on specific analysis of each customer. In Canada, good-standing receivables are deemed low risk and assigned a loss percentage of 0.2%.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Europe, expected losses are determined by each location in each region. Most locations have a majority of their receivables assigned to the low risk pool, which has an average expected loss percentage of 0.5%. About half of the locations have a portion of their receivables assigned as medium risk with an average expected loss percentage of 1.1%. Only a few locations have any receivables characterized as high risk and the average credit loss percentage for those locations is 2.8%. Collection risk is generally low as payment terms in certain key markets, such as Germany, are immediate and in many locations the ultimate customer is the government. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Asia Pacific region, receivables are characterized as low risk, which have an average expected loss percentage of 0.3%. Historical losses are low in this region where the use of credit insurance is often customary.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.054%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.746%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,031 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current period provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">432 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Recoveries (direct write-offs), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of end of period</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,227 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company did not make any material changes to the assignment of receivables to the different risk pools or to the expected loss reserves in the quarter. The company is monitoring the impacts of the COVID-19 pandemic and the possibility for an impact on collections, but to date this has not materially impacted 2021. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For collections receivables, the estimated allowance for uncollectible amounts is based primarily on management’s evaluation of the financial condition of each customer. In addition, as a result of the company's financing arrangement with DLL, a third-party financing company which the company has worked with since 2000, management monitors the collection status of these contracts in accordance with the company’s limited recourse obligations and provides amounts necessary for estimated losses in the allowance for doubtful accounts and establishes reserves for specific customers as needed. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company writes off uncollectible trade accounts receivable after such receivables are moved to collection status and legal remedies are exhausted. See Concentration of Credit Risk in the Notes to the Condensed Consolidated Financial Statements for a description of the financing arrangement. Long-term installment receivables are included in “Other Assets” on the condensed consolidated balance sheet.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has recorded a contingent liability in the amount of $314,000 related to the contingent aspect of the company's guarantee associated with its arrangement with DLL. The contingent liability is recorded applying the same expected loss model used for the trade and installment receivables recorded on the company's books. Specifically, historical loss history is used to determine the expected loss percentage, which is then adjusted judgmentally to consider other factors, as needed.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company’s U.S. customers electing to finance their purchases can do so using DLL. The installment receivables recorded on the books of the company represent a single portfolio segment of finance receivables to the independent provider channel and long-term care customers. The portfolio segment is comprised of two classes of receivables </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">distinguished by geography and credit quality. The U.S. installment receivables are the first class and represent installment receivables repurchased from DLL because the customers were in default. Default with DLL is defined as a customer being delinquent by three payments. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated allowance for uncollectible amounts and evaluation for both classes of installment receivables is based on the company’s quarterly review of the financial condition of each individual customer with the allowance for doubtful accounts adjusted accordingly. Installments are individually and not collectively reviewed. The company assesses the bad debt reserve levels based upon the status of the customer’s adherence to a legally negotiated payment schedule and the company’s ability to enforce judgments, liens, etc.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of granting or extending credit, the company utilizes a scoring model to generate a composite score that considers each customer’s consumer credit score and/or D&amp;B credit rating, payment history, security collateral and time in business. Additional analysis is performed for most customers desiring credit greater than $250,000, which generally includes a detailed review of the customer’s financial statements as well as consideration of other factors such as exposure to changing reimbursement laws.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income is recognized on installment receivables based on the terms of the installment agreements. Installment accounts are monitored and if a customer defaults on payments and is moved to collection, interest income is no longer recognized. Subsequent payments received once an account is put on non-accrual status are generally first applied to the principal balance and then to the interest. Accruing of interest on collection accounts would only be restarted if the account became current again.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All installment accounts are accounted for using the same methodology regardless of the duration of the installment agreements. When an account is placed in collection status, the company goes through a legal process for pursuing collection of outstanding amounts, the length of which typically approximates eighteen months. Any write-offs are made after the legal process has been completed. </span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables consist of the following (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:28.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Long-Term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Long-Term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Installment receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">345 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,254 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">704 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,105 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(53)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(94)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(325)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(162)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(487)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Installment receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">292 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">868 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,160 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">379 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">943 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,322 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables purchased from DLL during the nine months ended September 30, 2021 which increased the gross installments receivables by $93,000. No sales of </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">installment receivables were made by the company during the quarter. </span></div></div></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,514 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current period provision (benefit)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(105)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Direct write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,093)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of end of period</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of September 30, 2021 consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">239 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">239 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,254 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,254 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of December 31, 2020 consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">615 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">615 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables with a related allowance recorded as noted in the table above represent those installment receivables on a non-accrual basis. As of September 30, 2021, the company had no U.S. installment receivables past due of 90 days or more for which the company is still accruing interest. Individually, all U.S. installment receivables are </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assigned a specific allowance for doubtful accounts based on management’s review when the company does not expect to receive both the contractual principal and interest payments as specified in the loan agreement. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aging of the company’s installment receivables was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:27.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0-30 days past due</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31-60 days past due</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61-90 days past due</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90+ days past due</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.007%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,003 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">131,055 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer rebate reserve</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12,689)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10,730)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash discount reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,227)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,031)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other, principally returns and allowances reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(879)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">115,923 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">108,588 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 141003000 131055000 12689000 10730000 7285000 7320000 4227000 4031000 879000 386000 115923000 108588000 11000 0.010 0.002 0.005 0.011 0.028 0.003 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.054%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.746%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,031 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current period provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">432 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Recoveries (direct write-offs), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of end of period</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,227 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 4031000 432000 -236000 4227000 314000 3 250000 P18M <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables consist of the following (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:28.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Long-Term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Long-Term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Installment receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">345 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,254 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">704 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,105 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(53)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(94)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(325)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(162)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(487)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Installment receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">292 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">868 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,160 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">379 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">943 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,322 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div> 345000 909000 1254000 704000 1105000 1809000 53000 41000 94000 325000 162000 487000 292000 868000 1160000 379000 943000 1322000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,514 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current period provision (benefit)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(105)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Direct write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,093)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of end of period</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 487000 1514000 -105000 66000 288000 1093000 94000 487000 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of September 30, 2021 consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">239 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">239 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,254 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,254 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of December 31, 2020 consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">615 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">615 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of September 30, 2021 consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">239 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">239 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,254 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,254 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of December 31, 2020 consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">615 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">615 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 239000 239000 94000 0 1015000 1015000 0 0 1015000 1015000 0 0 239000 239000 94000 0 1254000 1254000 94000 0 615000 615000 487000 0 1194000 1194000 0 0 0 0 0 29000 1194000 1194000 0 29000 615000 615000 487000 0 1809000 1809000 487000 29000 P90D <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aging of the company’s installment receivables was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:27.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0-30 days past due</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31-60 days past due</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61-90 days past due</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90+ days past due</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1015000 0 1015000 1194000 0 1194000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 239000 239000 0 615000 615000 0 1254000 239000 1015000 1809000 615000 1194000 <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories, Net</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,545 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,264 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,842 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,174 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,046 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,335 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,484 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,545 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,264 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,842 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,174 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,046 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,335 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,484 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 70545000 55264000 69842000 51174000 10948000 9046000 151335000 115484000 <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Assets</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivables principally value added taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,006 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid inventory and freight</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable due from information technology provider</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,488 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,995 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoverable income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives (foreign currency forward exchange contracts)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,479 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,151 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,717 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>In the fourth quarter of 2019, the company entered into an agreement to outsource substantially all of the company’s information technology ("IT") business service activities, including, among other things, support, rationalization and upgrading of the company’s legacy information technology systems and implementation of a global enterprise resource planning system. The agreement provides for reimbursement by the IT provider of IT expenses incurred by the company which are shown as Receivable due from information technology provider above. The amount of pass through charges will diminish as IT expenses are recorded directly by the IT provider. In addition, a corresponding current payable is due to the information technology provider. Refer to "Accrued Expenses" in the notes to the Condensed Consolidated Financial Statements included elsewhere in this report. <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivables principally value added taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,006 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid inventory and freight</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable due from information technology provider</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,488 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,995 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoverable income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives (foreign currency forward exchange contracts)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,479 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,151 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,717 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 23006000 22500000 1864000 2700000 1488000 2995000 685000 2182000 606000 1321000 393000 633000 354000 208000 276000 3963000 7479000 8215000 36151000 44717000 <div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Long-Term Assets</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div><span><br/></span></div></div></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,278 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,048 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Installment receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long-Term Assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,177 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,925 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,278 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,048 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Installment receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long-Term Assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,177 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,925 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2372000 2327000 2278000 2048000 868000 943000 463000 411000 84000 85000 112000 111000 6177000 5925000 Property and Equipment<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,897 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,045 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,230 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,509 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,288 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,001 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,965 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,529 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358,276 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304,317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,212 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,243 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Machinery and equipment includes demonstration units placed in provider locations which are depreciated to their estimated recoverable values over their estimated useful lives. In the fourth quarter of 2019, the company initiated the first stage of an Enterprise Resource Planning ("ERP") software implementation. As a result of the initiation of the ERP project, the company capitalized certain costs in accordance with ASC 350 as shown in capitalized software above. <div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,897 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,045 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,230 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,509 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,288 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,001 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,965 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,529 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358,276 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304,317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,212 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,243 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 292897000 294045000 28230000 28509000 28149000 17527000 10288000 10001000 6965000 8194000 366529000 358276000 304317000 302033000 62212000 56243000 <div style="display:inline-block;vertical-align:top;width:46.666%"><div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in goodwill from December 31, 2020 to September 30, 2021 was due to foreign currency translation and goodwill impairment charge in the North America segment. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles—Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 350, goodwill is tested annually for impairment or whenever events or changes in circumstances indicate the carrying value of a reporting unit could be above its fair value. A reporting unit is defined as an operating segment or one level below. The company has historically determined that its reporting units were North America / HME, Europe, Institutional Products Group and Asia Pacific. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the company's reporting units of North America / HME and Institutional Products Group merged into one reporting unit of North America, consistent with the operating segment. Developments in the third quarter of 2021 and the conclusion of the reporting units merger were tied most closely to the actions of the company to implement components of a new ERP system which changes both the level of discrete financial information readily available and the go-forward manner in which the company assesses performance and allocates resources to the North America operating segment.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reporting unit change within the North America operating segment in the third quarter of 2021 was a triggering event and required the company to perform an interim goodwill impairment test. Based on the interim goodwill test, the company concluded that the carrying value of the North America reporting unit was above its fair value. That conclusion resulted in the recording of impairment of goodwill in the third quarter of 2021 of $28,564,000. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company completed its interim test in the third quarter of 2021 consistent with the process of its annual impairment assessment in the fourth quarter of each year or whenever events or changes in circumstances indicate the carrying value of a reporting unit could be below a reporting unit's fair value. The fair values of the company's reporting units were calculated using inputs that are not observable in the market and included management's own estimates regarding the assumptions that market participants would use and thus these inputs are deemed Level III inputs in regard to the fair value hierarchy. To calculate the fair values of the reporting units, the company utilizes a discounted cash flow method in which the company forecasts income statement and balance sheet amounts based on assumptions regarding projected sales growth, operating income, inventory turns, days' sales outstanding, etc. to forecast future cash flows. The projected operating income used has a significant impact upon the discounted cash flow methodology utilized in the </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">company's interim or annual impairment assessment as lower projected operating income would result in lower fair value estimates. The cash flows are discounted using a weighted average cost of capital (WACC) discount rate where the cost of debt is based on quoted rates for 20-year debt of potential acquirer companies of similar credit risk and the cost of equity is based upon the 20-year treasury rate for the risk-free rate, a market risk premium, the industry average beta and a small cap stock adjustment. The assumptions used are based on a market participant's point of view and yielded a discount rate of 11.19% in the third quarter of 2021's valuation for the company's impairment analysis for the reporting units with goodwill compared to 11.27% used in the annual impairment test in 2020. The WACC used has a significant impact upon the discounted cash flow methodology utilized in the company's impairment assessment as a higher WACC would decrease the fair value estimates.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company also utilizes an Enterprise Value (EV) to Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) Method to compute the fair value of its reporting units which considers potential acquirers and their EV to EBITDA multiples adjusted by an estimated premium. While more weight is given to the discounted cash flow method, the EV to EBITDA Method does provide corroborative evidence of the reasonableness of the discounted cash flow method results.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While there was no impairment in the third quarter of 2021 related to goodwill for the Europe reporting unit, a future potential impairment could be possible if actual results differ materially from forecasted results used in the valuation analysis. Furthermore, the company's valuation can differ materially if financial projections or the market inputs used to determine the WACC change significantly. For instance, higher interest rates or greater stock price volatility would increase the WACC and thus increase the chance of impairment. In consideration of this potential, the company assessed the results if the discount rate used were 100 basis points higher for the third quarter of 2021 impairment analysis and determined that there still would not be an indicator of potential impairment for the Europe reporting unit. In addition, business changes impacting the company's assessment of reporting units could possibly also have a material impact on impairment assessment results.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no goodwill in the Asia Pacific reporting unit and the results of the Europe reporting unit assessment quantified its fair value to be substantially in excess of carrying value in the interim goodwill assessment completed in the third quarter of 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the company's interim assessment of goodwill for impairment, the company also considers the potential for impairment of any intangible assets or other long-lived assets. </span></div></div>The company concluded there was no impairment of intangible or long-lived assets as of September 30, 2021. Refer to Other Long-Term Assets, Property and Equipment and Intangibles in the Notes to the Condensed Consolidated Financial Statements for a description of any other asset impairments and refer to Goodwill in the company's Annual Report on Form 10-K for the period ending December 31, 2020 for further disclosure regarding the company's impairment analysis review methodology. 28564000 <div style="margin-top:9pt"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangibles</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's intangibles consist of the following (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer lists</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,016 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,112 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,318 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,542 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,542 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,556 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,556 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,899 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,722 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,365 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,155 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,392 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All the company’s intangible assets have been assigned definite lives and continue to be amortized over their useful lives, except for trademarks shown above, which have indefinite lives. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in intangible balances reflected on the balance sheet from December 31, 2020 to September 30, 2021 were the result of foreign currency translation on historical cost and accumulated amortization.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company evaluates the carrying value of definite-lived assets annually in the fourth quarter and whenever events or circumstances indicate possible impairment. In the third quarter of 2021, the company assessed its intangible assets for impairment based on the goodwill impairment conclusion of North America. Based on the assessment, the company concluded there was no intangible asset impairment. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definite-lived assets are determined to be impaired if the future undiscounted cash </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">flows expected to be generated by the asset are less than the carrying value. Actual impairment amounts for definite-lived assets are then calculated using a discounted cash flow calculation. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any impairment for indefinite-lived intangible assets is calculated as the difference between the future discounted cash flows expected to be generated by the asset less than the carrying value for the asset. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets was $304,000 in the first nine months of 2021 and is expected to be $405,000 in 2021, $402,000 in 2022, $402,000 in 2023, </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$361,000 in 2024, $212,000 in 2025 and $211,000 in 2026. Amortized intangible assets are being amortized on a straight-line basis over remaining lives of 3 to 8 years with a weighted average remaining life of approximately 7 years.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's intangibles consist of the following (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer lists</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,016 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,112 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,318 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,542 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,542 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,556 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,556 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,899 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,722 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,365 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,155 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,392 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's intangibles consist of the following (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer lists</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,016 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,112 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,318 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,542 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,542 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,556 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,556 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,899 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,722 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,365 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,155 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,392 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 54222000 54222000 54502000 54502000 25016000 25112000 7889000 7318000 7924000 7204000 5542000 5542000 5556000 5556000 2904000 1143000 2899000 979000 1149000 1140000 1162000 1151000 96722000 69365000 97155000 69392000 304000 405000 402000 402000 361000 212000 211000 P3Y P8Y P7Y <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Expenses</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of accruals for the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes other than income taxes, primarily value added taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,710 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,869 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,029 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,991 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,917 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,375 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,463 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT service contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,038 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,823 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,076 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,413 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,516 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,901 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,242 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,644 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities (foreign currency forward exchange contracts)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,249 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental executive retirement program liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, principally trade accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,634 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,955 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,210 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,273 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the company's products are covered by warranties against defects in material and workmanship for various periods depending on the product from the date of sales to the customer. Certain components carry a lifetime warranty. A provision for estimated warranty cost is recorded at the time of sale based upon actual experience. In addition, the company has sold extended warranties that, while immaterial, require the company to defer the revenue associated with those warranties until earned. The company has established procedures to appropriately defer such revenue. The company continuously assesses the adequacy of its product warranty accrual and makes adjustments as needed. Historical analysis is primarily used to determine the company's warranty reserves. Claims history is reviewed and provisions are adjusted as needed. However, the company does consider other events, such as a product field action and recalls, which could require additional warranty reserve provision.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued rebates relate to several volume incentive programs the company offers its customers. The company accounts for these rebates as a reduction of revenue when the products are sold. Rebates are netted against gross accounts receivables. If rebates are in excess of such receivables, they are then classified as accrued expenses. The reduction in accrued rebates from December 31, 2020 to September 30, 2021 primarily relates to payments principally made in the first quarter each year, earned from the previous year.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reduction in accrued severance from December 31, 2020 to September 30, 2021 primarily relates to payments of restructuring costs with respect to the German manufacturing facility consolidation.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2019, the company entered into an agreement with an IT provider to outsource substantially all of the company’s information technology business service activities, including, among other things, support, rationalization and upgrading of the company’s legacy information technology systems and implementation of a global ERP. Accrued expenses related to IT outsourcing are reflected in IT service contracts. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,991 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties provided during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in liability for pre-existing warranties during the period, including expirations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Warranty reserves are subject to adjustment in future periods as new developments change the company's estimate of the total cost. <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of accruals for the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes other than income taxes, primarily value added taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,710 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,869 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,029 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,991 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,917 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,375 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,463 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT service contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,038 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,823 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,076 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,413 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,516 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,901 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,242 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,644 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities (foreign currency forward exchange contracts)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,249 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental executive retirement program liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, principally trade accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,634 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,955 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,210 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,273 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 27103000 32710000 24869000 34029000 11363000 10991000 8917000 7375000 4463000 3190000 4038000 3799000 3823000 2076000 3413000 3516000 2901000 2453000 2242000 8644000 2086000 1432000 804000 6249000 652000 878000 511000 585000 391000 391000 6634000 7955000 104210000 126273000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,991 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties provided during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in liability for pre-existing warranties during the period, including expirations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 10991000 5087000 5187000 472000 11363000 <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term Debt</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 5.00%, due in February 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 4.50%, due in June 2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,637 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,869 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes Series I at 5.00%, due in November 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,073 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes Series II at 5.00%, due November 2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,270 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,919 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 4.25%, due in March 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,793 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,039 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,455 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,053 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current maturities of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,121)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,612)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306,334 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,441 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2015, the company entered into an Amended and Restated Revolving Credit and Security Agreement, which was subsequently amended (the “Credit Agreement”) and which matures on January 16, 2024. The Credit Agreement was entered into by and among the company, certain of the company’s direct and indirect U.S. and Canadian subsidiaries and certain of the company’s European subsidiaries (together with the company, the “Borrowers”), certain other of the company’s direct and indirect U.S., Canadian and European subsidiaries (the “Guarantors”), and PNC Bank, National Association (“PNC”), JPMorgan Chase Bank, N.A., J.P. Morgan Europe Limited, KeyBank National Association, and Citizens Bank, National Association (the “Lenders”). PNC is the administrative agent (the “Administrative Agent”) and J.P. Morgan Europe Limited is the European agent (the “European Agent”) under the Credit Agreement. In connection with entering into the company's Credit Agreement, the company incurred fees which were capitalized and are being amortized as interest expense. As of September 30, 2021, debt fees yet to be amortized through January 2024 totaled $817,000. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company had outstanding letters of credit of $8,350,000 and $7,752,000 as of September 30, 2021 and December 31, 2020, respectively. Outstanding letters of credit and other reserves impacting borrowing capacity were $7,641,000 and $7,616,000 as of September 30, 2021 and December 31, 2020, respectively. The company had $22,150,000 outstanding borrowings under its North America Credit Facility as of September 30, 2021. The company had outstanding borrowings of $9,446,000 (€8,000,000) under its French Credit Facility and $6,600,000 (£4,800,000) under its UK Credit Facility as of September 30, 2021, together referred </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to as the European Credit Facility. The company had outstanding borrowings of $20,000,000 under its North America Credit Facility as of December 31, 2020. The company had outstanding borrowings of $7,636,000 (€6,400,000) under its French Credit Facility and $3,866,000 (£2,900,000) under its UK Credit Facility as of December 31, 2020, together referred to as the European Credit Facility. The weighted average interest rate on all borrowings, excluding finance leases, was 4.4% for the nine months ended September 30, 2021 and 4.6% for the year ended December 31, 2020.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">North America Borrowers Credit Facility</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the company's North America Borrowers, the Credit Agreement provides for an asset-based-lending senior secured revolving credit facility which is secured by substantially all the company’s U.S. and Canadian assets, other than real estate. The Credit Agreement provides the company and the other Borrowers with a credit facility in an aggregate principal amount of $60,000,000, subject to availability based on a borrowing base formula, under a senior secured revolving credit, letter of credit and swing line loan facility (the “North America Credit Facility”). Up to $20,000,000 of the North America Credit Facility will be available for issuance of letters of credit. The aggregate principal amount of the North America Credit Facility may be increased by up to $25,000,000 to the extent requested by the company and agreed to by any Lender or new financial institution approved by the Administrative Agent. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate borrowing availability under the North America Credit Facility is determined based on a borrowing </span></div></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">base formula. The aggregate usage under the North America Credit Facility may not exceed an amount equal to the sum of (a) 85% of eligible U.S. accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (b) the lesser of (i) 70% of eligible U.S. inventory and eligible foreign in-transit inventory and (ii) 85% of the net orderly liquidation value of eligible U.S. inventory and eligible foreign in-transit inventory (not to exceed $4,000,000), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (c) the lesser of (i) 80% of the net orderly liquidation value of U.S. eligible machinery and equipment and (ii) $0 as of September 30, 2021 (subject to reduction as provided in the Credit Agreement), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (d) 85% of eligible Canadian accounts receivable, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (e) the lesser of (i) 70% of eligible Canadian inventory and (ii) 85% of the net orderly liquidation value of eligible Canadian inventory, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (f) swing loans outstanding under the North America Credit Facility, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (g) letters of credit issued and undrawn under the North America Credit Facility, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (h) a $3,000,000 minimum availability reserve, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (i) other reserves required by the Administrative Agent, and in each case subject to the definitions and limitations in the Credit Agreement. As of September 30, 2021, the company was in compliance with all covenant requirements. As of September 30, 2021, the company had gross borrowing base of $40,566,000 and net borrowing availability of $23,176,000 under the North America Credit Facility under the Credit Agreement, considering the minimum availability reserve, then-outstanding letters of credit, other reserves and the $6,750,000 dominion trigger amount described below. Borrowings under the North America Credit Facility are secured by substantially all of the company’s U.S. and Canadian assets, other than real estate.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest will accrue on outstanding indebtedness under the Credit Agreement at the LIBOR rate, plus a margin ranging from 2.25% to 2.75%, or at the alternate base rate, plus a margin ranging from 1.25% to 1.75%, as selected by the company. Borrowings under the North America Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary representations, warranties and covenants. Exceptions to the operating covenants in the Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale and leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Credit Agreement, as amended. The Credit Agreement also contains a covenant requiring the company to maintain minimum availability under the North America Credit Facility of not less than (i) 12.5% of the maximum amount that may be drawn under the North America Credit Facility for five (5) consecutive business days, or (ii) 11.25% of the maximum amount that may be drawn under the North American facility on any business day. The company also is subject to dominion </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">triggers under the North America Credit Facility requiring the company to maintain borrowing capacity of not less than $6,750,000 on any business day or any five consecutive days in order to avoid triggering full control by an agent for the Lenders of the company's cash receipts for application to the company’s obligations under the agreement.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary default provisions, with certain grace periods and exceptions, which provide for events of default that include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption of any material manufacturing facilities for more than 10 consecutive days. The proceeds of the North America Credit Facility will be used to finance the working capital and other business needs of the company. There was $22,150,000 of outstanding borrowings under the North America Credit Facility on September 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">European Credit Facility</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement also provides for a revolving credit, letter of credit and swing line loan facility which gives the company and the European Borrowers the ability to borrow up to an aggregate principal amount of $30,000,000, with a $5,000,000 sublimit for letters of credit and a $2,000,000 sublimit for swing line loans (the “European Credit Facility”). Up to $15,000,000 of the European Credit Facility will be available to each of Invacare Limited (the “UK Borrower”) and Invacare Poirier SAS (the “French Borrower” and, together with the UK Borrower, the “European Borrowers”). The European Credit Facility matures in January 2024, together with the U.S. and Canadian Credit Facility. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate borrowing availability for each European Borrower under the European Credit Facility is determined based on a borrowing base formula. The aggregate borrowings of each of the European Borrowers under the European Credit Facility may not exceed an amount equal to (a) 85% of the European Borrower’s eligible accounts receivable, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) the European Borrower’s borrowings and swing line loans outstanding under the European Credit Facility, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) the European Borrower’s letters of credit issued and undrawn under the European Credit Facility, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) a $3,000,000 minimum availability reserve, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) other reserves required by the European Agent, and in each case subject to the definitions and limitations in the Credit Agreement. As of September 30, 2021, the gross borrowing base to the European Borrowers under the European Credit Facility was $22,684,000 and the net borrowing availability was $16,310,000, considering the $3,000,000 minimum availability reserve and a $3,375,000 dominion trigger amount described below. Borrowing availability is based on a prior </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">month base in USD. Actual borrowings in GBP and EUR fluctuate in USD between date of borrowing and when translated for consolidated reporting. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate principal amount of the European Credit Facility may be increased by up to $10,000,000 to the extent requested by the company and agreed to by any Lender or Lenders that wish to increase their lending participation or, if not agreed to by any Lender, a new financial institution that agrees to join the European Credit Facility and that is approved by the Administrative Agent and the European Agent.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest will accrue on outstanding indebtedness under the European Credit Facility at the LIBOR rate, plus a margin ranging from 2.50% to 3.00%, or for swing line loans, at the overnight LIBOR rate, plus a margin ranging from 2.50% to 3.00%, as selected by the company. The margin that will be adjusted quarterly based on utilization. Borrowings under the European Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Credit Facility is secured by substantially all the personal property assets of the UK Borrower and its in-country subsidiaries, and all the receivables of the French Borrower and its in-country subsidiaries. The UK and French facilities (which comprise the European Credit Facility) are cross collateralized, and the US personal property assets previously pledged under the U.S. and Canadian Credit Facility also serve as collateral for the European Credit Facility. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Credit Facility is subject to customary representations, warranties and covenants generally consistent with those applicable to the U.S. and Canadian Credit Facility. Exceptions to the operating covenants in the Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale/leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Credit Agreement. The Credit Agreement also contains a covenant requiring the European Borrowers to maintain undrawn availability under the European Credit Facility of not less than (i) 12.5% of the maximum amount that may be drawn under the European Credit Facility for five (5) consecutive business days, or (ii) 11.25% of the maximum amount that may be drawn under the European credit facility on any business day. The European Borrowers also are subject to cash dominion triggers under the European Credit Facility requiring the European Borrower to maintain borrowing capacity of not less than $3,750,000 on any business day or $3,375,000 for five consecutive business days in order to avoid triggering full control by an agent for the Lenders of the European </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrower’s cash receipts for application to its obligations under the European Credit Facility. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Credit Facility is subject to customary default provisions, with certain grace periods and exceptions, consistent with those applicable to the U.S. and Canadian Credit Facility, which provide that events of default include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, cross-default, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption in the operations of any material manufacturing facility for more than 10 consecutive days. The proceeds of the European Credit Facility will be used to finance the working capital and other business needs of the company. As of September 30, 2021, the company had borrowings of $9,446,000 (€8,000,000) under its French Credit Facility and $6,600,000 (£4,800,000) under its UK Credit Facility as of September 30, 2021, together referred to as the European Credit Facility.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Credit Agreement was amended to provide for, among other things, the addition of the company's Netherlands subsidiary as a guarantor under the European revolving credit facility, amendments to the restrictive covenants in the Credit Agreement to (1) increase the maximum amount of permitted miscellaneous indebtedness to $30,000,000 from $10,000,000 and (2) permit up to $9,000,000 of financing based on certain European public and government receivables, and terms that, upon the occurrence of certain events related to a transition from the use of LIBOR, permit the agent for the lenders to amend the Credit Agreement to replace the LIBOR rate and/or the Euro rate with a benchmark replacement rate.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Credit Agreement was further amended to permit the issuance of the 2026 Notes and the capped call transactions entered into by the company in connection with the issuance of the 2026 Notes, as further discussed in the sections below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes due 2021</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2016, the company issued $150,000,000 aggregate principal amount of 5.00% Convertible Senior Notes due 2021 (the “2021 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2021 Notes bore interest at a rate of 5.00% per year payable semi-annually in arrears on February 15 and August 15 of each year, beginning August 15, 2016. The 2021 Notes matured on February 15, 2021. At maturity, $1,250,000 principal amount of 2021 Notes were outstanding, which the company repaid in cash. </span></div><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2021 Notes, the company entered into privately negotiated convertible note hedge transactions with two financial institutions (the “option counterparties”). The company evaluated the note hedges under the applicable accounting literature, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 815, and determined that the note hedges should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $27,975,000. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company entered into separate, privately negotiated warrant transactions with the option counterparties at a higher strike price relating to the same number of the company’s common shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding common shares and the company’s earnings per share to the extent that the price of the company’s common shares exceeds the strike price of those warrants. The initial strike price of the warrants is $22.4175 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 815, and determined that the warrants met the definition of a derivative, are indexed to the company's own stock and should be classified in shareholder's equity. The amount paid for the warrants and capitalized in shareholder's equity was $12,376,000.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the offering of the 2021 Notes were approximately $144,034,000, after deducting fees and offering expenses of $5,966,000, which were paid in 2016. These debt issuance costs were capitalized and were amortized as interest expense through February 2021. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2019, the company used an aggregate of $14,708,000 in cash to repurchase a total amount of $16,000,000 in principal amount of 2021 Notes. After recognizing expenses on unamortized fees and discounts associated with the repurchased 2021 Notes, the repurchases resulted in a net reduction of debt of $14,367,000 and a net loss on the repurchases of $280,000.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the company entered into separate privately negotiated agreements with certain holders of its 2021 Notes to exchange $72,909,000 in aggregate principal amount of 2021 Notes for aggregate consideration of $72,909,000 in aggregate principal amount of new 5.00% Convertible Senior Exchange Notes due 2024 (the “Series I 2024 Notes”) of the company and $6,928,000 in cash. Refer to "Convertible senior notes Series I due 2024" </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for more information. As a result of the exchange transaction in the fourth quarter of 2019 and the repurchase of $16,000,000 in principal amount of 2021 Notes in the third quarter of 2019, a partial unwind of the note hedge options and warrants entered into with the issuance of the 2021 Notes also occurred during the fourth quarter of 2019. Note hedge options outstanding related to the 2021 Notes were reduced from the original number of 300,000 to 138,182 and warrants relating to the 2021 Notes were reduced from the initial number of 9,007,380 to 3,860,624. The partial unwind of the note hedge options and warrants resulted in no net impact to cash or paid in capital.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Exchange Notes due 2024 (the “Series II 2024 Notes”) of the company and $5,593,000 in cash.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the company repurchased $24,466,000 aggregate principal amount of 2021 Notes, resulting in a $761,000 loss on debt extinguishment. As a result of the repurchase of 2021 Notes in the third quarter of 2020 and the exchange of 2021 Notes for new notes in the second quarter of 2020, a partial unwind of the note hedge options and warrants entered into with the issuance of the 2021 Notes also occurred. The partial unwind of the note hedge options and warrants resulted in no net impact to cash or paid-in-capital. Note hedge options outstanding relating to the 2021 Notes were reduced 62,341 and subsequently expired on February 15, 2021. The warrants began to expire on May 15, 2021 and then partially expire on each trading day over the 220 trading day period following May 15, 2021. Warrants outstanding on September 30, 2021 were 1,770,968. If exercised, one Common Share is issuable upon exercise of each warrant, but may be adjusted to include additional Common Shares for each warrant under certain circumstances if the relevant share price exceeds the warrant strike price for the relevant measurement period at the time of exercise. Common Shares are reserved for issuance upon exercise of the remaining warrants relating to the 2021 Notes at two Common Shares per warrant.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2021 Notes consist of the following (in thousands):</span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:44.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unamortized discount was reduced to $0 upon adoption of ASU 2020-06, effective January 1, 2021. The effective interest rate on the liability component was 11.1% upon original issuance including consideration of the discount. Non-cash discount interest expense of $261,000 and $1,767,000 was recognized for the three and nine months ended September 30, 2020. Interest expense of $0 and $8,000 was accrued for the three and nine months ended September 30, 2021, compared to $241,000 and $1,617,000 for the three and nine months ended September 30, 2020 based on the stated coupon rate of 5.0%.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes due 2022</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2017, the company issued $120,000,000 aggregate principal amount of 4.50% Convertible Senior Notes due 2022 (the “2022 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2022 Notes bear interest at a rate of 4.50% per year payable semi-annually in arrears on June 1 and December 1 of each year, beginning December 1, 2017. The 2022 Notes will mature on June 1, 2022, unless repurchased or converted in accordance with their terms prior to such date. Prior to December 1, 2021, the 2022 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Prior to May 16, 2019, the 2022 Notes were convertible, subject to certain conditions, into cash only. On May 16, 2019, the company obtained shareholder approval under applicable New York Stock Exchange rules such that conversion of the 2022 Notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. At September 30, 2021, $2,650,000 aggregate principal amount of the 2022 Notes remained outstanding, following the exchange transactions completed in the second quarter of 2020 and the repurchase of debt completed in the first quarter of 2021, as further discussed below.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2022 Notes may convert their 2022 Notes at their option at any time prior to the close of business on the business day immediately preceding December 1, 2021 only under the following circumstances: (1) during any fiscal </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quarter commencing after September 30, 2017 (and only during such fiscal quarter), if the last reported sale price of the company’s common shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2022 Notes on each applicable trading day; (2) during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQ1NDZiOTI4OTFkZjQzN2M5MzNhYTU2MDNhYzJlYzljL3NlYzpkNTQ2YjkyODkxZGY0MzdjOTMzYWE1NjAzYWMyZWM5Y18xMjEvZnJhZzozOTA3NWIxN2RkM2I0NGM3OWI0NGVhNjU5MjhjMDlmNy90ZXh0cmVnaW9uOjM5MDc1YjE3ZGQzYjQ0Yzc5YjQ0ZWE2NTkyOGMwOWY3XzIxOTA4_04a8fc95-d238-4633-abfd-b1486ae4f35b">five</span> business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2022 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2022 Notes on each such trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after December 1, 2021 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2022 Notes, holders may convert their 2022 Notes, at the option of the holder, regardless of the foregoing circumstances.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2022 Notes will have the right to require the company to repurchase all or some of their 2022 Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 61.6095 common shares per $1,000 principal amount of 2022 Notes (equivalent to an initial conversion price of approximately $16.23 per common share). Until the company received shareholder approval on May 16, 2019 authorizing it to elect to settle future conversions of the 2022 Notes in common shares, the company separately accounted for the conversion features as a derivative. The derivative was capitalized on the balance sheet as a long-term liability with adjustment to reflect fair value each quarter until the change to the conversion features as a result of the shareholder approval received on May 16, 2019 resulted in the termination of the derivative. The fair value of the convertible debt conversion liability at issuance was $28,859,000. The company recognized a loss of $6,193,000 in 2019 related to the convertible debt conversion liability. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2022 Notes, the company entered into privately negotiated convertible note hedge transactions with one financial institution (the “option counterparty”). These transactions cover, subject to customary anti-dilution adjustments, the number of the company’s common shares that will initially underlie the 2022 Notes, and are expected generally to reduce the potential equity dilution, and/or offset any cash payments in excess of the principal amount due, as the case may be, upon conversion of the 2022 Notes. The company evaluated the note hedges under the applicable accounting literature, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 815, and determined that the note hedges </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and were adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $24,780,000. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company entered into separate, privately negotiated warrant transactions with the option counterparty at a higher strike price relating to the same number of the company’s common shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding common shares and the company’s earnings per share to the extent that the price of the company’s common shares exceeds the strike price of those warrants. The initial strike price of the warrants is $21.4375 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 815, and determined that the warrants meet the definition of a derivative, are indexed to the company's own shares and should be classified in shareholder's equity. The amount paid for the warrants and capitalized in shareholder's equity was $14,100,000. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were 120,000 note hedge options relating to the 2022 Notes outstanding at September 30, 2021, but only 2,650 remained available for exercise. Note hedge options related to the 2022 Notes will expire on June 1, 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants relating to the 2022 Notes outstanding on September 30, 2021 were 7,393,141. If exercised, one common share is issuance upon exercise of each warrant, but may be adjusted under certain circumstances if the relevant share price exceeds the warrant strike price for the relevant share price exceeds the warrant strike price for the relevant measurement period at the time of exercise. Common shares are reserved for issuance upon exercise of the remaining warrants relating to the 2022 Notes at two common shares per warrant. The warrants will begin to expire on September 1, 2022 and then partially expire on each trading day over the 220 trading day period following September 1, 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the offering of the 2022 Notes were approximately $115,289,000, after deducting fees and offering expenses of $4,711,000, which were paid in 2017. These debt issuance costs were capitalized and are being amortized as interest expense through June 2022. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. A portion of the net proceeds from the offering were used to pay the cost of the convertible note hedge transactions (after such cost is partially offset by the proceeds to the company from the warrant transactions), which net cost was $10,680,000.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new Series II 2024 Notes and $5,593,000 in cash.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, the company repurchased $78,850,000 in principal amount of 2022 Notes, resulting in a loss on debt extinguishment of $709,000. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2022 notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(859)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,637 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,869 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unamortized discount was reduced to $0 upon adoption of ASU 2020-06, effective January 1, 2021. The effective interest rate on the liability component was 10.9% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption of ASU 2020-06 includes coupon interest and amortization of debt fees. Non-cash discount interest expense of $1,046,000 and $3,829,000 was recognized for the three and nine months ended September 30, 2020. Interest expense of $30,000 and $829,000 was accrued for the three and nine months ended September 30, 2021 compared to $917,000 and $3,487,000 for the three and nine months ended September 30, 2020 based on the stated coupon rate of 4.5%. The effective interest rate of the 2022 Notes as of September 30, 2021 was 5.3%. The 2022 Notes were not convertible as of September 30, 2021 nor was the applicable conversion threshold met. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes Series I due 2024</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the company entered into separate privately negotiated agreements with certain holders of its 2021 Notes to exchange $72,909,000 in aggregate principal amount of 2021 Notes for aggregate consideration of $72,909,000 in aggregate principal amount of new 5.00% Convertible Senior Exchange Notes due 2024 (the “Series I 2024 Notes”) of the company and $6,928,000 in cash. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes bear interest at a rate of 5.00% per year payable semi-annually in arrears on May 15 and November 15 of each </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year, beginning May 15, 2020. The notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series I 2024 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series 2024 Notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the maturity of the Series I 2024 Notes, the company may, at its election, redeem for cash all or part of the Series I 2024 Notes if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the Series I 2024 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series I 2024 Notes, which means the company is not required to redeem or retire the Series I 2024 Notes periodically.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series I 2024 Notes may convert their Series I 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending December 31, 2019 (and only during such calendar quarter), if the last reported sale price of the company’s common shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the Series I 2024 Notes on each applicable trading day; (2) during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQ1NDZiOTI4OTFkZjQzN2M5MzNhYTU2MDNhYzJlYzljL3NlYzpkNTQ2YjkyODkxZGY0MzdjOTMzYWE1NjAzYWMyZWM5Y18xMjEvZnJhZzozOTA3NWIxN2RkM2I0NGM3OWI0NGVhNjU5MjhjMDlmNy90ZXh0cmVnaW9uOjM5MDc1YjE3ZGQzYjQ0Yzc5YjQ0ZWE2NTkyOGMwOWY3XzMxMzEy_f506b36c-6b70-4b69-ba45-aa92114ccfe9">five</span> business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series I 2024 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s common shares and the applicable conversion rate for the Series I 2024 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series I 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the Series I 2024 Notes will have the right to require the company to repurchase all or some of their Series I 2024 </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 common shares per $1,000 principal amount of Series I 2024 Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series I 2024 Notes, holders may convert their Series I 2024 Notes, at the option of the holder, regardless of the foregoing circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A loss of $5,885,000 was recorded a part of the exchange transaction, which included the write-off of fees related to the portion of the 2021 Notes exchanged. Debt issuance costs of $1,394,000 were capitalized and are being amortized as interest expense through November 15, 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Series I 2024 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,888)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(836)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,037)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,073 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,984 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unamortized discount was reduced to $0 upon adoption of ASU 2020-06, effective January 1, 2021. The effective interest rate on the liability component was 8.77% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption includes coupon interest and amortization of debt fees. Non-cash discount interest expense of $468,000 and $1,370,000 was recognized for the three and nine months ended September 30, 2020. Interest expense of $911,000 and $2,733,000 was accrued for the three and nine months ended September 30, 2021 compared to $912,000 and $2,735,000 for the three and nine months ended September 30, 2020 based on the stated coupon rate of 5.0%. The effective interest rate of the Series I 2024 notes as of September 30, 2021 was 5.4%. The Series I 2024 Notes were not convertible as of September 30, 2021 nor was the applicable conversion threshold met.</span></div><div style="text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes Series II due 2024</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Exchange Notes due 2024 (the “Series II 2024 Notes”) of the company and $5,593,000 in cash. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series II 2024 Notes bear interest at a rate of 5.00% per year, payable semi-annually in arrears on May 15 and November 15 of each year, beginning November 15, 2020. The Series II 2024 Notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series II 2024 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series II 2024 Notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the maturity of the Series II 2024 Notes, the company may, at its election, redeem for cash all or part of the Series II 2024 Notes, if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the accreted principal amount of the Series II 2024 Notes to be redeemed, plus any accrued and unpaid interest, if any, on the original principal amount of the New Notes redeemed to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series II 2024 Notes, which means the company is not required to redeem or retire the Series II 2024 Notes periodically.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series II 2024 Notes may convert their Series II 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the company’s common shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the Series II 2024 Notes on each applicable trading day; (2) during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQ1NDZiOTI4OTFkZjQzN2M5MzNhYTU2MDNhYzJlYzljL3NlYzpkNTQ2YjkyODkxZGY0MzdjOTMzYWE1NjAzYWMyZWM5Y18xMjEvZnJhZzozOTA3NWIxN2RkM2I0NGM3OWI0NGVhNjU5MjhjMDlmNy90ZXh0cmVnaW9uOjM5MDc1YjE3ZGQzYjQ0Yzc5YjQ0ZWE2NTkyOGMwOWY3XzM2NzYy_b7de3423-ab56-4547-959a-82e5b5f476fa">five</span> business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series II 2024 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">company’s common shares and the applicable conversion rate for the Series II 2024 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series II 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the Series II 2024 Notes will have the right to require the company to repurchase all or some of their Series II 2024 Notes at 100% of the accreted principal amount, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 common shares per $1,000 principal amount of Series II 2024 Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series II 2024 Notes, holders may convert their Series II 2024 Notes, at the option of the holder, regardless of the foregoing circumstances.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The principal amount of the Series II 2024 Notes also will accrete at a rate of approximately 4.7% per year commencing June 4, 2020, compounding on a semi-annual basis. The accreted portion of the principal is payable in cash upon maturity but does not bear interest and is not convertible into the company’s common shares. The total amount accreted as of September 30, 2021 was $4,450,000, of which $890,000 and $2,637,000 was for the three and nine months ended September 30, 2021, respectively and $762,000 and $1,016,000 for the three and nine months ended September 30, 2020, respectively. Remaining accretion until maturity (at current principal) was $12,172,000 at September 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A loss of $6,599,000 was recorded a part of the exchange transaction, which included the write-off of fees related to portions of the 2021 Notes and 2022 Notes exchanged. Debt issuance costs of $1,505,000 were capitalized and are being amortized as interest expense through November 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Series II 2024 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component - including accretion</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,325 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,688 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,270 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,919 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unamortized discount was reduced to $0 upon adoption of ASU 2020-06, effective January 1, 2021. The </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effective interest rate on the liability component was 8.99% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption includes coupon interest, accretion and amortization of debt fees. Interest expense for accretion of $890,000 and $2,637,000 was accrued for the three and nine months ended September 30, 2021. Non-cash interest, including accretion, of $1,260,000 and $1,663,000 was recognized for the three and nine months ended September 30, 2020. Interest expense of $923,000 and $1,200,000 was recognized for the three and nine months ended September 30, 2020 compared to $923,000 and $2,770,000 for the three and nine months ended September 30, 2021 based on the stated coupon rate of 5.0%. The effective interest rate of the Series II 2024 Notes as of September 30, 2021 including coupon interest, amortization of debt fees and accretion to maturity was 10.3%. The Series II 2024 Notes were not convertible as of September 30, 2021 nor was the applicable conversion threshold met.</span></div><div style="text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes due 2026</span></div><div style="text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the company issued $125,000,000 aggregate principal amount of 4.25% Convertible Senior Notes due 2026 (the “2026 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes bear interest at a rate of 4.25% per year payable semi-annually in arrears on March 15 and September 15 of each year, beginning September 15, 2021. The notes will mature on March 15, 2026, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to September 15, 2025, the 2026 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The 2026 Notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company may not redeem the 2026 Notes prior to March 20, 2024. The company may, at its election, redeem for cash all or part of the 2026 Notes, on or after March 20, 2024, if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the 2026 Notes, </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which means the company is not required to redeem or retire the 2026 Notes periodically.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2026 Notes may convert their 2026 Notes at their option at any time prior to the close of business on the business day immediately preceding September 15, 2025 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2021 (and only during such calendar quarter), if the last reported sale price of the company’s common shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the 2026 Notes on each applicable trading day; (2) during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQ1NDZiOTI4OTFkZjQzN2M5MzNhYTU2MDNhYzJlYzljL3NlYzpkNTQ2YjkyODkxZGY0MzdjOTMzYWE1NjAzYWMyZWM5Y18xMjEvZnJhZzozOTA3NWIxN2RkM2I0NGM3OWI0NGVhNjU5MjhjMDlmNy90ZXh0cmVnaW9uOjM5MDc1YjE3ZGQzYjQ0Yzc5YjQ0ZWE2NTkyOGMwOWY3XzQyNDky_f07016f8-0f06-4c69-a2f7-0c9effdfdd5d">five</span> business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2026 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s common shares and the applicable conversion rate for the 2026 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls any or all of the 2026 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date. Holders of the 2026 Notes will have the right to require the company to repurchase all or some of their 2026 Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 94.6096 common shares per $1,000 principal amount of 2026 notes (equivalent to an initial conversion price of approximately $10.57 per common share). On or after September 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2026 Notes, holders may convert their 2026 Notes, at the option of the holder, regardless of the foregoing circumstances.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt issuance costs of $7,305,000 were capitalized and are being amortized as interest expense through March 2026. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2026 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,318)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,682 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense of $1,328,000 and $2,892,000 was accrued for the three and nine months ended September 30, 2021 based on the stated coupon rate of 4.25%. The effective interest rate of the 2026 Notes as of September 30, 2021 was 5.3%. The 2026 Notes were not convertible as of September 30, 2021 nor was the applicable conversion threshold met.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, in connection with the pricing of the 2026 Notes, the company entered into capped call transactions (the “Capped Call Transactions”) with certain option counterparties. The company used $18,787,000 of the net proceeds of the private offering of the 2026 Notes to pay the cost of the Capped Call Transactions with the offset recorded to additional paid-in-capital.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Capped Call Transactions are expected generally to reduce the potential dilution upon conversion of the 2026 Notes and/or offset any cash payments the company is required to make in excess of the principal amount of converted notes, as the case may be, in the event that the market price per share of the company’s common shares, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which is initially $10.57, corresponding to the initial conversion price of the 2026 Notes, subject to anti-dilution adjustments. If, however, the market price per company common share, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions, which is initially $16.58 (subject to adjustments), there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the Capped Call Transactions. The Capped Call Transactions expire March 15, 2026, subject to earlier exercise. There were 125,000 capped call options related to the 2026 Notes outstanding on September 30, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company will not be required to make any cash payments to the option counterparties upon the exercise of the options that are a part of the Capped Call Transactions, but the company will be entitled to receive from the option counterparties a number of company common shares, an amount of cash or a combination thereof generally based on the amount by which the market price per company common share, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions during the relevant valuation period under the Capped Call Transactions. However, if the market price per Company common share, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions during such valuation period, the number of company common shares and/or the amount of cash the company expects to receive upon exercise of the Capped Call Transactions will be capped based on the amount by </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which the cap price exceeds the strike price of the Capped Call Transactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For any conversions of the 2026 Notes prior to September 15, 2025, a corresponding portion of the relevant Capped Call Transactions may be terminated at the company’s option. Upon any such termination, the company expects to receive from the option counterparties a number of company common shares, or, if the company so elects, subject to certain conditions, an amount of cash, in each case, with a value equal to the fair value of such portion of the relevant Capped Call Transactions being terminated, as calculated in accordance with the terms of the relevant Capped Call Transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Capped Call Transactions are separate transactions, in each case, entered into by the company with the option counterparties, and are not part of the terms of the 2026 Notes and will not affect any holder’s rights under the 2026 Notes. Holders of the 2026 Notes will not have any rights with respect to the Capped Call Transactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CARES Act Loan</span></div>On May 15, 2020 the company entered into an unsecured loan agreement in the aggregate amount of $10,000,000 pursuant to sections 1102 and 1106 of the Coronavirus Aid, Relief and Economic Security, "CARES," Act which was evidenced by a promissory note, dated May 13, 2020, and bears interest at a fixed rate of 1.00%. Payments which were to commence in May 2021 under the program, had been deferred until the third quarter of 2021. This loan may be forgivable, partially or in full, if certain conditions are met, principally based on having been disbursed for permissible purposes and based on average levels of employment over a designated period of time. At the time of the loan, no assurance could be given that the company would be granted forgiveness of the loan upon application in whole or in part. As of June 30, 2021, the company had recorded $10,000,000 of the amount borrowed in current maturities of long term debt. <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 5.00%, due in February 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 4.50%, due in June 2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,637 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,869 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes Series I at 5.00%, due in November 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,073 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes Series II at 5.00%, due November 2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,270 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,919 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 4.25%, due in March 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,793 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,039 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,455 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,053 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current maturities of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,121)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,612)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306,334 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,441 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div> 0 1242000 2637000 73869000 72073000 62984000 77270000 64919000 118682000 0 38793000 42039000 309455000 245053000 3121000 5612000 306334000 239441000 817000 8350000 7752000 7641000 7616000 22150000 9446000 8000000 6600000 4800000 20000000 7636000 6400000 3866000 2900000 0.044 0.046 60000000 20000000 25000000 0.85 0.70 0.85 4000000 0.80 0 0.85 0.70 0.85 3000000 40566000 23176000 6750000 0.0225 0.0275 0.0125 0.0175 0.0025 0.00375 0.125 P5D 0.1125 6750000 P10D 22150000 30000000 5000000 2000000 15000000 0.85 3000000 22684000 16310000 3000000 3375000 10000000 0.0250 0.0300 0.0250 0.0300 0.0025 0.00375 0.125 P5D 0.1125 3750000 3375000 P10D 9446000 8000000 6600000 4800000 30000000 10000000 9000000 150000000 0.0500 0.0500 1250000 27975000 22.4175 12376000 144034000 5966000 14708000 16000000 14367000 -280000 72909000 72909000 0.0500 6928000 16000000 300000 138182 9007380 3860624 35375000 38500000 73875000 0.0500 5593000 24466000 761000 62341 1770968 The liability components of the 2021 Notes consist of the following (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:44.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 0 1250000 0 7000 0 -1000 0 1242000 0 0.111 261000 1767000 0 8000 241000 1617000 0.050 120000000 0.0450 0.0450 2650000 P20D 30 1.30 10 0.98 1 61.6095 1000 16.23 28859000 -6193000 24780000 21.4375 14100000 120000 2650 7393141 115289000 4711000 -10680000 35375000 38500000 73875000 5593000 78850000 709000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2022 notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(859)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,637 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,869 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 2650000 81500000 0 6772000 -13000 -859000 2637000 73869000 0 0.109 1046000 3829000 30000 829000 917000 3487000 0.045 0.053 72909000 72909000 0.0500 6928000 0.0500 1.30 P20D 30 1 P20D 30 1.30 10 0.98 1 67.6819 1000 14.78 5885000 1394000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Series I 2024 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,888)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(836)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,037)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,073 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,984 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 72909000 72909000 0 8888000 -836000 -1037000 72073000 62984000 0 0.0877 468000 1370000 911000 2733000 912000 2735000 0.050 5.4 35375000 38500000 73875000 0.0500 5593000 0.0500 1.30 P20D 30 1 P20D 30 1.30 10 0.98 1 67.6819 1000 14.78 0.047 4450000 890000 2637000 762000 1016000 12172000 6599000 1505000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Series II 2024 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component - including accretion</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,325 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,688 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,270 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,919 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 78325000 75688000 0 9461000 -1055000 -1308000 77270000 64919000 0 0.0899 890000 2637000 1260000 1663000 923000 1200000 923000 2770000 0.050 0.103 125000000 0.0425 0.0425 1.30 P20D 30 1 1000 P20D 30 1.30 10 0.98 1 94.6096 1000 10.57 7305000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2026 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,318)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,682 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 125000000 -6318000 118682000 1328000 2892000 0.0425 0.053 -18787000 10.57 16.58 125000 10000000 0.0100 10000000 10131000 <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Long-Term Obligations</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term obligations consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,234 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,304 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,063 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,088 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,380 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,318 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred gain on sale leaseback</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,257 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental executive retirement plan liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,222 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,368 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Death benefit obligation plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,723 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax obligation including interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,823 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long-Term Obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,781 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,474 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2015, the company entered into a real estate sale leaseback transaction which resulted in the company recording an initial deferred gain of $7,414,000, the majority of which is included in Other Long-Term Obligations and will be recognized over the 20-year life of the leases. The gains realized were $80,000 and $237,000 for the three and nine months ended September 30, 2021 respectively, compared to $77,000 and $228,000 for the three and nine months ended September 30, 2020, respectively.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term obligations consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,234 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,304 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,063 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,088 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,380 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,318 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred gain on sale leaseback</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,257 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental executive retirement plan liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,222 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,368 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Death benefit obligation plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,723 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax obligation including interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,823 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long-Term Obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,781 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,474 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 22909000 23234000 13374000 12304000 9063000 9088000 6380000 5318000 5257000 5502000 5222000 5368000 4537000 4723000 3124000 3114000 1915000 1823000 71781000 70474000 7414000 80000 237000 77000 228000 <div style="text-align:justify"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases and Commitments</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company reviews new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and certain non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2021, the company is committed under non-cancelable leases, which have initial or remaining terms in excess of one year and expire on various dates through 2040. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2015, the company </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. and Canadian Credit Facility</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded four finance leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the consolidated balance sheet. The gains realized were $80,000 and $237,000 for the three and nine months ended September 30, 2021 compared to $77,000 and $228,000 for the three and nine months ended September 30, 2020. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, the company entered into a 20-year lease agreement in Germany. The lease commenced in July 2020. The lease increased the company's finance lease obligation by $36,916,000 and increased the finance lease expense compared to previous periods.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December of 2020, the company entered into a 12.6-year lease agreement in Germany. The lease increased the company's finance lease obligation by $5,561,000 and increased the finance lease expense compared to previous periods. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expenses for the three and nine months ended September 30, 2021 and September 30, 2020, respectively, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.321%"><tr><td style="width:1.0%"/><td style="width:28.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,811 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,926 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,592 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">764 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,825 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,936 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,575 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,003 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,417 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,265 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">980 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,807 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,346 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,294 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating and finance lease commitments, as of September 30, 2021, are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance <br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,578 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,022 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,068 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,424 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,892 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,808 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,442 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,350 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,565 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,649 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,727 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts representing interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,461)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,432)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,188 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,295 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities of lease obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,118)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,553)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,070 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,742 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow amounts for the nine months ended September 30, 2021 were as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Activity: Cash paid in measurement of amounts for lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,501 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,311 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,345 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,763 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2021: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.47%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.12%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div></div> <div style="text-align:justify"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases and Commitments</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company reviews new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and certain non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2021, the company is committed under non-cancelable leases, which have initial or remaining terms in excess of one year and expire on various dates through 2040. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2015, the company </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. and Canadian Credit Facility</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded four finance leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the consolidated balance sheet. The gains realized were $80,000 and $237,000 for the three and nine months ended September 30, 2021 compared to $77,000 and $228,000 for the three and nine months ended September 30, 2020. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, the company entered into a 20-year lease agreement in Germany. The lease commenced in July 2020. The lease increased the company's finance lease obligation by $36,916,000 and increased the finance lease expense compared to previous periods.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December of 2020, the company entered into a 12.6-year lease agreement in Germany. The lease increased the company's finance lease obligation by $5,561,000 and increased the finance lease expense compared to previous periods. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expenses for the three and nine months ended September 30, 2021 and September 30, 2020, respectively, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.321%"><tr><td style="width:1.0%"/><td style="width:28.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,811 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,926 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,592 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">764 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,825 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,936 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,575 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,003 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,417 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,265 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">980 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,807 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,346 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,294 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating and finance lease commitments, as of September 30, 2021, are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance <br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,578 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,022 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,068 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,424 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,892 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,808 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,442 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,350 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,565 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,649 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,727 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts representing interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,461)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,432)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,188 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,295 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities of lease obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,118)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,553)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,070 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,742 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow amounts for the nine months ended September 30, 2021 were as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Activity: Cash paid in measurement of amounts for lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,501 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,311 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,345 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,763 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2021: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.47%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.12%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div></div> P1Y P20Y 23000000 2275000 P20Y Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases. 7414000 257000 32339000 80000 237000 77000 228000 P20Y 36916000 P12Y7M6D 5561000 <div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expenses for the three and nine months ended September 30, 2021 and September 30, 2020, respectively, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.321%"><tr><td style="width:1.0%"/><td style="width:28.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,811 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,926 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,592 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">764 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,825 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,936 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,575 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,003 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,417 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,265 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">980 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,807 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,346 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,294 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div> 1811000 1926000 5592000 6210000 764000 1077000 2825000 2936000 2575000 3003000 8417000 9146000 1146000 829000 3487000 1483000 1265000 980000 3807000 2346000 2411000 1809000 7294000 3829000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating and finance lease commitments, as of September 30, 2021, are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance <br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,578 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,022 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,068 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,424 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,892 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,808 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,442 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,350 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,565 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,649 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,727 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts representing interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,461)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,432)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,188 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,295 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities of lease obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,118)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,553)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,070 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,742 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating and finance lease commitments, as of September 30, 2021, are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance <br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,578 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,022 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,068 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,424 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,892 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,808 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,442 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,350 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,565 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,649 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,727 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts representing interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,461)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,432)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,188 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,295 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities of lease obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,118)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,553)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,070 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,742 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2578000 2022000 7068000 4424000 6964000 2466000 6892000 1808000 6797000 1442000 80350000 2565000 110649000 14727000 41461000 2432000 69188000 12295000 3118000 4553000 66070000 7742000 <div style="margin-top:4pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow amounts for the nine months ended September 30, 2021 were as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Activity: Cash paid in measurement of amounts for lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,501 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,311 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,345 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,763 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div> 8501000 6311000 14812000 5418000 6345000 11763000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2021: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.47%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.12%</span></td></tr></table></div> P16Y1M6D P4Y10M24D 0.0647 0.0712 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has two revenue streams: products and services. Services include repair, refurbishment, preventive maintenance and rental of product. Services for the North America segment include maintenance and repair of products. Services for the Europe segment include repair, refurbishment and preventive maintenance services. Services in All Other, are in the Asia Pacific region, and include rental and repair of products.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2021 and September 30, 2020 (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,671 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,355 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,026 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,936 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,054 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,332 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,395 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,805 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224,200 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,417 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,097 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259,623 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,275 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">632,313 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,953 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646,266 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,043 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,242 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,285 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,821 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,055 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,428 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207,292 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,614 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211,906 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329,943 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,204 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339,147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,999 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,595 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,565 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,339 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">613,507 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,139 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">626,646 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="padding-right:4.5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's revenues are principally related to the sale of products, approximately 98%, with the remaining 2% related to services including repair, refurbishment, preventive maintenance and rental of products. While the company has a significant amount of contract types, the sales split by contract type is as follows: general terms and conditions (30%), large national customers (30%), governments, principally pursuant to tender contracts (21%) and other customers including buying groups and independent customers (19%). </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All product and substantially all service revenues are recognized at a point in time. The remaining service revenue, recognized over time, are reflected in the Europe segment and include multiple performance obligations. For such contracts, the company allocates revenue to each performance obligation based on its relative standalone selling price. The company generally determines the standalone selling price based on the expected cost-plus margin methodology.    </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the company’s products and services. Revenue is measured as the amount of consideration expected to be received in exchange for transferring product or providing services. The amount of consideration received and revenue recognized by the company can vary as a result of variable consideration terms included in the contracts related to customer rebates, cash discounts and return policies. Customer rebates and cash discounts are estimated based on the most likely amount principle and these estimates are based on historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such the company estimates the expected returns based on an analysis of historical experience. The company adjusts its estimate of revenue at the earlier of when the most likely amount of consideration it expects to receive changes or when the consideration becomes fixed. The company generally does not expect that there will be significant changes to its estimates of variable consideration (refer to “Receivables” and "Accrued Expenses" in the Notes to the Condensed Consolidated </span></div></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Statements include elsewhere in this report for more detail). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the contract, the company may defer the recognition of a portion of the revenue at the end of a reporting period to align with transfer of control of the company’s products to the customer. In addition, to the extent performance obligations are satisfied over time, the company defers revenue recognition until the performance obligations are satisfied. As of September 30, 2021 and December 31, 2020, the company had deferred revenue of $3,413,000 and $3,516,000, respectively, related to outstanding performance obligations.</span></div> The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2021 and September 30, 2020 (in thousands):<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,671 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,355 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,026 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,936 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,054 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,332 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,395 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,805 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224,200 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,417 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,097 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259,623 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,275 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">632,313 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,953 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646,266 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,043 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,242 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,285 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,821 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,055 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,428 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207,292 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,614 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211,906 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329,943 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,204 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339,147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,999 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,595 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,565 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,339 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">613,507 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,139 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">626,646 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table> 123671000 3355000 127026000 87936000 118000 88054000 7788000 1332000 9120000 219395000 4805000 224200000 0.98 0.02 1 351680000 9417000 361097000 259623000 652000 260275000 21010000 3884000 24894000 632313000 13953000 646266000 0.98 0.02 1 113043000 3242000 116285000 87821000 234000 88055000 6428000 1138000 7566000 207292000 4614000 211906000 0.98 0.02 1 329943000 9204000 339147000 260999000 596000 261595000 22565000 3339000 25904000 613507000 13139000 626646000 0.98 0.02 1 0.98 0.02 0.30 0.30 0.21 0.19 3413000 3516000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Equity Compensation</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company’s Common Shares have a $0.25 stated value. The Common Shares and the Class B Common Shares generally have identical rights, terms and conditions and vote together as a single class on most issues, except that the Class B Common Shares have ten votes per share and, in general, can only be transferred to family members or for estate planning purposes. Holders of Class B Common Shares are entitled to convert their shares into Common Shares at any time on a share-for-share basis. When Class B Common Shares are transferred out of a familial relationship, they automatically convert to Common Shares.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, 3,667 Class B Common Shares remained outstanding. Prior conversions of Class B Common Shares have virtually eliminated the company’s dual class voting structure. As of September 30, 2021, the holders of the Common Shares represented approximately 99.9% of the company’s total outstanding voting power.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Compensation Plan</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2018, the shareholders of the company approved the Invacare Corporation 2018 Equity Compensation Plan (the “2018 Plan”), which was adopted on March 27, 2018 by the company's Board of Directors (the “Board”). The company’s Board adopted the 2018 Plan in order to authorize additional Common Shares for grant as equity compensation, and to reflect changes to Section 162(m) of the Internal Revenue Code (the “Code”) resulting from the U.S. Tax Cuts and Jobs Act of 2017. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following shareholder approval of the 2018 Plan, all of the Common Shares then-remaining available for issuance under the Invacare Corporation 2013 Equity Compensation Plan (the “2013 Plan”) and all of the Common Shares that were forfeited or remained unpurchased or undistributed upon termination or expiration of awards under the 2013 Plan and under the Invacare Corporation 2003 Performance Plan (the “2003 Plan”), become available for issuance under the 2018 Plan. Awards granted previously under the 2013 Plan and 2003 Plan will remain in effect under their original terms.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of stock options or stock appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a stock option or a SAR will count against the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003 </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Management Development Committee of the Board (the “Compensation Committee”), in its discretion, may grant an award under the 2018 Plan to any director or employee of the company or an affiliate. As of September 30, 2021, 3,439,806 Common Shares were available for future issuance under the 2018 Plan in connection with the following types of awards with respect to the company's Common Shares: incentive stock options, nonqualified stock options, SARs, restricted stock, restricted stock units, unrestricted stock and performance shares. The Compensation Committee also may grant performance units that are payable in cash. The Compensation Committee has the authority to determine which participants will receive awards, the amount of the awards and the other terms and conditions of the awards. The Common Shares available for future issuance under the 2018 Plan as of September 30, 2021 includes an additional 2,500,000 Common Shares that were added pursuant to an amendment approved by shareholders at the company’s 2021 annual shareholders meeting on May 20, 2021. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, an aggregate of 802,637 Common Shares underlie awards which were forfeited or expired unexercised under the 2003 and 2013 Plans and thus are available to be transferred under the 2018 Plan.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Plan provides that shares granted come from the company's authorized but unissued Common Shares or treasury shares. In addition, the company's stock-based compensation plans allow employee participants to exchange shares for minimum withholding taxes, which results in the company acquiring treasury shares. </span></div></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of equity-based compensation expense recognized as part of SG&amp;A expenses in All Other in business segment reporting were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock and restricted stock units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,570 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,471 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">799 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,494 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,369 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,965 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan and previous plans, which is related to non-vested options and shares, was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock and restricted stock units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,924 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,021 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total unrecognized stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,945 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unrecognized compensation cost will be adjusted for future changes in actual and estimated forfeitures and for updated vesting assumptions for the performance share awards (refer to "Stock Options" and "Performance Shares and Performance Share Units" below). No tax benefits for stock compensation were realized during the three and nine months ended September 30, 2021 and 2020, respectively, due to a valuation allowance against deferred tax assets. In accordance with ASC 718, any tax benefits resulting from tax deductions in excess of the compensation expense recognized is classified as a component of financing cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, non-qualified stock option awards have a term of ten years and were granted with an exercise price per share equal to the fair market value of the company’s Common Shares on the date of grant. </span></div></div></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock option activity for the nine months ended September 30, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,081,804 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.07 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(331,645)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.71</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercise price range at September 30, 2021</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.15 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">to</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.47 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercisable at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,159 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares available for grant at September 30, 2021*</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,439,806 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> *    Shares available for grant under the 2018 Plan as of September 30, 2021 reduced by net restricted stock and restricted stock unit and performance share and performance share unit award activity of 2,671,108 shares.</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock options outstanding at September 30, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:21.044%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Prices</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>Outstanding at<br/>September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12.15 – $20.00</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Plan provides for a one-year minimum vesting period for stock options and, generally, options must be exercised within ten years from the date granted. No stock options were issued in 2021 or 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock and Restricted Stock Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about restricted stock and restricted stock units (primarily for non-U.S. recipients):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.197%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock / units unvested at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145,058 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.62 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647,743 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.46 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(550,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,685)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.47 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock / units unvested at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,186,858 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restricted awards generally vest ratably over the three years after the award date. Unearned restricted stock compensation, determined as the market value of the shares at the date of grant, is being amortized on a straight-line basis over the vesting period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Shares and Performance Share Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about performance shares and performance share units (primarily for non-U.S. recipients):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.716%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares / units unvested at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,026,785 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">471,819 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.49 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares / units unvested at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,498,604 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, performance shares and performance share units (for non-U.S. recipients) were granted as performance awards with a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQ1NDZiOTI4OTFkZjQzN2M5MzNhYTU2MDNhYzJlYzljL3NlYzpkNTQ2YjkyODkxZGY0MzdjOTMzYWE1NjAzYWMyZWM5Y18xMzMvZnJhZzpjYThmYjIxNzgzNjg0NjdiYWE5ZDU5OWMzNDhjYTZjNC90ZXh0cmVnaW9uOmNhOGZiMjE3ODM2ODQ2N2JhYTlkNTk5YzM0OGNhNmM0XzczMjk_97caa6c6-e04a-46e4-a784-f11315754810">three</span> year performance period with payouts based on achievement of certain performance goals. The awards are classified as equity awards as they will be settled in common shares upon vesting. The number of shares earned will be determined at the end of the three-year performance period based on achievement of performance criteria for January 1, 2018 through December 31, 2020, January 1, 2019 through </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2021, January 1, 2020 through December 31, 2022 and January 1, 2021 through December 31, 2023, respectively established by the Compensation Committee at the time of grant. Recipients will be entitled to receive a number of Common Shares equal to the number of performance shares that vest based upon the levels of achievement which may range between 0% and 150% of the target number of shares with the target being 100% of the initial grant. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the performance awards is based on the stock price on the date of grant discounted for the estimated value of dividends foregone as the awards are not eligible for dividends except to the extent vested. The grant fair value is further updated each reporting period while variable accounting applies. The company assesses the probability that the performance targets will be met with expense recognized whenever it is probable that at least the minimum performance criteria will be achieved. Depending upon the company's assessment of the probability of achievement of the goals, the company may not recognize any expense associated with performance awards in a given period, may reverse prior expense recorded or record additional expense to recognize the cumulative estimated achievement level of proportionate term of the award. Performance award compensation expense is generally expected to be recognized over three years. The company continues to recognize expense related to the awards granted in 2019, 2020 and 2021 as it is considered probable that the performance goals for those awards will be met.</span></div>In the third quarter of 2021, reduced stock compensation expense was a benefit and is attributable to updated payout projections and change in the share price. 0.25 10 3667 0.999 The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of stock options or stock appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a stock option or a SAR will count against the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003 Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share. 3439806 2500000 802637 <div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of equity-based compensation expense recognized as part of SG&amp;A expenses in All Other in business segment reporting were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock and restricted stock units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,570 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,471 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">799 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,494 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,369 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,965 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4570000 4471000 799000 2494000 5369000 6965000 <div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan and previous plans, which is related to non-vested options and shares, was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock and restricted stock units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,924 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,021 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total unrecognized stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,945 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 7924000 4021000 11945000 P10Y <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock option activity for the nine months ended September 30, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,081,804 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.07 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(331,645)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.71</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercise price range at September 30, 2021</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.15 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">to</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.47 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercisable at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,159 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares available for grant at September 30, 2021*</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,439,806 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div> *    Shares available for grant under the 2018 Plan as of September 30, 2021 reduced by net restricted stock and restricted stock unit and performance share and performance share unit award activity of 2,671,108 shares 1081804 16.07 331645 23.71 750159 12.69 12.15 17.47 750159 3439806 2671108 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock options outstanding at September 30, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:21.044%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Prices</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>Outstanding at<br/>September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12.15 – $20.00</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 12.15 20.00 750159 P4Y2M12D 12.69 750159 12.69 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about restricted stock and restricted stock units (primarily for non-U.S. recipients):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.197%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock / units unvested at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145,058 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.62 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647,743 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.46 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(550,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,685)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.47 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock / units unvested at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,186,858 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1145058 8.62 647743 8.46 550258 9.34 55685 8.47 1186858 8.20 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about performance shares and performance share units (primarily for non-U.S. recipients):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.716%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares / units unvested at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,026,785 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">471,819 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.49 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares / units unvested at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,498,604 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1026785 8.55 471819 8.49 1498604 8.53 0 1.50 1 P3Y <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income by Component</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income ("OCI") (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,381 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,069)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,079 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,467)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,155)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,976)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,226 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,096)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,103 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,329 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(517)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,674)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,436 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,103)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(643)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,570)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,103)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,333)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,096)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,103 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,455 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,468)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,648 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,231 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,501)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,724 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,231 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,762)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,989 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,420)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,898 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,491)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,299)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,128 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,788 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,929)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,340)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,641 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,788 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,929)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(988)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,509 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,420)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated OCI were as follows (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.161%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount reclassified from OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount reclassified from OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Affected line item in the Statement of Comprehensive (Income) Loss</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and interest costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts hedging sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts hedging purchases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loss before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income ("OCI") (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,381 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,069)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,079 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,467)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,155)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,976)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,226 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,096)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,103 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,329 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(517)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,674)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,436 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,103)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(643)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,570)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,103)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,333)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,096)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,103 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,455 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,468)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,648 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,231 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,501)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,724 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,231 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,762)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,989 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,420)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,898 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,491)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,299)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,128 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,788 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,929)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,340)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,641 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,788 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,929)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(988)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,509 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,420)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div> 60381000 2146000 -4069000 -1379000 57079000 -19155000 -47000 -209000 944000 -18467000 0 0 -182000 -309000 -491000 -19155000 -47000 -27000 1253000 -17976000 41226000 2099000 -4096000 -126000 39103000 50329000 -517000 -3674000 -702000 45436000 -9103000 2616000 -440000 -643000 -7570000 0 0 -18000 -1219000 -1237000 -9103000 2616000 -422000 576000 -6333000 41226000 2099000 -4096000 -126000 39103000 16455000 -9133000 -3468000 794000 4648000 35231000 713000 281000 -2501000 33724000 0 0 474000 -739000 -265000 35231000 713000 -193000 -1762000 33989000 51686000 -8420000 -3661000 -968000 38637000 8898000 -2491000 -3299000 20000 3128000 42788000 -5929000 122000 -1340000 35641000 0 0 484000 -352000 132000 42788000 -5929000 -362000 -988000 35509000 51686000 -8420000 -3661000 -968000 38637000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated OCI were as follows (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.161%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount reclassified from OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount reclassified from OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Affected line item in the Statement of Comprehensive (Income) Loss</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and interest costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts hedging sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts hedging purchases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loss before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div> -182000 -474000 -18000 484000 0 0 0 0 182000 -474000 18000 -484000 476000 481000 657000 -692000 92000 1259000 -746000 -1029000 384000 778000 1403000 337000 75000 39000 184000 -15000 309000 739000 1219000 352000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Charges Related to Restructuring Activities</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's restructuring charges were originally necessitated primarily by continued declines in Medicare and Medicaid reimbursement by the U.S. government, as well as similar healthcare reimbursement pressures abroad, which negatively affect the company's customers (e.g. home health care providers) and continued pricing pressures faced by the company due to the outsourcing by competitors to lower cost locations. Restructuring decisions were also the result of reduced profitability in each of the segments. Restructuring actions have continued into 2021.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2021, charges totaled $2,476,000 which were related to North America of $975,000 and Europe of $1,501,000. In North America costs were incurred related to severance. The European charges were for severance costs of $895,000 and contract terminations of $606,000, primarily related to the closure of a German manufacturing facility. Payments for the nine months ended September 30, 2021 were $7,367,000 and the cash payments were funded with the company's cash on hand. The 2021 charges are expected to be paid out within 24 months.</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2020, charges totaled $4,657,000 which were related to North America of $865,000, Europe of $3,674,000 and All Other of $118,000. In North America and All Other, costs were incurred related to severance. The European charges were for severance costs $3,328,000 and contract terminations $346,000 primarily related to the closure of a German manufacturing facility. Payments for the nine months ended September 30, 2020 were $5,692,000 and the cash payments were funded with company's cash on hand. Most of the 2020 charges have been paid out.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in accrued balances related to the charges, either as a result of revisions to the plans or changes in estimates. In addition, the savings anticipated as a result of the company's restructuring plans have been or are expected to be achieved, primarily resulting in reduced salary and benefit costs principally impacting selling, general and administrative expenses, and to a lesser extent, costs of products sold. To date, the company's liquidity has been sufficient to absorb these charges and payments. </span></div></div></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2021 is as follows (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:45.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Severance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Terminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020 Balances</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,904 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,908 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,249 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,253 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,047)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,047)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,283)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,283)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021 Balances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(541)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021 Balances</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(509)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(543)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:45.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Severance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Terminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021 Balances</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table> 2476000 975000 1501000 895000 606000 7367000 P24M 4657000 865000 3674000 118000 3328000 346000 5692000 <div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2021 is as follows (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:45.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Severance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Terminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020 Balances</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,904 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,908 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,249 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,253 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,047)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,047)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,283)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,283)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021 Balances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(541)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021 Balances</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(509)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(543)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:45.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Severance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Terminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021 Balances</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table> 179000 0 179000 5904000 4000 5908000 166000 0 166000 6249000 4000 6253000 822000 0 822000 454000 276000 730000 0 0 0 1276000 276000 1552000 236000 0 236000 6047000 0 6047000 0 0 0 6283000 0 6283000 765000 0 765000 311000 280000 591000 166000 0 166000 1242000 280000 1522000 31000 0 31000 408000 108000 516000 0 0 0 439000 108000 547000 91000 0 91000 234000 198000 432000 18000 0 18000 343000 198000 541000 705000 0 705000 485000 190000 675000 148000 0 148000 1338000 190000 1528000 122000 0 122000 33000 222000 255000 0 0 0 155000 222000 377000 225000 0 225000 308000 34000 342000 -24000 0 -24000 509000 34000 543000 602000 0 602000 210000 378000 588000 172000 0 172000 984000 378000 1362000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The company had an effective tax rate of 8.8% and 11.3% on losses before tax for the three and nine months ended September 30, 2021, respectively, compared to an expected benefit of 21.0% on the pre-tax loss for each period. The company had an effective tax rate of 39.2% and 26.8% on losses before tax for the three and nine months ended September 30, 2020, respectively, compared to an expected benefit of 21.0% on the pre-tax loss for each period. The company's effective tax rate for the three and nine months ended September 30, 2021 and September 30, 2020 were unfavorable as compared to the U.S. federal statutory rate, principally due to the negative impact of the company not being able to record tax benefits related to the significant losses in countries which had tax valuation allowances. The effective tax rate was increased for the three and nine months ended September 30, 2021 and September 30, 2020 by certain taxes outside the United States, excluding countries with tax valuation allowances, that were at an effective rate higher than the U.S. statutory rate, except for the gain on the disposition of Dynamic Controls which was not taxable locally for the three months ended March 31, 2020. In addition, the company had accrued withholding taxes on earnings of its Chinese subsidiary based on the expectation of not permanently reinvesting those earnings. The sale of this entity, without such distribution resulted in the reversal of this accrual in the amount of $988,000 for the three months ended March 31, 2020. As a result of the impairment of goodwill in North America in the three and nine months ended September 30, 2021, the company recorded a reversal of deferred taxes related to the tax deductible goodwill previously deducted by the company, resulting in the company recognizing a tax benefit of $661,000 for the three and nine months ended September 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div> -0.088 -0.113 0.210 -0.392 -0.268 0.210 988000 661000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Net Loss Per Common Share</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.611%"><tr><td style="width:1.0%"/><td style="width:53.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,826 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,826 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options and awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,488 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,530 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,371 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,313 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share *</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2021, shares associated with equity compensation awards of 682,668 and 1,163,526, respectively, and for the three and nine months September 30, 2020, shares associated with equity compensation awards of 1,703,694 and 1,703,694, respectively, were excluded from the weighted average common shares assuming dilution as incremental shares were anti-dilutive. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, the majority of the anti-dilutive incremental shares were awards granted at an exercise price above $14.49, which was higher than the average fair market value price of $7.30 and $8.30 for the three and nine months ended September 30, 2021. At September 30, 2020, the majority of the anti-dilutive incremental shares were awards granted at an exercise price above $24.45 or above, which was higher than the average fair market value price of $6.93 and $7.12 for the three and nine months ended September 30, 2020.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2021 and September 30, 2020, respectively, no shares were included in the common shares assuming dilution related to the company's issued warrants as the average market price of the company shares for these periods did not exceed the strike price of the warrants.</span></div>Further, upon adoption of ASU 2020-06, effective in 2021 for the company, use of the if-converted earnings per share method is required. However, no shares were included in the weighted average common shares assuming dilution for the three months and nine months ended September 30, 2021 related to the company's convertible senior notes as conversion prices were above the company's average stock price for the period and other requirements for the notes to be convertible to shares were not met. <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.611%"><tr><td style="width:1.0%"/><td style="width:53.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,826 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,826 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options and awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,488 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,530 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,371 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,313 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share *</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.</span></div> 35013000 34419000 34826000 34213000 -22759000 -7276000 -47501000 -23163000 -0.65 -0.21 -1.36 -0.68 35013000 34419000 34826000 34213000 475000 111000 545000 100000 35488000 34530000 35371000 34313000 -22759000 -7276000 -47501000 -23163000 -0.65 -0.21 -1.36 -0.68 682668 1163526 1703694 1703694 14.49 7.30 8.30 24.45 6.93 7.12 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company manufactures and distributes durable medical equipment to the home health care, retail and extended care markets. The company performs credit evaluations of its customers’ financial condition. The company utilizes De Lage Landen, Inc. (“DLL”), a third-party financing company, to provide lease financing to Invacare's U.S. customers. The DLL agreement provides for direct leasing between DLL and the Invacare customer. The company retains a recourse obligation of $858,000 at September 30, 2021 to DLL for events of default under the contracts, which total $6,919,000 at September 30, 2021. Guarantees, ASC 460, requires the company to record a guarantee liability as it relates to the limited recourse obligation. As such, the company has recorded a liability for this guarantee obligation within other long-term obligations. The company's recourse is reevaluated by DLL biannually, considers activity between the biannual dates and excludes any receivables purchased by the company from DLL. The company monitors the collections status of these contracts and has provided amounts for estimated losses in its allowances for doubtful accounts in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASC 310-10-05-4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Credit losses are provided for in the financial statements.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities located throughout the United States, Australia, Canada, New Zealand and Europe or also direct from governmental entities in certain countries. A significant portion of products sold to dealers, both foreign and domestic, is ultimately funded through government reimbursement programs such as Medicare and Medicaid. Changes in these programs can have a significant shift in reimbursement to customers from managed care entities. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability. In addition, reimbursement guidelines in the home health care industry have a substantial impact on the nature and type of equipment an end user can obtain as well as the timing of reimbursement and, thus, affect the product mix, pricing and payment patterns of the company’s customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div></div></div> 858000 6919000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Derivatives</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 815 requires companies to recognize all derivative instruments in the consolidated balance sheet as either assets or liabilities at fair value. The accounting for changes in fair value of a derivative is dependent upon whether or not the derivative has been designated and qualifies for hedge accounting treatment and the type of hedging relationship. For derivatives designated and qualifying as hedging instruments, the company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Flow Hedging Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company uses derivative instruments in an attempt to manage its exposure to transactional foreign currency exchange risk. Foreign forward exchange contracts are used to manage the price risk associated with forecasted sales denominated in foreign currencies and the price risk associated with forecasted purchases of inventory over the next twelve months.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company recognizes its derivative instruments as assets or liabilities in the consolidated balance sheet measured at fair value. All the company’s derivative instruments are designated and qualify as cash flow hedges. Accordingly, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The remaining gain or loss on the derivative instrument in excess of the cumulative change in the fair value of the hedged item, if any, is recognized in current earnings during the period of change.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect against increases/decreases in forecasted foreign currency cash flows resulting from inventory purchases/sales over the next year, the company utilizes foreign currency forward contracts to hedge portions of its forecasted purchases/sales denominated in foreign currencies. The gains and losses are included in cost of products sold and selling, general and administrative expenses on the condensed consolidated statement of comprehensive income (loss). If it is later determined that a hedged forecasted transaction is unlikely to occur, any prospective gains or losses on the forward contracts would be recognized in earnings. The company does not expect any material amount of hedge ineffectiveness related to forward contract cash flow hedges during the next twelve months.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has historically not recognized any material amount of ineffectiveness related to forward contract cash flow hedges because the company generally limits its hedges to between 50% and 90% of total forecasted transactions for a given entity’s exposure to currency rate changes and the transactions hedged are recurring in nature. Furthermore, most of the hedged transactions are related to intercompany sales and purchases for which settlement occurs on a specific day each month. Forward contracts with a total notional amount in USD of $90,800,000 and $155,783,000 matured for the nine months ended September 30, 2021 and September 30, 2020, respectively.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Net Gain<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Net Gain<br/>(Loss)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / CHF</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,675 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / EUR</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,840 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,187 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / MXN</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / CHF</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,037 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,960 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,162 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / NOK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AUD / NZD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DKK / SEK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOK / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AUD / THB</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,963 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NZD / THB</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / THB</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,152 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / THB</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,332 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP / THB</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,525 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,228 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(814)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives Not Qualifying or Designated for Hedge Accounting Treatment</span></div><div><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company utilizes foreign currency forward contracts that are not designated as hedges in accordance with ASC 815. These contracts are entered into to eliminate the risk associated with the settlement of short-term intercompany trading receivables and payables between Invacare Corporation and its foreign subsidiaries. The currency forward contracts are entered into at the same time as the intercompany </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivables or payables are created so that upon settlement, the gain/loss on the settlement is offset by the gain/loss on the foreign currency forward contract. No material net gain or loss was realized by the company in 2021 or 2020 related to these contracts and the associated short-term intercompany trading receivables and payables.</span></div></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2021 and 2020, respectively, and outstanding were as follows (in thousands USD):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:52.307%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain<br/>(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / AUD</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,153 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,046 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / CAD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,616 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / EUR</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">60,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / DKK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,732 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,690 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / GBP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38,144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,062 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">338 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / NOK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,597 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">AUD / NZD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,579 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">AUD / THB</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,206 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / THB</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / THB</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">GBP / THB</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">184,936 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,315)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54,750 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the company’s derivative instruments were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Derivatives designated as hedging instruments under ASC 815</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">267 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">432 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,238 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Derivatives not designated as hedging instruments under ASC 815</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">339 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">897 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">606 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,086 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,321 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,432 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the company’s foreign currency forward exchange contract assets and liabilities are included in Other Current Assets and Accrued Expenses, respectively in the Condensed Consolidated Balance Sheets. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of derivative instruments on Accumulated Other Comprehensive Income (OCI) and the Condensed Statement of Comprehensive Income (Loss) was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:39.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.156%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives (foreign currency forward exchange contracts) in ASC 815 cash flow hedge<br/>relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain<br/>(Loss) Recognized  in Accumulated OCI on Derivatives<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Reclassified from<br/>Accumulated OCI into<br/>Income (Effective<br/>Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized in Income on<br/>Derivatives (Ineffective  Portion and Amount Excluded from<br/>Effectiveness Testing)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">944 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(352)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives (foreign currency forward exchange contracts) not designated as hedging<br/>instruments under ASC 815</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized in Income on Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(592)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,315)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,077)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains or losses recognized as the result of the settlement of cash flow hedge foreign currency forward contracts are recognized in net sales for hedges of inventory sales and in cost of products sold for hedges of inventory purchases. For the three and nine months ended September 30, 2021, net sales were decreased by $476,000 and $657,000 while cost of products sold was decreased by $92,000 and increased by $746,000 for net pre-tax realized losses of $384,000 and $1,403,000, respectively. For the three and nine months ended September 30, 2020, net sales were increased by $481,000 and $692,000 while cost of products sold was increased by $1,259,000 and $1,029,000 for net realized pre-tax losses of $778,000 and $337,000, respectively.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Losses of $592,000 and $1,315,000 were recognized in selling, general and administrative (SG&amp;A) expenses for the three and nine months ended September 30, 2021 compared to losses of $1,320,000 and $1,077,000 for the three and nine months ended September 30, 2020 related to forward contracts not designated as hedging instruments. The forward contracts were entered into to offset gains/losses that were also recorded in SG&amp;A expenses on intercompany trade receivables or payables. The gains/losses on the non-designated hedging instruments were substantially offset by gains/losses on intercompany trade payables.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's derivative agreements provide the counterparties with a right of set off in the event of a default. The right of set off would enable the counterparty to offset any net payment due by the counterparty to the company under the applicable agreement by any amount due by the company to the counterparty under any other agreement. For example, the terms of the agreement would permit a counterparty to a derivative contract that is also a lender under the company's Credit Agreement to reduce any derivative settlement amounts owed to the company under the derivative contract by any amounts owed to the counterparty by the company under the Credit Agreement. In addition, the agreements contain cross-default provisions that could trigger a default by the company under the agreement in the event of a default by the company under another agreement with the same counterparty. The company presents derivatives on a net basis in its financial statements for those subject to provisions that are similar to master netting agreements.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div></div> 0.50 0.90 90800000 155783000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Net Gain<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Net Gain<br/>(Loss)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / CHF</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,675 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / EUR</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,840 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,187 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / MXN</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / CHF</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,037 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,960 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,162 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / NOK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AUD / NZD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DKK / SEK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOK / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AUD / THB</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,963 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NZD / THB</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / THB</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,152 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / THB</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,332 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP / THB</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,525 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,228 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(814)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 321000 4000 1675000 -11000 14840000 83000 56187000 -636000 644000 -23000 2467000 -19000 727000 -4000 2658000 -41000 817000 98000 2230000 334000 1119000 2000 5037000 10000 4960000 -218000 19060000 44000 2882000 -40000 10162000 -73000 1215000 -66000 4167000 -64000 190000 1000 781000 -13000 750000 6000 3329000 9000 823000 -39000 3431000 -50000 0 0 4963000 -221000 425000 -42000 1755000 -55000 624000 60000 4152000 -56000 188000 13000 1332000 18000 0 0 842000 10000 30525000 -165000 124228000 -814000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2021 and 2020, respectively, and outstanding were as follows (in thousands USD):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:52.307%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain<br/>(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / AUD</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,153 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,046 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / CAD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,616 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / EUR</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">60,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / DKK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,732 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,690 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / GBP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38,144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,062 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">338 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / NOK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,597 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">AUD / NZD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,579 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">AUD / THB</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,206 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / THB</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / THB</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">GBP / THB</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">184,936 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,315)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54,750 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 6153000 50000 6046000 -159000 14616000 -74000 8320000 88000 60000000 -494000 0 0 21732000 -198000 8690000 207000 38144000 -438000 16062000 338000 22798000 11000 9053000 264000 4597000 -37000 0 0 8157000 -22000 0 0 6790000 -77000 6579000 -35000 5000 0 0 0 1206000 -107000 0 0 414000 40000 0 0 126000 9000 0 0 198000 22000 0 0 184936000 -1315000 54750000 703000 <div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the company’s derivative instruments were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Derivatives designated as hedging instruments under ASC 815</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">267 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">432 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,238 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Derivatives not designated as hedging instruments under ASC 815</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">339 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">897 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">606 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,086 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,321 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,432 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 267000 432000 424000 1238000 339000 1654000 897000 194000 606000 2086000 1321000 1432000 The effect of derivative instruments on Accumulated Other Comprehensive Income (OCI) and the Condensed Statement of Comprehensive Income (Loss) was as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:39.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.156%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives (foreign currency forward exchange contracts) in ASC 815 cash flow hedge<br/>relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain<br/>(Loss) Recognized  in Accumulated OCI on Derivatives<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Reclassified from<br/>Accumulated OCI into<br/>Income (Effective<br/>Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized in Income on<br/>Derivatives (Ineffective  Portion and Amount Excluded from<br/>Effectiveness Testing)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">944 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(352)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives (foreign currency forward exchange contracts) not designated as hedging<br/>instruments under ASC 815</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized in Income on Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(592)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,315)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,077)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 944000 -309000 51000 -643000 -1219000 -37000 -2501000 -739000 -662000 -1340000 -352000 -718000 592000 1315000 -1320000 -1077000 476000 657000 -92000 746000 384000 1403000 481000 692000 -1259000 -1029000 778000 337000 592000 1315000 -1320000 -1077000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Fair Values</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 820, the inputs used to derive the fair value of assets and liabilities are analyzed and assigned a level I, II or III priority, with level I being the highest and level III being the lowest in the hierarchy. Level I inputs are quoted prices in active markets for identical assets or liabilities. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level II inputs are quoted prices for similar assets or liabilities in active markets: quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. Level III inputs are based on valuations derived from valuation techniques in which one or more significant inputs are unobservable. </span></div></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:46.048%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.923%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basis for Fair Value Measurements at Reporting Date</span></td></tr><tr style="height:32pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets for Identical<br/>Assets / (Liabilities)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable<br/>Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level III</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward exchange contracts—net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward exchange contracts—net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values and fair values of the company’s financial instruments are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:58.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,656 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,656 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,298 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,298 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Installment receivables, net of reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts in Other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts in Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,086)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,086)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt (including current maturities of long-term debt) *</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(309,455)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279,747)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245,053)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237,948)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Notes </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,637)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,559)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,869)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,633)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series I 2024 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,073)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,984)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,035)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series II 2024 Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,270)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,697)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,919)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,090)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,682)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,793)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,793)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,039)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,926)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* The company's total debt is shown net of applicable discounts and fees associated with the convertible senior notes due in 2021, 2022, 2024 and 2026 on the company's condensed consolidated balance sheet. Accordingly, the fair values of the convertible senior notes due in 2021, 2022, 2024 and 2026 included in the long-term debt presented in this table are also shown net of the discounts and fees. Discount balances applicable to the company's convertible senior notes were eliminated upon adoption of ASU 2020-06 on January 1, 2021, but are included in the balances above for the period prior to adoption. Refer to Long-Term Debt footnote for discount balances by convertible senior notes series. Total debt excludes operating and finance leases obligations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company, in estimating its fair value disclosures for financial instruments, used the following methods and assumptions:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash, cash equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying value reported in the balance sheet for cash, cash equivalents equals its fair value.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other investments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The company has an investment in a limited partnership, which is accounted for using the cost method, adjusted for any estimated declines in value. The investment was acquired in private placement and there is no quoted market price or stated rate of return. The company does not have the ability to easily sell the investment. The company completes an evaluation of the residual value related to such investments in the fourth quarter of each year.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Installment receivables:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying value reported in the balance sheet for installment receivables approximates its fair value. The interest rates associated with these receivables have not varied significantly since inception. Management believes that after consideration of the credit risk, the net book value of the installment receivables approximates market value.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward contracts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company operates internationally, and as a result, is exposed to foreign currency fluctuations. Specifically, the exposure includes intercompany loans and third-party sales or payments. In an attempt to reduce this exposure, foreign currency forward contracts are utilized and accounted for as hedging instruments. The forward contracts are used to hedge the following currencies: AUD, CAD, CHF, DKK, EUR, GBP, MXN, NOK, NZD, SEK, THB, and USD. The company does not use derivative financial instruments for speculative purposes. Fair values for the company’s foreign exchange forward contracts are based on quoted market prices for contracts with similar maturities. The company’s forward contracts are included in Other current assets or Accrued expenses in the condensed consolidated balance sheets. </span>Total debt: Fair value for the company’s convertible debt is based on quoted market-based estimates as of the end of the period, while the revolving credit facility fair value is based upon an estimate of the market for similar borrowing arrangements. The fair values are deemed to be categorized as Level 2 in the fair value hierarchy. Other total debt is primarily attributable to credit facilities borrowings where the carrying value reported in the balance approximates its fair value and the CARES Act Loan as of December 31, 2020 which utilized the fair value factor of the 2022 Notes to approximate fair value. <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:46.048%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.923%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basis for Fair Value Measurements at Reporting Date</span></td></tr><tr style="height:32pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets for Identical<br/>Assets / (Liabilities)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable<br/>Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level III</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward exchange contracts—net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward exchange contracts—net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 0 -1480000 0 0 -111000 0 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values and fair values of the company’s financial instruments are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:58.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,656 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,656 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,298 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,298 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Installment receivables, net of reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts in Other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts in Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,086)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,086)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt (including current maturities of long-term debt) *</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(309,455)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279,747)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245,053)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237,948)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Notes </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,637)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,559)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,869)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,633)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series I 2024 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,073)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,984)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,035)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series II 2024 Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,270)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,697)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,919)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,090)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,682)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,793)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,793)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,039)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,926)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* The company's total debt is shown net of applicable discounts and fees associated with the convertible senior notes due in 2021, 2022, 2024 and 2026 on the company's condensed consolidated balance sheet. Accordingly, the fair values of the convertible senior notes due in 2021, 2022, 2024 and 2026 included in the long-term debt presented in this table are also shown net of the discounts and fees. Discount balances applicable to the company's convertible senior notes were eliminated upon adoption of ASU 2020-06 on January 1, 2021, but are included in the balances above for the period prior to adoption. Refer to Long-Term Debt footnote for discount balances by convertible senior notes series. Total debt excludes operating and finance leases obligations.</span></div> 73656000 73656000 105298000 105298000 84000 84000 85000 85000 1160000 1160000 1322000 1322000 606000 606000 1321000 1321000 2086000 2086000 1432000 1432000 309455000 279747000 245053000 237948000 0 0 1242000 1264000 2637000 2559000 73869000 70633000 72073000 64643000 62984000 60035000 77270000 73697000 64919000 64090000 118682000 100055000 0 0 38793000 38793000 42039000 41926000 <div style="margin-bottom:6pt;text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company operates in two primary business segments: North America and Europe with each selling the company's primary product categories, which include: lifestyle, mobility and seating and respiratory therapy products. Sales in Asia Pacific are reported in All Other and include products similar to those sold in North America and Europe. The accounting policies of each segment are the same as those described in the summary of significant accounting policies for the company's consolidated financial statements. Intersegment sales and transfers are based on the costs to manufacture plus a reasonable profit element. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment performance is measured and resources are allocated based on a number of factors, with the primary income or loss measure being segment operating income (loss). Segment operating income (loss) represents net sales less cost of products sold less selling general and administrative expenses. Segment operating income (loss) </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excludes unallocated corporate general and administrative expenses not allocated to the segments and intersegment sales and profit eliminations, which are included in All Other. In addition, segment operating income (loss) further excludes charges related to restructuring activities, asset impairment and gain on sale of business (as applicable).</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This performance measure, segment operating income (loss), is used by the Chief Operating Decision Maker (CODM) for purposes of making decisions about allocating resources to a segment and assessing its performance. In addition, this metric is reviewed by the company's Board of Directors regarding segment performance and is a key metric in the performance management assessment of the company's employees. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information by segment is as follows (in thousands):</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:52.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">127,026 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116,285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">361,097 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">339,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,054 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,055 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">260,275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">261,595 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">224,200 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">211,906 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">646,266 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">626,646 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,758 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,438 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,044 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23,625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45,903 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,645 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,265 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30,768 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,661 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">84,439 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restructuring charges before income taxes</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">975 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,580 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,476 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,657 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,554 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18,378 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,624 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,523)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,992 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,759 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3,856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,082)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(19,025)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17,377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Charge expense related to restructuring activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,580)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,476)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gain on sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(28,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(28,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(24,766)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,930 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,995)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,139 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gain (loss) on debt extinguishment including debt finance charges and associated fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,422 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,284)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,395)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18,098)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(21,042)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(20,919)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5,226)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(42,671)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18,263)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales by product, are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:52.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">61,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50,307 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">181,628 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">160,628 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,535 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54,851 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">152,660 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147,275 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,070 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,583 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,057 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13,196 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,564 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">127,026 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116,285 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">361,097 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">339,147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38,666 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41,845 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">114,951 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">124,888 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28,414 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26,572 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,243 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,485 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20,856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62,429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53,626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">233 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">652 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">596 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,054 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,055 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">260,275 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">261,595 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,757 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,230 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,375 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,736 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,176 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,504 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,326 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,372 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,928 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,120 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,566 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25,904 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">224,200 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">211,906 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">646,266 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">626,646 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes various services, including repair services, equipment rentals and external contracting.</span></div> <div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information by segment is as follows (in thousands):</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:52.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">127,026 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116,285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">361,097 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">339,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,054 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,055 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">260,275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">261,595 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">224,200 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">211,906 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">646,266 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">626,646 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,758 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,438 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,044 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23,625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45,903 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,645 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,265 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30,768 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,661 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">84,439 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restructuring charges before income taxes</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">975 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,580 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,476 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,657 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,554 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18,378 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,624 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,523)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,992 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,759 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3,856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,082)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(19,025)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17,377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Charge expense related to restructuring activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,580)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,476)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gain on sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(28,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(28,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(24,766)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,930 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,995)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,139 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gain (loss) on debt extinguishment including debt finance charges and associated fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,422 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,284)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,395)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18,098)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(21,042)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(20,919)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5,226)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(42,671)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18,263)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 127026000 116285000 361097000 339147000 88054000 88055000 260275000 261595000 9120000 7566000 24894000 25904000 224200000 211906000 646266000 626646000 6221000 6027000 17758000 14438000 15044000 23625000 45903000 66356000 0 1116000 0 3645000 21265000 30768000 63661000 84439000 255000 1434000 1501000 3674000 122000 146000 975000 865000 0 0 0 118000 377000 1580000 2476000 4657000 9554000 7600000 18378000 16624000 -1523000 2992000 -2308000 5759000 -3856000 -6082000 -19025000 -17377000 377000 1580000 2476000 4657000 0 0 0 9790000 28564000 0 28564000 0 -24766000 2930000 -33995000 10139000 10131000 -761000 9422000 -7360000 -6284000 -7395000 -18098000 -21042000 -20919000 -5226000 -42671000 -18263000 <div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales by product, are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:52.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">61,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50,307 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">181,628 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">160,628 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,535 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54,851 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">152,660 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147,275 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,070 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,583 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,057 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13,196 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,564 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">127,026 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116,285 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">361,097 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">339,147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38,666 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41,845 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">114,951 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">124,888 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28,414 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26,572 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,243 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,485 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20,856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62,429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53,626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">233 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">652 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">596 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,054 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,055 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">260,275 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">261,595 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,757 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,230 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,375 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,736 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,176 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,504 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,326 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,372 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,928 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,120 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,566 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25,904 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">224,200 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">211,906 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">646,266 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">626,646 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes various services, including repair services, equipment rentals and external contracting.</span></div> 61683000 50307000 181628000 160628000 56535000 54851000 152660000 147275000 4225000 6070000 13613000 16680000 4583000 5057000 13196000 14564000 127026000 116285000 361097000 339147000 38666000 41845000 114951000 124888000 28414000 26572000 82243000 82485000 20856000 19405000 62429000 53626000 118000 233000 652000 596000 88054000 88055000 260275000 261595000 3171000 2670000 9239000 10757000 3230000 3375000 8736000 10176000 1215000 195000 2547000 1043000 1504000 1326000 4372000 3928000 9120000 7566000 24894000 25904000 224200000 211906000 646266000 626646000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions in which various plaintiffs seek damages for injuries allegedly caused by defective products. All the product liability lawsuits that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended or prohibited diplomatic or trade relations. The amount recorded for identified contingent liabilities is based on estimates. Amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. Actual costs to be incurred in future periods may vary from the estimates, given the inherent uncertainties in evaluating certain exposures.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a medical device manufacturer, the company is subject to extensive government regulation, including numerous laws directed at preventing fraud and abuse and laws regulating reimbursement under various government programs. The marketing, invoicing, documenting, developing, testing, manufacturing, labeling, promoting, distributing and other practices of health care suppliers and medical device manufacturers are all subject to government scrutiny. Most of the company's facilities are subject to inspection at any time by the FDA or similar medical device regulatory agencies in other jurisdictions. Violations of law or regulations can result in administrative, civil and criminal penalties and sanctions, which could have a material adverse effect on the company's business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medical Device Regulatory Matters</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA in the United States and comparable medical device regulatory authorities in other jurisdictions regulate virtually all aspects of the marketing, invoicing, documenting, development, testing, manufacturing, labeling, promotion, distribution and other practices regarding medical devices. The company and its products are subject to the laws and regulations of the FDA and other regulatory bodies in the various jurisdictions where the company's products are manufactured or sold. The company's failure to comply with the regulatory requirements of the FDA and other applicable medical device regulatory requirements can subject the company to administrative or judicially imposed sanctions or </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enforcement actions. These sanctions include injunctions, consent decrees, warning letters, civil penalties, criminal penalties, product seizure or detention, product recalls and total or partial suspension of production.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2012, the company became subject to a consent decree of injunction filed by the FDA with respect to the company's Corporate facility and its Taylor Street manufacturing facility in Elyria, Ohio. The consent decree initially limited the company's (i) manufacture and distribution of power and manual wheelchairs, wheelchair components and wheelchair sub-assemblies at or from its Taylor Street manufacturing facility, except in verified cases of medical necessity, (ii) design activities related to wheelchairs and power beds that take place at the impacted Elyria facilities and (iii) replacement, service and repair of products already in use from the Taylor Street manufacturing facility. Under the terms of the consent decree, in order to resume full operations, the company had to successfully complete independent, third-party expert certification audits at the impacted Elyria facilities, comprising three distinct certification reports separately submitted to, and subject to acceptance by, the FDA; submit its own report to the FDA; and successfully complete a reinspection by the FDA of the company's Corporate and Taylor Street facilities.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 24, 2017, following its June 2017 reinspection of the Corporate and Taylor Street facilities, the FDA notified the company that it is in substantial compliance with the FDA Act, FDA regulations and the terms of the consent decree and, that the company was permitted to resume full operations at those facilities including the resumption of unrestricted sales of products made in those facilities.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consent decree will continue in effect for at least five years from July 24, 2017, during which time the company's Corporate and Taylor Street facilities must complete two semi-annual audits in the first year and then four annual audits in the next four years performed by a company-retained expert firm. The expert audit firm will determine whether the facilities remain in continuous compliance with the FDA Act, FDA regulations and the terms of the consent decree. The FDA has the authority to inspect these facilities and any other FDA registered facility, at any time. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has continued to actively inspect the company's facilities, other than through the processes established under the consent decree. The company expects that the FDA will, from time to time, inspect substantially all the company's domestic and foreign FDA-registered facilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the FDA inspected the company's Corporate and Taylor Street facilities in Elyria and North Ridgeville, </span></div></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ohio and issued its observations on Form 843. The company has submitted its response to FDA in a timely manner. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of regulatory claims, proceedings, investigations, or litigation are difficult to predict. An unfavorable resolution or outcome of any FDA warning letters or inspectional observations, or other FDA enforcement related to company facilities, could materially and adversely affect the company's business, financial condition, and results of operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The limitations previously imposed by the FDA consent decree negatively affected net sales in the North America segment and, to a certain extent, the Asia Pacific region beginning in 2012. The limitations led to delays in new product introductions. Further, uncertainty regarding how long the limitations would be in effect limited the company's ability to renegotiate and bid on certain customer contracts and otherwise led to a decline in customer orders.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the company has been permitted to resume full operations at the Corporate and Taylor Street facilities, the negative effect of the consent decree on customer orders and net sales in the North America segment and Asia Pacific region has been considerable, and it is uncertain as to whether, or how quickly, the company will be able to rebuild net sales to more typical historical levels, irrespective of market conditions. Accordingly, when compared to the company's 2010 results, the previous limitations in the consent decree had, and likely may continue to have, a material adverse effect on the company's business, financial condition and results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Warranty Matters</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's warranty reserves are subject to adjustment in future periods based on historical analysis of warranty claims and as new developments occur that may change the company's estimates related to specific product recalls. Refer to Current Liabilities in the Notes to the Condensed Consolidated Financial Statements for the total provision amounts and a reconciliation of the changes in the warranty accrual.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of the above contingencies could have an adverse impact on the company's financial condition or results of operations. </span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding the consent decree, other regulatory matters, and risks and trends that may impact the company’s financial condition or results of operations, please see the following sections of the company's Annual Report on Form 10-K for the year ended December 31, 2020: Item 1. Business - Government Regulation and Item 1A. Risk Factors; Item 3. Legal Proceedings; and Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources.</span></div>  *    Shares available for grant under the 2018 Plan as of September 30, 2021 reduced by net restricted stock and restricted stock unit and performance share and performance share unit award activity of 2,671,108 shares. Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss. XML 23 R1.htm IDEA: XBRL DOCUMENT v3.21.2
DEI Document - shares
 9 Months Ended
Sep. 30, 2021
Oct. 25, 2021
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2021  
Document Transition Report false  
Entity File Number 001-15103  
Entity Registrant Name INVACARE CORPORATION  
Entity Incorporation, State or Country Code OH  
Entity Tax Identification Number 95-2680965  
Entity Address, Address Line One One Invacare Way,  
Entity Address, City or Town Elyria,  
Entity Address, State or Province OH  
Entity Address, Postal Zip Code 44035  
City Area Code 440  
Local Phone Number 329-6000  
Title of 12(b) Security Common Shares, without par value  
Trading Symbol IVC  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0000742112  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Common Shares [Member]    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   35,019,682
Class B Common Shares [Member]    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   3,667

XML 24 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statement of Comprehensive Income (Loss) - USD ($)
shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Statement of Comprehensive Income [Abstract]        
Net Sales $ 224,200,000 $ 211,906,000 $ 646,266,000 $ 626,646,000
Cost of products sold 163,890,000 151,866,000 470,500,000 446,968,000
Gross Profit 60,310,000 60,040,000 175,766,000 179,678,000
Selling, general and administrative expenses 56,135,000 55,530,000 178,721,000 174,672,000
Gain on sale of business 0 0 0 9,790,000
Charges related to restructuring activities 377,000 1,580,000 2,476,000 4,657,000
Goodwill, Impairment Loss 28,564,000 0 28,564,000 0
Operating Income (Loss) (24,766,000) 2,930,000 (33,995,000) 10,139,000
Loss (gain) on debt extinguishment including debt finance charges and fees (10,131,000) 761,000 (9,422,000) 7,360,000
Interest expense 6,284,000 7,402,000 18,099,000 21,132,000
Interest Income, Other 0 7,000 1,000 90,000
Loss Before Income Taxes (20,919,000) (5,226,000) (42,671,000) (18,263,000)
Income tax provision 1,840,000 2,050,000 4,830,000 4,900,000
Net Loss $ (22,759,000) $ (7,276,000) $ (47,501,000) $ (23,163,000)
Dividends Declared per Common Share $ 0 $ 0 $ 0 $ 0.0125
Net Loss per Share—Basic        
Net Loss per Share—Basic $ (0.65) $ (0.21) $ (1.36) $ (0.68)
Weighted Average Shares Outstanding—Basic 35,013 34,419 34,826 34,213
Loss per Share—Assuming Dilution        
Loss per Share—Assuming Dilution [1] $ (0.65) $ (0.21) $ (1.36) $ (0.68)
Weighted Average Shares Outstanding—Assuming Dilution 35,488 34,530 35,371 34,313
Other comprehensive income (loss):        
Foreign currency translation adjustments $ (19,202,000) $ 35,944,000 $ (6,487,000) $ 36,859,000
Defined Benefit Plans:        
Amortization of prior service costs and unrecognized losses (27,000) (193,000) (422,000) (362,000)
Deferred tax adjustment resulting from defined benefit plan activity 20,000 9,000 (43,000) 25,000
Valuation reserve associated with defined benefit plan activity (20,000) (9,000) 43,000 (25,000)
Current period gain (loss) on cash flow hedges 1,423,000 (2,047,000) 649,000 (1,159,000)
Deferred tax benefit (provision) related to gain on cash flow hedges (170,000) 285,000 (73,000) 171,000
Other Comprehensive Income (Loss) (17,976,000) 33,989,000 (6,333,000) 35,509,000
Comprehensive Income (Loss) $ (40,735,000) $ 26,713,000 $ (53,834,000) $ 12,346,000
Net Sales, as a Percent of Net Sales 100.00% 100.00% 100.00% 100.00%
Cost of Products Sold, as a Percent of Net Sales 73.10% 71.70% 72.80% 71.30%
Gross Profit, as a Percent of Net Sales 26.90% 28.30% 27.20% 28.70%
Selling, general and administrative expenses, as a Percent of Net Sales 25.00% 26.20% 27.70% 27.90%
Gain on sale of business, as a Percent of Net Sales 0.00% 0.00% 0.00% (1.60%)
Charges related to restructuring activities, as a Percent of Net Sales 0.20% 0.70% 0.40% 0.70%
Impairment of goodwill, as a Percent of net Sales 12.70% 0.00% 4.40% 0.00%
Operating Gain (Loss), as a Percent of Net Sales (11.00%) 1.40% (5.30%) 1.60%
Interest expense, as a Percent of Net Sales 2.80% 3.50% 2.80% 3.40%
Interest income, as a Percent of Net Sales 0.00% 0.00% 0.00% 0.00%
Gain (loss) Before Income Taxes, as a Percent of Net Sales (9.30%) (2.50%) (6.60%) (2.90%)
Income Tax Provision, as a Percent of Net Sales 0.80% 1.00% 0.70% 0.80%
Net Gain (Loss), as a percent of Net Sales (10.20%) (3.40%) (7.40%) (3.70%)
Net loss (gain) on debt extinguishment, as a Percent of Net Sales [Line Items] (4.50%) 0.40% (1.50%) 1.20%
[1] Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
XML 25 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 73,656 $ 105,298
Trade receivables, net 115,923 108,588
Installment receivables, net 292 379
Inventories, net 151,335 115,484
Other current assets 36,151 44,717
Total Current Assets 377,357 374,466
Other Assets 6,177 5,925
Intangibles, net 27,357 27,763
Property and Equipment, net 62,212 56,243
Finance Lease, Right-of-Use Asset 65,758 64,031
Operating Lease, Right-of-Use Asset 12,480 15,092
Goodwill 370,739 402,461
Total Assets 922,080 945,981
Current Liabilities    
Accounts payable 110,234 85,424
Accrued expenses 104,210 126,273
Current taxes payable 5,203 3,359
Current portion of long-term debt 3,121 5,612
Current portion of finance lease obligations 3,118 3,405
Current portion of operating lease obligations 4,553 6,313
Total Current Liabilities 230,439 230,386
Long-Term Debt 306,334 239,441
Finance Lease Long-Term Obligations 66,070 63,137
Operating Leases Long-Term Obligations 7,742 8,697
Other Long-Term Obligations 71,781 70,474
Shareholders’ Equity    
Preferred Shares (Authorized 300 shares; none outstanding) 0 0
Additional paid-in-capital 277,711 326,088
Retained earnings 20,707 58,538
Accumulated other comprehensive income 39,103 45,436
Treasury Shares (4,397 and 4,184 shares at September 30, 2021 and December 31, 2020, respectively) (107,786) (106,034)
Total Shareholders’ Equity 239,714 333,846
Total Liabilities and Shareholders’ Equity 922,080 945,981
Common Shares [Member]    
Shareholders’ Equity    
Common Shares 9,977 9,816
Class B Common Shares [Member]    
Shareholders’ Equity    
Common Shares $ 2 $ 2
XML 26 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Parentheticals) - shares
shares in Thousands
Sep. 30, 2021
Dec. 31, 2020
Preferred Stock, Shares Authorized 300 300
Preferred Stock, Shares Outstanding 0 0
Treasury Stock, Shares 4,397 4,184
Common Shares [Member]    
Common Stock, Shares Authorized 150,000 150,000
Common Stock, Shares, Issued 39,417 38,613
Class B Common Shares [Member]    
Common Stock, Shares Authorized 12,000 12,000
Common Stock, Shares, Issued 4 4
XML 27 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statement Of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Purchases of capped calls $ (18,787,000) $ 0
Convertible Debt Discount Amortization and Accretion 2,637,000 8,629,000
Goodwill, Impairment Loss 28,564,000 0
Operating Activities    
Net loss (47,501,000) (23,163,000)
Adjustments to reconcile net loss to net cash used by operating activities:    
Gain on sale of business 0 9,790,000
Depreciation and amortization 12,511,000 10,360,000
Amortization of operating lease right of use assets 4,757,000 5,284,000
Provision for losses on trade and installment receivables 327,000 554,000
Provision (benefit) for deferred income taxes (148,000) 111,000
Provision for other deferred liabilities 165,000 594,000
Provision for equity compensation 5,369,000 6,965,000
Gain on disposals of property and equipment (232,000) (1,066,000)
Loss (gain) on debt extinguishment including debt finance charges and fees (9,422,000) 7,360,000
Amortization of debt fees 1,622,000 1,329,000
Changes in operating assets and liabilities:    
Trade receivables (8,030,000) 6,160,000
Installment sales contracts, net 222,000 532,000
Inventories, net (37,199,000) (22,021,000)
Other current assets 8,215,000 1,691,000
Accounts payable 24,769,000 5,903,000
Accrued expenses (24,182,000) 1,616,000
Other long-term liabilities 731,000 (226,000)
Net Cash Provided by (Used in) Operating Activities (36,825,000) 822,000
Investing Activities    
Purchases of property and equipment (14,397,000) (16,824,000)
Proceeds from sale of property and equipment 23,000 396,000
Proceeds from sale of business 0 14,563,000
Change in other long-term assets (93,000) 67,000
Other 0 2,176,000
Net Cash Used by Investing Activities (14,467,000) (3,974,000)
Financing Activities    
Proceeds from revolving lines of credit and long-term borrowings 154,830,000 72,551,000
Repurchases of convertible debt, payments on revolving lines of credit and finance leases (109,139,000) (59,483,000)
Payment of financing costs (5,369,000) (1,307,000)
Payment of dividends 0 (414,000)
Payments to debt holders 0 (5,593,000)
Purchases of capped calls (18,787,000) 0
Purchases of treasury shares (1,752,000) (1,702,000)
Net Cash Provided by Financing Activities 19,783,000 4,052,000
Effect of exchange rate changes on cash (133,000) 5,862,000
Cash, Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (31,642,000) 6,762,000
Cash and cash equivalents at beginning of year 105,298,000 80,063,000
Cash and cash equivalents at end of period $ 73,656,000 $ 86,825,000
XML 28 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statement of Shareholders' Equity Statement - USD ($)
$ in Thousands
Total
Common Stock [Member]
Common Stock [Member]
Class B Common Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock [Member]
Total Shareholders’ Equity at Dec. 31, 2019 $ 308,516 $ 9,588 $ 2 $ 312,650 $ 87,475 $ 3,128 $ (104,327)
Allocated Share-based Compensation Expense 2,494     2,494      
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 3,890 137   4,334     (581)
Net Loss (23,163)       (23,163)    
Foreign currency translation adjustments 36,859            
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 36,859            
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax (988)         (988)  
Amortization of prior service costs and unrecognized losses (362)            
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax (362)            
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12,346            
Exchange of Convertible Notes 5,021     5,021      
Payments of Ordinary Dividends, Common Stock (414)            
Dividends, Common Stock, Cash (414)            
Purchases of capped calls 0            
Total Shareholders’ Equity at Sep. 30, 2020 330,489 9,815 2 324,409 63,655 38,637 (106,029)
Stock Issued During Period, Value, Stock Options Exercised (1,121) (90)   (90)     (1,121)
Adoption of Credit Loss Standard (243)       (243)    
Total Shareholders’ Equity at Jun. 30, 2020 302,146 9,815 2 322,770 70,931 4,648 (106,020)
Allocated Share-based Compensation Expense 818     818      
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 812     821     (9)
Net Loss (7,276)       (7,276)    
Foreign currency translation adjustments 35,944            
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 35,944            
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax (1,762)         (1,762)  
Amortization of prior service costs and unrecognized losses (193)            
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax (193)            
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 26,713            
Total Shareholders’ Equity at Sep. 30, 2020 330,489 9,815 2 324,409 63,655 38,637 (106,029)
Total Shareholders’ Equity at Dec. 31, 2020 333,846 9,816 2 326,088 58,538 45,436 (106,034)
Allocated Share-based Compensation Expense 131 52   747     (668)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 3,486 109   4,461     (1,084)
Net Loss (47,501)       (47,501)    
Foreign currency translation adjustments (6,487)            
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (6,487)            
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 576         576  
Amortization of prior service costs and unrecognized losses (422)            
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax (422)            
Comprehensive Income (Loss), Net of Tax, Attributable to Parent (53,834)            
Payments of Ordinary Dividends, Common Stock 0            
Adoption of ASU 2020-06 (25,128)     (34,798) 9,670    
Purchases of capped calls (18,787)     (18,787)      
Total Shareholders’ Equity at Sep. 30, 2021 239,714 9,977 2 277,711 20,707 39,103 (107,786)
Total Shareholders’ Equity at Jun. 30, 2021 280,890 9,977 2 278,152 43,466 57,079 (107,786)
Allocated Share-based Compensation Expense (1,250) 0   (1,250)     0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 809 0   809     0
Net Loss (22,759)       (22,759)    
Foreign currency translation adjustments (19,202)            
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (19,202)            
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 1,253         1,253  
Amortization of prior service costs and unrecognized losses (27)            
Comprehensive Income (Loss), Net of Tax, Attributable to Parent (40,735)            
Total Shareholders’ Equity at Sep. 30, 2021 $ 239,714 $ 9,977 $ 2 $ 277,711 $ 20,707 $ 39,103 $ (107,786)
XML 29 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Accounting Policies
 9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Accounting Policies Accounting Policies
Principles of Consolidation:  The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2021 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2021 and 2020, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year.

Use of Estimates:  The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.

Recent Accounting Pronouncements (Already Adopted): 
In August 2020, the FASB issued ASU 2020-06 "Debt with Conversion and Other Options" (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity's Own Equity (Subtopic 815-40)", which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. ASU 2020-06 removes from U.S. GAAP the separation models for (1) convertible debt with a cash conversion feature (CCF) and (2) convertible instrument with a beneficial conversion feature (BCF). As a result, after adopting the ASU’s guidance, entities will not separately present in equity an embedded conversion feature in such debt. Instead, they will account for a convertible debt instrument wholly as debt, and for convertible preferred stock wholly as preferred stock (i.e., as a single unit of account), unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC 815 or (2) a convertible debt instrument was issued at a substantial premium. The guidance may be early adopted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years.

The company adopted ASU 2020-06 effective January 1, 2021, using the modified retrospective method, which resulted
in the removal of convertible debt discounts of $25,218,000, adjustment of $34,798,000 to additional paid-in-capital and $9,670,000 adjustment to retained earnings. Convertible debt discounts prior to adoption of ASU 2020-06 were amortized over the convertible debt term through interest expense. Subsequent to adoption, convertible debt discounts are not applicable when accounting for debt as a single unit of account. Interest expense for the three and nine months ended September 30, 2020 related to debt discount amortization (which was not recognized in 2021 due to adoption) were $2,273,000 or $0.07 per basic and diluted share and $7,613,000 or $0.22 per basic and diluted share, respectively. There was no impact of adoption on performance metrics used for short-term or long-term incentive compensation. Accretion specific to the Series II 2024 Notes was unaffected by adoption. Due to the valuation allowance, there was no net impact to income taxes for the adoption. Subsequent to adoption weighted average shares when calculating diluted earnings per share requires the application of the if-converted method for all convertible instruments.

Recent Accounting Pronouncements (Not Yet Adopted): 
In March 2020, the FASB issued ASU 2020-04 "Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting," which is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates if certain criteria are met. The guidance may be adopted in any period prior to the guidance expiration on December 31, 2022. The company is currently reviewing the impact of the adoption of ASU 2020-04 but does not expect the adoption to have a material impact on the company's financial statements.
XML 30 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Divested Businesses (Notes)
 9 Months Ended
Sep. 30, 2021
Divested Businesses [Abstract]  
Divested Businesses
Divested Businesses
On March 7, 2020, the company, completed the sale (the “Transaction”) of its subsidiary, Dynamic Controls, a New Zealand incorporated unlimited company (“Dynamic Controls”), to Allied Motion Christchurch Limited, a New Zealand limited company (the “Purchaser”), pursuant to a Securities Purchase Agreement among the company, Invacare Holdings New Zealand, a New Zealand incorporated unlimited company, and the Purchaser, dated March 6, 2020 (the “Purchase Agreement”). Dynamic Controls was a producer of electronic control systems for powered medical mobility devices, including systems incorporating the LiNX™ technology platform. Dynamic Controls was a component of the All Other Segment.
Dynamic Controls was a supplier of power mobility products and respiratory components to the company as well as supplying power mobility products to external customers. Sales in 2020 through the date of disposition were $5,331,000, including intercompany sales of $2,532,000, compared to sales for the full year of 2019 of $30,261,000, including intercompany sales of $13,087,000. Income before income taxes was approximately $445,000 in 2020, through the date of disposition, compared to $853,000 in 2019, inclusive of intercompany profits on sales to the company.
The transaction was the result of considering options for the products sold by Dynamic Controls which resulted in selling the business to a third-party which can provide access to further technological innovations to further differentiate the company’s power mobility products.
The gross proceeds from the Transaction were $14,563,000, net of taxes and expenses. The company realized a pre-tax gain of $9,790,000 with a remaining accrued expenses balance of $172,000 as of September 30, 2021.
The Purchase Agreement contains customary indemnification obligations of each party with respect to breaches of their respective representations, warranties and covenants, and certain other specified matters, which are subject to certain exceptions, terms and limitations described further in the Purchase Agreement.

At the closing of the Transaction, the parties entered into a supply agreement pursuant to which Dynamic Controls will supply certain electronic components as required by the company for the five-year period following the Transaction, including ongoing supply and support of the LiNX™ electronic control system with informatics technology, continued contract manufacturing of certain electronic components for the company’s respiratory products and continued infrastructure and applications support for the
informatics solution for the company’s respiratory products. The estimated continued inflows and outflows following the disposal with the Purchaser are not expected to be material to the company.
The assets and liabilities of Dynamic Controls as of March 7, 2020 consisted of the following (in thousands):
March 7, 2020
Trade receivables, net$4,129 
Inventories, net3,082 
Other assets855 
Property and equipment, net600 
Operating lease assets, net2,127 
Total assets$10,793 
Accounts payable$4,692 
Accrued expenses2,473 
Current taxes payable41 
Current portion of operating lease obligations366 
Long-term obligations1,019 
Total liabilities$8,591 

Trade receivables as of March 7, 2020 includes receivables previously classified as intercompany related to product sold by Dynamic Controls to other Invacare entities.
XML 31 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Receivables
 9 Months Ended
Sep. 30, 2021
Receivables [Abstract]  
Receivables
Receivables

Receivables consist of the following (in thousands):
September 30, 2021December 31, 2020
Accounts receivable, gross$141,003 $131,055 
Customer rebate reserve(12,689)(10,730)
Cash discount reserves(7,285)(7,320)
Allowance for doubtful accounts(4,227)(4,031)
Other, principally returns and allowances reserves(879)(386)
Accounts receivable, net$115,923 $108,588 

Reserves for customer rebates and cash discounts are recorded as a reduction in revenue and netted against gross accounts receivable. Customer rebates in excess of a given customer's accounts receivable balance are classified in Accrued Expenses. Customer rebates and cash discounts are estimated based on the most likely amount principle as well as historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such, the company estimates the expected returns based on an analysis of historical experience and adjusts revenue accordingly.

During the third quarter of 2021, the company entered into an agreement with a bank to sell certain trade receivables with governmental entity customers in the Nordic Region without recourse. Under ASC 860, the sale of the receivables qualify as a true sale and not a secured borrowing. No gain or loss was recorded on the sale of the receivables. Bank charges are recorded as interest expense. Interest expense attributable to the program for these bank charges was $11,000 for the three months ended September 30, 2021.

Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities predominantly located throughout the United States, Australia, Canada, New Zealand and Europe. A significant portion of products sold to providers, both foreign and domestic, are ultimately funded through government reimbursement programs such as Medicare and Medicaid in the U.S. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability.

The company's approach is to separate its receivables into good-standing and collection receivables. Good-standing
receivables are assigned to risk pools of high, medium and low. The risk pools are driven by the specifics associated with the geography of origination. Expected loss percentages are calculated and assigned to each risk pool, driven primarily by historical experience. The historical loss percentages are calculated for each risk pool and then judgmentally revised to consider current risk factors as well as consideration of the impact of forecasted events, as applicable. The expected loss percentages are then applied to receivables balances each period to determine the allowance for doubtful accounts.

In North America, excluding Canada, good-standing receivables are assigned to the low risk pool and assigned an expected loss percentage of 1.0% as these receivables are deemed to share the same risk profile and collections efforts are the same. Installment receivables in North America are characterized as collection receivables and thus reserves based on specific analysis of each customer. In Canada, good-standing receivables are deemed low risk and assigned a loss percentage of 0.2%.

In Europe, expected losses are determined by each location in each region. Most locations have a majority of their receivables assigned to the low risk pool, which has an average expected loss percentage of 0.5%. About half of the locations have a portion of their receivables assigned as medium risk with an average expected loss percentage of 1.1%. Only a few locations have any receivables characterized as high risk and the average credit loss percentage for those locations is 2.8%. Collection risk is generally low as payment terms in certain key markets, such as Germany, are immediate and in many locations the ultimate customer is the government.

In the Asia Pacific region, receivables are characterized as low risk, which have an average expected loss percentage of 0.3%. Historical losses are low in this region where the use of credit insurance is often customary.


The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2021
Balance as of beginning of period$4,031 
Current period provision432 
Recoveries (direct write-offs), net(236)
Balance as of end of period$4,227 

The company did not make any material changes to the assignment of receivables to the different risk pools or to the expected loss reserves in the quarter. The company is monitoring the impacts of the COVID-19 pandemic and the possibility for an impact on collections, but to date this has not materially impacted 2021.

For collections receivables, the estimated allowance for uncollectible amounts is based primarily on management’s evaluation of the financial condition of each customer. In addition, as a result of the company's financing arrangement with DLL, a third-party financing company which the company has worked with since 2000, management monitors the collection status of these contracts in accordance with the company’s limited recourse obligations and provides amounts necessary for estimated losses in the allowance for doubtful accounts and establishes reserves for specific customers as needed.

The company writes off uncollectible trade accounts receivable after such receivables are moved to collection status and legal remedies are exhausted. See Concentration of Credit Risk in the Notes to the Condensed Consolidated Financial Statements for a description of the financing arrangement. Long-term installment receivables are included in “Other Assets” on the condensed consolidated balance sheet.

The company has recorded a contingent liability in the amount of $314,000 related to the contingent aspect of the company's guarantee associated with its arrangement with DLL. The contingent liability is recorded applying the same expected loss model used for the trade and installment receivables recorded on the company's books. Specifically, historical loss history is used to determine the expected loss percentage, which is then adjusted judgmentally to consider other factors, as needed.

The company’s U.S. customers electing to finance their purchases can do so using DLL. The installment receivables recorded on the books of the company represent a single portfolio segment of finance receivables to the independent provider channel and long-term care customers. The portfolio segment is comprised of two classes of receivables
distinguished by geography and credit quality. The U.S. installment receivables are the first class and represent installment receivables repurchased from DLL because the customers were in default. Default with DLL is defined as a customer being delinquent by three payments.

The estimated allowance for uncollectible amounts and evaluation for both classes of installment receivables is based on the company’s quarterly review of the financial condition of each individual customer with the allowance for doubtful accounts adjusted accordingly. Installments are individually and not collectively reviewed. The company assesses the bad debt reserve levels based upon the status of the customer’s adherence to a legally negotiated payment schedule and the company’s ability to enforce judgments, liens, etc.

For purposes of granting or extending credit, the company utilizes a scoring model to generate a composite score that considers each customer’s consumer credit score and/or D&B credit rating, payment history, security collateral and time in business. Additional analysis is performed for most customers desiring credit greater than $250,000, which generally includes a detailed review of the customer’s financial statements as well as consideration of other factors such as exposure to changing reimbursement laws.

Interest income is recognized on installment receivables based on the terms of the installment agreements. Installment accounts are monitored and if a customer defaults on payments and is moved to collection, interest income is no longer recognized. Subsequent payments received once an account is put on non-accrual status are generally first applied to the principal balance and then to the interest. Accruing of interest on collection accounts would only be restarted if the account became current again.

All installment accounts are accounted for using the same methodology regardless of the duration of the installment agreements. When an account is placed in collection status, the company goes through a legal process for pursuing collection of outstanding amounts, the length of which typically approximates eighteen months. Any write-offs are made after the legal process has been completed.
Installment receivables consist of the following (in thousands):
 September 30, 2021December 31, 2020
 CurrentLong-TermTotalCurrentLong-TermTotal
Installment receivables$345 $909 $1,254 $704 $1,105 $1,809 
Allowance for doubtful accounts(53)(41)(94)(325)(162)(487)
Installment receivables, net$292 $868 $1,160 $379 $943 $1,322 
Installment receivables purchased from DLL during the nine months ended September 30, 2021 which increased the gross installments receivables by $93,000. No sales of
installment receivables were made by the company during the quarter.

The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2021		Year Ended December 31, 2020
Balance as of beginning of period$487 $1,514 
Current period provision (benefit)(105)66 
Direct write-offs charged against the allowance(288)(1,093)
Balance as of end of period$94 $487 
 
Installment receivables by class as of September 30, 2021 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$239 $239 $94 $— 
Asia Pacific
Non-Impaired installment receivables with no related allowance recorded1,015 1,015 — — 
Total
Non-Impaired installment receivables with no related allowance recorded1,015 1,015 — — 
Impaired installment receivables with a related allowance recorded239 239 94 — 
Total installment receivables$1,254 $1,254 $94 $— 
Installment receivables by class as of December 31, 2020 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$615 $615 $487 $— 
Asia Pacific
Non-impaired installment receivables with no related allowance recorded1,194 1,194 — — 
Canada
Non-impaired installment receivables with no related allowance recorded— — — 29 
Total
Non-impaired installment receivables with no related allowance recorded1,194 1,194 — 29 
Impaired installment receivables with a related allowance recorded615 615 487 — 
Total installment receivables$1,809 $1,809 $487 $29 

Installment receivables with a related allowance recorded as noted in the table above represent those installment receivables on a non-accrual basis. As of September 30, 2021, the company had no U.S. installment receivables past due of 90 days or more for which the company is still accruing interest. Individually, all U.S. installment receivables are
assigned a specific allowance for doubtful accounts based on management’s review when the company does not expect to receive both the contractual principal and interest payments as specified in the loan agreement.


The aging of the company’s installment receivables was as follows (in thousands):
September 30, 2021December 31, 2020
TotalU.S.Asia PacificTotalU.S.Asia Pacific
Current$1,015 $— $1,015 $1,194 $— $1,194 
0-30 days past due— — — — — — 
31-60 days past due— — — — — — 
61-90 days past due— — — — — — 
90+ days past due239 239 — 615 615 — 
$1,254 $239 $1,015 $1,809 $615 $1,194 
XML 32 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Inventories
 9 Months Ended
Sep. 30, 2021
Inventory Disclosure [Abstract]  
Inventories
Inventories, Net

Inventories consist of the following (in thousands):
September 30, 2021December 31, 2020
Finished goods$70,545 $55,264 
Raw materials69,842 51,174 
Work in process10,948 9,046 
Inventories, net$151,335 $115,484 
XML 33 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Other Current Assets
 9 Months Ended
Sep. 30, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Other Current Assets
Other Current Assets


Other current assets consist of the following (in thousands):
September 30, 2021December 31, 2020
Tax receivables principally value added taxes$23,006 $22,500 
Prepaid inventory and freight1,864 2,700 
Receivable due from information technology provider1,488 2,995 
Recoverable income taxes685 2,182 
Derivatives (foreign currency forward exchange contracts)606 1,321 
Service contracts393 633 
Deferred financing fees354 208 
Prepaid insurance276 3,963 
Prepaid and other current assets7,479 8,215 
Other Current Assets$36,151 $44,717 
In the fourth quarter of 2019, the company entered into an agreement to outsource substantially all of the company’s information technology ("IT") business service activities, including, among other things, support, rationalization and upgrading of the company’s legacy information technology systems and implementation of a global enterprise resource planning system. The agreement provides for reimbursement by the IT provider of IT expenses incurred by the company which are shown as Receivable due from information technology provider above. The amount of pass through charges will diminish as IT expenses are recorded directly by the IT provider. In addition, a corresponding current payable is due to the information technology provider. Refer to "Accrued Expenses" in the notes to the Condensed Consolidated Financial Statements included elsewhere in this report.
XML 34 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Other Long-Term Assets
 9 Months Ended
Sep. 30, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Other Long-Term Assets
Other Long-Term Assets


Other long-term assets consist of the following (in thousands):
September 30, 2021December 31, 2020
Cash surrender value of life insurance policies$2,372 $2,327 
Deferred income taxes2,278 2,048 
Installment receivables868 943 
Deferred financing fees463 411 
Investments84 85 
Other112 111 
Other Long-Term Assets$6,177 $5,925 
XML 35 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Property And Equipment
 9 Months Ended
Sep. 30, 2021
Property, Plant and Equipment [Abstract]  
Property And Equipment Property and Equipment
Property and equipment consist of the following (in thousands):
September 30, 2021December 31, 2020
Machinery and equipment$292,897 $294,045 
Land, buildings and improvements28,230 28,509 
Capitalized software28,149 17,527 
Furniture and fixtures10,288 10,001 
Leasehold improvements6,965 8,194 
Property and Equipment, gross366,529 358,276 
Accumulated depreciation(304,317)(302,033)
Property and Equipment, net$62,212 $56,243 
Machinery and equipment includes demonstration units placed in provider locations which are depreciated to their estimated recoverable values over their estimated useful lives. In the fourth quarter of 2019, the company initiated the first stage of an Enterprise Resource Planning ("ERP") software implementation. As a result of the initiation of the ERP project, the company capitalized certain costs in accordance with ASC 350 as shown in capitalized software above.
XML 36 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill
 9 Months Ended
Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill
Goodwill
The change in goodwill from December 31, 2020 to September 30, 2021 was due to foreign currency translation and goodwill impairment charge in the North America segment.

In accordance with Intangibles—Goodwill and Other, ASC 350, goodwill is tested annually for impairment or whenever events or changes in circumstances indicate the carrying value of a reporting unit could be above its fair value. A reporting unit is defined as an operating segment or one level below. The company has historically determined that its reporting units were North America / HME, Europe, Institutional Products Group and Asia Pacific.

During the third quarter of 2021, the company's reporting units of North America / HME and Institutional Products Group merged into one reporting unit of North America, consistent with the operating segment. Developments in the third quarter of 2021 and the conclusion of the reporting units merger were tied most closely to the actions of the company to implement components of a new ERP system which changes both the level of discrete financial information readily available and the go-forward manner in which the company assesses performance and allocates resources to the North America operating segment.

The reporting unit change within the North America operating segment in the third quarter of 2021 was a triggering event and required the company to perform an interim goodwill impairment test. Based on the interim goodwill test, the company concluded that the carrying value of the North America reporting unit was above its fair value. That conclusion resulted in the recording of impairment of goodwill in the third quarter of 2021 of $28,564,000.

The company completed its interim test in the third quarter of 2021 consistent with the process of its annual impairment assessment in the fourth quarter of each year or whenever events or changes in circumstances indicate the carrying value of a reporting unit could be below a reporting unit's fair value. The fair values of the company's reporting units were calculated using inputs that are not observable in the market and included management's own estimates regarding the assumptions that market participants would use and thus these inputs are deemed Level III inputs in regard to the fair value hierarchy. To calculate the fair values of the reporting units, the company utilizes a discounted cash flow method in which the company forecasts income statement and balance sheet amounts based on assumptions regarding projected sales growth, operating income, inventory turns, days' sales outstanding, etc. to forecast future cash flows. The projected operating income used has a significant impact upon the discounted cash flow methodology utilized in the
company's interim or annual impairment assessment as lower projected operating income would result in lower fair value estimates. The cash flows are discounted using a weighted average cost of capital (WACC) discount rate where the cost of debt is based on quoted rates for 20-year debt of potential acquirer companies of similar credit risk and the cost of equity is based upon the 20-year treasury rate for the risk-free rate, a market risk premium, the industry average beta and a small cap stock adjustment. The assumptions used are based on a market participant's point of view and yielded a discount rate of 11.19% in the third quarter of 2021's valuation for the company's impairment analysis for the reporting units with goodwill compared to 11.27% used in the annual impairment test in 2020. The WACC used has a significant impact upon the discounted cash flow methodology utilized in the company's impairment assessment as a higher WACC would decrease the fair value estimates.

The company also utilizes an Enterprise Value (EV) to Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) Method to compute the fair value of its reporting units which considers potential acquirers and their EV to EBITDA multiples adjusted by an estimated premium. While more weight is given to the discounted cash flow method, the EV to EBITDA Method does provide corroborative evidence of the reasonableness of the discounted cash flow method results.

While there was no impairment in the third quarter of 2021 related to goodwill for the Europe reporting unit, a future potential impairment could be possible if actual results differ materially from forecasted results used in the valuation analysis. Furthermore, the company's valuation can differ materially if financial projections or the market inputs used to determine the WACC change significantly. For instance, higher interest rates or greater stock price volatility would increase the WACC and thus increase the chance of impairment. In consideration of this potential, the company assessed the results if the discount rate used were 100 basis points higher for the third quarter of 2021 impairment analysis and determined that there still would not be an indicator of potential impairment for the Europe reporting unit. In addition, business changes impacting the company's assessment of reporting units could possibly also have a material impact on impairment assessment results.

There is no goodwill in the Asia Pacific reporting unit and the results of the Europe reporting unit assessment quantified its fair value to be substantially in excess of carrying value in the interim goodwill assessment completed in the third quarter of 2021.
As part of the company's interim assessment of goodwill for impairment, the company also considers the potential for impairment of any intangible assets or other long-lived assets.
The company concluded there was no impairment of intangible or long-lived assets as of September 30, 2021. Refer to Other Long-Term Assets, Property and Equipment and Intangibles in the Notes to the Condensed Consolidated Financial Statements for a description of any other asset impairments and refer to Goodwill in the company's Annual Report on Form 10-K for the period ending December 31, 2020 for further disclosure regarding the company's impairment analysis review methodology.
XML 37 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Intangibles
 9 Months Ended
Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Other Intangibles
Intangibles

The company's intangibles consist of the following (in thousands):
 
 September 30, 2021December 31, 2020
 Historical
Cost		Accumulated
Amortization		Historical
Cost		Accumulated
Amortization
Customer lists$54,222 $54,222 $54,502 $54,502 
Trademarks25,016 — 25,112 — 
Developed technology7,889 7,318 7,924 7,204 
Patents5,542 5,542 5,556 5,556 
License agreements2,904 1,143 2,899 979 
Other1,149 1,140 1,162 1,151 
Intangibles$96,722 $69,365 $97,155 $69,392 

All the company’s intangible assets have been assigned definite lives and continue to be amortized over their useful lives, except for trademarks shown above, which have indefinite lives.

The changes in intangible balances reflected on the balance sheet from December 31, 2020 to September 30, 2021 were the result of foreign currency translation on historical cost and accumulated amortization.

The company evaluates the carrying value of definite-lived assets annually in the fourth quarter and whenever events or circumstances indicate possible impairment. In the third quarter of 2021, the company assessed its intangible assets for impairment based on the goodwill impairment conclusion of North America. Based on the assessment, the company concluded there was no intangible asset impairment.

Definite-lived assets are determined to be impaired if the future undiscounted cash flows expected to be generated by the asset are less than the carrying value. Actual impairment amounts for definite-lived assets are then calculated using a discounted cash flow calculation.

Any impairment for indefinite-lived intangible assets is calculated as the difference between the future discounted cash flows expected to be generated by the asset less than the carrying value for the asset.

Amortization expense related to intangible assets was $304,000 in the first nine months of 2021 and is expected to be $405,000 in 2021, $402,000 in 2022, $402,000 in 2023,
$361,000 in 2024, $212,000 in 2025 and $211,000 in 2026. Amortized intangible assets are being amortized on a straight-line basis over remaining lives of 3 to 8 years with a weighted average remaining life of approximately 7 years.
XML 38 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued Expenses
 9 Months Ended
Sep. 30, 2021
Payables and Accruals [Abstract]  
Accrued Expenses
Accrued Expenses

Accrued expenses consist of accruals for the following (in thousands):
September 30, 2021December 31, 2020
Taxes other than income taxes, primarily value added taxes$27,103 $32,710 
Salaries and wages24,869 34,029 
Warranty11,363 10,991 
Professional8,917 7,375 
Freight4,463 3,190 
IT service contracts4,038 3,799 
Interest3,823 2,076 
Deferred revenue3,413 3,516 
Product liability, current portion2,901 2,453 
Rebates2,242 8,644 
Derivative liabilities (foreign currency forward exchange contracts)2,086 1,432 
Severance804 6,249 
Insurance652 878 
Rent511 585 
Supplemental executive retirement program liability391 391 
Other items, principally trade accruals6,634 7,955 
Accrued Expenses$104,210 $126,273 

Generally, the company's products are covered by warranties against defects in material and workmanship for various periods depending on the product from the date of sales to the customer. Certain components carry a lifetime warranty. A provision for estimated warranty cost is recorded at the time of sale based upon actual experience. In addition, the company has sold extended warranties that, while immaterial, require the company to defer the revenue associated with those warranties until earned. The company has established procedures to appropriately defer such revenue. The company continuously assesses the adequacy of its product warranty accrual and makes adjustments as needed. Historical analysis is primarily used to determine the company's warranty reserves. Claims history is reviewed and provisions are adjusted as needed. However, the company does consider other events, such as a product field action and recalls, which could require additional warranty reserve provision.







Accrued rebates relate to several volume incentive programs the company offers its customers. The company accounts for these rebates as a reduction of revenue when the products are sold. Rebates are netted against gross accounts receivables. If rebates are in excess of such receivables, they are then classified as accrued expenses. The reduction in accrued rebates from December 31, 2020 to September 30, 2021 primarily relates to payments principally made in the first quarter each year, earned from the previous year.

The reduction in accrued severance from December 31, 2020 to September 30, 2021 primarily relates to payments of restructuring costs with respect to the German manufacturing facility consolidation.

In the fourth quarter of 2019, the company entered into an agreement with an IT provider to outsource substantially all of the company’s information technology business service activities, including, among other things, support, rationalization and upgrading of the company’s legacy information technology systems and implementation of a global ERP. Accrued expenses related to IT outsourcing are reflected in IT service contracts.

The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):
Balance as of January 1, 2021$10,991 
Warranties provided during the period5,087 
Settlements made during the period(5,187)
Changes in liability for pre-existing warranties during the period, including expirations472 
Balance as of September 30, 2021$11,363 
Warranty reserves are subject to adjustment in future periods as new developments change the company's estimate of the total cost.
XML 39 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Long-Term Debt
 9 Months Ended
Sep. 30, 2021
Debt Disclosure [Abstract]  
Debt Disclosure
Long-Term Debt

Debt consists of the following (in thousands):
September 30, 2021December 31, 2020
Convertible senior notes at 5.00%, due in February 2021$— $1,242 
Convertible senior notes at 4.50%, due in June 20222,637 73,869 
Convertible senior notes Series I at 5.00%, due in November 202472,073 62,984 
Convertible senior notes Series II at 5.00%, due November 202477,270 64,919 
Convertible senior notes at 4.25%, due in March 2026118,682 — 
Other obligations38,793 42,039 
309,455 245,053 
Less current maturities of long-term debt(3,121)(5,612)
Long-Term Debt$306,334 $239,441 
On September 30, 2015, the company entered into an Amended and Restated Revolving Credit and Security Agreement, which was subsequently amended (the “Credit Agreement”) and which matures on January 16, 2024. The Credit Agreement was entered into by and among the company, certain of the company’s direct and indirect U.S. and Canadian subsidiaries and certain of the company’s European subsidiaries (together with the company, the “Borrowers”), certain other of the company’s direct and indirect U.S., Canadian and European subsidiaries (the “Guarantors”), and PNC Bank, National Association (“PNC”), JPMorgan Chase Bank, N.A., J.P. Morgan Europe Limited, KeyBank National Association, and Citizens Bank, National Association (the “Lenders”). PNC is the administrative agent (the “Administrative Agent”) and J.P. Morgan Europe Limited is the European agent (the “European Agent”) under the Credit Agreement. In connection with entering into the company's Credit Agreement, the company incurred fees which were capitalized and are being amortized as interest expense. As of September 30, 2021, debt fees yet to be amortized through January 2024 totaled $817,000.

The company had outstanding letters of credit of $8,350,000 and $7,752,000 as of September 30, 2021 and December 31, 2020, respectively. Outstanding letters of credit and other reserves impacting borrowing capacity were $7,641,000 and $7,616,000 as of September 30, 2021 and December 31, 2020, respectively. The company had $22,150,000 outstanding borrowings under its North America Credit Facility as of September 30, 2021. The company had outstanding borrowings of $9,446,000 (€8,000,000) under its French Credit Facility and $6,600,000 (£4,800,000) under its UK Credit Facility as of September 30, 2021, together referred
to as the European Credit Facility. The company had outstanding borrowings of $20,000,000 under its North America Credit Facility as of December 31, 2020. The company had outstanding borrowings of $7,636,000 (€6,400,000) under its French Credit Facility and $3,866,000 (£2,900,000) under its UK Credit Facility as of December 31, 2020, together referred to as the European Credit Facility. The weighted average interest rate on all borrowings, excluding finance leases, was 4.4% for the nine months ended September 30, 2021 and 4.6% for the year ended December 31, 2020.

North America Borrowers Credit Facility

For the company's North America Borrowers, the Credit Agreement provides for an asset-based-lending senior secured revolving credit facility which is secured by substantially all the company’s U.S. and Canadian assets, other than real estate. The Credit Agreement provides the company and the other Borrowers with a credit facility in an aggregate principal amount of $60,000,000, subject to availability based on a borrowing base formula, under a senior secured revolving credit, letter of credit and swing line loan facility (the “North America Credit Facility”). Up to $20,000,000 of the North America Credit Facility will be available for issuance of letters of credit. The aggregate principal amount of the North America Credit Facility may be increased by up to $25,000,000 to the extent requested by the company and agreed to by any Lender or new financial institution approved by the Administrative Agent.

The aggregate borrowing availability under the North America Credit Facility is determined based on a borrowing
base formula. The aggregate usage under the North America Credit Facility may not exceed an amount equal to the sum of (a) 85% of eligible U.S. accounts receivable plus (b) the lesser of (i) 70% of eligible U.S. inventory and eligible foreign in-transit inventory and (ii) 85% of the net orderly liquidation value of eligible U.S. inventory and eligible foreign in-transit inventory (not to exceed $4,000,000), plus (c) the lesser of (i) 80% of the net orderly liquidation value of U.S. eligible machinery and equipment and (ii) $0 as of September 30, 2021 (subject to reduction as provided in the Credit Agreement), plus (d) 85% of eligible Canadian accounts receivable, plus (e) the lesser of (i) 70% of eligible Canadian inventory and (ii) 85% of the net orderly liquidation value of eligible Canadian inventory, less (f) swing loans outstanding under the North America Credit Facility, less (g) letters of credit issued and undrawn under the North America Credit Facility, less (h) a $3,000,000 minimum availability reserve, less (i) other reserves required by the Administrative Agent, and in each case subject to the definitions and limitations in the Credit Agreement. As of September 30, 2021, the company was in compliance with all covenant requirements. As of September 30, 2021, the company had gross borrowing base of $40,566,000 and net borrowing availability of $23,176,000 under the North America Credit Facility under the Credit Agreement, considering the minimum availability reserve, then-outstanding letters of credit, other reserves and the $6,750,000 dominion trigger amount described below. Borrowings under the North America Credit Facility are secured by substantially all of the company’s U.S. and Canadian assets, other than real estate.

Interest will accrue on outstanding indebtedness under the Credit Agreement at the LIBOR rate, plus a margin ranging from 2.25% to 2.75%, or at the alternate base rate, plus a margin ranging from 1.25% to 1.75%, as selected by the company. Borrowings under the North America Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization.

The Credit Agreement contains customary representations, warranties and covenants. Exceptions to the operating covenants in the Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale and leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Credit Agreement, as amended. The Credit Agreement also contains a covenant requiring the company to maintain minimum availability under the North America Credit Facility of not less than (i) 12.5% of the maximum amount that may be drawn under the North America Credit Facility for five (5) consecutive business days, or (ii) 11.25% of the maximum amount that may be drawn under the North American facility on any business day. The company also is subject to dominion
triggers under the North America Credit Facility requiring the company to maintain borrowing capacity of not less than $6,750,000 on any business day or any five consecutive days in order to avoid triggering full control by an agent for the Lenders of the company's cash receipts for application to the company’s obligations under the agreement.

The Credit Agreement contains customary default provisions, with certain grace periods and exceptions, which provide for events of default that include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption of any material manufacturing facilities for more than 10 consecutive days. The proceeds of the North America Credit Facility will be used to finance the working capital and other business needs of the company. There was $22,150,000 of outstanding borrowings under the North America Credit Facility on September 30, 2021.

European Credit Facility

The Credit Agreement also provides for a revolving credit, letter of credit and swing line loan facility which gives the company and the European Borrowers the ability to borrow up to an aggregate principal amount of $30,000,000, with a $5,000,000 sublimit for letters of credit and a $2,000,000 sublimit for swing line loans (the “European Credit Facility”). Up to $15,000,000 of the European Credit Facility will be available to each of Invacare Limited (the “UK Borrower”) and Invacare Poirier SAS (the “French Borrower” and, together with the UK Borrower, the “European Borrowers”). The European Credit Facility matures in January 2024, together with the U.S. and Canadian Credit Facility.

The aggregate borrowing availability for each European Borrower under the European Credit Facility is determined based on a borrowing base formula. The aggregate borrowings of each of the European Borrowers under the European Credit Facility may not exceed an amount equal to (a) 85% of the European Borrower’s eligible accounts receivable, less (b) the European Borrower’s borrowings and swing line loans outstanding under the European Credit Facility, less (c) the European Borrower’s letters of credit issued and undrawn under the European Credit Facility, less (d) a $3,000,000 minimum availability reserve, less (e) other reserves required by the European Agent, and in each case subject to the definitions and limitations in the Credit Agreement. As of September 30, 2021, the gross borrowing base to the European Borrowers under the European Credit Facility was $22,684,000 and the net borrowing availability was $16,310,000, considering the $3,000,000 minimum availability reserve and a $3,375,000 dominion trigger amount described below. Borrowing availability is based on a prior
month base in USD. Actual borrowings in GBP and EUR fluctuate in USD between date of borrowing and when translated for consolidated reporting.

The aggregate principal amount of the European Credit Facility may be increased by up to $10,000,000 to the extent requested by the company and agreed to by any Lender or Lenders that wish to increase their lending participation or, if not agreed to by any Lender, a new financial institution that agrees to join the European Credit Facility and that is approved by the Administrative Agent and the European Agent.

Interest will accrue on outstanding indebtedness under the European Credit Facility at the LIBOR rate, plus a margin ranging from 2.50% to 3.00%, or for swing line loans, at the overnight LIBOR rate, plus a margin ranging from 2.50% to 3.00%, as selected by the company. The margin that will be adjusted quarterly based on utilization. Borrowings under the European Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization.

The European Credit Facility is secured by substantially all the personal property assets of the UK Borrower and its in-country subsidiaries, and all the receivables of the French Borrower and its in-country subsidiaries. The UK and French facilities (which comprise the European Credit Facility) are cross collateralized, and the US personal property assets previously pledged under the U.S. and Canadian Credit Facility also serve as collateral for the European Credit Facility.

The European Credit Facility is subject to customary representations, warranties and covenants generally consistent with those applicable to the U.S. and Canadian Credit Facility. Exceptions to the operating covenants in the Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale/leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Credit Agreement. The Credit Agreement also contains a covenant requiring the European Borrowers to maintain undrawn availability under the European Credit Facility of not less than (i) 12.5% of the maximum amount that may be drawn under the European Credit Facility for five (5) consecutive business days, or (ii) 11.25% of the maximum amount that may be drawn under the European credit facility on any business day. The European Borrowers also are subject to cash dominion triggers under the European Credit Facility requiring the European Borrower to maintain borrowing capacity of not less than $3,750,000 on any business day or $3,375,000 for five consecutive business days in order to avoid triggering full control by an agent for the Lenders of the European
Borrower’s cash receipts for application to its obligations under the European Credit Facility.

The European Credit Facility is subject to customary default provisions, with certain grace periods and exceptions, consistent with those applicable to the U.S. and Canadian Credit Facility, which provide that events of default include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, cross-default, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption in the operations of any material manufacturing facility for more than 10 consecutive days. The proceeds of the European Credit Facility will be used to finance the working capital and other business needs of the company. As of September 30, 2021, the company had borrowings of $9,446,000 (€8,000,000) under its French Credit Facility and $6,600,000 (£4,800,000) under its UK Credit Facility as of September 30, 2021, together referred to as the European Credit Facility.

In January 2021, the Credit Agreement was amended to provide for, among other things, the addition of the company's Netherlands subsidiary as a guarantor under the European revolving credit facility, amendments to the restrictive covenants in the Credit Agreement to (1) increase the maximum amount of permitted miscellaneous indebtedness to $30,000,000 from $10,000,000 and (2) permit up to $9,000,000 of financing based on certain European public and government receivables, and terms that, upon the occurrence of certain events related to a transition from the use of LIBOR, permit the agent for the lenders to amend the Credit Agreement to replace the LIBOR rate and/or the Euro rate with a benchmark replacement rate.

In March 2021, the Credit Agreement was further amended to permit the issuance of the 2026 Notes and the capped call transactions entered into by the company in connection with the issuance of the 2026 Notes, as further discussed in the sections below.

Convertible senior notes due 2021

In the first quarter of 2016, the company issued $150,000,000 aggregate principal amount of 5.00% Convertible Senior Notes due 2021 (the “2021 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2021 Notes bore interest at a rate of 5.00% per year payable semi-annually in arrears on February 15 and August 15 of each year, beginning August 15, 2016. The 2021 Notes matured on February 15, 2021. At maturity, $1,250,000 principal amount of 2021 Notes were outstanding, which the company repaid in cash.

In connection with the offering of the 2021 Notes, the company entered into privately negotiated convertible note hedge transactions with two financial institutions (the “option counterparties”). The company evaluated the note hedges under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the note hedges should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $27,975,000.

The company entered into separate, privately negotiated warrant transactions with the option counterparties at a higher strike price relating to the same number of the company’s common shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding common shares and the company’s earnings per share to the extent that the price of the company’s common shares exceeds the strike price of those warrants. The initial strike price of the warrants is $22.4175 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the warrants met the definition of a derivative, are indexed to the company's own stock and should be classified in shareholder's equity. The amount paid for the warrants and capitalized in shareholder's equity was $12,376,000.

The net proceeds from the offering of the 2021 Notes were approximately $144,034,000, after deducting fees and offering expenses of $5,966,000, which were paid in 2016. These debt issuance costs were capitalized and were amortized as interest expense through February 2021. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

During the third quarter of 2019, the company used an aggregate of $14,708,000 in cash to repurchase a total amount of $16,000,000 in principal amount of 2021 Notes. After recognizing expenses on unamortized fees and discounts associated with the repurchased 2021 Notes, the repurchases resulted in a net reduction of debt of $14,367,000 and a net loss on the repurchases of $280,000.

During the fourth quarter of 2019, the company entered into separate privately negotiated agreements with certain holders of its 2021 Notes to exchange $72,909,000 in aggregate principal amount of 2021 Notes for aggregate consideration of $72,909,000 in aggregate principal amount of new 5.00% Convertible Senior Exchange Notes due 2024 (the “Series I 2024 Notes”) of the company and $6,928,000 in cash. Refer to "Convertible senior notes Series I due 2024"
below for more information. As a result of the exchange transaction in the fourth quarter of 2019 and the repurchase of $16,000,000 in principal amount of 2021 Notes in the third quarter of 2019, a partial unwind of the note hedge options and warrants entered into with the issuance of the 2021 Notes also occurred during the fourth quarter of 2019. Note hedge options outstanding related to the 2021 Notes were reduced from the original number of 300,000 to 138,182 and warrants relating to the 2021 Notes were reduced from the initial number of 9,007,380 to 3,860,624. The partial unwind of the note hedge options and warrants resulted in no net impact to cash or paid in capital.

During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Exchange Notes due 2024 (the “Series II 2024 Notes”) of the company and $5,593,000 in cash.

During the third quarter of 2020, the company repurchased $24,466,000 aggregate principal amount of 2021 Notes, resulting in a $761,000 loss on debt extinguishment. As a result of the repurchase of 2021 Notes in the third quarter of 2020 and the exchange of 2021 Notes for new notes in the second quarter of 2020, a partial unwind of the note hedge options and warrants entered into with the issuance of the 2021 Notes also occurred. The partial unwind of the note hedge options and warrants resulted in no net impact to cash or paid-in-capital. Note hedge options outstanding relating to the 2021 Notes were reduced 62,341 and subsequently expired on February 15, 2021. The warrants began to expire on May 15, 2021 and then partially expire on each trading day over the 220 trading day period following May 15, 2021. Warrants outstanding on September 30, 2021 were 1,770,968. If exercised, one Common Share is issuable upon exercise of each warrant, but may be adjusted to include additional Common Shares for each warrant under certain circumstances if the relevant share price exceeds the warrant strike price for the relevant measurement period at the time of exercise. Common Shares are reserved for issuance upon exercise of the remaining warrants relating to the 2021 Notes at two Common Shares per warrant.
The liability components of the 2021 Notes consist of the following (in thousands):
September 30, 2021December 31, 2020
Principal amount of liability component$— $1,250 
Unamortized discount— (7)
Debt fees— (1)
Net carrying amount of liability component$— $1,242 

The unamortized discount was reduced to $0 upon adoption of ASU 2020-06, effective January 1, 2021. The effective interest rate on the liability component was 11.1% upon original issuance including consideration of the discount. Non-cash discount interest expense of $261,000 and $1,767,000 was recognized for the three and nine months ended September 30, 2020. Interest expense of $0 and $8,000 was accrued for the three and nine months ended September 30, 2021, compared to $241,000 and $1,617,000 for the three and nine months ended September 30, 2020 based on the stated coupon rate of 5.0%.

Convertible senior notes due 2022

In the second quarter of 2017, the company issued $120,000,000 aggregate principal amount of 4.50% Convertible Senior Notes due 2022 (the “2022 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2022 Notes bear interest at a rate of 4.50% per year payable semi-annually in arrears on June 1 and December 1 of each year, beginning December 1, 2017. The 2022 Notes will mature on June 1, 2022, unless repurchased or converted in accordance with their terms prior to such date. Prior to December 1, 2021, the 2022 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Prior to May 16, 2019, the 2022 Notes were convertible, subject to certain conditions, into cash only. On May 16, 2019, the company obtained shareholder approval under applicable New York Stock Exchange rules such that conversion of the 2022 Notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. At September 30, 2021, $2,650,000 aggregate principal amount of the 2022 Notes remained outstanding, following the exchange transactions completed in the second quarter of 2020 and the repurchase of debt completed in the first quarter of 2021, as further discussed below.

Holders of the 2022 Notes may convert their 2022 Notes at their option at any time prior to the close of business on the business day immediately preceding December 1, 2021 only under the following circumstances: (1) during any fiscal
quarter commencing after September 30, 2017 (and only during such fiscal quarter), if the last reported sale price of the company’s common shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2022 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2022 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2022 Notes on each such trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after December 1, 2021 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2022 Notes, holders may convert their 2022 Notes, at the option of the holder, regardless of the foregoing circumstances.

Holders of the 2022 Notes will have the right to require the company to repurchase all or some of their 2022 Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 61.6095 common shares per $1,000 principal amount of 2022 Notes (equivalent to an initial conversion price of approximately $16.23 per common share). Until the company received shareholder approval on May 16, 2019 authorizing it to elect to settle future conversions of the 2022 Notes in common shares, the company separately accounted for the conversion features as a derivative. The derivative was capitalized on the balance sheet as a long-term liability with adjustment to reflect fair value each quarter until the change to the conversion features as a result of the shareholder approval received on May 16, 2019 resulted in the termination of the derivative. The fair value of the convertible debt conversion liability at issuance was $28,859,000. The company recognized a loss of $6,193,000 in 2019 related to the convertible debt conversion liability.

In connection with the offering of the 2022 Notes, the company entered into privately negotiated convertible note hedge transactions with one financial institution (the “option counterparty”). These transactions cover, subject to customary anti-dilution adjustments, the number of the company’s common shares that will initially underlie the 2022 Notes, and are expected generally to reduce the potential equity dilution, and/or offset any cash payments in excess of the principal amount due, as the case may be, upon conversion of the 2022 Notes. The company evaluated the note hedges under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the note hedges
should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and were adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $24,780,000.

The company entered into separate, privately negotiated warrant transactions with the option counterparty at a higher strike price relating to the same number of the company’s common shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding common shares and the company’s earnings per share to the extent that the price of the company’s common shares exceeds the strike price of those warrants. The initial strike price of the warrants is $21.4375 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the warrants meet the definition of a derivative, are indexed to the company's own shares and should be classified in shareholder's equity. The amount paid for the warrants and capitalized in shareholder's equity was $14,100,000.

There were 120,000 note hedge options relating to the 2022 Notes outstanding at September 30, 2021, but only 2,650 remained available for exercise. Note hedge options related to the 2022 Notes will expire on June 1, 2022.

Warrants relating to the 2022 Notes outstanding on September 30, 2021 were 7,393,141. If exercised, one common share is issuance upon exercise of each warrant, but may be adjusted under certain circumstances if the relevant share price exceeds the warrant strike price for the relevant share price exceeds the warrant strike price for the relevant measurement period at the time of exercise. Common shares are reserved for issuance upon exercise of the remaining warrants relating to the 2022 Notes at two common shares per warrant. The warrants will begin to expire on September 1, 2022 and then partially expire on each trading day over the 220 trading day period following September 1, 2022.

The net proceeds from the offering of the 2022 Notes were approximately $115,289,000, after deducting fees and offering expenses of $4,711,000, which were paid in 2017. These debt issuance costs were capitalized and are being amortized as interest expense through June 2022. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. A portion of the net proceeds from the offering were used to pay the cost of the convertible note hedge transactions (after such cost is partially offset by the proceeds to the company from the warrant transactions), which net cost was $10,680,000.

During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new Series II 2024 Notes and $5,593,000 in cash.

During the first quarter of 2021, the company repurchased $78,850,000 in principal amount of 2022 Notes, resulting in a loss on debt extinguishment of $709,000.

The liability components of the 2022 notes consist of the following (in thousands):
September 30, 2021December 31, 2020
Principal amount of liability component$2,650 $81,500 
Unamortized discount— (6,772)
Debt fees(13)(859)
Net carrying amount of liability component$2,637 $73,869 

The unamortized discount was reduced to $0 upon adoption of ASU 2020-06, effective January 1, 2021. The effective interest rate on the liability component was 10.9% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption of ASU 2020-06 includes coupon interest and amortization of debt fees. Non-cash discount interest expense of $1,046,000 and $3,829,000 was recognized for the three and nine months ended September 30, 2020. Interest expense of $30,000 and $829,000 was accrued for the three and nine months ended September 30, 2021 compared to $917,000 and $3,487,000 for the three and nine months ended September 30, 2020 based on the stated coupon rate of 4.5%. The effective interest rate of the 2022 Notes as of September 30, 2021 was 5.3%. The 2022 Notes were not convertible as of September 30, 2021 nor was the applicable conversion threshold met.

Convertible senior notes Series I due 2024

During the fourth quarter of 2019, the company entered into separate privately negotiated agreements with certain holders of its 2021 Notes to exchange $72,909,000 in aggregate principal amount of 2021 Notes for aggregate consideration of $72,909,000 in aggregate principal amount of new 5.00% Convertible Senior Exchange Notes due 2024 (the “Series I 2024 Notes”) of the company and $6,928,000 in cash.

The notes bear interest at a rate of 5.00% per year payable semi-annually in arrears on May 15 and November 15 of each
year, beginning May 15, 2020. The notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series I 2024 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series 2024 Notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election.

Prior to the maturity of the Series I 2024 Notes, the company may, at its election, redeem for cash all or part of the Series I 2024 Notes if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the Series I 2024 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series I 2024 Notes, which means the company is not required to redeem or retire the Series I 2024 Notes periodically.

Holders of the Series I 2024 Notes may convert their Series I 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending December 31, 2019 (and only during such calendar quarter), if the last reported sale price of the company’s common shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the Series I 2024 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series I 2024 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s common shares and the applicable conversion rate for the Series I 2024 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series I 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the Series I 2024 Notes will have the right to require the company to repurchase all or some of their Series I 2024
Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 common shares per $1,000 principal amount of Series I 2024 Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series I 2024 Notes, holders may convert their Series I 2024 Notes, at the option of the holder, regardless of the foregoing circumstances.

A loss of $5,885,000 was recorded a part of the exchange transaction, which included the write-off of fees related to the portion of the 2021 Notes exchanged. Debt issuance costs of $1,394,000 were capitalized and are being amortized as interest expense through November 15, 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

The liability components of the Series I 2024 Notes consist of the following (in thousands):
September 30, 2021December 31, 2020
Principal amount of liability component$72,909 $72,909 
Unamortized discount— (8,888)
Debt fees(836)(1,037)
Net carrying amount of liability component$72,073 $62,984 

The unamortized discount was reduced to $0 upon adoption of ASU 2020-06, effective January 1, 2021. The effective interest rate on the liability component was 8.77% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption includes coupon interest and amortization of debt fees. Non-cash discount interest expense of $468,000 and $1,370,000 was recognized for the three and nine months ended September 30, 2020. Interest expense of $911,000 and $2,733,000 was accrued for the three and nine months ended September 30, 2021 compared to $912,000 and $2,735,000 for the three and nine months ended September 30, 2020 based on the stated coupon rate of 5.0%. The effective interest rate of the Series I 2024 notes as of September 30, 2021 was 5.4%. The Series I 2024 Notes were not convertible as of September 30, 2021 nor was the applicable conversion threshold met.

Convertible senior notes Series II due 2024

During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of
2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Exchange Notes due 2024 (the “Series II 2024 Notes”) of the company and $5,593,000 in cash.

The Series II 2024 Notes bear interest at a rate of 5.00% per year, payable semi-annually in arrears on May 15 and November 15 of each year, beginning November 15, 2020. The Series II 2024 Notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series II 2024 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series II 2024 Notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election.

Prior to the maturity of the Series II 2024 Notes, the company may, at its election, redeem for cash all or part of the Series II 2024 Notes, if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the accreted principal amount of the Series II 2024 Notes to be redeemed, plus any accrued and unpaid interest, if any, on the original principal amount of the New Notes redeemed to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series II 2024 Notes, which means the company is not required to redeem or retire the Series II 2024 Notes periodically.

Holders of the Series II 2024 Notes may convert their Series II 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the company’s common shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the Series II 2024 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series II 2024 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the
company’s common shares and the applicable conversion rate for the Series II 2024 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series II 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the Series II 2024 Notes will have the right to require the company to repurchase all or some of their Series II 2024 Notes at 100% of the accreted principal amount, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 common shares per $1,000 principal amount of Series II 2024 Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series II 2024 Notes, holders may convert their Series II 2024 Notes, at the option of the holder, regardless of the foregoing circumstances.

The principal amount of the Series II 2024 Notes also will accrete at a rate of approximately 4.7% per year commencing June 4, 2020, compounding on a semi-annual basis. The accreted portion of the principal is payable in cash upon maturity but does not bear interest and is not convertible into the company’s common shares. The total amount accreted as of September 30, 2021 was $4,450,000, of which $890,000 and $2,637,000 was for the three and nine months ended September 30, 2021, respectively and $762,000 and $1,016,000 for the three and nine months ended September 30, 2020, respectively. Remaining accretion until maturity (at current principal) was $12,172,000 at September 30, 2021.

A loss of $6,599,000 was recorded a part of the exchange transaction, which included the write-off of fees related to portions of the 2021 Notes and 2022 Notes exchanged. Debt issuance costs of $1,505,000 were capitalized and are being amortized as interest expense through November 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

The liability components of the Series II 2024 Notes consist of the following (in thousands):
September 30, 2021December 31, 2020
Principal amount of liability component - including accretion$78,325 $75,688 
Unamortized discount— (9,461)
Debt fees(1,055)(1,308)
Net carrying amount of liability component$77,270 $64,919 

The unamortized discount was reduced to $0 upon adoption of ASU 2020-06, effective January 1, 2021. The
effective interest rate on the liability component was 8.99% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption includes coupon interest, accretion and amortization of debt fees. Interest expense for accretion of $890,000 and $2,637,000 was accrued for the three and nine months ended September 30, 2021. Non-cash interest, including accretion, of $1,260,000 and $1,663,000 was recognized for the three and nine months ended September 30, 2020. Interest expense of $923,000 and $1,200,000 was recognized for the three and nine months ended September 30, 2020 compared to $923,000 and $2,770,000 for the three and nine months ended September 30, 2021 based on the stated coupon rate of 5.0%. The effective interest rate of the Series II 2024 Notes as of September 30, 2021 including coupon interest, amortization of debt fees and accretion to maturity was 10.3%. The Series II 2024 Notes were not convertible as of September 30, 2021 nor was the applicable conversion threshold met.

Convertible senior notes due 2026

In the first quarter of 2021, the company issued $125,000,000 aggregate principal amount of 4.25% Convertible Senior Notes due 2026 (the “2026 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act.

The notes bear interest at a rate of 4.25% per year payable semi-annually in arrears on March 15 and September 15 of each year, beginning September 15, 2021. The notes will mature on March 15, 2026, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to September 15, 2025, the 2026 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The 2026 Notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election.

The company may not redeem the 2026 Notes prior to March 20, 2024. The company may, at its election, redeem for cash all or part of the 2026 Notes, on or after March 20, 2024, if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the 2026 Notes,
which means the company is not required to redeem or retire the 2026 Notes periodically.

Holders of the 2026 Notes may convert their 2026 Notes at their option at any time prior to the close of business on the business day immediately preceding September 15, 2025 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2021 (and only during such calendar quarter), if the last reported sale price of the company’s common shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the 2026 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2026 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s common shares and the applicable conversion rate for the 2026 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls any or all of the 2026 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date. Holders of the 2026 Notes will have the right to require the company to repurchase all or some of their 2026 Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 94.6096 common shares per $1,000 principal amount of 2026 notes (equivalent to an initial conversion price of approximately $10.57 per common share). On or after September 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2026 Notes, holders may convert their 2026 Notes, at the option of the holder, regardless of the foregoing circumstances.

Debt issuance costs of $7,305,000 were capitalized and are being amortized as interest expense through March 2026. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

The liability components of the 2026 Notes consist of the following (in thousands):
September 30, 2021
Principal amount of liability component$125,000 
Debt fees(6,318)
Net carrying amount of liability component$118,682 

Interest expense of $1,328,000 and $2,892,000 was accrued for the three and nine months ended September 30, 2021 based on the stated coupon rate of 4.25%. The effective interest rate of the 2026 Notes as of September 30, 2021 was 5.3%. The 2026 Notes were not convertible as of September 30, 2021 nor was the applicable conversion threshold met.

In March 2021, in connection with the pricing of the 2026 Notes, the company entered into capped call transactions (the “Capped Call Transactions”) with certain option counterparties. The company used $18,787,000 of the net proceeds of the private offering of the 2026 Notes to pay the cost of the Capped Call Transactions with the offset recorded to additional paid-in-capital.

The Capped Call Transactions are expected generally to reduce the potential dilution upon conversion of the 2026 Notes and/or offset any cash payments the company is required to make in excess of the principal amount of converted notes, as the case may be, in the event that the market price per share of the company’s common shares, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which is initially $10.57, corresponding to the initial conversion price of the 2026 Notes, subject to anti-dilution adjustments. If, however, the market price per company common share, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions, which is initially $16.58 (subject to adjustments), there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the Capped Call Transactions. The Capped Call Transactions expire March 15, 2026, subject to earlier exercise. There were 125,000 capped call options related to the 2026 Notes outstanding on September 30, 2021.

The company will not be required to make any cash payments to the option counterparties upon the exercise of the options that are a part of the Capped Call Transactions, but the company will be entitled to receive from the option counterparties a number of company common shares, an amount of cash or a combination thereof generally based on the amount by which the market price per company common share, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions during the relevant valuation period under the Capped Call Transactions. However, if the market price per Company common share, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions during such valuation period, the number of company common shares and/or the amount of cash the company expects to receive upon exercise of the Capped Call Transactions will be capped based on the amount by
which the cap price exceeds the strike price of the Capped Call Transactions.

For any conversions of the 2026 Notes prior to September 15, 2025, a corresponding portion of the relevant Capped Call Transactions may be terminated at the company’s option. Upon any such termination, the company expects to receive from the option counterparties a number of company common shares, or, if the company so elects, subject to certain conditions, an amount of cash, in each case, with a value equal to the fair value of such portion of the relevant Capped Call Transactions being terminated, as calculated in accordance with the terms of the relevant Capped Call Transaction.

The Capped Call Transactions are separate transactions, in each case, entered into by the company with the option counterparties, and are not part of the terms of the 2026 Notes and will not affect any holder’s rights under the 2026 Notes. Holders of the 2026 Notes will not have any rights with respect to the Capped Call Transactions.

CARES Act Loan
On May 15, 2020 the company entered into an unsecured loan agreement in the aggregate amount of $10,000,000 pursuant to sections 1102 and 1106 of the Coronavirus Aid, Relief and Economic Security, "CARES," Act which was evidenced by a promissory note, dated May 13, 2020, and bears interest at a fixed rate of 1.00%. Payments which were to commence in May 2021 under the program, had been deferred until the third quarter of 2021. This loan may be forgivable, partially or in full, if certain conditions are met, principally based on having been disbursed for permissible purposes and based on average levels of employment over a designated period of time. At the time of the loan, no assurance could be given that the company would be granted forgiveness of the loan upon application in whole or in part. As of June 30, 2021, the company had recorded $10,000,000 of the amount borrowed in current maturities of long term debt.
XML 40 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Other Long-Term Obligations
 9 Months Ended
Sep. 30, 2021
Other Liabilities Disclosure [Abstract]  
Other Long-Term Obligations
Other Long-Term Obligations

Other long-term obligations consist of the following (in thousands):
September 30, 2021December 31, 2020
Deferred income taxes$22,909 $23,234 
Product liability13,374 12,304 
Pension 9,063 9,088 
Deferred compensation6,380 5,318 
Deferred gain on sale leaseback5,257 5,502 
Supplemental executive retirement plan liability5,222 5,368 
Death benefit obligation plan4,537 4,723 
Uncertain tax obligation including interest3,124 3,114 
Other1,915 1,823 
Other Long-Term Obligations$71,781 $70,474 

On April 23, 2015, the company entered into a real estate sale leaseback transaction which resulted in the company recording an initial deferred gain of $7,414,000, the majority of which is included in Other Long-Term Obligations and will be recognized over the 20-year life of the leases. The gains realized were $80,000 and $237,000 for the three and nine months ended September 30, 2021 respectively, compared to $77,000 and $228,000 for the three and nine months ended September 30, 2020, respectively.
XML 41 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Leases and Commitments (Notes)
 9 Months Ended
Sep. 30, 2021
Leases [Abstract]  
Lessee, Finance Leases
Leases and Commitments

The company reviews new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and certain non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.

The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2021, the company is committed under non-cancelable leases, which have initial or remaining terms in excess of one year and expire on various dates through 2040.

On April 23, 2015, the company sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the U.S. and Canadian Credit Facility. The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases.

In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company
recorded four finance leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the consolidated balance sheet. The gains realized were $80,000 and $237,000 for the three and nine months ended September 30, 2021 compared to $77,000 and $228,000 for the three and nine months ended September 30, 2020.

In December 2018, the company entered into a 20-year lease agreement in Germany. The lease commenced in July 2020. The lease increased the company's finance lease obligation by $36,916,000 and increased the finance lease expense compared to previous periods.

In December of 2020, the company entered into a 12.6-year lease agreement in Germany. The lease increased the company's finance lease obligation by $5,561,000 and increased the finance lease expense compared to previous periods.
Lease expenses for the three and nine months ended September 30, 2021 and September 30, 2020, respectively, were as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Operating leases$1,811 $1,926 $5,592 $6,210 
Variable and short-term leases764 1,077 2,825 2,936 
Total operating leases$2,575 $3,003 $8,417 $9,146 
Finance lease interest cost$1,146 $829 $3,487 $1,483 
Finance lease depreciation1,265 980 3,807 2,346 
Total finance leases$2,411 $1,809 $7,294 $3,829 












Future minimum operating and finance lease commitments, as of September 30, 2021, are as follows (in thousands):
Finance 
Leases		Operating Leases
2021$2,578 $2,022 
20227,068 4,424 
20236,964 2,466 
20246,892 1,808 
20256,797 1,442 
Thereafter80,350 2,565 
Total future minimum lease payments110,649 14,727 
Amounts representing interest(41,461)(2,432)
Present value of minimum lease payments69,188 12,295 
Less: current maturities of lease obligations(3,118)(4,553)
Long-term lease obligations$66,070 $7,742 
Supplemental cash flow amounts for the nine months ended September 30, 2021 were as follows (in thousands):
Cash Activity: Cash paid in measurement of amounts for lease liabilitiesSeptember 30, 2021
Operating leases$8,501 
Finance leases6,311 
Total$14,812 
Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligationsSeptember 30, 2021
Operating leases$5,418 
Finance leases6,345 
Total$11,763 




















Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2021:
September 30, 2021
Weighted-average remaining lease term - finance leases16.1 years
Weighted-average remaining lease term - operating leases4.9 years
Weighted-average discount rate - finance leases6.47%
Weighted-average discount rate - operating leases7.12%
Lessee, Operating Leases
Leases and Commitments

The company reviews new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and certain non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.

The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2021, the company is committed under non-cancelable leases, which have initial or remaining terms in excess of one year and expire on various dates through 2040.

On April 23, 2015, the company sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the U.S. and Canadian Credit Facility. The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases.

In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company
recorded four finance leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the consolidated balance sheet. The gains realized were $80,000 and $237,000 for the three and nine months ended September 30, 2021 compared to $77,000 and $228,000 for the three and nine months ended September 30, 2020.

In December 2018, the company entered into a 20-year lease agreement in Germany. The lease commenced in July 2020. The lease increased the company's finance lease obligation by $36,916,000 and increased the finance lease expense compared to previous periods.

In December of 2020, the company entered into a 12.6-year lease agreement in Germany. The lease increased the company's finance lease obligation by $5,561,000 and increased the finance lease expense compared to previous periods.
Lease expenses for the three and nine months ended September 30, 2021 and September 30, 2020, respectively, were as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Operating leases$1,811 $1,926 $5,592 $6,210 
Variable and short-term leases764 1,077 2,825 2,936 
Total operating leases$2,575 $3,003 $8,417 $9,146 
Finance lease interest cost$1,146 $829 $3,487 $1,483 
Finance lease depreciation1,265 980 3,807 2,346 
Total finance leases$2,411 $1,809 $7,294 $3,829 












Future minimum operating and finance lease commitments, as of September 30, 2021, are as follows (in thousands):
Finance 
Leases		Operating Leases
2021$2,578 $2,022 
20227,068 4,424 
20236,964 2,466 
20246,892 1,808 
20256,797 1,442 
Thereafter80,350 2,565 
Total future minimum lease payments110,649 14,727 
Amounts representing interest(41,461)(2,432)
Present value of minimum lease payments69,188 12,295 
Less: current maturities of lease obligations(3,118)(4,553)
Long-term lease obligations$66,070 $7,742 
Supplemental cash flow amounts for the nine months ended September 30, 2021 were as follows (in thousands):
Cash Activity: Cash paid in measurement of amounts for lease liabilitiesSeptember 30, 2021
Operating leases$8,501 
Finance leases6,311 
Total$14,812 
Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligationsSeptember 30, 2021
Operating leases$5,418 
Finance leases6,345 
Total$11,763 




















Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2021:
September 30, 2021
Weighted-average remaining lease term - finance leases16.1 years
Weighted-average remaining lease term - operating leases4.9 years
Weighted-average discount rate - finance leases6.47%
Weighted-average discount rate - operating leases7.12%
XML 42 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Revenue
 9 Months Ended
Sep. 30, 2021
Revenue [Abstract]  
Revenue Recognition, Deferred Revenue [Policy Text Block]
Revenue

The company has two revenue streams: products and services. Services include repair, refurbishment, preventive maintenance and rental of product. Services for the North America segment include maintenance and repair of products. Services for the Europe segment include repair, refurbishment and preventive maintenance services. Services in All Other, are in the Asia Pacific region, and include rental and repair of products.

The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2021 and September 30, 2020 (in thousands):
Three Months Ended September 30, 2021
ProductServiceTotal
Europe$123,671 $3,355 $127,026 
North America87,936 118 88,054 
All Other7,788 1,332 9,120 
Total$219,395 $4,805 $224,200 
% Split98%2%100%
Nine Months Ended September 30, 2021
ProductServiceTotal
Europe$351,680 $9,417 $361,097 
North America259,623 652 260,275 
All Other21,010 3,884 24,894 
Total$632,313 $13,953 $646,266 
% Split98%2%100%
Three Months Ended September 30, 2020
ProductServiceTotal
Europe$113,043 $3,242 $116,285 
North America87,821 234 88,055 
All Other6,428 1,138 7,566 
Total$207,292 $4,614 $211,906 
% Split98%2%100%
Nine Months Ended September 30, 2020
ProductServiceTotal
Europe$329,943 $9,204 $339,147 
North America260,999 596 261,595 
All Other22,565 3,339 25,904 
Total$613,507 $13,139 $626,646 
% Split98%2%100%
The company's revenues are principally related to the sale of products, approximately 98%, with the remaining 2% related to services including repair, refurbishment, preventive maintenance and rental of products. While the company has a significant amount of contract types, the sales split by contract type is as follows: general terms and conditions (30%), large national customers (30%), governments, principally pursuant to tender contracts (21%) and other customers including buying groups and independent customers (19%).

All product and substantially all service revenues are recognized at a point in time. The remaining service revenue, recognized over time, are reflected in the Europe segment and include multiple performance obligations. For such contracts, the company allocates revenue to each performance obligation based on its relative standalone selling price. The company generally determines the standalone selling price based on the expected cost-plus margin methodology.    

Revenue is recognized when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the company’s products and services. Revenue is measured as the amount of consideration expected to be received in exchange for transferring product or providing services. The amount of consideration received and revenue recognized by the company can vary as a result of variable consideration terms included in the contracts related to customer rebates, cash discounts and return policies. Customer rebates and cash discounts are estimated based on the most likely amount principle and these estimates are based on historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such the company estimates the expected returns based on an analysis of historical experience. The company adjusts its estimate of revenue at the earlier of when the most likely amount of consideration it expects to receive changes or when the consideration becomes fixed. The company generally does not expect that there will be significant changes to its estimates of variable consideration (refer to “Receivables” and "Accrued Expenses" in the Notes to the Condensed Consolidated
Financial Statements include elsewhere in this report for more detail).

Depending on the terms of the contract, the company may defer the recognition of a portion of the revenue at the end of a reporting period to align with transfer of control of the company’s products to the customer. In addition, to the extent performance obligations are satisfied over time, the company defers revenue recognition until the performance obligations are satisfied. As of September 30, 2021 and December 31, 2020, the company had deferred revenue of $3,413,000 and $3,516,000, respectively, related to outstanding performance obligations.
XML 43 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Compensation
 9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Shareholders' Equity Transactions
Equity Compensation

The company’s Common Shares have a $0.25 stated value. The Common Shares and the Class B Common Shares generally have identical rights, terms and conditions and vote together as a single class on most issues, except that the Class B Common Shares have ten votes per share and, in general, can only be transferred to family members or for estate planning purposes. Holders of Class B Common Shares are entitled to convert their shares into Common Shares at any time on a share-for-share basis. When Class B Common Shares are transferred out of a familial relationship, they automatically convert to Common Shares.

As of September 30, 2021, 3,667 Class B Common Shares remained outstanding. Prior conversions of Class B Common Shares have virtually eliminated the company’s dual class voting structure. As of September 30, 2021, the holders of the Common Shares represented approximately 99.9% of the company’s total outstanding voting power.

Equity Compensation Plan

On May 17, 2018, the shareholders of the company approved the Invacare Corporation 2018 Equity Compensation Plan (the “2018 Plan”), which was adopted on March 27, 2018 by the company's Board of Directors (the “Board”). The company’s Board adopted the 2018 Plan in order to authorize additional Common Shares for grant as equity compensation, and to reflect changes to Section 162(m) of the Internal Revenue Code (the “Code”) resulting from the U.S. Tax Cuts and Jobs Act of 2017.
Following shareholder approval of the 2018 Plan, all of the Common Shares then-remaining available for issuance under the Invacare Corporation 2013 Equity Compensation Plan (the “2013 Plan”) and all of the Common Shares that were forfeited or remained unpurchased or undistributed upon termination or expiration of awards under the 2013 Plan and under the Invacare Corporation 2003 Performance Plan (the “2003 Plan”), become available for issuance under the 2018 Plan. Awards granted previously under the 2013 Plan and 2003 Plan will remain in effect under their original terms.
The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of stock options or stock appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a stock option or a SAR will count against the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003
Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share.
The Compensation and Management Development Committee of the Board (the “Compensation Committee”), in its discretion, may grant an award under the 2018 Plan to any director or employee of the company or an affiliate. As of September 30, 2021, 3,439,806 Common Shares were available for future issuance under the 2018 Plan in connection with the following types of awards with respect to the company's Common Shares: incentive stock options, nonqualified stock options, SARs, restricted stock, restricted stock units, unrestricted stock and performance shares. The Compensation Committee also may grant performance units that are payable in cash. The Compensation Committee has the authority to determine which participants will receive awards, the amount of the awards and the other terms and conditions of the awards. The Common Shares available for future issuance under the 2018 Plan as of September 30, 2021 includes an additional 2,500,000 Common Shares that were added pursuant to an amendment approved by shareholders at the company’s 2021 annual shareholders meeting on May 20, 2021. 

At September 30, 2021, an aggregate of 802,637 Common Shares underlie awards which were forfeited or expired unexercised under the 2003 and 2013 Plans and thus are available to be transferred under the 2018 Plan.
The 2018 Plan provides that shares granted come from the company's authorized but unissued Common Shares or treasury shares. In addition, the company's stock-based compensation plans allow employee participants to exchange shares for minimum withholding taxes, which results in the company acquiring treasury shares.
The amounts of equity-based compensation expense recognized as part of SG&A expenses in All Other in business segment reporting were as follows (in thousands):
For the Nine Months Ended September 30,
20212020
Restricted stock and restricted stock units$4,570 $4,471 
Performance shares and performance share units799 2,494 
Total stock-based compensation expense$5,369 $6,965 

As of September 30, 2021, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan and previous plans, which is related to non-vested options and shares, was as follows (in thousands):
September 30, 2021
Restricted stock and restricted stock units$7,924 
Performance shares and performance share units4,021 
Total unrecognized stock-based compensation expense$11,945 


Total unrecognized compensation cost will be adjusted for future changes in actual and estimated forfeitures and for updated vesting assumptions for the performance share awards (refer to "Stock Options" and "Performance Shares and Performance Share Units" below). No tax benefits for stock compensation were realized during the three and nine months ended September 30, 2021 and 2020, respectively, due to a valuation allowance against deferred tax assets. In accordance with ASC 718, any tax benefits resulting from tax deductions in excess of the compensation expense recognized is classified as a component of financing cash flows.

Stock Options

Generally, non-qualified stock option awards have a term of ten years and were granted with an exercise price per share equal to the fair market value of the company’s Common Shares on the date of grant.

The following table summarizes information about stock option activity for the nine months ended September 30, 2021:
Weighted Average
Exercise Price
Options outstanding at January 1, 20211,081,804 $16.07 
Forfeited(331,645)23.71
Options outstanding at September 30, 2021750,159 $12.69 
Options exercise price range at September 30, 2021$12.15 to$17.47 
Options exercisable at September 30, 2021750,159 
Shares available for grant at September 30, 2021*3,439,806 
________
 *    Shares available for grant under the 2018 Plan as of September 30, 2021 reduced by net restricted stock and restricted stock unit and performance share and performance share unit award activity of 2,671,108 shares.

The following table summarizes information about stock options outstanding at September 30, 2021:
 Options OutstandingOptions Exercisable
Exercise PricesNumber
Outstanding at
September 30, 2021		Weighted Average
Remaining
Contractual Life (Years)		Weighted Average
Exercise Price		Number
September 30, 2021		Weighted Average
Exercise Price
$12.15 – $20.00
750,159 4.2$12.69 750,159 $12.69 
The 2018 Plan provides for a one-year minimum vesting period for stock options and, generally, options must be exercised within ten years from the date granted. No stock options were issued in 2021 or 2020.

Restricted Stock and Restricted Stock Units

The following table summarizes information about restricted stock and restricted stock units (primarily for non-U.S. recipients):
Weighted Average Fair Value
Restricted stock / units unvested at January 1, 20211,145,058 $8.62 
Granted647,743 8.46 
Vested(550,258)9.34 
Forfeited(55,685)8.47 
Restricted stock / units unvested at September 30, 20211,186,858 $8.20 

The restricted awards generally vest ratably over the three years after the award date. Unearned restricted stock compensation, determined as the market value of the shares at the date of grant, is being amortized on a straight-line basis over the vesting period.

Performance Shares and Performance Share Units

The following table summarizes information about performance shares and performance share units (primarily for non-U.S. recipients):
 Weighted Average Fair Value
Performance shares / units unvested at January 1, 20211,026,785 $8.55 
Granted471,819 8.49 
Performance shares / units unvested at September 30, 20211,498,604 $8.53 


During the nine months ended September 30, 2021, performance shares and performance share units (for non-U.S. recipients) were granted as performance awards with a three year performance period with payouts based on achievement of certain performance goals. The awards are classified as equity awards as they will be settled in common shares upon vesting. The number of shares earned will be determined at the end of the three-year performance period based on achievement of performance criteria for January 1, 2018 through December 31, 2020, January 1, 2019 through
December 31, 2021, January 1, 2020 through December 31, 2022 and January 1, 2021 through December 31, 2023, respectively established by the Compensation Committee at the time of grant. Recipients will be entitled to receive a number of Common Shares equal to the number of performance shares that vest based upon the levels of achievement which may range between 0% and 150% of the target number of shares with the target being 100% of the initial grant.

The fair value of the performance awards is based on the stock price on the date of grant discounted for the estimated value of dividends foregone as the awards are not eligible for dividends except to the extent vested. The grant fair value is further updated each reporting period while variable accounting applies. The company assesses the probability that the performance targets will be met with expense recognized whenever it is probable that at least the minimum performance criteria will be achieved. Depending upon the company's assessment of the probability of achievement of the goals, the company may not recognize any expense associated with performance awards in a given period, may reverse prior expense recorded or record additional expense to recognize the cumulative estimated achievement level of proportionate term of the award. Performance award compensation expense is generally expected to be recognized over three years. The company continues to recognize expense related to the awards granted in 2019, 2020 and 2021 as it is considered probable that the performance goals for those awards will be met.
In the third quarter of 2021, reduced stock compensation expense was a benefit and is attributable to updated payout projections and change in the share price.
XML 44 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Accumulated Other Comprehensive Income (Loss) by Component
 9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss) by Component
Accumulated Other Comprehensive Income by Component

Changes in accumulated other comprehensive income ("OCI") (in thousands):
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2021$60,381 $2,146 $(4,069)$(1,379)$57,079 
OCI before reclassifications(19,155)(47)(209)944 (18,467)
Amount reclassified from accumulated OCI— — 182 309 491 
Net current-period OCI(19,155)(47)(27)1,253 (17,976)
September 30, 2021$41,226 $2,099 $(4,096)$(126)$39,103 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2020$50,329 $(517)$(3,674)$(702)$45,436 
OCI before reclassifications(9,103)2,616 (440)(643)(7,570)
Amount reclassified from accumulated OCI— — 18 1,219 1,237 
Net current-period OCI(9,103)2,616 (422)576 (6,333)
September 30, 2021$41,226 $2,099 $(4,096)$(126)$39,103 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2020$16,455 $(9,133)$(3,468)$794 $4,648 
OCI before reclassifications35,231 713 281 (2,501)33,724 
Amount reclassified from accumulated OCI— — (474)739 265 
Net current-period OCI35,231 713 (193)(1,762)33,989 
September 30, 2020$51,686 $(8,420)$(3,661)$(968)$38,637 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2019$8,898 $(2,491)$(3,299)$20 $3,128 
OCI before reclassifications42,788 (5,929)122 (1,340)35,641 
Amount reclassified from accumulated OCI— — (484)352 (132)
Net current-period OCI42,788 (5,929)(362)(988)35,509 
September 30, 2020$51,686 $(8,420)$(3,661)$(968)$38,637 
Reclassifications out of accumulated OCI were as follows (in thousands):
Amount reclassified from OCIAmount reclassified from OCIAffected line item in the Statement of Comprehensive (Income) Loss
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Defined Benefit Plans 
Service and interest costs$182 $(474)$18 $(484)Selling, general and administrative expenses
Tax— — — — Income tax provision
Total after tax$182 $(474)$18 $(484)
Derivatives
Foreign currency forward contracts hedging sales$476 $(481)$657 $(692)Net sales
Foreign currency forward contracts hedging purchases(92)1,259 746 1,029 Cost of products sold
Total loss before tax384 778 1,403 337 
Tax(75)(39)(184)15 Income tax provision
Total after tax$309 $739 $1,219 $352 
XML 45 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Charges Related To Restructuring Activities
 9 Months Ended
Sep. 30, 2021
Restructuring and Related Activities [Abstract]  
Charges Related To Restructuring Activities
Charges Related to Restructuring Activities

The company's restructuring charges were originally necessitated primarily by continued declines in Medicare and Medicaid reimbursement by the U.S. government, as well as similar healthcare reimbursement pressures abroad, which negatively affect the company's customers (e.g. home health care providers) and continued pricing pressures faced by the company due to the outsourcing by competitors to lower cost locations. Restructuring decisions were also the result of reduced profitability in each of the segments. Restructuring actions have continued into 2021.

For the nine months ended September 30, 2021, charges totaled $2,476,000 which were related to North America of $975,000 and Europe of $1,501,000. In North America costs were incurred related to severance. The European charges were for severance costs of $895,000 and contract terminations of $606,000, primarily related to the closure of a German manufacturing facility. Payments for the nine months ended September 30, 2021 were $7,367,000 and the cash payments were funded with the company's cash on hand. The 2021 charges are expected to be paid out within 24 months.
For the nine months ended September 30, 2020, charges totaled $4,657,000 which were related to North America of $865,000, Europe of $3,674,000 and All Other of $118,000. In North America and All Other, costs were incurred related to severance. The European charges were for severance costs $3,328,000 and contract terminations $346,000 primarily related to the closure of a German manufacturing facility. Payments for the nine months ended September 30, 2020 were $5,692,000 and the cash payments were funded with company's cash on hand. Most of the 2020 charges have been paid out.
There have been no material changes in accrued balances related to the charges, either as a result of revisions to the plans or changes in estimates. In addition, the savings anticipated as a result of the company's restructuring plans have been or are expected to be achieved, primarily resulting in reduced salary and benefit costs principally impacting selling, general and administrative expenses, and to a lesser extent, costs of products sold. To date, the company's liquidity has been sufficient to absorb these charges and payments.
A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2021 is as follows (in thousands):
SeveranceContract TerminationsTotal
December 31, 2020 Balances
North America$179 $— $179 
Europe5,904 4 5,908 
All Other166 — 166 
Total6,249 4 6,253 
Charges
North America 822 — 822 
Europe454 276 730 
All Other— — — 
Total 1,276 276 1,552 
Payments
North America (236)— (236)
Europe (6,047)— (6,047)
All Other— — — 
Total (6,283)— (6,283)
March 31, 2021 Balances
North America765 — 765 
Europe311 280 591 
All Other166 — 166 
Total$1,242 $280 $1,522 
Charges
North America$31 $— $31 
Europe408 108 516 
All Other— — — 
Total439 108 547 
Payments
North America(91)— (91)
Europe(234)(198)(432)
All Other(18)— (18)
Total(343)(198)(541)
June 30, 2021 Balances
North America705 — 705 
Europe485 190 675 
All Other148 — 148 
Total$1,338 $190 $1,528 
Charges
North America122 — 122 
Europe33 222 255 
All Other— — — 
Total155 222 377 
Payments
North America(225)— (225)
Europe(308)(34)(342)
All Other24 — 24 
Total(509)(34)(543)
SeveranceContract TerminationsTotal
September 30, 2021 Balances
North America602 — 602 
Europe210 378 588 
All Other172 — 172 
Total$984 $378 $1,362 
XML 46 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes
 9 Months Ended
Sep. 30, 2021
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes

The company had an effective tax rate of 8.8% and 11.3% on losses before tax for the three and nine months ended September 30, 2021, respectively, compared to an expected benefit of 21.0% on the pre-tax loss for each period. The company had an effective tax rate of 39.2% and 26.8% on losses before tax for the three and nine months ended September 30, 2020, respectively, compared to an expected benefit of 21.0% on the pre-tax loss for each period. The company's effective tax rate for the three and nine months ended September 30, 2021 and September 30, 2020 were unfavorable as compared to the U.S. federal statutory rate, principally due to the negative impact of the company not being able to record tax benefits related to the significant losses in countries which had tax valuation allowances. The effective tax rate was increased for the three and nine months ended September 30, 2021 and September 30, 2020 by certain taxes outside the United States, excluding countries with tax valuation allowances, that were at an effective rate higher than the U.S. statutory rate, except for the gain on the disposition of Dynamic Controls which was not taxable locally for the three months ended March 31, 2020. In addition, the company had accrued withholding taxes on earnings of its Chinese subsidiary based on the expectation of not permanently reinvesting those earnings. The sale of this entity, without such distribution resulted in the reversal of this accrual in the amount of $988,000 for the three months ended March 31, 2020. As a result of the impairment of goodwill in North America in the three and nine months ended September 30, 2021, the company recorded a reversal of deferred taxes related to the tax deductible goodwill previously deducted by the company, resulting in the company recognizing a tax benefit of $661,000 for the three and nine months ended September 30, 2021.
XML 47 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Net Earnings (Loss) Per Common Share
 9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Net Earnings (Loss) Per Common Share
Net Loss Per Common Share

The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.
(In thousands except per share data)For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Basic
Weighted average common shares outstanding35,013 34,419 34,826 34,213 
Net loss$(22,759)$(7,276)$(47,501)$(23,163)
Net loss per common share$(0.65)$(0.21)$(1.36)$(0.68)
Diluted
Weighted average common shares outstanding35,013 34,419 34,826 34,213 
Share options and awards475 111 545 100 
Weighted average common shares assuming dilution35,488 34,530 35,371 34,313 
Net loss$(22,759)$(7,276)$(47,501)$(23,163)
Net loss per common share *$(0.65)$(0.21)$(1.36)$(0.68)
________
* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
For the three and nine months ended September 30, 2021, shares associated with equity compensation awards of 682,668 and 1,163,526, respectively, and for the three and nine months September 30, 2020, shares associated with equity compensation awards of 1,703,694 and 1,703,694, respectively, were excluded from the weighted average common shares assuming dilution as incremental shares were anti-dilutive.

At September 30, 2021, the majority of the anti-dilutive incremental shares were awards granted at an exercise price above $14.49, which was higher than the average fair market value price of $7.30 and $8.30 for the three and nine months ended September 30, 2021. At September 30, 2020, the majority of the anti-dilutive incremental shares were awards granted at an exercise price above $24.45 or above, which was higher than the average fair market value price of $6.93 and $7.12 for the three and nine months ended September 30, 2020.

For the three and nine months ended September 30, 2021 and September 30, 2020, respectively, no shares were included in the common shares assuming dilution related to the company's issued warrants as the average market price of the company shares for these periods did not exceed the strike price of the warrants.
Further, upon adoption of ASU 2020-06, effective in 2021 for the company, use of the if-converted earnings per share method is required. However, no shares were included in the weighted average common shares assuming dilution for the three months and nine months ended September 30, 2021 related to the company's convertible senior notes as conversion prices were above the company's average stock price for the period and other requirements for the notes to be convertible to shares were not met.
XML 48 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Concentration Of Credit Risk
 9 Months Ended
Sep. 30, 2021
Risks and Uncertainties [Abstract]  
Concentration Of Credit Risk
Concentration of Credit Risk

The company manufactures and distributes durable medical equipment to the home health care, retail and extended care markets. The company performs credit evaluations of its customers’ financial condition. The company utilizes De Lage Landen, Inc. (“DLL”), a third-party financing company, to provide lease financing to Invacare's U.S. customers. The DLL agreement provides for direct leasing between DLL and the Invacare customer. The company retains a recourse obligation of $858,000 at September 30, 2021 to DLL for events of default under the contracts, which total $6,919,000 at September 30, 2021. Guarantees, ASC 460, requires the company to record a guarantee liability as it relates to the limited recourse obligation. As such, the company has recorded a liability for this guarantee obligation within other long-term obligations. The company's recourse is reevaluated by DLL biannually, considers activity between the biannual dates and excludes any receivables purchased by the company from DLL. The company monitors the collections status of these contracts and has provided amounts for estimated losses in its allowances for doubtful accounts in accordance with Receivables, ASC 310-10-05-4. Credit losses are provided for in the financial statements.































Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities located throughout the United States, Australia, Canada, New Zealand and Europe or also direct from governmental entities in certain countries. A significant portion of products sold to dealers, both foreign and domestic, is ultimately funded through government reimbursement programs such as Medicare and Medicaid. Changes in these programs can have a significant shift in reimbursement to customers from managed care entities. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability. In addition, reimbursement guidelines in the home health care industry have a substantial impact on the nature and type of equipment an end user can obtain as well as the timing of reimbursement and, thus, affect the product mix, pricing and payment patterns of the company’s customers.
XML 49 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives
 9 Months Ended
Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives
Derivatives

ASC 815 requires companies to recognize all derivative instruments in the consolidated balance sheet as either assets or liabilities at fair value. The accounting for changes in fair value of a derivative is dependent upon whether or not the derivative has been designated and qualifies for hedge accounting treatment and the type of hedging relationship. For derivatives designated and qualifying as hedging instruments, the company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

Cash Flow Hedging Strategy

The company uses derivative instruments in an attempt to manage its exposure to transactional foreign currency exchange risk. Foreign forward exchange contracts are used to manage the price risk associated with forecasted sales denominated in foreign currencies and the price risk associated with forecasted purchases of inventory over the next twelve months.

The company recognizes its derivative instruments as assets or liabilities in the consolidated balance sheet measured at fair value. All the company’s derivative instruments are designated and qualify as cash flow hedges. Accordingly, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The remaining gain or loss on the derivative instrument in excess of the cumulative change in the fair value of the hedged item, if any, is recognized in current earnings during the period of change.



















To protect against increases/decreases in forecasted foreign currency cash flows resulting from inventory purchases/sales over the next year, the company utilizes foreign currency forward contracts to hedge portions of its forecasted purchases/sales denominated in foreign currencies. The gains and losses are included in cost of products sold and selling, general and administrative expenses on the condensed consolidated statement of comprehensive income (loss). If it is later determined that a hedged forecasted transaction is unlikely to occur, any prospective gains or losses on the forward contracts would be recognized in earnings. The company does not expect any material amount of hedge ineffectiveness related to forward contract cash flow hedges during the next twelve months.

The company has historically not recognized any material amount of ineffectiveness related to forward contract cash flow hedges because the company generally limits its hedges to between 50% and 90% of total forecasted transactions for a given entity’s exposure to currency rate changes and the transactions hedged are recurring in nature. Furthermore, most of the hedged transactions are related to intercompany sales and purchases for which settlement occurs on a specific day each month. Forward contracts with a total notional amount in USD of $90,800,000 and $155,783,000 matured for the nine months ended September 30, 2021 and September 30, 2020, respectively.






Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):
 September 30, 2021December 31, 2020
 Notional
Amount		Unrealized
Net Gain
(Loss)		Notional
Amount		Unrealized
Net Gain
(Loss)
USD / CHF321 4 1,675 (11)
USD / EUR14,840 83 56,187 (636)
USD / GBP644 (23)2,467 (19)
USD / SEK727 (4)2,658 (41)
USD / MXN817 98 2,230 334 
EUR / CHF1,119 2 5,037 10 
EUR / GBP4,960 (218)19,060 44 
EUR / SEK2,882 (40)10,162 (73)
EUR / NOK1,215 (66)4,167 (64)
AUD / NZD190 1 781 (13)
DKK / SEK750 6 3,329 9 
NOK / SEK823 (39)3,431 (50)
AUD / THB— — 4,963 (221)
NZD / THB425 (42)1,755 (55)
USD / THB624 60 4,152 (56)
EUR / THB188 13 1,332 18 
GBP / THB— — 842 10 
$30,525 $(165)$124,228 $(814)

Derivatives Not Qualifying or Designated for Hedge Accounting Treatment

The company utilizes foreign currency forward contracts that are not designated as hedges in accordance with ASC 815. These contracts are entered into to eliminate the risk associated with the settlement of short-term intercompany trading receivables and payables between Invacare Corporation and its foreign subsidiaries. The currency forward contracts are entered into at the same time as the intercompany
receivables or payables are created so that upon settlement, the gain/loss on the settlement is offset by the gain/loss on the foreign currency forward contract. No material net gain or loss was realized by the company in 2021 or 2020 related to these contracts and the associated short-term intercompany trading receivables and payables.
Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2021 and 2020, respectively, and outstanding were as follows (in thousands USD):
 September 30, 2021December 31, 2020
 Notional
Amount		Gain
(Loss)		Notional
Amount		Gain
(Loss)
USD / AUD$6,153 $50 $6,046 $(159)
USD / CAD14,616 (74)8,320 88 
USD / EUR60,000 (494)— — 
USD / DKK21,732 (198)8,690 207 
USD / GBP38,144 (438)16,062 338 
USD / NOK22,798 11 9,053 264 
USD / SEK4,597 (37)— — 
EUR / GBP8,157 (22)— — 
AUD / NZD6,790 (77)6,579 (35)
EUR / CHF5 — — — 
AUD / THB1,206 (107)— — 
USD / THB414 40 — — 
EUR / THB126 9 — — 
GBP / THB198 22 — — 
$184,936 $(1,315)$54,750 $703 

The fair values of the company’s derivative instruments were as follows (in thousands):
 September 30, 2021December 31, 2020
 AssetsLiabilitiesAssetsLiabilities
Derivatives designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts$267 $432 $424 $1,238 
Derivatives not designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts339 1,654 897 194 
Total derivatives$606 $2,086 $1,321 $1,432 

The fair values of the company’s foreign currency forward exchange contract assets and liabilities are included in Other Current Assets and Accrued Expenses, respectively in the Condensed Consolidated Balance Sheets.

The effect of derivative instruments on Accumulated Other Comprehensive Income (OCI) and the Condensed Statement of Comprehensive Income (Loss) was as follows (in thousands):
Derivatives (foreign currency forward exchange contracts) in ASC 815 cash flow hedge
relationships		Amount of Gain
(Loss) Recognized  in Accumulated OCI on Derivatives
(Effective Portion)		Amount of Gain (Loss)
Reclassified from
Accumulated OCI into
Income (Effective
Portion)		Amount of Gain (Loss)
Recognized in Income on
Derivatives (Ineffective  Portion and Amount Excluded from
Effectiveness Testing)
Three months ended September 30, 2021
Foreign currency forward exchange contracts$944 $(309)$51 
Nine months ended September 30, 2021
Foreign currency forward exchange contracts$(643)$(1,219)$(37)
Three months ended September 30, 2020
Foreign currency forward exchange contracts$(2,501)$(739)$(662)
Nine months ended September 30, 2020
Foreign currency forward exchange contracts$(1,340)$(352)$(718)
Derivatives (foreign currency forward exchange contracts) not designated as hedging
instruments under ASC 815		  Amount of Gain (Loss)
Recognized in Income on Derivatives
Three months ended September 30, 2021
Foreign currency forward exchange contracts$(592)
Nine months ended September 30, 2021
Foreign currency forward exchange contracts$(1,315)
Three months ended September 30, 2020
Foreign currency forward exchange contracts$(1,320)
Nine months ended September 30, 2020
Foreign currency forward exchange contracts$(1,077)
The gains or losses recognized as the result of the settlement of cash flow hedge foreign currency forward contracts are recognized in net sales for hedges of inventory sales and in cost of products sold for hedges of inventory purchases. For the three and nine months ended September 30, 2021, net sales were decreased by $476,000 and $657,000 while cost of products sold was decreased by $92,000 and increased by $746,000 for net pre-tax realized losses of $384,000 and $1,403,000, respectively. For the three and nine months ended September 30, 2020, net sales were increased by $481,000 and $692,000 while cost of products sold was increased by $1,259,000 and $1,029,000 for net realized pre-tax losses of $778,000 and $337,000, respectively.

Losses of $592,000 and $1,315,000 were recognized in selling, general and administrative (SG&A) expenses for the three and nine months ended September 30, 2021 compared to losses of $1,320,000 and $1,077,000 for the three and nine months ended September 30, 2020 related to forward contracts not designated as hedging instruments. The forward contracts were entered into to offset gains/losses that were also recorded in SG&A expenses on intercompany trade receivables or payables. The gains/losses on the non-designated hedging instruments were substantially offset by gains/losses on intercompany trade payables.

The company's derivative agreements provide the counterparties with a right of set off in the event of a default. The right of set off would enable the counterparty to offset any net payment due by the counterparty to the company under the applicable agreement by any amount due by the company to the counterparty under any other agreement. For example, the terms of the agreement would permit a counterparty to a derivative contract that is also a lender under the company's Credit Agreement to reduce any derivative settlement amounts owed to the company under the derivative contract by any amounts owed to the counterparty by the company under the Credit Agreement. In addition, the agreements contain cross-default provisions that could trigger a default by the company under the agreement in the event of a default by the company under another agreement with the same counterparty. The company presents derivatives on a net basis in its financial statements for those subject to provisions that are similar to master netting agreements.
XML 50 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Values
 9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments
Fair Values

Pursuant to ASC 820, the inputs used to derive the fair value of assets and liabilities are analyzed and assigned a level I, II or III priority, with level I being the highest and level III being the lowest in the hierarchy. Level I inputs are quoted prices in active markets for identical assets or liabilities.



Level II inputs are quoted prices for similar assets or liabilities in active markets: quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. Level III inputs are based on valuations derived from valuation techniques in which one or more significant inputs are unobservable.
The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):
 Basis for Fair Value Measurements at Reporting Date
Quoted Prices in Active
Markets for Identical
Assets / (Liabilities)		Significant Other
Observable
Inputs		Significant Other
Unobservable
Inputs
Level ILevel IILevel III
September 30, 2021
Forward exchange contracts—net—$(1,480)—
December 31, 2020
Forward exchange contracts—net—$(111)—

The carrying values and fair values of the company’s financial instruments are as follows (in thousands):
 September 30, 2021December 31, 2020
 Carrying ValueFair ValueCarrying ValueFair Value
Cash and cash equivalents$73,656 $73,656 $105,298 $105,298 
Other investments84 84 85 85 
Installment receivables, net of reserves1,160 1,160 1,322 1,322 
Forward contracts in Other current assets606 606 1,321 1,321 
Forward contracts in Accrued expenses(2,086)(2,086)(1,432)(1,432)
Total debt (including current maturities of long-term debt) *(309,455)(279,747)(245,053)(237,948)
2021 Notes — — (1,242)(1,264)
2022 Notes(2,637)(2,559)(73,869)(70,633)
Series I 2024 Notes(72,073)(64,643)(62,984)(60,035)
Series II 2024 Notes(77,270)(73,697)(64,919)(64,090)
2026 Notes(118,682)(100,055)— — 
Other(38,793)(38,793)(42,039)(41,926)
________
* The company's total debt is shown net of applicable discounts and fees associated with the convertible senior notes due in 2021, 2022, 2024 and 2026 on the company's condensed consolidated balance sheet. Accordingly, the fair values of the convertible senior notes due in 2021, 2022, 2024 and 2026 included in the long-term debt presented in this table are also shown net of the discounts and fees. Discount balances applicable to the company's convertible senior notes were eliminated upon adoption of ASU 2020-06 on January 1, 2021, but are included in the balances above for the period prior to adoption. Refer to Long-Term Debt footnote for discount balances by convertible senior notes series. Total debt excludes operating and finance leases obligations.
The company, in estimating its fair value disclosures for financial instruments, used the following methods and assumptions:

Cash, cash equivalents: The carrying value reported in the balance sheet for cash, cash equivalents equals its fair value.

Other investments: The company has an investment in a limited partnership, which is accounted for using the cost method, adjusted for any estimated declines in value. The investment was acquired in private placement and there is no quoted market price or stated rate of return. The company does not have the ability to easily sell the investment. The company completes an evaluation of the residual value related to such investments in the fourth quarter of each year.

Installment receivables: The carrying value reported in the balance sheet for installment receivables approximates its fair value. The interest rates associated with these receivables have not varied significantly since inception. Management believes that after consideration of the credit risk, the net book value of the installment receivables approximates market value.
Forward contracts: The company operates internationally, and as a result, is exposed to foreign currency fluctuations. Specifically, the exposure includes intercompany loans and third-party sales or payments. In an attempt to reduce this exposure, foreign currency forward contracts are utilized and accounted for as hedging instruments. The forward contracts are used to hedge the following currencies: AUD, CAD, CHF, DKK, EUR, GBP, MXN, NOK, NZD, SEK, THB, and USD. The company does not use derivative financial instruments for speculative purposes. Fair values for the company’s foreign exchange forward contracts are based on quoted market prices for contracts with similar maturities. The company’s forward contracts are included in Other current assets or Accrued expenses in the condensed consolidated balance sheets. Total debt: Fair value for the company’s convertible debt is based on quoted market-based estimates as of the end of the period, while the revolving credit facility fair value is based upon an estimate of the market for similar borrowing arrangements. The fair values are deemed to be categorized as Level 2 in the fair value hierarchy. Other total debt is primarily attributable to credit facilities borrowings where the carrying value reported in the balance approximates its fair value and the CARES Act Loan as of December 31, 2020 which utilized the fair value factor of the 2022 Notes to approximate fair value.
XML 51 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments
 9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
Business Segments
Business Segments
The company operates in two primary business segments: North America and Europe with each selling the company's primary product categories, which include: lifestyle, mobility and seating and respiratory therapy products. Sales in Asia Pacific are reported in All Other and include products similar to those sold in North America and Europe. The accounting policies of each segment are the same as those described in the summary of significant accounting policies for the company's consolidated financial statements. Intersegment sales and transfers are based on the costs to manufacture plus a reasonable profit element.

Segment performance is measured and resources are allocated based on a number of factors, with the primary income or loss measure being segment operating income (loss). Segment operating income (loss) represents net sales less cost of products sold less selling general and administrative expenses. Segment operating income (loss)
excludes unallocated corporate general and administrative expenses not allocated to the segments and intersegment sales and profit eliminations, which are included in All Other. In addition, segment operating income (loss) further excludes charges related to restructuring activities, asset impairment and gain on sale of business (as applicable).

This performance measure, segment operating income (loss), is used by the Chief Operating Decision Maker (CODM) for purposes of making decisions about allocating resources to a segment and assessing its performance. In addition, this metric is reviewed by the company's Board of Directors regarding segment performance and is a key metric in the performance management assessment of the company's employees.


The information by segment is as follows (in thousands):
 For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Revenues from external customers
Europe$127,026 $116,285 $361,097 $339,147 
North America88,054 88,055 260,275 261,595 
All Other (Asia Pacific)9,120 7,566 24,894 25,904 
Consolidated$224,200 $211,906 $646,266 $626,646 
Intersegment revenues
Europe$6,221 $6,027 $17,758 $14,438 
North America15,044 23,625 45,903 66,356 
All Other (Asia Pacific)— 1,116 — 3,645 
Consolidated$21,265 $30,768 $63,661 $84,439 
Restructuring charges before income taxes
Europe$255 $1,434 $1,501 $3,674 
North America122 146 975 865 
All Other— — — 118 
Consolidated$377 $1,580 $2,476 $4,657 
Operating income (loss)
Europe$9,554 $7,600 $18,378 $16,624 
North America(1,523)2,992 (2,308)5,759 
All Other(3,856)(6,082)(19,025)(17,377)
Charge expense related to restructuring activities(377)(1,580)(2,476)(4,657)
Gain on sale of business— — — 9,790 
Impairment of goodwill(28,564)— (28,564)— 
Consolidated operating income (loss)(24,766)2,930 (33,995)10,139 
Gain (loss) on debt extinguishment including debt finance charges and associated fees10,131 (761)9,422 (7,360)
Net interest expense(6,284)(7,395)(18,098)(21,042)
Loss before income taxes$(20,919)$(5,226)$(42,671)$(18,263)
Net sales by product, are as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Europe
Lifestyle$61,683 $50,307 $181,628 $160,628 
Mobility and Seating56,535 54,851 152,660 147,275 
Respiratory Therapy4,225 6,070 13,613 16,680 
Other(1)4,583 5,057 13,196 14,564 
$127,026 $116,285 $361,097 $339,147 
North America
Lifestyle$38,666 $41,845 $114,951 $124,888 
Mobility and Seating28,414 26,572 82,243 82,485 
Respiratory Therapy20,856 19,405 62,429 53,626 
Other(1)118 233 652 596 
$88,054 $88,055 $260,275 $261,595 
All Other (Asia Pacific)
Mobility and Seating$3,171 $2,670 $9,239 $10,757 
Lifestyle3,230 3,375 8,736 10,176 
Respiratory Therapy1,215 195 2,547 1,043 
Other(1)1,504 1,326 4,372 3,928 
$9,120 $7,566 $24,894 $25,904 
Total Consolidated$224,200 $211,906 $646,266 $626,646 
   ________________________
(1)Includes various services, including repair services, equipment rentals and external contracting.
XML 52 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Contingencies
 9 Months Ended
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
Contingencies
Contingencies
General

In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions in which various plaintiffs seek damages for injuries allegedly caused by defective products. All the product liability lawsuits that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended or prohibited diplomatic or trade relations. The amount recorded for identified contingent liabilities is based on estimates. Amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. Actual costs to be incurred in future periods may vary from the estimates, given the inherent uncertainties in evaluating certain exposures.

As a medical device manufacturer, the company is subject to extensive government regulation, including numerous laws directed at preventing fraud and abuse and laws regulating reimbursement under various government programs. The marketing, invoicing, documenting, developing, testing, manufacturing, labeling, promoting, distributing and other practices of health care suppliers and medical device manufacturers are all subject to government scrutiny. Most of the company's facilities are subject to inspection at any time by the FDA or similar medical device regulatory agencies in other jurisdictions. Violations of law or regulations can result in administrative, civil and criminal penalties and sanctions, which could have a material adverse effect on the company's business.

Medical Device Regulatory Matters
The FDA in the United States and comparable medical device regulatory authorities in other jurisdictions regulate virtually all aspects of the marketing, invoicing, documenting, development, testing, manufacturing, labeling, promotion, distribution and other practices regarding medical devices. The company and its products are subject to the laws and regulations of the FDA and other regulatory bodies in the various jurisdictions where the company's products are manufactured or sold. The company's failure to comply with the regulatory requirements of the FDA and other applicable medical device regulatory requirements can subject the company to administrative or judicially imposed sanctions or
enforcement actions. These sanctions include injunctions, consent decrees, warning letters, civil penalties, criminal penalties, product seizure or detention, product recalls and total or partial suspension of production.
In December 2012, the company became subject to a consent decree of injunction filed by the FDA with respect to the company's Corporate facility and its Taylor Street manufacturing facility in Elyria, Ohio. The consent decree initially limited the company's (i) manufacture and distribution of power and manual wheelchairs, wheelchair components and wheelchair sub-assemblies at or from its Taylor Street manufacturing facility, except in verified cases of medical necessity, (ii) design activities related to wheelchairs and power beds that take place at the impacted Elyria facilities and (iii) replacement, service and repair of products already in use from the Taylor Street manufacturing facility. Under the terms of the consent decree, in order to resume full operations, the company had to successfully complete independent, third-party expert certification audits at the impacted Elyria facilities, comprising three distinct certification reports separately submitted to, and subject to acceptance by, the FDA; submit its own report to the FDA; and successfully complete a reinspection by the FDA of the company's Corporate and Taylor Street facilities.
On July 24, 2017, following its June 2017 reinspection of the Corporate and Taylor Street facilities, the FDA notified the company that it is in substantial compliance with the FDA Act, FDA regulations and the terms of the consent decree and, that the company was permitted to resume full operations at those facilities including the resumption of unrestricted sales of products made in those facilities.
The consent decree will continue in effect for at least five years from July 24, 2017, during which time the company's Corporate and Taylor Street facilities must complete two semi-annual audits in the first year and then four annual audits in the next four years performed by a company-retained expert firm. The expert audit firm will determine whether the facilities remain in continuous compliance with the FDA Act, FDA regulations and the terms of the consent decree. The FDA has the authority to inspect these facilities and any other FDA registered facility, at any time.
The FDA has continued to actively inspect the company's facilities, other than through the processes established under the consent decree. The company expects that the FDA will, from time to time, inspect substantially all the company's domestic and foreign FDA-registered facilities.
In June 2021, the FDA inspected the company's Corporate and Taylor Street facilities in Elyria and North Ridgeville,
Ohio and issued its observations on Form 843. The company has submitted its response to FDA in a timely manner.
The results of regulatory claims, proceedings, investigations, or litigation are difficult to predict. An unfavorable resolution or outcome of any FDA warning letters or inspectional observations, or other FDA enforcement related to company facilities, could materially and adversely affect the company's business, financial condition, and results of operations.
The limitations previously imposed by the FDA consent decree negatively affected net sales in the North America segment and, to a certain extent, the Asia Pacific region beginning in 2012. The limitations led to delays in new product introductions. Further, uncertainty regarding how long the limitations would be in effect limited the company's ability to renegotiate and bid on certain customer contracts and otherwise led to a decline in customer orders.
Although the company has been permitted to resume full operations at the Corporate and Taylor Street facilities, the negative effect of the consent decree on customer orders and net sales in the North America segment and Asia Pacific region has been considerable, and it is uncertain as to whether, or how quickly, the company will be able to rebuild net sales to more typical historical levels, irrespective of market conditions. Accordingly, when compared to the company's 2010 results, the previous limitations in the consent decree had, and likely may continue to have, a material adverse effect on the company's business, financial condition and results of operations.
Warranty Matters
The company's warranty reserves are subject to adjustment in future periods based on historical analysis of warranty claims and as new developments occur that may change the company's estimates related to specific product recalls. Refer to Current Liabilities in the Notes to the Condensed Consolidated Financial Statements for the total provision amounts and a reconciliation of the changes in the warranty accrual.
Any of the above contingencies could have an adverse impact on the company's financial condition or results of operations.
For additional information regarding the consent decree, other regulatory matters, and risks and trends that may impact the company’s financial condition or results of operations, please see the following sections of the company's Annual Report on Form 10-K for the year ended December 31, 2020: Item 1. Business - Government Regulation and Item 1A. Risk Factors; Item 3. Legal Proceedings; and Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources.
XML 53 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Principles of Consolidation Principles of Consolidation:  The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2021 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2021 and 2020, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year.
Use of Estimates Use of Estimates:  The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.
Recent Accounting Pronouncements
Recent Accounting Pronouncements (Already Adopted): 
In August 2020, the FASB issued ASU 2020-06 "Debt with Conversion and Other Options" (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity's Own Equity (Subtopic 815-40)", which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. ASU 2020-06 removes from U.S. GAAP the separation models for (1) convertible debt with a cash conversion feature (CCF) and (2) convertible instrument with a beneficial conversion feature (BCF). As a result, after adopting the ASU’s guidance, entities will not separately present in equity an embedded conversion feature in such debt. Instead, they will account for a convertible debt instrument wholly as debt, and for convertible preferred stock wholly as preferred stock (i.e., as a single unit of account), unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC 815 or (2) a convertible debt instrument was issued at a substantial premium. The guidance may be early adopted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years.

The company adopted ASU 2020-06 effective January 1, 2021, using the modified retrospective method, which resulted
in the removal of convertible debt discounts of $25,218,000, adjustment of $34,798,000 to additional paid-in-capital and $9,670,000 adjustment to retained earnings. Convertible debt discounts prior to adoption of ASU 2020-06 were amortized over the convertible debt term through interest expense. Subsequent to adoption, convertible debt discounts are not applicable when accounting for debt as a single unit of account. Interest expense for the three and nine months ended September 30, 2020 related to debt discount amortization (which was not recognized in 2021 due to adoption) were $2,273,000 or $0.07 per basic and diluted share and $7,613,000 or $0.22 per basic and diluted share, respectively. There was no impact of adoption on performance metrics used for short-term or long-term incentive compensation. Accretion specific to the Series II 2024 Notes was unaffected by adoption. Due to the valuation allowance, there was no net impact to income taxes for the adoption. Subsequent to adoption weighted average shares when calculating diluted earnings per share requires the application of the if-converted method for all convertible instruments.
New Accounting Pronouncements, Not yet Adopted Recent Accounting Pronouncements (Not Yet Adopted): In March 2020, the FASB issued ASU 2020-04 "Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting," which is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates if certain criteria are met. The guidance may be adopted in any period prior to the guidance expiration on December 31, 2022. The company is currently reviewing the impact of the adoption of ASU 2020-04 but does not expect the adoption to have a material impact on the company's financial statements.
XML 54 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Divested Businesses (Tables)
 2 Months Ended
Mar. 07, 2020
Divested Businesses [Abstract]  
Assets and Liabilities of Divested Business [Table Text Block]
The assets and liabilities of Dynamic Controls as of March 7, 2020 consisted of the following (in thousands):
March 7, 2020
Trade receivables, net$4,129 
Inventories, net3,082 
Other assets855 
Property and equipment, net600 
Operating lease assets, net2,127 
Total assets$10,793 
Accounts payable$4,692 
Accrued expenses2,473 
Current taxes payable41 
Current portion of operating lease obligations366 
Long-term obligations1,019 
Total liabilities$8,591 
XML 55 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Receivables (Tables)
 9 Months Ended
Sep. 30, 2021
Receivables [Abstract]  
Schedule of Accounts Receivable
Receivables consist of the following (in thousands):
September 30, 2021December 31, 2020
Accounts receivable, gross$141,003 $131,055 
Customer rebate reserve(12,689)(10,730)
Cash discount reserves(7,285)(7,320)
Allowance for doubtful accounts(4,227)(4,031)
Other, principally returns and allowances reserves(879)(386)
Accounts receivable, net$115,923 $108,588 
Schedule for Allowance for Credit Losses
The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2021
Balance as of beginning of period$4,031 
Current period provision432 
Recoveries (direct write-offs), net(236)
Balance as of end of period$4,227 
Schedule of Installment Receivables
Installment receivables consist of the following (in thousands):
 September 30, 2021December 31, 2020
 CurrentLong-TermTotalCurrentLong-TermTotal
Installment receivables$345 $909 $1,254 $704 $1,105 $1,809 
Allowance for doubtful accounts(53)(41)(94)(325)(162)(487)
Installment receivables, net$292 $868 $1,160 $379 $943 $1,322 
Schedule of Installment Receivables Allowance for Doubtful Accounts
The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2021		Year Ended December 31, 2020
Balance as of beginning of period$487 $1,514 
Current period provision (benefit)(105)66 
Direct write-offs charged against the allowance(288)(1,093)
Balance as of end of period$94 $487 
Schedule of Installment Receivables by Class
Installment receivables by class as of September 30, 2021 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$239 $239 $94 $— 
Asia Pacific
Non-Impaired installment receivables with no related allowance recorded1,015 1,015 — — 
Total
Non-Impaired installment receivables with no related allowance recorded1,015 1,015 — — 
Impaired installment receivables with a related allowance recorded239 239 94 — 
Total installment receivables$1,254 $1,254 $94 $— 
Installment receivables by class as of December 31, 2020 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$615 $615 $487 $— 
Asia Pacific
Non-impaired installment receivables with no related allowance recorded1,194 1,194 — — 
Canada
Non-impaired installment receivables with no related allowance recorded— — — 29 
Total
Non-impaired installment receivables with no related allowance recorded1,194 1,194 — 29 
Impaired installment receivables with a related allowance recorded615 615 487 — 
Total installment receivables$1,809 $1,809 $487 $29 
Schedule of Financing Receivables
Installment receivables by class as of September 30, 2021 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$239 $239 $94 $— 
Asia Pacific
Non-Impaired installment receivables with no related allowance recorded1,015 1,015 — — 
Total
Non-Impaired installment receivables with no related allowance recorded1,015 1,015 — — 
Impaired installment receivables with a related allowance recorded239 239 94 — 
Total installment receivables$1,254 $1,254 $94 $— 
Installment receivables by class as of December 31, 2020 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$615 $615 $487 $— 
Asia Pacific
Non-impaired installment receivables with no related allowance recorded1,194 1,194 — — 
Canada
Non-impaired installment receivables with no related allowance recorded— — — 29 
Total
Non-impaired installment receivables with no related allowance recorded1,194 1,194 — 29 
Impaired installment receivables with a related allowance recorded615 615 487 — 
Total installment receivables$1,809 $1,809 $487 $29 
Schedule of Aging of Installment Receivables
The aging of the company’s installment receivables was as follows (in thousands):
September 30, 2021December 31, 2020
TotalU.S.Asia PacificTotalU.S.Asia Pacific
Current$1,015 $— $1,015 $1,194 $— $1,194 
0-30 days past due— — — — — — 
31-60 days past due— — — — — — 
61-90 days past due— — — — — — 
90+ days past due239 239 — 615 615 — 
$1,254 $239 $1,015 $1,809 $615 $1,194 
XML 56 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Inventories (Tables)
 9 Months Ended
Sep. 30, 2021
Inventory Disclosure [Abstract]  
Schedule of Inventory
Inventories consist of the following (in thousands):
September 30, 2021December 31, 2020
Finished goods$70,545 $55,264 
Raw materials69,842 51,174 
Work in process10,948 9,046 
Inventories, net$151,335 $115,484 
XML 57 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Other Current Assets (Tables)
 9 Months Ended
Sep. 30, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Other Current Assets
Other current assets consist of the following (in thousands):
September 30, 2021December 31, 2020
Tax receivables principally value added taxes$23,006 $22,500 
Prepaid inventory and freight1,864 2,700 
Receivable due from information technology provider1,488 2,995 
Recoverable income taxes685 2,182 
Derivatives (foreign currency forward exchange contracts)606 1,321 
Service contracts393 633 
Deferred financing fees354 208 
Prepaid insurance276 3,963 
Prepaid and other current assets7,479 8,215 
Other Current Assets$36,151 $44,717 
XML 58 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Other Long-Term Assets (Tables)
 9 Months Ended
Sep. 30, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Other Assets, Noncurrent
Other long-term assets consist of the following (in thousands):
September 30, 2021December 31, 2020
Cash surrender value of life insurance policies$2,372 $2,327 
Deferred income taxes2,278 2,048 
Installment receivables868 943 
Deferred financing fees463 411 
Investments84 85 
Other112 111 
Other Long-Term Assets$6,177 $5,925 
XML 59 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Property And Equipment (Tables)
 9 Months Ended
Sep. 30, 2021
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment
Property and equipment consist of the following (in thousands):
September 30, 2021December 31, 2020
Machinery and equipment$292,897 $294,045 
Land, buildings and improvements28,230 28,509 
Capitalized software28,149 17,527 
Furniture and fixtures10,288 10,001 
Leasehold improvements6,965 8,194 
Property and Equipment, gross366,529 358,276 
Accumulated depreciation(304,317)(302,033)
Property and Equipment, net$62,212 $56,243 
XML 60 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Intangibles (Tables)
 9 Months Ended
Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Indefinite-Lived Intangible Assets
The company's intangibles consist of the following (in thousands):
 
 September 30, 2021December 31, 2020
 Historical
Cost		Accumulated
Amortization		Historical
Cost		Accumulated
Amortization
Customer lists$54,222 $54,222 $54,502 $54,502 
Trademarks25,016 — 25,112 — 
Developed technology7,889 7,318 7,924 7,204 
Patents5,542 5,542 5,556 5,556 
License agreements2,904 1,143 2,899 979 
Other1,149 1,140 1,162 1,151 
Intangibles$96,722 $69,365 $97,155 $69,392 
Schedule of Finite-Lived Intangible Assets
The company's intangibles consist of the following (in thousands):
 
 September 30, 2021December 31, 2020
 Historical
Cost		Accumulated
Amortization		Historical
Cost		Accumulated
Amortization
Customer lists$54,222 $54,222 $54,502 $54,502 
Trademarks25,016 — 25,112 — 
Developed technology7,889 7,318 7,924 7,204 
Patents5,542 5,542 5,556 5,556 
License agreements2,904 1,143 2,899 979 
Other1,149 1,140 1,162 1,151 
Intangibles$96,722 $69,365 $97,155 $69,392 
XML 61 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued Expenses (Tables)
 9 Months Ended
Sep. 30, 2021
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses
Accrued expenses consist of accruals for the following (in thousands):
September 30, 2021December 31, 2020
Taxes other than income taxes, primarily value added taxes$27,103 $32,710 
Salaries and wages24,869 34,029 
Warranty11,363 10,991 
Professional8,917 7,375 
Freight4,463 3,190 
IT service contracts4,038 3,799 
Interest3,823 2,076 
Deferred revenue3,413 3,516 
Product liability, current portion2,901 2,453 
Rebates2,242 8,644 
Derivative liabilities (foreign currency forward exchange contracts)2,086 1,432 
Severance804 6,249 
Insurance652 878 
Rent511 585 
Supplemental executive retirement program liability391 391 
Other items, principally trade accruals6,634 7,955 
Accrued Expenses$104,210 $126,273 
Schedule of Product Warranty Liability
The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):
Balance as of January 1, 2021$10,991 
Warranties provided during the period5,087 
Settlements made during the period(5,187)
Changes in liability for pre-existing warranties during the period, including expirations472 
Balance as of September 30, 2021$11,363 
XML 62 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Long-Term Debt (Tables)
 9 Months Ended
Sep. 30, 2021
Debt Disclosure [Abstract]  
Schedule of Long-term Debt Instruments
Debt consists of the following (in thousands):
September 30, 2021December 31, 2020
Convertible senior notes at 5.00%, due in February 2021$— $1,242 
Convertible senior notes at 4.50%, due in June 20222,637 73,869 
Convertible senior notes Series I at 5.00%, due in November 202472,073 62,984 
Convertible senior notes Series II at 5.00%, due November 202477,270 64,919 
Convertible senior notes at 4.25%, due in March 2026118,682 — 
Other obligations38,793 42,039 
309,455 245,053 
Less current maturities of long-term debt(3,121)(5,612)
Long-Term Debt$306,334 $239,441 
Liability Components of Convertible 2021 Note The liability components of the 2021 Notes consist of the following (in thousands):
September 30, 2021December 31, 2020
Principal amount of liability component$— $1,250 
Unamortized discount— (7)
Debt fees— (1)
Net carrying amount of liability component$— $1,242 
Liability Components of Convertible 2022 Note
The liability components of the 2022 notes consist of the following (in thousands):
September 30, 2021December 31, 2020
Principal amount of liability component$2,650 $81,500 
Unamortized discount— (6,772)
Debt fees(13)(859)
Net carrying amount of liability component$2,637 $73,869 
Liability Components of Convertible 2024 Note
The liability components of the Series I 2024 Notes consist of the following (in thousands):
September 30, 2021December 31, 2020
Principal amount of liability component$72,909 $72,909 
Unamortized discount— (8,888)
Debt fees(836)(1,037)
Net carrying amount of liability component$72,073 $62,984 
Liability Components of Convertible Series II 2024 Note
The liability components of the Series II 2024 Notes consist of the following (in thousands):
September 30, 2021December 31, 2020
Principal amount of liability component - including accretion$78,325 $75,688 
Unamortized discount— (9,461)
Debt fees(1,055)(1,308)
Net carrying amount of liability component$77,270 $64,919 
Liability Components of Convertible 2026 Note
The liability components of the 2026 Notes consist of the following (in thousands):
September 30, 2021
Principal amount of liability component$125,000 
Debt fees(6,318)
Net carrying amount of liability component$118,682 
XML 63 R41.htm IDEA: XBRL DOCUMENT v3.21.2
Other Long-Term Obligations (Tables)
 9 Months Ended
Sep. 30, 2021
Other Liabilities Disclosure [Abstract]  
Other Noncurrent Liabilities
Other long-term obligations consist of the following (in thousands):
September 30, 2021December 31, 2020
Deferred income taxes$22,909 $23,234 
Product liability13,374 12,304 
Pension 9,063 9,088 
Deferred compensation6,380 5,318 
Deferred gain on sale leaseback5,257 5,502 
Supplemental executive retirement plan liability5,222 5,368 
Death benefit obligation plan4,537 4,723 
Uncertain tax obligation including interest3,124 3,114 
Other1,915 1,823 
Other Long-Term Obligations$71,781 $70,474 
XML 64 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Leases and Commitments (Tables)
 9 Months Ended
Sep. 30, 2021
Leases [Abstract]  
Lease, Cost [Table]
Lease expenses for the three and nine months ended September 30, 2021 and September 30, 2020, respectively, were as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Operating leases$1,811 $1,926 $5,592 $6,210 
Variable and short-term leases764 1,077 2,825 2,936 
Total operating leases$2,575 $3,003 $8,417 $9,146 
Finance lease interest cost$1,146 $829 $3,487 $1,483 
Finance lease depreciation1,265 980 3,807 2,346 
Total finance leases$2,411 $1,809 $7,294 $3,829 
Schedule of Cash Flow, Supplemental Disclosures [Table]
Supplemental cash flow amounts for the nine months ended September 30, 2021 were as follows (in thousands):
Cash Activity: Cash paid in measurement of amounts for lease liabilitiesSeptember 30, 2021
Operating leases$8,501 
Finance leases6,311 
Total$14,812 
Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligationsSeptember 30, 2021
Operating leases$5,418 
Finance leases6,345 
Total$11,763 
Weighted-Average Remaining Lease Terms and Discount Rates [Table]
Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2021:
September 30, 2021
Weighted-average remaining lease term - finance leases16.1 years
Weighted-average remaining lease term - operating leases4.9 years
Weighted-average discount rate - finance leases6.47%
Weighted-average discount rate - operating leases7.12%
Lessee, Operating Lease, Liability, Maturity
Future minimum operating and finance lease commitments, as of September 30, 2021, are as follows (in thousands):
Finance 
Leases		Operating Leases
2021$2,578 $2,022 
20227,068 4,424 
20236,964 2,466 
20246,892 1,808 
20256,797 1,442 
Thereafter80,350 2,565 
Total future minimum lease payments110,649 14,727 
Amounts representing interest(41,461)(2,432)
Present value of minimum lease payments69,188 12,295 
Less: current maturities of lease obligations(3,118)(4,553)
Long-term lease obligations$66,070 $7,742 
Finance Lease, Liability, Fiscal Year Maturity
Future minimum operating and finance lease commitments, as of September 30, 2021, are as follows (in thousands):
Finance 
Leases		Operating Leases
2021$2,578 $2,022 
20227,068 4,424 
20236,964 2,466 
20246,892 1,808 
20256,797 1,442 
Thereafter80,350 2,565 
Total future minimum lease payments110,649 14,727 
Amounts representing interest(41,461)(2,432)
Present value of minimum lease payments69,188 12,295 
Less: current maturities of lease obligations(3,118)(4,553)
Long-term lease obligations$66,070 $7,742 
XML 65 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue (Tables)
 9 Months Ended
Sep. 30, 2021
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Revenue Recognition, Multiple-deliverable Arrangements The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2021 and September 30, 2020 (in thousands):
Three Months Ended September 30, 2021
ProductServiceTotal
Europe$123,671 $3,355 $127,026 
North America87,936 118 88,054 
All Other7,788 1,332 9,120 
Total$219,395 $4,805 $224,200 
% Split98%2%100%
Nine Months Ended September 30, 2021
ProductServiceTotal
Europe$351,680 $9,417 $361,097 
North America259,623 652 260,275 
All Other21,010 3,884 24,894 
Total$632,313 $13,953 $646,266 
% Split98%2%100%
Three Months Ended September 30, 2020
ProductServiceTotal
Europe$113,043 $3,242 $116,285 
North America87,821 234 88,055 
All Other6,428 1,138 7,566 
Total$207,292 $4,614 $211,906 
% Split98%2%100%
Nine Months Ended September 30, 2020
ProductServiceTotal
Europe$329,943 $9,204 $339,147 
North America260,999 596 261,595 
All Other22,565 3,339 25,904 
Total$613,507 $13,139 $626,646 
% Split98%2%100%
XML 66 R44.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Compensation (Tables)
 9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
The amounts of equity-based compensation expense recognized as part of SG&A expenses in All Other in business segment reporting were as follows (in thousands):
For the Nine Months Ended September 30,
20212020
Restricted stock and restricted stock units$4,570 $4,471 
Performance shares and performance share units799 2,494 
Total stock-based compensation expense$5,369 $6,965 
Schedule of Unrecognized Compensation Cost, Nonvested Awards
As of September 30, 2021, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan and previous plans, which is related to non-vested options and shares, was as follows (in thousands):
September 30, 2021
Restricted stock and restricted stock units$7,924 
Performance shares and performance share units4,021 
Total unrecognized stock-based compensation expense$11,945 
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes information about stock option activity for the nine months ended September 30, 2021:
Weighted Average
Exercise Price
Options outstanding at January 1, 20211,081,804 $16.07 
Forfeited(331,645)23.71
Options outstanding at September 30, 2021750,159 $12.69 
Options exercise price range at September 30, 2021$12.15 to$17.47 
Options exercisable at September 30, 2021750,159 
Shares available for grant at September 30, 2021*3,439,806 
________
 *    Shares available for grant under the 2018 Plan as of September 30, 2021 reduced by net restricted stock and restricted stock unit and performance share and performance share unit award activity of 2,671,108 shares
Schedule of Share-based Compensation, Stock Options Outstanding
The following table summarizes information about stock options outstanding at September 30, 2021:
 Options OutstandingOptions Exercisable
Exercise PricesNumber
Outstanding at
September 30, 2021		Weighted Average
Remaining
Contractual Life (Years)		Weighted Average
Exercise Price		Number
September 30, 2021		Weighted Average
Exercise Price
$12.15 – $20.00
750,159 4.2$12.69 750,159 $12.69 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table summarizes information about restricted stock and restricted stock units (primarily for non-U.S. recipients):
Weighted Average Fair Value
Restricted stock / units unvested at January 1, 20211,145,058 $8.62 
Granted647,743 8.46 
Vested(550,258)9.34 
Forfeited(55,685)8.47 
Restricted stock / units unvested at September 30, 20211,186,858 $8.20 
Share-based Compensation, Performance Shares Award Unvested Activity
The following table summarizes information about performance shares and performance share units (primarily for non-U.S. recipients):
 Weighted Average Fair Value
Performance shares / units unvested at January 1, 20211,026,785 $8.55 
Granted471,819 8.49 
Performance shares / units unvested at September 30, 20211,498,604 $8.53 
XML 67 R45.htm IDEA: XBRL DOCUMENT v3.21.2
Accumulated Other Comprehensive Income (Loss) by Component (Tables)
 9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
Changes in accumulated other comprehensive income ("OCI") (in thousands):
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2021$60,381 $2,146 $(4,069)$(1,379)$57,079 
OCI before reclassifications(19,155)(47)(209)944 (18,467)
Amount reclassified from accumulated OCI— — 182 309 491 
Net current-period OCI(19,155)(47)(27)1,253 (17,976)
September 30, 2021$41,226 $2,099 $(4,096)$(126)$39,103 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2020$50,329 $(517)$(3,674)$(702)$45,436 
OCI before reclassifications(9,103)2,616 (440)(643)(7,570)
Amount reclassified from accumulated OCI— — 18 1,219 1,237 
Net current-period OCI(9,103)2,616 (422)576 (6,333)
September 30, 2021$41,226 $2,099 $(4,096)$(126)$39,103 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2020$16,455 $(9,133)$(3,468)$794 $4,648 
OCI before reclassifications35,231 713 281 (2,501)33,724 
Amount reclassified from accumulated OCI— — (474)739 265 
Net current-period OCI35,231 713 (193)(1,762)33,989 
September 30, 2020$51,686 $(8,420)$(3,661)$(968)$38,637 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2019$8,898 $(2,491)$(3,299)$20 $3,128 
OCI before reclassifications42,788 (5,929)122 (1,340)35,641 
Amount reclassified from accumulated OCI— — (484)352 (132)
Net current-period OCI42,788 (5,929)(362)(988)35,509 
September 30, 2020$51,686 $(8,420)$(3,661)$(968)$38,637 
Schedule of Amounts Recognized in Other Comprehensive Income (Loss)
Reclassifications out of accumulated OCI were as follows (in thousands):
Amount reclassified from OCIAmount reclassified from OCIAffected line item in the Statement of Comprehensive (Income) Loss
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Defined Benefit Plans 
Service and interest costs$182 $(474)$18 $(484)Selling, general and administrative expenses
Tax— — — — Income tax provision
Total after tax$182 $(474)$18 $(484)
Derivatives
Foreign currency forward contracts hedging sales$476 $(481)$657 $(692)Net sales
Foreign currency forward contracts hedging purchases(92)1,259 746 1,029 Cost of products sold
Total loss before tax384 778 1,403 337 
Tax(75)(39)(184)15 Income tax provision
Total after tax$309 $739 $1,219 $352 
XML 68 R46.htm IDEA: XBRL DOCUMENT v3.21.2
Charges Related To Restructuring Activities (Tables)
 9 Months Ended
Sep. 30, 2021
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs
A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2021 is as follows (in thousands):
SeveranceContract TerminationsTotal
December 31, 2020 Balances
North America$179 $— $179 
Europe5,904 4 5,908 
All Other166 — 166 
Total6,249 4 6,253 
Charges
North America 822 — 822 
Europe454 276 730 
All Other— — — 
Total 1,276 276 1,552 
Payments
North America (236)— (236)
Europe (6,047)— (6,047)
All Other— — — 
Total (6,283)— (6,283)
March 31, 2021 Balances
North America765 — 765 
Europe311 280 591 
All Other166 — 166 
Total$1,242 $280 $1,522 
Charges
North America$31 $— $31 
Europe408 108 516 
All Other— — — 
Total439 108 547 
Payments
North America(91)— (91)
Europe(234)(198)(432)
All Other(18)— (18)
Total(343)(198)(541)
June 30, 2021 Balances
North America705 — 705 
Europe485 190 675 
All Other148 — 148 
Total$1,338 $190 $1,528 
Charges
North America122 — 122 
Europe33 222 255 
All Other— — — 
Total155 222 377 
Payments
North America(225)— (225)
Europe(308)(34)(342)
All Other24 — 24 
Total(509)(34)(543)
SeveranceContract TerminationsTotal
September 30, 2021 Balances
North America602 — 602 
Europe210 378 588 
All Other172 — 172 
Total$984 $378 $1,362 
XML 69 R47.htm IDEA: XBRL DOCUMENT v3.21.2
Net Earnings (Loss) Per Common Share (Tables)
 9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.
(In thousands except per share data)For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Basic
Weighted average common shares outstanding35,013 34,419 34,826 34,213 
Net loss$(22,759)$(7,276)$(47,501)$(23,163)
Net loss per common share$(0.65)$(0.21)$(1.36)$(0.68)
Diluted
Weighted average common shares outstanding35,013 34,419 34,826 34,213 
Share options and awards475 111 545 100 
Weighted average common shares assuming dilution35,488 34,530 35,371 34,313 
Net loss$(22,759)$(7,276)$(47,501)$(23,163)
Net loss per common share *$(0.65)$(0.21)$(1.36)$(0.68)
________
* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
XML 70 R48.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives (Tables)
 9 Months Ended
Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Notional Amounts of Outstanding Derivative Positions
Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):
 September 30, 2021December 31, 2020
 Notional
Amount		Unrealized
Net Gain
(Loss)		Notional
Amount		Unrealized
Net Gain
(Loss)
USD / CHF321 4 1,675 (11)
USD / EUR14,840 83 56,187 (636)
USD / GBP644 (23)2,467 (19)
USD / SEK727 (4)2,658 (41)
USD / MXN817 98 2,230 334 
EUR / CHF1,119 2 5,037 10 
EUR / GBP4,960 (218)19,060 44 
EUR / SEK2,882 (40)10,162 (73)
EUR / NOK1,215 (66)4,167 (64)
AUD / NZD190 1 781 (13)
DKK / SEK750 6 3,329 9 
NOK / SEK823 (39)3,431 (50)
AUD / THB— — 4,963 (221)
NZD / THB425 (42)1,755 (55)
USD / THB624 60 4,152 (56)
EUR / THB188 13 1,332 18 
GBP / THB— — 842 10 
$30,525 $(165)$124,228 $(814)
Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location
Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2021 and 2020, respectively, and outstanding were as follows (in thousands USD):
 September 30, 2021December 31, 2020
 Notional
Amount		Gain
(Loss)		Notional
Amount		Gain
(Loss)
USD / AUD$6,153 $50 $6,046 $(159)
USD / CAD14,616 (74)8,320 88 
USD / EUR60,000 (494)— — 
USD / DKK21,732 (198)8,690 207 
USD / GBP38,144 (438)16,062 338 
USD / NOK22,798 11 9,053 264 
USD / SEK4,597 (37)— — 
EUR / GBP8,157 (22)— — 
AUD / NZD6,790 (77)6,579 (35)
EUR / CHF5 — — — 
AUD / THB1,206 (107)— — 
USD / THB414 40 — — 
EUR / THB126 9 — — 
GBP / THB198 22 — — 
$184,936 $(1,315)$54,750 $703 
Schedule of Derivatives Instruments Statements of Financial Position, Fair Value
The fair values of the company’s derivative instruments were as follows (in thousands):
 September 30, 2021December 31, 2020
 AssetsLiabilitiesAssetsLiabilities
Derivatives designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts$267 $432 $424 $1,238 
Derivatives not designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts339 1,654 897 194 
Total derivatives$606 $2,086 $1,321 $1,432 
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) The effect of derivative instruments on Accumulated Other Comprehensive Income (OCI) and the Condensed Statement of Comprehensive Income (Loss) was as follows (in thousands):
Derivatives (foreign currency forward exchange contracts) in ASC 815 cash flow hedge
relationships		Amount of Gain
(Loss) Recognized  in Accumulated OCI on Derivatives
(Effective Portion)		Amount of Gain (Loss)
Reclassified from
Accumulated OCI into
Income (Effective
Portion)		Amount of Gain (Loss)
Recognized in Income on
Derivatives (Ineffective  Portion and Amount Excluded from
Effectiveness Testing)
Three months ended September 30, 2021
Foreign currency forward exchange contracts$944 $(309)$51 
Nine months ended September 30, 2021
Foreign currency forward exchange contracts$(643)$(1,219)$(37)
Three months ended September 30, 2020
Foreign currency forward exchange contracts$(2,501)$(739)$(662)
Nine months ended September 30, 2020
Foreign currency forward exchange contracts$(1,340)$(352)$(718)
Derivatives (foreign currency forward exchange contracts) not designated as hedging
instruments under ASC 815		  Amount of Gain (Loss)
Recognized in Income on Derivatives
Three months ended September 30, 2021
Foreign currency forward exchange contracts$(592)
Nine months ended September 30, 2021
Foreign currency forward exchange contracts$(1,315)
Three months ended September 30, 2020
Foreign currency forward exchange contracts$(1,320)
Nine months ended September 30, 2020
Foreign currency forward exchange contracts$(1,077)
XML 71 R49.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Values (Tables)
 9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):
 Basis for Fair Value Measurements at Reporting Date
Quoted Prices in Active
Markets for Identical
Assets / (Liabilities)		Significant Other
Observable
Inputs		Significant Other
Unobservable
Inputs
Level ILevel IILevel III
September 30, 2021
Forward exchange contracts—net—$(1,480)—
December 31, 2020
Forward exchange contracts—net—$(111)—
Fair Value, by Balance Sheet Grouping
The carrying values and fair values of the company’s financial instruments are as follows (in thousands):
 September 30, 2021December 31, 2020
 Carrying ValueFair ValueCarrying ValueFair Value
Cash and cash equivalents$73,656 $73,656 $105,298 $105,298 
Other investments84 84 85 85 
Installment receivables, net of reserves1,160 1,160 1,322 1,322 
Forward contracts in Other current assets606 606 1,321 1,321 
Forward contracts in Accrued expenses(2,086)(2,086)(1,432)(1,432)
Total debt (including current maturities of long-term debt) *(309,455)(279,747)(245,053)(237,948)
2021 Notes — — (1,242)(1,264)
2022 Notes(2,637)(2,559)(73,869)(70,633)
Series I 2024 Notes(72,073)(64,643)(62,984)(60,035)
Series II 2024 Notes(77,270)(73,697)(64,919)(64,090)
2026 Notes(118,682)(100,055)— — 
Other(38,793)(38,793)(42,039)(41,926)
________
* The company's total debt is shown net of applicable discounts and fees associated with the convertible senior notes due in 2021, 2022, 2024 and 2026 on the company's condensed consolidated balance sheet. Accordingly, the fair values of the convertible senior notes due in 2021, 2022, 2024 and 2026 included in the long-term debt presented in this table are also shown net of the discounts and fees. Discount balances applicable to the company's convertible senior notes were eliminated upon adoption of ASU 2020-06 on January 1, 2021, but are included in the balances above for the period prior to adoption. Refer to Long-Term Debt footnote for discount balances by convertible senior notes series. Total debt excludes operating and finance leases obligations.
XML 72 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments (Tables)
 9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The information by segment is as follows (in thousands):
 For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Revenues from external customers
Europe$127,026 $116,285 $361,097 $339,147 
North America88,054 88,055 260,275 261,595 
All Other (Asia Pacific)9,120 7,566 24,894 25,904 
Consolidated$224,200 $211,906 $646,266 $626,646 
Intersegment revenues
Europe$6,221 $6,027 $17,758 $14,438 
North America15,044 23,625 45,903 66,356 
All Other (Asia Pacific)— 1,116 — 3,645 
Consolidated$21,265 $30,768 $63,661 $84,439 
Restructuring charges before income taxes
Europe$255 $1,434 $1,501 $3,674 
North America122 146 975 865 
All Other— — — 118 
Consolidated$377 $1,580 $2,476 $4,657 
Operating income (loss)
Europe$9,554 $7,600 $18,378 $16,624 
North America(1,523)2,992 (2,308)5,759 
All Other(3,856)(6,082)(19,025)(17,377)
Charge expense related to restructuring activities(377)(1,580)(2,476)(4,657)
Gain on sale of business— — — 9,790 
Impairment of goodwill(28,564)— (28,564)— 
Consolidated operating income (loss)(24,766)2,930 (33,995)10,139 
Gain (loss) on debt extinguishment including debt finance charges and associated fees10,131 (761)9,422 (7,360)
Net interest expense(6,284)(7,395)(18,098)(21,042)
Loss before income taxes$(20,919)$(5,226)$(42,671)$(18,263)
Revenue from External Customer [Line Items]  
Revenue from External Customers by Products and Services [Table Text Block]
Net sales by product, are as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2021202020212020
Europe
Lifestyle$61,683 $50,307 $181,628 $160,628 
Mobility and Seating56,535 54,851 152,660 147,275 
Respiratory Therapy4,225 6,070 13,613 16,680 
Other(1)4,583 5,057 13,196 14,564 
$127,026 $116,285 $361,097 $339,147 
North America
Lifestyle$38,666 $41,845 $114,951 $124,888 
Mobility and Seating28,414 26,572 82,243 82,485 
Respiratory Therapy20,856 19,405 62,429 53,626 
Other(1)118 233 652 596 
$88,054 $88,055 $260,275 $261,595 
All Other (Asia Pacific)
Mobility and Seating$3,171 $2,670 $9,239 $10,757 
Lifestyle3,230 3,375 8,736 10,176 
Respiratory Therapy1,215 195 2,547 1,043 
Other(1)1,504 1,326 4,372 3,928 
$9,120 $7,566 $24,894 $25,904 
Total Consolidated$224,200 $211,906 $646,266 $626,646 
   ________________________
(1)Includes various services, including repair services, equipment rentals and external contracting.
XML 73 R51.htm IDEA: XBRL DOCUMENT v3.21.2
Accounting Policies (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2020
Sep. 30, 2021
Accounting Policies [Abstract]      
Adoption of ASU 2020-06, Convertible Debt Discounts Removed     $ 25,218,000
Debt Discount Amortization, per Basic and Diluted Share $ 0.07 $ 0.22  
Amortization of Debt Discount (Premium) $ 2,273,000 $ 7,613,000  
XML 74 R52.htm IDEA: XBRL DOCUMENT v3.21.2
Divested Businesses (Details) - USD ($)
 2 Months Ended 3 Months Ended 9 Months Ended
Mar. 07, 2020
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Divested Businesses [Abstract]              
Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $ 4,129,000            
Disposal Group, Including Discontinued Operation, Revenue 5,331,000       $ 30,261,000    
Disposal Group, Including Discontinued Operation, Inter-Company Revenue 2,532,000       13,087,000    
Disposal Group, Including Discontinued Operation, Earnings Before Taxes 445,000       $ 853,000    
Proceeds from sale of business           $ 0 $ 14,563,000
Gain on sale of business   $ 0 $ (9,790,000) $ 0   0 9,790,000
Disposal Group, Including Discontinued Operation, Inventory 3,082,000            
Disposal Group, Including Discontinued Operation, Other Assets 855,000            
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment 600,000            
Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset 2,127,000            
Total Assets 10,793,000            
Disposal Group, Including Discontinued Operation, Accounts Payable 4,692,000            
Disposal Group, Including Discontinued Operation, Accrued Liabilities 2,473,000            
Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable 41,000            
Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current 366,000            
Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent 1,019,000            
Disposal Group, Including Discontinued Operation, Liabilities $ 8,591,000            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Gain on sale of business   0 $ (9,790,000) $ 0   0 $ 9,790,000
Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance   $ 172,000       $ 172,000  
XML 75 R53.htm IDEA: XBRL DOCUMENT v3.21.2
Receivables (Narrative) (Details)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2021
USD ($)
payment
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Contingent Liability, Guarantee   $ 314,000
Number of missed payments before delinquent | payment   3
Credit amount requiring additional analysis   $ 250,000
Average period of adjudication   18 months
Financing Receivables Not Past 90 Days Due   90 days
Interest Expense, Sale of Receivables $ 11,000  
Risk Level, Low    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Receivables, Expected Loss Percentage, North America excluding Canada   1.00%
Receivables, Expected Loss Percentage, Canada   0.20%
Receivables, Expected Loss Percentage, Europe   0.50%
Receivables, Expected Loss Percentage, AsiaPac   0.30%
Risk Level, Medium    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Receivables, Expected Loss Percentage, Canada   1.10%
Risk Level, High    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Receivables, Expected Loss Percentage, Canada   2.80%
XML 76 R54.htm IDEA: XBRL DOCUMENT v3.21.2
Receivables (Schedule of Accounts Receivable) (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Schedule of Accounts Receivable [Abstract]    
Accounts receivable, gross $ 141,003 $ 131,055
Customer rebate reserve (12,689) (10,730)
Cash discount reserves (7,285) (7,320)
Allowance for doubtful accounts (4,227) (4,031)
Other, principally returns and allowances reserves (879) (386)
Accounts Receivable, Net $ 115,923 $ 108,588
XML 77 R55.htm IDEA: XBRL DOCUMENT v3.21.2
Receivables Schedule for Allowance for Credit Losses (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Financing Receivable, Allowance for Credit Losses [Line Items]    
Allowance for Credit Losses $ 4,227 $ 4,031
Allowance for Loan and Lease Losses, Adjustments, Other 432  
Financing Receivable, Allowance for Credit Losses, Write-downs $ (236)  
XML 78 R56.htm IDEA: XBRL DOCUMENT v3.21.2
Receivables (Installment Recevables) (Details) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Dec. 31, 2019
Receivables [Abstract]      
Non-Impaired Financing Receivable, Related Allowance $ 0 $ 0  
Installment Receivables, Current 345,000 704,000  
Installment Receivables, Long-Term 909,000 1,105,000  
Total Installment Receivables 1,254,000 1,809,000  
Total Unearned Interest (3,413,000) (3,516,000)  
Allowance for doubtful accounts, current (53,000) (325,000)  
Allowance for doubtful accounts, long-term (41,000) (162,000)  
Allowance for doubtful accounts (94,000) (487,000) $ (1,514,000)
Installment receivables, net 292,000 379,000  
Installment receivables, net, long-term 868,000 943,000  
Installment receivables, net $ 1,160,000 $ 1,322,000  
XML 79 R57.htm IDEA: XBRL DOCUMENT v3.21.2
Receivables (Rollforward of Allowance for Doubtful Accounts) (Details) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Allowance for Doubtful Accounts [Roll Forward]    
Balance as of beginning of period $ 487 $ 1,514
Current period provision (benefit) (105) 66
Direct write-offs charged against the allowance (288) (1,093)
Balance as of end of period $ 94 $ 487
XML 80 R58.htm IDEA: XBRL DOCUMENT v3.21.2
Receivables (Installment Receivables by Class) (Details) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Total Installment Receivables    
Non-Impaired installment receivables with no related allowance recorded $ 1,015 $ 1,194
Impaired installment receivables with a related allowance recorded 239 615
Total installment receivables 1,254 1,809
Unpaid Principal Balance    
Impaired installment receivables with a related allowance recorded 239 615
Non-Impaired installment receivables with no related allowance recorded 1,015 1,194
Total installment receivables 1,254 1,809
Non-Impaired Financing Receivable, Related Allowance 0 0
Related Allowance for Doubtful Accounts    
Impaired Financing Receivable, Related Allowance 94 487
Interest Income Recognized    
Non-Impaired installment receivables with no related allowance recorded 0 29
Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method 0 0
Total installment receivables 0 29
All Other    
Total Installment Receivables    
Non-Impaired installment receivables with no related allowance recorded 1,015 1,194
Unpaid Principal Balance    
Non-Impaired installment receivables with no related allowance recorded 1,015 1,194
Non-Impaired Financing Receivable, Related Allowance 0 0
Interest Income Recognized    
Non-Impaired installment receivables with no related allowance recorded 0 0
North America (NA)    
Total Installment Receivables    
Impaired installment receivables with a related allowance recorded 239 615
Unpaid Principal Balance    
Impaired installment receivables with a related allowance recorded 239 615
Related Allowance for Doubtful Accounts    
Impaired Financing Receivable, Related Allowance 94 487
Interest Income Recognized    
Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method $ 0 0
IVC Canada    
Total Installment Receivables    
Non-Impaired installment receivables with no related allowance recorded   0
Unpaid Principal Balance    
Non-Impaired installment receivables with no related allowance recorded   0
Non-Impaired Financing Receivable, Related Allowance   0
Interest Income Recognized    
Non-Impaired installment receivables with no related allowance recorded   $ 29
XML 81 R59.htm IDEA: XBRL DOCUMENT v3.21.2
Receivables (Aging of Installment Receivables) (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Financing Receivable, Recorded Investment, Past Due [Line Items]    
0-30 days past due $ 0 $ 0
31-60 days past due 0 0
61-90 days past due 0 0
90+ days past due 239 615
Installment Receivable, Not Past Due 1,015 1,194
Financing Receivable, Gross 1,254 1,809
All Other    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
0-30 days past due 0 0
31-60 days past due 0 0
61-90 days past due 0 0
90+ days past due 0 0
Installment Receivable, Not Past Due 1,015 1,194
Financing Receivable, Gross 1,015 1,194
North America (NA)    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
0-30 days past due 0 0
31-60 days past due 0 0
61-90 days past due 0 0
90+ days past due 239 615
Installment Receivable, Not Past Due 0 0
Financing Receivable, Gross $ 239 $ 615
XML 82 R60.htm IDEA: XBRL DOCUMENT v3.21.2
Inventories (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Inventory Disclosure [Abstract]    
Finished goods $ 70,545 $ 55,264
Raw materials 69,842 51,174
Work in process 10,948 9,046
Inventories, net $ 151,335 $ 115,484
XML 83 R61.htm IDEA: XBRL DOCUMENT v3.21.2
Other Current Assets Components of Other Current Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Tax receivables principally value added taxes $ 23,006 $ 22,500
Prepaid inventory and freight 1,864 2,700
Receivable due from information technology provider 1,488 2,995
Prepaid insurance 276 3,963
Derivatives (foreign currency forward exchange contracts) 606 1,321
Recoverable income taxes 685 2,182
Service contracts 393 633
Deferred financing fees 354 208
Prepaid and other current assets 7,479 8,215
Other current assets $ 36,151 $ 44,717
XML 84 R62.htm IDEA: XBRL DOCUMENT v3.21.2
Other Long-Term Assets Components of Other Long-Term Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Cash surrender value of life insurance policies $ 2,372 $ 2,327
Deferred income taxes 2,278 2,048
Installment receivables 868 943
Deferred financing fees 463 411
Investments 84 85
Other 112 111
Other Long-Term Assets $ 6,177 $ 5,925
XML 85 R63.htm IDEA: XBRL DOCUMENT v3.21.2
Property And Equipment (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 366,529 $ 358,276
Less allowance for depreciation (304,317) (302,033)
Property and equipment, net 62,212 56,243
Machinery and equipment    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 292,897 294,045
Land, buildings and improvements    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 28,230 28,509
Furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 10,288 10,001
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 6,965 8,194
Capitalized Software [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 28,149 $ 17,527
XML 86 R64.htm IDEA: XBRL DOCUMENT v3.21.2
Intangibles (Narrative) (Details)
 9 Months Ended
Sep. 30, 2021
USD ($)
Finite-Lived Intangible Assets [Line Items]  
Amortization expense $ 304,000
Minimum  
Finite-Lived Intangible Assets [Line Items]  
Finite-Lived intangible assets, useful life 3 years
Maximum  
Finite-Lived Intangible Assets [Line Items]  
Finite-Lived intangible assets, useful life 8 years
Weighted Average  
Finite-Lived Intangible Assets [Line Items]  
Finite-Lived intangible assets, useful life 7 years
XML 87 R65.htm IDEA: XBRL DOCUMENT v3.21.2
Intangibles (Intangible Table) (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost $ 96,722 $ 97,155
Accumulated Amortization 69,365 69,392
Customer lists    
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost 54,222 54,502
Accumulated Amortization 54,222 54,502
Developed technology    
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost 7,889 7,924
Accumulated Amortization 7,318 7,204
Patents    
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost 5,542 5,556
Accumulated Amortization 5,542 5,556
License agreements    
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost 2,904 2,899
Accumulated Amortization 1,143 979
Other    
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost 1,149 1,162
Accumulated Amortization 1,140 1,151
Trademarks    
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost $ 25,016 $ 25,112
XML 88 R66.htm IDEA: XBRL DOCUMENT v3.21.2
Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details)
Sep. 30, 2021
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Future amortization expense, remainder of fiscal year $ 405,000
Future amortization expense, 2022 402,000
Future amortization expense, 2023 402,000
Future amortization expense, 2024 361,000
Future amortization expense, 2025 212,000
Future amortization expense, 2026 $ 211,000
XML 89 R67.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued Expenses Components of Accrued Expenses (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Payables and Accruals [Abstract]    
Taxes other than income taxes, primarily value added taxes $ 27,103 $ 32,710
Salaries and wages 24,869 34,029
Warranty 11,363 10,991
Professional 8,917 7,375
IT service contracts 4,038 3,799
Deferred revenue 3,413 3,516
Interest 3,823 2,076
Derivative liabilities (foreign currency forward exchange contracts) 2,086 1,432
Freight 4,463 3,190
Product liability, current portion 2,901 2,453
Severance 804 6,249
Insurance 652 878
Rent 511 585
Supplemental executive retirement program liability 391 391
Rebates 2,242 8,644
Other items, principally trade accruals 6,634 7,955
Accrued expenses $ 104,210 $ 126,273
XML 90 R68.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued Expenses Warranty Schedule (Details)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
USD ($)
Product Liability Contingency  
Balance as of January 1, 2021 $ 10,991
Warranties provided during the period 5,087
Settlements made during the period (5,187)
Changes in liability for pre-existing warranties during the period, including expirations 472
Balance as of September 30, 2021 $ 11,363
XML 91 R69.htm IDEA: XBRL DOCUMENT v3.21.2
Long-Term Debt (Details)
 3 Months Ended 4 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
Sep. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Dec. 31, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
$ / shares
shares
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Mar. 11, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2017
USD ($)
Jun. 30, 2017
USD ($)
Dec. 31, 2016
USD ($)
Mar. 31, 2016
USD ($)
Debt Instrument [Line Items]                              
Long-term debt $ 309,455,000           $ 309,455,000       $ 245,053,000        
Long-term Debt and Capital Lease Obligations, Current (3,121,000)           (3,121,000)       (5,612,000)        
Long-term debt net of current maturities 306,334,000           306,334,000       239,441,000        
Accretion Expense $ 890,000           $ 2,637,000                
Accretion Rate 4.70%           4.70%                
Gain (Loss) on Repurchase of Debt Instrument                 $ 280,000            
Loss (gain) on debt extinguishment including debt finance charges and fees $ 10,131,000   $ (761,000)     $ 761,000 $ 9,422,000 $ (7,360,000)              
Purchases of capped calls             $ 18,787,000 0              
Cap Price of Capped Call Transaction | $ / shares $ 16.58           $ 16.58                
Lifetime to date - Accretion Expense     762,000       $ 4,450,000 1,016,000              
Remaining Accretion $ 12,172,000           $ 12,172,000                
CARES Act Loan [Member]                              
Debt Instrument [Line Items]                              
Interest rate (as a percent) 1.00%           1.00%                
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% February 2021                              
Debt Instrument [Line Items]                              
Debt Instrument, Face Amount $ 0           $ 0       1,250,000       $ 150,000,000
Long-term debt 0           0       1,242,000        
Debt Instrument, Unamortized Discount 0           0       (7,000)        
Debt Instrument, Fee Amount 0           0       (1,000)        
Debt Instrument, Net Carrying Amount $ 0           $ 0       1,242,000        
Interest rate (as a percent) 5.00%           5.00%                
Debt Instrument Repurchase Amount, Cash Paid                 14,708,000            
Debt Instrument, Repurchase Amount     $ 24,466,000     $ 24,466,000   $ 24,466,000 16,000,000            
Debt Instrurment Repurchase Amount, Net Reduction of debt                 $ 14,367,000            
Debt Instrument Exchange Amount       $ 35,375,000 $ 72,909,000                    
Debt Instrument, Hedge Options     62,341   138,182 62,341   62,341             300,000
Debt Instrument, Warrants Issued and Outstanding 1,770,968       3,860,624   1,770,968               9,007,380
Debt Instrument, Increase, Accrued Interest $ 0   $ 241,000       $ 8,000 $ 1,617,000              
Debt Instrument, Fee Amount                           $ 5,966,000  
Debt Instrument, Interest Rate, Effective Percentage 11.10%           11.10%                
Debt Instrument, Non-Cash Interest Expense Recognized in the Period     261,000         1,767,000              
Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]                              
Debt Instrument [Line Items]                              
Debt Instrument, Face Amount $ 2,650,000           $ 2,650,000       81,500,000   $ 120,000,000    
Long-term debt 2,637,000           2,637,000       73,869,000        
Debt Instrument, Unamortized Discount 0           0       (6,772,000)        
Debt Instrument, Fee Amount (13,000)           (13,000)       (859,000)        
Debt Instrument, Net Carrying Amount $ 2,637,000           $ 2,637,000       73,869,000        
Interest rate (as a percent) 4.50%           4.50%                
Debt Instrument Exchange Amount       38,500,000                      
Debt Instrument, Hedge Options 120,000           120,000                
Debt Instrument, Increase, Accrued Interest $ 30,000   917,000       $ 829,000 3,487,000              
Percent of the Applicable Conversion Price 130.00%           130.00%                
Last Reported Sales Price Period, Common Stock             20 days                
Debt Instrument, Convertible, Threshold Consecutive Trading Days             30                
Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%           100.00%                
Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000           $ 1,000                
Business Day Period             5 years                
Debt Instrument, Convertible, Threshold Trading Days             10                
Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%           98.00%                
Convertible Preferred Stock, Shares Issued upon Conversion | shares 61.6095           61.6095                
Debt Instrument, Convertible, Conversion Price | $ / shares $ 16.23           $ 16.23                
Debt Instrument, Fee Amount                       $ 4,711,000      
Class of Warrant or Right, Outstanding | shares 7,393,141           7,393,141                
Debt Instrument, Hedge Options available for exercise 2,650           2,650                
Debt Instrument, Interest Rate, Effective Percentage 5.30%           5.30%                
Debt Instrument, Interest Rate on Liability Component, Effective Percentage 10.90%           10.90%                
Debt Instrument, Non-Cash Interest Expense Recognized in the Period     1,046,000         3,829,000              
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024 [Domain]                              
Debt Instrument [Line Items]                              
Long-term debt $ 72,073,000           $ 72,073,000       62,984,000        
Debt Instrument, Convertible, Threshold Trading Days             10                
Convertible Subordinated Debt | Series II Convertible Senior Notes at 5.00% November 2024 [Domain]                              
Debt Instrument [Line Items]                              
Long-term debt 77,270,000           $ 77,270,000       64,919,000        
Business Day Period             5 years                
Convertible Subordinated Debt | Convertible Senior Notes at 4.25% March 2026 [Domain]                              
Debt Instrument [Line Items]                              
Debt Instrument, Face Amount                   $ 125,000,000          
Long-term debt $ 118,682,000           $ 118,682,000       0        
Interest rate (as a percent) 4.25%           4.25%                
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024                              
Debt Instrument [Line Items]                              
Debt Instrument, Face Amount $ 72,909,000           $ 72,909,000       72,909,000        
Debt Instrument, Unamortized Discount 0           0       (8,888,000)        
Debt Instrument, Fee Amount (836,000)           (836,000)       (1,037,000)        
Debt Instrument, Net Carrying Amount $ 72,073,000           $ 72,073,000       62,984,000        
Interest rate (as a percent) 5.00%           5.00%                
Debt Instrument Repurchase Amount, Cash Paid         $ 6,928,000                    
Debt Instrument, Increase, Accrued Interest $ 911,000   912,000       $ 2,733,000 2,735,000              
Percent of the Applicable Conversion Price 130.00%           130.00%                
Last Reported Sales Price Period, Common Stock             20 days                
Debt Instrument, Convertible, Threshold Consecutive Trading Days             30                
Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%           100.00%                
Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000           $ 1,000                
Business Day Period             5 years                
Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%           98.00%                
Convertible Preferred Stock, Shares Issued upon Conversion | shares 67.6819           67.6819                
Debt Instrument, Convertible, Conversion Price | $ / shares $ 14.78           $ 14.78                
Debt Instrument, Loss on Exchange         5,885,000                    
Debt Instrument, Fee Amount         $ 1,394,000                    
Debt Instrument, Interest Rate, Effective Percentage 540.00%           540.00%                
Debt Instrument, Interest Rate on Liability Component, Effective Percentage 8.77%           8.77%                
Debt Instrument, Non-Cash Interest Expense Recognized in the Period     468,000         1,370,000              
Convertible Subordinated Debt | Series II Convertible Senior Notes at 5.00% November 2024                              
Debt Instrument [Line Items]                              
Debt Instrument, Face Amount $ 78,325,000           $ 78,325,000       75,688,000        
Debt Instrument, Unamortized Discount 0           0       (9,461,000)        
Debt Instrument, Fee Amount (1,055,000)           (1,055,000)       (1,308,000)        
Debt Instrument, Net Carrying Amount $ 77,270,000           $ 77,270,000       64,919,000        
Interest rate (as a percent) 5.00%           5.00%                
Debt Instrument Repurchase Amount, Cash Paid                     5,593,000        
Debt Instrument Exchange Amount       73,875,000                      
Debt Instrument, Increase, Accrued Interest $ 923,000   923,000       $ 2,770,000 1,200,000              
Percent of the Applicable Conversion Price 130.00%           130.00%                
Last Reported Sales Price Period, Common Stock             20 days                
Debt Instrument, Convertible, Threshold Consecutive Trading Days             30                
Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%           100.00%                
Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000           $ 1,000                
Debt Instrument, Convertible, Threshold Trading Days             10                
Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%           98.00%                
Convertible Preferred Stock, Shares Issued upon Conversion | shares 67.6819           67.6819                
Debt Instrument, Convertible, Conversion Price | $ / shares $ 14.78           $ 14.78                
Debt Instrument, Loss on Exchange   $ 709,000   $ 6,599,000                      
Debt Instrument, Fee Amount                     1,505,000        
Debt Instrument, Interest Rate, Effective Percentage 10.30%           10.30%                
Debt Instrument, Interest Rate on Liability Component, Effective Percentage 8.99%           8.99%                
Debt Instrument, Non-Cash Interest Expense Recognized in the Period $ 890,000   $ 1,260,000       $ 2,637,000 $ 1,663,000              
Convertible Subordinated Debt | Convertible Senior Notes at 4.25% March 2026                              
Debt Instrument [Line Items]                              
Debt Instrument, Face Amount 125,000,000           125,000,000                
Debt Instrument, Fee Amount (6,318,000)           (6,318,000)                
Debt Instrument, Net Carrying Amount $ 118,682,000           $ 118,682,000                
Interest rate (as a percent) 4.25%           4.25%                
Debt Instrument, Increase, Accrued Interest $ 1,328,000           $ 2,892,000                
Percent of the Applicable Conversion Price 130.00%           130.00%                
Last Reported Sales Price Period, Common Stock             20 days                
Debt Instrument, Convertible, Threshold Consecutive Trading Days             30                
Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%           100.00%                
Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000           $ 1,000                
Business Day Period             5 days                
Debt Instrument, Convertible, Threshold Trading Days             10                
Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%           98.00%                
Convertible Preferred Stock, Shares Issued upon Conversion | shares 94.6096           94.6096                
Debt Instrument, Convertible, Conversion Price | $ / shares $ 10.57           $ 10.57                
Debt Instrument, Fee Amount                   $ 7,305,000          
Capped Call Options, Outstanding 125,000           125,000                
Debt Instrument, Interest Rate, Effective Percentage 5.30%           5.30%                
Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022                              
Debt Instrument [Line Items]                              
Debt Instrument, Repurchase Amount   $ 78,850,000                          
Other Notes and Capital Lease Obligations                              
Debt Instrument [Line Items]                              
Long-term debt $ 38,793,000           $ 38,793,000       42,039,000        
Senior secured revolving credit facility, due in October 2015 | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                              
Debt Instrument [Line Items]                              
Line of Credit Facility, Fair Value of Amount Outstanding 22,150,000           22,150,000       20,000,000        
Line of Credit Facility, Covenant Feature, Dominion Trigger 6,750,000           6,750,000                
Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) 9,446,000           9,446,000       7,636,000        
Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) 6,600,000           6,600,000       3,866,000        
Line Of Credit Facility Gross Borrowing Base $ 40,566,000           $ 40,566,000                
Minimum required undrawn balance (as a percent) 11.25%           11.25%                
Senior secured revolving credit facility, due in October 2015 | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement) | Euro Member Countries, Euro                              
Debt Instrument [Line Items]                              
Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) $ 8,000,000           $ 8,000,000       6,400,000        
Senior secured revolving credit facility, due in October 2015 | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement) | United Kingdom, Pounds                              
Debt Instrument [Line Items]                              
Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) 4,800,000           4,800,000       $ 2,900,000        
Senior secured revolving credit facility, due in October 2015 | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                              
Debt Instrument [Line Items]                              
Line of Credit Facility, Covenant Feature, Dominion Trigger 3,750,000           3,750,000                
Line Of Credit Facility Gross Borrowing Base $ 22,684,000           $ 22,684,000                
Minimum required undrawn balance (as a percent) 12.50%           12.50%                
Remaining borrowing capacity $ 30,000,000           $ 30,000,000                
Line of Credit Facility, Covenant Feature, Prior Limit 10,000,000           10,000,000                
Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables 9,000,000           9,000,000                
Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days $ 3,375,000           $ 3,375,000                
Senior secured revolving credit facility, due in October 2015 | Line of Credit | Revolving Credit and Security Agreement (North America Credit Agreement)                              
Debt Instrument [Line Items]                              
Minimum required undrawn balance (as a percent) 12.50%           12.50%                
XML 92 R70.htm IDEA: XBRL DOCUMENT v3.21.2
Long-Term Debt Components of Convertible Debt (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2019
Jun. 30, 2017
Mar. 31, 2016
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Debt Instrument [Line Items]                
Issuance of warrants         $ 12,376,000      
Long-term debt $ 309,455,000         $ 309,455,000   $ 245,053,000
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% February 2021                
Debt Instrument [Line Items]                
Debt Instrument, Increase, Accrued Interest 0 $ 241,000       8,000 $ 1,617,000  
Debt Instrument, Face Amount $ 0       $ 150,000,000 $ 0   1,250,000
Interest rate (as a percent) 5.00%         5.00%    
Unamortized discount $ 0         $ 0   (7,000)
Long-term debt 0         0   1,242,000
Debt fees 0         0   (1,000)
Debt Instrument, Net Carrying Amount 0         0   1,242,000
Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]                
Debt Instrument [Line Items]                
Debt Instrument, Increase, Accrued Interest 30,000 917,000       829,000 3,487,000  
Debt Instrument, Face Amount $ 2,650,000     $ 120,000,000   $ 2,650,000   81,500,000
Issuance of warrants       $ 14,100,000        
Interest rate (as a percent) 4.50%         4.50%    
Unamortized discount $ 0         $ 0   (6,772,000)
Long-term debt 2,637,000         2,637,000   73,869,000
Debt fees (13,000)         (13,000)   (859,000)
Debt Instrument, Net Carrying Amount 2,637,000         2,637,000   73,869,000
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024 [Domain]                
Debt Instrument [Line Items]                
Long-term debt 72,073,000         72,073,000   62,984,000
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024                
Debt Instrument [Line Items]                
Debt Instrument, Increase, Accrued Interest 911,000 $ 912,000       2,733,000 $ 2,735,000  
Debt Instrument, Loss on Exchange     $ 5,885,000          
Debt Instrument, Face Amount $ 72,909,000         $ 72,909,000   72,909,000
Interest rate (as a percent) 5.00%         5.00%    
Unamortized discount $ 0         $ 0   (8,888,000)
Debt fees (836,000)         (836,000)   (1,037,000)
Debt Instrument, Net Carrying Amount $ 72,073,000         $ 72,073,000   $ 62,984,000
XML 93 R71.htm IDEA: XBRL DOCUMENT v3.21.2
Long-Term Debt Narrative (Details) - USD ($)
 3 Months Ended 4 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2017
Mar. 31, 2016
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2019
Mar. 11, 2021
Dec. 31, 2020
May 15, 2020
Sep. 30, 2019
Dec. 31, 2017
Dec. 31, 2016
Debt Instrument [Line Items]                                  
Issuance of warrants             $ 12,376,000                    
Payments for Repurchase of Common Stock                 $ 1,752,000 $ 1,702,000              
Amortization of debt fees                 1,622,000 1,329,000              
Loss (gain) on debt extinguishment including debt finance charges and fees $ (10,131,000)   $ 761,000         $ (761,000) $ (9,422,000) 7,360,000              
CARES Act Loan [Member]                                  
Debt Instrument [Line Items]                                  
Interest rate (as a percent) 1.00%               1.00%                
Unsecured Debt                           $ 10,000,000      
Unsecured Debt, Current $ 10,000,000               $ 10,000,000                
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024 [Domain]                                  
Debt Instrument [Line Items]                                  
Debt Instrument, Convertible, Threshold Trading Days                 10                
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024                                  
Debt Instrument [Line Items]                                  
Debt Instrument, Fee Amount         $ 1,394,000           $ 1,394,000            
Debt Instrument, Face Amount $ 72,909,000               $ 72,909,000       $ 72,909,000        
Interest rate (as a percent) 5.00%               5.00%                
Debt Instrument Repurchase Amount, Cash Paid         6,928,000           6,928,000            
Last Reported Sales Price Period, Common Stock                 20 days                
Debt Instrument, Convertible, Threshold Consecutive Trading Days                 30                
Percent of the Applicable Conversion Price 130.00%               130.00%                
Business Day Period                 5 years                
Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%               98.00%                
Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%               100.00%                
Convertible Preferred Stock, Shares Issued upon Conversion 67.6819               67.6819                
Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000               $ 1,000                
Debt Instrument, Convertible, Conversion Price $ 14.78               $ 14.78                
Debt Instrument, Net Carrying Amount $ 72,073,000               $ 72,073,000       62,984,000        
Debt Instrument, Fee Amount (836,000)               (836,000)       (1,037,000)        
Debt Instrument, Unamortized Discount $ 0               $ 0       (8,888,000)        
Debt Instrument, Interest Rate, Effective Percentage 540.00%               540.00%                
Debt Instrument, Non-Cash Interest Expense Recognized in the Period     468,000             1,370,000              
Debt Instrument, Increase, Accrued Interest $ 911,000   912,000           $ 2,733,000 2,735,000              
Debt Instrument, Loss on Exchange         5,885,000                        
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% February 2021                                  
Debt Instrument [Line Items]                                  
Debt Instrument, Fee Amount                                 $ 5,966,000
Debt Instrument, Face Amount $ 0           $ 150,000,000   $ 0       1,250,000        
Interest rate (as a percent) 5.00%               5.00%                
Debt Instrument Exchange Amount       $ 35,375,000 $ 72,909,000                        
Debt Instrument Repurchase Amount, Cash Paid                             $ 14,708,000    
Debt Instrument, Repurchase Amount     24,466,000         $ 24,466,000   24,466,000         $ 16,000,000    
Convertible due 2021 - Bond Hedge, Fair Value at Issuance $ 27,975,000               $ 27,975,000                
Derivative, Price Risk Option Strike Price $ 22.4175               $ 22.4175                
Debt Instrument, Net Proceeds                                 $ 144,034,000
Debt Instrument, Net Carrying Amount $ 0               $ 0       1,242,000        
Debt Instrument, Fee Amount 0               0       (1,000)        
Debt Instrument, Unamortized Discount $ 0               $ 0       (7,000)        
Debt Instrument, Interest Rate, Effective Percentage 11.10%               11.10%                
Debt Instrument, Non-Cash Interest Expense Recognized in the Period     261,000             1,767,000              
Debt Instrument, Increase, Accrued Interest $ 0   241,000           $ 8,000 1,617,000              
Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]                                  
Debt Instrument [Line Items]                                  
Debt Instrument, Fee Amount                               $ 4,711,000  
Debt Instrument, Face Amount $ 2,650,000         $ 120,000,000     $ 2,650,000       81,500,000        
Interest rate (as a percent) 4.50%               4.50%                
Debt Instrument Exchange Amount       38,500,000                          
Last Reported Sales Price Period, Common Stock                 20 days                
Debt Instrument, Convertible, Threshold Consecutive Trading Days                 30                
Percent of the Applicable Conversion Price 130.00%               130.00%                
Business Day Period                 5 years                
Debt Instrument, Convertible, Threshold Trading Days                 10                
Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%               98.00%                
Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%               100.00%                
Convertible Preferred Stock, Shares Issued upon Conversion 61.6095               61.6095                
Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000               $ 1,000                
Debt Instrument, Convertible, Conversion Price $ 16.23               $ 16.23                
Convertible Debt Conversion Feature, Fair Value at Issuance           28,859,000                      
Convertible Debt Conversion Feature Gain (Loss)                     $ 6,193,000            
Convertible due 2022 - Bond Hedge, Fair Value at Issuance           $ 24,780,000                      
Derivative, Price Risk Option Strike Price           $ 21.4375                      
Issuance of warrants           $ 14,100,000                      
Debt Instrument, Net Proceeds           115,289,000                      
Debt Instrument, Net Carrying Amount $ 2,637,000               $ 2,637,000       73,869,000        
Debt Instrument, Fee Amount (13,000)               (13,000)       (859,000)        
Derivative, Amount of Hedged Item           $ (10,680,000)                      
Debt Instrument, Unamortized Discount $ 0               $ 0       (6,772,000)        
Debt Instrument, Interest Rate, Effective Percentage 5.30%               5.30%                
Debt Instrument, Non-Cash Interest Expense Recognized in the Period     1,046,000             3,829,000              
Debt Instrument, Increase, Accrued Interest $ 30,000   917,000           $ 829,000 3,487,000              
Convertible Subordinated Debt | Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain]                                  
Debt Instrument [Line Items]                                  
Unamortized Financing Costs                 817,000                
Convertible Subordinated Debt | Series II Convertible Senior Notes at 5.00% November 2024                                  
Debt Instrument [Line Items]                                  
Debt Instrument, Fee Amount                         1,505,000        
Debt Instrument, Face Amount $ 78,325,000               $ 78,325,000       75,688,000        
Interest rate (as a percent) 5.00%               5.00%                
Debt Instrument Exchange Amount       73,875,000                          
Debt Instrument Repurchase Amount, Cash Paid                         5,593,000        
Last Reported Sales Price Period, Common Stock                 20 days                
Debt Instrument, Convertible, Threshold Consecutive Trading Days                 30                
Percent of the Applicable Conversion Price 130.00%               130.00%                
Debt Instrument, Convertible, Threshold Trading Days                 10                
Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%               98.00%                
Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%               100.00%                
Convertible Preferred Stock, Shares Issued upon Conversion 67.6819               67.6819                
Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000               $ 1,000                
Debt Instrument, Convertible, Conversion Price $ 14.78               $ 14.78                
Debt Instrument, Net Carrying Amount $ 77,270,000               $ 77,270,000       64,919,000        
Debt Instrument, Fee Amount (1,055,000)               (1,055,000)       (1,308,000)        
Debt Instrument, Unamortized Discount $ 0               $ 0       $ (9,461,000)        
Debt Instrument, Interest Rate, Effective Percentage 10.30%               10.30%                
Debt Instrument, Non-Cash Interest Expense Recognized in the Period $ 890,000   1,260,000           $ 2,637,000 1,663,000              
Debt Instrument, Increase, Accrued Interest 923,000   $ 923,000           $ 2,770,000 $ 1,200,000              
Debt Instrument, Loss on Exchange   $ 709,000   $ 6,599,000                          
Convertible Subordinated Debt | Series II Convertible Senior Notes at 5.00% November 2024 [Domain]                                  
Debt Instrument [Line Items]                                  
Business Day Period                 5 years                
Convertible Subordinated Debt | Convertible Senior Notes at 4.25% March 2026                                  
Debt Instrument [Line Items]                                  
Debt Instrument, Fee Amount                       $ 7,305,000          
Debt Instrument, Face Amount $ 125,000,000               $ 125,000,000                
Interest rate (as a percent) 4.25%               4.25%                
Last Reported Sales Price Period, Common Stock                 20 days                
Debt Instrument, Convertible, Threshold Consecutive Trading Days                 30                
Percent of the Applicable Conversion Price 130.00%               130.00%                
Business Day Period                 5 days                
Debt Instrument, Convertible, Threshold Trading Days                 10                
Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%               98.00%                
Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%               100.00%                
Convertible Preferred Stock, Shares Issued upon Conversion 94.6096               94.6096                
Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000               $ 1,000                
Debt Instrument, Convertible, Conversion Price $ 10.57               $ 10.57                
Debt Instrument, Net Carrying Amount $ 118,682,000               $ 118,682,000                
Debt Instrument, Fee Amount $ (6,318,000)               $ (6,318,000)                
Debt Instrument, Interest Rate, Effective Percentage 5.30%               5.30%                
Debt Instrument, Increase, Accrued Interest $ 1,328,000               $ 2,892,000                
Revolving Credit Facility | Line of Credit                                  
Debt Instrument [Line Items]                                  
Weighted average interest rate (as a percent) 4.40%               4.40%       4.60%        
Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Borrowing capacity $ 30,000,000               $ 30,000,000                
Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent                 85.00%                
Minimum availability reserve 3,000,000               $ 3,000,000                
Line of Credit Facility, Covenant Feature, Dominion Trigger 3,750,000               3,750,000                
Line of Credit Facility, Remaining Borrowing Capacity 16,310,000               16,310,000                
Remaining borrowing capacity $ 30,000,000               $ 30,000,000                
Minimum required undrawn balance (as a percent) 12.50%               12.50%                
Consecutive business days for minimum undrawn balance                 5 days                
Interruption of material manufacturing facilities, period                 10 days                
Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Line of Credit Facility, Fair Value of Amount Outstanding $ 22,150,000               $ 22,150,000       $ 20,000,000        
Borrowing capacity 60,000,000               60,000,000                
Additional increase in borrowing capacity available 25,000,000               $ 25,000,000                
Percentage of domestic accounts receivable                 85.00%                
Percentage of eligible domestic inventory and in-transit inventory                 70.00%                
Percentage of net orderly liquidation value of domestic inventory                 85.00%                
Maximum value of net orderly liquidation value domestic inventory and in-transit inventory 4,000,000               $ 4,000,000                
Net orderly liquidation value of domestic eligible machinery and equipment                 80.00%                
Additional amount of machinery and equipment 0               $ 0                
Percentage of eligible Canadian accounts receivable                 85.00%                
Percentage of eligible Canadian inventory                 70.00%                
Percentage of net orderly liquidation value of eligible Canadian inventory                 85.00%                
Minimum availability reserve 3,000,000               $ 3,000,000                
Line of Credit Facility, Current Borrowing Capacity 23,176,000               23,176,000                
Line of Credit Facility, Covenant Feature, Dominion Trigger $ 6,750,000               $ 6,750,000                
Minimum required undrawn balance (as a percent) 11.25%               11.25%                
Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance                 5 days                
Interruption of material manufacturing facilities, period                 10 days                
Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) $ 9,446,000               $ 9,446,000       7,636,000        
Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) 6,600,000               6,600,000       3,866,000        
Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement) | Euro Member Countries, Euro                                  
Debt Instrument [Line Items]                                  
Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) 8,000,000               8,000,000       6,400,000        
Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement) | United Kingdom, Pounds                                  
Debt Instrument [Line Items]                                  
Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) 4,800,000               4,800,000       2,900,000        
Letter of Credit                                  
Debt Instrument [Line Items]                                  
Line of Credit Facility, Fair Value of Amount Outstanding 7,641,000               7,641,000       7,616,000        
Letters of Credit Outstanding, Amount 8,350,000               8,350,000       $ 7,752,000        
Letter of Credit | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Borrowing capacity 5,000,000               5,000,000                
Letter of Credit | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Borrowing capacity 20,000,000               20,000,000                
Swing Line Loans | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Borrowing capacity 2,000,000               2,000,000                
Amount Available to Invacare Limited and Invacare Poirier SAS | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Borrowing capacity $ 15,000,000               $ 15,000,000                
Minimum | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Commitment fee percentage                 0.25%                
Minimum | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Commitment fee percentage                 0.25%                
Minimum | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Basis spread on variable rate                 2.50%                
Minimum | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Basis spread on variable rate                 2.25%                
Minimum | Base Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Basis spread on variable rate                 2.50%                
Minimum | Base Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Basis spread on variable rate                 1.25%                
Maximum | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Commitment fee percentage                 0.375%                
Maximum | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Commitment fee percentage                 0.375%                
Maximum | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Basis spread on variable rate                 3.00%                
Maximum | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Basis spread on variable rate                 2.75%                
Maximum | Base Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Basis spread on variable rate                 3.00%                
Maximum | Base Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                  
Debt Instrument [Line Items]                                  
Basis spread on variable rate                 1.75%                
XML 94 R72.htm IDEA: XBRL DOCUMENT v3.21.2
Long-Term Debt Sale Leaseback Transactions (Details)
Apr. 23, 2015
USD ($)
Sale Leaseback Transaction [Line Items]  
Sale Leaseback Transaction, Deferred Gain, Gross $ 7,414,000
XML 95 R73.htm IDEA: XBRL DOCUMENT v3.21.2
Other Long-Term Obligations (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Apr. 23, 2015
Other Liabilities Disclosure [Abstract]            
Deferred income taxes $ 22,909,000   $ 22,909,000   $ 23,234,000  
Product liability 13,374,000   13,374,000   12,304,000  
Pension 9,063,000   9,063,000   9,088,000  
Deferred compensation 6,380,000   6,380,000   5,318,000  
Deferred gain on sale leaseback, Net 5,257,000   5,257,000   5,502,000  
Supplemental executive retirement plan liability 5,222,000   5,222,000   5,368,000  
Death benefit obligation plan 4,537,000   4,537,000   4,723,000  
Uncertain tax obligation including interest 3,124,000   3,124,000   3,114,000  
Other 1,915,000   1,915,000   1,823,000  
Other Long-Term Obligations 71,781,000   71,781,000   $ 70,474,000  
Sale Leaseback Transaction, Deferred Gain, Gross           $ 7,414,000
Sale and Leaseback Transaction, Gain (Loss), Net $ 80,000 $ 77,000 $ 237,000 $ 228,000    
XML 96 R74.htm IDEA: XBRL DOCUMENT v3.21.2
Leases and Commitments (Details) - USD ($)
 3 Months Ended 9 Months Ended
Apr. 23, 2015
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2015
Sep. 30, 2021
Sep. 30, 2020
Dec. 01, 2020
Jul. 01, 2020
Lessee, Lease, Description [Line Items]                
Finance Lease, Liability             $ 5,561,000 $ 36,916,000
Sale Leaseback Transaction, Lease Term         20 years      
Sale and Leaseback Transaction, Gain (Loss), Net   $ 80,000 $ 77,000   $ 237,000 $ 228,000    
Sale Leaseback Transaction, Annual Payments         $ 2,275,000      
Sale Leaseback Transaction, Net Proceeds, Investing Activities       $ 23,000,000        
Sale Leaseback Transaction, Lease Terms         Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases.      
Sale Leaseback Transaction, Deferred Gain, Gross $ 7,414,000              
Sale Leaseback Transaction, Immediate Loss Recognized 257,000              
Capital Lease Obligations $ 32,339,000              
20 Years                
Lessee, Lease, Description [Line Items]                
Lessee, Finance Lease, Term of Contract   20 years     20 years      
12.6 Years                
Lessee, Lease, Description [Line Items]                
Lessee, Finance Lease, Term of Contract   12 years 7 months 6 days     12 years 7 months 6 days      
Minimum                
Lessee, Lease, Description [Line Items]                
General Lease Term         1 year      
Maximum                
Lessee, Lease, Description [Line Items]                
General Lease Term         20 years      
XML 97 R75.htm IDEA: XBRL DOCUMENT v3.21.2
Leases and Commitments Lease Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Leases [Abstract]        
Operating Lease, Expense $ 1,811 $ 1,926 $ 5,592 $ 6,210
Short-term Lease, Cost 764 1,077 2,825 2,936
Operating Lease, Cost 2,575 3,003 8,417 9,146
Finance Lease, Interest Expense 1,146 829 3,487 1,483
Finance Lease, Right-of-Use Asset, Amortization 1,265 980 3,807 2,346
Financing Lease, Cost $ 2,411 $ 1,809 $ 7,294 $ 3,829
XML 98 R76.htm IDEA: XBRL DOCUMENT v3.21.2
Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Leases [Abstract]    
Finance Lease, Liability, Payments, Due Next Twelve Months $ 2,578  
2021 2,022  
Finance Lease, Liability, Payments, Due Year Two 7,068  
2022 4,424  
Finance Lease, Liability, Payments, Due Year Three 6,964  
Finance Lease, Liability, Payments, Due Year Four 6,892  
Finance Lease, Liability, Payments, Due Year Five 6,797  
2025 1,442  
Finance Lease, Liability, Payments, Due after Year Five 80,350  
Thereafter 2,565  
Finance Lease, Liability, Payments, Due 110,649  
Total future minimum lease payments 14,727  
Financing Leases, Future Minimum Payments, Interest Included in Payments (41,461)  
Operating Leases, Future Minimum Payments, Interest Included in Payments (2,432)  
Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments 69,188  
Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments 12,295  
Finance Lease, Liability, Current (3,118) $ (3,405)
Operating Lease, Liability, Current (4,553) (6,313)
Financing Lease Liability, non-current 66,070  
Operating Leases Long-Term Obligations 7,742 $ 8,697
2023 2,466  
2024 $ 1,808  
XML 99 R77.htm IDEA: XBRL DOCUMENT v3.21.2
Leases and Commitments Supplemental Cash Flow Information (Details)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
USD ($)
Leases [Abstract]  
Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities $ 8,501
Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities 6,311
Total Cash Paid in Measurement of Amounts for Lease Liabilities 14,812
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 5,418
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability 6,345
Right-of-Use Asset Obtained in Exchange for Total Lease Liability $ 11,763
XML 100 R78.htm IDEA: XBRL DOCUMENT v3.21.2
Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details)
Sep. 30, 2021
Leases [Abstract]  
Finance Lease, Weighted Average Remaining Lease Term 16 years 1 month 6 days
Operating Lease, Weighted Average Remaining Lease Term 4 years 10 months 24 days
Finance Lease, Weighted Average Discount Rate, Percent 6.47%
Operating Lease, Weighted Average Discount Rate, Percent 7.12%
XML 101 R79.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales $ 224,200,000 $ 211,906,000 $ 646,266,000 $ 626,646,000  
Net Revenue 100.00% 100.00% 100.00% 100.00%  
Deferred Revenue $ 3,413,000   $ 3,413,000   $ 3,516,000
Product          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales $ 219,395,000 $ 207,292,000 $ 632,313,000 $ 613,507,000  
Net Revenue 98.00% 98.00% 98.00% 98.00%  
Service          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales $ 4,805,000 $ 4,614,000 $ 13,953,000 $ 13,139,000  
Net Revenue 2.00% 2.00% 2.00% 2.00%  
Europe (EMEA)          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales $ 127,026,000 $ 116,285,000 $ 361,097,000 $ 339,147,000  
Europe (EMEA) | Product          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 123,671,000 113,043,000 351,680,000 329,943,000  
Europe (EMEA) | Service          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 3,355,000 3,242,000 9,417,000 9,204,000  
North America (NA)          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 88,054,000 88,055,000 260,275,000 261,595,000  
North America (NA) | Product          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 87,936,000 87,821,000 259,623,000 260,999,000  
North America (NA) | Service          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 118,000 234,000 652,000 596,000  
All Other          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 9,120,000 7,566,000 24,894,000 25,904,000  
All Other | Product          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 7,788,000 6,428,000 21,010,000 22,565,000  
All Other | Service          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales $ 1,332,000 $ 1,138,000 $ 3,884,000 $ 3,339,000  
General Terms and Conditions          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Contract Type Sales Split     30.00%    
Large National Customers          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Contract Type Sales Split     30.00%    
Government Tenders          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Contract Type Sales Split     21.00%    
Other Customers          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Contract Type Sales Split     19.00%    
XML 102 R80.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Compensation (Narrative) (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
votes
$ / shares
shares
Sep. 30, 2020
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common Stock, Par or Stated Value Per Share | $ / shares $ 0.25   $ 0.25  
Share-based Compensation Arrangement by Share-based Payment Award, Description     The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of stock options or stock appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a stock option or a SAR will count against the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003 Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share.  
Allocated Share-based Compensation Expense | $ $ (1,250) $ 818 $ 131 $ 2,494
Selling, General and Administrative Expenses        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Allocated Share-based Compensation Expense | $     $ 5,369 6,965
Performance Shares        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Net award activity (in shares)     2,671,108  
Award requisite service period     3 years  
Performance achievement level, lower range     0.00%  
Performance achievement level, upper range     150.00%  
Performance achievement level, target range     100.00%  
Performance Shares | Selling, General and Administrative Expenses        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Allocated Share-based Compensation Expense | $     $ 799 $ 2,494
Stock Options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expiration period     10 years  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant [1] 3,439,806   3,439,806  
2013 Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 Plan 802,637   802,637  
2018 Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized     2,500,000  
Weighted Average | Performance Shares        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Period for recognition of unrecognized compensation costs     3 years  
Class B Common Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common Stock, Number of Votes | votes     10  
Common Stock, Shares, Issued 3,667   3,667  
Common Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common Stock, Holders Percentage of Total Outstanding     99.90%  
[1]  *    Shares available for grant under the 2018 Plan as of September 30, 2021 reduced by net restricted stock and restricted stock unit and performance share and performance share unit award activity of 2,671,108 shares.
XML 103 R81.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Compensation Share-based Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Allocated Share-based Compensation Expense $ (1,250) $ 818 $ 131 $ 2,494
Selling, General and Administrative Expenses        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Allocated Share-based Compensation Expense     5,369 6,965
Restricted Stock and Restricted Stock Units (RSUs) | Selling, General and Administrative Expenses        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Allocated Share-based Compensation Expense     4,570 4,471
Performance Shares | Selling, General and Administrative Expenses        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Allocated Share-based Compensation Expense     $ 799 $ 2,494
XML 104 R82.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Compensation Unrecognized Compensation Expense (Details)
$ in Thousands
Sep. 30, 2021
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 11,945
Performance Shares  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized 4,021
Restricted Stock and Restricted Stock Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 7,924
XML 105 R83.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Compensation (Options Activity) (Details)
 9 Months Ended
Sep. 30, 2021
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Options outstanding at beginning of period (in shares) | shares 1,081,804
Canceled (in shares) | shares (331,645)
Options outstanding at end of period (in shares) | shares 750,159
Weighted Average Exercise Price  
Options outstanding at beginning of period - Weighted Average Exercise Price (in dollars per share) $ 16.07
Canceled - Weighted Average Exercise Price (in dollars per share) 23.71
Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share) $ 12.69
Options exercisable at end of period (in shares) | shares 750,159
Stock Options  
Weighted Average Exercise Price  
Options available for grant at end of period (in shares) | shares 3,439,806 [1]
$12.15 – $20.00  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price range, lower limit (in dollars per share) $ 12.15
$12.15 – $20.00 | Stock Options  
Weighted Average Exercise Price  
Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share) 12.69
Range of Exercise Price Max [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price range, upper limit (in dollars per share) $ 17.47
[1]  *    Shares available for grant under the 2018 Plan as of September 30, 2021 reduced by net restricted stock and restricted stock unit and performance share and performance share unit award activity of 2,671,108 shares.
XML 106 R84.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Compensation (Stock Options Outstanding by Exercise Price) (Details) - $ / shares
 9 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 12.69 $ 16.07
$12.15 – $20.00    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, lower limit (in dollars per share) 12.15  
$12.15 – $20.00 | Minimum    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, upper limit (in dollars per share) 12.15  
$12.15 – $20.00 | Maximum    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, upper limit (in dollars per share) $ 20.00  
Stock Options | $12.15 – $20.00    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Options Outstanding - Number Outstanding at end of period (in shares) 750,159  
Options Outstanding - Weighted Average Remaining Contractual Life 4 years 2 months 12 days  
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 12.69  
Options Exercisable - Number Exercisable At end of period (in shares) 750,159  
Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 12.69  
XML 107 R85.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Compensation Restricted Stock Activity (Details) - Restricted Stock and Restricted Stock Units (RSUs)
 9 Months Ended
Sep. 30, 2021
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance | shares 1,145,058
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 647,743
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares (55,685)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance | shares 1,186,858
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 8.62
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares 8.46
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares 8.47
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 8.20
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares 550,258
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares $ 9.34
XML 108 R86.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Compensation Performance Share Activity (Details) - Performance Shares - $ / shares
 9 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1,498,604 1,026,785
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 8.53 $ 8.55
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 471,819  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 8.49  
XML 109 R87.htm IDEA: XBRL DOCUMENT v3.21.2
Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
Beginning Balance $ 57,079 $ 4,648 $ 45,436 $ 3,128
OCI before reclassifications (18,467) 33,724 (7,570) 35,641
Amount reclassified from accumulated OCI 491 265 1,237 (132)
Other Comprehensive Income (Loss) (17,976) 33,989 (6,333) 35,509
Ending Balance 39,103 38,637 39,103 38,637
Accumulated Translation Adjustment [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
Beginning Balance 60,381 16,455 50,329 8,898
OCI before reclassifications (19,155) 35,231 (9,103) 42,788
Amount reclassified from accumulated OCI 0 0 0 0
Other Comprehensive Income (Loss) (19,155) 35,231 (9,103) 42,788
Ending Balance 41,226 51,686 41,226 51,686
Accumulated Long-Term Notes Adjustment [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
Beginning Balance 2,146 (9,133) (517) (2,491)
OCI before reclassifications (47) 713 2,616 (5,929)
Amount reclassified from accumulated OCI 0 0 0 0
Other Comprehensive Income (Loss) (47) 713 2,616 (5,929)
Ending Balance 2,099 (8,420) 2,099 (8,420)
Accumulated Defined Benefit Plans Adjustment [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
Beginning Balance (4,069) (3,468) (3,674) (3,299)
OCI before reclassifications (209) 281 (440) 122
Amount reclassified from accumulated OCI 182 (474) 18 (484)
Other Comprehensive Income (Loss) (27) (193) (422) (362)
Ending Balance (4,096) (3,661) (4,096) (3,661)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
Beginning Balance (1,379) 794 (702) 20
OCI before reclassifications 944 (2,501) (643) (1,340)
Amount reclassified from accumulated OCI 309 739 1,219 352
Other Comprehensive Income (Loss) 1,253 (1,762) 576 (988)
Ending Balance $ (126) $ (968) $ (126) $ (968)
XML 110 R88.htm IDEA: XBRL DOCUMENT v3.21.2
Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Cost of Products Sold $ 163,890 $ 151,866 $ 470,500 $ 446,968
Amortization of prior service costs and unrecognized gains 56,135 55,530 178,721 174,672
Income tax provision (1,840) (2,050) (4,830) (4,900)
Net Sales 224,200 211,906 646,266 626,646
Accumulated Defined Benefit Plans Adjustment [Member] | Reclassification out of Accumulated Other Comprehensive Income        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Amortization of prior service costs and unrecognized gains (182) (474) (18) 484
Income tax provision 0 0 0 0
Net loss from Continuing Operations 182 (474) 18 (484)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Income (Loss) from Continuing Operations before Income Taxes 384 778 1,403 337
Income tax provision (75) (39) (184) 15
Net loss from Continuing Operations 309 739 1,219 352
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Cost of Products Sold 92 1,259 (746) (1,029)
Net Sales $ 476 $ 481 $ 657 $ (692)
XML 111 R89.htm IDEA: XBRL DOCUMENT v3.21.2
Charges Related To Restructuring Activities (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Restructuring Reserve [Roll Forward]            
Beginning Balance $ 1,528,000 $ 1,522,000 $ 6,253,000   $ 6,253,000  
Charges 377,000 547,000 1,552,000 $ 1,580,000 2,476,000 $ 4,657,000
Payments (543,000) (541,000) (6,283,000)   (7,367,000) (5,692,000)
Ending Balance 1,362,000 1,528,000 1,522,000   1,362,000  
Severance            
Restructuring Reserve [Roll Forward]            
Beginning Balance 1,338,000 1,242,000 6,249,000   6,249,000  
Charges 155,000 439,000 1,276,000      
Payments (509,000) (343,000) (6,283,000)      
Ending Balance 984,000 1,338,000 1,242,000   984,000  
Contract Termination            
Restructuring Reserve [Roll Forward]            
Beginning Balance 190,000 280,000 4,000   4,000  
Charges 222,000 108,000 276,000      
Payments (34,000) (198,000) 0      
Ending Balance 378,000 190,000 280,000   378,000  
North America (NA)            
Restructuring Reserve [Roll Forward]            
Beginning Balance 705,000 765,000 179,000   179,000  
Charges 122,000 31,000 822,000 146,000 975,000 865,000
Restructuring Reserve, Accrual Adjustment 122,000       975,000  
Payments (225,000) (91,000) (236,000)      
Ending Balance 602,000 705,000 765,000   602,000  
North America (NA) | Severance            
Restructuring Reserve [Roll Forward]            
Beginning Balance 705,000 765,000 179,000   179,000  
Charges 122,000 31,000 822,000     865,000
Payments (225,000) (91,000) (236,000)      
Ending Balance 602,000 705,000 765,000   602,000  
North America (NA) | Contract Termination            
Restructuring Reserve [Roll Forward]            
Beginning Balance 0 0 0   0  
Restructuring Reserve, Accrual Adjustment 0 0 0      
Payments 0 0 0      
Ending Balance 0 0 0   0  
Europe (EMEA)            
Restructuring Reserve [Roll Forward]            
Beginning Balance 675,000 591,000 5,908,000   5,908,000  
Charges 255,000 516,000 730,000 1,434,000 1,501,000 3,674,000
Payments (342,000) (432,000) (6,047,000)      
Ending Balance 588,000 675,000 591,000   588,000  
Europe (EMEA) | Severance            
Restructuring Reserve [Roll Forward]            
Beginning Balance 485,000 311,000 5,904,000   5,904,000  
Charges 33,000 408,000 454,000   895,000 3,328,000
Payments (308,000) (234,000) (6,047,000)      
Ending Balance 210,000 485,000 311,000   210,000  
Europe (EMEA) | Contract Termination            
Restructuring Reserve [Roll Forward]            
Beginning Balance 190,000 280,000 4,000   4,000  
Charges 222,000 108,000 276,000   606,000 346,000
Payments (34,000) (198,000) 0      
Ending Balance 378,000 190,000 280,000   378,000  
All Other            
Restructuring Reserve [Roll Forward]            
Beginning Balance 148,000 166,000 166,000   166,000  
Charges 0 0 0 $ 0 0 118,000
Payments 24,000 (18,000) 0      
Ending Balance 172,000 148,000 166,000   172,000  
All Other | Severance            
Restructuring Reserve [Roll Forward]            
Beginning Balance 148,000 166,000 166,000   166,000  
Charges 0 0 0     $ 118,000
Payments 24,000 (18,000) 0      
Ending Balance 172,000 148,000 166,000   172,000  
All Other | Contract Termination            
Restructuring Reserve [Roll Forward]            
Beginning Balance 0 0 0   0  
Charges 0 0 0      
Payments 0 0 0      
Ending Balance $ 0 $ 0 $ 0   $ 0  
XML 112 R90.htm IDEA: XBRL DOCUMENT v3.21.2
Charges Related To Restructuring Activities Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Restructuring Cost and Reserve [Line Items]            
Charges $ 377,000 $ 547,000 $ 1,552,000 $ 1,580,000 $ 2,476,000 $ 4,657,000
Restructuring and Related Activities, Expected Payout Period         24 months  
Payments (543,000) (541,000) (6,283,000)   $ (7,367,000) (5,692,000)
Severance            
Restructuring Cost and Reserve [Line Items]            
Charges 155,000 439,000 1,276,000      
Payments (509,000) (343,000) (6,283,000)      
Contract Termination            
Restructuring Cost and Reserve [Line Items]            
Charges 222,000 108,000 276,000      
Payments (34,000) (198,000) 0      
North America (NA)            
Restructuring Cost and Reserve [Line Items]            
Charges 122,000 31,000 822,000 146,000 975,000 865,000
Restructuring Reserve, Accrual Adjustment 122,000       975,000  
Payments (225,000) (91,000) (236,000)      
North America (NA) | Severance            
Restructuring Cost and Reserve [Line Items]            
Charges 122,000 31,000 822,000     865,000
Payments (225,000) (91,000) (236,000)      
North America (NA) | Contract Termination            
Restructuring Cost and Reserve [Line Items]            
Restructuring Reserve, Accrual Adjustment 0 0 0      
Payments 0 0 0      
Europe (EMEA)            
Restructuring Cost and Reserve [Line Items]            
Charges 255,000 516,000 730,000 1,434,000 1,501,000 3,674,000
Payments (342,000) (432,000) (6,047,000)      
Europe (EMEA) | Severance            
Restructuring Cost and Reserve [Line Items]            
Charges 33,000 408,000 454,000   895,000 3,328,000
Payments (308,000) (234,000) (6,047,000)      
Europe (EMEA) | Contract Termination            
Restructuring Cost and Reserve [Line Items]            
Charges 222,000 108,000 276,000   606,000 346,000
Payments (34,000) (198,000) 0      
All Other            
Restructuring Cost and Reserve [Line Items]            
Charges 0 0 0 $ 0 $ 0 118,000
Payments 24,000 (18,000) 0      
All Other | Severance            
Restructuring Cost and Reserve [Line Items]            
Charges 0 0 0     $ 118,000
Payments 24,000 (18,000) 0      
All Other | Contract Termination            
Restructuring Cost and Reserve [Line Items]            
Charges 0 0 0      
Payments $ 0 $ 0 $ 0      
XML 113 R91.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes (Narrative) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Valuation Allowance [Line Items]          
Reversal of Accrued Withholding Taxes on Earnings     $ 988,000    
Effective income tax rate, continuing operations (8.80%) (39.20%)   (11.30%) (26.80%)
U.S. statutory income tax rate       21.00% 21.00%
Deferred Tax Reversal, related to Goodwill Impairment $ 661,000        
Effective income tax rate, continuing operations (8.80%) (39.20%)   (11.30%) (26.80%)
U.S. statutory income tax rate       21.00% 21.00%
XML 114 R92.htm IDEA: XBRL DOCUMENT v3.21.2
Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Net Loss per Share—Basic        
Average common shares outstanding 35,013 34,419 34,826 34,213
Net Loss $ (22,759) $ (7,276) $ (47,501) $ (23,163)
Net earnings (loss) per common share $ (0.65) $ (0.21) $ (1.36) $ (0.68)
Loss per Share—Assuming Dilution        
Average common shares outstanding 35,013 34,419 34,826 34,213
Stock options and awards 475 111 545 100
Average common shares assuming dilution 35,488 34,530 35,371 34,313
Net Loss $ (22,759) $ (7,276) $ (47,501) $ (23,163)
Net earnings (loss) per per common share—assuming dilution (in dollars per share) [1] $ (0.65) $ (0.21) $ (1.36) $ (0.68)
[1] Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
XML 115 R93.htm IDEA: XBRL DOCUMENT v3.21.2
Net Earnings (Loss) Per Common Share Textuals (Details) - Stock Options - $ / shares
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share, amount 682,668 1,703,694 1,163,526 1,703,694
Antidilutive share granted, average exercise price $ 14.49 $ 24.45 $ 14.49 $ 24.45
Fair value stock price $ 7.30 $ 6.93 $ 8.30 $ 7.12
XML 116 R94.htm IDEA: XBRL DOCUMENT v3.21.2
Concentration Of Credit Risk (Details)
Sep. 30, 2021
USD ($)
Risks and Uncertainties [Abstract]  
Retained Recourse Obligation For Events Of Default Under Contracts $ 858,000
Events of Default Under Contract by Third Party $ 6,919,000
XML 117 R95.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives Notional Amounts - Designated as Hedges (Details) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount $ 184,936 $ 54,750
Gain (Loss) (1,315) 703
Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 30,525 124,228
Unrealized Gain (Loss) (165) (814)
USD / CHF | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 321 1,675
Unrealized Gain (Loss) 4 (11)
USD / EUR | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 14,840 56,187
Unrealized Gain (Loss) 83 (636)
USD / GBP | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 644 2,467
Unrealized Gain (Loss) (23) (19)
USD / SEK | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 727 2,658
Unrealized Gain (Loss) (4) (41)
USD / MXN | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 817 2,230
Unrealized Gain (Loss) 98 334
EUR / CHF | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 1,119 5,037
Unrealized Gain (Loss) 2 10
EUR / GBP | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 8,157 0
Gain (Loss) (22) 0
EUR / GBP | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 4,960 19,060
Unrealized Gain (Loss) (218) 44
EUR / SEK | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 2,882 10,162
Unrealized Gain (Loss) (40) (73)
EUR / NOK | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 5 0
Gain (Loss) 0 0
EUR / NOK | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 1,215 4,167
Unrealized Gain (Loss) (66) (64)
AUD / NZD | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 6,790 6,579
Gain (Loss) (77) (35)
AUD / NZD | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 190 781
Unrealized Gain (Loss) 1 (13)
DKK / SEK | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 750 3,329
Unrealized Gain (Loss) 6 9
NOK / SEK | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 823 3,431
Unrealized Gain (Loss) (39) (50)
AUD / THB | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 1,206 0
Gain (Loss) (107) 0
AUD / THB | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 0 4,963
Unrealized Gain (Loss) 0 (221)
NZD / THB | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 425 1,755
Unrealized Gain (Loss) (42) (55)
USD / THB | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 414 0
Gain (Loss) 40 0
USD / THB | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 624 4,152
Unrealized Gain (Loss) 60 (56)
EUR / THB | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 126 0
Gain (Loss) 9 0
EUR / THB | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 188 1,332
Unrealized Gain (Loss) 13 18
GBP / THB | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 198 0
Gain (Loss) 22 0
GBP / THB | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 0 842
Unrealized Gain (Loss) $ 0 $ 10
XML 118 R96.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives Notional Amounts - Not Designated as Hedges (Details) - Not Designated as Hedging Instrument [Member] - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Derivative [Line Items]        
Notional Amount   $ 184,936   $ 54,750
Gain (Loss)   (1,315)   703
Forward exchange contracts—net        
Derivative [Line Items]        
Gain (Loss) $ (1,320)   $ (1,077)  
USD / AUD        
Derivative [Line Items]        
Notional Amount   6,153   6,046
Gain (Loss)   50   (159)
USD / CAD        
Derivative [Line Items]        
Notional Amount   14,616   8,320
Gain (Loss)   (74)   88
USD / DKK        
Derivative [Line Items]        
Notional Amount   21,732   8,690
Gain (Loss)   (198)   207
USD / GBP        
Derivative [Line Items]        
Notional Amount   38,144   16,062
Gain (Loss)   (438)   338
USD / NOK        
Derivative [Line Items]        
Notional Amount   22,798   9,053
Gain (Loss)   11   264
USD / SEK        
Derivative [Line Items]        
Notional Amount   4,597   0
Gain (Loss)   (37)   0
AUD / NZD        
Derivative [Line Items]        
Notional Amount   6,790   6,579
Gain (Loss)   (77)   (35)
AUD / THB        
Derivative [Line Items]        
Notional Amount   1,206   0
Gain (Loss)   (107)   0
USD / THB        
Derivative [Line Items]        
Notional Amount   414   0
Gain (Loss)   40   0
EUR / THB        
Derivative [Line Items]        
Notional Amount   126   0
Gain (Loss)   9   0
GBP / THB        
Derivative [Line Items]        
Notional Amount   198   0
Gain (Loss)   22   0
EUR / GBP        
Derivative [Line Items]        
Notional Amount   8,157   0
Gain (Loss)   (22)   0
EUR / NOK        
Derivative [Line Items]        
Notional Amount   5   0
Gain (Loss)   0   0
EUR / USD        
Derivative [Line Items]        
Notional Amount   60,000   0
Gain (Loss)   $ (494)   $ 0
XML 119 R97.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives Balance Sheet Location (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Other Current Assets    
Derivatives, Fair Value [Line Items]    
Derivative assets $ 606 $ 1,321
Other Current Assets | Foreign currency forward contracts | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative assets 267 424
Other Current Assets | Foreign currency forward contracts | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative assets 339 897
Accrued Expenses    
Derivatives, Fair Value [Line Items]    
Derivative liabilities 2,086 1,432
Accrued Expenses | Foreign currency forward contracts | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative liabilities 432 1,238
Accrued Expenses | Foreign currency forward contracts | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative liabilities $ 1,654 $ 194
XML 120 R98.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives Gain (Loss) in Statement of Finacial Position (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Cash Flow Hedging [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Gain (Loss) $ 384,000 $ 778,000 $ 1,403,000 $ 337,000  
Foreign currency forward contracts | Cash Flow Hedging [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] 944,000 (2,501,000) (643,000) (1,340,000)  
Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (309,000) (739,000) (1,219,000) (352,000)  
Amount of Gain (Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) $ 51,000 (662,000) (37,000) (718,000)  
Not Designated as Hedging Instrument [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Gain (Loss)     $ (1,315,000)   $ 703,000
Not Designated as Hedging Instrument [Member] | Foreign currency forward contracts          
Derivative Instruments, Gain (Loss) [Line Items]          
Gain (Loss)   $ (1,320,000)   $ (1,077,000)  
XML 121 R99.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2017
Mar. 31, 2016
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Derivative [Line Items]              
Proceeds from Issuance of Warrants       $ 12,376,000      
Foreign currency forward contracts              
Derivative [Line Items]              
Notional amount of derivatives, matured during period         $ 90,800,000 $ 155,783,000  
Selling, General and Administrative Expenses | Foreign currency forward contracts              
Derivative [Line Items]              
Gain (Loss) $ (592,000)       $ (1,315,000)    
Minimum              
Derivative [Line Items]              
Derivative, percentage of forcasted transactions with currency rate exposure         50.00%    
Maximum              
Derivative [Line Items]              
Derivative, percentage of forcasted transactions with currency rate exposure         90.00%    
Cash Flow Hedging [Member]              
Derivative [Line Items]              
Gain (Loss) (384,000) $ (778,000)     $ (1,403,000) (337,000)  
Cash Flow Hedging [Member] | Sales [Member]              
Derivative [Line Items]              
Gain (Loss) (476,000) (481,000)     (657,000) (692,000)  
Cash Flow Hedging [Member] | Cost of Sales [Member]              
Derivative [Line Items]              
Gain (Loss) 92,000 $ 1,259,000     (746,000) $ 1,029,000  
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% February 2021              
Derivative [Line Items]              
Debt Instrument, Face Amount $ 0     $ 150,000,000 $ 0   $ 1,250,000
Interest rate (as a percent) 5.00%       5.00%    
Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]              
Derivative [Line Items]              
Proceeds from Issuance of Warrants     $ 14,100,000        
Debt Instrument, Face Amount $ 2,650,000   $ 120,000,000   $ 2,650,000   $ 81,500,000
Interest rate (as a percent) 4.50%       4.50%    
XML 122 R100.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives Fair Value of Convertible Debt Hedges (Details)
 12 Months Ended
Dec. 31, 2019
USD ($)
Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]  
Derivative Instruments and Hedging Activities Disclosures [Line Items]  
Convertible Debt Conversion Feature Gain (Loss) $ (6,193,000)
XML 123 R101.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - Forward exchange contracts—net - Fair Value, Measurements, Recurring - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets (liabilities), at fair value, net $ 0 $ 0
Fair Value, Inputs, Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets (liabilities), at fair value, net (1,480) (111)
Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets (liabilities), at fair value, net $ 0 $ 0
XML 124 R102.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Cash and cash equivalents $ 73,656 $ 105,298 $ 86,825 $ 80,063
Carrying Value        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Cash and cash equivalents 73,656 105,298    
Other investments 84 85    
Installment receivables, net of reserves 1,160 1,322    
Debt Instrument, Fair Value Disclosure (309,455) (245,053)    
Carrying Value | Convertible Senior Notes at 5.00% February 2021        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Debt Instrument, Fair Value Disclosure 0 (1,242)    
Carrying Value | Convertible Senior Notes at 4.50% February 2022        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Debt Instrument, Fair Value Disclosure (2,637) (73,869)    
Carrying Value | Convertible Senior Notes at 5.00% November 2024        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Debt Instrument, Fair Value Disclosure (72,073) (62,984)    
Carrying Value | Series II Convertible Senior Notes at 5.00% November 2024        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Debt Instrument, Fair Value Disclosure (77,270) (64,919)    
Carrying Value | Other Notes and Capital Lease Obligations        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Debt Instrument, Fair Value Disclosure (38,793) (42,039)    
Carrying Value | Convertible Senior Notes at 4.25% March 2026        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Debt Instrument, Fair Value Disclosure (118,682) 0    
Fair Value        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Cash and cash equivalents 73,656 105,298    
Other investments 84 85    
Installment receivables, net of reserves 1,160 1,322    
Debt Instrument, Fair Value Disclosure (279,747) (237,948)    
Fair Value | Convertible Senior Notes at 5.00% February 2021        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Debt Instrument, Fair Value Disclosure 0 (1,264)    
Fair Value | Convertible Senior Notes at 4.50% February 2022        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Debt Instrument, Fair Value Disclosure (2,559) (70,633)    
Fair Value | Convertible Senior Notes at 5.00% November 2024        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Debt Instrument, Fair Value Disclosure (64,643) (60,035)    
Fair Value | Series II Convertible Senior Notes at 5.00% November 2024        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Debt Instrument, Fair Value Disclosure (73,697) (64,090)    
Fair Value | Other Notes and Capital Lease Obligations        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Debt Instrument, Fair Value Disclosure (38,793) (41,926)    
Fair Value | Convertible Senior Notes at 4.25% March 2026        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Debt Instrument, Fair Value Disclosure (100,055) 0    
Foreign currency forward contracts | Other Current Assets | Carrying Value        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative assets 606 1,321    
Foreign currency forward contracts | Other Current Assets | Fair Value        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative assets 606 1,321    
Foreign currency forward contracts | Accrued Expenses | Carrying Value        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative liabilities (2,086) (1,432)    
Foreign currency forward contracts | Accrued Expenses | Fair Value        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative liabilities (2,086) (1,432)    
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 [Member] | Foreign currency forward contracts        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative assets (liabilities), at fair value, net 0 0    
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Foreign currency forward contracts        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative assets (liabilities), at fair value, net (1,480) (111)    
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 [Member] | Foreign currency forward contracts        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative assets (liabilities), at fair value, net $ 0 $ 0    
XML 125 R103.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments (Information by Segment) (Details) - USD ($)
 3 Months Ended 4 Months Ended 9 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Segment Reporting Information [Line Items]                
Net Sales $ 224,200,000     $ 211,906,000   $ 646,266,000 $ 626,646,000  
Restructuring Reserve 1,362,000 $ 1,528,000 $ 1,522,000     1,362,000   $ 6,253,000
Charges (377,000) (547,000) (1,552,000) (1,580,000)   (2,476,000) (4,657,000)  
Gain on sale of business 0   (9,790,000) 0   0 9,790,000  
Goodwill, Impairment Loss (28,564,000)     0   (28,564,000) 0  
Operating Income (Loss) (24,766,000)     2,930,000   (33,995,000) 10,139,000  
Interest Revenue (Expense), Net (6,284,000)     (7,395,000)   (18,098,000) (21,042,000)  
Earnings (loss) before income taxes (20,919,000)     (5,226,000)   (42,671,000) (18,263,000)  
Loss (gain) on debt extinguishment including debt finance charges and fees 10,131,000     (761,000) $ 761,000 9,422,000 (7,360,000)  
Europe (EMEA)                
Segment Reporting Information [Line Items]                
Net Sales 127,026,000     116,285,000   361,097,000 339,147,000  
Restructuring Reserve 588,000 675,000 591,000     588,000   5,908,000
Charges (255,000) (516,000) (730,000) (1,434,000)   (1,501,000) (3,674,000)  
Operating Income (Loss) 9,554,000     7,600,000   18,378,000 16,624,000  
North America (NA)                
Segment Reporting Information [Line Items]                
Net Sales 88,054,000     88,055,000   260,275,000 261,595,000  
Restructuring Reserve 602,000 705,000 765,000     602,000   179,000
Restructuring Reserve, Accrual Adjustment 122,000         975,000    
Charges (122,000) (31,000) (822,000) (146,000)   (975,000) (865,000)  
Operating Income (Loss) (1,523,000)     2,992,000   (2,308,000) 5,759,000  
All Other                
Segment Reporting Information [Line Items]                
Net Sales 9,120,000     7,566,000   24,894,000 25,904,000  
Restructuring Reserve 172,000 148,000 166,000     172,000   166,000
Charges 0 0 0 0   0 (118,000)  
Operating Income (Loss) (3,856,000)     (6,082,000)   (19,025,000) (17,377,000)  
Operating Segments [Member] | Europe (EMEA)                
Segment Reporting Information [Line Items]                
Net Sales 127,026,000     116,285,000   361,097,000 339,147,000  
Operating Segments [Member] | North America (NA)                
Segment Reporting Information [Line Items]                
Net Sales 88,054,000     88,055,000   260,275,000 261,595,000  
Operating Segments [Member] | All Other                
Segment Reporting Information [Line Items]                
Net Sales 9,120,000     7,566,000   24,894,000 25,904,000  
Intersegment revenues                
Segment Reporting Information [Line Items]                
Net Sales 21,265,000     30,768,000   63,661,000 84,439,000  
Intersegment revenues | Europe (EMEA)                
Segment Reporting Information [Line Items]                
Net Sales 6,221,000     6,027,000   17,758,000 14,438,000  
Intersegment revenues | North America (NA)                
Segment Reporting Information [Line Items]                
Net Sales 15,044,000     23,625,000   45,903,000 66,356,000  
Intersegment revenues | All Other                
Segment Reporting Information [Line Items]                
Net Sales 0     1,116,000   0 3,645,000  
Severance                
Segment Reporting Information [Line Items]                
Restructuring Reserve 984,000 1,338,000 1,242,000     984,000   6,249,000
Charges (155,000) (439,000) (1,276,000)          
Severance | Europe (EMEA)                
Segment Reporting Information [Line Items]                
Restructuring Reserve 210,000 485,000 311,000     210,000   5,904,000
Charges (33,000) (408,000) (454,000)     (895,000) (3,328,000)  
Severance | North America (NA)                
Segment Reporting Information [Line Items]                
Restructuring Reserve 602,000 705,000 765,000     602,000   179,000
Charges (122,000) (31,000) (822,000)       (865,000)  
Severance | All Other                
Segment Reporting Information [Line Items]                
Restructuring Reserve 172,000 148,000 166,000     172,000   166,000
Charges 0 0 0       (118,000)  
Contract Termination                
Segment Reporting Information [Line Items]                
Restructuring Reserve 378,000 190,000 280,000     378,000   4,000
Charges (222,000) (108,000) (276,000)          
Contract Termination | Europe (EMEA)                
Segment Reporting Information [Line Items]                
Restructuring Reserve 378,000 190,000 280,000     378,000   4,000
Charges (222,000) (108,000) (276,000)     (606,000) (346,000)  
Contract Termination | North America (NA)                
Segment Reporting Information [Line Items]                
Restructuring Reserve 0 0 0     0   0
Restructuring Reserve, Accrual Adjustment 0 0 0          
Contract Termination | All Other                
Segment Reporting Information [Line Items]                
Restructuring Reserve 0 0 0     0   $ 0
Charges 0 $ 0 $ 0          
Lifestyle Products [Domain] | Operating Segments [Member] | Europe (EMEA)                
Segment Reporting Information [Line Items]                
Net Sales 61,683,000     50,307,000   181,628,000 160,628,000  
Lifestyle Products [Domain] | Operating Segments [Member] | North America (NA)                
Segment Reporting Information [Line Items]                
Net Sales 38,666,000     41,845,000   114,951,000 124,888,000  
Lifestyle Products [Domain] | Operating Segments [Member] | All Other                
Segment Reporting Information [Line Items]                
Net Sales 3,230,000     3,375,000   8,736,000 10,176,000  
Mobility and Seating [Domain] | Operating Segments [Member] | Europe (EMEA)                
Segment Reporting Information [Line Items]                
Net Sales 56,535,000     54,851,000   152,660,000 147,275,000  
Mobility and Seating [Domain] | Operating Segments [Member] | North America (NA)                
Segment Reporting Information [Line Items]                
Net Sales 28,414,000     26,572,000   82,243,000 82,485,000  
Mobility and Seating [Domain] | Operating Segments [Member] | All Other                
Segment Reporting Information [Line Items]                
Net Sales 3,171,000     2,670,000   9,239,000 10,757,000  
Respiratory Therapy [Domain] | Operating Segments [Member] | Europe (EMEA)                
Segment Reporting Information [Line Items]                
Net Sales 4,225,000     6,070,000   13,613,000 16,680,000  
Respiratory Therapy [Domain] | Operating Segments [Member] | North America (NA)                
Segment Reporting Information [Line Items]                
Net Sales 20,856,000     19,405,000   62,429,000 53,626,000  
Respiratory Therapy [Domain] | Operating Segments [Member] | All Other                
Segment Reporting Information [Line Items]                
Net Sales 1,215,000     195,000   2,547,000 1,043,000  
Other [Domain] | Operating Segments [Member] | Europe (EMEA)                
Segment Reporting Information [Line Items]                
Net Sales 4,583,000     5,057,000   13,196,000 14,564,000  
Other [Domain] | Operating Segments [Member] | North America (NA)                
Segment Reporting Information [Line Items]                
Net Sales 118,000     233,000   652,000 596,000  
Other [Domain] | Operating Segments [Member] | All Other                
Segment Reporting Information [Line Items]                
Net Sales $ 1,504,000     $ 1,326,000   $ 4,372,000 $ 3,928,000  
EXCEL 126 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

H XN,)2('ZJR!SR#? MMX1\TXC-!]'Z'!89^R*@'Z@#49_!N6\99&\8K@'-('2(Y#B_0<&^J@SH?SO!FB_&TEARF^-"(H?"0&-#Y@GXUB&W3;#FBX[ ,$YK1?HP*LG82:J2A*V2 MVE" -"/!W;;2.QXOB8J\0W\0%6&3@W^?N0%^L(OPR&>H[%N&J-K]]I^^>+_( M"Y%FKV3HZMN>=^O#(U\$5QSX8N3S62+8I LD09)IG>-6D)^-41MY*<:! ;NO M!W;;6 FHKIFATCW4NES_2B!#], *T4UBI4#$8S?2#6_ (#G00_++3XR!!N 3 MXX !;6 )M%LX,0[$!+7JQ#A@,!GH8?)E)\9 Y9H3XTU*]E5D@!GH =/PQ!BH M!3XQ#AAP!:]S9RLPO[,5<#>!_Z;C;*!=]7'V!@7[NC-,#?[&XVR@;/L0')*C0Z#43R,_0T$^PHQ5 Y>^S@[,#K.AJ3Z5]\9)H>[/LX. M)>?4P2%VA]?1(;&^ @S&0SW*#NW!]_F,)-6RL$F0?0[%2!E'D:]Y9< P/-1C MN$%/G<\T7G#>U(=#,A?O,A1O/0-,LX^=0S%MC+XS4 M7EO(P#>$HM47Y X_MY7W4H+HT'-5*<&007"HAV##IT*?0TFBV$,:AS9D0!M: MGKH"61!#?)QI)GLW)L:RVC2,"L9BF$E#OJ7)MK]Q%!P',K>MT2!1DD& M;N$V;V8?AV*L>( D]V<,Y<8R.>U6Q4 NA'+*;)6M]*GG=;,/3)N<@W0ZB0AU M@$:!9ME'#*8B2Y@RS9]&XBGN<+AAD7$D20L'8:A.9U8@!CM88>)*74A?A/!)A.=+DMR.&R9%%-"JQRPU= M9'4X]G6+[Z@B[KEHM!,S,%"+;%\EZ=!Z'$E.-OV1^OP[9F 6VYYLZA/1BR:&]L>0X%A$M] /-'K3>;@:[ M:PU^D64B.5"*XX,8V65-7Y[%[EH$TMB@V$ ES*GTDB-2D[VR:P%ZF07+#93@ MJ"=&MK>,S-)F7;T]SR_$H1A'GIN+CCO1WOLL+T;JH)F&WIRNEA>/]-FSKKK! MW3Q?X@:;BX[EHJ[F(C.MAU/1TLDP35MU%>OR5@8R8YG,0>P%NB7'L7&,K-_Y M;)2[@MI!(U7V:I.2 W4YHH^1;4Y[&QFLXZ[97L8FEF2 .L'^9=M NL8-L^,7 MTCJ#0!T.H!%'7#*RS(_;)<:ZZGLI+RPFPD\[P0 0/)<)XE"R]5W()-O+8JIQ MX>A11I:9"(/78"==I;U]6\)\\DDF&/BQ9M/FF;$ 3JJ=Y9",:))ZC%=H%^DD MQ/-: <16AA>!H&K@FT"()Z_:(7N5=XC]?SC?$NJSUS;1,30BGK)J1YQ5/&F5 M+6N5UI?XUE776TNN)KF'>(XJ@*3*FOT(B4]MVN=VX@9F)#OH.H=P2(]PUL1W M0'W-A)*O">N" Z4X% +XLUZ>EH):@/-2B"?/LF7/VD)FJFO3)#6%."8L!'!0 MO2PY!=6NR4YM5'2@)@Y,ZAQ3?)LHZ*#4>" &2#&VG+VK&V-SXG% M7GVO,Q@"I8'D0"D.X0'"JQUDS[ $UR7P#XD-5.*0'Z"PVD+VK&VAEQ4;'?JA MH ,D-U""0WJ .VOC[!F6!'LH"B()F8B9[$ %#OP!MBS;I)B$Y>H@<)'X;N[< M2'1 F8-B@X4)9S!VPIM"SS&A*"+.1*^#+/99(XBC53 MC2/(0@!#UC5YS&>/S544NB>G51VGI+.T>J918A.AU9M8\Q?ML/&\RCMAZT<< M?10"Z)G^W7PQ$QW_A.Y7-<"FMA$-T(!WZ*GFWV8%QW#! )BX'!H#C%/F)J5=%_AX7Q#2F/'-IV61+T@GM?[#']I.HD6= AJ9[E"+^E6=/]Y#%)9\GM:I;2E4R*1P5PR")9('L*'D(?*YB>1 *P[P ,8JI5;7I,[9 MUI-+G&9R?2344D'S;1BB0@:B XTX\ ,8H%C';\W6OB<^O5&M?1/10<)1.Z M]NNY=K=:0FF]]2[4"26@,00G'CFB*00P3>W&.QB3)SO7@".20MYNOGN!HWI" M ->3O9+XOJ[*B(T''1;[R).>/&,GW77%I&Y751_#B+M]Y%C.Y.R%A@E*= MR?CBK6O@2(8CCD( Y"OI60S!=R9$\(8#E MJ:]"1BHG+Z:DF#T[LY3B[73UA6:/W:H759-KH&_4P @<:@)T3IW;O^ZC7HF7 M&><82=B8/,4J\815,I0<*,U_9Y$>!\?&AEK/RGDR>:"UM/K6SM1BKHI[@-8C M> 9R(.P#WYS']J]D_?+2O+/'7?TZ(KQ.1GYS;-!U#HT!!BG%^C])LF1*@U+S M/4O?C,%RX> =()N"^@PL;'WE!EL3A\, #Y/EUF2MBKYU>- Y'B@$$$%9Q_8R M&BCY+A.(6*R/[3G"* 0Q1BEC^]4WVIG&P(&$8\)%H>3+!HQ$!_IP>!T WYFT MY5Q%(&&GD.RP8E!YIR4 ]02!FE ?DHFK_& ML(JB?ZS&YG^.-=$S2&0%A: *A0!6K%?,M- *ZM2^L_KZ7;H=T$$MTB[C MKYW[G&\2[.8;>3F>*@005;W6\@I%5R.2NQJFDF.99.#IG!*._@H!_%>O.Y5^ M9&E]NGI!JZ AU;YS10=W2"XT4(7S1UKZJJW/(LXY &BN7F,S"L5'4UXDGT&& MDF.99,/IH9Y!G!L!4&I=DHJ"K-EI/T>(A<*=T&H@CO * 8Q7V\W-2NBPPD#& M4VTL.99+(@V(A/SW#@/ VMBMY : TW!?=VE(0HD5N5)'W51RC"1\7&'H:VZJ M<#1;".#9&L[05[^MP#%GH7 W4,AQ82& #,LP(R\AK5(DL TD!YWE\ D@D-JJ M[:S/DCAZ*A3M!GTXGB@$$$69&DZRV2N.4DQ$!]WE@ '@<;IINMH,PV6>9.6K M+SN.PPGMAL0)<2Q."*!Q,K6>Y$OD%,:#)0>=Y< !X'IJ,>]C=\;E5#D=GL=D MDA34FNF\<>-J6ZT_O,I3&A<4SLW'F]]\FV4_G^]T=J;/.S3.0-Y=?C[]?__%[+4T.1.+=7*_AR)40 M0%9TG)1IZ92+@B13ISF_*M(&K^K[VG(S V\QH1MH'/L1 HB$?A%&GO^1LL5<^1!>+23 M]Q68X^S! &?/!J;45P@M5\RQ[6" ;>, C0#?6VXVA7,-)O MS;NVG?6ZX_A<,-I)!@AS["P89&>Q,IR^,@/#<3L[,KLW^'?[.ILL3HXH!J.= MY(DPQ_^" ?X7^[T5J- %KEYACN$% \0JOXN9[=[JT'/$*QCM)#F&.1P4#/"KVI@0J!)]%\?L2J__!N0=V$;TEQ MGV:E,R-WM*G187T&7]1/WKM?JGSQ?H^NJ=N\JO)Y\^,#'1!2U +T[W=Y7G6_ MU T\Y<7/1IT/_P]02P,$% @ J8-;4X"(:*GQ 0 _0, !D !X;"]W M;W)K&ULE5-?:]LP$/\J0NRA@RQR[*0MQ3$T#>L* M&82F[1[&'A3['(M(EBPJYS=8EC9\!QMPK\W:8,0&ED(HJ*W0-3%0 MSNG]Y&Z1^/R0\":@M6=KXBO9:KWWP5,QIY$W!!)RYQDX_H[P %)Z(K3QL^>D M@Z0'GJ]/[)]#[5C+EEMXT/*;*%PUI[>4%%#R@W3/NOT"?3TSSY=K:<.7M%WN M+*$D/UBG50]&!TK4W9^_]WTX \23"X"X!\3!=R<47"ZYXUEJ=$N,ST8VOPBE M!C2:$[6_E(TS>"H0Y[*5KG>?7L HLH2M(QLN@:P R]SR?$]>#*\M#_VSY&H) MC@MI/Z;,H;+'L[Q7670J\065^\:,29R,2!Q-9J^;);GZ\ <+0]^#^7@P'P?: MY +M9;?D^PISR9,#97_\0RD9E)*@-/UOI1$VK@1CH""/. ,C\FBTM7]K4:=P M'13\K!RSF^ED&D51RH[GUMC9;?K!^,K-3F#_)92(C,8W,TI,]]BZP.DF7/!6 M.WPN85GA?(+Q"7A>:NU.@7\SP\1GOP%02P,$% @ J8-;4Q=PO>\]! MG1 !D !X;"]W;W)K&ULI5A1;Z,X$/XK5G0/ MK=0MV$!(JC12VY3>2MW;:K.]>SC=@P.3Q"I@SG::[K\_8RCABF&1]B4!\WTS M\S&3\3B+(QJN'(<&>\AH_*2%Y#K)ULN,JKTK=@YLA! M$T/*4H>X[M3)*,LGRX59>Q++!3^HE.7P)) \9!D5/VXAY,YTC ]GIR@Z\><% 2#.)/!D?9ND:EE WG M+^7-Y^1ZXI8100JQ*DU0_?4*=Y"FI24=Q[^UT4GCLR2VK]^M1T:\%K.A$NYX M^A=+U/YZ,IN@!+;TD*IO_/@[U(),@#%/I?E$QPKKSR0*)A;\:YL\'^(X6VR@F[XIOR:#!-127R',O$'$)ML1S-Y[NVN3\FO?[7_,> M#=-7$&LZ[J4_#--O"G&)B%?2<3"0"J\I/L_8\X:+C]$-2YEB(-&*R3CE\B M_7VSD4KH5O7/@">_\>0;3WZO\"T( 0EB>>% M?E?.6&!D 1+/[91,A^54VYM-Q+3CA6$C8)P7(WI M"M.3@C1=U*8G[/B?>J7[CWI&XJ(N+O!POYY9HVJI2-$7P!O&A M'(KT>*68,,NH2&D^_/.:6R00TI4Z$A=9<-ZT/Y/8/>WR[D]R2=4>;2"'+5.( M-YN\T6C=U-U.*'[@6;(X%AC9@"'Q^L6U1A@\*.XYCT&HLDAU6V^+T\T^/20L MW^DK!0*DM5YKZ^W /$PL/7(L,+("<7^/Q.0DE0Q*-3NF503I]N4Y#BPB1@(C M&W VE*_3KH^]GXNPSYQ6:5XGD!"',VS1-A89U"LRYZP(U+?5!5^L%>A!!A;8&TH412_^XM^&(I3&ULM5AM;^(X$/XK(W0?6HF%."$!5BU2%]HNJ_:NZLN=3J?[8((!JTF).FTLM$Z_MMLJ7+"8 MJI9(68+?S(2,J<9;.6^K5#(ZM: X:KN.$[1CRI/&X,2NW-- M,_)U['H&8"W^Y&RE=J[!'&4BQ*.Y&4]/&XY1Q"(6:D-!\>.)#5D4&2;4\3,G M;11[&N#N]8;]PAX>#S.AB@U%]!>?ZL5IH]> *9O19:1OQ>H[RP_D&[Y01,K^ MAU5F&W@-")=*BS@'HX*8)]DG?CF@=RB@GP/Z-AVR^-G@CZBF@Q,I5B"- M-;*9"YM!%HTQYXE)]CLM\5N..#VX8I@I"F@RA:&(8ZXQD;6"HQ'3E$?J&+[ MP]T(CGX[/FEKW,^@VF'._2WC=BNXSU+9 M=K@NL0OP0^K(??L;0%GF/@+BF! MCPZ'.R7P\X/AI>(O/B;^\F/BO]?#1RQL@4,JX>-Z^(]E5 5O8WX52>862>9: M/J\RR91BK DVV9HP8BJ4/+7%[I\KM(6Q9K'ZMV8GK]C)LSMU*G:ZX E-0K;9 MZ8K3"8^X7I>Y,&,*+)/I"4\#WP^(X^")GW9]M6_G!7T2[!J^T-HIM'9JM=[1 M*!$CW$N:*&I;0.XIN&E[7@36C4M6XTR\D^F]+-+6A0N8E=E,X MNA)*'3?A=Z;+'G)_SWT]9\_)HWVK;G?/ZF+?RO7VS2Y+S-Q>9;R"PAG!N^-U MEB1+&L$-7=OZ61:TH$14UZ]4U2U4==^M"B,"-U*$C$U5$\;)$U.:)W,X,Q,& MUYR5"3WOECC9<9Q*I;U":>\7Y'NI[^J)SVFX #$#O6 P$TL)D66C<\E8ULY" MD6 [2Q2:X!H0YXMY0G!82]B*1@I[KEY8.*YHY)# +&=6HS3*LA/5%,P=FB$S MQ=7-IOB7? F7,D-3+K%#RT=T_DNZ5.*,*O4:<*& P08GD=$^:SP)D5Z90%&; M5M$:)FN+H&D:\9!.T)'#FW$+'I(IR[F,ZS9Z7I^_:5=#$:3YH& 8K<2$B/&Z,7S_E@5IQ5#+!O6.!]O\9CS_E)XQ,$RE<'N&( M7)SW!47N7,F,%./$S!L6T#29H+C2QN$VZ$:+0'M9G,V:JU9-]>P7"=]_=\*/ MV(Q)XSY30K&02JRA91-6?[\N=DBG\EDDSG;N<]XM;AS';,I-/IK2#KD?A#8[/5J*#)5UCPY0RR*$D->.IF_ M9\3(Y^(/3R=D.YZ0^OF$N*W@[>!L&SP)/CLXV[9-ZOOV1X)3STS;!^!=5+#VS' 5+?MJ^Q/,?+N(YK6VE)_Y,CYVXKIUM?.2]Q:I!% M7:J:T=\@(=:Q=7JV==*MKY/7]/D-/[H[/]0^^Y>:NRV%;OUOM0/]6$]25T[: M.Z]%S)N[:RKG9@B,V RYG%87BXO,7H9E-UJD]DW)1&@M8GNY8#C<2&. W\^$ MT)L;\_*E>"4Y^!]02P,$% @ J8-;4TJN&-55 P 4@L !D !X;"]W M;W)K&ULI59=;]HP%/TK5M2'5FJ;Q/FN (D"U2:M M6E76[6':@PN&6$UL9IO2[=?/=D(&<4!T>R&Q?6\N"4/S @5B7)>*_;G'!-GW'=[83CV292SWA#GHKM,13+)]6#UR-W$9E M3DI,!6$4<+SH.T/_9I)IO %\)7@C=MZ!=O+,V(L>?)SW'4]O"!=X)K4"4H]7 M/,)%H874-G[6FDX34A-WW[?J=\:[\O*,!!ZQXAN9R[SOI Z8XP5:%_*1;3[@ MVD^D]6:L$.87;"IL$CA@MA:2E359[: DM'JBMSH/.P2ETTV -0&V">$!0E 3 M@E,CA#4A/#5"5!.,=;?R;A(W1A(->IQM -=HI:9?3/8-6^6+4%TG4\G5*E$\ M.?B$598%0'0.1JPLB50U( 4PTV#RILI1+Y^/L42D$!?@"CQ-Q^#\[ *< 4+! MEYRMA2*+GBO5;K2F.ZLCWU:1X8'( ;AG5.8"3.@'4- N\20 _Z'?L9G4[WNNS\7_3)/T??2T;0U$5@](+C=?%]^"PD M5__F'T!W[JJ[R\[AY( M!RB#\3YH;(.B*(/[H(D-BJ'O-: ]NU%C-SIJ=YHS+J\DYN76[X@)V66VTHEV MHB=QV/)J8WPO25I>;1!,8=3RV@'*@KC;:]QXC=]WM(>LQG;P*&GM<&2# L\+ M6EYM4!KZK81,;%#FAP>\)HW7Y*C7.T(1G>&MTX]4'3$6\E@U)_;A[6ZC@F&IZIW\1KH! MZ$I":F\+QNVCMT%9ZK628&."U&LGP0;!X-#)9TT2LA.2<$*59]9U D/K]K)! M?NJU#]P&)3!KW0T3&Q3LED[EU=UI$DK,EZ8[$V#&UE16WX5FMFD AZ;O:(+PD5H, +%J& M,Y\>\)X\$/'UL.2RY;2C;&E&\H*R''"RFXT^P/<+Y*N JLSD:N(2$HV0@V!Y=@2W9X3(57]CQ#]),*%#C;5A:5)_@V/1U1V!3%H)E3; DR&A> M?^.G1HA> /0M :@)0.<&>$V 5TVT)JNF=8L%GD\Y.P*N>LO1U$6E314M9T-S M]1@?!)>_4ADGYO=$:E G&_!@F49%?(1B0+$6O'WS#KP!- >KA)6%C"ZFCI#<*KNS M:1AO:D9D87P@AVO@N5< N0@:PA?#X;=D(\-A%>[^&NY(M5K)4"L9JL;SAB7[ MZ\.Z$%PNP[\'QO3:,;UJ3-\R9BTIJ06] O<4KVE*Q?,56.+G2MDK<%L2\)D\ M"; ZDO11/AR6B\0H9YTKK'*I]_AQCH(HGCJ/!D*_)?0'"2W:W]1103^7BY Y M5]#F"BZBQ@^"N52#F;@"C2MR0XL&8*)9=E,6K#)!<&D>YC )CI8-(G,8-#M MJJS[VLH)C(7/U=)!N78LZ7I%'5Y$";P3A _KT63J$\:N%[@6Q*Z(0C2(N$J( MW':H_,:L2"\K01A8DG95%EZDS!J)//U)03?T)Q:FKJ["X<*Z8@*G8%<;;M88 M;EH9ZZ&!,O+HA1?Z$;*MU*[TPG-J;VON4I"3O4"GU,=T:Z^PW,*_%G,2PDLK\ W MG,J7ENWD-D!HW8SLIOH/8XL-PLX!X+ %_ >]?Y]=MPB(T,16 SJ3@+_K$HN2 MQ!V G9;$0GVLYK[/FNA1EU]H&&[>-$[W.ID>XN8S\(O!-J4[?0 M@YZ%NG,A=(X+=>>$'G3.\O%F %PWG3!T(XOIH-[.?=AT3M]B^.^;]02P,$% @ J8-;4^%*VG++ M @ !@@ !D !X;"]W;W)K&ULM95+3^,P$,>_ MBA5Q G(HV^41FH+:)% 5!1V#ZL]N,FTL7#LK.U0^/;K1^OM0EMQ8"^)["#+4IF%,$MK MO(09J*=Z*O0L]"H%J8!)PAD2L!@&H_AB/##VUN [@97<&B,3R9SS9S.Y*89! M9(" 0JZ, M:O%Y@ I49(8_Q>:P9^2^.X/=ZH7]O8=2QS+&'"Z0]2J'(8] -4 MP (W5#WPU3=8Q],Q>CFGTC[1:FT;!2AOI.+5VED35(2Y-WY=YV'+(8GW."1K MA\1RNXTLY256.$L%7R%AK+6:&=A0K;>&(\P7X+"A,H3=(0(0X\E;Z26D6FH M-)=1#_,UP]@Q)'L8!NB.,U5*=,4**/[U#W4\/JAD$]0X.2@X@_H$$D5@9^+=YEV[N?D_7[)^ M)XK3\&4'@]SUR-V#R(_\Q&P)EO)=Y7C>MUVT MO0^TG7;WO./]V9S?JP*,.O@S5UW_S5W'?(.BR5A$E%8:-?HO*>3)%S7 M<1/%:WO3S[G2?<,.2]VH01@#_7W!N=I,S :^]6=_ %!+ P04 " "I@UM3 M%!_RUT0" !1!@ &0 'AL+W=O^_.G"<[8Q]=B4CPK"KMIE%)5%_&LS2=A;V-G$;*F2&A<6W%8I8?=76)G=-!I&AXVEW)3D M-^+9I!8;O$?Z42\L1W''4DB%VDFCP>)Z&LV'EU>9OQ\N_)2X5L+AM:D>9$'E M-/H408%KL:UH:7:?L?5S[OER4[GPA%U[-XD@WSHRJ@6S B5U\Q;/;1V. &GV M!B!M 6G0W20**F\$B=G$FAU8?YO9_")8#6@6)[5ORCU9/I6,H]E79$L.A"[@ MVB@EB0M.#AZ"&RP^SI_0*\U7+5:$G?T'*/]0!&R1FD23I\"8_95N<8' TGCP$$Z_I>'\\[#^4D]>/%%GL$";^O-D@_'%NQZ]6:&PO=V]R:W-H965T&&%XL5 M7T?%:;;AJ?SE/LO7D9!?\X=QL9$_G(SQZ/G ;/ZQ$>6 \G6RB!S[GXOOF)I??QDV49;SF M:1%G*7S\GQDE5?$$[X098A( M_GGD,YXD921Y'?_604?-.4OB_N?GZ%?5X.5@[J*"S[+DKW@I5N_K$ZP'99;Q%EA35_^AIAW4D>+$M1+:NR?(*UG&Z^QO]K!.Q1Y!Q8 *I M">0E@740:$V@AYZ!U01VZ!GLFF ?2G!J@E/E?I>L*M-!)*+I),^>4%ZB9;3R M0U6NBBT3'*=E9\U%+G^-)4],;_DC3[<S<9"WF" M$C9>U,$N=\%(1S"*KK-4K H4IDN^!/B!F>\;^&,YL&9TY'ETE\08<,XWIXA: M[Q&Q" :N9W8XW8*&\[:SAV\[^Y69'O"%I&.(WLHE;3J%5O%H3Z?<\D7VD,:E M+KQ'UW("QYN$?UCR1"I$'MTE'%WD>90^<*D_HD!_?Y%QT&?!U\4_AJM@S56P MZBI8QU5\E6([CQ)>0-VYHSH5M934QRDA3&JL_#<9/^[7'4!B[%N.A@QTI,,< MXNC($$!*'&LA6V.VFS';O6.NLP^-VDS&EG5J6;]#S7\L,3B6&!Y!;&7,:3+F M&",%_)[G.5^:TN9HY:(,4[T!#L1= 3@;=Q??;8;B&H=RDV?+[4(8DN(UD;P! M)[#?7(5__ 3V@6GI4]_6)S" M%SB$[U^.M*AA (5# $DIK;E=M806\IEK;=, MX1ZV[W5-X6.)P;'$\ AB.V=[*Q-L##7G^6.\X*981,4B _8^5AZ*Z?'=7W/W M&Y!Y%M#\$-#!3.]] (CE= )Z'T1*;'?O*\?&_99MZGTSFW2V_G&\X$A>^'I> M.U_*[;'9!L-M+F\YFY^UV] XEK$7VE-8.@ MV"&>/E4" $H=;/DN, 4 */4Q,^B_LE[L'5Y3]!_J=W6L#!7[ U:7*(\C_1[7 M6=V::[>J2QT7Z]6%H-*N&; V Z#EHLO35_PA!"6^WX[:'KER*F)VJI?5[78-SU=Q6!&ADZ]&,29*WHD]9$&5*1#S/9*YH(Z654\N1?0EQJP#"4@Q@)3B M3EP=&H)0;+=O!-KC5B9$>DQ(*^M!>DR4UI,A[[.(\@7RACNMFMLJF^M3P&Q! MI$=TX0X )+%]AP#+30CJ6+[?O=ZDRH=HCP]!!>Z79*KDGN(!"TR5-5!R?(%K M;MM%/;V\ (Y0X%8"P#FV+MPA@),]T%W6O>U'LP%=) GZ0ZQX;LJ=$G?*AJRA M<@/:O[?774-;]S9,@.U, .C:P!YE )\WR]WB&$M'V#L5+E/-3L/$TE#Q)> MJI2=ND/65!D -2_VS37U]%*Y'C0Q=:##B X, *!49PRL@2$DL9UN5Z7*;*C9 M;/9KVJ^U3(DYLX9\ZJ TGYF7^.;G#AC8/*&Z.,X@(*9 30$@]3Q@FD) :MBV M89!EFU;-@GAMS MKR28#;DCQ)1D,_-B_'6Y-\?JS[U2<&96\(^9''Y:CEFV?[KLR;H223;D3HVM M1-4VKY!?E?6>6 3W9-U6&FN;-7;G'X;5Z^O2[DY%O:[ M4C[>>Q%$IO"A>F6G0(MLFXK=D_[F:/-:T$7U,LR+XY?X;(:!XP$^"W0KJ5+Y2WF"YN6JZ?]02P,$% @ J8-;4W[;>ICE!P Q2( !D !X;"]W M;W)K&ULS5IM;]LV$/XKA/>"='!M4;(5.TL".(FS M%5B[H.G+AZ(?&(FVA4JB1E)V/>S'[TC)HF3+M+>F@//!D2C>\>'=\;DCIEH"+]P@,2H'!L9"&I<#PV!'\4L#7MB^,I2U]1R2Y MON1LA;CJ#=K4A7:7E@8#1ZF*K$?)X6D$R36Z90G$JB#:VV=O".=$ M>?P%.KNCDD2Q>(%^1'TD%H13@:(4O4\C*;K0"-?O%BP7) W%95\")*6X'Y3# MWQ;#NWN&]]!KELJ%0-,TI&&+_-0N/[;(]\$4E3WNX M^/WC'3K[\869>?'; O/N>*U.J;5MLO\=VY))*HX >/^M !O6]*KH\K1:;Y]: M!>>E6OEA,\0F$&#IG )%2?2T1O5^#V2MFR&XHAQN",2!OY XIRB!\H+..B?6LBW178QTDB/I A\ M>>WTW.%E?UGWZ(%.C4D,JTD,K9/X9JMVT1T5 8\R)=46A_;QWRTHQ D>H8>8 MI"@7P @$S?)T'CW%M##8RX#EJ8S2.4JH7# 8,8<%RM%J$04+1 G\;%RA;:V? MQFLE "J)=CV;(:'\A)C&*92KB@:2018-HF+27.4.@P4PT4"F4 G(&V%3@>,5"@ 5:"MO #9@@JE! MW3*CD5H:\)Q35:> =);S8*%C"EI!620DCYYRU2W/8(:2'DW MT\.68+0!GFC $GI@>C,UD* JU*D6 F( Y*E3JGNXJ0\!:BJ- ]>^AZ4YT:W-& MPFK-,%=8% 4\BQ6=_48KUV,=8<^2%/R*3WTKGTWBF 4Z!>QEUNE7=:US0ELJ M*/3[-99_B=VAT\P%=[N]1GBTE2]V^V /-_O<[_9Q!^-!>TXYKVQP;L\I4-L# M4W31;Q1B$>)*L=TD!!^J]:V+P8T1A,7DHVJXT6D4!N,*T/C[QL!TO..5H>>/ MMUQ7=!K6.OEC?T\Y@!U3PSM6\%"SZ#UF&M"2!RT6P;6M 3X-)V'70'*M,WT# M>^V".O265&U=SH!*"^IK+:E+A763N_XYQLYHC]5-;8L]>\AH')S"#DI ED2" M\F4$'L@HCUC[7L:NT$-K2KC5=Z;.Q?9"MQX2P.H171;NBN$B[J*8089!VHNM M0.W*G9[C_&2#:2I9;"\E#\#,L\P*TZX<#P\"-2D"VW/$ :"2\#F$YGZD=NW8 M.8C4$#FV,_DN&0!C/1.]8\/O^$0('AN&Q]^;XO$NQY^/MRF^I=/^].P:CG?M M'*^WK.C/8BMD.^@P].Z>"+V[AMY=.[U/39FXGT4/Z,#.01IU#<>[=DI^AJWV MFZI +U?CI"K0U<;F-U4"MTSSY@"R3_AS6R5:2M73G3?PQB/'WRHTC^C8M)E) M/:X].YA]SZ?75,W=&ALF5;C#$PE7DQ1<.VT_?W04S0*]-WOW&6>)V1:U^MS? M<>7(<7WO?-OE!_LU[6!2CFM/.68O>(S'30YQ3R2'N":'N/8<\JP>GX1AI(0A M'6^H(9<+V/7_W7X4[N[N'F"3J?[:'>B9Y.+9D\M'_0(&L$Z64!W,50+\3WL* MSR0=[T22CF>2CF=/& \ZTV@RYC1@\S3:G%/D:=D #D%!'6W A&P[%)X>&.MP MB>_5SM;M&> V)D*@FZT#L"-6H&>HW!NV[MP&BH6;+88M!_A_%'DW=BGU,<*%R$A KSH9Q"/E2]JY_OD' M[#N__E+\V_U]W#X\5G2HCV?WOAF!DH5F4D=1H6/S:A)H-,P#=6B[1JG:%5/U MBB!0^:5\?Y.&NXTY\*Y^DM4RCS[8V=-:"#0/@P"4V_7/<1<[H\W[D#;?]&MO MS!,*>W?U;8,HCMF+%W%5:_7]Q(W^:F"K_19?W.&6]BF^N&]KGPR$SZ/4H%B.@-X3N\J &J+U>N_P502P,$% @ J8-;4UF-$F5, P N P !D M !X;"]W;W)K&ULS5=;;]HP%/XK5M2'5FJ;.Y<* MD"BPK=(J(5BWAVD/;G(@5A.;VJ84:3]^MA/2 (%56ROU!6SG?.=\YY+CD\Z* M\0>1 $CTG*54=*U$RL65;8LH@0R+2[8 JI[,&,^P5%L^M\6" XX-*$MMSW$: M=H8)M7H=2+U@=WK+/ G,3=RU',X(4 M(JE58/7W! -(4ZU)\7@LE%JE30VLKC?:/QGGE3/W6," I3](+).NU;)0##.\ M3.6$K;Y X5"H]44L%>87K0I9QT+14DB6%6#%(",T_\?/12 J *6G'N 5 &\7 M$!P ^ 7 ?ZV%H $K[40%@#CNIW[;@(WQ!+W.IRM$-?22IM>F.@;M(H7H;I0 MII*KIT3A9&_TN"1RC08L4Z4GL$G>-,$<+G3XX^T'HV>]!G0Z!(E)*L[0!;J; M#M'IR1DZ082B;PE;"DQCT;&E(J=-V%%!Y#HGXAT@XJ-;1F4BT(C&$-?@A\?Q M[2-X6P6EC(RWB=X;@V?P>OA3IT[_V=]],_6MX+AEV7B M&WW^(7V'2J+/.:9S4*U#HOOU5NF,\=H<]U>8Q^?;L $3$OW\JJR@&PF9^'6$ M8U!R# S'X #'?IJR"$ME^6\%7%>=N>Z&T:V[ZU/OPO5"%;NG:L[WI5IN:UMF MN"_C^NZVS&A?Q@O:02FTY7]8^A\>]7^JNBVA\W/T&2APG"+U(J)^K)H&$9)C MW9 W 1!'PMTHS34^;$DT2X[-]RN)8:X[K"0I]!OMG4SN"S7:C; ^DZV2=NLH M[0FHA)'(\)8L>C"9W#N\HT0*=#J9WJE&_!N]4?K;)3DQ=LEV?5>6'@?-\TOMY/K MOV>:_;UNW&SOON=B2Q3Y^)YHFE'-Q;/, M$16\E@638R]7JKKQ?9GF6!)YQ2MD^F3)14F4WHJ5+RN!)+-!9>&'03#P2T*9 M%T?6-A5QQ->JH RG N2Z+(G8WF'!Z['7\7:&&5WERAC\.*K("A-4\VHJ],YW M*!DMD4G*&0AY#ADJP+->/U-VSU M] U>R@MIGU"WOH$'Z5HJ7K;!FD%)6?,FK^T][ 6$G0,!81L06MY-(LORGB@2 M1X+7((RW1C,+*]5&:W*4F:(D2NA3JN-4_/"RIFH+$U[J,DMB;VK.!*9\Q>@_ MS-Z>/+R:-<+Y/2I""WD!9T 9_,SY6A*6R*G*S0R0HM;/<0;$X$?C'E>J?@5@C"5J@_*P6++>S[ M3(=1UA+J64._0/9=5P;>(D*#8T!3A$,-+^,'9 M!J72=LM$7KY5,.%2:1\%6]VR,U>HSZZ^H32PE$QW;N).9]3K1_[F$R4]IZ1W M5,D4A?T7L)T(>>1Z^@ZT?QKU&CA"@].K5T.IOU>OGNZ*S\LU=$*&1X7,-#5! M4T,O43Q]!MVG\,$X9U1).)\E! Y1$ !D !X;"]W;W)K M&ULS5AM;]I($/XK*S>JDE."O6LPD (2H:FN4J.B M1'?]$-V'Q5[ BNUU=]>02/?C;W9M; C&Y6@J]8OM?9F99V;GQ;.#-1=/+I=(3]FB0T@5[8.JO="I@ M9)=<@C!FB0QY@@2;#ZTQOIZ0CB8P._X.V5IN?2.MRHSS)SWX' PM1R-B$?.5 M9D'AM6(3%D6:$^#X7C"U2IF:QT+^9E4/"Z( 4$<)OF;/A>&.(: % 3D%0%V#Q"X M!8%K%,V1&;4^4D5' \'72.C=P$U_&-L8:M F3/0Q/B@!JR'0J='M]RQ4+VC" M8W ,28UIS[^F^BW16-L8EB_0^4>F:!C)BX&M0*JFM?U"PDTN@1R0T$=W/%%+ MB6Z3@ 6[]#:@+2&3#>0;TLCP@:4MY#J7B#@$GR$;R2453.;/!OYN:1+7\',KK1O!+MV&0M!DP4#)U9H]H*V]TWIBYD>KZD(+E%A0/C(E%0T"<)D@1[O M>10A<#Z]YY\&H.T2:-L ;1\ NCDFOB6$ C2V")-$#_@#75$A-E)NK-DODH'K;KN6UG&Z]M?JE M+OWC'.LMD>8BL;,%E;BM+JZ'BITJU3H_[WUOJ4B!9\?FI.4=\%"\53/P48JP M'!B=1>ST,"ID'1M'F%0H22/*!\7]ITTJ;H@;7!4&W%P93H]-7.5T?%Q2IRNH MM\:R\*^&%E!YU$_8>#^ONVVWWW.\TLAFX^0'X!YQ4]W"53G S?7@#-P0=]#[ M=SV"\0=T1IR6XS1QKA(\]GYM\4:/7X E^JQ8+!N5K1(Z[C8J6SI):L+7P+A$ M\/\,L1N%<:C^3T1WZR(:'RB+N"H)N+DFU!X(N-31,50E;-S_13%$JD1+?K-$ M6^#9*1D-F994F98T9]I[[2P:]"MH=_09/=ZQ>,9$DY.2*ED2\GO$#:FR+7%/ MB)LL34^(FT+43MQT6^T#?Q]$9^O=F2JUD>;4MIFD84&F:I_0B:)V7<)N>Q M::.@(P\R'\X4CCAA"H92@=5U<$B3 B"*]B>S! Y!KX#QS8T"_(SEAW!@-B

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�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�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�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end XML 127 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 128 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 129 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 704 618 1 true 123 0 false 6 false false R1.htm 000010001 - Document - DEI Document Sheet http://www.invacare.com/role/DEIDocument DEI Document Cover 1 false false R2.htm 100010002 - Statement - Condensed Consolidated Statement of Comprehensive Income (Loss) Sheet http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss Condensed Consolidated Statement of Comprehensive Income (Loss) Statements 2 false false R3.htm 100020003 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.invacare.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 3 false false R4.htm 100030004 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 4 false false R5.htm 100040005 - Statement - Condensed Consolidated Statement Of Cash Flows Sheet http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows Condensed Consolidated Statement Of Cash Flows Statements 5 false false R6.htm 100050006 - Statement - Condensed Consolidated Statement of Shareholders' Equity Statement Sheet http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement Condensed Consolidated Statement of Shareholders' Equity Statement Statements 6 false false R7.htm 210011001 - Disclosure - Accounting Policies Sheet http://www.invacare.com/role/AccountingPolicies Accounting Policies Notes 7 false false R8.htm 210041002 - Disclosure - Divested Businesses (Notes) Notes http://www.invacare.com/role/DivestedBusinessesNotes Divested Businesses (Notes) Notes 8 false false R9.htm 210071003 - Disclosure - Receivables Sheet http://www.invacare.com/role/Receivables Receivables Notes 9 false false R10.htm 210161004 - Disclosure - Inventories Sheet http://www.invacare.com/role/Inventories Inventories Notes 10 false false R11.htm 210191005 - Disclosure - Other Current Assets Sheet http://www.invacare.com/role/OtherCurrentAssets Other Current Assets Notes 11 false false R12.htm 210221006 - Disclosure - Other Long-Term Assets Sheet http://www.invacare.com/role/OtherLongTermAssets Other Long-Term Assets Notes 12 false false R13.htm 210261007 - Disclosure - Property And Equipment Sheet http://www.invacare.com/role/PropertyAndEquipment Property And Equipment Notes 13 false false R14.htm 210291008 - Disclosure - Goodwill Sheet http://www.invacare.com/role/Goodwill Goodwill Notes 14 false false R15.htm 210311009 - Disclosure - Intangibles Sheet http://www.invacare.com/role/Intangibles Intangibles Notes 15 false false R16.htm 210361010 - Disclosure - Accrued Expenses Sheet http://www.invacare.com/role/AccruedExpenses Accrued Expenses Notes 16 false false R17.htm 210401011 - Disclosure - Long-Term Debt Sheet http://www.invacare.com/role/LongTermDebt Long-Term Debt Notes 17 false false R18.htm 210471012 - Disclosure - Other Long-Term Obligations Sheet http://www.invacare.com/role/OtherLongTermObligations Other Long-Term Obligations Notes 18 false false R19.htm 210501013 - Disclosure - Leases and Commitments (Notes) Notes http://www.invacare.com/role/LeasesandCommitmentsNotes Leases and Commitments (Notes) Notes 19 false false R20.htm 210571014 - Disclosure - Revenue Revenue Sheet http://www.invacare.com/role/RevenueRevenue Revenue Revenue Notes 20 false false R21.htm 210601015 - Disclosure - Equity Compensation Sheet http://www.invacare.com/role/EquityCompensation Equity Compensation Notes 21 false false R22.htm 210701016 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component Sheet http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponent Accumulated Other Comprehensive Income (Loss) by Component Notes 22 false false R23.htm 210741017 - Disclosure - Charges Related To Restructuring Activities Sheet http://www.invacare.com/role/ChargesRelatedToRestructuringActivities Charges Related To Restructuring Activities Notes 23 false false R24.htm 210781018 - Disclosure - Income Taxes Sheet http://www.invacare.com/role/IncomeTaxes Income Taxes Notes 24 false false R25.htm 210801019 - Disclosure - Net Earnings (Loss) Per Common Share Sheet http://www.invacare.com/role/NetEarningsLossPerCommonShare Net Earnings (Loss) Per Common Share Notes 25 false false R26.htm 210841020 - Disclosure - Concentration Of Credit Risk Sheet http://www.invacare.com/role/ConcentrationOfCreditRisk Concentration Of Credit Risk Notes 26 false false R27.htm 210861021 - Disclosure - Derivatives Sheet http://www.invacare.com/role/Derivatives Derivatives Notes 27 false false R28.htm 210941022 - Disclosure - Fair Values Sheet http://www.invacare.com/role/FairValues Fair Values Notes 28 false false R29.htm 210981023 - Disclosure - Business Segments Sheet http://www.invacare.com/role/BusinessSegments Business Segments Notes 29 false false R30.htm 211011024 - Disclosure - Contingencies Sheet http://www.invacare.com/role/Contingencies Contingencies Notes 30 false false R31.htm 220022001 - Disclosure - Accounting Policies (Policies) Sheet http://www.invacare.com/role/AccountingPoliciesPolicies Accounting Policies (Policies) Policies http://www.invacare.com/role/AccountingPolicies 31 false false R32.htm 230053001 - Disclosure - Divested Businesses (Tables) Sheet http://www.invacare.com/role/DivestedBusinessesTables Divested Businesses (Tables) Tables http://www.invacare.com/role/DivestedBusinessesNotes 32 false false R33.htm 230083002 - Disclosure - Receivables (Tables) Sheet http://www.invacare.com/role/ReceivablesTables Receivables (Tables) Tables http://www.invacare.com/role/Receivables 33 false false R34.htm 230173003 - Disclosure - Inventories (Tables) Sheet http://www.invacare.com/role/InventoriesTables Inventories (Tables) Tables http://www.invacare.com/role/Inventories 34 false false R35.htm 230203004 - Disclosure - Other Current Assets (Tables) Sheet http://www.invacare.com/role/OtherCurrentAssetsTables Other Current Assets (Tables) Tables http://www.invacare.com/role/OtherCurrentAssets 35 false false R36.htm 230233005 - Disclosure - Other Long-Term Assets (Tables) Sheet http://www.invacare.com/role/OtherLongTermAssetsTables Other Long-Term Assets (Tables) Tables http://www.invacare.com/role/OtherLongTermAssets 36 false false R37.htm 230273006 - Disclosure - Property And Equipment (Tables) Sheet http://www.invacare.com/role/PropertyAndEquipmentTables Property And Equipment (Tables) Tables http://www.invacare.com/role/PropertyAndEquipment 37 false false R38.htm 230323007 - Disclosure - Intangibles (Tables) Sheet http://www.invacare.com/role/IntangiblesTables Intangibles (Tables) Tables http://www.invacare.com/role/Intangibles 38 false false R39.htm 230373008 - Disclosure - Accrued Expenses (Tables) Sheet http://www.invacare.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://www.invacare.com/role/AccruedExpenses 39 false false R40.htm 230413009 - Disclosure - Long-Term Debt (Tables) Sheet http://www.invacare.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://www.invacare.com/role/LongTermDebt 40 false false R41.htm 230483010 - Disclosure - Other Long-Term Obligations (Tables) Sheet http://www.invacare.com/role/OtherLongTermObligationsTables Other Long-Term Obligations (Tables) Tables http://www.invacare.com/role/OtherLongTermObligations 41 false false R42.htm 230513011 - Disclosure - Leases and Commitments (Tables) Sheet http://www.invacare.com/role/LeasesandCommitmentsTables Leases and Commitments (Tables) Tables http://www.invacare.com/role/LeasesandCommitmentsNotes 42 false false R43.htm 230583012 - Disclosure - Revenue (Tables) Sheet http://www.invacare.com/role/RevenueTables Revenue (Tables) Tables http://www.invacare.com/role/RevenueRevenue 43 false false R44.htm 230613013 - Disclosure - Equity Compensation (Tables) Sheet http://www.invacare.com/role/EquityCompensationTables Equity Compensation (Tables) Tables http://www.invacare.com/role/EquityCompensation 44 false false R45.htm 230713014 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Tables) Sheet http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables Accumulated Other Comprehensive Income (Loss) by Component (Tables) Tables http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponent 45 false false R46.htm 230753015 - Disclosure - Charges Related To Restructuring Activities (Tables) Sheet http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables Charges Related To Restructuring Activities (Tables) Tables http://www.invacare.com/role/ChargesRelatedToRestructuringActivities 46 false false R47.htm 230813016 - Disclosure - Net Earnings (Loss) Per Common Share (Tables) Sheet http://www.invacare.com/role/NetEarningsLossPerCommonShareTables Net Earnings (Loss) Per Common Share (Tables) Tables http://www.invacare.com/role/NetEarningsLossPerCommonShare 47 false false R48.htm 230873017 - Disclosure - Derivatives (Tables) Sheet http://www.invacare.com/role/DerivativesTables Derivatives (Tables) Tables http://www.invacare.com/role/Derivatives 48 false false R49.htm 230953018 - Disclosure - Fair Values (Tables) Sheet http://www.invacare.com/role/FairValuesTables Fair Values (Tables) Tables http://www.invacare.com/role/FairValues 49 false false R50.htm 230993019 - Disclosure - Business Segments (Tables) Sheet http://www.invacare.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.invacare.com/role/BusinessSegments 50 false false R51.htm 240034001 - Disclosure - Accounting Policies (Details) Sheet http://www.invacare.com/role/AccountingPoliciesDetails Accounting Policies (Details) Details http://www.invacare.com/role/AccountingPoliciesPolicies 51 false false R52.htm 240064002 - Disclosure - Divested Businesses (Details) Sheet http://www.invacare.com/role/DivestedBusinessesDetails Divested Businesses (Details) Details http://www.invacare.com/role/DivestedBusinessesTables 52 false false R53.htm 240094003 - Disclosure - Receivables (Narrative) (Details) Sheet http://www.invacare.com/role/ReceivablesNarrativeDetails Receivables (Narrative) (Details) Details http://www.invacare.com/role/ReceivablesTables 53 false false R54.htm 240104004 - Disclosure - Receivables (Schedule of Accounts Receivable) (Details) Sheet http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails Receivables (Schedule of Accounts Receivable) (Details) Details http://www.invacare.com/role/ReceivablesTables 54 false false R55.htm 240114005 - Disclosure - Receivables Schedule for Allowance for Credit Losses (Details) Sheet http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails Receivables Schedule for Allowance for Credit Losses (Details) Details 55 false false R56.htm 240124006 - Disclosure - Receivables (Installment Recevables) (Details) Sheet http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails Receivables (Installment Recevables) (Details) Details http://www.invacare.com/role/ReceivablesTables 56 false false R57.htm 240134007 - Disclosure - Receivables (Rollforward of Allowance for Doubtful Accounts) (Details) Sheet http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails Receivables (Rollforward of Allowance for Doubtful Accounts) (Details) Details http://www.invacare.com/role/ReceivablesTables 57 false false R58.htm 240144008 - Disclosure - Receivables (Installment Receivables by Class) (Details) Sheet http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails Receivables (Installment Receivables by Class) (Details) Details http://www.invacare.com/role/ReceivablesTables 58 false false R59.htm 240154009 - Disclosure - Receivables (Aging of Installment Receivables) (Details) Sheet http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails Receivables (Aging of Installment Receivables) (Details) Details http://www.invacare.com/role/ReceivablesTables 59 false false R60.htm 240184010 - Disclosure - Inventories (Details) Sheet http://www.invacare.com/role/InventoriesDetails Inventories (Details) Details http://www.invacare.com/role/InventoriesTables 60 false false R61.htm 240214011 - Disclosure - Other Current Assets Components of Other Current Assets (Details) Sheet http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails Other Current Assets Components of Other Current Assets (Details) Details 61 false false R62.htm 240244012 - Disclosure - Other Long-Term Assets Components of Other Long-Term Assets (Details) Sheet http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails Other Long-Term Assets Components of Other Long-Term Assets (Details) Details 62 false false R63.htm 240284014 - Disclosure - Property And Equipment (Details) Sheet http://www.invacare.com/role/PropertyAndEquipmentDetails Property And Equipment (Details) Details http://www.invacare.com/role/PropertyAndEquipmentTables 63 false false R64.htm 240334016 - Disclosure - Intangibles (Narrative) (Details) Sheet http://www.invacare.com/role/IntangiblesNarrativeDetails Intangibles (Narrative) (Details) Details http://www.invacare.com/role/IntangiblesTables 64 false false R65.htm 240344017 - Disclosure - Intangibles (Intangible Table) (Details) Sheet http://www.invacare.com/role/IntangiblesIntangibleTableDetails Intangibles (Intangible Table) (Details) Details http://www.invacare.com/role/IntangiblesTables 65 false false R66.htm 240354018 - Disclosure - Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details) Sheet http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details) Details http://www.invacare.com/role/IntangiblesTables 66 false false R67.htm 240384019 - Disclosure - Accrued Expenses Components of Accrued Expenses (Details) Sheet http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails Accrued Expenses Components of Accrued Expenses (Details) Details 67 false false R68.htm 240394020 - Disclosure - Accrued Expenses Warranty Schedule (Details) Sheet http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails Accrued Expenses Warranty Schedule (Details) Details 68 false false R69.htm 240424021 - Disclosure - Long-Term Debt (Details) Sheet http://www.invacare.com/role/LongTermDebtDetails Long-Term Debt (Details) Details http://www.invacare.com/role/LongTermDebtTables 69 false false R70.htm 240444023 - Disclosure - Long-Term Debt Components of Convertible Debt (Details) Sheet http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails Long-Term Debt Components of Convertible Debt (Details) Details 70 false false R71.htm 240454024 - Disclosure - Long-Term Debt Narrative (Details) Sheet http://www.invacare.com/role/LongTermDebtNarrativeDetails Long-Term Debt Narrative (Details) Details 71 false false R72.htm 240464025 - Disclosure - Long-Term Debt Sale Leaseback Transactions (Details) Sheet http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails Long-Term Debt Sale Leaseback Transactions (Details) Details 72 false false R73.htm 240494026 - Disclosure - Other Long-Term Obligations (Details) Sheet http://www.invacare.com/role/OtherLongTermObligationsDetails Other Long-Term Obligations (Details) Details http://www.invacare.com/role/OtherLongTermObligationsTables 73 false false R74.htm 240524027 - Disclosure - Leases and Commitments (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsDetails Leases and Commitments (Details) Details http://www.invacare.com/role/LeasesandCommitmentsTables 74 false false R75.htm 240534028 - Disclosure - Leases and Commitments Lease Expenses (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails Leases and Commitments Lease Expenses (Details) Details 75 false false R76.htm 240544029 - Disclosure - Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details) Details 76 false false R77.htm 240554030 - Disclosure - Leases and Commitments Supplemental Cash Flow Information (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails Leases and Commitments Supplemental Cash Flow Information (Details) Details 77 false false R78.htm 240564031 - Disclosure - Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details) Details 78 false false R79.htm 240594032 - Disclosure - Revenue (Details) Sheet http://www.invacare.com/role/RevenueDetails Revenue (Details) Details http://www.invacare.com/role/RevenueTables 79 false false R80.htm 240624033 - Disclosure - Equity Compensation (Narrative) (Details) Sheet http://www.invacare.com/role/EquityCompensationNarrativeDetails Equity Compensation (Narrative) (Details) Details http://www.invacare.com/role/EquityCompensationTables 80 false false R81.htm 240634034 - Disclosure - Equity Compensation Share-based Compensation Expense (Details) Sheet http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails Equity Compensation Share-based Compensation Expense (Details) Details 81 false false R82.htm 240644035 - Disclosure - Equity Compensation Unrecognized Compensation Expense (Details) Sheet http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails Equity Compensation Unrecognized Compensation Expense (Details) Details 82 false false R83.htm 240654036 - Disclosure - Equity Compensation (Options Activity) (Details) Sheet http://www.invacare.com/role/EquityCompensationOptionsActivityDetails Equity Compensation (Options Activity) (Details) Details http://www.invacare.com/role/EquityCompensationTables 83 false false R84.htm 240664037 - Disclosure - Equity Compensation (Stock Options Outstanding by Exercise Price) (Details) Sheet http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails Equity Compensation (Stock Options Outstanding by Exercise Price) (Details) Details http://www.invacare.com/role/EquityCompensationTables 84 false false R85.htm 240674038 - Disclosure - Equity Compensation Restricted Stock Activity (Details) Sheet http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails Equity Compensation Restricted Stock Activity (Details) Details 85 false false R86.htm 240684039 - Disclosure - Equity Compensation Performance Share Activity (Details) Sheet http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails Equity Compensation Performance Share Activity (Details) Details 86 false false R87.htm 240724041 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details) Sheet http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details) Details http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables 87 false false R88.htm 240734042 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details) Sheet http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details) Details http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables 88 false false R89.htm 240764043 - Disclosure - Charges Related To Restructuring Activities (Details) Sheet http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails Charges Related To Restructuring Activities (Details) Details http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables 89 false false R90.htm 240774044 - Disclosure - Charges Related To Restructuring Activities Narrative (Details) Sheet http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails Charges Related To Restructuring Activities Narrative (Details) Details http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables 90 false false R91.htm 240794045 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.invacare.com/role/IncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) Details http://www.invacare.com/role/IncomeTaxes 91 false false R92.htm 240824046 - Disclosure - Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details) Sheet http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details) Details http://www.invacare.com/role/NetEarningsLossPerCommonShareTables 92 false false R93.htm 240834047 - Disclosure - Net Earnings (Loss) Per Common Share Textuals (Details) Sheet http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails Net Earnings (Loss) Per Common Share Textuals (Details) Details http://www.invacare.com/role/NetEarningsLossPerCommonShareTables 93 false false R94.htm 240854048 - Disclosure - Concentration Of Credit Risk (Details) Sheet http://www.invacare.com/role/ConcentrationOfCreditRiskDetails Concentration Of Credit Risk (Details) Details http://www.invacare.com/role/ConcentrationOfCreditRisk 94 false false R95.htm 240884049 - Disclosure - Derivatives Notional Amounts - Designated as Hedges (Details) Sheet http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails Derivatives Notional Amounts - Designated as Hedges (Details) Details 95 false false R96.htm 240894050 - Disclosure - Derivatives Notional Amounts - Not Designated as Hedges (Details) Sheet http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails Derivatives Notional Amounts - Not Designated as Hedges (Details) Details 96 false false R97.htm 240904051 - Disclosure - Derivatives Balance Sheet Location (Details) Sheet http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails Derivatives Balance Sheet Location (Details) Details 97 false false R98.htm 240914052 - Disclosure - Derivatives Gain (Loss) in Statement of Finacial Position (Details) Sheet http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails Derivatives Gain (Loss) in Statement of Finacial Position (Details) Details 98 false false R99.htm 240924053 - Disclosure - Derivatives Narrative (Details) Sheet http://www.invacare.com/role/DerivativesNarrativeDetails Derivatives Narrative (Details) Details 99 false false R100.htm 240934054 - Disclosure - Derivatives Fair Value of Convertible Debt Hedges (Details) Sheet http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails Derivatives Fair Value of Convertible Debt Hedges (Details) Details 100 false false R101.htm 240964055 - Disclosure - Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) Sheet http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) Details http://www.invacare.com/role/FairValuesTables 101 false false R102.htm 240974056 - Disclosure - Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details) Sheet http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details) Details http://www.invacare.com/role/FairValuesTables 102 false false R103.htm 241004057 - Disclosure - Business Segments (Information by Segment) (Details) Sheet http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails Business Segments (Information by Segment) (Details) Details http://www.invacare.com/role/BusinessSegmentsTables 103 false false All Reports Book All Reports ivc-20210930.htm ivc-20210930.xsd ivc-20210930_cal.xml ivc-20210930_def.xml ivc-20210930_lab.xml ivc-20210930_pre.xml q32021ivc10-qexhibit101.htm q32021ivc10-qexhibit102.htm q32021ivcex311.htm q32021ivcex312.htm q32021ivcex321.htm q32021ivcex322.htm ivc-20210930_g1.jpg ivc-20210930_g2.jpg ivc-20210930_g3.jpg ivc-20210930_g4.jpg ivc-20210930_g5.jpg ivc-20210930_g6.jpg ivc-20210930_g7.jpg ivc-20210930_g8.jpg http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/currency/2020-01-31 http://fasb.org/srt/2020-01-31 true true JSON 132 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ivc-20210930.htm": { "axisCustom": 2, "axisStandard": 29, "contextCount": 704, "dts": { "calculationLink": { "local": [ "ivc-20210930_cal.xml" ] }, "definitionLink": { "local": [ "ivc-20210930_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "ivc-20210930.htm" ] }, "labelLink": { "local": [ "ivc-20210930_lab.xml" ] }, "presentationLink": { "local": [ "ivc-20210930_pre.xml" ] }, "schema": { "local": [ "ivc-20210930.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 915, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 1, "http://www.invacare.com/20210930": 4, "http://xbrl.sec.gov/dei/2020-01-31": 5, "total": 10 }, "keyCustom": 164, "keyStandard": 454, "memberCustom": 63, "memberStandard": 57, "nsprefix": "ivc", "nsuri": "http://www.invacare.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000010001 - Document - DEI Document", "role": "http://www.invacare.com/role/DEIDocument", "shortName": "DEI Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210161004 - Disclosure - Inventories", "role": "http://www.invacare.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i4dcdf44484a54430b6348f5d4547353e_D20190101-20191231", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ConvertibleDebtConversionFeatureGainLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240934054 - Disclosure - Derivatives Fair Value of Convertible Debt Hedges (Details)", "role": "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "shortName": "Derivatives Fair Value of Convertible Debt Hedges (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R101": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i98a71692be174cde816f16e73471f85d_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240964055 - Disclosure - Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details)", "role": "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "shortName": "Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R102": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240974056 - Disclosure - Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details)", "role": "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "shortName": "Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ia62b087045ca408a8bb49fd630cde533_I20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "div", "div", "us-gaap:RevenueRecognitionDeferredRevenue", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241004057 - Disclosure - Business Segments (Information by Segment) (Details)", "role": "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "shortName": "Business Segments (Information by Segment) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:InterestRevenueExpenseNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210191005 - Disclosure - Other Current Assets", "role": "http://www.invacare.com/role/OtherCurrentAssets", "shortName": "Other Current Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210221006 - Disclosure - Other Long-Term Assets", "role": "http://www.invacare.com/role/OtherLongTermAssets", "shortName": "Other Long-Term Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210261007 - Disclosure - Property And Equipment", "role": "http://www.invacare.com/role/PropertyAndEquipment", "shortName": "Property And Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210291008 - Disclosure - Goodwill", "role": "http://www.invacare.com/role/Goodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210311009 - Disclosure - Intangibles", "role": "http://www.invacare.com/role/Intangibles", "shortName": "Intangibles", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210361010 - Disclosure - Accrued Expenses", "role": "http://www.invacare.com/role/AccruedExpenses", "shortName": "Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210401011 - Disclosure - Long-Term Debt", "role": "http://www.invacare.com/role/LongTermDebt", "shortName": "Long-Term Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210471012 - Disclosure - Other Long-Term Obligations", "role": "http://www.invacare.com/role/OtherLongTermObligations", "shortName": "Other Long-Term Obligations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210501013 - Disclosure - Leases and Commitments (Notes)", "role": "http://www.invacare.com/role/LeasesandCommitmentsNotes", "shortName": "Leases and Commitments (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "div", "div", "us-gaap:RevenueRecognitionDeferredRevenue", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010002 - Statement - Condensed Consolidated Statement of Comprehensive Income (Loss)", "role": "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "shortName": "Condensed Consolidated Statement of Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionDeferredRevenue", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210571014 - Disclosure - Revenue Revenue", "role": "http://www.invacare.com/role/RevenueRevenue", "shortName": "Revenue Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionDeferredRevenue", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210601015 - Disclosure - Equity Compensation", "role": "http://www.invacare.com/role/EquityCompensation", "shortName": "Equity Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210701016 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component", "role": "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponent", "shortName": "Accumulated Other Comprehensive Income (Loss) by Component", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210741017 - Disclosure - Charges Related To Restructuring Activities", "role": "http://www.invacare.com/role/ChargesRelatedToRestructuringActivities", "shortName": "Charges Related To Restructuring Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210781018 - Disclosure - Income Taxes", "role": "http://www.invacare.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210801019 - Disclosure - Net Earnings (Loss) Per Common Share", "role": "http://www.invacare.com/role/NetEarningsLossPerCommonShare", "shortName": "Net Earnings (Loss) Per Common Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210841020 - Disclosure - Concentration Of Credit Risk", "role": "http://www.invacare.com/role/ConcentrationOfCreditRisk", "shortName": "Concentration Of Credit Risk", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210861021 - Disclosure - Derivatives", "role": "http://www.invacare.com/role/Derivatives", "shortName": "Derivatives", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210941022 - Disclosure - Fair Values", "role": "http://www.invacare.com/role/FairValues", "shortName": "Fair Values", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210981023 - Disclosure - Business Segments", "role": "http://www.invacare.com/role/BusinessSegments", "shortName": "Business Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020003 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211011024 - Disclosure - Contingencies", "role": "http://www.invacare.com/role/Contingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "220022001 - Disclosure - Accounting Policies (Policies)", "role": "http://www.invacare.com/role/AccountingPoliciesPolicies", "shortName": "Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i91f803773ad9419abcd6ab723e0c9201_D20200101-20200307", "decimals": null, "first": true, "lang": "en-US", "name": "ivc:AssetsandLiabilitiesofDivestedBusinessTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230053001 - Disclosure - Divested Businesses (Tables)", "role": "http://www.invacare.com/role/DivestedBusinessesTables", "shortName": "Divested Businesses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i91f803773ad9419abcd6ab723e0c9201_D20200101-20200307", "decimals": null, "first": true, "lang": "en-US", "name": "ivc:AssetsandLiabilitiesofDivestedBusinessTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "ivc:ScheduleofAccountsReceivableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230083002 - Disclosure - Receivables (Tables)", "role": "http://www.invacare.com/role/ReceivablesTables", "shortName": "Receivables (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "ivc:ScheduleofAccountsReceivableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230173003 - Disclosure - Inventories (Tables)", "role": "http://www.invacare.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230203004 - Disclosure - Other Current Assets (Tables)", "role": "http://www.invacare.com/role/OtherCurrentAssetsTables", "shortName": "Other Current Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230233005 - Disclosure - Other Long-Term Assets (Tables)", "role": "http://www.invacare.com/role/OtherLongTermAssetsTables", "shortName": "Other Long-Term Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230273006 - Disclosure - Property And Equipment (Tables)", "role": "http://www.invacare.com/role/PropertyAndEquipmentTables", "shortName": "Property And Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230323007 - Disclosure - Intangibles (Tables)", "role": "http://www.invacare.com/role/IntangiblesTables", "shortName": "Intangibles (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230373008 - Disclosure - Accrued Expenses (Tables)", "role": "http://www.invacare.com/role/AccruedExpensesTables", "shortName": "Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030004 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230413009 - Disclosure - Long-Term Debt (Tables)", "role": "http://www.invacare.com/role/LongTermDebtTables", "shortName": "Long-Term Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230483010 - Disclosure - Other Long-Term Obligations (Tables)", "role": "http://www.invacare.com/role/OtherLongTermObligationsTables", "shortName": "Other Long-Term Obligations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230513011 - Disclosure - Leases and Commitments (Tables)", "role": "http://www.invacare.com/role/LeasesandCommitmentsTables", "shortName": "Leases and Commitments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:RevenueRecognitionDeferredRevenue", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230583012 - Disclosure - Revenue (Tables)", "role": "http://www.invacare.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:RevenueRecognitionDeferredRevenue", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230613013 - Disclosure - Equity Compensation (Tables)", "role": "http://www.invacare.com/role/EquityCompensationTables", "shortName": "Equity Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230713014 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Tables)", "role": "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables", "shortName": "Accumulated Other Comprehensive Income (Loss) by Component (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230753015 - Disclosure - Charges Related To Restructuring Activities (Tables)", "role": "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables", "shortName": "Charges Related To Restructuring Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230813016 - Disclosure - Net Earnings (Loss) Per Common Share (Tables)", "role": "http://www.invacare.com/role/NetEarningsLossPerCommonShareTables", "shortName": "Net Earnings (Loss) Per Common Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230873017 - Disclosure - Derivatives (Tables)", "role": "http://www.invacare.com/role/DerivativesTables", "shortName": "Derivatives (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230953018 - Disclosure - Fair Values (Tables)", "role": "http://www.invacare.com/role/FairValuesTables", "shortName": "Fair Values (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:PurchaseOfCappedCalls", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040005 - Statement - Condensed Consolidated Statement Of Cash Flows", "role": "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "shortName": "Condensed Consolidated Statement Of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": "-3", "lang": "en-US", "name": "ivc:ConvertibleDebtDiscountAmortizationAndAccretion", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230993019 - Disclosure - Business Segments (Tables)", "role": "http://www.invacare.com/role/BusinessSegmentsTables", "shortName": "Business Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:AdoptionOfASU202006ConvertibleDebtDiscountsRemoved", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240034001 - Disclosure - Accounting Policies (Details)", "role": "http://www.invacare.com/role/AccountingPoliciesDetails", "shortName": "Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:AdoptionOfASU202006ConvertibleDebtDiscountsRemoved", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:AssetsandLiabilitiesofDivestedBusinessTableTextBlock", "div", "div", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i82ceb2522a114fbbada496679208a9ef_I20200307", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240064002 - Disclosure - Divested Businesses (Details)", "role": "http://www.invacare.com/role/DivestedBusinessesDetails", "shortName": "Divested Businesses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:AssetsandLiabilitiesofDivestedBusinessTableTextBlock", "div", "div", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i82ceb2522a114fbbada496679208a9ef_I20200307", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ContingentLiabilityGuarantee", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240094003 - Disclosure - Receivables (Narrative) (Details)", "role": "http://www.invacare.com/role/ReceivablesNarrativeDetails", "shortName": "Receivables (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ContingentLiabilityGuarantee", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:ScheduleofAccountsReceivableTableTextBlock", "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240104004 - Disclosure - Receivables (Schedule of Accounts Receivable) (Details)", "role": "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails", "shortName": "Receivables (Schedule of Accounts Receivable) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:ScheduleofAccountsReceivableTableTextBlock", "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:AllowanceforCreditLossesTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:AllowanceforCreditLosses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240114005 - Disclosure - Receivables Schedule for Allowance for Credit Losses (Details)", "role": "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails", "shortName": "Receivables Schedule for Allowance for Credit Losses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:AllowanceforCreditLossesTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:AllowanceforCreditLosses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:FinancingReceivablesTableTextBlock", "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:NonImpairedFinancingReceivableRelatedAllowance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240124006 - Disclosure - Receivables (Installment Recevables) (Details)", "role": "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails", "shortName": "Receivables (Installment Recevables) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:NotesAndLoansReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i48ff8d1ca48845e5b2e14170b1f9efb8_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240134007 - Disclosure - Receivables (Rollforward of Allowance for Doubtful Accounts) (Details)", "role": "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails", "shortName": "Receivables (Rollforward of Allowance for Doubtful Accounts) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllowanceForLoanAndLeaseLossesAdjustmentsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:FinancingReceivablesTableTextBlock", "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:FinancingReceivablewithNoRelatedAllowanceRecordedInvestment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240144008 - Disclosure - Receivables (Installment Receivables by Class) (Details)", "role": "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "shortName": "Receivables (Installment Receivables by Class) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:FinancingReceivablesTableTextBlock", "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:FinancingReceivablewithNoRelatedAllowanceRecordedInvestment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PastDueFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:InstallmentReceivable0To30DaysPastDue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240154009 - Disclosure - Receivables (Aging of Installment Receivables) (Details)", "role": "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "shortName": "Receivables (Aging of Installment Receivables) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PastDueFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:InstallmentReceivable0To30DaysPastDue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "idb666748566c4685a50a92b1e0c9899c_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050006 - Statement - Condensed Consolidated Statement of Shareholders' Equity Statement", "role": "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "shortName": "Condensed Consolidated Statement of Shareholders' Equity Statement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "idb666748566c4685a50a92b1e0c9899c_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240184010 - Disclosure - Inventories (Details)", "role": "http://www.invacare.com/role/InventoriesDetails", "shortName": "Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ValueAddedTaxReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240214011 - Disclosure - Other Current Assets Components of Other Current Assets (Details)", "role": "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails", "shortName": "Other Current Assets Components of Other Current Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ValueAddedTaxReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueOfLifeInsurance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240244012 - Disclosure - Other Long-Term Assets Components of Other Long-Term Assets (Details)", "role": "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails", "shortName": "Other Long-Term Assets Components of Other Long-Term Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueOfLifeInsurance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240284014 - Disclosure - Property And Equipment (Details)", "role": "http://www.invacare.com/role/PropertyAndEquipmentDetails", "shortName": "Property And Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240334016 - Disclosure - Intangibles (Narrative) (Details)", "role": "http://www.invacare.com/role/IntangiblesNarrativeDetails", "shortName": "Intangibles (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240344017 - Disclosure - Intangibles (Intangible Table) (Details)", "role": "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "shortName": "Intangibles (Intangible Table) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240354018 - Disclosure - Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details)", "role": "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails", "shortName": "Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240384019 - Disclosure - Accrued Expenses Components of Accrued Expenses (Details)", "role": "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails", "shortName": "Accrued Expenses Components of Accrued Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i48ff8d1ca48845e5b2e14170b1f9efb8_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrualClassifiedCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240394020 - Disclosure - Accrued Expenses Warranty Schedule (Details)", "role": "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails", "shortName": "Accrued Expenses Warranty Schedule (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrualWarrantiesIssued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240424021 - Disclosure - Long-Term Debt (Details)", "role": "http://www.invacare.com/role/LongTermDebtDetails", "shortName": "Long-Term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i48ff8d1ca48845e5b2e14170b1f9efb8_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210011001 - Disclosure - Accounting Policies", "role": "http://www.invacare.com/role/AccountingPolicies", "shortName": "Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i54282cb299554bb28fed89984fc790fe_D20160101-20160331", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240444023 - Disclosure - Long-Term Debt Components of Convertible Debt (Details)", "role": "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "shortName": "Long-Term Debt Components of Convertible Debt (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R71": { "firstAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i54282cb299554bb28fed89984fc790fe_D20160101-20160331", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240454024 - Disclosure - Long-Term Debt Narrative (Details)", "role": "http://www.invacare.com/role/LongTermDebtNarrativeDetails", "shortName": "Long-Term Debt Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "iba0fb7a42b794f03bc8d73ba5f885e7a_I20200515", "decimals": "-6", "lang": "en-US", "name": "us-gaap:UnsecuredDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib84ad00fca514976a09fefaa29cb29ba_I20150423", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:SaleLeasebackTransactionDeferredGainGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240464025 - Disclosure - Long-Term Debt Sale Leaseback Transactions (Details)", "role": "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails", "shortName": "Long-Term Debt Sale Leaseback Transactions (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240494026 - Disclosure - Other Long-Term Obligations (Details)", "role": "http://www.invacare.com/role/OtherLongTermObligationsDetails", "shortName": "Other Long-Term Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i48ff8d1ca48845e5b2e14170b1f9efb8_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7878a7bc4e3447a6996ea5e85fb61949_I20201201", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240524027 - Disclosure - Leases and Commitments (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsDetails", "shortName": "Leases and Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7878a7bc4e3447a6996ea5e85fb61949_I20201201", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240534028 - Disclosure - Leases and Commitments Lease Expenses (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails", "shortName": "Leases and Commitments Lease Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240544029 - Disclosure - Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails", "shortName": "Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:OperatingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240554030 - Disclosure - Leases and Commitments Supplemental Cash Flow Information (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails", "shortName": "Leases and Commitments Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:OperatingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:WeightedAverageRemainingLeaseTermsandDiscountRatesTableTextBlock", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240564031 - Disclosure - Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails", "shortName": "Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:WeightedAverageRemainingLeaseTermsandDiscountRatesTableTextBlock", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "div", "div", "us-gaap:RevenueRecognitionDeferredRevenue", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240594032 - Disclosure - Revenue (Details)", "role": "http://www.invacare.com/role/RevenueDetails", "shortName": "Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "div", "div", "us-gaap:RevenueRecognitionDeferredRevenue", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "2", "lang": "en-US", "name": "ivc:NetRevenue", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210041002 - Disclosure - Divested Businesses (Notes)", "role": "http://www.invacare.com/role/DivestedBusinessesNotes", "shortName": "Divested Businesses (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240624033 - Disclosure - Equity Compensation (Narrative) (Details)", "role": "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "shortName": "Equity Compensation (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240634034 - Disclosure - Equity Compensation Share-based Compensation Expense (Details)", "role": "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "shortName": "Equity Compensation Share-based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "iefb5312bd89f4312af64367936482aca_D20210101-20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240644035 - Disclosure - Equity Compensation Unrecognized Compensation Expense (Details)", "role": "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails", "shortName": "Equity Compensation Unrecognized Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i48ff8d1ca48845e5b2e14170b1f9efb8_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240654036 - Disclosure - Equity Compensation (Options Activity) (Details)", "role": "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "shortName": "Equity Compensation (Options Activity) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i48ff8d1ca48845e5b2e14170b1f9efb8_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240664037 - Disclosure - Equity Compensation (Stock Options Outstanding by Exercise Price) (Details)", "role": "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "shortName": "Equity Compensation (Stock Options Outstanding by Exercise Price) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ic3f1da03d3284ddc9a0331c17819df3c_D20210101-20210930", "decimals": "2", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i5baa18e104394f8bbea6696748cfc2f0_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240674038 - Disclosure - Equity Compensation Restricted Stock Activity (Details)", "role": "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "shortName": "Equity Compensation Restricted Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i5baa18e104394f8bbea6696748cfc2f0_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i3305238fd7f14f35a89f26fbcb02ffaf_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240684039 - Disclosure - Equity Compensation Performance Share Activity (Details)", "role": "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "shortName": "Equity Compensation Performance Share Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i3305238fd7f14f35a89f26fbcb02ffaf_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ie974bed59d0343bab81018aa157d79c8_I20210630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240724041 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details)", "role": "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "shortName": "Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ie974bed59d0343bab81018aa157d79c8_I20210630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240734042 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details)", "role": "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "shortName": "Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i20c70ac7dacb4a0c9561679b6986a037_D20210701-20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ie974bed59d0343bab81018aa157d79c8_I20210630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240764043 - Disclosure - Charges Related To Restructuring Activities (Details)", "role": "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "shortName": "Charges Related To Restructuring Activities (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210071003 - Disclosure - Receivables", "role": "http://www.invacare.com/role/Receivables", "shortName": "Receivables", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240774044 - Disclosure - Charges Related To Restructuring Activities Narrative (Details)", "role": "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "shortName": "Charges Related To Restructuring Activities Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i07029670dd5b4fa989c023d7df7ec998_D20210101-20210930", "decimals": null, "lang": "en-US", "name": "ivc:RestructuringAndRelatedActivitiesExpectedPayoutPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "iafcbae5c80864af1a95b811e7f5bea91_D20200101-20200331", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ReversalofAccruedWithholdingTaxesonEarnings", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240794045 - Disclosure - Income Taxes (Narrative) (Details)", "role": "http://www.invacare.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "iafcbae5c80864af1a95b811e7f5bea91_D20200101-20200331", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ReversalofAccruedWithholdingTaxesonEarnings", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240824046 - Disclosure - Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details)", "role": "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails", "shortName": "Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ib0076e7a586b44f7b20ad6b128d45a9c_D20210701-20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "iab98f514142d42f19528feb56c2223d3_D20210701-20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240834047 - Disclosure - Net Earnings (Loss) Per Common Share Textuals (Details)", "role": "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails", "shortName": "Net Earnings (Loss) Per Common Share Textuals (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "iab98f514142d42f19528feb56c2223d3_D20210701-20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ConcentrationRiskRetainedRecourseObligationForDefaultofCustomerLeaseObligationsUnderContract", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240854048 - Disclosure - Concentration Of Credit Risk (Details)", "role": "http://www.invacare.com/role/ConcentrationOfCreditRiskDetails", "shortName": "Concentration Of Credit Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i7841b09302f44bd280079cd2f247484f_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ConcentrationRiskRetainedRecourseObligationForDefaultofCustomerLeaseObligationsUnderContract", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "if789900010d744f4917bfcd8ae24d650_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:NotionalAmountDerivative", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240884049 - Disclosure - Derivatives Notional Amounts - Designated as Hedges (Details)", "role": "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "shortName": "Derivatives Notional Amounts - Designated as Hedges (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i64cd20d3179d41b2b446903f922fa24a_I20210930", "decimals": "-3", "lang": "en-US", "name": "ivc:NotionalAmountDerivative", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "if789900010d744f4917bfcd8ae24d650_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:NotionalAmountDerivative", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240894050 - Disclosure - Derivatives Notional Amounts - Not Designated as Hedges (Details)", "role": "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails", "shortName": "Derivatives Notional Amounts - Not Designated as Hedges (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i3111baf6d43e45d6a5694d80882412a8_I20210930", "decimals": "-3", "lang": "en-US", "name": "ivc:NotionalAmountDerivative", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "id586263e778b4ed284eecb640a8e2232_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240904051 - Disclosure - Derivatives Balance Sheet Location (Details)", "role": "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "shortName": "Derivatives Balance Sheet Location (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "id586263e778b4ed284eecb640a8e2232_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i6df3acbab55a4806be77f5e2d95cf472_D20210701-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240914052 - Disclosure - Derivatives Gain (Loss) in Statement of Finacial Position (Details)", "role": "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "shortName": "Derivatives Gain (Loss) in Statement of Finacial Position (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "ia3283678adbb464f8f46cd9e57946fbb_D20210701-20210930", "decimals": "-3", "lang": "en-US", "name": "ivc:AmountOfGainLossRecognizedInAccumulatedOCIOnDerivativesEffectivePortion", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i54282cb299554bb28fed89984fc790fe_D20160101-20160331", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240924053 - Disclosure - Derivatives Narrative (Details)", "role": "http://www.invacare.com/role/DerivativesNarrativeDetails", "shortName": "Derivatives Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20210930.htm", "contextRef": "i6a380ce1f78a4702a0320e377c5be330_D20210101-20210930", "decimals": "0", "lang": "en-US", "name": "ivc:NotionalAmountOfDerivativesMaturedDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 123, "tag": { "currency_AllCurrenciesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "All Currencies [Domain]", "terseLabel": "All Currencies [Domain]" } } }, "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "currency_EUR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Euro Member Countries, Euro", "terseLabel": "Euro Member Countries, Euro" } } }, "localname": "EUR", "nsuri": "http://xbrl.sec.gov/currency/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "currency_GBP": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "United Kingdom, Pounds", "terseLabel": "United Kingdom, Pounds" } } }, "localname": "GBP", "nsuri": "http://xbrl.sec.gov/currency/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r673" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r674" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r676" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r671" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r672" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "tradingSymbolItemType" }, "ivc_A126YearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "12.6 Years", "label": "12.6 Years [Member]", "terseLabel": "12.6 Years" } } }, "localname": "A126YearsMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "ivc_A2013PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2013 Plan [Member]", "label": "2013 Plan [Member]", "terseLabel": "2013 Plan [Member]" } } }, "localname": "A2013PlanMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_A2018PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2018 Plan", "label": "2018 Plan [Member]", "terseLabel": "2018 Plan [Member]" } } }, "localname": "A2018PlanMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_A20YearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "20 Years", "label": "20 Years [Member]", "terseLabel": "20 Years" } } }, "localname": "A20YearsMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "ivc_AccretionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accretion Rate", "label": "Accretion Rate", "terseLabel": "Accretion Rate" } } }, "localname": "AccretionRate", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "percentItemType" }, "ivc_AccruedFreightExpenseCurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Freight Accrual, Current [Line Items]", "label": "Accrued Freight Expense, Current", "terseLabel": "Freight" } } }, "localname": "AccruedFreightExpenseCurrent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AccumulatedLongTermNotesAdjustmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accumulated Long-Term Notes Adjustment [Member]", "label": "Accumulated Long-Term Notes Adjustment [Member]", "terseLabel": "Accumulated Long-Term Notes Adjustment [Member]" } } }, "localname": "AccumulatedLongTermNotesAdjustmentMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "ivc_AdoptionOfASU202006": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adoption of ASU 2020-06", "label": "Adoption of ASU 2020-06", "terseLabel": "Adoption of ASU 2020-06" } } }, "localname": "AdoptionOfASU202006", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "ivc_AdoptionOfASU202006ConvertibleDebtDiscountsRemoved": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adoption of ASU 2020-06, Convertible Debt Discounts Removed", "label": "Adoption of ASU 2020-06, Convertible Debt Discounts Removed", "terseLabel": "Adoption of ASU 2020-06, Convertible Debt Discounts Removed" } } }, "localname": "AdoptionOfASU202006ConvertibleDebtDiscountsRemoved", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AdoptionOfCreditLossStandard": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adoption of Credit Loss Standard", "label": "Adoption of Credit Loss Standard", "terseLabel": "Adoption of Credit Loss Standard" } } }, "localname": "AdoptionOfCreditLossStandard", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "ivc_AllOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All Other", "label": "All Other [Member]", "terseLabel": "All Other" } } }, "localname": "AllOtherMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_AllowanceforCreditLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allowance for Credit Losses", "label": "Allowance for Credit Losses", "terseLabel": "Allowance for Credit Losses" } } }, "localname": "AllowanceforCreditLosses", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AllowanceforCreditLossesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Allowance for Credit Losses", "label": "Allowance for Credit Losses [Table Text Block]", "terseLabel": "Schedule for Allowance for Credit Losses" } } }, "localname": "AllowanceforCreditLossesTableTextBlock", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "ivc_AllowanceforCreditLossesWritedowns": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Allowance for Credit Losses, Write-downs", "label": "Allowance for Credit Losses, Write-downs", "terseLabel": "Financing Receivable, Allowance for Credit Losses, Write-downs" } } }, "localname": "AllowanceforCreditLossesWritedowns", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AllowanceforLossesAdjustmentsOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allowance for Losses, Adjustments, Other", "label": "Allowance for Losses, Adjustments, Other", "terseLabel": "Allowance for Loan and Lease Losses, Adjustments, Other" } } }, "localname": "AllowanceforLossesAdjustmentsOther", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AmountAvailabletoInvacareLimitedandInvacarePoirierSASDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Invacare Limited and Invacare Poirier SAS", "label": "Amount Available to Invacare Limited and Invacare Poirier SAS [Domain]", "terseLabel": "Amount Available to Invacare Limited and Invacare Poirier SAS" } } }, "localname": "AmountAvailabletoInvacareLimitedandInvacarePoirierSASDomain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_AmountOfGainLossRecognizedInAccumulatedOCIOnDerivativesEffectivePortion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Gain (Loss)\u00a0Recognized \u00a0in Accumulated OCI on Derivatives (Effective Portion)", "label": "Amount of Gain (Loss)\u00a0Recognized \u00a0in Accumulated OCI on Derivatives (Effective Portion)", "terseLabel": "Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]" } } }, "localname": "AmountOfGainLossRecognizedInAccumulatedOCIOnDerivativesEffectivePortion", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AssetsandLiabilitiesofDivestedBusinessTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets and Liabilities of Divested Business", "label": "Assets and Liabilities of Divested Business [Table Text Block]", "terseLabel": "Assets and Liabilities of Divested Business [Table Text Block]" } } }, "localname": "AssetsandLiabilitiesofDivestedBusinessTableTextBlock", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesTables" ], "xbrltype": "textBlockItemType" }, "ivc_AverageFairValueStockPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average Fair Value Stock Price", "label": "Average Fair Value Stock Price", "terseLabel": "Fair value stock price" } } }, "localname": "AverageFairValueStockPrice", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "perShareItemType" }, "ivc_BusinessDayPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Day Period", "label": "Business Day Period", "terseLabel": "Business Day Period" } } }, "localname": "BusinessDayPeriod", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_CARESActLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CARES Act Loan", "label": "CARES Act Loan [Member]", "terseLabel": "CARES Act Loan [Member]" } } }, "localname": "CARESActLoanMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_CapPriceOfCappedCallTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cap Price of Capped Call Transaction", "label": "Cap Price of Capped Call Transaction", "terseLabel": "Cap Price of Capped Call Transaction" } } }, "localname": "CapPriceOfCappedCallTransaction", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "perShareItemType" }, "ivc_CapitalizedSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capitalized Software [Member]", "label": "Capitalized Software [Member]", "terseLabel": "Capitalized Software [Member]" } } }, "localname": "CapitalizedSoftwareMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ivc_CappedCallOptionsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capped Call Options, Outstanding", "label": "Capped Call Options, Outstanding", "terseLabel": "Capped Call Options, Outstanding" } } }, "localname": "CappedCallOptionsOutstanding", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "integerItemType" }, "ivc_CashDiscountReserves": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 3.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash Discount Reserves", "label": "Cash Discount Reserves", "negatedTerseLabel": "Cash discount reserves" } } }, "localname": "CashDiscountReserves", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ChargesrelatedtorestructuringactivitiesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Charges related to restructuring activities, as a Percent of Net Sales", "label": "Charges related to restructuring activities, as a Percent of Net Sales", "terseLabel": "Charges related to restructuring activities, as a Percent of Net Sales" } } }, "localname": "ChargesrelatedtorestructuringactivitiesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_CommonStockHoldersPercentageofTotalOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, Holders Percentage of Total Outstanding", "label": "Common Stock, Holders Percentage of Total Outstanding", "terseLabel": "Common Stock, Holders Percentage of Total Outstanding" } } }, "localname": "CommonStockHoldersPercentageofTotalOutstanding", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_CommonStockNumberofVotes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, Number of Votes", "label": "Common Stock, Number of Votes", "terseLabel": "Common Stock, Number of Votes" } } }, "localname": "CommonStockNumberofVotes", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "integerItemType" }, "ivc_ConcentrationRiskRecourseforCustomerLeaseObligationUnderDefault": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Concentration Risk, Recourse for Customer Lease Obligation Under Default", "label": "Concentration Risk, Recourse for Customer Lease Obligation Under Default", "terseLabel": "Events of Default Under Contract by Third Party" } } }, "localname": "ConcentrationRiskRecourseforCustomerLeaseObligationUnderDefault", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConcentrationRiskRetainedRecourseObligationForDefaultofCustomerLeaseObligationsUnderContract": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Concentration Risk, Retained Recourse Obligation For Default of Customer Lease Obligations Under Contract", "label": "Concentration Risk, Retained Recourse Obligation For Default of Customer Lease Obligations Under Contract", "terseLabel": "Retained Recourse Obligation For Events Of Default Under Contracts" } } }, "localname": "ConcentrationRiskRetainedRecourseObligationForDefaultofCustomerLeaseObligationsUnderContract", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ContingentLiabilityGuarantee": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contingent Liability, Guarantee", "label": "Contingent Liability, Guarantee", "terseLabel": "Contingent Liability, Guarantee" } } }, "localname": "ContingentLiabilityGuarantee", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ContractTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract Type [Axis]", "label": "Contract Type [Axis]", "terseLabel": "Contract Type [Axis]" } } }, "localname": "ContractTypeAxis", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "stringItemType" }, "ivc_ContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Contract Type [Axis]", "label": "Contract Type [Domain]", "terseLabel": "Contract Type [Domain]" } } }, "localname": "ContractTypeDomain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_ContractTypeSalesSplit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract Type Sales Split", "label": "Contract Type Sales Split", "terseLabel": "Contract Type Sales Split" } } }, "localname": "ContractTypeSalesSplit", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "percentItemType" }, "ivc_ConvertibleDebtConversionFeatureFairValueatIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible Debt Conversion Feature, Fair Value at Issuance", "label": "Convertible Debt Conversion Feature, Fair Value at Issuance", "terseLabel": "Convertible Debt Conversion Feature, Fair Value at Issuance" } } }, "localname": "ConvertibleDebtConversionFeatureFairValueatIssuance", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebtConversionFeatureGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible Debt Conversion Feature Gain (Loss)", "label": "Convertible Debt Conversion Feature Gain (Loss)", "negatedTerseLabel": "Convertible Debt Conversion Feature Gain (Loss)", "terseLabel": "Convertible Debt Conversion Feature Gain (Loss)" } } }, "localname": "ConvertibleDebtConversionFeatureGainLoss", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebtConversionRateofCommmonSharesPrincipal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible Debt, Conversion Rate of Commmon Shares, Principal", "label": "Convertible Debt, Conversion Rate of Commmon Shares, Principal", "terseLabel": "Convertible Debt, Conversion Rate of Commmon Shares, Principal" } } }, "localname": "ConvertibleDebtConversionRateofCommmonSharesPrincipal", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebtDiscountAmortizationAndAccretion": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Convertible Debt Discount Amortization and Accretion", "label": "Convertible Debt Discount Amortization and Accretion", "terseLabel": "Convertible Debt Discount Amortization and Accretion" } } }, "localname": "ConvertibleDebtDiscountAmortizationAndAccretion", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleSeniorNotesAt425March2026Domain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes at 4.25% March 2026", "label": "Convertible Senior Notes at 4.25% March 2026 [Domain]", "terseLabel": "Convertible Senior Notes at 4.25% March 2026 [Domain]" } } }, "localname": "ConvertibleSeniorNotesAt425March2026Domain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesAt425March2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes at 4.25% March 2026", "label": "Convertible Senior Notes at 4.25% March 2026 [Member]", "terseLabel": "Convertible Senior Notes at 4.25% March 2026" } } }, "localname": "ConvertibleSeniorNotesAt425March2026Member", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesAt450February2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes at 4.50% February 2022", "label": "Convertible Senior Notes at 4.50% February 2022 [Member]", "terseLabel": "Convertible Senior Notes at 4.50% February 2022" } } }, "localname": "ConvertibleSeniorNotesAt450February2022Member", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesPercentageofPrincipalRequiredforRepurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes, Percentage of Principal Required for Repurchase", "label": "Convertible Senior Notes, Percentage of Principal Required for Repurchase", "terseLabel": "Convertible Senior Notes, Percentage of Principal Required for Repurchase" } } }, "localname": "ConvertibleSeniorNotesPercentageofPrincipalRequiredforRepurchase", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ConvertibleSeniorNotesat4.50February2022Domain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes at 4.50% February 2022", "label": "Convertible Senior Notes at 4.50% February 2022 [Domain]", "terseLabel": "Convertible Senior Notes at 4.50% February 2022 [Domain]" } } }, "localname": "ConvertibleSeniorNotesat4.50February2022Domain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesat5.00February2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes at 5.00% February 2021 [Member]", "label": "Convertible Senior Notes at 5.00% February 2021 [Member]", "terseLabel": "Convertible Senior Notes at 5.00% February 2021" } } }, "localname": "ConvertibleSeniorNotesat5.00February2021Member", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesat5.00November2024Domain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes at 5.00% November 2024 [Domain]", "label": "Convertible Senior Notes at 5.00% November 2024 [Domain]", "terseLabel": "Convertible Senior Notes at 5.00% November 2024 [Domain]" } } }, "localname": "ConvertibleSeniorNotesat5.00November2024Domain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesat5.00November2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Subordinated Debentures at 4.125% February 2027 [Member]", "label": "Convertible Senior Notes at 5.00% November 2024 [Member]", "terseLabel": "Convertible Senior Notes at 5.00% November 2024" } } }, "localname": "ConvertibleSeniorNotesat5.00November2024Member", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorSubordinatedDebenturesat5.00February2021Domain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Subordinated Debentures at 5.00% February 2021", "label": "Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain]", "terseLabel": "Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain]" } } }, "localname": "ConvertibleSeniorSubordinatedDebenturesat5.00February2021Domain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_Convertibledue2021BondHedgeFairValueatIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible due 2021 - Bond Hedge, Fair Value at Issuance", "label": "Convertible due 2021 - Bond Hedge, Fair Value at Issuance", "terseLabel": "Convertible due 2021 - Bond Hedge, Fair Value at Issuance" } } }, "localname": "Convertibledue2021BondHedgeFairValueatIssuance", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_Convertibledue2022BondHedgeFairValueatIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible due 2022 - Bond Hedge, Fair Value at Issuance", "label": "Convertible due 2022 - Bond Hedge, Fair Value at Issuance", "terseLabel": "Convertible due 2022 - Bond Hedge, Fair Value at Issuance" } } }, "localname": "Convertibledue2022BondHedgeFairValueatIssuance", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_CostofProductsSoldasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cost of Products Sold, as a Percent of Net Sales", "label": "Cost of Products Sold, as a Percent of Net Sales", "terseLabel": "Cost of Products Sold, as a Percent of Net Sales" } } }, "localname": "CostofProductsSoldasaPercentofNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_CustomerRebateReserve": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Customer Rebate Reserve", "label": "Customer Rebate Reserve", "negatedTerseLabel": "Customer rebate reserve" } } }, "localname": "CustomerRebateReserve", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtDiscountAmortizationPerBasicAndDilutedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Discount Amortization, per Basic and Diluted Share", "label": "Debt Discount Amortization, per Basic and Diluted Share", "terseLabel": "Debt Discount Amortization, per Basic and Diluted Share" } } }, "localname": "DebtDiscountAmortizationPerBasicAndDilutedShare", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesDetails" ], "xbrltype": "perShareItemType" }, "ivc_DebtInstrumentExchangeAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument Exchange Amount", "label": "Debt Instrument Exchange Amount", "terseLabel": "Debt Instrument Exchange Amount" } } }, "localname": "DebtInstrumentExchangeAmount", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentFeeAmountNetBalanceShownasaLiability": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails": { "order": 1.0, "parentTag": "ivc_DebtInstrumentNetCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Fee Amount, Net Balance Shown as a Liability", "label": "Debt Instrument, Fee Amount, Net Balance Shown as a Liability", "terseLabel": "Debt Instrument, Fee Amount", "verboseLabel": "Debt fees" } } }, "localname": "DebtInstrumentFeeAmountNetBalanceShownasaLiability", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentHedgeOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Hedge Options", "label": "Debt Instrument, Hedge Options", "terseLabel": "Debt Instrument, Hedge Options" } } }, "localname": "DebtInstrumentHedgeOptions", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "integerItemType" }, "ivc_DebtInstrumentHedgeOptionsAvailableForExercise": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Hedge Options available for exercise", "label": "Debt Instrument, Hedge Options available for exercise", "terseLabel": "Debt Instrument, Hedge Options available for exercise" } } }, "localname": "DebtInstrumentHedgeOptionsAvailableForExercise", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "integerItemType" }, "ivc_DebtInstrumentInterestRateOnLiabilityComponentEffectivePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Interest Rate on Liability Component, Effective Percentage", "label": "Debt Instrument, Interest Rate on Liability Component, Effective Percentage", "terseLabel": "Debt Instrument, Interest Rate on Liability Component, Effective Percentage" } } }, "localname": "DebtInstrumentInterestRateOnLiabilityComponentEffectivePercentage", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "percentItemType" }, "ivc_DebtInstrumentLossonExchange": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Loss on Exchange", "label": "Debt Instrument, Loss on Exchange", "terseLabel": "Debt Instrument, Loss on Exchange" } } }, "localname": "DebtInstrumentLossonExchange", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentNetCarryingAmount": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Net Carrying Amount", "label": "Debt Instrument, Net Carrying Amount", "terseLabel": "Debt Instrument, Net Carrying Amount", "totalLabel": "Debt Instrument, Net Carrying Amount" } } }, "localname": "DebtInstrumentNetCarryingAmount", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentNetProceeds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Net Proceeds", "label": "Debt Instrument, Net Proceeds", "terseLabel": "Debt Instrument, Net Proceeds" } } }, "localname": "DebtInstrumentNetProceeds", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentNonCashInterestExpenseRecognizedinthePeriod": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Non-Cash Interest Expense Recognized in the Period", "label": "Debt Instrument, Non-Cash Interest Expense Recognized in the Period", "terseLabel": "Debt Instrument, Non-Cash Interest Expense Recognized in the Period" } } }, "localname": "DebtInstrumentNonCashInterestExpenseRecognizedinthePeriod", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentRepurchaseAmountCashPaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument Repurchase Amount, Cash Paid", "label": "Debt Instrument Repurchase Amount, Cash Paid", "terseLabel": "Debt Instrument Repurchase Amount, Cash Paid" } } }, "localname": "DebtInstrumentRepurchaseAmountCashPaid", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentWarrantsIssuedandOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Warrants Issued and Outstanding", "label": "Debt Instrument, Warrants Issued and Outstanding", "terseLabel": "Debt Instrument, Warrants Issued and Outstanding" } } }, "localname": "DebtInstrumentWarrantsIssuedandOutstanding", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "integerItemType" }, "ivc_DebtInstrurmentRepurchaseAmountNetReductionofdebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrurment Repurchase Amount, Net Reduction of debt", "label": "Debt Instrurment Repurchase Amount, Net Reduction of debt", "terseLabel": "Debt Instrurment Repurchase Amount, Net Reduction of debt" } } }, "localname": "DebtInstrurmentRepurchaseAmountNetReductionofdebt", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DeferredGainOnSaleLeasebackNet": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 8.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred gain on sale leaseback, Net", "label": "Deferred gain on sale leaseback, Net", "terseLabel": "Deferred gain on sale leaseback, Net" } } }, "localname": "DeferredGainOnSaleLeasebackNet", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DeferredTaxReversalRelatedToGoodwillImpairment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Reversal, related to Goodwill Impairment", "label": "Deferred Tax Reversal, related to Goodwill Impairment", "terseLabel": "Deferred Tax Reversal, related to Goodwill Impairment" } } }, "localname": "DeferredTaxReversalRelatedToGoodwillImpairment", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DerivativeInstrumentsandHedgingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative Instruments and Hedging Activities [Abstract]", "label": "Derivative Instruments and Hedging Activities [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities [Abstract]" } } }, "localname": "DerivativeInstrumentsandHedgingActivitiesAbstract", "nsuri": "http://www.invacare.com/20210930", "xbrltype": "stringItemType" }, "ivc_DerivativePercentageOfForcastedTransactionsWithCurrencyRateExposure": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative, Percentage of Forcasted Transactions With Currency Rate Exposure", "label": "Derivative, Percentage of Forcasted Transactions With Currency Rate Exposure", "terseLabel": "Derivative, percentage of forcasted transactions with currency rate exposure" } } }, "localname": "DerivativePercentageOfForcastedTransactionsWithCurrencyRateExposure", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationDivestitureAccrualBalance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance", "label": "Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance", "terseLabel": "Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationDivestitureAccrualBalance", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationEarningsBeforeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Earnings Before Taxes", "label": "Disposal Group, Including Discontinued Operation, Earnings Before Taxes", "terseLabel": "Disposal Group, Including Discontinued Operation, Earnings Before Taxes" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationEarningsBeforeTaxes", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationInterCompanyRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Inter-Company Revenue", "label": "Disposal Group, Including Discontinued Operation, Inter-Company Revenue", "terseLabel": "Disposal Group, Including Discontinued Operation, Inter-Company Revenue" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationInterCompanyRevenue", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current", "label": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current", "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent", "label": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent", "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNonCurrent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightofUseAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset", "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightofUseAsset", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DivestedBusinessesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Divested Businesses [Abstract]", "label": "Divested Businesses [Abstract]", "terseLabel": "Divested Businesses [Abstract]" } } }, "localname": "DivestedBusinessesAbstract", "nsuri": "http://www.invacare.com/20210930", "xbrltype": "stringItemType" }, "ivc_EuropeEMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Europe (EMEA)", "label": "Europe (EMEA) [Member]", "terseLabel": "Europe (EMEA)" } } }, "localname": "EuropeEMEAMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_ExchangeOfConvertibleNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Exchange of Convertible Notes", "label": "Exchange of Convertible Notes", "terseLabel": "Exchange of Convertible Notes" } } }, "localname": "ExchangeOfConvertibleNotes", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeaseCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Lease, Cost", "label": "Financing Lease, Cost", "terseLabel": "Financing Lease, Cost" } } }, "localname": "FinancingLeaseCost", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeaseLiabilitynoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Financing Lease Liability, non-current", "label": "Financing Lease Liability, non-current", "terseLabel": "Financing Lease Liability, non-current" } } }, "localname": "FinancingLeaseLiabilitynoncurrent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities", "label": "Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities", "terseLabel": "Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities" } } }, "localname": "FinancingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeasesFutureMinimumPaymentsInterestIncludedinPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Leases, Future Minimum Payments, Interest Included in Payments", "label": "Financing Leases, Future Minimum Payments, Interest Included in Payments", "negatedTerseLabel": "Financing Leases, Future Minimum Payments, Interest Included in Payments" } } }, "localname": "FinancingLeasesFutureMinimumPaymentsInterestIncludedinPayments", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeasesFutureMinimumPaymentsPresentValueofNetMinimumPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "label": "Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "terseLabel": "Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments" } } }, "localname": "FinancingLeasesFutureMinimumPaymentsPresentValueofNetMinimumPayments", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableCreditLimit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable Credit Limit", "label": "Financing Receivable Credit Limit", "terseLabel": "Credit amount requiring additional analysis" } } }, "localname": "FinancingReceivableCreditLimit", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableGross": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, Gross", "label": "Financing Receivable, Gross", "totalLabel": "Financing Receivable, Gross" } } }, "localname": "FinancingReceivableGross", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableInterestIncomeAccrualMethod": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, Interest Income, Accrual Method", "label": "Financing Receivable, Interest Income, Accrual Method", "totalLabel": "Total installment receivables" } } }, "localname": "FinancingReceivableInterestIncomeAccrualMethod", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableRecordedInvestment": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, Recorded Investment", "label": "Financing Receivable, Recorded Investment", "totalLabel": "Total installment receivables" } } }, "localname": "FinancingReceivableRecordedInvestment", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableUnpaidPrincipalBalance": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, Unpaid Principal Balance", "label": "Financing Receivable, Unpaid Principal Balance", "totalLabel": "Total installment receivables" } } }, "localname": "FinancingReceivableUnpaidPrincipalBalance", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivablesNotAccruingInterestPast90DaysDue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing Receivables Not Accruing Interest Past 90 Days Due", "label": "Financing Receivables Not Accruing Interest Past 90 Days Due", "terseLabel": "Financing Receivables Not Past 90 Days Due" } } }, "localname": "FinancingReceivablesNotAccruingInterestPast90DaysDue", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_FinancingReceivablesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing Receivables [Table Text Block]", "label": "Financing Receivables [Table Text Block]", "terseLabel": "Schedule of Financing Receivables" } } }, "localname": "FinancingReceivablesTableTextBlock", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "ivc_FinancingReceivablewithNoRelatedAllowanceInterestIncomeAccrualMethod": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 1.0, "parentTag": "ivc_FinancingReceivableInterestIncomeAccrualMethod", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, with No Related Allowance, Interest Income, Accrual Method", "label": "Financing Receivable, with No Related Allowance, Interest Income, Accrual Method", "terseLabel": "Non-Impaired installment receivables with no related allowance recorded" } } }, "localname": "FinancingReceivablewithNoRelatedAllowanceInterestIncomeAccrualMethod", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivablewithNoRelatedAllowanceRecordedInvestment": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 1.0, "parentTag": "ivc_FinancingReceivableRecordedInvestment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, with No Related Allowance, Recorded Investment", "label": "Financing Receivable, with No Related Allowance, Recorded Investment", "terseLabel": "Non-Impaired installment receivables with no related allowance recorded" } } }, "localname": "FinancingReceivablewithNoRelatedAllowanceRecordedInvestment", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivablewithNoRelatedAllowanceUnpaidPrincipalBalance": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 1.0, "parentTag": "ivc_FinancingReceivableUnpaidPrincipalBalance", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, with No Related Allowance, Unpaid Principal Balance", "label": "Financing Receivable, with No Related Allowance, Unpaid Principal Balance", "terseLabel": "Non-Impaired installment receivables with no related allowance recorded" } } }, "localname": "FinancingReceivablewithNoRelatedAllowanceUnpaidPrincipalBalance", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FiniteLivedandIndefiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Line Items] for Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table]", "label": "Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedandIndefiniteLivedIntangibleAssetsLineItems", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "stringItemType" }, "ivc_ForeignExchangeForwardAUDNZDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward AUD / NZD [Member]", "label": "Foreign Exchange Forward AUD / NZD [Member]", "terseLabel": "AUD / NZD" } } }, "localname": "ForeignExchangeForwardAUDNZDMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardAUDTHBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward AUD / THB", "label": "Foreign Exchange Forward AUD / THB [Member]", "terseLabel": "AUD / THB" } } }, "localname": "ForeignExchangeForwardAUDTHBMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardAUDUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward AUD / USD [Member]", "label": "Foreign Exchange Forward AUD / USD [Member]", "terseLabel": "USD / AUD" } } }, "localname": "ForeignExchangeForwardAUDUSDMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardCADUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward CAD / USD [Member]", "label": "Foreign Exchange Forward CAD / USD [Member]", "terseLabel": "USD / CAD" } } }, "localname": "ForeignExchangeForwardCADUSDMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardContractsByExchangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward Contracts, by Exchange [Axis]", "label": "Foreign Exchange Forward Contracts, by Exchange [Axis]", "terseLabel": "Foreign Exchange Forward Contracts, by Exchange [Axis]" } } }, "localname": "ForeignExchangeForwardContractsByExchangeAxis", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "stringItemType" }, "ivc_ForeignExchangeForwardContractsByExchangeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward Contracts, by Exchange [Domain]", "label": "Foreign Exchange Forward Contracts, by Exchange [Domain]", "terseLabel": "Foreign Exchange Forward Contracts, by Exchange [Domain]" } } }, "localname": "ForeignExchangeForwardContractsByExchangeDomain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardDKKSEKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward DKK / SEK [Member]", "label": "Foreign Exchange Forward DKK / SEK [Member]", "terseLabel": "DKK / SEK" } } }, "localname": "ForeignExchangeForwardDKKSEKMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardDKKUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward DKK / USD [Member]", "label": "Foreign Exchange Forward DKK / USD [Member]", "terseLabel": "USD / DKK" } } }, "localname": "ForeignExchangeForwardDKKUSDMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURCHFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward EUR / CHF [Member]", "label": "Foreign Exchange Forward EUR / CHF [Member]", "terseLabel": "EUR / CHF" } } }, "localname": "ForeignExchangeForwardEURCHFMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURGBPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward EUR / GBP [Member]", "label": "Foreign Exchange Forward EUR / GBP [Member]", "terseLabel": "EUR / GBP" } } }, "localname": "ForeignExchangeForwardEURGBPMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURNOKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward EUR / NOK [Member]", "label": "Foreign Exchange Forward EUR / NOK [Member]", "terseLabel": "EUR / NOK" } } }, "localname": "ForeignExchangeForwardEURNOKMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURSEKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward EUR / SEK [Member]", "label": "Foreign Exchange Forward EUR / SEK [Member]", "terseLabel": "EUR / SEK" } } }, "localname": "ForeignExchangeForwardEURSEKMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURTHBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward EUR / THB", "label": "Foreign Exchange Forward EUR / THB [Member]", "terseLabel": "EUR / THB" } } }, "localname": "ForeignExchangeForwardEURTHBMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward EUR / USD [Member]", "label": "Foreign Exchange Forward EUR / USD [Member]", "terseLabel": "EUR / USD" } } }, "localname": "ForeignExchangeForwardEURUSDMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardGBPTHBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward GBP / THB", "label": "Foreign Exchange Forward GBP / THB [Member]", "terseLabel": "GBP / THB" } } }, "localname": "ForeignExchangeForwardGBPTHBMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardGBPUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward GBP / USD [Member]", "label": "Foreign Exchange Forward GBP / USD [Member]", "terseLabel": "USD / GBP" } } }, "localname": "ForeignExchangeForwardGBPUSDMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardNOKSEKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward NOK / SEK [Member]", "label": "Foreign Exchange Forward NOK / SEK [Member]", "terseLabel": "NOK / SEK" } } }, "localname": "ForeignExchangeForwardNOKSEKMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardNOKUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward NOK / USD [Member]", "label": "Foreign Exchange Forward NOK / USD [Member]", "terseLabel": "USD / NOK" } } }, "localname": "ForeignExchangeForwardNOKUSDMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardNZDTHBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward NZD / THB", "label": "Foreign Exchange Forward NZD / THB [Member]", "terseLabel": "NZD / THB" } } }, "localname": "ForeignExchangeForwardNZDTHBMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardSEKUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward SEK/USD", "label": "Foreign Exchange Forward SEK/USD [Member]", "terseLabel": "USD / SEK" } } }, "localname": "ForeignExchangeForwardSEKUSDMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDCHFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / CHF", "label": "Foreign Exchange Forward USD / CHF [Member]", "terseLabel": "USD / CHF" } } }, "localname": "ForeignExchangeForwardUSDCHFMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDEURMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / EUR [Member]", "label": "Foreign Exchange Forward USD / EUR [Member]", "terseLabel": "USD / EUR" } } }, "localname": "ForeignExchangeForwardUSDEURMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDGBPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / GBP [Member]", "label": "Foreign Exchange Forward USD / GBP [Member]", "terseLabel": "USD / GBP" } } }, "localname": "ForeignExchangeForwardUSDGBPMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDMXPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / MXP [Member]", "label": "Foreign Exchange Forward USD / MXP [Member]", "terseLabel": "USD / MXN" } } }, "localname": "ForeignExchangeForwardUSDMXPMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDSEKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / SEK [Member]", "label": "Foreign Exchange Forward USD / SEK [Member]", "terseLabel": "USD / SEK" } } }, "localname": "ForeignExchangeForwardUSDSEKMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDTHBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / THB", "label": "Foreign Exchange Forward USD / THB [Member]", "terseLabel": "USD / THB" } } }, "localname": "ForeignExchangeForwardUSDTHBMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_GainlossBeforeIncomeTaxesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gain (loss) Before Income Taxes, as a Percent of Net Sales", "label": "Gain (loss) Before Income Taxes, as a Percent of Net Sales", "terseLabel": "Gain (loss) Before Income Taxes, as a Percent of Net Sales" } } }, "localname": "GainlossBeforeIncomeTaxesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_GainonsaleofbusinessasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gain on sale of business, as a Percent of Net Sales", "label": "Gain on sale of business, as a Percent of Net Sales", "terseLabel": "Gain on sale of business, as a Percent of Net Sales" } } }, "localname": "GainonsaleofbusinessasaPercentofNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_GeneralLeaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General Lease Term", "label": "General Lease Term", "terseLabel": "General Lease Term" } } }, "localname": "GeneralLeaseTerm", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "durationItemType" }, "ivc_GeneralTermsandConditionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General Terms and Conditions [Member]", "label": "General Terms and Conditions [Member]", "terseLabel": "General Terms and Conditions" } } }, "localname": "GeneralTermsandConditionsMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_GovernmentTendersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government Tenders [Member]", "label": "Government Tenders [Member]", "terseLabel": "Government Tenders" } } }, "localname": "GovernmentTendersMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_GrossProfitasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross Profit, as a Percent of Net Sales", "label": "Gross Profit, as a Percent of Net Sales", "terseLabel": "Gross Profit, as a Percent of Net Sales" } } }, "localname": "GrossProfitasaPercentofNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_ITServiceContract": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "IT Service Contract", "label": "IT Service Contract", "terseLabel": "IT service contracts" } } }, "localname": "ITServiceContract", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_IVCCanadaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IVC Canada", "label": "IVC Canada [Member]", "terseLabel": "IVC Canada" } } }, "localname": "IVCCanadaMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "domainItemType" }, "ivc_ImpairedFinancingReceivableRelatedAllowanceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Impaired Financing Receivable, Related Allowance [Abstract]", "label": "Impaired Financing Receivable, Related Allowance [Abstract]", "terseLabel": "Related Allowance for Doubtful Accounts" } } }, "localname": "ImpairedFinancingReceivableRelatedAllowanceAbstract", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "ivc_ImpairmentOfGoodwillAsAPercentOfNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Impairment of goodwill, as a Percent of net Sales", "label": "Impairment of goodwill, as a Percent of net Sales", "terseLabel": "Impairment of goodwill, as a Percent of net Sales" } } }, "localname": "ImpairmentOfGoodwillAsAPercentOfNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_IncomeTaxProvisionasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Tax Provision, as a Percent of Net Sales", "label": "Income Tax Provision, as a Percent of Net Sales", "terseLabel": "Income Tax Provision, as a Percent of Net Sales" } } }, "localname": "IncomeTaxProvisionasaPercentofNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_InstallmentReceivable0To30DaysPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 2.0, "parentTag": "ivc_FinancingReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Installment Receivable, 0 to 30 Days Past Due", "label": "Installment Receivable, 0 to 30 Days Past Due", "terseLabel": "0-30 days past due" } } }, "localname": "InstallmentReceivable0To30DaysPastDue", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InstallmentReceivable31To60DaysPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 3.0, "parentTag": "ivc_FinancingReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Installment Receivable, 31 to 60 Days Past Due", "label": "Installment Receivable, 31 to 60 Days Past Due", "terseLabel": "31-60 days past due" } } }, "localname": "InstallmentReceivable31To60DaysPastDue", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InstallmentReceivableGreaterThan90DaysPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 5.0, "parentTag": "ivc_FinancingReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Installment Receivable, Greater than 90 Days Past Due", "label": "Installment Receivable, Greater than 90 Days Past Due", "terseLabel": "90+ days past due" } } }, "localname": "InstallmentReceivableGreaterThan90DaysPastDue", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InstallmentReceivableNotPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 1.0, "parentTag": "ivc_FinancingReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Installment Receivable, Not Past Due", "label": "Installment Receivable, Not Past Due", "terseLabel": "Installment Receivable, Not Past Due" } } }, "localname": "InstallmentReceivableNotPastDue", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InstallmentSales61To90DaysPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 4.0, "parentTag": "ivc_FinancingReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Installment Sales, 61 to 90 Days Past Due", "label": "Installment Sales, 61 to 90 Days Past Due", "terseLabel": "61-90 days past due" } } }, "localname": "InstallmentSales61To90DaysPastDue", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InterestExpenseSaleOfReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest Expense, Sale of Receivables", "label": "Interest Expense, Sale of Receivables", "terseLabel": "Interest Expense, Sale of Receivables" } } }, "localname": "InterestExpenseSaleOfReceivables", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InterestexpenseasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest expense, as a Percent of Net Sales", "label": "Interest expense, as a Percent of Net Sales", "terseLabel": "Interest expense, as a Percent of Net Sales" } } }, "localname": "InterestexpenseasaPercentofNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_InterestincomeasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest income, as a Percent of Net Sales", "label": "Interest income, as a Percent of Net Sales", "terseLabel": "Interest income, as a Percent of Net Sales" } } }, "localname": "InterestincomeasaPercentofNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_LargeNationalCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Large National Customers [Member]", "label": "Large National Customers [Member]", "terseLabel": "Large National Customers" } } }, "localname": "LargeNationalCustomersMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_LastReportedSalesPricePeriodCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Last Reported Sales Price Period, Common Stock", "label": "Last Reported Sales Price Period, Common Stock", "terseLabel": "Last Reported Sales Price Period, Common Stock" } } }, "localname": "LastReportedSalesPricePeriodCommonStock", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_LiabilityComponentsOfConvertible2026NoteTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability Components of Convertible 2026 Note", "label": "Liability Components of Convertible 2026 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible 2026 Note" } } }, "localname": "LiabilityComponentsOfConvertible2026NoteTableTextBlock", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsOfConvertibleSeriesII2024NoteTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability Components of Convertible Series II 2024 Note", "label": "Liability Components of Convertible Series II 2024 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible Series II 2024 Note" } } }, "localname": "LiabilityComponentsOfConvertibleSeriesII2024NoteTableTextBlock", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsofConvertible2021NoteTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Table Text Block] for Liability Components of Convertible 2021 Note", "label": "Liability Components of Convertible 2021 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible 2021 Note" } } }, "localname": "LiabilityComponentsofConvertible2021NoteTableTextBlock", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsofConvertible2022NoteTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability Components of Convertible 2022 Note [Table Text Block] [Table Text Block]", "label": "Liability Components of Convertible 2022 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible 2022 Note" } } }, "localname": "LiabilityComponentsofConvertible2022NoteTableTextBlock", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsofConvertible2024NoteTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability Components of Convertible 2024 Note", "label": "Liability Components of Convertible 2024 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible 2024 Note" } } }, "localname": "LiabilityComponentsofConvertible2024NoteTableTextBlock", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LifeInsuranceLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 9.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Life Insurance Liability, Noncurrent", "label": "Life Insurance Liability, Noncurrent", "terseLabel": "Death benefit obligation plan" } } }, "localname": "LifeInsuranceLiabilityNoncurrent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LifestyleProductsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lifestyle Products", "label": "Lifestyle Products [Domain]", "terseLabel": "Lifestyle Products [Domain]" } } }, "localname": "LifestyleProductsDomain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "ivc_LifetimeToDateAccretionExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lifetime to date - Accretion Expense", "label": "Lifetime to date - Accretion Expense", "terseLabel": "Lifetime to date - Accretion Expense" } } }, "localname": "LifetimeToDateAccretionExpense", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityCovenantFeatureDominionTriggerForFiveConsecutiveDays": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days", "label": "Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days", "terseLabel": "Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days" } } }, "localname": "LineOfCreditFacilityCovenantFeatureDominionTriggerForFiveConsecutiveDays", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityCovenantFeatureIncreaseLimitBasedOnReceivables": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables", "label": "Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables", "terseLabel": "Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables" } } }, "localname": "LineOfCreditFacilityCovenantFeatureIncreaseLimitBasedOnReceivables", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityCovenantFeaturePriorLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Covenant Feature, Prior Limit", "label": "Line of Credit Facility, Covenant Feature, Prior Limit", "terseLabel": "Line of Credit Facility, Covenant Feature, Prior Limit" } } }, "localname": "LineOfCreditFacilityCovenantFeaturePriorLimit", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityForeignCurrencyFairValueOfAmountOutstandingFrance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)", "label": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)", "terseLabel": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)" } } }, "localname": "LineOfCreditFacilityForeignCurrencyFairValueOfAmountOutstandingFrance", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityForeignCurrencyFairValueOfAmountOutstandingUK": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)", "label": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)", "terseLabel": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)" } } }, "localname": "LineOfCreditFacilityForeignCurrencyFairValueOfAmountOutstandingUK", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityGrossBorrowingBase": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility Gross Borrowing Base", "label": "Line Of Credit Facility Gross Borrowing Base", "terseLabel": "Line Of Credit Facility Gross Borrowing Base" } } }, "localname": "LineOfCreditFacilityGrossBorrowingBase", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceConsecutiveBusinessDaysforUndrawnBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn Balance", "label": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn Balance", "terseLabel": "Consecutive business days for minimum undrawn balance" } } }, "localname": "LineofCreditCovenantComplianceConsecutiveBusinessDaysforUndrawnBalance", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_LineofCreditCovenantComplianceConsecutiveBusinessDaysforUndrawn_Balance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance", "label": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance", "terseLabel": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance" } } }, "localname": "LineofCreditCovenantComplianceConsecutiveBusinessDaysforUndrawn_Balance", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_LineofCreditCovenantComplianceInterruptionofManufacturingFacilitiesPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Interruption of Manufacturing Facilities Period", "label": "Line of Credit, Covenant Compliance, Interruption of Manufacturing Facilities Period", "terseLabel": "Interruption of material manufacturing facilities, period" } } }, "localname": "LineofCreditCovenantComplianceInterruptionofManufacturingFacilitiesPeriod", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityAdditionalLongLivedAssetAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Additional Long-Lived Asset Amount", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Additional Long-Lived Asset Amount", "terseLabel": "Additional amount of machinery and equipment" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityAdditionalLongLivedAssetAmount", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityAvailabilityReserveMinimum": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Availability Reserve, Minimum", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Availability Reserve, Minimum", "terseLabel": "Minimum availability reserve" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityAvailabilityReserveMinimum", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesDomesticPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Domestic, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Domestic, Percent", "terseLabel": "Percentage of eligible domestic inventory and in-transit inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesDomesticPercent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesForeignLiquidationValuePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Liquidation Value, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Liquidation Value, Percent", "terseLabel": "Percentage of net orderly liquidation value of eligible Canadian inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesForeignLiquidationValuePercent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesForeignPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Percent", "terseLabel": "Percentage of eligible Canadian inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesForeignPercent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesLiquidationValueAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Amount", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Amount", "terseLabel": "Maximum value of net orderly liquidation value domestic inventory and in-transit inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesLiquidationValueAmount", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesLiquidationValuePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Percent", "terseLabel": "Percentage of net orderly liquidation value of domestic inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesLiquidationValuePercent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityPropertyPlantandEquipmentLiquidationValuePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Property, Plant and Equipment, Liquidation Value, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Property, Plant and Equipment, Liquidation Value, Percent", "terseLabel": "Net orderly liquidation value of domestic eligible machinery and equipment" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityPropertyPlantandEquipmentLiquidationValuePercent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesDomesticPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Domestic, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Domestic, Percent", "terseLabel": "Percentage of domestic accounts receivable" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesDomesticPercent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesEuropePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent", "terseLabel": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesEuropePercent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesForeignPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Foreign, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Foreign, Percent", "terseLabel": "Percentage of eligible Canadian accounts receivable" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesForeignPercent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceRequiredUndrawnBalanceMinimumPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Required Undrawn Balance, Minimum, Percent", "label": "Line of Credit, Covenant Compliance, Required Undrawn Balance, Minimum, Percent", "terseLabel": "Minimum required undrawn balance (as a percent)" } } }, "localname": "LineofCreditCovenantComplianceRequiredUndrawnBalanceMinimumPercent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditFacilityAdditionalBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Additional Borrowing Capacity", "label": "Line of Credit Facility, Additional Borrowing Capacity", "terseLabel": "Additional increase in borrowing capacity available" } } }, "localname": "LineofCreditFacilityAdditionalBorrowingCapacity", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditFacilityCovenantFeatureDominionTrigger": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Covenant Feature, Dominion Trigger", "label": "Line of Credit Facility, Covenant Feature, Dominion Trigger", "terseLabel": "Line of Credit Facility, Covenant Feature, Dominion Trigger" } } }, "localname": "LineofCreditFacilityCovenantFeatureDominionTrigger", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditFacilityCovenantFeatureIncreaseLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Covenant Feature, Increase Limit", "label": "Line of Credit Facility, Covenant Feature, Increase Limit", "terseLabel": "Remaining borrowing capacity" } } }, "localname": "LineofCreditFacilityCovenantFeatureIncreaseLimit", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_MobilityandSeatingDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mobility and Seating", "label": "Mobility and Seating [Domain]", "terseLabel": "Mobility and Seating [Domain]" } } }, "localname": "MobilityandSeatingDomain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "ivc_NetGainLossasapercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Gain (Loss), as a percent of Net Sales", "label": "Net Gain (Loss), as a percent of Net Sales", "terseLabel": "Net Gain (Loss), as a percent of Net Sales" } } }, "localname": "NetGainLossasapercentofNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_NetLossGainOnDebtExtinguishmentAsAPercentOfNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net loss (gain) on debt extinguishment, as a Percent of Net Sales", "label": "Net loss (gain) on debt extinguishment, as a Percent of Net Sales", "terseLabel": "Net loss (gain) on debt extinguishment, as a Percent of Net Sales [Line Items]" } } }, "localname": "NetLossGainOnDebtExtinguishmentAsAPercentOfNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_NetRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Revenue", "label": "Net Revenue", "terseLabel": "Net Revenue" } } }, "localname": "NetRevenue", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "percentItemType" }, "ivc_NetSalesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Sales, as a Percent of Net Sales", "label": "Net Sales, as a Percent of Net Sales", "terseLabel": "Net Sales, as a Percent of Net Sales" } } }, "localname": "NetSalesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_NewAccountingPronouncementsNotYetAdoptedPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Accounting Pronouncements, Not yet Adopted", "label": "New Accounting Pronouncements, Not yet Adopted [Policy Text Block]", "terseLabel": "New Accounting Pronouncements, Not yet Adopted" } } }, "localname": "NewAccountingPronouncementsNotYetAdoptedPolicyTextBlock", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ivc_NonImpairedFinancingReceivableRelatedAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non-Impaired Financing Receivable, Related Allowance", "label": "Non-Impaired Financing Receivable, Related Allowance", "terseLabel": "Non-Impaired Financing Receivable, Related Allowance" } } }, "localname": "NonImpairedFinancingReceivableRelatedAllowance", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_NorthAmericaNAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "North America (NA)", "label": "North America (NA) [Member]", "terseLabel": "North America (NA)" } } }, "localname": "NorthAmericaNAMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_NotesLoansAndFinancingReceivablesNumberOfMissedPaymentsBeforeDelinquent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes, Loans, and Financing Receivables, Number of Missed Payments before Delinquent", "label": "Notes, Loans, and Financing Receivables, Number of Missed Payments before Delinquent", "terseLabel": "Number of missed payments before delinquent" } } }, "localname": "NotesLoansAndFinancingReceivablesNumberOfMissedPaymentsBeforeDelinquent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "integerItemType" }, "ivc_NotesLoansFinancingReceivableAveragePeriodOfAdjudication": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes, Loans, Financing Receivable, Average Period of Adjudication", "label": "Notes, Loans, Financing Receivable, Average Period of Adjudication", "terseLabel": "Average period of adjudication" } } }, "localname": "NotesLoansFinancingReceivableAveragePeriodOfAdjudication", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_NotionalAmountDerivative": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Notional Amount, Derivative", "label": "Notional Amount, Derivative", "terseLabel": "Notional Amount" } } }, "localname": "NotionalAmountDerivative", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_NotionalAmountOfDerivativesMaturedDuringPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Notional Amount of Derivatives, Matured During Period", "label": "Notional Amount of Derivatives, Matured During Period", "terseLabel": "Notional amount of derivatives, matured during period" } } }, "localname": "NotionalAmountOfDerivativesMaturedDuringPeriod", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_OperatingGainLossasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating Gain (Loss), as a Percent of Net Sales", "label": "Operating Gain (Loss), as a Percent of Net Sales", "terseLabel": "Operating Gain (Loss), as a Percent of Net Sales" } } }, "localname": "OperatingGainLossasaPercentofNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_OperatingLeaseRightofUseAmortization": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Right-of-Use, Amortization", "label": "Operating Lease, Right-of-Use, Amortization", "terseLabel": "Amortization of operating lease right of use assets" } } }, "localname": "OperatingLeaseRightofUseAmortization", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ivc_OperatingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities", "label": "Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities", "terseLabel": "Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities" } } }, "localname": "OperatingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ivc_OperatingLeasesFutureMinimumPaymentsInterestIncludedinPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Leases, Future Minimum Payments, Interest Included in Payments", "label": "Operating Leases, Future Minimum Payments, Interest Included in Payments", "negatedTerseLabel": "Operating Leases, Future Minimum Payments, Interest Included in Payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsInterestIncludedinPayments", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_OperatingLeasesFutureMinimumPaymentsPresentValueofNetMinimumPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "label": "Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "terseLabel": "Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsPresentValueofNetMinimumPayments", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_OtherComprehensiveIncomeLossDeferredTaxValuationReserve": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Deferred Tax Valuation Reserve", "label": "Other Comprehensive Income (Loss), Deferred Tax Valuation Reserve", "terseLabel": "Valuation reserve associated with defined benefit plan activity" } } }, "localname": "OtherComprehensiveIncomeLossDeferredTaxValuationReserve", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ivc_OtherCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Customers [Member]", "label": "Other Customers [Member]", "terseLabel": "Other Customers" } } }, "localname": "OtherCustomersMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_OtherDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other", "label": "Other [Domain]", "terseLabel": "Other [Domain]" } } }, "localname": "OtherDomain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "ivc_OtherNotesandCapitalLeaseObligationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Notes and Capital Lease Obligations [Member]", "label": "Other Notes and Capital Lease Obligations [Member]", "terseLabel": "Other Notes and Capital Lease Obligations" } } }, "localname": "OtherNotesandCapitalLeaseObligationsMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ivc_PaymentsToDebtHolders": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments to Debt Holders", "label": "Payments to Debt Holders", "negatedTerseLabel": "Payments to debt holders" } } }, "localname": "PaymentsToDebtHolders", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ivc_PercentoftheApplicableConversionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percent of the Applicable Conversion Price", "label": "Percent of the Applicable Conversion Price", "terseLabel": "Percent of the Applicable Conversion Price" } } }, "localname": "PercentoftheApplicableConversionPrice", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_PercentoftheProductoftheLastReportedSalePriceCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percent of the Product of the Last Reported Sale Price, Common Shares", "label": "Percent of the Product of the Last Reported Sale Price, Common Shares", "terseLabel": "Percent of the Product of the Last Reported Sale Price, Common Shares" } } }, "localname": "PercentoftheProductoftheLastReportedSalePriceCommonShares", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_PrepaidDebtFees": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid Debt Fees", "label": "Prepaid Debt Fees", "terseLabel": "Deferred financing fees" } } }, "localname": "PrepaidDebtFees", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_PrepaidInventory": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 7.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid Inventory", "label": "Prepaid Inventory", "terseLabel": "Prepaid inventory and freight" } } }, "localname": "PrepaidInventory", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_PrepaidServiceContracts": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid Service Contracts", "label": "Prepaid Service Contracts", "terseLabel": "Service contracts" } } }, "localname": "PrepaidServiceContracts", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ProductLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 9.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Product Liability, Current", "label": "Product Liability, Current", "terseLabel": "Product liability, current portion" } } }, "localname": "ProductLiabilityCurrent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ProductLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Product Liability, Noncurrent", "label": "Product Liability, Noncurrent", "terseLabel": "Product liability" } } }, "localname": "ProductLiabilityNoncurrent", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_PurchaseOfCappedCalls": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase of Capped Calls", "label": "Purchase of Capped Calls", "negatedTerseLabel": "Purchases of capped calls", "terseLabel": "Purchases of capped calls" } } }, "localname": "PurchaseOfCappedCalls", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RangeOfExercisePriceMaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range of Exercise Price Max", "label": "Range of Exercise Price Max [Member]", "terseLabel": "Range of Exercise Price Max [Member]" } } }, "localname": "RangeOfExercisePriceMaxMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "domainItemType" }, "ivc_RangeOfExercisePriceRangeMinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range of Exercise Price Range Min", "label": "Range of Exercise Price Range Min [Member]", "terseLabel": "$12.15 \u2013 $20.00" } } }, "localname": "RangeOfExercisePriceRangeMinMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "domainItemType" }, "ivc_ReceivableDueFromInformationTechnologyProvider": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Receivable Due From Information Technology Provider", "label": "Receivable Due From Information Technology Provider", "terseLabel": "Receivable due from information technology provider" } } }, "localname": "ReceivableDueFromInformationTechnologyProvider", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ReceivablesExpectedLossPercentageAsiaPac": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivables, Expected Loss Percentage, AsiaPac", "label": "Receivables, Expected Loss Percentage, AsiaPac", "terseLabel": "Receivables, Expected Loss Percentage, AsiaPac" } } }, "localname": "ReceivablesExpectedLossPercentageAsiaPac", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ReceivablesExpectedLossPercentageCanada": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivables, Expected Loss Percentage, Canada", "label": "Receivables, Expected Loss Percentage, Canada", "terseLabel": "Receivables, Expected Loss Percentage, Canada" } } }, "localname": "ReceivablesExpectedLossPercentageCanada", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ReceivablesExpectedLossPercentageEurope": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivables, Expected Loss Percentage, Europe", "label": "Receivables, Expected Loss Percentage, Europe", "terseLabel": "Receivables, Expected Loss Percentage, Europe" } } }, "localname": "ReceivablesExpectedLossPercentageEurope", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ReceivablesExpectedLossPercentageNorthAmericaExcludingCanada": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivables, Expected Loss Percentage, North America excluding Canada", "label": "Receivables, Expected Loss Percentage, North America excluding Canada", "terseLabel": "Receivables, Expected Loss Percentage, North America excluding Canada" } } }, "localname": "ReceivablesExpectedLossPercentageNorthAmericaExcludingCanada", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_RemainingAccretion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining Accretion", "label": "Remaining Accretion", "terseLabel": "Remaining Accretion" } } }, "localname": "RemainingAccretion", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RespiratoryTherapyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Respiratory Therapy", "label": "Respiratory Therapy [Domain]", "terseLabel": "Respiratory Therapy [Domain]" } } }, "localname": "RespiratoryTherapyDomain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "ivc_RestrictedStockandRestrictedStockUnitsRSUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock and Restricted Stock Units (RSUs) [Member]", "label": "Restricted Stock and Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock and Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockandRestrictedStockUnitsRSUsMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "ivc_RestructuringAndRelatedActivitiesExpectedPayoutPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restructuring and Related Activities, Expected Payout Period", "label": "Restructuring and Related Activities, Expected Payout Period", "terseLabel": "Restructuring and Related Activities, Expected Payout Period" } } }, "localname": "RestructuringAndRelatedActivitiesExpectedPayoutPeriod", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_ReturnsandAllowancesReserve": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 5.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Returns and Allowances Reserve", "label": "Returns and Allowances Reserve", "negatedTerseLabel": "Other, principally returns and allowances reserves" } } }, "localname": "ReturnsandAllowancesReserve", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue [Abstract]", "label": "Revenue [Abstract]", "terseLabel": "Revenue [Abstract]" } } }, "localname": "RevenueAbstract", "nsuri": "http://www.invacare.com/20210930", "xbrltype": "stringItemType" }, "ivc_ReversalofAccruedWithholdingTaxesonEarnings": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reversal of Accrued Withholding Taxes on Earnings", "label": "Reversal of Accrued Withholding Taxes on Earnings", "terseLabel": "Reversal of Accrued Withholding Taxes on Earnings" } } }, "localname": "ReversalofAccruedWithholdingTaxesonEarnings", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RevolvingCreditAndSecurityAgreementNorthAmericaCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving Credit and Security Agreement (North America Credit Agreement)", "label": "Revolving Credit and Security Agreement (North America Credit Agreement) [Member]", "terseLabel": "Revolving Credit and Security Agreement (North America Credit Agreement)" } } }, "localname": "RevolvingCreditAndSecurityAgreementNorthAmericaCreditAgreementMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ivc_RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving Credit and Security Agreement (Europe Credit Agreement) [Member] [Domain]", "label": "Revolving Credit and Security Agreement (Europe Credit Agreement) [Member] [Domain]", "terseLabel": "Revolving Credit and Security Agreement (Europe Credit Agreement)" } } }, "localname": "RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_RevolvingCreditandSecurityAgreementNewCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving Credit and Security Agreement (New Credit Agreement) [Member]", "label": "Revolving Credit and Security Agreement (New Credit Agreement) [Member]", "terseLabel": "Revolving Credit and Security Agreement (New Credit Agreement)" } } }, "localname": "RevolvingCreditandSecurityAgreementNewCreditAgreementMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_RightofUseAssetObtainedinExchangeforTotalLeaseLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Right-of-Use Asset Obtained in Exchange for Total Lease Liability", "label": "Right-of-Use Asset Obtained in Exchange for Total Lease Liability", "terseLabel": "Right-of-Use Asset Obtained in Exchange for Total Lease Liability" } } }, "localname": "RightofUseAssetObtainedinExchangeforTotalLeaseLiability", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RiskFactorAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Risk Factor", "label": "Risk Factor [Axis]", "terseLabel": "Risk Factor [Axis]" } } }, "localname": "RiskFactorAxis", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "ivc_RiskFactorDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Risk Factor", "label": "Risk Factor [Domain]", "terseLabel": "Risk Factor [Domain]" } } }, "localname": "RiskFactorDomain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_SaleLeasebackTransactionAnnualPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Annual Payments", "label": "Sale Leaseback Transaction, Annual Payments", "terseLabel": "Sale Leaseback Transaction, Annual Payments" } } }, "localname": "SaleLeasebackTransactionAnnualPayments", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_SaleLeasebackTransactionImmediateLossRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Immediate Loss Recognized", "label": "Sale Leaseback Transaction, Immediate Loss Recognized", "terseLabel": "Sale Leaseback Transaction, Immediate Loss Recognized" } } }, "localname": "SaleLeasebackTransactionImmediateLossRecognized", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_SaleLeasebackTransactionLeaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Lease Term", "label": "Sale Leaseback Transaction, Lease Term", "terseLabel": "Sale Leaseback Transaction, Lease Term" } } }, "localname": "SaleLeasebackTransactionLeaseTerm", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "durationItemType" }, "ivc_SaleLeasebackTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transactions [Abstract]", "label": "Sale Leaseback Transactions [Abstract]", "terseLabel": "Sale Leaseback Transactions [Abstract]" } } }, "localname": "SaleLeasebackTransactionsAbstract", "nsuri": "http://www.invacare.com/20210930", "xbrltype": "stringItemType" }, "ivc_ScheduleforAllowanceforCreditLossesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule for Allowance for Credit Losses [Abstract]", "label": "Schedule for Allowance for Credit Losses [Abstract]", "terseLabel": "Schedule for Allowance for Credit Losses [Abstract]" } } }, "localname": "ScheduleforAllowanceforCreditLossesAbstract", "nsuri": "http://www.invacare.com/20210930", "xbrltype": "stringItemType" }, "ivc_ScheduleofAccountsReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Accounts Receivable [Abstract]", "label": "Schedule of Accounts Receivable [Abstract]", "terseLabel": "Schedule of Accounts Receivable [Abstract]" } } }, "localname": "ScheduleofAccountsReceivableAbstract", "nsuri": "http://www.invacare.com/20210930", "xbrltype": "stringItemType" }, "ivc_ScheduleofAccountsReceivableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Table Text Block] for Schedule of Accounts Receivable [Table]", "label": "Schedule of Accounts Receivable [Table Text Block]", "terseLabel": "Schedule of Accounts Receivable" } } }, "localname": "ScheduleofAccountsReceivableTableTextBlock", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "ivc_ScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "stringItemType" }, "ivc_SellinggeneralandadministrativeexpensesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Selling, general and administrative expenses, as a Percent of Net Sales", "label": "Selling, general and administrative expenses, as a Percent of Net Sales", "terseLabel": "Selling, general and administrative expenses, as a Percent of Net Sales" } } }, "localname": "SellinggeneralandadministrativeexpensesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_SeriesIIConvertibleSeniorNotesAt500November2024Domain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series II Convertible Senior Notes at 5.00% November 2024", "label": "Series II Convertible Senior Notes at 5.00% November 2024 [Domain]", "terseLabel": "Series II Convertible Senior Notes at 5.00% November 2024 [Domain]" } } }, "localname": "SeriesIIConvertibleSeniorNotesAt500November2024Domain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_SeriesIIConvertibleSeniorNotesAt500November2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series II Convertible Senior Notes at 5.00% November 2024", "label": "Series II Convertible Senior Notes at 5.00% November 2024 [Member]", "terseLabel": "Series II Convertible Senior Notes at 5.00% November 2024" } } }, "localname": "SeriesIIConvertibleSeniorNotesAt500November2024Member", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Services [Member]", "label": "Services [Member]", "terseLabel": "Service" } } }, "localname": "ServicesMember", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfShareAwardsUnderlyingFrom2003And2013Plans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 and 2013 Plans", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 and 2013 Plans", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 Plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfShareAwardsUnderlyingFrom2003And2013Plans", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ivc_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementLowerRangePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Lower Range, Percentage", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Lower Range, Percentage", "terseLabel": "Performance achievement level, lower range" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementLowerRangePercentage", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Level of Performance Award Achievement, Target", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Percentage", "terseLabel": "Performance achievement level, target range" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementPercentage", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementUpperRangePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Upper Range, Percentage", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Upper Range, Percentage", "terseLabel": "Performance achievement level, upper range" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementUpperRangePercentage", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_SwingLineLoansDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swing Line Loans [Domain]", "label": "Swing Line Loans [Domain]", "terseLabel": "Swing Line Loans" } } }, "localname": "SwingLineLoansDomain", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_TotalCashPaidinMeasurementofAmountsforLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total Cash Paid in Measurement of Amounts for Lease Liabilities", "label": "Total Cash Paid in Measurement of Amounts for Lease Liabilities", "terseLabel": "Total Cash Paid in Measurement of Amounts for Lease Liabilities" } } }, "localname": "TotalCashPaidinMeasurementofAmountsforLeaseLiabilities", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ivc_UnamortizedFinancingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unamortized Financing Costs", "label": "Unamortized Financing Costs", "terseLabel": "Unamortized Financing Costs" } } }, "localname": "UnamortizedFinancingCosts", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_WeightedAverageRemainingLeaseTermsandDiscountRatesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted-Average Remaining Lease Terms and Discount Rates [Table Text Block]", "label": "Weighted-Average Remaining Lease Terms and Discount Rates [Table Text Block]", "terseLabel": "Weighted-Average Remaining Lease Terms and Discount Rates [Table]" } } }, "localname": "WeightedAverageRemainingLeaseTermsandDiscountRatesTableTextBlock", "nsuri": "http://www.invacare.com/20210930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r201", "r214", "r215", "r216", "r217", "r219", "r221", "r225" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r201", "r214", "r215", "r216", "r217", "r219", "r221", "r225" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r84", "r141" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Currency [Axis]", "terseLabel": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r389", "r392", "r568", "r569", "r570", "r571", "r572", "r573", "r593", "r641", "r644" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r389", "r392", "r568", "r569", "r570", "r571", "r572", "r573", "r593", "r641", "r644" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r227", "r370", "r371", "r594", "r640", "r642" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/BusinessSegmentsTables", "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r227", "r370", "r371", "r594", "r640", "r642" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/BusinessSegmentsTables", "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r378", "r389", "r392", "r568", "r569", "r570", "r571", "r572", "r573", "r593", "r641", "r644" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r378", "r389", "r392", "r568", "r569", "r570", "r571", "r572", "r573", "r593", "r641", "r644" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r147", "r148", "r149", "r150", "r151", "r152", "r155", "r156", "r157", "r159", "r160", "r161", "r162", "r163", "r180", "r257", "r258", "r428", "r444", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]", "terseLabel": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r147", "r148", "r149", "r150", "r151", "r152", "r155", "r156", "r157", "r159", "r160", "r161", "r162", "r163", "r180", "r257", "r258", "r428", "r444", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]", "terseLabel": "Restatement [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario, Unspecified [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r228", "r229", "r370", "r372", "r643", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r228", "r229", "r370", "r372", "r643", "r658", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r336", "r390", "r561" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails" ], "xbrltype": "stringItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r568", "r570", "r573" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]", "terseLabel": "Weighted Average" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Information by type of receivable.", "label": "Receivable Type [Axis]", "terseLabel": "Receivable Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Information by billing status of receivables.", "label": "Billing Status, Type [Axis]", "terseLabel": "Billing Status, Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByIndustryOfCounterpartyTypeAxis": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Information by industry of counterparty. A counterparty is the other party that participates in a financial transaction.", "label": "Industry of Counterparty, Type [Axis]", "terseLabel": "Industry of Counterparty, Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivablesByIndustryOfCounterpartyTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Information by legal entity of counterparty. A counterparty is the other party that participates in a financial transaction.", "label": "Legal Entity of Counterparty, Type [Axis]", "terseLabel": "Legal Entity of Counterparty, Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.", "label": "Accounts Payable and Accrued Liabilities [Member]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r62" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGross": { "auth_ref": [ "r233" ], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, before Allowance for Credit Loss", "terseLabel": "Accounts receivable, gross" } } }, "localname": "AccountsReceivableGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r42", "r621" ], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, after Allowance for Credit Loss", "totalLabel": "Accounts Receivable, Net" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r19", "r42", "r233", "r234" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade receivables, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionExpense": { "auth_ref": [ "r320", "r321" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.", "label": "Accretion Expense", "terseLabel": "Accretion Expense" } } }, "localname": "AccretionExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "auth_ref": [ "r28", "r65", "r431" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrual for Taxes Other than Income Taxes, Current", "terseLabel": "Taxes other than income taxes, primarily value added taxes" } } }, "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedInsuranceCurrent": { "auth_ref": [ "r27", "r28", "r65" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 10.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Insurance, Current", "terseLabel": "Insurance" } } }, "localname": "AccruedInsuranceCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r65" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses", "totalLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesMember": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.", "label": "Accrued Liabilities [Member]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccruedMarketingCostsCurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Marketing Costs, Current", "terseLabel": "Rebates" } } }, "localname": "AccruedMarketingCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r27", "r28", "r65" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 8.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Professional" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedRentCurrent": { "auth_ref": [ "r27", "r28", "r65" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 13.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Rent, Current", "terseLabel": "Rent" } } }, "localname": "AccruedRentCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r27", "r28", "r65" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Salaries, Current", "terseLabel": "Salaries and wages" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r89", "r94", "r97", "r469" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Accumulated Defined Benefit Plans Adjustment [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r60", "r312" ], "calculation": { "http://www.invacare.com/role/PropertyAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Less allowance for depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r88", "r94", "r97", "r468" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]", "terseLabel": "Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r45", "r91", "r93", "r94", "r627", "r652", "r656" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Accumulated other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r522", "r523", "r524", "r525", "r526", "r528" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r90", "r94", "r97", "r147", "r148", "r150", "r469", "r647", "r648" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r87", "r94", "r97", "r469", "r523", "r524", "r525", "r526", "r528" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Accumulated Translation Adjustment [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r43", "r428" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r147", "r148", "r150", "r425", "r426", "r427" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis": { "auth_ref": [ "r151", "r152", "r153", "r154" ], "lang": { "en-us": { "role": { "documentation": "Information by type of change in accounting principle. Excludes change from amendment to accounting standards.", "label": "Change in Accounting Principle, Type [Axis]", "terseLabel": "Adjustments for Change in Accounting Principle [Axis]" } } }, "localname": "AdjustmentsForChangeInAccountingPrincipleAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsForErrorCorrectionDomain": { "auth_ref": [ "r149", "r155", "r156", "r159", "r160", "r162", "r163" ], "lang": { "en-us": { "role": { "documentation": "Type of error correction.", "label": "Error Correction, Type [Domain]", "terseLabel": "Adjustments for Error Correction [Domain]" } } }, "localname": "AdjustmentsForErrorCorrectionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r151", "r152", "r153", "r154", "r253", "r254", "r255", "r256", "r257", "r258", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r441", "r442", "r443", "r444", "r596", "r597", "r598", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r394", "r418", "r429" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Allocated Share-based Compensation Expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": { "auth_ref": [ "r237", "r265" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.", "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Schedule of Installment Receivables Allowance for Doubtful Accounts" } } }, "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r244", "r259", "r261", "r264" ], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 4.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "negatedTerseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForLoanAndLeaseLossesAdjustmentsNet": { "auth_ref": [ "r242" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other addition (reduction) in allowance reserve for credit loss.", "label": "Allowance for Loan and Lease Losses, Adjustments, Other", "terseLabel": "Current period provision (benefit)" } } }, "localname": "AllowanceForLoanAndLeaseLossesAdjustmentsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForNotesAndLoansReceivableCurrent": { "auth_ref": [ "r49", "r244", "r259" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 1.0, "parentTag": "us-gaap_FinancingReceivableAllowanceForCreditLosses", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable, classified as current.", "label": "Financing Receivable, Allowance for Credit Loss, Current", "negatedLabel": "Allowance for doubtful accounts, current" } } }, "localname": "AllowanceForNotesAndLoansReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent": { "auth_ref": [ "r49", "r244", "r259" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 2.0, "parentTag": "us-gaap_FinancingReceivableAllowanceForCreditLosses", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable, classified as noncurrent.", "label": "Financing Receivable, Allowance for Credit Loss, Noncurrent", "negatedLabel": "Allowance for doubtful accounts, long-term" } } }, "localname": "AllowanceForNotesAndLoansReceivableNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r118", "r134", "r530" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of Debt Discount (Premium)" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r113", "r134", "r532" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt fees" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r134", "r298", "r305" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "terseLabel": "Arrangements and Non-arrangement Transactions [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r139", "r209", "r216", "r223", "r252", "r465", "r471", "r520", "r603", "r623" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r23", "r25", "r79", "r139", "r252", "r465", "r471", "r520" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r0", "r1", "r10", "r12", "r15", "r315" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Assets", "terseLabel": "Total Assets" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r395", "r420" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]", "terseLabel": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]", "terseLabel": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r395", "r420" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r482", "r487" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalLeaseObligations": { "auth_ref": [ "r36", "r535", "r626" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.", "label": "Capital Lease Obligations", "terseLabel": "Capital Lease Obligations" } } }, "localname": "CapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Value" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r17", "r57", "r136" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of year", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r131", "r521" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Cash, Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging [Member]" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashSurrenderValueOfLifeInsurance": { "auth_ref": [ "r26", "r61" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.", "label": "Cash Surrender Value of Life Insurance", "terseLabel": "Cash surrender value of life insurance policies" } } }, "localname": "CashSurrenderValueOfLifeInsurance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInAccountingPrincipleMember": { "auth_ref": [ "r151", "r152", "r153", "r154" ], "lang": { "en-us": { "role": { "documentation": "Change in accounting principle. Excludes change from amendment to accounting standards.", "label": "Change in Accounting Principle, Type [Domain]", "terseLabel": "Adjustments for Change in Accounting Principle [Domain]" } } }, "localname": "ChangeInAccountingPrincipleMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Information by type of borrower determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Type of Borrower [Axis]", "terseLabel": "Class of Financing Receivable, Type of Borrower [Axis]" } } }, "localname": "ClassOfFinancingReceivableTypeOfBorrowerAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of entity or individual who borrows funds.", "label": "Class of Financing Receivable, Type of Borrower [Domain]", "terseLabel": "Class of Financing Receivable, Type of Borrower [Domain]" } } }, "localname": "ClassOfFinancingReceivableTypeOfBorrowerDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r138", "r139", "r167", "r171", "r172", "r174", "r176", "r184", "r185", "r186", "r252", "r520" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/DEIDocument", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Derivative, Price Risk Option Strike Price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Class of Warrant or Right, Outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CollateralAxis": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Information by category of collateral or no collateral, from lender's perspective.", "label": "Collateral Held [Axis]", "terseLabel": "Collateral [Axis]" } } }, "localname": "CollateralAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CollateralDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of collateral or no collateral, from lender's perspective.", "label": "Collateral Held [Domain]", "terseLabel": "Collateral [Domain]" } } }, "localname": "CollateralDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Class B Common Shares [Member]", "verboseLabel": "Class B Common Shares [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/DEIDocument", "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends Declared per Common Share" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r147", "r148" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]", "verboseLabel": "Common Shares [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/DEIDocument", "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r40", "r361" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValueOutstanding": { "auth_ref": [ "r40" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.", "label": "Common Stock, Value, Outstanding", "terseLabel": "Common Shares" } } }, "localname": "CommonStockValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r100", "r102", "r103", "r110", "r614", "r636" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "terseLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive Income (Loss)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r109", "r119", "r613", "r635" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) by Component" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponent" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r191", "r192", "r231", "r518", "r519" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r191", "r192", "r231", "r518", "r519", "r657" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r191", "r192", "r231", "r518", "r519", "r657" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Concentration Of Credit Risk" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ConcentrationOfCreditRisk" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r191", "r192", "r231", "r518", "r519" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r137", "r467" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractTerminationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of a contract associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Contract Termination [Member]", "terseLabel": "Contract Termination" } } }, "localname": "ContractTerminationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r38", "r39", "r362", "r363" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Convertible Preferred Stock, Shares Issued upon Conversion", "terseLabel": "Convertible Preferred Stock, Shares Issued upon Conversion" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleSubordinatedDebtMember": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Debt that places a lender in a lien position behind debt having a higher priority of repayment in liquidation of the entity's assets which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible Subordinated Debt [Member]", "terseLabel": "Convertible Subordinated Debt" } } }, "localname": "ConvertibleSubordinatedDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r116", "r139", "r252", "r520" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of products sold", "verboseLabel": "Cost of Products Sold" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossStatusAxis": { "auth_ref": [ "r249", "r279", "r284" ], "lang": { "en-us": { "role": { "documentation": "Information by credit loss status of financial asset.", "label": "Credit Loss Status [Axis]", "terseLabel": "Credit Loss Status [Axis]" } } }, "localname": "CreditLossStatusAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditLossStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit loss status of financial asset.", "label": "Credit Loss Status [Domain]", "terseLabel": "Credit Loss Status [Domain]" } } }, "localname": "CreditLossStatusDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerListsMember": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.", "label": "Customer Lists [Member]", "verboseLabel": "Customer lists" } } }, "localname": "CustomerListsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt Disclosure" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r34", "r35", "r36", "r604", "r606", "r620" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt Instrument, Convertible, Conversion Price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Debt Instrument, Convertible, Threshold Consecutive Trading Days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Debt Instrument, Convertible, Threshold Trading Days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r531", "r533" ], "calculation": { "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails": { "order": 3.0, "parentTag": "ivc_DebtInstrumentNetCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r515" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "negatedTerseLabel": "Debt Instrument, Fair Value Disclosure" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFeeAmount": { "auth_ref": [ "r69" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.", "label": "Debt Instrument, Fee Amount", "terseLabel": "Debt Instrument, Fee Amount" } } }, "localname": "DebtInstrumentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r143" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt Instrument, Increase, Accrued Interest", "terseLabel": "Debt Instrument, Increase, Accrued Interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r68", "r357", "r531" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Debt Instrument, Interest Rate, Effective Percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate (as a percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRepurchaseAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value amount of debt instrument that was repurchased.", "label": "Debt Instrument, Repurchase Amount", "terseLabel": "Debt Instrument, Repurchase Amount" } } }, "localname": "DebtInstrumentRepurchaseAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r70", "r142", "r362", "r364", "r365", "r366", "r530", "r531", "r533", "r619" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r530", "r533" ], "calculation": { "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails": { "order": 2.0, "parentTag": "ivc_DebtInstrumentNetCarryingAmount", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Unamortized discount", "negatedTerseLabel": "Debt Instrument, Unamortized Discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationCashBasedArrangementsLiabilityCurrent": { "auth_ref": [ "r373", "r374" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for deferred compensation arrangements payable within one year (or the normal operating cycle, if longer). Represents currently earned compensation under cash arrangements (such as a profit-sharing plan, rabbi trust, and employee contract--excluding equity-based arrangements) that is not actually paid until a later date.", "label": "Deferred Compensation Cash-based Arrangements, Liability, Current", "terseLabel": "Supplemental executive retirement program liability" } } }, "localname": "DeferredCompensationCashBasedArrangementsLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for deferred compensation arrangements payable after one year (or the normal operating cycle, if longer). Represents currently earned compensation under cash arrangements (such as a profit-sharing plan, rabbi trust, and employee contract--excluding equity-based arrangements) that is not actually paid until a later date.", "label": "Deferred Compensation Cash-based Arrangements, Liability, Classified, Noncurrent", "terseLabel": "Supplemental executive retirement plan liability" } } }, "localname": "DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).", "label": "Deferred Compensation Liability, Classified, Noncurrent", "terseLabel": "Deferred compensation" } } }, "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]", "terseLabel": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DeferredFinanceCostsNoncurrentNet": { "auth_ref": [ "r61", "r532" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Noncurrent, Net", "terseLabel": "Deferred financing fees" } } }, "localname": "DeferredFinanceCostsNoncurrentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r134", "r140", "r440", "r447", "r448", "r449" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Provision (benefit) for deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.", "label": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "negatedTerseLabel": "Total Unearned Interest", "terseLabel": "Deferred Revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r50" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 12.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpense": { "auth_ref": [ "r438", "r439" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.", "label": "Deferred Tax Assets, Tax Deferred Expense", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": { "auth_ref": [ "r37", "r375", "r376", "r377" ], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.", "label": "Liability, Defined Benefit Pension Plan, Noncurrent", "terseLabel": "Pension" } } }, "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r134", "r204" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAmountOfHedgedItem": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of hedged item in hedging relationship. Excludes hedged asset or liability.", "label": "Derivative, Amount of Hedged Item", "terseLabel": "Derivative, Amount of Hedged Item" } } }, "localname": "DerivativeAmountOfHedgedItem", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r82", "r83", "r515" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "verboseLabel": "Derivative assets" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsCurrent": { "auth_ref": [ "r82" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset, Current", "terseLabel": "Derivatives (foreign currency forward exchange contracts)" } } }, "localname": "DerivativeAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": { "auth_ref": [ "r474" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.", "label": "Derivative Assets (Liabilities), at Fair Value, Net", "terseLabel": "Derivative assets (liabilities), at fair value, net" } } }, "localname": "DerivativeAssetsLiabilitiesAtFairValueNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r81", "r85", "r485", "r575" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Gross Asset", "verboseLabel": "Derivative assets" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r81", "r85", "r485", "r575" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Gross Liability", "terseLabel": "Derivative liabilities" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r484" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "negatedLabel": "Gain (Loss)", "terseLabel": "Gain (Loss)", "verboseLabel": "Gain (Loss)" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r483", "r486", "r493", "r496" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r504" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivatives" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/Derivatives" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivatives and hedging activities.", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r480", "r483", "r493" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r480", "r483", "r493", "r496", "r497", "r501", "r503" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r490", "r495" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "terseLabel": "Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet": { "auth_ref": [ "r491", "r502" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.", "label": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net", "terseLabel": "Amount of Gain (Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)" } } }, "localname": "DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r82", "r83", "r515" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "negatedLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r82" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 16.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative liabilities (foreign currency forward exchange contracts)" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r475", "r477", "r478", "r480", "r481", "r488", "r493", "r499", "r500", "r503" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument [Member]" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Shareholders' Equity Transactions" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": { "auth_ref": [ "r0", "r1", "r10", "r315" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net", "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": { "auth_ref": [ "r0", "r1", "r10", "r315" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable", "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts Payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxPayable": { "auth_ref": [ "r0", "r1", "r10", "r315" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as income tax obligations attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable", "terseLabel": "Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities": { "auth_ref": [ "r0", "r1", "r10", "r315" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities", "terseLabel": "Disposal Group, Including Discontinued Operation, Accrued Liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": { "auth_ref": [ "r0", "r1", "r10", "r315" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Inventory", "terseLabel": "Disposal Group, Including Discontinued Operation, Inventory" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": { "auth_ref": [ "r0", "r1", "r10", "r315" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Other Assets", "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": { "auth_ref": [ "r0", "r1", "r10", "r315" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment", "terseLabel": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "auth_ref": [ "r9", "r15" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Revenue", "terseLabel": "Disposal Group, Including Discontinued Operation, Revenue" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r388", "r391" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Groups, Including Discontinued Operations, Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r367" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends, Common Stock, Cash", "negatedTerseLabel": "Dividends, Common Stock, Cash" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r111", "r155", "r156", "r157", "r158", "r159", "r165", "r167", "r174", "r175", "r176", "r180", "r181", "r615", "r637" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net Loss per Share\u2014Basic", "verboseLabel": "Net earnings (loss) per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Net Loss per Share\u2014Basic" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r111", "r155", "r156", "r157", "r158", "r159", "r167", "r174", "r175", "r176", "r180", "r181", "r615", "r637" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net earnings (loss) per per common share\u2014assuming dilution (in dollars per share)", "verboseLabel": "Loss per Share\u2014Assuming Dilution" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Loss per Share\u2014Assuming Dilution" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r177", "r178", "r179", "r182" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Earnings (Loss) Per Common Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r521" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate, continuing operations" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r433", "r450" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "U.S. statutory income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r419" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Period for recognition of unrecognized compensation costs" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Severance" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails", "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]", "terseLabel": "Revenue from External Customer [Line Items]" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r147", "r148", "r150", "r152", "r160", "r163", "r183", "r256", "r361", "r367", "r425", "r426", "r427", "r443", "r444", "r522", "r523", "r524", "r525", "r526", "r528", "r647", "r648", "r649" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesByIndustryAxis": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Axis]", "terseLabel": "Industry Sector [Axis]" } } }, "localname": "EquitySecuritiesByIndustryAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquitySecuritiesIndustryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Domain]", "terseLabel": "Industry Sector [Domain]" } } }, "localname": "EquitySecuritiesIndustryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": { "auth_ref": [ "r149", "r155", "r156", "r159", "r160", "r162", "r163" ], "lang": { "en-us": { "role": { "documentation": "Information by type of error correction.", "label": "Error Correction, Type [Axis]", "terseLabel": "Adjustments for Error Corrections [Axis]" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "verboseLabel": "Fair Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r505", "r506", "r507", "r511" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r505", "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r505", "r516" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Fair Value, by Balance Sheet Grouping" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r387", "r506", "r565", "r566", "r567" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r505", "r512" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r505", "r506", "r508", "r509", "r513" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r510" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValues" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r379", "r380", "r385", "r387", "r506", "r565" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r379", "r380", "r385", "r387", "r506", "r566" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r387", "r506", "r567" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Fair Value, Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r387", "r565", "r566", "r567" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r510", "r513" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Measurements, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r482", "r488", "r501" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r543", "r547", "r556" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Finance Lease, Interest Expense" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r542", "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "terseLabel": "Finance Lease, Liability" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r542" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "negatedTerseLabel": "Finance Lease, Liability, Current", "terseLabel": "Current portion of finance lease obligations" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.", "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Finance Lease, Liability, Fiscal Year Maturity" } } }, "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r542" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Finance Lease Long-Term Obligations" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Payment, Due", "terseLabel": "Finance Lease, Liability, Payments, Due" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, after Year Five", "terseLabel": "Finance Lease, Liability, Payments, Due after Year Five" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "terseLabel": "Finance Lease, Liability, Payments, Due Next Twelve Months" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Five", "terseLabel": "Finance Lease, Liability, Payments, Due Year Five" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "terseLabel": "Finance Lease, Liability, Payments, Due Year Four" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "terseLabel": "Finance Lease, Liability, Payments, Due Year Three" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "terseLabel": "Finance Lease, Liability, Payments, Due Year Two" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r541" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "terseLabel": "Finance Lease, Right-of-Use Asset" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r543", "r547", "r556" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Finance Lease, Right-of-Use Asset, Amortization" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r553", "r556" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r552", "r556" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r250", "r251", "r260", "r265", "r266", "r267", "r269", "r280", "r281", "r282", "r283", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLosses": { "auth_ref": [ "r235", "r259", "r261", "r264", "r608" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 1.0, "parentTag": "us-gaap_NotesReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, Allowance for Credit Loss", "negatedTotalLabel": "Allowance for doubtful accounts", "periodEndLabel": "Balance as of end of period", "periodStartLabel": "Balance as of beginning of period" } } }, "localname": "FinancingReceivableAllowanceForCreditLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails", "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financing Receivable, Allowance for Credit Loss [Line Items]", "terseLabel": "Financing Receivable, Allowance for Credit Losses [Line Items]" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Allowance for Doubtful Accounts [Roll Forward]" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesWriteOffs": { "auth_ref": [ "r236", "r263", "r277" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of writeoff of financing receivable, charged against allowance for credit loss.", "label": "Financing Receivable, Allowance for Credit Loss, Writeoff", "negatedTerseLabel": "Direct write-offs charged against the allowance" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesWriteOffs", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableImpairedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financing Receivable, Impaired [Line Items]", "terseLabel": "Financing Receivable, Impaired [Line Items]" } } }, "localname": "FinancingReceivableImpairedLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivablePortfolioSegmentAxis": { "auth_ref": [ "r260", "r265", "r270" ], "lang": { "en-us": { "role": { "documentation": "Information by the level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses.", "label": "Financing Receivable Portfolio Segment [Axis]", "terseLabel": "Financing Receivable Portfolio Segment [Axis]" } } }, "localname": "FinancingReceivablePortfolioSegmentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivablePortfolioSegmentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses.", "label": "Financing Receivable Portfolio Segment [Domain]", "terseLabel": "Financing Receivable Portfolio Segment" } } }, "localname": "FinancingReceivablePortfolioSegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": { "auth_ref": [ "r243", "r245", "r246", "r266", "r267", "r269", "r271", "r273", "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Axis]", "terseLabel": "Class of Financing Receivable, Type [Axis]" } } }, "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Domain]", "terseLabel": "Class of Financing Receivable, Type" } } }, "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financing Receivable, Past Due [Line Items]", "terseLabel": "Financing Receivable, Recorded Investment, Past Due [Line Items]" } } }, "localname": "FinancingReceivableRecordedInvestmentPastDueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Finite-Lived intangible assets, useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r304" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r306" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "Future amortization expense, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "Future amortization expense, remainder of fiscal year" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r306" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "Future amortization expense, 2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r306" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "Future amortization expense, 2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r306" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "Future amortization expense, 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r306" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "Future amortization expense, 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r299", "r301", "r304", "r308", "r595", "r599" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r304", "r599" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Historical Cost" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r299", "r303" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Forward exchange contracts\u2014net", "verboseLabel": "Foreign currency forward contracts" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnRepurchaseOfDebtInstrument": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from the difference between the repurchase price of a debt instrument initially issued by the entity and the net carrying amount of the debt at the time of its repurchase.", "label": "Gain (Loss) on Repurchase of Debt Instrument", "negatedTerseLabel": "Gain (Loss) on Repurchase of Debt Instrument" } } }, "localname": "GainLossOnRepurchaseOfDebtInstrument", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfBusiness": { "auth_ref": [ "r134", "r470" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.", "label": "Gain (Loss) on Disposition of Business", "terseLabel": "Gain on sale of business" } } }, "localname": "GainLossOnSaleOfBusiness", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r134" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Gain on disposals of property and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r134", "r358", "r359" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Loss (gain) on debt extinguishment including debt finance charges and fees", "terseLabel": "Loss (gain) on debt extinguishment including debt finance charges and fees" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicDistributionAxis": { "auth_ref": [ "r276", "r617", "r618" ], "lang": { "en-us": { "role": { "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Axis]", "terseLabel": "Geographic Distribution [Axis]" } } }, "localname": "GeographicDistributionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GeographicDistributionDomain": { "auth_ref": [ "r617", "r618" ], "lang": { "en-us": { "role": { "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Domain]", "terseLabel": "Geographic Distribution [Domain]" } } }, "localname": "GeographicDistributionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r289", "r291", "r601" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r134", "r290", "r292", "r294" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "negatedTerseLabel": "Goodwill, Impairment Loss", "terseLabel": "Goodwill, Impairment Loss" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r114", "r139", "r209", "r215", "r219", "r222", "r225", "r252", "r520" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r480", "r497" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairedFinancingReceivableInterestIncomeAccrualMethodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impaired Financing Receivable, Interest Income, Accrual Method [Abstract]", "terseLabel": "Interest Income Recognized" } } }, "localname": "ImpairedFinancingReceivableInterestIncomeAccrualMethodAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairedFinancingReceivableRecordedInvestmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impaired Financing Receivable, Recorded Investment [Abstract]", "terseLabel": "Total Installment Receivables" } } }, "localname": "ImpairedFinancingReceivableRecordedInvestmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairedFinancingReceivableRelatedAllowance": { "auth_ref": [ "r239" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit losses related to recorded investment.", "label": "Impaired Financing Receivable, Related Allowance", "terseLabel": "Impaired Financing Receivable, Related Allowance" } } }, "localname": "ImpairedFinancingReceivableRelatedAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivableUnpaidPrincipalBalanceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impaired Financing Receivable, Unpaid Principal Balance [Abstract]", "terseLabel": "Unpaid Principal Balance" } } }, "localname": "ImpairedFinancingReceivableUnpaidPrincipalBalanceAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod": { "auth_ref": [ "r241" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 2.0, "parentTag": "ivc_FinancingReceivableInterestIncomeAccrualMethod", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income, recognized on accrual basis, on financing receivables, for which there is a related allowance for credit losses and are recognized as impaired.", "label": "Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method", "terseLabel": "Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method" } } }, "localname": "ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment": { "auth_ref": [ "r238" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 2.0, "parentTag": "ivc_FinancingReceivableRecordedInvestment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in impaired financing receivables for which there is a related allowance for credit losses.", "label": "Impaired Financing Receivable, with Related Allowance, Recorded Investment", "terseLabel": "Impaired installment receivables with a related allowance recorded" } } }, "localname": "ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance": { "auth_ref": [ "r240" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 2.0, "parentTag": "ivc_FinancingReceivableUnpaidPrincipalBalance", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unpaid principal balance of impaired financing receivables for which there is a related allowance for credit losses.", "label": "Impaired Financing Receivable, with Related Allowance, Unpaid Principal Balance", "terseLabel": "Impaired installment receivables with a related allowance recorded" } } }, "localname": "ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivablesTableTextBlock": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of impaired financing receivables.", "label": "Impaired Financing Receivables [Table Text Block]", "terseLabel": "Schedule of Installment Receivables by Class" } } }, "localname": "ImpairedFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r115", "r135", "r155", "r156", "r157", "r158", "r173", "r176", "r462" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "terseLabel": "Net loss from continuing operations", "totalLabel": "Net loss from Continuing Operations" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r107", "r209", "r215", "r219", "r222", "r225", "r600", "r611", "r618", "r638" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Earnings (loss) before income taxes", "totalLabel": "Loss Before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r144", "r209", "r215", "r219", "r222", "r225" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "Income (Loss) from Continuing Operations before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r388", "r391" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r1", "r3", "r4", "r5", "r6", "r7", "r8", "r11", "r13", "r14", "r15", "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r434", "r435", "r437", "r445", "r451", "r453", "r454", "r455" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r140", "r162", "r163", "r207", "r432", "r446", "r452", "r639" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedTerseLabel": "Income tax provision", "terseLabel": "Income tax provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r74", "r610", "r633" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income Taxes Receivable, Current", "terseLabel": "Recoverable income taxes" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r133" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r133" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Trade receivables" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r133" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInFinanceReceivables": { "auth_ref": [ "r133" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in outstanding loans including accrued interest.", "label": "Increase (Decrease) in Finance Receivables", "negatedLabel": "Installment sales contracts, net" } } }, "localname": "IncreaseDecreaseInFinanceReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r133" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories, net" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherDeferredLiability": { "auth_ref": [ "r133" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred obligations classified as other.", "label": "Increase (Decrease) in Other Deferred Liability", "terseLabel": "Other long-term liabilities" } } }, "localname": "IncreaseDecreaseInOtherDeferredLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r133" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r168", "r169", "r170", "r176" ], "calculation": { "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Stock options and awards" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r300", "r307" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r307" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Historical Cost" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r300", "r307" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IndustryOfCounterpartyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The industry of the party or parties having primary responsibility to meet the obligations of the arrangement with the entity.", "label": "Industry of Counterparty [Domain]", "terseLabel": "Industry of Counterparty [Domain]" } } }, "localname": "IndustryOfCounterpartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Other Intangibles" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/Intangibles" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r297", "r302" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangibles, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r105", "r203", "r529", "r532", "r616" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "terseLabel": "Interest Income, Other" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r28", "r29", "r65" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 11.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRevenueExpenseNet": { "auth_ref": [ "r209" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest revenue (income derived from investments in debt securities and on cash and cash equivalents) net of interest expense (cost of borrowed funds accounted for as interest).", "label": "Interest Revenue (Expense), Net", "terseLabel": "Interest Revenue (Expense), Net" } } }, "localname": "InterestRevenueExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r201", "r214", "r215", "r216", "r217", "r219", "r221", "r225" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Eliminations [Member]", "terseLabel": "Intersegment revenues" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r51", "r285" ], "calculation": { "http://www.invacare.com/role/InventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r18", "r77" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.invacare.com/role/InventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r53", "r285" ], "calculation": { "http://www.invacare.com/role/InventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r52", "r285" ], "calculation": { "http://www.invacare.com/role/InventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandBuildingsAndImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate held and additions or improvements to real estate held and structures used in the conduct of business.", "label": "Land, Buildings and Improvements [Member]", "terseLabel": "Land, buildings and improvements" } } }, "localname": "LandBuildingsAndImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseContractualTermAxis": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Information by contractual term of lease arrangement.", "label": "Lease Contractual Term [Axis]", "terseLabel": "Lease Contractual Term [Axis]" } } }, "localname": "LeaseContractualTermAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseContractualTermDomain": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Contractual term of lease arrangement.", "label": "Lease Contractual Term [Domain]", "terseLabel": "Lease Contractual Term [Domain]" } } }, "localname": "LeaseContractualTermDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease, Cost [Table]" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LegalEntityTypeOfCounterpartyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nature of the other party participating in a financial transaction.", "label": "Legal Entity Type of Counterparty [Domain]", "terseLabel": "Legal Entity Type of Counterparty [Domain]" } } }, "localname": "LegalEntityTypeOfCounterpartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeFinanceLeaseTermOfContract1": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Finance Lease, Term of Contract", "terseLabel": "Lessee, Finance Lease, Term of Contract" } } }, "localname": "LesseeFinanceLeaseTermOfContract1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeFinanceLeasesTextBlock": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.", "label": "Lessee, Finance Leases [Text Block]", "terseLabel": "Lessee, Finance Leases" } } }, "localname": "LesseeFinanceLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Lessee, Operating Lease, Liability, Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "terseLabel": "Total future minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Lessee, Operating Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of Credit Outstanding, Amount" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r48", "r139", "r252", "r520", "r607", "r629" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r67", "r139", "r252", "r466", "r471", "r472", "r520" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r0", "r1", "r10", "r12", "r15", "r315" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r71" ], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "terseLabel": "Uncertain tax obligation including interest" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LicensingAgreementsMember": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).", "label": "Licensing Agreements [Member]", "verboseLabel": "License agreements" } } }, "localname": "LicensingAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "auth_ref": [ "r63" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Current Borrowing Capacity", "terseLabel": "Line of Credit Facility, Current Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": { "auth_ref": [ "r515" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of the amount outstanding under the credit facility.", "label": "Line of Credit Facility, Fair Value of Amount Outstanding", "terseLabel": "Line of Credit Facility, Fair Value of Amount Outstanding" } } }, "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r63" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r63" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Commitment fee percentage" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]", "terseLabel": "Receivables" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/Receivables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "London Interbank Offered Rate (LIBOR)" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r36" ], "calculation": { "http://www.invacare.com/role/LongTermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-term Debt and Lease Obligation", "verboseLabel": "Long-term debt net of current maturities" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "auth_ref": [ "r65" ], "calculation": { "http://www.invacare.com/role/LongTermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as current.", "label": "Long-term Debt and Lease Obligation, Current", "negatedTerseLabel": "Long-term Debt and Capital Lease Obligations, Current" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/LongTermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.", "label": "Long-term Debt and Lease Obligation, Including Current Maturities", "terseLabel": "Long-term debt", "totalLabel": "Long-term debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r64" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r70" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-Term Debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r58" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-term Investments", "terseLabel": "Investments" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r70", "r354" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Weighted average interest rate (as a percent)" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r346", "r347" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyDisclosures": { "auth_ref": [ "r343", "r344" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.", "label": "Contingencies Disclosure [Text Block]", "terseLabel": "Contingencies" } } }, "localname": "LossContingencyDisclosures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/Contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r346", "r347" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r16", "r460" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "terseLabel": "Divested Businesses" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r131" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r131" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used by Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r131", "r132", "r135" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Provided by (Used in) Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used by operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r15", "r98", "r101", "r108", "r135", "r139", "r151", "r155", "r156", "r157", "r158", "r162", "r163", "r173", "r209", "r215", "r219", "r222", "r225", "r252", "r520", "r612", "r634" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net Loss", "totalLabel": "Net Loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument [Member]" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NotesAndLoansReceivableGrossCurrent": { "auth_ref": [ "r19", "r20", "r75", "r234" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 1.0, "parentTag": "us-gaap_NotesReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable, classified as current.", "label": "Financing Receivable, before Allowance for Credit Loss, Current", "terseLabel": "Installment Receivables, Current" } } }, "localname": "NotesAndLoansReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableGrossNoncurrent": { "auth_ref": [ "r233" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 2.0, "parentTag": "us-gaap_NotesReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable, classified as noncurrent.", "label": "Financing Receivable, before Allowance for Credit Loss, Noncurrent", "terseLabel": "Installment Receivables, Long-Term" } } }, "localname": "NotesAndLoansReceivableGrossNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetCurrent": { "auth_ref": [ "r19", "r20", "r41", "r233", "r234", "r609" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.", "label": "Financing Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Installment receivables, net", "totalLabel": "Installment receivables, net" } } }, "localname": "NotesAndLoansReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetNoncurrent": { "auth_ref": [ "r42" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 }, "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.", "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent", "terseLabel": "Installment receivables", "totalLabel": "Installment receivables, net, long-term" } } }, "localname": "NotesAndLoansReceivableNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails", "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableGross": { "auth_ref": [ "r268", "r277", "r278" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable.", "label": "Financing Receivable, before Allowance for Credit Loss", "totalLabel": "Total Installment Receivables" } } }, "localname": "NotesReceivableGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableNet": { "auth_ref": [ "r42", "r233", "r268" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, after Allowance for Credit Loss", "totalLabel": "Installment receivables, net" } } }, "localname": "NotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r209", "r215", "r219", "r222", "r225" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating Income (Loss)", "totalLabel": "Operating Income (Loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r548", "r556" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating Lease, Cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r544" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating Lease, Expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r542" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "negatedTerseLabel": "Operating Lease, Liability, Current", "terseLabel": "Current portion of operating lease obligations" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r542" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating Leases Long-Term Obligations" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r541" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating Lease, Right-of-Use Asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r553", "r556" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r552", "r556" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r214", "r215", "r216", "r217", "r219", "r225" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments [Member]" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r146", "r164", "r196", "r473" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "Accounting Policies" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r27", "r28", "r29", "r65" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 15.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other items, principally trade accruals" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r78" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets", "totalLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Other Assets Disclosure [Text Block]", "terseLabel": "Other Long-Term Assets" } } }, "localname": "OtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r61" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other Assets", "totalLabel": "Other Long-Term Assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent [Abstract]", "terseLabel": "Defined Benefit Plans:" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": { "auth_ref": [ "r92" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax", "negatedTerseLabel": "Deferred tax adjustment resulting from defined benefit plan activity" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r463", "r464", "r468" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r91", "r95", "r96", "r386" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax", "terseLabel": "Amortization of prior service costs and unrecognized losses" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": { "auth_ref": [ "r91", "r95", "r96", "r386" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax", "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r94", "r104", "r522", "r524", "r528" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "OCI before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r88", "r91" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": { "auth_ref": [ "r91" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent", "terseLabel": "Current period gain (loss) on cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": { "auth_ref": [ "r92" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 6.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax", "negatedTerseLabel": "Deferred tax benefit (provision) related to gain on cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r99", "r102", "r104", "r109", "r361", "r522", "r527", "r528", "r613", "r635" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Other Comprehensive Income (Loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r482", "r501" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other Current Assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other current assets.", "label": "Other Current Assets [Text Block]", "terseLabel": "Other Current Assets" } } }, "localname": "OtherCurrentAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherEmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r65" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 14.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Other Employee-related Liabilities, Current", "terseLabel": "Severance" } } }, "localname": "OtherEmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInvestments": { "auth_ref": [ "r58", "r632" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments classified as other.", "label": "Other Investments", "terseLabel": "Other investments" } } }, "localname": "OtherInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]", "terseLabel": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "Other Liabilities Disclosure [Text Block]", "terseLabel": "Other Long-Term Obligations" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligations" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r71" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other Long-Term Obligations", "totalLabel": "Other Long-Term Obligations" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r135" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedTerseLabel": "Provision for other deferred liabilities" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Table Text Block]", "terseLabel": "Other Noncurrent Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r21", "r24", "r288" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 9.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Other Prepaid Expense, Current", "terseLabel": "Prepaid and other current assets" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilitiesNoncurrent": { "auth_ref": [ "r37", "r605", "r624" ], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.", "label": "Other Sundry Liabilities, Noncurrent", "terseLabel": "Other" } } }, "localname": "OtherSundryLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PastDueFinancingReceivablesTableTextBlock": { "auth_ref": [ "r245", "r246", "r266", "r278" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of aging analysis for financing receivable.", "label": "Financing Receivable, Past Due [Table Text Block]", "terseLabel": "Schedule of Aging of Installment Receivables" } } }, "localname": "PastDueFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]", "terseLabel": "Patents" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]", "terseLabel": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForProceedsFromLongtermInvestments": { "auth_ref": [ "r145" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount paid (received) by the reporting entity through acquisition or sale and maturities of long-term investments which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.", "label": "Payments for (Proceeds from) Long-term Investments", "negatedLabel": "Change in other long-term assets" } } }, "localname": "PaymentsForProceedsFromLongtermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r122", "r124", "r145" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "terseLabel": "Other" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r127" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Purchases of treasury shares", "terseLabel": "Payments for Repurchase of Common Stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r130", "r323" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedTerseLabel": "Payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r127" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Payment of dividends", "negatedTerseLabel": "Payments of Ordinary Dividends, Common Stock" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r129" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "negatedTerseLabel": "Payment of financing costs" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r123" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance Shares" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r395", "r420" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r39" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred Shares (Authorized 300\u00a0shares; none outstanding)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent": { "auth_ref": [ "r33", "r602", "r622" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Noncurrent", "terseLabel": "Other" } } }, "localname": "PrepaidExpenseAndOtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [ "r22", "r24", "r287", "r288" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 8.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Insurance", "terseLabel": "Prepaid insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "auth_ref": [ "r120" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "terseLabel": "Proceeds from sale of business" } } }, "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r126" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Proceeds from revolving lines of credit and long-term borrowings" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r125" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Issuance of warrants", "verboseLabel": "Proceeds from Issuance of Warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r121" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from sale of property and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductLiabilityContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Liability Contingency [Line Items]", "terseLabel": "Product Liability Contingency" } } }, "localname": "ProductLiabilityContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductLiabilityContingencyTable": { "auth_ref": [ "r335", "r337", "r338", "r339", "r340", "r341", "r342" ], "lang": { "en-us": { "role": { "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.", "label": "Product Liability Contingency [Table]", "terseLabel": "Product Liability Contingency [Table]" } } }, "localname": "ProductLiabilityContingencyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Product" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r65", "r345", "r349" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Product Warranty Accrual, Current", "periodEndLabel": "Balance as of September 30, 2021", "periodStartLabel": "Balance as of January 1, 2021", "terseLabel": "Warranty" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails", "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r350" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Settlements made during the period" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease": { "auth_ref": [ "r352" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the standard and extended product warranty accrual from changes in estimates attributable to preexisting product warranties.", "label": "Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties", "terseLabel": "Changes in liability for pre-existing warranties during the period, including expirations" } } }, "localname": "ProductWarrantyAccrualPreexistingIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Warranties provided during the period" } } }, "localname": "ProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r60", "r313" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment by Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r319", "r659", "r660", "r661" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property And Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r59", "r311" ], "calculation": { "http://www.invacare.com/role/PropertyAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r31", "r32", "r313", "r631" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.invacare.com/role/PropertyAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and Equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r31", "r313" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r31", "r311" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r112", "r262" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "verboseLabel": "Provision for losses on trade and installment receivables" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivableTypeDomain": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.", "label": "Receivable [Domain]", "terseLabel": "Receivable [Domain]" } } }, "localname": "ReceivableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]", "terseLabel": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesBillingStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amounts due from customers (or dealers) within the next year (or operating cycle, if longer) for goods or services that have been delivered or used, but not yet paid.", "label": "Receivables Billing Status [Domain]", "terseLabel": "Receivables Billing Status [Domain]" } } }, "localname": "ReceivablesBillingStatusDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesFairValueDisclosure": { "auth_ref": [ "r49", "r80", "r609", "r630" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of receivables, including, but not limited to, trade account receivables, note receivables, and loan receivables.", "label": "Receivables, Fair Value Disclosure", "terseLabel": "Installment receivables, net of reserves" } } }, "localname": "ReceivablesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r94", "r97", "r104", "r522", "r526", "r528" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTerseLabel": "Amount reclassified from accumulated OCI" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r128" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedLabel": "Repurchases of convertible debt, payments on revolving lines of credit and finance leases" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Charges Related To Restructuring Activities" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r134", "r322", "r327", "r332" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "negatedTerseLabel": "Charges", "terseLabel": "Charges", "verboseLabel": "Charges related to restructuring activities" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Cost and Reserve [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r323", "r329" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Restructuring Reserve" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveAccrualAdjustment1": { "auth_ref": [ "r322", "r328" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.", "label": "Restructuring Reserve, Accrual Adjustment", "terseLabel": "Restructuring Reserve, Accrual Adjustment" } } }, "localname": "RestructuringReserveAccrualAdjustment1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r44", "r367", "r428", "r628", "r651", "r656" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r147", "r148", "r150", "r152", "r160", "r163", "r256", "r425", "r426", "r427", "r443", "r444", "r647", "r649" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionDeferredRevenue": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing unearned income or deferred revenue related to transactions involving the sale of a product or performance of services.", "label": "Revenue Recognition, Deferred Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition, Deferred Revenue [Policy Text Block]" } } }, "localname": "RevenueRecognitionDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueRevenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionMultipleDeliverableArrangementsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue Recognition, Multiple-deliverable Arrangements [Line Items]", "terseLabel": "Revenue Recognition, Multiple-deliverable Arrangements [Line Items]" } } }, "localname": "RevenueRecognitionMultipleDeliverableArrangementsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning the recognition of revenue arrangements under which the entity does or will perform multiple revenue-generating activities, categorized by type of arrangement, including certain revenue arrangements that include software elements. This item does not include multiple-deliverable arrangements for industries that prepare disclosures under specific requirements (for instance, construction-type and production-type contracts) otherwise provided for in the taxonomy.", "label": "Revenue Recognition, Multiple-deliverable Arrangements [Table]", "terseLabel": "Revenue Recognition, Multiple-deliverable Arrangements [Table]" } } }, "localname": "RevenueRecognitionMultipleDeliverableArrangementsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the recognition of revenue arrangements under which the entity does or will perform multiple revenue-generating activities, categorized by type of arrangement. This item includes certain revenue arrangements that include software elements. This item does not include multiple-deliverable arrangements for industries that prepare disclosures under specific requirements (for instance, construction-type and production-type contracts) otherwise provided for in the taxonomy.", "label": "Revenue Recognition, Multiple-deliverable Arrangements [Table Text Block]", "terseLabel": "Revenue Recognition, Multiple-deliverable Arrangements" } } }, "localname": "RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r106", "r139", "r200", "r201", "r214", "r220", "r221", "r227", "r228", "r231", "r252", "r520", "r618" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net Sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility", "verboseLabel": "Senior secured revolving credit facility, due in October 2015" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": { "auth_ref": [ "r551", "r556" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability", "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability" } } }, "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r551", "r556" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RiskLevelHighMember": { "auth_ref": [ "r348", "r498" ], "lang": { "en-us": { "role": { "documentation": "An entity's internal risk assessment as having high risk.", "label": "Risk Level, High [Member]", "terseLabel": "Risk Level, High" } } }, "localname": "RiskLevelHighMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RiskLevelLowMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity's internal risk assessment as having low risk.", "label": "Risk Level, Low [Member]", "terseLabel": "Risk Level, Low" } } }, "localname": "RiskLevelLowMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RiskLevelMediumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity's internal risk assessment as having medium risk.", "label": "Risk Level, Medium [Member]", "terseLabel": "Risk Level, Medium" } } }, "localname": "RiskLevelMediumMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]", "terseLabel": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SaleAndLeasebackTransactionGainLossNet": { "auth_ref": [ "r550", "r556", "r559" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.", "label": "Sale and Leaseback Transaction, Gain (Loss), Net", "terseLabel": "Sale and Leaseback Transaction, Gain (Loss), Net" } } }, "localname": "SaleAndLeasebackTransactionGainLossNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionDeferredGainGross": { "auth_ref": [ "r536" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the gain recorded in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller to be recognized in future periods.", "label": "Sale Leaseback Transaction, Deferred Gain, Gross", "terseLabel": "Sale Leaseback Transaction, Deferred Gain, Gross" } } }, "localname": "SaleLeasebackTransactionDeferredGainGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails", "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionDescriptionAxis": { "auth_ref": [ "r537", "r560" ], "lang": { "en-us": { "role": { "documentation": "Information pertinent to a sale and leaseback transaction, by transaction.", "label": "Sale Leaseback Transaction, Description [Axis]", "terseLabel": "Sale Leaseback Transaction, Description [Axis]" } } }, "localname": "SaleLeasebackTransactionDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionLeaseTerms": { "auth_ref": [ "r537", "r558" ], "lang": { "en-us": { "role": { "documentation": "A description of the terms of the lease(s) related to the assets being leased-back in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction, Lease Terms", "terseLabel": "Sale Leaseback Transaction, Lease Terms" } } }, "localname": "SaleLeasebackTransactionLeaseTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Sale Leaseback Transaction [Line Items]", "terseLabel": "Sale Leaseback Transaction [Line Items]" } } }, "localname": "SaleLeasebackTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The name of the significant provisions of the transaction involving the sale of property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction, Name [Domain]", "terseLabel": "Sale Leaseback Transaction, Name [Domain]" } } }, "localname": "SaleLeasebackTransactionNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleLeasebackTransactionNetProceedsInvestingActivities": { "auth_ref": [ "r538", "r539", "r540" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow after closing and debt issuance costs received by a seller-lessee in a sale-leaseback recognized in investing activities.", "label": "Sale Leaseback Transaction, Net Proceeds, Investing Activities", "terseLabel": "Sale Leaseback Transaction, Net Proceeds, Investing Activities" } } }, "localname": "SaleLeasebackTransactionNetProceedsInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionTable": { "auth_ref": [ "r534", "r537", "r560" ], "lang": { "en-us": { "role": { "documentation": "A summary of the elements of a transaction involving the entity's sale of property to another party and the lease of the property back to the entity.", "label": "Sale Leaseback Transaction [Table]", "terseLabel": "Sale Leaseback Transaction [Table]" } } }, "localname": "SaleLeasebackTransactionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SalesMember": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.", "label": "Sales [Member]", "terseLabel": "Sales [Member]" } } }, "localname": "SalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of Installment Receivables" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Expenses" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r94", "r527", "r528" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.", "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of Cash Flow, Supplemental Disclosures [Table]" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]", "terseLabel": "Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r70", "r142", "r362", "r364", "r365", "r366", "r530", "r531", "r533", "r619" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Instruments" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.", "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Derivatives Instruments Statements of Financial Position, Fair Value" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r176" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r394", "r417", "r429" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table]", "terseLabel": "Revenue from External Customers by Products and Services [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "terseLabel": "Revenue from External Customers by Products and Services [Table Text Block]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r505", "r506" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about allowance for credit loss on financing receivable.", "label": "Financing Receivable, Allowance for Credit Loss [Table]", "terseLabel": "Schedule of Financing Receivable, Allowance for Credit Losses [Table]" } } }, "localname": "ScheduleOfFinancingReceivableAllowanceForCreditLossesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFinancingReceivablesPastDueTable": { "auth_ref": [ "r266", "r278" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about aging analysis for financing receivable.", "label": "Financing Receivable, Past Due [Table]", "terseLabel": "Schedule of Financing Receivables Past Due [Table]" } } }, "localname": "ScheduleOfFinancingReceivablesPastDueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r299", "r303", "r595" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r299", "r303" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r293", "r295" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfImpairedFinancingReceivableTable": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "Schedule of the recorded investment, unpaid principal balance, associated allowance, average recorded investment, accounting policies, and interest income recognized on the accrual and cash basis for impaired financing receivables by class of financing receivable.", "label": "Schedule of Impaired Financing Receivable [Table]", "terseLabel": "Schedule of Impaired Financing Receivable [Table]" } } }, "localname": "ScheduleOfImpairedFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r307", "r309" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r30", "r54", "r55", "r56" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r476" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": { "auth_ref": [ "r61" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of noncurrent assets.", "label": "Schedule of Other Assets, Noncurrent [Table Text Block]", "terseLabel": "Schedule of Other Assets, Noncurrent" } } }, "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other current assets.", "label": "Schedule of Other Current Assets [Table Text Block]", "terseLabel": "Schedule of Other Current Assets" } } }, "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r492", "r494" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.", "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]", "terseLabel": "Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location" } } }, "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of Product Warranty Liability" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r60", "r313" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule of Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r325", "r326", "r330" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r323", "r331" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring and Related Costs" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r209", "r212", "r218", "r293" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r209", "r212", "r218", "r293" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Reporting Information, by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r395", "r420" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]", "terseLabel": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Stock Options Outstanding" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r401", "r412", "r413" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Stock Options, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]", "terseLabel": "Schedule of Unrecognized Compensation Cost, Nonvested Awards" } } }, "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r197", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r214", "r215", "r216", "r217", "r219", "r220", "r221", "r222", "r223", "r225", "r231", "r640" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails", "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails", "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r197", "r198", "r199", "r209", "r213", "r219", "r223", "r224", "r225", "r226", "r227", "r230", "r231", "r232" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Business Segments" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r117" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative expenses", "verboseLabel": "Amortization of prior service costs and unrecognized gains" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, General and Administrative Expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r133" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Provision for equity compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period", "terseLabel": "Award requisite service period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": { "auth_ref": [ "r393", "r396" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Description", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance", "periodStartLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance", "periodStartLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "The net total number of shares (or other type of equity) under an equity-based award plan, other than a stock option plan, that were granted, vested and forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)", "terseLabel": "Net award activity (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Options available for grant at end of period (in shares)", "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Options exercisable at end of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Antidilutive share granted, average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Canceled (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r403", "r420" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options outstanding at end of period (in shares)", "periodStartLabel": "Options outstanding at beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share)", "periodStartLabel": "Options outstanding at beginning of period - Weighted Average Exercise Price (in dollars per share)", "terseLabel": "Options Outstanding - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r393", "r399" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Canceled - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.", "label": "Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block]", "terseLabel": "Share-based Compensation, Performance Shares Award Unvested Activity" } } }, "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]", "terseLabel": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]", "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]", "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit", "terseLabel": "Exercise price range, lower limit (in dollars per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Options Exercisable - Number Exercisable At end of period (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "terseLabel": "Options Outstanding - Number Outstanding at end of period (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit", "terseLabel": "Exercise price range, upper limit (in dollars per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options Exercisable - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Options Outstanding - Weighted Average Remaining Contractual Life" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r549", "r556" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term Lease, Cost", "terseLabel": "Short-term Lease, Cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r2", "r197", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r214", "r215", "r216", "r217", "r219", "r220", "r221", "r222", "r223", "r225", "r231", "r293", "r316", "r324", "r333", "r640" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails", "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails", "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r38", "r39", "r40", "r138", "r139", "r167", "r171", "r172", "r174", "r176", "r184", "r185", "r186", "r252", "r361", "r520" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/DEIDocument", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r73", "r147", "r148", "r150", "r152", "r160", "r163", "r183", "r256", "r361", "r367", "r425", "r426", "r427", "r443", "r444", "r522", "r523", "r524", "r525", "r526", "r528", "r647", "r648", "r649" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r147", "r148", "r150", "r183", "r594" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r361", "r367" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r73", "r361", "r367" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "negatedTerseLabel": "Stock Issued During Period, Value, Stock Options Exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r40", "r46", "r47", "r139", "r247", "r252", "r520" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Total Shareholders\u2019 Equity", "periodStartLabel": "Total Shareholders\u2019 Equity", "totalLabel": "Total Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by business subsegments.", "label": "Subsegments [Axis]", "terseLabel": "Subsegments [Axis]" } } }, "localname": "SubsegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Subsegments [Domain]", "terseLabel": "Subsegments [Domain]" } } }, "localname": "SubsegmentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "terseLabel": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "terseLabel": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r64" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Current taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r250", "r251", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r72", "r368" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r72", "r368" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury Stock, Shares" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r72", "r368", "r369" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury Shares (4,397 and 4,184 shares at September 30, 2021 and December 31, 2020, respectively)" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r151", "r152", "r153", "r154", "r253", "r254", "r255", "r256", "r257", "r258", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r441", "r442", "r443", "r444", "r596", "r597", "r598", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "terseLabel": "Type of Arrangement and Non-arrangement Transactions [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnDerivatives": { "auth_ref": [ "r134" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.", "label": "Unrealized Gain (Loss) on Derivatives", "terseLabel": "Unrealized Gain (Loss)" } } }, "localname": "UnrealizedGainLossOnDerivatives", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebt": { "auth_ref": [ "r36", "r606", "r626" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Unsecured Debt", "terseLabel": "Unsecured Debt" } } }, "localname": "UnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebtCurrent": { "auth_ref": [ "r34", "r604", "r625" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer.", "label": "Unsecured Debt, Current", "terseLabel": "Unsecured Debt, Current" } } }, "localname": "UnsecuredDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r187", "r188", "r189", "r190", "r193", "r194", "r195" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Valuation Allowance [Line Items]", "terseLabel": "Valuation Allowance [Line Items]" } } }, "localname": "ValuationAllowanceLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceTable": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance.", "label": "Valuation Allowance [Table]", "terseLabel": "Valuation Allowance [Table]" } } }, "localname": "ValuationAllowanceTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValueAddedTaxReceivableCurrent": { "auth_ref": [ "r78" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.", "label": "Value Added Tax Receivable, Current", "terseLabel": "Tax receivables principally value added taxes" } } }, "localname": "ValueAddedTaxReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r166", "r176" ], "calculation": { "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted Average Shares\u00a0Outstanding\u2014Assuming Dilution", "totalLabel": "Average common shares assuming dilution" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r165", "r176" ], "calculation": { "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted Average Shares\u00a0Outstanding\u2014Basic", "verboseLabel": "Average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r119": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r146": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r16": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=2122178" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r164": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r182": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r196": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r232": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953550-111524" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5066-111524" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5111-111524" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953401-111524" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r249": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196854" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921830-210448" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921833-210448" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "79", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922352-210448" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "80", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922355-210448" }, "r279": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/subtopic&trid=82887181" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r284": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/subtopic&trid=82887182" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r286": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r296": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/subtopic&trid=2144439" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r319": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r334": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r343": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/subtopic&trid=2127163" }, "r344": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "450", "URI": "http://asc.fasb.org/subtopic&trid=2127197" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68070138&loc=d3e11281-110244" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12524-110249" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(4))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4875-112606" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=75028277&loc=d3e19793-108362" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r455": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r473": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5708775-113959" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1),(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r504": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121549808&loc=d3e36991-112694" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121596030&loc=d3e49567-112750" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121586228&loc=d3e50796-112755" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "50", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121602674&loc=d3e51831-112757" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121602674&loc=d3e51840-112757" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121602674&loc=d3e51843-112757" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r557": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121606570&loc=SL77919786-209982" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121606570&loc=SL77919786-209982" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121606570&loc=SL77919786-209982" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(f,g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r671": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r672": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r673": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r674": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r675": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r676": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a),(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13728-122682" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" } }, "version": "2.1" } ZIP 133 0000742112-21-000076-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000742112-21-000076-xbrl.zip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